0001628280-23-005649.txt : 20230228 0001628280-23-005649.hdr.sgml : 20230228 20230228172843 ACCESSION NUMBER: 0001628280-23-005649 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 129 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230228 DATE AS OF CHANGE: 20230228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Luminar Technologies, Inc./DE CENTRAL INDEX KEY: 0001758057 STANDARD INDUSTRIAL CLASSIFICATION: MOTOR VEHICLE PARTS & ACCESSORIES [3714] IRS NUMBER: 831804317 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38791 FILM NUMBER: 23687599 BUSINESS ADDRESS: STREET 1: 2603 DISCOVERY DRIVE, SUITE 100 CITY: ORLANDO STATE: FL ZIP: 32826 BUSINESS PHONE: 407-900-5259 MAIL ADDRESS: STREET 1: 2603 DISCOVERY DRIVE, SUITE 100 CITY: ORLANDO STATE: FL ZIP: 32826 FORMER COMPANY: FORMER CONFORMED NAME: Luminar Technologies, Inc./FL DATE OF NAME CHANGE: 20201203 FORMER COMPANY: FORMER CONFORMED NAME: Gores Metropoulos, Inc. DATE OF NAME CHANGE: 20181102 10-K 1 lazr-20221231.htm 10-K lazr-20221231
Luminar Technologies, Inc./DE00017580572022FYfalse.3333P1YP1Y.33331125252525P1Y00017580572022-01-012022-12-3100017580572022-06-30iso4217:USD0001758057us-gaap:CommonClassAMember2023-02-17xbrli:shares0001758057us-gaap:CommonClassBMember2023-02-1700017580572022-12-3100017580572021-12-310001758057srt:AffiliatedEntityMember2022-12-310001758057srt:AffiliatedEntityMember2021-12-310001758057us-gaap:PreferredStockMember2022-12-31iso4217:USDxbrli:shares0001758057us-gaap:PreferredStockMember2021-12-310001758057us-gaap:CommonClassAMember2021-12-310001758057us-gaap:CommonClassAMember2022-12-310001758057us-gaap:CommonClassBMember2021-12-310001758057us-gaap:CommonClassBMember2022-12-310001758057us-gaap:ProductMember2022-01-012022-12-310001758057us-gaap:ProductMember2021-01-012021-12-310001758057us-gaap:ProductMember2020-01-012020-12-310001758057us-gaap:ServiceMember2022-01-012022-12-310001758057us-gaap:ServiceMember2021-01-012021-12-310001758057us-gaap:ServiceMember2020-01-012020-12-3100017580572021-01-012021-12-3100017580572020-01-012020-12-310001758057lazr:SeriesAConvertiblePreferredStockMember2019-12-310001758057lazr:SeriesXConvertiblePreferredStockMember2019-12-310001758057us-gaap:PreferredStockMember2019-12-310001758057us-gaap:CommonStockMemberus-gaap:CommonClassAMember2019-12-310001758057us-gaap:CommonStockMemberus-gaap:CommonClassBMember2019-12-310001758057us-gaap:AdditionalPaidInCapitalMember2019-12-310001758057us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001758057us-gaap:TreasuryStockCommonMember2019-12-310001758057us-gaap:RetainedEarningsMember2019-12-3100017580572019-12-310001758057lazr:SeriesXConvertiblePreferredStockMember2020-01-012020-12-310001758057us-gaap:CommonStockMemberus-gaap:CommonClassAMember2020-01-012020-12-310001758057us-gaap:PreferredStockMember2020-01-012020-12-310001758057us-gaap:CommonStockMemberus-gaap:CommonClassBMember2020-01-012020-12-310001758057us-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-310001758057lazr:SeriesAConvertiblePreferredStockMember2020-01-012020-12-310001758057us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-12-310001758057us-gaap:RetainedEarningsMember2020-01-012020-12-310001758057lazr:SeriesAConvertiblePreferredStockMember2020-12-310001758057lazr:SeriesXConvertiblePreferredStockMember2020-12-310001758057us-gaap:PreferredStockMember2020-12-310001758057us-gaap:CommonStockMemberus-gaap:CommonClassAMember2020-12-310001758057us-gaap:CommonStockMemberus-gaap:CommonClassBMember2020-12-310001758057us-gaap:AdditionalPaidInCapitalMember2020-12-310001758057us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001758057us-gaap:TreasuryStockCommonMember2020-12-310001758057us-gaap:RetainedEarningsMember2020-12-3100017580572020-12-310001758057us-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-310001758057us-gaap:TreasuryStockCommonMember2021-01-012021-12-310001758057us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-01-012021-12-310001758057us-gaap:CommonStockMemberlazr:OptogrationIncMemberus-gaap:CommonClassAMember2021-01-012021-12-310001758057lazr:OptogrationIncMemberus-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-310001758057lazr:OptogrationIncMember2021-01-012021-12-310001758057us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-01-012021-12-310001758057us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-12-310001758057us-gaap:RetainedEarningsMember2021-01-012021-12-310001758057us-gaap:PreferredStockMember2021-12-310001758057us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-12-310001758057us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-12-310001758057us-gaap:AdditionalPaidInCapitalMember2021-12-310001758057us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001758057us-gaap:TreasuryStockCommonMember2021-12-310001758057us-gaap:RetainedEarningsMember2021-12-310001758057us-gaap:TreasuryStockCommonMember2022-01-012022-12-310001758057us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-01-012022-12-310001758057us-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-310001758057lazr:ECARXHoldingsIncECXMemberus-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-01-012022-12-310001758057lazr:ECARXHoldingsIncECXMemberus-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-310001758057lazr:ECARXHoldingsIncECXMember2022-01-012022-12-310001758057us-gaap:CommonStockMemberlazr:FreedomPhotonicsMemberus-gaap:CommonClassAMember2022-01-012022-12-310001758057lazr:FreedomPhotonicsMemberus-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-310001758057lazr:FreedomPhotonicsMember2022-01-012022-12-310001758057us-gaap:CommonStockMemberus-gaap:CommonClassAMemberlazr:SolficeMember2022-01-012022-12-310001758057lazr:SolficeMemberus-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-310001758057lazr:SolficeMember2022-01-012022-12-310001758057us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-12-310001758057us-gaap:RetainedEarningsMember2022-01-012022-12-310001758057us-gaap:PreferredStockMember2022-12-310001758057us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-12-310001758057us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-12-310001758057us-gaap:AdditionalPaidInCapitalMember2022-12-310001758057us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001758057us-gaap:TreasuryStockCommonMember2022-12-310001758057us-gaap:RetainedEarningsMember2022-12-310001758057lazr:FreedomPhotonicsMember2021-01-012021-12-310001758057lazr:FreedomPhotonicsMember2020-01-012020-12-310001758057lazr:SolficeMember2021-01-012021-12-310001758057lazr:SolficeMember2020-01-012020-12-310001758057lazr:SeriesXConvertiblePreferredStockMember2022-01-012022-12-310001758057lazr:SeriesXConvertiblePreferredStockMember2021-01-012021-12-310001758057us-gaap:AccountingStandardsUpdate201602Member2022-01-012022-12-310001758057us-gaap:AccountingStandardsUpdate201602Member2021-01-012021-12-310001758057us-gaap:AccountingStandardsUpdate201602Member2020-01-012020-12-310001758057us-gaap:IPOMemberlazr:GoresMetropoulosMember2019-02-05lazr:operating_segment0001758057lazr:CustomerOneMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2022-01-012022-12-31xbrli:pure0001758057us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMemberlazr:CustomerTwoMember2022-01-012022-12-310001758057us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMemberlazr:CustomerThreeMember2022-01-012022-12-310001758057lazr:CustomerOneMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2021-01-012021-12-310001758057us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMemberlazr:CustomerTwoMember2021-01-012021-12-310001758057us-gaap:OtherMachineryAndEquipmentMembersrt:MinimumMember2022-01-012022-12-310001758057us-gaap:OtherMachineryAndEquipmentMembersrt:MaximumMember2022-01-012022-12-310001758057lazr:ComputerHardwareAndSoftwareMembersrt:MinimumMember2022-01-012022-12-310001758057lazr:ComputerHardwareAndSoftwareMembersrt:MaximumMember2022-01-012022-12-310001758057srt:MinimumMemberlazr:DemonstrationFleetAndDemonstrationUnitsMember2022-01-012022-12-310001758057srt:MaximumMemberlazr:DemonstrationFleetAndDemonstrationUnitsMember2022-01-012022-12-310001758057us-gaap:VehiclesMember2022-01-012022-12-310001758057us-gaap:FurnitureAndFixturesMember2022-01-012022-12-310001758057srt:MinimumMemberlazr:ToolingMember2022-01-012022-12-310001758057srt:MaximumMemberlazr:ToolingMember2022-01-012022-12-310001758057lazr:ToolingMember2022-12-310001758057lazr:ToolingMember2021-12-310001758057srt:MinimumMember2022-01-012022-12-310001758057srt:MaximumMember2022-01-012022-12-310001758057us-gaap:IPOMemberlazr:GoresMetropoulosMember2019-02-052019-02-050001758057lazr:GoresMetropoulosMemberus-gaap:CommonClassAMemberlazr:PublicWarrantsMember2019-02-050001758057us-gaap:PrivatePlacementMemberlazr:GoresMetropoulosMemberlazr:PrivateWarrantsMember2019-02-052019-02-050001758057us-gaap:PrivatePlacementMemberlazr:GoresMetropoulosMemberlazr:PrivateWarrantsMember2019-02-050001758057lazr:GoresMetropoulosMemberlazr:PrivateWarrantsMemberus-gaap:CommonClassAMember2019-02-050001758057lazr:PublicWarrantsMember2020-12-310001758057lazr:PrivateWarrantsMember2020-12-310001758057lazr:PrivateWarrantsMember2021-03-310001758057lazr:PublicWarrantsMember2021-03-310001758057lazr:PrivateAndPublicWarrantsMember2021-03-012021-03-310001758057lazr:PublicWarrantsMember2021-03-012021-03-310001758057lazr:PrivateWarrantsMember2021-12-310001758057lazr:PublicWarrantsMember2021-12-310001758057lazr:PrivateWarrantsMember2022-01-310001758057lazr:PrivateWarrantsMember2022-04-300001758057lazr:PrivateWarrantsMember2022-01-012022-01-310001758057lazr:PrivateWarrantsMember2022-04-012022-04-300001758057lazr:PrivateWarrantsMember2022-12-310001758057lazr:FreedomPhotonicsMember2022-04-132022-04-130001758057lazr:FreedomPhotonicsMember2022-04-130001758057lazr:CustomerBacklogMembersrt:MaximumMemberlazr:FreedomPhotonicsMember2022-04-132022-04-130001758057lazr:CustomerBacklogMemberlazr:FreedomPhotonicsMember2022-04-130001758057lazr:FreedomPhotonicsMemberus-gaap:CustomerRelationshipsMember2022-04-132022-04-130001758057lazr:FreedomPhotonicsMemberus-gaap:CustomerRelationshipsMember2022-04-130001758057us-gaap:DevelopedTechnologyRightsMemberlazr:FreedomPhotonicsMember2022-04-132022-04-130001758057us-gaap:DevelopedTechnologyRightsMemberlazr:FreedomPhotonicsMember2022-04-130001758057us-gaap:InProcessResearchAndDevelopmentMemberlazr:FreedomPhotonicsMember2022-04-130001758057us-gaap:TradeNamesMemberlazr:FreedomPhotonicsMember2022-04-132022-04-130001758057us-gaap:TradeNamesMemberlazr:FreedomPhotonicsMember2022-04-130001758057us-gaap:AcquisitionRelatedCostsMember2022-01-012022-12-310001758057us-gaap:AcquisitionRelatedCostsMember2021-01-012021-12-310001758057lazr:StockBasedCompensationCostsMember2022-01-012022-12-310001758057lazr:StockBasedCompensationCostsMember2021-01-012021-12-310001758057us-gaap:AcquisitionRelatedCostsMember2021-03-310001758057lazr:SolficeMember2022-06-152022-06-150001758057lazr:OptogrationIncMember2021-08-032021-08-030001758057lazr:OptogrationMilestoneAwardsMemberus-gaap:CommonClassAMember2022-08-012022-08-310001758057lazr:OptogrationMilestoneAwardsMemberus-gaap:CommonClassAMember2022-12-310001758057lazr:OptogrationIncMember2021-08-030001758057lazr:OptogrationIncMemberus-gaap:CustomerRelationshipsMember2021-08-032021-08-030001758057lazr:OptogrationIncMemberus-gaap:CustomerRelationshipsMember2021-12-310001758057us-gaap:TradeNamesMemberlazr:OptogrationIncMember2021-08-032021-08-030001758057us-gaap:TradeNamesMemberlazr:OptogrationIncMember2021-12-310001758057lazr:OptogrationIncMemberus-gaap:DevelopedTechnologyRightsMember2021-08-032021-08-030001758057lazr:OptogrationIncMemberus-gaap:DevelopedTechnologyRightsMember2021-12-3100017580572020-12-020001758057us-gaap:CommonClassAMember2020-12-020001758057us-gaap:CommonClassBMember2020-12-020001758057us-gaap:CommonClassAMember2020-12-022020-12-020001758057lazr:GoresMetropoulosMember2020-12-022020-12-020001758057lazr:GoresMetropoulosMember2020-12-02lazr:triggeringEvent0001758057srt:MinimumMemberus-gaap:CommonClassAMember2020-12-020001758057srt:MaximumMemberus-gaap:CommonClassAMember2020-12-020001758057lazr:GoresMetropoulosMember2021-08-112021-08-110001758057lazr:GoresMetropoulosMemberus-gaap:CommonClassAMember2021-08-112021-08-110001758057lazr:GoresMetropoulosMemberus-gaap:CommonClassBMember2021-08-112021-08-110001758057lazr:GoresMetropoulosMember2021-08-110001758057lazr:GoresMetropoulosMemberlazr:SharePriceTriggeringEventOneMemberus-gaap:CommonClassAMember2021-08-110001758057lazr:GoresMetropoulosMemberlazr:SharePriceTriggeringEventTwoMemberus-gaap:CommonClassAMember2021-08-110001758057lazr:GoresMetropoulosMemberlazr:SharePriceTriggeringEventThreeMemberus-gaap:CommonClassAMember2021-08-110001758057lazr:GoresMetropoulosMemberlazr:SharePriceTriggeringEventFourMemberus-gaap:CommonClassAMember2021-08-110001758057lazr:GoresMetropoulosMemberlazr:SharePriceTriggeringEventFiveMemberus-gaap:CommonClassAMember2021-08-110001758057lazr:SharePriceTriggeringEventSixMemberlazr:GoresMetropoulosMemberus-gaap:CommonClassAMember2021-08-1100017580572020-12-022020-12-020001758057us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMember2020-12-020001758057us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedTermMember2020-12-020001758057lazr:GoresMetropoulosMemberlazr:PrivateAndPublicWarrantsMember2020-12-020001758057lazr:GoresMetropoulosMemberus-gaap:CommonStockMemberus-gaap:CommonClassAMember2020-12-022020-12-020001758057srt:NorthAmericaMember2022-01-012022-12-310001758057us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMembersrt:NorthAmericaMember2022-01-012022-12-310001758057srt:NorthAmericaMember2021-01-012021-12-310001758057us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMembersrt:NorthAmericaMember2021-01-012021-12-310001758057srt:NorthAmericaMember2020-01-012020-12-310001758057us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMembersrt:NorthAmericaMember2020-01-012020-12-310001758057srt:AsiaPacificMember2022-01-012022-12-310001758057us-gaap:GeographicConcentrationRiskMembersrt:AsiaPacificMemberus-gaap:RevenueFromContractWithCustomerMember2022-01-012022-12-310001758057srt:AsiaPacificMember2021-01-012021-12-310001758057us-gaap:GeographicConcentrationRiskMembersrt:AsiaPacificMemberus-gaap:RevenueFromContractWithCustomerMember2021-01-012021-12-310001758057srt:AsiaPacificMember2020-01-012020-12-310001758057us-gaap:GeographicConcentrationRiskMembersrt:AsiaPacificMemberus-gaap:RevenueFromContractWithCustomerMember2020-01-012020-12-310001758057lazr:EuropeAndMiddleEastMember2022-01-012022-12-310001758057us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberlazr:EuropeAndMiddleEastMember2022-01-012022-12-310001758057lazr:EuropeAndMiddleEastMember2021-01-012021-12-310001758057us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberlazr:EuropeAndMiddleEastMember2021-01-012021-12-310001758057lazr:EuropeAndMiddleEastMember2020-01-012020-12-310001758057us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberlazr:EuropeAndMiddleEastMember2020-01-012020-12-310001758057us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2022-01-012022-12-310001758057us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2021-01-012021-12-310001758057us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2020-01-012020-12-310001758057us-gaap:TransferredAtPointInTimeMember2022-01-012022-12-310001758057lazr:RevenueRecognitionTimingConcentrationRiskMemberus-gaap:TransferredAtPointInTimeMemberus-gaap:RevenueFromContractWithCustomerMember2022-01-012022-12-310001758057us-gaap:TransferredAtPointInTimeMember2021-01-012021-12-310001758057lazr:RevenueRecognitionTimingConcentrationRiskMemberus-gaap:TransferredAtPointInTimeMemberus-gaap:RevenueFromContractWithCustomerMember2021-01-012021-12-310001758057us-gaap:TransferredAtPointInTimeMember2020-01-012020-12-310001758057lazr:RevenueRecognitionTimingConcentrationRiskMemberus-gaap:TransferredAtPointInTimeMemberus-gaap:RevenueFromContractWithCustomerMember2020-01-012020-12-310001758057us-gaap:TransferredOverTimeMember2022-01-012022-12-310001758057lazr:RevenueRecognitionTimingConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:TransferredOverTimeMember2022-01-012022-12-310001758057us-gaap:TransferredOverTimeMember2021-01-012021-12-310001758057lazr:RevenueRecognitionTimingConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:TransferredOverTimeMember2021-01-012021-12-310001758057us-gaap:TransferredOverTimeMember2020-01-012020-12-310001758057lazr:RevenueRecognitionTimingConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:TransferredOverTimeMember2020-01-012020-12-310001758057lazr:RevenueRecognitionTimingConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2022-01-012022-12-310001758057lazr:RevenueRecognitionTimingConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2021-01-012021-12-310001758057lazr:RevenueRecognitionTimingConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2020-01-012020-12-310001758057lazr:AutonomySolutionsSegmentMember2022-01-012022-12-310001758057lazr:AutonomySolutionsSegmentMemberlazr:SegmentConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2022-01-012022-12-310001758057lazr:AutonomySolutionsSegmentMember2021-01-012021-12-310001758057lazr:AutonomySolutionsSegmentMemberlazr:SegmentConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2021-01-012021-12-310001758057lazr:AutonomySolutionsSegmentMember2020-01-012020-12-310001758057lazr:AutonomySolutionsSegmentMemberlazr:SegmentConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2020-01-012020-12-310001758057lazr:AdvancedTechnologiesAndServicesSegmentMember2022-01-012022-12-310001758057lazr:SegmentConcentrationRiskMemberlazr:AdvancedTechnologiesAndServicesSegmentMemberus-gaap:RevenueFromContractWithCustomerMember2022-01-012022-12-310001758057lazr:AdvancedTechnologiesAndServicesSegmentMember2021-01-012021-12-310001758057lazr:SegmentConcentrationRiskMemberlazr:AdvancedTechnologiesAndServicesSegmentMemberus-gaap:RevenueFromContractWithCustomerMember2021-01-012021-12-310001758057lazr:AdvancedTechnologiesAndServicesSegmentMember2020-01-012020-12-310001758057lazr:SegmentConcentrationRiskMemberlazr:AdvancedTechnologiesAndServicesSegmentMemberus-gaap:RevenueFromContractWithCustomerMember2020-01-012020-12-310001758057lazr:SegmentConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2022-01-012022-12-310001758057lazr:SegmentConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2021-01-012021-12-310001758057lazr:SegmentConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2020-01-012020-12-310001758057lazr:VolvoCarTechnologyFundWarrantMemberus-gaap:CommonClassAMember2020-03-310001758057lazr:VolvoCarTechnologyFundWarrantMember2020-03-31lazr:tranche0001758057lazr:VolvoCarTechnologyFundWarrantMember2021-01-012021-12-3100017580572023-01-012022-12-310001758057us-gaap:USTreasurySecuritiesMember2022-12-310001758057us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember2022-12-310001758057us-gaap:CommercialPaperMember2022-12-310001758057us-gaap:CorporateBondSecuritiesMember2022-12-310001758057us-gaap:AssetBackedSecuritiesMember2022-12-310001758057lazr:MarketableSecuritiesMember2022-12-310001758057us-gaap:USTreasurySecuritiesMember2021-12-310001758057us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember2021-12-310001758057us-gaap:CommercialPaperMember2021-12-310001758057us-gaap:CorporateBondSecuritiesMember2021-12-310001758057us-gaap:AssetBackedSecuritiesMember2021-12-310001758057us-gaap:CashAndCashEquivalentsMember2021-12-310001758057lazr:MarketableSecuritiesMember2021-12-310001758057us-gaap:MoneyMarketFundsMemberus-gaap:CashAndCashEquivalentsMember2022-12-310001758057us-gaap:MoneyMarketFundsMemberus-gaap:CashAndCashEquivalentsMember2021-12-310001758057lazr:MarketableSecuritiesMemberus-gaap:EquityMethodInvestmentsMember2022-12-310001758057lazr:MarketableSecuritiesMemberus-gaap:EquityMethodInvestmentsMember2021-12-310001758057lazr:NonMarketableEquityInvestmentMemberus-gaap:OtherNoncurrentAssetsMember2022-12-310001758057lazr:NonMarketableEquityInvestmentMemberus-gaap:OtherNoncurrentAssetsMember2021-12-310001758057lazr:RoboticResearchOpCoLLCMemberlazr:ClassAPreferredUnitsMember2021-12-012021-12-310001758057lazr:RoboticResearchOpCoLLCMemberus-gaap:CommonClassAMember2021-12-012021-12-310001758057lazr:RoboticResearchOpCoLLCMember2021-12-310001758057lazr:RoboticResearchOpCoLLCMember2022-10-012022-12-310001758057lazr:ClassAPreferredUnitsMemberlazr:ECARXHoldingsIncMember2022-12-012022-12-310001758057lazr:ECARXHoldingsIncMemberus-gaap:CommonClassAMember2022-12-012022-12-310001758057lazr:ECARXHoldingsIncMember2022-12-310001758057us-gaap:MachineryAndEquipmentMember2022-12-310001758057us-gaap:MachineryAndEquipmentMember2021-12-310001758057lazr:ComputerHardwareAndSoftwareMember2022-12-310001758057lazr:ComputerHardwareAndSoftwareMember2021-12-310001758057us-gaap:LandMember2022-12-310001758057us-gaap:LandMember2021-12-310001758057us-gaap:LeaseholdImprovementsMember2022-12-310001758057us-gaap:LeaseholdImprovementsMember2021-12-310001758057us-gaap:VehiclesMember2022-12-310001758057us-gaap:VehiclesMember2021-12-310001758057us-gaap:FurnitureAndFixturesMember2022-12-310001758057us-gaap:FurnitureAndFixturesMember2021-12-310001758057us-gaap:ConstructionInProgressMember2022-12-310001758057us-gaap:ConstructionInProgressMember2021-12-3100017580572022-01-012022-03-310001758057lazr:OptogrationIncMemberus-gaap:CustomerRelationshipsMember2022-12-310001758057lazr:OptogrationIncMemberus-gaap:CustomerRelationshipsMember2022-01-012022-12-310001758057lazr:OptogrationIncMemberus-gaap:CustomerRelationshipsMember2021-01-012021-12-310001758057lazr:CustomerBacklogMemberlazr:OptogrationIncMember2022-12-310001758057lazr:CustomerBacklogMemberlazr:OptogrationIncMember2022-01-012022-12-310001758057lazr:CustomerBacklogMemberlazr:OptogrationIncMember2021-12-310001758057us-gaap:TradeNamesMemberlazr:OptogrationIncMember2022-12-310001758057us-gaap:TradeNamesMemberlazr:OptogrationIncMember2022-01-012022-12-310001758057lazr:AssembledWorkforceMemberlazr:OptogrationIncMember2022-12-310001758057lazr:AssembledWorkforceMemberlazr:OptogrationIncMember2021-12-310001758057lazr:OptogrationIncMemberus-gaap:DevelopedTechnologyRightsMember2022-12-310001758057lazr:OptogrationIncMemberus-gaap:DevelopedTechnologyRightsMember2022-01-012022-12-310001758057lazr:OptogrationIncMemberus-gaap:DevelopedTechnologyRightsMember2021-01-012021-12-310001758057us-gaap:InProcessResearchAndDevelopmentMemberlazr:OptogrationIncMember2022-12-310001758057us-gaap:InProcessResearchAndDevelopmentMemberlazr:OptogrationIncMember2021-12-310001758057lazr:OptogrationIncMember2022-12-310001758057lazr:OptogrationIncMember2022-01-012022-12-310001758057lazr:OptogrationIncMember2021-12-310001758057lazr:OptogrationIncMember2020-01-012020-12-310001758057lazr:AutonomySolutionsSegmentMember2021-12-310001758057lazr:AdvancedTechnologiesAndServicesSegmentMember2021-12-310001758057lazr:AutonomySolutionsSegmentMemberlazr:FreedomPhotonicsMember2022-01-012022-12-310001758057lazr:AdvancedTechnologiesAndServicesSegmentMemberlazr:FreedomPhotonicsMember2022-01-012022-12-310001758057lazr:AutonomySolutionsSegmentMember2022-12-310001758057lazr:AdvancedTechnologiesAndServicesSegmentMember2022-12-310001758057us-gaap:ConvertibleDebtMemberlazr:ConvertibleSeniorNotesDue2026Member2021-12-310001758057us-gaap:ConvertibleDebtMemberlazr:ConvertibleSeniorNotesDue2026Member2021-12-012021-12-310001758057us-gaap:ConvertibleDebtMemberlazr:ConvertibleSeniorNotesDue2026Member2021-01-012021-12-310001758057us-gaap:ConvertibleDebtMemberlazr:ConvertibleSeniorNotesDue2026Memberus-gaap:CommonClassAMember2021-12-310001758057us-gaap:ConvertibleDebtMemberus-gaap:DebtInstrumentRedemptionPeriodOneMemberlazr:ConvertibleSeniorNotesDue2026Memberus-gaap:CommonClassAMember2021-12-012021-12-310001758057us-gaap:ConvertibleDebtMemberus-gaap:DebtInstrumentRedemptionPeriodOneMemberlazr:ConvertibleSeniorNotesDue2026Member2021-12-012021-12-31lazr:trading_daylazr:consecutive_trading_day0001758057us-gaap:ConvertibleDebtMemberus-gaap:DebtInstrumentRedemptionPeriodTwoMemberlazr:ConvertibleSeniorNotesDue2026Member2021-12-012021-12-310001758057us-gaap:ConvertibleDebtMemberlazr:ConvertibleSeniorNotesDue2026Memberus-gaap:DebtInstrumentRedemptionPeriodThreeMember2021-12-012021-12-31lazr:consecutive_business_day0001758057us-gaap:ConvertibleDebtMemberlazr:ConvertibleSeniorNotesDue2026Member2022-12-310001758057us-gaap:ConvertibleDebtMemberlazr:ConvertibleSeniorNotesDue2026Member2022-01-012022-12-310001758057us-gaap:SeniorNotesMember2020-01-012020-12-310001758057lazr:A20172018And2020WarrantsMember2020-01-012020-12-310001758057lazr:A20172018And2020WarrantsMember2020-12-310001758057us-gaap:FairValueInputsLevel3Memberlazr:PrivateWarrantsMemberus-gaap:MeasurementInputExpectedTermMember2022-12-310001758057us-gaap:FairValueInputsLevel3Memberlazr:PrivateWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2022-12-310001758057us-gaap:FairValueInputsLevel3Memberlazr:PrivateWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2022-12-310001758057lazr:PrivateWarrantsMemberus-gaap:WarrantMember2021-12-310001758057lazr:PrivateWarrantsMemberus-gaap:WarrantMember2022-01-012022-12-310001758057lazr:PrivateWarrantsMemberus-gaap:WarrantMember2022-12-310001758057us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2022-12-310001758057us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Member2022-12-310001758057us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2022-12-310001758057us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2022-12-310001758057us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001758057us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-12-310001758057us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001758057us-gaap:FairValueMeasurementsRecurringMember2022-12-310001758057us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001758057us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-12-310001758057us-gaap:FairValueInputsLevel3Memberus-gaap:USTreasurySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001758057us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001758057us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001758057us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-12-310001758057us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001758057us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001758057us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001758057us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-12-310001758057us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001758057us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001758057us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2022-12-310001758057us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel2Member2022-12-310001758057us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2022-12-310001758057us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2022-12-310001758057us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2022-12-310001758057us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:AssetBackedSecuritiesMember2022-12-310001758057us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2022-12-310001758057us-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2022-12-310001758057lazr:PrivateWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001758057lazr:PrivateWarrantsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-12-310001758057us-gaap:FairValueInputsLevel3Memberlazr:PrivateWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001758057lazr:PrivateWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001758057us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2021-12-310001758057us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Member2021-12-310001758057us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2021-12-310001758057us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2021-12-310001758057us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMember2021-12-310001758057us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel2Member2021-12-310001758057us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMember2021-12-310001758057us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMember2021-12-310001758057us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001758057us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-12-310001758057us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001758057us-gaap:FairValueMeasurementsRecurringMember2021-12-310001758057us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001758057us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-12-310001758057us-gaap:FairValueInputsLevel3Memberus-gaap:USTreasurySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001758057us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001758057us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001758057us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-12-310001758057us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001758057us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001758057us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001758057us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-12-310001758057us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001758057us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001758057us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2021-12-310001758057us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel2Member2021-12-310001758057us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2021-12-310001758057us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2021-12-310001758057us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2021-12-310001758057us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:AssetBackedSecuritiesMember2021-12-310001758057us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2021-12-310001758057us-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2021-12-310001758057lazr:PrivateWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001758057lazr:PrivateWarrantsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-12-310001758057us-gaap:FairValueInputsLevel3Memberlazr:PrivateWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001758057lazr:PrivateWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001758057us-gaap:FairValueInputsLevel2Member2022-12-310001758057us-gaap:FairValueInputsLevel2Member2021-12-310001758057lazr:SeriesAConvertiblePreferredStockMember2019-06-240001758057lazr:SeriesXConvertiblePreferredStockMember2020-08-012020-09-300001758057lazr:SeriesXConvertiblePreferredStockMember2020-09-300001758057lazr:SeriesXConvertiblePreferredStockMember2020-10-012020-10-310001758057lazr:SeriesXConvertiblePreferredStockMember2020-10-310001758057lazr:SeriesAAndSeriesXConvertiblePreferredStockMember2020-12-022020-12-0200017580572019-06-242020-12-020001758057us-gaap:WarrantMember2022-01-012022-12-310001758057us-gaap:WarrantMember2021-01-012021-12-310001758057us-gaap:WarrantMember2020-01-012020-12-310001758057lazr:ShareBasedPaymentArrangementEquityClassifiedAwardsMember2022-01-012022-12-310001758057lazr:ShareBasedPaymentArrangementEquityClassifiedAwardsMember2021-01-012021-12-310001758057lazr:ShareBasedPaymentArrangementEquityClassifiedAwardsMember2020-01-012020-12-310001758057lazr:ShareBasedPaymentArrangementLiabilityClassifiedAwardsMember2022-01-012022-12-310001758057lazr:ShareBasedPaymentArrangementLiabilityClassifiedAwardsMember2021-01-012021-12-310001758057lazr:ShareBasedPaymentArrangementLiabilityClassifiedAwardsMember2020-01-012020-12-310001758057lazr:VendorStockInLieuOfCashProgramMember2022-01-012022-12-310001758057lazr:VendorStockInLieuOfCashProgramMember2021-01-012021-12-310001758057lazr:VendorStockInLieuOfCashProgramMember2020-01-012020-12-310001758057us-gaap:ConvertibleDebtSecuritiesMember2022-01-012022-12-310001758057us-gaap:ConvertibleDebtSecuritiesMember2021-01-012021-12-310001758057us-gaap:ConvertibleDebtSecuritiesMember2020-01-012020-12-310001758057lazr:EarnOutSharesMember2022-01-012022-12-310001758057lazr:EarnOutSharesMember2021-01-012021-12-310001758057lazr:EarnOutSharesMember2020-01-012020-12-310001758057us-gaap:ConvertibleDebtSecuritiesMember2022-12-31lazr:vote0001758057us-gaap:CommonClassAMember2021-01-012021-12-310001758057us-gaap:CommonClassBMember2021-01-012021-12-310001758057us-gaap:CommonStockMember2021-07-010001758057us-gaap:CommonStockMember2021-12-210001758057lazr:GoresMetropoulosMembersrt:ChiefExecutiveOfficerMemberus-gaap:PreferredStockMember2020-12-022020-12-020001758057lazr:GoresMetropoulosMemberus-gaap:CommonStockMembersrt:ChiefExecutiveOfficerMemberus-gaap:CommonClassAMember2020-12-022020-12-020001758057lazr:GoresMetropoulosMembersrt:ChiefExecutiveOfficerMemberus-gaap:CommonClassAMember2020-12-020001758057lazr:GoresMetropoulosMemberus-gaap:CommonClassBMembersrt:ChiefExecutiveOfficerMember2020-12-020001758057lazr:GoresMetropoulosMembersrt:ChiefExecutiveOfficerMember2020-12-022020-12-020001758057us-gaap:CommonClassAMember2021-10-012021-12-310001758057us-gaap:CommonClassAMember2022-01-012022-03-310001758057us-gaap:CommonClassAMember2022-04-012022-06-300001758057us-gaap:PreferredStockMember2015-12-310001758057us-gaap:CommonClassAMemberlazr:DaimlerNorthAmericaCorporationMember2021-11-012021-11-300001758057us-gaap:ResearchAndDevelopmentExpenseMemberlazr:DaimlerNorthAmericaCorporationMember2022-01-012022-12-310001758057us-gaap:CommonClassAMemberlazr:DaimlerNorthAmericaCorporationMember2022-01-012022-12-310001758057lazr:DaimlerNorthAmericaCorporationMember2022-12-310001758057lazr:VendorStockInLieuOfCashProgramMember2021-12-310001758057lazr:VendorStockInLieuOfCashProgramMember2022-12-310001758057lazr:A2020PlanMember2022-12-310001758057lazr:Amended2020PlanMember2022-06-012022-06-300001758057us-gaap:SubsequentEventMemberus-gaap:CommonClassAMemberlazr:Amended2020PlanMember2023-01-012023-01-010001758057lazr:A2015PlanMemberus-gaap:EmployeeStockOptionMember2022-01-012022-12-310001758057lazr:A2015PlanMemberus-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2022-01-012022-12-310001758057us-gaap:ShareBasedCompensationAwardTrancheTwoMemberlazr:A2015PlanMemberus-gaap:EmployeeStockOptionMember2022-01-012022-12-310001758057lazr:A2015PlanMemberus-gaap:EmployeeStockOptionMember2021-01-012021-12-310001758057us-gaap:EmployeeStockOptionMember2022-01-012022-12-310001758057us-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2019-01-012019-06-300001758057us-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2019-01-012019-06-300001758057us-gaap:ShareBasedCompensationAwardTrancheTwoMemberus-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2019-01-012019-06-300001758057us-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2019-07-012022-12-310001758057us-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2021-12-310001758057us-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2022-01-012022-12-310001758057us-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2022-12-310001758057us-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2021-01-012021-12-310001758057us-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2020-01-012020-12-310001758057srt:MaximumMemberus-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-310001758057us-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2021-12-310001758057us-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2022-01-012022-12-310001758057us-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2022-12-310001758057us-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2021-01-012021-12-310001758057lazr:A2020PlanMemberlazr:FixedValueEquityAwardsMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2022-01-012022-12-310001758057us-gaap:EmployeeStockMember2020-12-310001758057us-gaap:CommonClassAMemberus-gaap:EmployeeStockMember2020-12-012020-12-310001758057us-gaap:EmployeeStockMember2020-12-012020-12-310001758057us-gaap:EmployeeStockMember2022-01-012022-12-310001758057us-gaap:EmployeeStockMember2022-05-162022-05-160001758057us-gaap:EmployeeStockMember2022-11-162022-11-160001758057lazr:OptogrationMilestoneAwardsMember2021-08-032021-08-030001758057lazr:OptogrationMilestoneAwardsMember2021-08-012022-12-310001758057lazr:FreedomPhotonicsAwardsMember2022-04-012022-04-300001758057lazr:FreedomPhotonicsAwardsMember2022-01-012022-12-310001758057lazr:SolficeAwardsMember2022-06-012022-06-300001758057lazr:SolficeAwardsMember2022-01-012022-12-310001758057srt:ChiefExecutiveOfficerMemberus-gaap:RestrictedStockUnitsRSUMember2022-05-022022-05-020001758057srt:ChiefExecutiveOfficerMemberus-gaap:RestrictedStockUnitsRSUMember2022-08-192022-08-190001758057lazr:ChiefLegalOfficerMemberus-gaap:RestrictedStockUnitsRSUMember2022-08-192022-08-190001758057srt:ExecutiveOfficerMemberus-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-310001758057srt:ExecutiveOfficerMemberlazr:MarketOneMemberMemberus-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-310001758057srt:ExecutiveOfficerMemberus-gaap:RestrictedStockUnitsRSUMemberlazr:MarketTwoMemberMember2022-01-012022-12-310001758057srt:ExecutiveOfficerMemberlazr:MarketThreeMemberMemberus-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-310001758057srt:ExecutiveOfficerMemberus-gaap:RestrictedStockUnitsRSUMember2022-12-310001758057us-gaap:EmployeeStockOptionMember2022-01-012022-12-310001758057us-gaap:EmployeeStockOptionMember2021-01-012021-12-310001758057us-gaap:EmployeeStockOptionMember2020-01-012020-12-310001758057lazr:RestrictedStockAwardsMember2022-01-012022-12-310001758057lazr:RestrictedStockAwardsMember2021-01-012021-12-310001758057lazr:RestrictedStockAwardsMember2020-01-012020-12-310001758057us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-310001758057us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-12-310001758057us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-12-310001758057us-gaap:EmployeeStockMember2022-01-012022-12-310001758057us-gaap:EmployeeStockMember2021-01-012021-12-310001758057us-gaap:EmployeeStockMember2020-01-012020-12-310001758057lazr:FixedValueEquityAwardsMember2022-01-012022-12-310001758057lazr:FixedValueEquityAwardsMember2021-01-012021-12-310001758057lazr:FixedValueEquityAwardsMember2020-01-012020-12-310001758057lazr:OptogrationAwardsMember2022-01-012022-12-310001758057lazr:OptogrationAwardsMember2021-01-012021-12-310001758057lazr:OptogrationAwardsMember2020-01-012020-12-310001758057lazr:FreedomPhotonicsAwardsMember2022-01-012022-12-310001758057lazr:FreedomPhotonicsAwardsMember2021-01-012021-12-310001758057lazr:FreedomPhotonicsAwardsMember2020-01-012020-12-310001758057lazr:SolficeAwardsMember2022-01-012022-12-310001758057lazr:SolficeAwardsMember2021-01-012021-12-310001758057lazr:SolficeAwardsMember2020-01-012020-12-310001758057lazr:OtherAwardsMember2022-01-012022-12-310001758057lazr:OtherAwardsMember2021-01-012021-12-310001758057lazr:OtherAwardsMember2020-01-012020-12-310001758057us-gaap:CostOfSalesMember2022-01-012022-12-310001758057us-gaap:CostOfSalesMember2021-01-012021-12-310001758057us-gaap:CostOfSalesMember2020-01-012020-12-310001758057us-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-12-310001758057us-gaap:ResearchAndDevelopmentExpenseMember2021-01-012021-12-310001758057us-gaap:ResearchAndDevelopmentExpenseMember2020-01-012020-12-310001758057us-gaap:SellingAndMarketingExpenseMember2022-01-012022-12-310001758057us-gaap:SellingAndMarketingExpenseMember2021-01-012021-12-310001758057us-gaap:SellingAndMarketingExpenseMember2020-01-012020-12-310001758057us-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-12-310001758057us-gaap:GeneralAndAdministrativeExpenseMember2021-01-012021-12-310001758057us-gaap:GeneralAndAdministrativeExpenseMember2020-01-012020-12-310001758057us-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2022-01-012022-12-310001758057us-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2021-01-012021-06-300001758057lazr:A2020PlanMemberlazr:FixedValueEquityAwardsMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2022-01-012022-12-310001758057lazr:A2020PlanMemberlazr:FixedValueEquityAwardsMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2022-01-012022-12-310001758057lazr:A2020PlanMemberlazr:FixedValueEquityAwardsMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2022-01-012022-12-310001758057lazr:A2020PlanMemberlazr:FixedValueEquityAwardsMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberlazr:ShareBasedPaymentArrangementTrancheFourMember2022-01-012022-12-3100017580572021-10-3100017580572022-09-30lazr:renewal_option0001758057srt:MinimumMember2022-12-310001758057srt:MaximumMember2022-12-310001758057us-gaap:AccountingStandardsUpdate201602Member2021-01-010001758057us-gaap:DomesticCountryMember2022-12-310001758057us-gaap:StateAndLocalJurisdictionMember2022-12-310001758057us-gaap:DomesticCountryMemberus-gaap:ResearchMember2022-12-310001758057us-gaap:ResearchMemberus-gaap:StateAndLocalJurisdictionMember2022-12-310001758057us-gaap:DomesticCountryMember2022-01-012022-12-310001758057us-gaap:ForeignCountryMember2022-01-012022-12-310001758057us-gaap:DomesticCountryMember2022-01-010001758057us-gaap:ForeignCountryMember2022-01-0100017580572022-01-010001758057lazr:AutonomySolutionsSegmentMemberus-gaap:IntersegmentEliminationMember2022-01-012022-12-310001758057lazr:AdvancedTechnologiesAndServicesSegmentMemberus-gaap:IntersegmentEliminationMember2022-01-012022-12-310001758057us-gaap:IntersegmentEliminationMember2022-01-012022-12-310001758057lazr:AutonomySolutionsSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-12-310001758057us-gaap:OperatingSegmentsMemberlazr:AdvancedTechnologiesAndServicesSegmentMember2022-01-012022-12-310001758057us-gaap:OperatingSegmentsMember2022-01-012022-12-310001758057lazr:AutonomySolutionsSegmentMemberus-gaap:OperatingSegmentsMember2022-12-310001758057us-gaap:OperatingSegmentsMemberlazr:AdvancedTechnologiesAndServicesSegmentMember2022-12-310001758057us-gaap:OperatingSegmentsMember2022-12-310001758057us-gaap:IntersegmentEliminationMember2022-12-310001758057lazr:AutonomySolutionsSegmentMemberus-gaap:IntersegmentEliminationMember2021-01-012021-12-310001758057lazr:AdvancedTechnologiesAndServicesSegmentMemberus-gaap:IntersegmentEliminationMember2021-01-012021-12-310001758057us-gaap:IntersegmentEliminationMember2021-01-012021-12-310001758057lazr:AutonomySolutionsSegmentMemberus-gaap:OperatingSegmentsMember2021-01-012021-12-310001758057us-gaap:OperatingSegmentsMemberlazr:AdvancedTechnologiesAndServicesSegmentMember2021-01-012021-12-310001758057us-gaap:OperatingSegmentsMember2021-01-012021-12-310001758057lazr:AutonomySolutionsSegmentMemberus-gaap:OperatingSegmentsMember2021-12-310001758057us-gaap:OperatingSegmentsMemberlazr:AdvancedTechnologiesAndServicesSegmentMember2021-12-310001758057us-gaap:OperatingSegmentsMember2021-12-310001758057us-gaap:IntersegmentEliminationMember2021-12-310001758057lazr:AutonomySolutionsSegmentMemberus-gaap:IntersegmentEliminationMember2020-01-012020-12-310001758057lazr:AdvancedTechnologiesAndServicesSegmentMemberus-gaap:IntersegmentEliminationMember2020-01-012020-12-310001758057us-gaap:IntersegmentEliminationMember2020-01-012020-12-310001758057lazr:AutonomySolutionsSegmentMemberus-gaap:OperatingSegmentsMember2020-01-012020-12-310001758057us-gaap:OperatingSegmentsMemberlazr:AdvancedTechnologiesAndServicesSegmentMember2020-01-012020-12-310001758057us-gaap:OperatingSegmentsMember2020-01-012020-12-310001758057lazr:AutonomySolutionsSegmentMemberus-gaap:OperatingSegmentsMember2020-12-310001758057us-gaap:OperatingSegmentsMemberlazr:AdvancedTechnologiesAndServicesSegmentMember2020-12-310001758057us-gaap:OperatingSegmentsMember2020-12-310001758057us-gaap:IntersegmentEliminationMember2020-12-310001758057lazr:CustomerOneMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2022-01-012022-12-310001758057us-gaap:CustomerConcentrationRiskMemberlazr:CustomerTwoMemberus-gaap:RevenueFromContractWithCustomerMember2022-01-012022-12-310001758057lazr:CustomerOneMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2021-01-012021-12-310001758057us-gaap:CustomerConcentrationRiskMemberlazr:CustomerTwoMemberus-gaap:RevenueFromContractWithCustomerMember2021-01-012021-12-310001758057lazr:CustomerOneMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2020-01-012020-12-310001758057lazr:MrHengMember2021-02-280001758057lazr:MrHengMember2021-01-012021-12-310001758057lazr:MrHengMember2021-12-310001758057lazr:MrAlecGoresMember2022-12-310001758057lazr:SeagateMemberus-gaap:SubsequentEventMember2023-01-012023-01-310001758057lazr:SwissReMemberus-gaap:SubsequentEventMember2023-02-012023-02-28

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
(Mark One)
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2022
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number 001-38791
LUMINAR TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
Delaware83-1804317
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
2603 Discovery DriveSuite 100OrlandoFlorida32826
(Address of Principal Executive Offices)(Zip Code)
(407) 900-5259
Registrant's telephone number, including area code
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which registered
Class A common stock, par value of $0.0001 per shareLAZRThe Nasdaq Stock Market LLC
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes No
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.   Yes     No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filerAccelerated filer
Non-accelerated filerSmaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes     No ☒
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. □
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). □
The aggregate market value of the voting stock held by non-affiliates of the registrant was approximately $1.5 billion as of June 30, 2022 (the last business day of the registrant’s most recently completed second fiscal quarter) based upon the closing sale price on The Nasdaq Stock Market reported for such date. Shares of Common Stock held by each officer and director and by each person who may be deemed to be an affiliate have been excluded. This determination of affiliate status is not necessarily a conclusive determination for other purposes.
As of February 17, 2023, the registrant had 272,176,538 shares of Class A common stock, par value $0.0001 per share and 97,088,670 shares of Class B common stock, par value $0.0001 per share, outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
Part III incorporates by reference certain information from the registrant’s definitive proxy statement (the “Proxy Statement”) relating to its 2023 Annual Meeting of Stockholders. The Proxy Statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.


TABLE OF CONTENTS
Page



CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS
This Annual Report on Form 10-K (this “Form 10-K”) includes forward-looking statements in addition to historical information. These forward-looking statements are included throughout this Form 10-K, including in the sections entitled “Business,” “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and in other sections of this Form 10-K and include statements regarding product plans, future growth, sales estimates/Order Book numbers, market opportunities, strategic initiatives, industry positioning, customer acquisition and retention, revenue growth and anticipated impacts on our business of the ongoing COVID-19 pandemic and related public health measures. In some cases, you can identify these statements by forward-looking words such as “outlook,” “believes,” “expects,” “future,” “potential,” “continues,” “may,” “will,” “should,” “could,” “seeks,” “approximately,” “predicts,” “intends,” “plans,” “estimates,” “anticipates” or the negative version of these words or other comparable words or phrases, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements, which are subject to risks, uncertainties and assumptions about us, may include projections of our future financial performance, our anticipated growth strategies and anticipated trends in our business.
These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements, including, our history of losses and our expectation that we will continue to incur significant expenses, including substantial R&D costs, and continuing losses for the foreseeable future as well as our limited operating history which makes it difficult to evaluate our future prospects and the risks and challenges we may encounter; our strategic initiatives which may prove more costly than we currently anticipate and potential failure to increase our revenue to offset these initiatives; whether our lidar products are selected for inclusion in autonomous driving or ADAS systems by automotive OEMs or their suppliers, and whether we will be de-selected by any customers; the lengthy period of time from a major commercial win to implementation and the risks of cancellation or postponement of the contract or unsuccessful implementation; potential inaccuracies in our forward looking estimates of certain metrics, including Order Book, our future cost of goods sold (COGS) and bill of materials (BOM) and total addressable market; the discontinuation, lack of success of our customers in developing and commercializing products using our solutions or loss of business with respect to a particular vehicle model or technology package and whether end automotive consumers will demand and be willing to pay for such features; our inability to reduce and control the cost of the inputs on which we rely, which could negatively impact the adoption of our products and our profitability; the effect of continued pricing pressures, competition from other lidar manufacturers, automotive original equipment manufacturers (“OEMs”) cost reduction initiatives and the ability of automotive OEMs to re-source or cancel vehicle or technology programs which may result in lower than anticipated margins, or losses, which may adversely affect our business; general economic uncertainty and the effect of general economic conditions on our industry in particular, including the level of demand and financial performance of the autonomous vehicle industry and market adoption of lidar as well as developments in alternative technology and the increasingly competitive environment in which we operate, which includes established competitors and market participants that have substantially greater resources; our ability to achieve technological feasibility and commercialize our software products and the requirement to continue to develop new products and product innovations due to rapidly changing markets and government regulations of such technologies; our ability to manage our growth and expand our business operations effectively, including into international markets, such as China, which exposes us to operational, financial and regulatory risks; adverse impacts due to limited availability and quality of materials, supplies, and capital equipment, or dependency on third-party service providers and single-source suppliers; the project-based nature of our orders, which can cause our results of operations to fluctuate on a quarterly and annual basis; whether we will be able to successfully transition our engineering designs into high volume manufacturing, including our ability to transition to an outsourced manufacturing business model and whether we and our outsourcing partners and suppliers can successfully operate complex machinery; whether we can successfully select, execute or integrate our acquisitions; whether the complexity of our products results in undetected defects and reliability issues which could reduce market adoption of our new products, limit our ability to manufacture, damage our reputation and expose us to product liability, warranty and other claims; our ability to maintain and adequately manage our inventory; our ability to remediate the material weakness in our internal controls over financial reporting; our ability to protect and enforce our intellectual property rights; availability of qualified personnel, loss of highly skilled personnel and dependence on Austin Russell, our Founder, President and Chief Executive Officer; the impact of inflation and our stock price on our ability to hire and retain highly skilled personnel; the amount and timing of future sales and whether the average selling prices of our products could decrease rapidly over the life of the product as well as our dependence on a few key customers, who are often large corporations with substantial negotiating power; our ability to establish and maintain confidence in our long-term business prospects among customers and analysts and within our industry; whether we are subject to negative publicity; the effects of the ongoing coronavirus (COVID-19) pandemic or other infectious diseases, health epidemics, pandemics and natural disasters on Luminar’s business; interruption or failure of our information technology and communications systems; cybersecurity risks to our operational systems, security systems, infrastructure, integrated software in our lidar solutions; market instability


exacerbated by geopolitical conflicts, including Russia and China and including the effect of sanctions and trade restrictions that may affect supply chain or sales opportunities; and those other factors discussed in the section entitled “Risk Factors” in this Form 10-K. You should specifically consider the numerous risks outlined in the section of this Form 10-K entitled “Risk Factors.” Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements. Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. We undertake no obligation to update any forward-looking statements made in this Form 10-K to reflect events or circumstances after the date of this Form 10-K or to reflect new information or the occurrence of unanticipated events, except as required by law.
In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this Annual Report on Form 10-K, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely upon these statements.


PART I
ITEM 1. BUSINESS.
Overview
Luminar is a global automotive technology company ushering in a new era of vehicle safety and autonomy. Over the past decade, Luminar has been building from the chip-level up, our light detection and ranging sensor, or lidar, which is expected to meet the demanding performance, safety, reliability and cost requirements to enable next generation safety and autonomous capabilities for passenger and commercial vehicles as well as other adjacent markets.
The global mobility and e-mobility sector is increasingly focused on safety and autonomy, specifically next generation advanced driver assistance systems, or ADAS, and highway autonomy for passenger and commercial vehicles. Our products provide increased situational awareness in a broad range of driving environments through improved and higher confidence detection and planning at all vehicle speeds. Our portfolio encompasses sensor hardware and in-development perception and decision-making software as well as a high definition “3D” mapping engine that improve existing vehicle safety features and enable new levels of vehicle automation for passenger, commercial and other applications.
Our Markets
The Society of Automotive Engineers (“SAE”) defines levels of automation as follows, which SAE updates from time to time:
Level 0—No Driving Automation: In this level, the human is fully responsible for all dynamic driving tasks (“DDT”) at all times, even if an active safety system assists in the task. “L0” is defined as driver support features that are limited to warnings or momentary emergency intervention. Examples of warnings include blind spot warning or lane departure warnings. Examples of features with momentary assistance include automated emergency braking (“AEB”) and lane keep assist (“LKA”).
Level 1—Driver Assistance: In this level, while the human is fully responsible for all DDT at all times, an active safety system may assist by executing either the longitudinal or the lateral vehicle motion control subtask, and disengages immediately upon driver request. Examples include lane centering support (“LCS”) or the more widely adopted adaptive cruise control (“ACC”). These features are viewed as comfort features, easing the driving load from the driver during extended highway drives.
Level 2—Partial Driving Automation: In this level, the human is fully responsible for all DDT at all times, even if an active safety system assists in the task.
The term L2+ is often used for today’s higher capability systems, many of which add a driver monitoring system, such as camera or steering wheel sensing to ensure the human driver remains engaged, but require the driver remain attentive at all times.
Level 3—Conditional Driving Automation: In this level, the automated driving system (“ADS”) performs the entire DDT while engaged. The driver is responsible to verify the operational readiness of the ADS, determine whether to engage the system, and becomes the fallback-ready user when the ADS is engaged. The ADS permits engagement and operation only within its operational design domains (“ODD”).
Level 4—High Driving Automation: In this level, the ADS performs the entire DDT while engaged. The driver is responsible to verify the operational readiness of the ADS, determine whether to engage the system, and becomes a passenger when the ADS is engaged (when physically present in the vehicle). The ADS permits engagement and operation only within its ODD.
Level 5—Full Driving Automation: In this level, the ADS performs the entire DDT while engaged. It is the designation for vehicles that when placed in automated driving mode, can drive everywhere and in all conditions without human intervention or even occupants.
We believe the market is currently segmented in two distinct categories: (1) ADAS (L0 / L1 / L2) and (2) autonomous driving (L3 / L4 / L5). Within these two segments, we believe the largest near-term business opportunities exist for technologies that enhance, not replace, the driver in ADAS and highway autonomy applications (L3). We believe our products meaningfully improve ADAS functionality and are also key enablers for highway autonomy.


ADAS and Proactive SafetyTM
ADAS standards are primarily driven by both the European and North American markets. The European New Car Assessment Program (“NCAP”), a voluntary vehicle safety performance assessment program which uses a 5-star safety rating system, requires a minimum level of crash mitigation functionality such as automated emergency braking (“AEB”) (for vehicles, pedestrians, and cyclists), lane keep assist (“LKA”), speed alert systems and other ADAS features for a vehicle to have a 5-star rating. Furthermore, we believe the European Union may be moving toward mandates of these advanced functions.
The U.S. is less focused on mandates at this time and instead allows the U.S. New Car Assessment Program (known as the “Stars on Cars” program) and designations such as the Insurance Institute for Highway Safety “Top Safety Pick” and “Top Safety Pick+” to drive adoption and provide consumers with an understanding of the vehicle’s advanced crash avoidance capability. Through 2022, working with the National Highway Traffic Safety Administration (“NHTSA”), 20 automakers have made progress towards equipping most new passenger vehicles with a low-speed AEB system that includes forward-collision warning.
With global safety rating programs and the OEMs competing to deliver more safety and comfort features to their customers, it is reasonable to expect near complete adoption of ADAS functionalities in new vehicles produced by Europe, U.S., Japan, and South Korea by 2026. We expect adoption rates to increase significantly in China as well.
According to NHTSA, the number of automotive fatalities globally still exceeds one million annually and the social costs of accidents continue to exceed $500 billion in the United States alone. While the increased application of existing ADAS technology should help reduce the number of accidents and fatalities, we believe there is significant room for improvement in these technologies. In particular, we believe there is a significant opportunity to reduce collisions with a capable lidar sensing system that increases the quality and reliability of the perception data collected by vehicles and enables improved ADAS functionality in a wider range of environmental conditions and higher speeds. We have been developing a turn-key ADAS system known as Proactive SafetyTM that leverages our core sensor and software technologies. Intended functionality for Proactive SafetyTM currently under development includes Automatic Emergency Braking, Automatic Emergency Steering, and Adaptive Cruise Control, which are expected to represent a new generation of vehicle safety, meant to enable accident avoidance instead of merely mitigating crash severity.
Highway Autonomy
Our focus since inception has been to enable ubiquitous safety and autonomy and we view highway autonomy, in combination with Proactive SafetyTM, as providing the most value to the end consumer for the foreseeable future. The market appears to be trending in this direction, targeting hands-off and eyes-off operations in a more controlled setting than the urban environment. While there has historically been a significant focus on investment and development of robo-taxi solutions, we believe the passenger vehicles and commercial vehicle sectors will be the greatest source of demand for our products over the next several years.
Passenger Vehicle Market
The passenger vehicle market is very large. We expect that approximately 100 million new passenger and commercial vehicles will be manufactured annually, on average, this decade. In order to realize a vehicle feature’s maximum societal benefits, the ultimate goal in the automotive industry is to achieve widespread adoption of next-gen safety and highway autonomous features in all vehicles. We expect a technology adoption ramp-up over time as automated functionality matures, costs and pricing are reduced, and consumers become more familiar with the full benefits and capabilities of a safe autonomy system. We believe there is a substantial market opportunity for our products once development of Proactive SafetyTM is complete and coupled with autonomy due to the public benefit of the overall anticipated safety increase.
Commercial Trucking Market
The amount of goods transported by trucking globally continues to rise year-over-year. The application of ADAS technology continues to grow and the interest in autonomy for commercial transport is at an all-time high. The business case for trucking highway autonomy includes: lower operating costs, increased utilization of the vehicles and more time spent on the road.
Robo-Taxi Market
The robo-taxi industry continues to develop through investment and partnerships by leading technology companies and mainstays from the automotive industry. Although the timeline for widespread deployment of robo taxies continues to be pushed out due to the complexity of the technical requirements, as well as the need for regional and federal governmental support, funding for infrastructure, and a sensing and compute solution that must anticipate every possible mixed-traffic scenario, the robo-taxi market remains an important market for lidar both for near-term validation and for long-term demand.
2

Adjacent Markets
Adjacent markets such as last mile delivery, aerospace and defense, robotics and security offer use cases for which our technology is well suited. Our goal is to scale our core markets and utilize our robust solutions to best serve these adjacent markets where it makes sense for us and our partners.
Our Products
Our Iris and other products are described in further detail below:
Hardware
Iris: Iris lidar combines laser transmitter and receiver and provides long-range, 1550 nm sensory meeting OEM specs for advanced safety and autonomy. This technology provides efficient automotive-grade, and affordable solutions that are scalable, reliable, and optional for series production. Iris lidar sensors are dynamically configurable dual-axis scan sensors that detect objects up to 600 meters away over a horizontal field of view of 120° and a software configurable vertical field of view of up to 30°, providing high point densities in excess of 200 points per square degree enable long-range detection, tracking, and classification over the whole field of view. Iris is refined to meet the size, weight, cost, power, and reliability requirements of automotive qualified series production sensors. Iris features our vertically integrated receiver, detector, and laser solutions developed by our Advanced Technologies & Services segment companies - Freedom Photonics, Black Forest Engineering, and Optogration. The internal development of these key technologies gives us a significant advantage in the development of our product roadmap.
Software
Software presently under development includes the following:
Core Sensor Software: Our lidar sensors are configurable and capture valuable information extracted from the raw point-cloud to promote the development and performance of perception software. Our core sensor software features are being designed to help our commercial partners to operate and integrate our lidar sensors and control, and enrich the sensor data stream before perception processing.
Perception Software: Our perception software is in design to transform lidar point-cloud data into actionable information about the environment surrounding the vehicle. This information includes classifying static objects such as lane markings, road surface, curbs, signs and buildings as well as other vehicles, pedestrians, cyclists and animals. Through internal development as well as the recent acquisition of certain assets of Solfice (aka Civil Maps), we expect to be able to utilize our point-cloud data to achieve precise vehicle localization and to create and provide continuous updates to a high definition map of a vehicle’s environment.
Sentinel: Sentinel is our full-stack software platform for safety and autonomy that will enable Proactive SafetyTM and highway autonomy for cars and commercial trucks.
Our software products are in designing and coding phase of the development and had not yet achieved technological feasibility as at end of 2022.
Competition
The market for lidar-enabled vehicle features, on and off road, is an emerging one with many potential applications in the development stage. As a result, we face competition for lidar hardware business from a range of companies seeking to have their products incorporated into these applications. We believe we hold a strong position based on both hardware product performance and maturity, and our growing ability to develop deeply integrated software capabilities needed to provide autonomous and safety solutions to our customers.
Within the automotive autonomy software space, the competitive landscape is still nascent and primarily focused on developing robo-taxi technologies as opposed to autonomous software solutions for passenger vehicles. Other autonomous software providers include: in-house OEM software teams; automotive silicon providers; large technology companies and newer technology companies focused on autonomous software. We partner with several of these autonomous software providers to provide our lidar and other products.
Beyond automotive, the adjacent markets, including delivery bots and mapping, among others, are highly competitive. There are entrenched incumbents and competitors, including from China, particularly around ultra-low cost products that are widely available.
3

Intellectual Property
Our success and competitive advantage depend in part upon our ability to develop and protect our core technology and intellectual property. We own a portfolio of intellectual property, including patents and registered trademarks, confidential technical information, and expertise in the development of lidar technology and software for autonomous vehicles.
We have filed patent and trademark applications in order to further secure these rights and strengthen our ability to defend against third parties who may infringe on our rights. Additionally, we protect our proprietary rights through agreements with our commercial partners, supply-chain vendors, employees, and consultants, as well as close monitoring of the developments and products in the industry.
As of January 2023, we had 135 issued patents (130 U.S. and 5 international), 125 pending applications (61 U.S. and 64 international), of which one U.S. application has been allowed. In addition, we have three registered U.S. trademarks, 22 registered foreign trademarks and 70 pending trademark applications.
Manufacturing Process
We build and design certain critical components in-house, including our receiver ASIC and InGaAs photodiode. We have an internal advanced manufacturing line located in Orlando, Florida, where we develop the manufacturing and testing processes, including capturing any related intellectual property necessary to develop our products. Our manufacturing processes and knowledge are a key differentiator for us in the market.
Extended component lead times and bottlenecks in the supply chain have created supply challenges for the entire market in the past and may continue through 2023 or beyond.
In May 2021, we announced our series manufacturing partnerships with Celestica and Fabrinet. We are in process of installing our high-volume series production facility in Mexico, which will be operated by Celestica. We expect to start production at the high-volume facility in the second half of 2023. In the meantime, we are currently producing our Iris sensors at an existing facility owned and operated by Celestica.
Research and Development
Our research and development activities occur in various locations in the United States, Germany and India.
Our research and development team is responsible for creating new technologies and expanding lidar and perception and mapping software functionality. The team is responsible for ensuring our lidar is designed for manufacturability and testability. The team partners with our operations and supply chain functions to develop scalable commercial and reliable manufacturing processes and direct production material procurement.
Sales and Marketing
We use customer feedback to specifically tailor our product and approach to build and expand our relationships with potential commercial partners. In parallel, marketing and communications drive our brand equity and narrative through ongoing announcements, campaigns, events, speaking opportunities, and public relations efforts.
The automotive value chain characteristically involves research and feasibility studies, followed by long-term product development cycles, including testing and qualification with the automakers which can last for several years. In general, automaker agreements do not guarantee potential volumes, which vehicle models will incorporate supplier components, or timing of purchases to their suppliers during this product development cycle. Instead, typically, after initial research and feasibility agreements and extensive competitive negotiations, automakers enter into development agreements that establish collaborations or partnerships to develop and integrate technology into the automaker’s vehicles or platforms intended for series production, frequently accompanied by non-recurring engineering (“NRE”) projects. While these collaboration or partnership agreements provide automakers the right to terminate the relationship without purchasing any production volume, factors such as difficulty of integrating complex technologies, sunken costs relating to NRE projects, impact on product roadmap, time to market, and risk of being unable to secure future supply may deter automakers to cancel collaboration or development agreements. Automakers typically only enter into blanket purchase orders or other definitive supply agreements with binding commitments several months before production is expected to begin. We identify major commercial wins only when we have entered into a collaboration, development, partnership or other similar agreement and have reason to believe that such engagement is expected to result in future series production. Given the customary business practices in the automotive industry, there remains potential risk that our major commercial wins may not ultimately generate any significant revenue (See Item 1A, Risk Factors for definition of major commercial win and further discussion of risk).
4

Government Regulation
Automotive safety regulation in the area of autonomy is split between two categories: (1) SAE Level 0-2 (including active safety, driver assist, and conditional autonomy); and (2) SAE Level 3-5 (partial through full autonomy) (commonly referred to as “higher autonomy”). In general, throughout the world, there is a positive legal environment that encourages consumer sale and use of SAE Level 0-2 functionality. The legal environment for SAE Level 3-5 functionality varies, generally encouraging the safe testing and development of higher autonomy functions, but restricting consumer use in personal vehicles and commercial use, as in automated trucking and taxis in many regions.
In the U.S., at both the federal and state level, nearly all SAE Level 0-2 functionality is permitted, while SAE Level 3-5 enjoys a positive environment for on-road testing and development, but mixed opportunities to deploy in consumer and commercial use. Federal regulation does not prohibit higher levels of autonomy today, but if National Highway Traffic Safety Administration deems an autonomy system unsafe, it would order a recall to remove vehicles from the road. Thus far, several U.S. states have expressly permitted SAE Level 4-5 levels of autonomy, while many remain silent, and others have laws that limit driverless operation. We believe regulations related to automotive autonomy technologies will continue to evolve to remove hurdles as state and federal regulators gain more experience with the technology.
In Europe, China, and the rest of the world, most automotive safety is regulated by a common system under the United Nations Economic Commission for Europe (UN/ECE). Under current UN/ECE standards, SAE Level 0-2 functionality may be deployed with certain restrictions such as road type and with driver monitoring, but higher SAE Level 3-5 functionality is limited to testing only. Safety regulators continue to work on standards for autonomy, but we expect this development process to be slower than in the U.S. However, China has increasingly departed from the common UN/ECE standards and is more likely to create its own regulation allowing higher levels of autonomy in the nearer term with a timeline more aligned with the U.S.
Given the intense work in these regulatory areas, there is a positive environment for deploying our lidar technology and Proactive SafetyTM today in SAE Level 0-2 systems. While there is risk that SAE Level 3-5 systems may be delayed by regulation in some countries, we expect a workable path forward over the next several years as a more permissive regulatory and political environment develops.
Employees
As of December 31, 2022, excluding contractors, we had almost 600 full-time employees primarily in the United States and Germany. None of our employees are represented by a labor union.
Our human capital resources objectives include, as applicable, identifying, recruiting, retaining, incentivizing and integrating our existing and new employees, advisors and consultants. The principal purposes of our equity and cash incentive plans are to attract, retain and reward personnel through the granting of stock-based and cash-based compensation awards, in order to increase stockholder value and the success of our company by motivating such individuals to perform to the best of their abilities and achieve our objectives.
Corporate Social Responsibilities and Sustainability
We are committed to active and responsible corporate citizenship. Our Corporate Social Responsibility (“CSR”) program is divided into seven elements (diversity and inclusion; human resources; finance/accounting; responsible sourcing; environmental, health and safety; trade compliance; and business ethics), each spearheaded by company leaders and subject matter experts in their respective areas. We expect ADAS and automated driving technologies to provide strong social benefits including reducing roadway injuries and fatalities, including in urban areas, making roadways more efficient by reducing commuting times and CO2 emissions, and offering improved productivity.
Available Information
Our Annual Report on Form 10-K reports, along with all other reports and amendments filed with or furnished to the SEC, are publicly available free of charge on the Investors section of our website at www.luminartech.com or at www.sec.gov as soon as reasonably practicable after these materials are filed with or furnished to the SEC. We also use our website as a tool to disclose important information about the company and comply with our disclosure obligations under Regulation Fair Disclosure. Our governance guidelines, code of conduct and Board committee charters are also posted on the Investors section of our website. The information on our website (or any webpages referenced in this Annual Report on Form 10-K) is not part of this or any other report we file with, or furnish to, the SEC.
5

ITEM 1A. RISK FACTORS.
Risk Factor Summary
Investing in our securities involves a high degree of risk. You should carefully consider all information in this Annual Report on Form 10-K, including our consolidated financial statements and related notes appearing elsewhere in this Form 10-K and Item 7. Management’s Discussion and Analysis of Financial Condition and results of operations,” before purchasing our securities. These risks are discussed more fully in the section titled “Risk Factors.” These risks and uncertainties include, but are not limited to, the following:
our history of losses and our expectation that we will continue to incur significant expenses, including substantial R&D costs, and continuing losses for the foreseeable future as well as our limited operating history which makes it difficult to evaluate our future prospects and the risks and challenges we may encounter;
our strategic initiatives which may prove more costly than we currently anticipate and potential failure to increase our revenue to offset these initiatives;
whether our lidar products are selected for inclusion in autonomous driving or ADAS systems by automotive OEMs or their suppliers, and whether we will be de-selected by any customers, and end customer adoption rates and demand for our products;
the lengthy period of time from a major commercial win to implementation and the risks of cancellation or postponement of the contract or unsuccessful implementation;
potential inaccuracies in our forward looking metrics and estimates, including our “Order Book,” and our future cost of goods sold (COGS) and bill of materials (BOM) and total addressable market;
the discontinuation, lack of success of our customers in developing and commercializing products using our solutions or loss of business with respect to a particular vehicle model or technology package and whether end automotive consumers will demand and be willing to pay for such features;
our inability to reduce and control the cost of the inputs on which we rely, which could negatively impact the adoption of our products and our profitability;
the effect of continued pricing pressures, competition from other lidar manufacturers, automotive original equipment manufacturers (“OEMs”) cost reduction initiatives and the ability of automotive OEMs to re-source or cancel vehicle or technology programs which may result in lower than anticipated margins, or losses, which may adversely affect our business;
general economic uncertainty and the effect of general economic conditions on our industry in particular, including the level of demand and financial performance of the autonomous vehicle industry and lidar industry;
specific economic and market uncertainty regarding the autonomous vehicle industry and lidar industry as a result of competitor failures, mergers, and delays;
market adoption of lidar as well as developments in alternative technology and the increasingly competitive environment in which we operate, which includes established competitors and market participants that have substantially greater resources;
our ability to achieve technological feasibility and commercialize our software products and the requirement to continue to develop new products and product innovations due to rapidly changing markets and government regulations of such technologies;
our ability to manage our growth and expand our business operations effectively, including into international markets, such as China, which exposes us to operational, financial and regulatory risks;
our sales have been primarily to customers making purchases for R&D projects and project-based orders which may cause potentially significant fluctuations in our quarterly and annual results of operations;
adverse impacts due to limited availability and quality of materials, supplies, and capital equipment, or dependency on third-party service providers and single source suppliers;
whether we will be able to successfully transition our engineering designs into high volume manufacturing, including our ability to transition to an outsourced manufacturing business model and whether we and our outsourcing partners and suppliers can successfully operate complex machinery;
our ability to establish and maintain confidence in our long-term business prospects among customers and analysts and within our industry and whether we are subject to negative publicity;
whether we can successfully select, execute or integrate our acquisitions;
whether the complexity of our products results in undetected defects and reliability issues which could reduce market adoption of our products, limit our ability to manufacture, damage our reputation and expose us to product liability, warranty and other claims;
our ability to maintain and adequately manage our inventory;
our ability to maintain an effective system of internal control over financial reporting;
our ability to protect and enforce our intellectual property rights;
availability of qualified personnel, loss of highly skilled personnel and dependence on Austin Russell, our Founder, President and Chief Executive Officer;
6

the impact of inflation and our stock price on our ability to hire and retain highly skilled personnel;
the amount and timing of future sales and whether the average selling prices of our products could decrease rapidly over the life of the product as well as our dependence on a few key customers, who are often large corporations with substantial negotiating power;
the effects of the ongoing coronavirus (COVID-19) pandemic or other infectious diseases, health epidemics, pandemics and natural disasters on Luminar’s business;
interruption or failure of our information technology and communications systems and cybersecurity risks to our operational systems, security systems, infrastructure, integrated software in our lidar solutions;
strict government regulation that is subject to amendment, repeal or new interpretation and our ability to comply with modified or new laws and regulations applying to our business;
market instability exacerbated by geopolitical conflicts, including Russia and China, and including the effect of sanctions and trade restrictions that may affect supply chain or sales opportunities;
whether the concentration of our stock ownership and voting power limits the ability of our stockholders to influence corporate matters; and
risks related to our indebtedness.
7

Risk Factors
Risks Related to Our Business and Industry
We are an early stage company with a history of losses, and we expect to incur significant expenses and continuing losses for the foreseeable future.
We have incurred net losses on an annual basis since our inception. We incurred net losses of $445.9 million, $238.0 million and $362.3 million for the years ended December 31, 2022, 2021 and 2020, respectively. We believe that we will continue to incur operating and net losses each quarter until at least the time we begin commercial deliveries of our lidar-based products, which are not expected to begin until late 2023 and may occur later or not at all as we face challenges setting up outsourced manufacturing. Even if we successfully develop and sell our lidar and software solutions, there can be no assurance that they will be commercially successful. Our potential profitability is dependent upon the successful development and successful commercial introduction and acceptance of our lidar solutions, which may not occur.
We expect the rate at which we will incur losses to be remain high in future periods as we:
expand our software development;
continue to utilize our third-party partners for design, testing and commercialization;
expand our production capabilities to produce our lidar solutions, including costs associated with outsourcing the production of our lidar solutions;
expand our design, development, installation and servicing capabilities to address production of more products for more customers in more countries;
build up inventories of parts and components for our lidar solutions;
produce an inventory of our lidar solutions; and
increase our sales and marketing activities and develop our distribution infrastructure.
Because we will incur the costs and expenses from these efforts before we receive incremental revenues with respect thereto, our losses in future periods will be significant. In addition, we may find that these efforts are more expensive than we currently anticipate or that these efforts may not result in revenues, which would further increase our losses.
Our limited operating history makes it difficult to evaluate our future prospects and the risks and challenges we may encounter.
We have been focused on developing lidar products for autonomous driving systems and driver assistance systems since 2012. This relatively limited operating history makes it difficult to evaluate our future prospects and the risks and challenges we may encounter. Risks and challenges we have faced or expect to face include our ability to:
produce and deliver lidar and software products of acceptable performance, volume, cost, and quality;
forecast our revenue and budget for and manage our expenses;
attract new customers and retain existing customers in the automotive supply chain where sourcing and volume production targets are not guaranteed;
comply with existing and new or modified laws and regulations applicable to our business;
plan for and manage capital expenditures for our current and future products, and manage our supply chain and supplier relationships related to our current and future products;
anticipate and respond to macroeconomic changes and changes in the markets in which we operate;
maintain and enhance the value of our reputation and brand;
effectively manage our growth and business operations, including the impacts of the COVID-19 pandemic on our business;
develop and protect intellectual property;
hire, integrate and retain talented people at all levels of its organization; and
successfully develop new solutions to enhance the experience of customers and consumers.
If we fail to address the risks and difficulties that we face, including those associated with the challenges listed above as well as those described elsewhere in this “Risk Factors” section, our business, financial condition and results of operations
8

could be adversely affected. Further, because we have limited historical financial data and operate in a rapidly evolving market, any predictions about our future revenue and expenses may not be as accurate as they would be if we had a longer operating history or operated in a more predictable market. We have encountered in the past, and will encounter in the future, risks and uncertainties frequently experienced by growing companies with limited operating histories in rapidly changing industries. If our assumptions regarding these risks and uncertainties, which we use to plan and operate our business, are incorrect or change, or if we do not address these risks successfully, our results of operations could differ materially from our expectations and our business, financial condition and results of operations could be adversely affected.
We continue to implement strategic initiatives designed to grow our business. These initiatives may prove more costly than we currently anticipate and we may not succeed in increasing our revenue in an amount sufficient to offset the costs of these initiatives and to achieve and maintain profitability.
We continue to make investments and implement initiatives designed to grow our business, including:
investing in R&D;
expanding our sales and marketing efforts to attract new customers;
investing in new applications and markets for our products;
investing in our manufacturing processes and partnerships to scale production;
protecting our intellectual property; and
investing in legal, accounting, human resources, and other administrative functions necessary to support our operations as a public company.
These initiatives may prove more expensive than we currently anticipate, and we may not succeed in increasing our revenue, if at all, in an amount sufficient to offset these higher expenses and to achieve and maintain profitability. The market opportunities we are pursuing are at an early stage of development, and it may be many years before the end markets we expect to serve generate demand for our products at scale. Our revenue may be adversely affected for a number of reasons, including:
the development and/or market acceptance of new technology that competes with our lidar products;
if certain automotive OEMs or other market participants change their autonomous vehicle and driver assistance technologies;
failure of our customers to commercialize autonomous systems that include our solutions;
our ability to create, validate, and manufacture at high volume, and ship product to customers;
our inability to effectively manage our inventory or manufacture products at scale, our inability to enter new markets or help our customers adapt our products for new applications; or
our failure to attract new customers or expand orders from existing customers or increasing competition.
Furthermore, it is difficult to predict the size and growth rate of our target markets, customer demand for our products, commercialization timelines, developments in autonomous sensing and related technology, the entry of competitive products, or the success of existing competitive products and services. For these reasons, we do not expect to achieve profitability over the near term. If our revenue does not grow over the long term, our ability to achieve and maintain profitability may be adversely affected, and the value of our business may significantly decrease.
If our lidar products are not selected for inclusion in autonomous driving systems or ADAS by automotive OEMs or their suppliers, our business will be materially and adversely affected.
Automotive OEMs and their suppliers design and develop autonomous driving and ADAS technology over several years. These automotive OEMs and suppliers undertake extensive testing or qualification processes prior to placing orders for large quantities of products such as our lidar products, because such products will function as part of a larger system or platform and must meet certain other specifications. We spend significant time and resources to have our products selected by automotive OEMs and their suppliers. We define the term “major win” or “major commercial win” to have occurred when (a) we have obtained a written agreement (e.g. non-binding expression of interest arrangement or an agreement for non-recurring engineering project) or public announcement with a major industry player, and (b) based on past experience in high volume production, leadership in autonomy, or market leadership of said major industry player, we expect to ultimately be awarded a significant commercial program, including OEM series production programs. If we do not achieve a major commercial win with respect to a particular vehicle model, we may not have an opportunity to supply our products to the automotive OEM for that vehicle model for a period of many years. In many cases, this period can be as long as seven or more years. If our products are not selected by an automotive OEM or its suppliers for one vehicle model or if our products are not successful in that
9

vehicle model, it is unlikely that our product will be deployed in other vehicle models of that OEM. If we fail to win a significant number of vehicle models from one or more of automotive OEMs or their suppliers, our business, results of operations and financial condition will be materially and adversely affected. For more information about certain risks related to product selection, see the Risk Factor captioned “The period of time from a major commercial win to implementation is long and we are subject to risks of cancellation or postponement of the contract or unsuccessful implementation.”
The period of time from a major commercial win to implementation is long and we are subject to risks of cancellation or postponement of the contract or unsuccessful implementation.
Prospective customers, including those in the automotive industry, generally must make significant commitments of resources to test and validate our products and confirm that they can integrate with other technologies before including them in any particular system, product or model. While certain customers have executed a non-binding expression of interest arrangement or engaged us for non-recurring engineering projects while they are evaluating our products, none of our customers make contractual commitments to use our lidar sensors or software until all test and validation activities have been completed, they have finalized plans for integrating our systems, have a positive expectation of the market demand for our features, and unrelated to us, have determined that vehicle is ready for market and there is appropriate consumer demand. We expect that only after this point will our customers consider entering into definitive volume production agreements.
Through the end of 2022, none of our customers have completed their on-going testing and validation or have entered into definitive volume production agreements with us and there is no assurance or guarantee that any of our customers, including any for which we have announced a “major win” or “major commercial win” will ever complete such testing and validation or enter into a definitive volume production agreement with us or that we will receive any revenues forecasted in connection with such “major win” or “major commercial win”.
The development cycles of our products with new customers varies widely depending on the application, market, customer and the complexity of the product. In the automotive market, for example, this development cycle can be as long as seven or more years. The development cycle in certain other markets can be several months to a few years. These development cycles result in us investing our resources prior to realizing any revenue from the commercialization or obtaining any firm commitments of pricing, volume or timing of purchases of our products by our customers. Further, we are subject to the risk that customers cancel or postpone implementation of our technology, as well as that we will not be able to integrate our technology successfully into a larger system with other sensing modalities. Additionally, our revenue could be materially less than forecasted estimates if the system, product or vehicle model that includes our lidar products is unsuccessful, including for reasons unrelated to our technology. Long development cycles and product cancellations or postponements may adversely affect our business, results of operations and financial condition. Thus, even if we have been successful in obtaining major commercial wins, long development cycles and product cancellations or postponements and failures to successfully integrate our technology may materially and adversely affect our business, results of operations and financial condition.
Our forward looking estimates of certain financial metrics may prove inaccurate.
We use various estimates in formulating our business plans. We base our estimates upon a number of assumptions that are inherently subject to significant business and economic uncertainties and contingencies, many of which are beyond our control. These estimates include our assessment of whether a “major win” or “major commercial win” has occurred. Our estimates therefore may prove inaccurate, causing the actual amount to differ from our estimates. The factors which may cause actual amounts to differ from our estimates include, without limitation:
the extent to which customers who have selected Luminar for a major commercial win include our hardware and software products into their systems, products or vehicle models;
the extent to which Luminar meets contractual terms and conditions;
the extent to which our technology is successfully integrated into our customers’ vehicles;
the timing of when our customers adopt our technology into their vehicles on a commercial basis which could be delayed for regulatory, safety or reliability issues unrelated to our technology;
undetected or unknown errors, defects or reliability issues in our hardware or software which could reduce the market adoption of our products or delay or stop production;
loss of business with respect to, or the failure or lack of commercial success of, a vehicle model for which we are a significant supplier for reasons unrelated to our technology; For more information about certain risks related to discontinuation or loss of business, see the risk factor captioned “The discontinuation or lack of commercial success of, or loss of business with respect to, a particular vehicle model or technology package for which we are a significant supplier could reduce our sales and adversely affect our profitability;”
10

a decline, for any reason, in the production levels of our customers, particularly with respect to models which incorporate our technology;
customer cancellations of their contracts;
the extent to which end customers select our products when purchasing a vehicle option package from vehicle manufacturers; and
other risk factors set forth in this Annual Report.
Specifically, we use “Order Book” as a metric to measure performance against anticipated achievement of planned key milestones of our business. Order Book is defined as the forward-looking cumulative billings estimate of Luminar’s hardware and software products over the lifetime of given vehicle production programs which Luminar’s technology is expected to be integrated into or provided for, based primarily on projected / actual contractual pricing terms and our good faith estimates of “take rate” of Luminar’s technology on vehicles. “Take rates” are the anticipated percentage of new vehicles to be equipped with Luminar’s technology based on a combination of original equipment manufacturer (“OEM”) product offering decisions and predicted end consumer purchasing decisions. We include programs in our Order Book when (a) we have obtained a written agreement (e.g., non-binding expression of interest arrangement or an agreement for non-recurring engineering project) or public announcement with a major industry player, and (b) we expect to ultimately be awarded a significant commercial program.
We believe Order Book provides useful information to investors as a supplemental performance metric as our products are currently in a pre-production stage and therefore there are currently no billings or revenues from commercial grade product sales. OEMs customarily place non-cancelable purchase orders with their automotive component suppliers only shortly before or during production. Consequently, we use Order Book to inform investors about the progress of expected adoption of our technologies by OEMs because there is, in our view, no other better metric available at our stage.
The Order Book estimate may be impacted by various factors as described in this Annual Report, including, but not limited to the following:
None of our customers make contractual commitments to use our lidar sensors and software until all test and validation activities have been completed, they have finalized plans for integrating our systems, have a positive expectation of the market demand for our features, and unrelated to us, have determined that their vehicle is ready for market and there is appropriate consumer demand. Consequently, there is no assurance or guarantee that any of our customers, including any programs which we included in our Order Book estimates will ever complete such testing and validation or enter into a definitive volume production agreement with us or that we will receive any billings or revenues forecasted in connection with such programs.
The development cycles of our products with new customers vary widely depending on the application, market, customer, and the complexity of the product. In the automotive market, for example, this development cycle can be as long as seven or more years. Variability in development cycles make it difficult to reliably estimate the pricing, volume or timing of purchases of our products by our customers.
Customers cancel or postpone implementation of our technology.
We may not be able to integrate our technology successfully into a larger system with other sensing modalities.
The product or vehicle model that is expected to include our lidar products may be unsuccessful, including for reasons unrelated to our technology.
These risks and uncertainties may cause our future actual sales to be materially different than that implied by the Order Book metric.
The discontinuation or lack of commercial success of, or loss of business with respect to, a particular vehicle model or technology package for which we are a significant supplier and the absence of demand from end automotive consumers for our features, could reduce our sales and adversely affect our profitability.
If we are able to secure major commercial wins and our solutions are included in these autonomous driving and ADAS products, we expect to enter into supply agreements with the relevant customer. Market practice dictates that these supply agreements typically require us to supply a customer’s requirements for a particular vehicle model or autonomous driving or ADAS product, rather than supply a set number of products. These requirement contracts can have short terms and/or can be subject to renegotiation, sometimes as frequently as annually, all of which may affect product pricing, and may be terminated by our customers at any time. Moreover, end automotive consumers must demand and be willing to pay for our features. Therefore, even if we are successful in obtaining major commercial wins and the systems into which our products are built are commercialized, the discontinuation of, the loss of business with respect to, or a lack of commercial success of a particular vehicle model or technology package for which we are a significant supplier, and the absence of demand from end automotive
11

consumers for our features, could mean that the expected sales of our products will not materialize which would materially and adversely affect our business.
Information concerning our future cost of goods sold (COGS) and bill of materials (BOM) estimates may prove inaccurate.
We periodically provide estimates of future cost of goods sold and bill of materials, which by necessity, are projections based on anticipated rates of future production of our customers and the timing of related expenditures, and there are uncertainties inherent in the creation and interpretation of such data.
Pricing negotiated in our supply agreements for key components like the receiver, ASIC and laser are dependent on volume estimates which may not be realized. Most of our components are manufactured using technologies that are highly complex and consequently, estimates of BOM and cost of goods sold may fluctuate due to many variable factors and assumptions, including but not limited to the following:
meeting certain volume estimates;
our reliance on key inputs and our ability to reduce and control the cost of such inputs. For more information about certain risks related to our reliance on key inputs and our inability to reduce and control the costs of such inputs, see the risk factor captioned “We are reliant on key inputs and our ability to reduce and control the cost of such inputs could negatively impact the adoption of our products and our profitability;
the risk of shortages and long lead times in the supply of key components and the risk that our suppliers discontinue or modify components used in its products. For more information about certain risks related to reliance on third party suppliers, see the risk factor captioned “We rely on third-party suppliers and because some of the raw materials and key components in our products come from limited or single source suppliers, we are susceptible to supply shortages, long lead times for components, and supply changes, any of which could disrupt our supply chain and could delay deliveries of our products to customers;”
consistency and adequate quality and quantity of piece parts, other raw materials and other bill of materials items;
contract negotiations and the execution of firm supply agreements;
future versions of our product design incorporating new components meeting our customers’ requirements and specifications. For more information about certain risks related to product selection, see the risk factor captioned “The period of time from a major commercial win to implementation is long and we are subject to risks of cancellation or postponement of the contract or unsuccessful implementation;”
the qualification of new versions of our key components. For more information about certain risks related to qualification, see the risk factor captioned “If our lidar products are not selected for inclusion in autonomous driving systems or ADAS by automotive OEMs or their suppliers, our business will be materially and adversely affected;”
defects in production processes (including system assembly) either within our facilities or at our suppliers;
any transitions or changes in our production process, planned or unplanned; and
other risk factors set forth in this Annual Report.
We are reliant on key inputs and our inability to reduce and control the cost of such inputs could negatively impact the adoption of our products and our profitability.
The production of our sensors is dependent on producing or sourcing certain key components and raw materials at acceptable price levels. If we are unable to adequately reduce and control the costs of such key components, we will be unable to realize manufacturing costs targets, which could reduce the market adoption of our products, damage our reputation with current or prospective customers, and harm our brand, business, prospects, financial condition and operating results.
Continued pricing pressures, automotive OEM cost reduction initiatives and the ability of automotive OEMs to re-source or cancel vehicle or technology programs may result in lower than anticipated margins, or losses, which may adversely affect our business.
Cost-cutting initiatives adopted by our customers often result in increased downward pressure on pricing. We expect that our agreements with automotive OEMs may require step-downs in pricing over the term of the agreement or, if commercialized, over the period of production. In addition, our automotive OEM customers often reserve the right to terminate their supply contracts for convenience, which enhances their ability to obtain price reductions. Automotive OEMs also possess significant leverage over their suppliers, including us, because the automotive component supply industry is highly competitive, serves a limited number of customers and has a high fixed cost base.
12

Accordingly, we expect to be subject to substantial continuing pressure from automotive OEMs and Tier 1 suppliers to reduce the price of our products. It is possible that pricing pressures beyond our expectations could intensify as automotive OEMs pursue restructuring, consolidation and cost-cutting initiatives. If we are unable to generate sufficient production cost savings in the future to offset price reductions, our gross margin and profitability would be adversely affected.
We expect to incur substantial R&D costs and devote significant resources to identifying and commercializing new products, which could significantly reduce our profitability and may never result in revenue to us.
Our future growth depends on penetrating new markets, adapting existing products to new applications and customer requirements, and introducing new products that achieve market acceptance. We plan to incur substantial, and potentially increasing, R&D costs as part of our efforts to design, develop, manufacture and commercialize new products and enhance existing products. Our R&D expenses were $185.3 million, $88.9 million and $38.7 million for the years ended December 31, 2022, 2021 and 2020, respectively, and are likely to grow in the future. Because we account for R&D as an operating expense, these expenditures will adversely affect our results of operations in the future. Further, our R&D program, including our software development efforts, may not produce successful results, and our new products may not achieve market acceptance, create additional revenue or become profitable.
Market adoption of lidar is uncertain. Developments in alternative technology may adversely affect the demand for our lidar technology. If market adoption of lidar does not continue to develop, or develops more slowly than we expect, or our investments in educating our customers about the advantages of lidar fail, our business will be adversely affected.
While our lidar-based ADAS and autonomous driving solutions can be applied to different use cases across end markets, nearly all of our revenue is generated from automotive applications. Despite the fact that the automotive industry has engaged in considerable effort to research and test lidar products for ADAS and autonomous driving applications, the automotive industry may not introduce lidar products in commercially available vehicles. We continually study emerging and competing sensing technologies and methodologies and we may add new sensing technologies. However, lidar products remain relatively new and it is possible that other sensing modalities, or a new disruptive modality based on new or existing technology, including a combination of technology, will achieve acceptance or leadership in the ADAS and autonomous driving industries. For example, significant developments in alternative technologies, such as cameras and radar, may materially and adversely affect our business in ways we do not currently anticipate. Existing and other camera and radar technologies may emerge as customers’ preferred alternative to our solutions. Any failure by us and our R&D efforts to develop new or enhanced technologies or processes, or to react to changes in existing technologies, could materially delay our development and introduction of new and enhanced products in the autonomous vehicle industry, which could result in the loss of competitiveness of our lidar solutions, decreased revenue and a loss of market share to competitors. As technologies change, we plan to upgrade or adapt our lidar solutions with the latest technology. However, our solutions may not compete effectively with alternative systems if we are not able to source and integrate the latest technology into our existing lidar solutions.
Even if lidar products are used in initial generations of autonomous driving technology and certain ADAS products, we cannot guarantee that lidar products will be designed into or included in subsequent generations of such commercialized technology. Many automakers are now concentrating on improving consumer vehicle ADAS technology and creating new conditional automation systems; however, as these products and features are newly emerging, consumer acceptance and pricing desirability remains uncertain, and automakers may discontinue or decrease use in favor of cheaper vehicles, particularly if government regulations and safety ratings do not support ADAS technology. In addition, we expect that initial generations of fully autonomous vehicles will be focused on limited applications, such as robo-taxis, and that mass market adoption of autonomous technology may lag behind these initial applications significantly. The speed of market growth for ADAS or autonomous vehicles is difficult if not impossible to predict, and it is more difficult to predict this market’s future growth in light of the economic consequences of the COVID-19 pandemic, geopolitical instability, rapid inflation, and recession. Educating customers about lidar, its advantages over other sensing technologies and lidar’s ability to convey value in different industries and deployments is also an integral part of developing new business and the lidar market generally and if customers have a negative perception of, or experience with, lidar or a competitor’s lidar products, they may be reluctant to adopt lidar in general or specifically our products. Our investments and efforts to educate potential customers and the market generally and to counter any adverse statements made by competitors or other market participants thus may not be successful.
Although we currently believe we are a leader in lidar-based systems for the autonomous vehicle market, by the time mass market adoption of autonomous vehicle technology is achieved, we expect competition among providers of sensing technology based on lidar and other modalities to increase substantially. If commercialization of lidar products is not successful, or not as successful as we or the market expects, or if other sensing modalities gain acceptance by developers of autonomous driving systems or ADAS, automotive OEMs, regulators and safety organizations or other market participants by the time autonomous vehicle technology achieves mass market adoption, our business, results of operations and financial condition will be materially and adversely affected.
13

In addition to automotive markets, we are investing in and pursuing market opportunities in other markets, including in aerospace, defense and aviation. We believe that our future revenue growth, if any, will depend in part on our ability to expand within new markets such as these and to enter new markets as they emerge. Each of these markets presents distinct risks and, in many cases, requires us to address the particular requirements of that market.
Addressing these requirements can be time-consuming and costly. The market for lidar technology outside of automotive applications is relatively new, rapidly developing and unproven in many markets or industries. Many of our customers outside of the automotive industry are still in the testing and development phases and we cannot be certain that they will commercialize products or systems with our lidar products or at all. We cannot be certain that lidar will be sold into these markets, or any market outside of the automotive market, at scale. Adoption of lidar products, including our products, outside of the automotive industry will depend on numerous factors, including: whether the technological capabilities of lidar and lidar-based products meet users’ current or anticipated needs, whether the benefits of designing lidar into larger sensing systems outweigh the costs, complexity and time needed to deploy such technology or replace or modify existing systems that may have used other modalities such as cameras and radar, whether users in other applications can move beyond the testing and development phases and proceed to commercializing systems supported by lidar technology and whether lidar developers such as us can keep pace with rapid technological change in certain developing markets and the global response to evolving conditions relating to the COVID-19 pandemic and the length of any associated work stoppages. If lidar technology does not achieve commercial success outside of the automotive industry, or if the market develops at a pace slower than we expect, our business, results of operation and financial condition will be materially and adversely affected.
We may experience difficulties in managing our growth and expanding our operations.
We expect to experience significant growth in the scope and nature of our operations. Our ability to manage our operations and future growth will require us to continue to improve our operational, financial and management controls, compliance programs and reporting systems. We are currently in the process of strengthening our compliance programs, including our compliance programs related to export controls, privacy and cybersecurity and anti-corruption. We may not be able to implement improvements in an efficient or timely manner and may discover deficiencies in existing controls, programs, systems and procedures, which could have an adverse effect on our business, reputation and financial results.
We rely on third-party suppliers and because some of the raw materials and key components in our products come from limited or single source suppliers, we are susceptible to supply shortages, long lead times for components, and supply changes, any of which could disrupt our supply chain and could delay deliveries of our products to customers.
Some of the components that go into the manufacture of our solutions are sourced from third-party suppliers. To date, we have produced our products in relatively limited quantities for use in R&D programs. Although we do not have any experience in managing our supply chain to manufacture and deliver our products at scale, our future success will depend on our ability to manage our supply chain to manufacture and deliver our products at scale. Some of the key components used to manufacture our products come from limited or single source suppliers. We are therefore subject to the risk of shortages and long lead times in the supply of these components, including integrated circuits which are in short supply in the near term, and the risk that our suppliers discontinue or modify components used in its products. We have a global supply chain and the COVID-19 pandemic and other health epidemics and outbreaks, as well as geopolitical events, and government trade restrictions, may adversely affect our ability to source components in a timely or cost effective manner from our third-party suppliers due to, among other things, work stoppages or interruptions. For example, our products depend on lasers and we currently consume a substantial portion of the available market. Any shortage of these lasers could materially and adversely affect our ability to manufacture our solutions. In addition, the lead times associated with certain components are lengthy and preclude rapid changes in quantities and delivery schedules. We have in the past experienced and may in the future experience component shortages and price fluctuations of certain key components and materials, and the predictability of the availability and pricing of these components may be limited. Component shortages or pricing fluctuations could be material in the future. In the event of a component shortage, supply interruption or material pricing change from suppliers of these components, we may not be able to develop alternate sources in a timely manner or at all in the case of sole or limited sources. Developing alternate sources of supply for these components may be time-consuming, difficult, and costly and we may not be able to source these components on terms that are acceptable to us, or at all, which may undermine our ability to meet our requirements or to fill customer orders in a timely manner. Any interruption or delay in the supply of any of these parts or components, or the inability to obtain these parts or components from alternate sources at acceptable prices and within a reasonable amount of time, would adversely affect our ability to meet our scheduled product deliveries to our customers. This could adversely affect our relationships with our customers and channel partners and could cause delays in shipment of our products and adversely affect our operating results. In addition, increased component costs could result in lower gross margins. Even where we are able to pass increased component costs along to our customers, there may be a lapse of time before we are able to do so such that we must absorb the increased cost. If we are unable to buy these components in quantities sufficient to meet our requirements on a timely basis, we
14

will not be able to deliver products to our customers, which may result in such customers using competitive products instead of ours.
Because our sales have been primarily to customers making purchases for R&D projects and our orders are project-based, we expect our results of operations to fluctuate on a quarterly and annual basis, which could cause our stock price to fluctuate or decline.
Our quarterly results of operations have fluctuated in the past and may vary significantly in the future. As such, historical comparisons of our operating results may not be meaningful. In particular, because our sales to date have primarily been to customers making purchases for R&D, sales in any given quarter can fluctuate based on the timing and success of our customers’ development projects. Accordingly, the results of any one quarter should not be relied upon as an indication of future performance. Our quarterly financial results may fluctuate as a result of a variety of factors, many of which are outside of our control and may not fully reflect the underlying performance of our business. These fluctuations could adversely affect our ability to meet our expectations or those of securities analysts, ratings agencies or investors. If we do not meet these expectations for any period, the value of our business and our securities could decline significantly. Factors that may cause these quarterly fluctuations include, without limitation, those listed below:
the timing and magnitude of orders and shipments of our products in any quarter;
pricing changes we may adopt to drive market adoption or in response to competitive pressure;
our ability to retain our existing customers and attract new customers;
our ability to develop, introduce, manufacture and ship in a timely manner products that meet customer requirements;
disruptions in our sales channels or termination of its relationship with important channel partners;
delays in customers’ purchasing cycles or deferments of customers’ purchases in anticipation of new products or up-dates from us or our competitors;
fluctuations in demand pressures for our products;
the mix of products sold in any quarter;
the duration of the global COVID-19 pandemic and the time it takes for economic recovery;
the timing and rate of broader market adoption of autonomous systems utilizing our solutions across the automotive and other market sectors;
market acceptance of lidar and further technological advancements by our competitors and other market participants;
the ability of our customers to commercialize systems that incorporate our products;
any change in the competitive dynamics of our markets, including consolidation of competitors, regulatory developments and new market entrants;
our ability to effectively manage our inventory;
changes in the source, cost, availability of and regulations pertaining to materials we use, including the effect of inflation on the cost of components for our products;
adverse litigation, judgments, settlements or other litigation-related costs, or claims that may give rise to such costs; and
general economic, industry and market conditions, including trade disputes.
Our transition to an outsourced manufacturing business model may not be successful, which could harm our ability to deliver products and recognize revenue.
We are in the initial stages of transitioning from a manufacturing model in which we primarily manufactured and assembled our products at our Orlando, Florida location, to one where we rely on third-party manufacturers in Mexico, Thailand and potentially other foreign and domestic locations. We believe the use of third-party manufacturers will have benefits, but in the near term, while we are beginning manufacturing with new partners, we may lose revenue, incur increased costs and potentially harm our customer relationships.
Reliance on third-party manufacturers reduces our control over the manufacturing process, including our ability to finalize changes through validation, reduced control over quality, product costs and product supply and timing. We may
15

experience delays in shipments or issues concerning product quality from our third-party manufacturers. If any of our third-party manufacturers experience interruptions, delays or disruptions in supplying our products, including due to natural disasters, the global COVID-19 pandemic, other health epidemics and outbreaks, geopolitical events, trade restrictions, or work stoppages or capacity constraints, our ability to ship products to distributors and customers would be delayed. In addition, unfavorable economic conditions could result in financial distress among third-party manufacturers upon which we rely, including those caused by tax or tariff changes, thereby increasing the risk of disruption of supplies necessary to fulfill our production requirements and meet customer demands. Additionally, if any of our third-party manufacturers experience quality control problems in their manufacturing operations and our products do not meet customer or regulatory requirements, we could be required to cover the cost of repair or replacement of any defective products. These delays or product quality issues could have an immediate and material adverse effect on our ability to fulfill orders and could have a negative effect on our operating results. In addition, such delays or issues with product quality could adversely affect our reputation and our relationship with our channel partners. If third-party manufacturers experience financial, operational, manufacturing capacity or other difficulties, or experience shortages in required components, or if they are otherwise unable or unwilling to continue to manufacture our products in required volumes or at all, our supply may be disrupted, we may be required to seek alternate manufacturers and we may be required to re-design our products. It would be time-consuming, and could be costly and impracticable, to begin to use new manufacturers and designs, and such changes could cause significant interruptions in supply and could have an adverse effect on our ability to meet our scheduled product deliveries and may subsequently lead to the loss of sales. While we take measures to protect our trade secrets, the use of third-party manufacturers may also risk disclosure of our innovative and proprietary manufacturing methodologies, which could adversely affect our business.
Our sales and operations in international markets, including our manufacturing operations, expose us to operational, financial and regulatory risks.
International sales comprise a significant amount of our overall revenue. Sales to international customers accounted for 14%, 29% and 71% of our revenue in 2022, 2021 and 2020, respectively. We are committed to growing our international sales. While we have committed resources, and are working closely with OEMs and other collaborators outside the United States, to expand our international operations and sales channels, these efforts may not be successful. We have also commenced international manufacturing operations. International operations, including any manufacturing operations, are subject to a number of other risks, including:
foreign currency and exchange rate fluctuations;
local economic conditions;
political and economic instability, wars and military conflicts, international terrorism and anti-American sentiment, particularly in emerging markets;
global or regional health crises, such as the COVID-19 pandemic or other health epidemics and outbreaks;
potential for violations of anti-corruption laws and regulations, such as those related to bribery and fraud;
tariffs, other trade barriers and restrictions and preference for locally branded products, and laws and business practices favoring local competition;
potential consequences of, and uncertainty related to, the “Brexit” process in the United Kingdom, which could lead to additional expense and complexity in doing business there;
increased difficulty in managing inventory;
difficulties in collecting receivables from foreign entities;
less effective protection of intellectual property;
foreign government regulatory requirements and stringent regulation of the autonomous or other systems or products using our products and stringent consumer protection and product compliance regulations, including but not limited to General Data Protection Regulation in the European Union, European competition law, the Restriction of Hazardous Substances Directive, the Waste Electrical and Electronic Equipment Directive and the European Ecodesign Directive, all of which are costly to comply with and may vary from country to country;
difficulties and costs of staffing and managing foreign operations;
import and export laws and requirements and the impact of tariffs;
potentially adverse tax consequences and changes in local tax and customs duty laws or changes in the enforcement, application or interpretation of such laws; and
U.S. government’s restrictions on certain technology transfer to certain countries of concern.
16

The occurrence of any of these risks could negatively affect our international business or increase our costs and decrease our profit margins and consequently materially and adversely affect our business, operating results and financial condition.
We, our outsourcing partners and our suppliers may rely on complex machinery for our production, which involves a significant degree of risk and uncertainty in terms of operational performance and costs.
We, our outsourcing partners and our suppliers may rely on complex machinery for the production, assembly and installation of our lidar solutions, which will involve a significant degree of uncertainty and risk in terms of operational performance and costs. Our production facilities and the facilities of our outsourcing partners and suppliers consist of large-scale machinery with high capital expense combining many components. These components may suffer unexpected malfunctions from time to time and will depend on repairs and spare parts to resume operations, which may not be available when needed. Unexpected malfunctions of these components may significantly affect the intended operational efficiency. Operational performance and costs can be difficult to predict and are often influenced by factors outside of our control, such as, but not limited to, scarcity of natural resources, environmental hazards and remediation, costs associated with decommissioning of machines, labor disputes and strikes, difficulty or delays in obtaining governmental permits, damages or defects in electronic systems, industrial accidents, fire, seismic activity and natural disasters. Should operational risks materialize, it may result in the personal injury to or death of workers, the loss of production equipment, damage to production facilities, monetary losses, delays and unanticipated fluctuations in production, environmental damage, administrative fines, increased insurance costs and potential legal liabilities, all which could have a material adverse effect on our business, prospects, financial condition or operating results.
As part of growing our business, we may make acquisitions. If we fail to successfully select, execute or integrate our acquisitions, then our business, results of operations and financial condition could be materially adversely affected, and our stock price could decline.
From time to time, we may undertake acquisitions to add new products and technologies, acquire talent, gain new sales channels or enter into new markets or sales territories. In addition to possible stockholder approval, we may need approvals and licenses from relevant government authorities for the acquisitions and to comply with any applicable laws and regulations, which could result in increased delay and costs, and may disrupt our business strategy if we fail to do so. Furthermore, acquisitions and the subsequent integration of new assets, businesses, key personnel, customers, vendors and suppliers require significant attention from our management and could result in a diversion of resources from our existing business, which in turn could have an adverse effect on our operations. Acquired assets or businesses may not generate the financial results we expect. Acquisitions could result in the use of substantial amounts of cash, dilutive issuances of equity securities, the occurrence of significant goodwill impairment charges, amortization expenses for other intangible assets and exposure to potential unknown liabilities of the acquired business. Moreover, the costs of identifying and consummating acquisitions may be significant.
To date, we have limited experience with acquisitions and the integration of acquired technology and personnel. Failure to successfully identify, complete, manage and integrate acquisitions could materially and adversely affect our business, financial condition and results of operations and could cause our stock price to decline.
Any failure to grow our relationship with Chinese customers and our proposed international expansion into China could expose us to substantial business, regulatory, political, financial and economic risks.
We have entered into relationships with Chinese customers pursuant to which we plan to establish a presence in China to support the collaboration between the parties and enable series production of autonomous vehicles utilizing our technology by 2023. Any failure in our ability to establish our presence in China, grow our relationship with Chinese OEMs, successfully launch our products and maintain product quality, or to realize the anticipated benefits of our relationships could harm our brand, prospects, financial condition and operating results and have an adverse effect on our business. Our proposed expansion into China could also expose us to substantial risks associated with doing business in China, such as, taxation, inflation, manufacturing, environmental and other regulations, foreign currency exchange rates, political risks, intellectual property risks, the labor market and property and financial regulations. Additionally, we would need to maintain compliance with the market’s ongoing development of standards to define deployment requirements for higher levels of autonomy.
Our ability to operate in China may also be adversely affected by changes in, or our failure to comply with, Chinese laws, regulations and standards. As we hire personnel to maintain our operations in China, we would also be exposed to risks associated with any changes to the employment and labor laws in China, which could increase our operating costs in China. There is also significant uncertainty about the future relationship between the United States and China with respect to political risks, including but not limited to, trade policies, technology transfer restrictions, treaties, government regulations and tariffs. See “Changes to trade policy, tariffs and import/export regulations may have a material adverse effect on our business, financial condition and results of operations” below.
17

The complexity of our products could result in unforeseen delays or expenses from undetected defects, errors or reliability issues in hardware or software which could reduce the market adoption of our new products, damage our reputation with current or prospective customers, expose us to product liability and other claims and adversely affect our operating costs.
Our products, including our hardware and in-development software, are highly technical and very complex and require high standards to manufacture and have in the past and will likely in the future experience defects, security vulnerabilities or other errors or reliability issues at various stages of development. We may be unable to timely release new products, manufacture existing products, correct problems that have arisen or correct such problems to our customers’ satisfaction. Additionally, undetected errors, defects or security vulnerabilities, especially as new products are introduced or as new versions are released, could result in serious injury to the end users of technology incorporating our products, or those in the surrounding area. Other consequences could include our customers never being able to commercialize technology incorporating our products, litigation against us, negative publicity and other consequences. These risks are particularly prevalent in the highly competitive autonomous driving and ADAS markets. Some errors or defects in our products may only be discovered after they have been tested, commercialized and deployed by customers. If an accident involving a vehicle using our technology were to occur and result in injuries or purported injuries or death, we may incur significant costs from product recalls and repair or replacement requirements, as well as lawsuits, including class actions for product liability or other claims against us by our customers and end users which could result in substantial costs and diversion of management resources. Our reputation or brand may also be damaged as a result of these problems and customers may be reluctant to buy our products, which could adversely affect our ability to retain existing customers and attract new customers and could adversely affect our financial results.
We could also face claims for breach of contract, fraud, tort or breach of warranty as a result of these problems, and our business liability insurance coverage could prove inadequate with respect to a claim and future coverage may be unavailable on acceptable terms or at all.
In addition, if lawmakers or governmental agencies were to determine that the use of our products or autonomous driving or certain ADAS applications increased the risk of injury to all or a subset of end users, they may pass laws or adopt regulations that limit the use of our products or increase our liability associated with the use of our products or that regulate the use of or delay the deployment of autonomous driving and ADAS technology. Any of these events could adversely affect our brand, relationships with customers, operating results or financial condition.
We may be subject to product liability or warranty claims that could result in significant direct or indirect costs, which could adversely affect our business and operating results.
We typically provide a limited-time warranty on our products. The occurrence of any material defects in our products could make us liable for damages and warranty claims. In addition, we could incur significant costs to correct any defects, warranty claims or other problems, including costs related to product recalls. Any negative publicity related to the perceived quality of our products could affect our brand image, partner and customer demand, and adversely affect our operating results and financial condition. Also, warranty, recall and product liability claims may result in litigation, including class actions, the occurrence of which could be costly, lengthy and distracting and adversely affect our business and operating results.
If we do not maintain sufficient inventory or if we do not adequately manage our inventory, we could lose sales or incur higher inventory-related expenses, which could negatively affect our operating results.
To ensure adequate inventory supply, we must forecast inventory needs and expenses, place orders sufficiently in advance with our suppliers and manufacturing partners and manufacture products based on our estimates of future demand for particular products. Fluctuations in the adoption of lidar products may affect our ability to forecast our future operating results, including revenue, gross margins, cash flows and profitability. Our ability to accurately forecast demand for our products could be affected by many factors, including the rapidly changing nature of the autonomous driving and ADAS markets in which we operate, the uncertainty surrounding the market acceptance and commercialization of lidar technology, the emergence of new markets, an increase or decrease in customer demand for our products or for products and services of our competitors, product introductions by competitors, the COVID-19 pandemic, other health epidemics and outbreaks, and any associated work stoppages or interruptions, unanticipated changes in general market conditions and the weakening of economic conditions or consumer confidence in future economic conditions. If our lidar products are commercialized in autonomous driving and ADAS applications, both of which are experiencing rapid growth in demand, we may face challenges acquiring adequate supplies to manufacture our products and/or we and our manufacturing partners may not be able to manufacture our products at a rate necessary to satisfy the levels of demand, which would negatively affect our revenue and operating results and could result in damage to our brand and customer relationships. This risk may be exacerbated by the fact that we may not carry or be able to obtain for our manufacturers a significant amount of inventory to satisfy short-term demand increases. If we fail to accurately forecast customer demand, we may experience excess inventory levels or a shortage of products available for sale.
18

Inventory levels in excess of customer demand may result in inventory write-downs or write-offs and the sale of excess inventory at discounted prices, which would adversely affect our financial results, including our gross margin, and have a negative effect on our brand.
The average selling prices of our products could decrease rapidly over the life of the product, which may negatively affect our revenue and gross margin.
We may experience declines in the average selling prices of our products generally as our customers seek to commercialize autonomous systems at prices low enough to achieve market acceptance. In order to sell products that have a falling average unit selling price and maintain margins at the same time, we will need to continually reduce product and manufacturing costs. To manage manufacturing costs, we must engineer the most cost-effective design for our products. We must also continuously drive initiatives to reduce labor cost, improve worker efficiency, reduce the cost of materials, use fewer materials and further lower overall product costs by carefully managing component prices, inventory and shipping cost. We also need to continually introduce new products with higher sales prices and gross margin to maintain our overall gross margin. If we are unable to manage the cost of older products or successfully introduce new products with higher gross margin, our revenue and overall gross margin would likely decline.
Adverse conditions in the automotive industry or the global economy more generally could have adverse effects on our results of operations.
While we make our strategic planning decisions based on the assumption that the markets we are targeting will grow, our business is dependent, in large part on, and directly affected by, business cycles and other factors affecting the global automobile industry and global economy generally. Automotive production and sales are highly cyclical and depend on general economic conditions and other factors, including consumer spending and preferences, changes in interest rates and credit availability, consumer confidence, fuel costs, fuel availability, environmental impact, governmental incentives and regulatory requirements, and political volatility, especially in energy-producing countries and growth markets. In addition, automotive production and sales can be affected by our automotive OEM customers’ ability to continue operating in response to challenging economic conditions and in response to labor relations issues, regulatory requirements, trade agreements and other factors, such as COVID-19’s impact on supply of semiconductors for automobiles. The volume of automotive production in North America, Europe and the rest of the world has fluctuated, sometimes significantly, from year to year, and we expect such fluctuations to give rise to fluctuations in the demand for our products. Any significant adverse change in any of these factors may result in a reduction in automotive sales and production by our automotive OEM customers and could have a material adverse effect on our business, results of operations and financial condition.
Because lidar is new and since many of the markets in which we compete are new and rapidly evolving, it is difficult to forecast long-term end-customer adoption rates and demand for our products.
We are pursuing opportunities in markets that are undergoing rapid changes, including technological and regulatory changes, and it is difficult to predict the timing and size of the opportunities. For example, autonomous driving and lidar-based ADAS applications require complex technology. Because these automotive systems depend on technology from many companies, commercialization of autonomous driving or ADAS products could be delayed or impaired on account of certain technological components of our or others not being ready to be deployed in vehicles. Although we currently are engaged with multiple commercial customers, these companies may not be able to commercialize our technology immediately, or at all. Regulatory, safety or reliability developments, many of which are outside of our control, could also cause delays or otherwise impair commercial adoption of these new technologies, including whether government policy, regulation, and consumer education and ratings programs support autonomous technology or improved driver assistance systems. Our future financial performance will depend on our ability to make timely investments in the correct market opportunities and to anticipate potential technological changes. If one or more of these markets experience a shift in customer or prospective customer demand, our products may not compete as effectively, if at all, and they may not be designed into commercialized products. Given the evolving nature of the markets in which we operate, it is difficult to predict customer demand or adoption rates for our products or the future growth of the markets in which we operate. As a result, any financial projections in this Annual Report and any market opportunity estimates and forecasts of market growth necessarily reflect various estimates and assumptions that may not prove accurate and these projections could differ materially from actual results due to the risks included in this “Risk Factors” section, among others. If demand does not develop or if we cannot accurately forecast customer demand, the size of our markets, inventory requirements or our future financial results, our business, results of operations and financial condition will be adversely affected. Even if markets experience the forecasted growth described in this Annual Report, we may not grow our business at similar rates, or at all, since our business is subject to many risks and uncertainties set forth in this Annual Report. Accordingly, the forecasts and estimates of market size and growth described in this Annual Report, including our estimates of the size of our total addressable market should not be taken as indicative of our future growth.
19

We currently have and target customers that are large corporations with substantial negotiating power, exacting product standards and potentially competitive internal solutions. If we are unable to sell our products to these customers, our prospects and results of operations will be adversely affected.
Many of our customers and potential customers are large, multinational corporations with substantial negotiating power relative to us and, in some instances, may have internal solutions that are competitive to our products. These large, multinational corporations also have significant development resources, which may allow them to acquire or develop independently, or in partnership with others, competitive technologies. Meeting the technical requirements and securing major commercial wins with any of these companies will require a substantial investment of our time and resources. We cannot assure you that our products will secure major commercial wins from these or other companies or that we will generate meaningful revenue from the sales of our products to these key potential customers. If our products are not selected by these large corporations or if these corporations develop or acquire competitive technology, it will have an adverse effect on our business.
We are substantially dependent on our partnership with a few key customers, and our business could be materially and adversely affected if our partnership with any of such customers were terminated. Our financial position and results could be materially and adversely affected if we were unable to collect our invoices for any of our key customers.
We are dependent on a collection of large customers with strong purchasing power. In 2022, 2021 and 2020, our top 10 customers represented 69%, 87% and 94% of our revenue, respectively. In 2022, Daimler and Scale.AI, in 2021, Daimler and Volvo and in 2020, Volvo accounted for more than 10% of our annual revenue. The loss of business from any of our major customers (whether by lower overall demand for our products, cancellation of existing contracts or product orders or the failure to design in our products or award us new business) could have a material adverse effect on our business.
To the extent autonomous vehicle and ADAS systems become accepted by major automotive OEMs, we expect that we will rely increasingly for our revenue on Tier 1 suppliers through which automotive OEMs procure components. We expect that these Tier 1 suppliers will be responsible for certain hardpoint and software configuration activities specific to each OEM, and they may not exclusively carry our solutions.
There can be no assurance that we will be able to maintain our relationship with any of our key customers and secure orders for our products. If we are unable to maintain our relationship any of our key customers, or if our arrangement is modified so that the economic terms become less favorable to us, then our business, financial results and position would be materially adversely affected. There is also a risk that one or more of our major customers could be unable to pay our invoices as they become due or that a customer will simply refuse to make such payments if it experiences financial difficulties. If a major customer were to enter into bankruptcy proceedings or similar proceedings whereby contractual commitments are subject to stay of execution and the possibility of legal or other modification, we could be forced to record a substantial loss.
If we are unable to establish and maintain confidence in our long-term business prospects among customers and analysts and within our industry or are subject to negative publicity, then our financial condition, operating results, business prospects and access to capital may suffer materially.
Customers may be less likely to purchase our lidar solutions if they are not convinced that our business will succeed or that our service and support and other operations will continue in the long term.
Similarly, suppliers and other third parties will be less likely to invest time and resources in developing business relationships with us if they are not convinced that our business will succeed. Accordingly, in order to build and maintain our business, we must maintain confidence among customers, suppliers, analysts, ratings agencies and other parties in our products, long-term financial viability and business prospects. Maintaining such confidence may be particularly complicated by certain factors including those that are largely outside of our control, such as our limited operating history, customer unfamiliarity with our lidar solutions, any delays in scaling production, delivery and service operations to meet demand, competition and uncertainty regarding the future of autonomous vehicles or our other services and our production and sales performance compared with market expectations.
We operate in a highly competitive market and some market participants have substantially greater resources. We compete against a large number of both established competitors and new market entrants.
The markets for sensing technology applicable to autonomous solutions in the automobile industry are highly competitive. Our future success will depend on our ability to remain a leader in our targeted markets by continuing to develop and protect from infringement advanced lidar technology in a timely manner and to stay ahead of existing and new competitors. Our competitors are numerous and they compete with us directly by offering lidar products and indirectly by attempting to solve some of the same challenges with different technology. We face competition from camera and radar companies, other developers of lidar products, Tier 1 suppliers and other technology and automotive supply companies, some of which have significantly greater resources than we do. In the automotive market, our competitors have commercialized both lidar and non-lidar-based ADAS technology that has achieved market adoption, strong brand recognition and may continue to improve. Other
20

competitors are working towards commercializing autonomous driving technology and either by themselves, or with a publicly announced partner, have substantial financial, marketing, R&D and other resources. Some of our customers in the autonomous vehicle and ADAS markets have announced development efforts or made acquisitions directed at creating their own lidar-based or other sensing technologies, which would compete with our solutions. We do not know how close these competitors are to commercializing autonomous driving systems or novel ADAS applications. In markets outside of the automotive industry, our competitors, like us, seek to develop new sensing applications across industries. Even in these emerging markets, we face substantial competition from numerous competitors seeking to prove the value of their technology.
Additionally, increased competition may result in pricing pressure and reduced margins and may impede our ability to increase the sales of our products or cause us to lose market share, any of which will adversely affect our business, results of operations and financial condition.
If we are unable to achieve technological feasibility and commercialize our software products, including our perception and decision-making software products such as our Proactive Safety™ and highway autonomy features, and other new solutions and improve existing solutions in a cost-effective and timely manner, then our competitive position would be negatively impacted and our business, results of operations and financial condition would be adversely affected. The markets in which we compete are characterized by rapid technological change, which requires us to continue to develop new products and product innovations and could adversely affect market adoption of our products.
Our future success will depend upon our ability to develop our software products, including our perception and decision-making software products such as our Proactive Safety™ and highway autonomy features, and our ability to introduce a variety of new capabilities, product offerings and innovations to our existing product offerings, to address the changing needs of the markets in which we offer our products.
We are currently working on developing perception and decision-making software products, including the Proactive Safety™ and highway autonomy features as well as the Sentinel solution, all of which are important components of our business plan and which have not achieved technological feasibility as of the end of the 2022 fiscal year. We may encounter significant unexpected technical and production challenges, or delays in completing the development of these and other solutions and ramping production in a cost-efficient manner. We cannot guarantee that such software or other new products will be successfully developed, released in a timely manner, or at all, or achieve satisfactory performance or market acceptance and any such failure could materially adversely affect our business, results of operations and financial condition, and cause our stock price to decline.
Delays in delivering new products that meet customer requirements could damage our relationships with customers and lead them to seek alternative sources of supply and we may not be able to achieve additional design wins with existing or new customers, or achieve broader market acceptance of our solutions. In addition, our success to date has been based on the delivery of our solutions to R&D programs in which developers are investing substantial capital to develop new systems. Our continued success relies on the success of the R&D phase of these customers as they expand into commercialized projects. As autonomous technology reaches the stage of large-scale commercialization, we will be required to develop and deliver solutions at price points that enable wider and ultimately mass-market adoption. Failure to achieve technological feasibility of our software products, or delays in introducing products and innovations, the failure to choose correctly among technical alternatives or the failure to offer innovative products or configurations at competitive prices may cause existing and potential customers to purchase our competitors’ products or turn to alternative sensing technology.
If we are unable to devote adequate resources to develop products or cannot otherwise successfully develop products or system configurations that meet customer requirements and on a timely basis or that remain competitive with technological alternatives, our products could lose market share, our revenue could decline, we may experience operating losses and our business and prospects would be adversely affected.
While we intend to invest substantial resources to remain on the forefront of technological development, continuing technological changes in sensing technology, lidar and the markets for these products, including the ADAS and autonomous driving industries, could adversely affect adoption of lidar and/or our products, either generally or for particular applications.
We had identified material weaknesses in our internal control over financial reporting as of December 31, 2021 and 2020. These material weaknesses were remediated in 2022, however, if we are unable to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results in a timely manner, which may adversely affect investor confidence in us and materially and adversely affect our business and operating results.
In connection with our financial statement close process for the years ended December 31, 2021 and 2020, we had identified material weaknesses in the design and operating effectiveness of our internal control over financial reporting. The material weaknesses we identified resulted from a lack of sufficient number of qualified personnel within our accounting and internal audit function who possessed an appropriate level of expertise to effectively perform functions relating to control environment, control activities, information and communication and monitoring. In addition, these material weaknesses
21

contributed to material weaknesses in information technology controls and journal entry review. These material weaknesses were remediated during the year ended December 31, 2022. For a further discussion of these material weaknesses and steps undertaken by our management for the remediation, see “Management’s Report on Internal Control over Financial Reporting” in Item 9A. Controls and Procedures.
A material weakness is a deficiency or combination of deficiencies in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our financial statements would not be prevented or detected on a timely basis. These deficiencies could result in additional material misstatements to our consolidated financial statements that may not be prevented or detected on a timely basis.
Although we have remediated the material weaknesses, additional weaknesses in our internal controls may be discovered in the future. Any failure to further develop or maintain effective controls, or any difficulties encountered in our implementation or improvement, could adversely affect our operating results, cause us to fail to meet our reporting obligations and result in a restatement of our financial statements for prior periods. If any of these were to occur, investors may lose confidence in the accuracy and completeness of our financial reports, the market price of our common stock could be adversely affected. In addition, we could become subject to litigation or investigations by Nasdaq, the SEC, or other regulatory authorities.
Our ability to use our net operating loss carryforwards and certain other tax attributes may be limited.
As of December 31, 2022, we had $597.0 million of U.S. federal and $547.8 million of state net operating loss carryforwards available to reduce future taxable income. Of the $597.0 million in U.S. federal operating loss carryforwards, $553.8 million will be carried forward indefinitely for U.S. federal tax purposes and $43.2 million will expire between 2035 and 2037. The $547.8 million of our U.S. state net operating loss carryforwards will expire beginning in 2036. It is possible that we will not generate taxable income in time to use these net operating loss carryforwards before their expiration or at all. Under legislative changes made in December 2017, U.S. federal net operating losses incurred in 2018 and in future years may be carried forward indefinitely, but the deductibility of such net operating losses is limited. It is uncertain if and to what extent various states will conform to the newly enacted federal tax law. In addition, the federal and state net operating loss carryforwards and certain tax credits may be subject to significant limitations under Section 382 and Section 383 of the U.S. Tax Code, respectively, and similar provisions of state law. Under those sections of the U.S. Tax Code, if a corporation undergoes an “ownership change,” the corporation’s ability to use its pre-change net operating loss carryforwards and other pre-change attributes, such as research tax credits, to offset its post-change income or tax may be limited. In general, an “ownership change” will occur if there is a cumulative change in our ownership by “5-percent shareholders” that exceeds 50 percentage points over a rolling three-year period. Similar rules may apply under state tax laws.
We are highly dependent on the services of Austin Russell, our Founder, President and Chief Executive Officer.
We are highly dependent on Austin Russell, our Founder, President and Chief Executive Officer. Mr. Russell created our first lidar product and he remains deeply involved in all aspects of our business, including product development. The loss of Mr. Russell would adversely affect our business because his loss could make it more difficult to, among other things, compete with other market participants, manage our R&D activities and retain existing customers or cultivate new ones. Negative public perception of, or negative news related to, Mr. Russell may adversely affect our brand, relationship with customers or standing in the industry.
Our business depends substantially on the efforts of our executive officers and highly skilled personnel, and our operations may be severely disrupted if we lost their services.
Competition for highly-skilled personnel is often intense, especially in Orlando, Florida and the San Francisco Bay Area, where two of our offices are located, and we may incur significant costs to attract highly-skilled personnel. We may not be successful in attracting, integrating, or retaining qualified personnel to fulfill our current or future needs. We have, from time to time, experienced, and we expect to continue to experience, difficulty in hiring and retaining highly skilled employees with appropriate qualifications. In addition, job candidates and existing employees often consider the value of the equity awards they receive in connection with their employment. Because we believe in an employee compensation philosophy based highly in equity to preserve capital and align employee interests with stockholders, a significant decrease in our stock price or the perceived value of our equity or equity awards may adversely affect our ability to retain highly skilled employees. If we fail to attract new personnel or fail to retain and motivate our current personnel, our business and future growth prospects could be adversely affected and attracting and retaining talent using equity may be more expensive.
Our business could be materially and adversely affected by the current global COVID-19 pandemic or other health epidemics and outbreaks.
The ongoing COVID-19 pandemic as well as other possible health epidemics and outbreaks could result in a material adverse impact on our or our customers’ business operations including reduction or suspension of operations in the U.S. or certain parts of the world. The ongoing COVID-19 pandemic may have the effect of heightening many of the other risks
22

described in this “Risk Factors” section, such as the demand for our products, our ability to achieve or maintain profitability and our ability to raise additional capital in the future. Our corporate headquarters and R&D and manufacturing base are located in Florida, which has a high number of COVID-19 pandemic cases. Our engineering and manufacturing operations, among others, cannot all be conducted in a remote working structure and often require on-site access to materials and equipment. We have customers with international operations in varying industries. We also depend on suppliers and manufacturers worldwide. Depending upon the duration of the ongoing COVID-19 pandemic and the associated business interruptions, our customers, suppliers, manufacturers and partners may suspend or delay their engagement with us, which could result in a material adverse effect on our financial condition. Our response to the ongoing COVID-19 pandemic may prove to be inadequate and we may be unable to continue our operations in the manner we had prior to the outbreak, and may endure interruptions, reputational harm, delays in our product development and shipments, all of which could have an adverse effect on our business, operating results, and financial condition. In addition, when the pandemic subsides, we cannot assure you as to the timing of any economic recovery, which could continue to have a material adverse effect on our target markets and our business.
Interruption or failure of our information technology and communications systems could impact our ability to effectively provide our services.
We plan to include in-vehicle services and functionality that utilize data connectivity to monitor performance and timely capture opportunities to enhance performance and functionality. The availability and effectiveness of our services depend on the continued operation of information technology and communications systems. Our systems will be vulnerable to damage or interruption from, among others, physical theft, fire, terrorist attacks, natural disasters, power loss, war, telecommunications failures, viruses, denial or degradation of service attacks, ransomware, social engineering schemes, insider theft or misuse or other attempts to harm our systems. We utilize reputable third-party service providers or vendors for all of our data other than our source code, and these providers could also be vulnerable to damage or interruption from actions or conditions similar to those that could damage our systems, including sabotage and intentional acts of vandalism causing potential disruptions. Some of our systems will not be fully redundant, and our disaster recovery planning cannot account for all eventualities. Any problems with our third-party cloud hosting providers could result in lengthy interruptions in our business. In addition, our in-vehicle services and functionality are highly technical and complex technology which may contain errors or vulnerabilities that could result in interruptions in our business or the failure of our systems.
We are subject to cybersecurity risks to our and our suppliers’ operational systems, security systems, infrastructure, integrated software in our lidar solutions and customer data processed by us or third-party vendors or suppliers and any material failure, weakness, interruption, cyber event, incident or breach of security could prevent us from effectively operating our business.
We are at risk for interruptions, outages and breaches of: operational and manufacturing systems, including business, financial, accounting, product development, data processing or production processes, owned by us or our third-party vendors or suppliers; facility security systems, owned by us or our third-party vendors or suppliers; in-product technology owned by us or our third-party vendors or suppliers; the integrated software in our lidar solutions; or customer or driver data that we process or our third-party vendors or suppliers process on our behalf. Such cyber incidents could materially disrupt operational systems and shipment of parts or products or result in a lockout of our operational systems; result in loss of intellectual property, trade secrets or other proprietary or competitively sensitive information; compromise certain information of customers, employees, suppliers, drivers or others; jeopardize the security of our facilities; or affect the performance of in-product technology and the integrated software in our lidar solutions. A cyber incident could be caused by disasters, insiders (through inadvertence or with malicious intent) or malicious third parties (including nation-states or nation-state supported actors) using sophisticated, targeted methods to circumvent firewalls, encryption and other security defenses, including hacking, fraud, trickery or other forms of deception. The techniques used by cyber attackers change frequently and may be difficult to detect for long periods of time. Although we maintain information technology measures designed to protect us against intellectual property theft, data breaches and other cyber incidents, such measures will require updates and improvements, and we cannot guarantee that such measures will be adequate to detect, prevent or mitigate cyber incidents.
Our cybersecurity controls and systems are young and still maturing. The implementation, maintenance, segregation and improvement of these systems requires significant management time, personnel, support and cost. Moreover, there are inherent risks associated with developing, improving, expanding and updating current systems, including the disruption of our data management, procurement, production execution, finance, supply chain and sales and service processes. These risks may affect our ability to manage our data and inventory, procure parts or supplies or produce, sell, deliver and service our solutions, adequately protect our intellectual property or achieve and maintain compliance with, or realize available benefits under, applicable laws, regulations and contracts. We cannot be sure that the systems upon which we rely, including those of our third-party vendors or suppliers, will be effectively implemented, maintained or expanded as planned. If we do not successfully implement, maintain or expand these systems as planned, our operations may be disrupted, our ability to accurately and timely report our financial results could be impaired, and deficiencies may arise in our internal control over financial reporting, which may impact our ability to certify our financial results. Moreover, our proprietary information or intellectual property could be
23

compromised or misappropriated and our reputation may be adversely affected. If these systems do not operate as we expect them to, we may be required to expend significant resources to make corrections or find alternative sources for performing these functions.
A significant cyber incident could impact production capability, harm our reputation, cause us to breach our contracts with other parties or subject us to regulatory actions or litigation, any of which could materially affect our business, prospects, financial condition and operating results. In addition, our insurance coverage for cyber-attacks may not be sufficient to cover all the losses we may experience as a result of a cyber incident.
Legal and Regulatory Risks Related to Our Business
We are subject to governmental export and import control laws and regulations. Our failure to comply with these laws and regulations could have an adverse effect on our business, prospects, financial condition and results of operations.
Our products and solutions are subject to export control and import laws and regulations, including the U.S. Export Administration Regulations, U.S. Customs regulations and various economic and trade sanctions regulations administered by the U.S. Treasury Department’s Office of Foreign Assets Controls. U.S. export control laws and regulations and economic sanctions prohibit the shipment of certain products and services to U.S. embargoed or sanctioned countries, governments and persons. In addition, complying with export control and sanctions regulations for a particular sale may be time-consuming and result in the delay or loss of sales opportunities. Exports of our products and technology must be made in compliance with these laws and regulations. If we fail to comply with these laws and regulations, we and certain of our employees could be subject to substantial civil or criminal penalties, including the possible loss of export or import privileges, fines, which may be imposed on us and responsible employees or managers and, in extreme cases, the incarceration of responsible employees or managers.
Changes to trade policy, tariffs and import/export regulations may have a material adverse effect on our business, financial condition and results of operations.
Geopolitical tensions and conflicts worldwide, including but not limited to China, may result in changing regulatory requirements, trade policies, export controls, import duties and economic disruptions that could impact our operating strategies in the territories or countries where we currently purchase our components, sell our products or conduct our business. The increasing focus on the strategic importance of autonomous vehicles, artificial intelligence (“AI”) technologies, and advanced semiconductors may result in additional regulatory restrictions that target products and services capable of enabling or facilitating advanced vehicle automation systems or AI systems, including some or all of our product and service offerings. Such restrictions could include additional unilateral or multilateral export controls on certain products or technology, including but not limited to AI technologies and advanced semiconductors, and include recent U.S. recent restrictions on advanced semiconductor trade to China and China restriction on the collection and use of mapping data, which may be important for automated vehicle software development. As geopolitical tensions have increased, products associated with autonomous vehicles and AI, are increasingly the focus of export control restrictions proposed by stakeholders in the U.S. and its allies, and it is likely that additional unilateral or multilateral controls will be adopted. Such controls may be very broad in scope and application, prohibit us from exporting our products to any or all customers in one or more markets, including but not limited to China and could negatively and materially impact our business, revenue, and financial results. Furthermore, disruption to worldwide semiconductor supply, including non-advanced semiconductors, has and may continue to affect production of vehicles.
The U.S. has recently instituted or proposed changes in trade policies that include the negotiation or termination of trade agreements, the imposition of higher tariffs on imports into the U.S., economic sanctions on individuals, corporations or countries, and other government regulations affecting trade between the U.S. and other countries where we conduct our business. Increasing use of economic sanctions may impact demand for our products or services, negatively impacting our business and financial results. Additional export restrictions may not only impact our ability to serve overseas markets, but also provoke responses from foreign governments, including China, that negatively impact our supply chain or our ability to provide our products and services to customers in all markets worldwide, which could also materially affect our business, financial condition and results of operations.
As a result of these developments, there may be greater restrictions and economic disincentives on international trade that could adversely affect our business. For example, such changes could adversely affect the automotive market, our ability to access key components or raw materials needed to manufacture our products (including, but not limited to, rare-earth metals), our ability to sell our products to customers outside of the U.S. and the demand for our products. It may be time-consuming and expensive for us to alter our business operations to adapt to or comply with any such changes, and any failure to do so could have a material adverse effect on our business, financial condition and results of operations.
24

We have in the past and may become involved in legal and regulatory proceedings and commercial or contractual disputes, which could have an adverse effect on our profitability and consolidated financial position.
We may be, from time to time, involved in litigation, regulatory proceedings and commercial or contractual disputes that may be significant. These matters may include, without limitation, disputes with our suppliers and customers, intellectual property claims, stockholder litigation, government investigations, class action lawsuits, personal injury claims, environmental issues, customs and value-added tax disputes and employment and tax issues. In addition, we have in the past and could face in the future a variety of labor and employment claims against us, which could include but is not limited to general discrimination, wage and hour, privacy, ERISA or disability claims. In such matters, government agencies or private parties may seek to recover from us very large, indeterminate amounts in penalties or monetary damages (including, in some cases, treble or punitive damages) or seek to limit our operations in some way. These types of lawsuits could require significant management time and attention or could involve substantial legal liability, adverse regulatory outcomes, and/or substantial expenses to defend. Often these cases raise complex factual and legal issues and create risks and uncertainties. No assurances can be given that any proceedings and claims will not have a material adverse impact on our operating results and consolidated financial position or that our established reserves or our available insurance will mitigate this impact.
We are subject to, and must remain in compliance with, numerous laws and governmental regulations concerning the manufacturing, use, distribution and sale of our products. Some of our customers also require that we comply with their own unique requirements relating to these matters.
We manufacture and sell products that contain electronic components, and such components may contain materials that are subject to government regulation in both the locations where we manufacture and assemble our products, as well as the locations where we sell our products. For example, certain laws or regulations limit the use of restricted materials or materials from certain regions, such as EU Registration, Evaluation, Authorisation and Restriction of Chemicals and the U.S. Toxic Substances Control Act and those that relate to conflict minerals or forced labor. Since we operate on a global basis, this is a complex process which requires continual monitoring of regulations and an ongoing compliance process to ensure that we and our suppliers are in compliance with existing regulations in each market where we operate. In addition, as a lidar technology company, we are subject to the Electronic Product Radiation Control Provisions of the Federal Food, Drug, and Cosmetic Act. These requirements are enforced by the FDA. Electronic product radiation includes laser technology. Regulations governing these products are intended to protect the public from hazardous or unnecessary exposure. Manufacturers are required to certify in product labeling and reports to the FDA that their products comply with applicable performance standards as well as maintain manufacturing, testing, and distribution records for their products. Failure to comply with these requirements could result in enforcement action by the FDA, which could require us to cease distribution of our products, recall or remediate products already distributed to customers, or subject us to FDA enforcement.
If there is an unanticipated new regulation that significantly impacts our use and sourcing of various components or requires more expensive components, that regulation could materially adversely affect our business, results of operations and financial condition.
Our products are used for autonomous driving and ADAS applications, which are subject to complicated regulatory schemes that vary from jurisdiction to jurisdiction. These are rapidly evolving areas where new regulations could impose limitations on the use of lidar generally or our products specifically, or may fail to support the benefits to safety of lidar-based driver assistance and crash avoidance technology. If we fail to adhere to these new regulations or fail to continually monitor the updates, we may be subject to litigation, loss of customers or negative publicity and our business, results of operations and financial condition will be adversely affected.
We are subject to various environmental laws and regulations that could impose substantial costs upon us and cause delays in building our production facilities.
Concerns over environmental pollution and climate change have produced significant legislative and regulatory efforts on a global basis, and we believe this will continue both in scope and in the number of countries participating. In addition, as climate change issues become more prevalent, foreign, federal, state and local governments and our customers have been responding to these issues. The increased focus on environmental sustainability may result in new regulations and customer requirements, or changes in current regulations and customer requirements, which could materially adversely impact our business, results of operations and financial condition. If we are unable to effectively manage real or perceived issues, including concerns about environmental impacts or similar matters, sentiments toward us or our products could be negatively impacted, and our business, results of operations or financial condition could suffer.
Our operations are and will be subject to international, federal, state and local environmental laws and regulations, and such laws and regulations could directly increase the cost of energy, which may have an effect on the way we manufacture products or utilize energy to produce our products. In addition, any new regulations or laws in the environmental area might increase the cost of raw materials or key components we use in our products. Environmental regulations require us to reduce
25

product energy usage, monitor and exclude an expanding list of restricted substances and to participate in required recovery and recycling of our products. Environmental and health and safety laws and regulations can be complex, and we have limited experience complying with them. Capital and operating expenses needed to comply with environmental laws and regulations can be significant, and violations may result in substantial fines and penalties, third-party damages, suspension of production or a cessation of our operations. Contamination at properties we operate, we formerly operated or to which hazardous substances were sent by us, may result in liability for us under environmental laws and regulations, including, but not limited to, the Comprehensive Environmental Response, Compensation and Liability Act, which can impose liability for the full amount of remediation-related costs without regard to fault, for the investigation and cleanup of contaminated soil and ground water, for building contamination and impacts to human health and for damages to natural resources. The costs of complying with environmental laws and regulations and any claims concerning noncompliance, or liability with respect to contamination in the future, could have a material adverse effect on our financial condition or operating results. We may face unexpected delays in obtaining the required permits and approvals in connection with our planned production facilities that could require significant time and financial resources and delay our ability to operate these facilities, which would adversely impact our business, prospects, financial condition and operating results.
Our business may be adversely affected by changes in regulations applicable to the automotive industry and laser market or concerns that drive further regulation of the automobile and laser market.
Government product safety regulations are an important factor for our business. Historically, these regulations have imposed ever-more stringent safety regulations and reporting requirements for vehicles and laser products. These safety regulations often require, or customers demand that, vehicles have more safety features per vehicle and more advanced safety products.
While we believe increasing automotive and laser safety standards will present a market opportunity for our products, government safety regulations are subject to change based on a number of factors that are not within our control, including new scientific or technological data, adverse publicity regarding the industry recalls and safety risks of autonomous driving and ADAS, accidents involving our products, domestic and foreign political developments or considerations, and litigation relating to our products and our competitors’ products. Changes in government regulations, especially in the autonomous driving and ADAS industries, could adversely affect our business. If government priorities shift and we are unable to adapt to changing regulations, our business may be materially and adversely affected.
Federal and local regulators impose more stringent compliance and reporting requirements in response to product recalls and safety issues in the automotive and laser industry. As cars that carry our sensors go into production, the obligations of complying with safety regulations and reporting requirements could increase and it could require increased resources and adversely affect our business.
In addition, as vehicle regulators globally continue to consider new and enhanced emissions requirements, including electrification, to meet environmental and economic needs as well as pursue new safety standards to address emerging traffic risks, OEMs may need to dedicate technology and cost additions to new vehicle designs to meet these emissions and safety requirements and, as a result, postpone the consumer cost pressures of new autonomous and ADAS features.
Failures, or perceived failures, to comply with privacy, data protection, and information security requirements in the variety of jurisdictions in which we operate may adversely impact our business, and such legal requirements are evolving, uncertain and may require improvements in, or changes to, our policies and operations.
Our current and potential future operations and sales subject us to laws and regulations addressing privacy and the collection, use, storage, disclosure, transfer and protection of a variety of types of data. For example, the European Commission has adopted the General Data Protection Regulation and California recently enacted the California Consumer Privacy Act of 2018, both of which provide for potentially material penalties for non-compliance. These regimes may, among other things, impose data security requirements, disclosure requirements, and restrictions on data collection, uses, and sharing that may impact our operations and the development of our business. While, generally, we do not have access to, collect, store, process, or share information collected by our solutions unless our customers choose to proactively provide such information to us, our products may evolve both to address potential customer requirements or to add new features and functionality. Therefore, the full impact of these privacy regimes on our business is rapidly evolving across jurisdictions and remains uncertain at this time.
We may also be affected by cyber-attacks and other means of gaining unauthorized access to our products, systems, and data. For instance, cyber criminals or insiders may target us or third parties with which we have business relationships to obtain data, or in a manner that disrupts our operations or compromises our products or the systems into which our products are integrated.
We are assessing the continually evolving privacy and data security regimes and measures we believe are appropriate in response. Since these data security regimes are evolving, uncertain and complex, especially for a global business like ours, we may need to update or enhance our compliance measures as our products, markets and customer demands further develop, and
26

these updates or enhancements may require implementation costs. In addition, we may not be able to monitor and react to all developments in a timely manner. The compliance measures we do adopt may prove ineffective. Any failure, or perceived failure, by us to comply with current and future regulatory or customer-driven privacy, data protection, and information security requirements, or to prevent or mitigate security breaches, cyber-attacks, or improper access to, use of, or disclosure of data, or any security issues or cyber-attacks affecting us, could result in significant liability, costs (including the costs of mitigation and recovery), and a material loss of revenue resulting from the adverse impact on our reputation and brand, loss of proprietary information and data, disruption to our business and relationships, and diminished ability to retain or attract customers and business partners. Such events may result in governmental enforcement actions and prosecutions, private litigation, fines and penalties or adverse publicity, and could cause customers and business partners to lose trust in us, which could have an adverse effect on our reputation and business.
Regulations related to conflict minerals may cause us to incur additional expenses and could limit the supply and increase the costs of certain metals used in the manufacturing of our products.
We are subject to the requirements under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, or the Dodd-Frank Act, that will require us to determine, disclose and report whether our products contain conflict minerals. The implementation of these requirements could adversely affect the sourcing, availability and pricing of the materials used in the manufacture of components used in our products. In addition, we will incur additional costs to comply with the disclosure requirements, including costs related to conducting diligence procedures to determine the sources of conflict minerals that may be used in or necessary to the production of our products and, if applicable, potential changes to products, processes or sources of supply as a consequence of such verification activities. It is also possible that our reputation may be adversely affected if we determine that certain of our products contain minerals not determined to be conflict-free or if we are unable to alter our products, processes or sources of supply to avoid use of such materials.
Risks Related to Our Intellectual Property
Despite the actions we are taking to defend and protect our intellectual property, we may not be able to adequately protect or enforce our intellectual property rights or prevent unauthorized parties from copying or reverse engineering our solutions. Our efforts to protect and enforce our intellectual property rights and prevent third parties from violating our rights may be costly.
The success of our products and our business depends in part on our ability to obtain patents and other intellectual property rights and maintain adequate legal protection for our products in the United States and other international jurisdictions. We rely on a combination of patent, service mark, trademark and trade secret laws, as well as confidentiality procedures and contractual restrictions, to establish and protect our proprietary rights, all of which provide only limited protection.
We cannot be assured that any patents will be issued with respect to our currently pending patent applications or that any trademarks will be registered with respect to our currently pending applications in a manner that gives us adequate defensive protection or competitive advantages, if at all, or that any patents issued to us or any trademarks registered by us will not be challenged, invalidated or circumvented. We have filed for patents and trademarks in the United States and in certain international jurisdictions, but such protections may not be available in all countries in which we operate or in which we seek to enforce our intellectual property rights, or may be difficult to enforce in practice. Our currently-issued patents and trademarks and any patents and trademarks that may be issued or registered, as applicable, in the future with respect to pending or future applications may not provide sufficiently broad protection or may not prove to be enforceable in actions against alleged infringers. We cannot be certain that the steps we have taken will prevent unauthorized use of our technology or the reverse engineering of our technology. Moreover, others may independently develop technologies that are competitive to us or infringe our intellectual property.
Protecting against the unauthorized use of our intellectual property, products and other proprietary rights is expensive and difficult, particularly internationally. We believe that our patents are foundational in the area of lidar products and intends to enforce the intellectual property portfolio we have built over the years. Unauthorized parties may attempt to copy or reverse engineer our lidar technology or certain aspects of our solutions that we consider proprietary. Litigation may be necessary in the future to enforce or defend our intellectual property rights, to prevent unauthorized parties from copying or reverse engineering our solutions, to determine the validity and scope of the proprietary rights of others or to block the importation of infringing products into the United States.
Any such litigation, whether initiated by us or a third party, could result in substantial costs and diversion of management resources, either of which could adversely affect our business, operating results and financial condition. Even if we obtain favorable outcomes in litigation, we may not be able to obtain adequate remedies, especially in the context of unauthorized parties copying or reverse engineering our solutions.
27

Further, many of our current and potential competitors have the ability to dedicate substantially greater resources to defending intellectual property infringement claims and to enforcing their intellectual property rights than we have. Attempts to enforce our rights against third parties could also provoke these third parties to assert their own intellectual property or other rights against us or result in a holding that invalidates or narrows the scope of our rights, in whole or in part. Effective patent, trademark, service mark, copyright and trade secret protection may not be available in every country in which our products are available and competitors based in other countries may sell infringing products in one or more markets. Failure to adequately protect our intellectual property rights could result in our competitors offering similar products, potentially resulting in the loss of some of our competitive advantage and a decrease in our revenue, which would adversely affect our business, operating results, financial condition and prospects.
Third-party claims that we are infringing intellectual property, whether successful or not, could subject us to costly and time-consuming litigation or expensive licenses, and our business could be adversely affected.
Although we hold key patents related to our products, a number of companies, both within and outside of the lidar industry, hold other patents covering aspects of lidar products. In addition to these patents, participants in this industry typically also protect their technology, especially embedded software, through copyrights and trade secrets. As a result, there is frequent litigation based on allegations of infringement, misappropriation or other violations of intellectual property rights. We have received, and in the future may receive, inquiries from other intellectual property holders and may become subject to claims that we infringe their intellectual property rights, particularly as we expand our presence in the market, expand to new use cases and face increasing competition. In addition, parties may claim that the names and branding of our products infringe their trademark rights in certain countries or territories. If such a claim were to prevail, we may have to change the names and branding of our products in the affected territories and we could incur other costs.
We currently have a number of agreements in effect pursuant to which we have agreed to defend, indemnify and hold harmless our customers, suppliers, and channel partners and other partners from damages and costs which may arise from the infringement by our products of third-party patents or other intellectual property rights. The scope of these indemnity obligations varies, but may, in some instances, include indemnification for damages and expenses, including attorneys’ fees. Our insurance may not cover all intellectual property infringement claims. A claim that our products infringe a third party’s intellectual property rights, even if untrue, could adversely affect our relationships with our customers, may deter future customers from purchasing our products and could expose us to costly litigation and settlement expenses. Even if we are not a party to any litigation between a customer and a third party relating to infringement by our products, an adverse outcome in any such litigation could make it more difficult for us to defend our products against intellectual property infringement claims in any subsequent litigation in which we are a named party. Any of these results could adversely affect our brand and operating results.
Our defense of intellectual property rights claims brought against us or our customers, suppliers and channel partners, with or without merit, could be time-consuming, expensive to litigate or settle, divert management resources and attention and force us to acquire intellectual property rights and licenses, which may involve substantial royalty or other payments and may not be available on acceptable terms or at all. Further, a party making such a claim, if successful, could secure a judgment that requires us to pay substantial damages or obtain an injunction. An adverse determination also could invalidate our intellectual property rights and adversely affect our ability to offer our products to our customers and may require that we procure or develop substitute products that do not infringe, which could require significant effort and expense. Any of these events could adversely affect our business, operating results, financial condition and prospects.
Our intellectual property applications for registration may not issue or be registered, which may have a material adverse effect on our ability to prevent others from commercially exploiting products similar to ours.
We cannot be certain that we are the first inventor of the subject matter to which we have filed a particular patent application, or if we are the first party to file such a patent application. If another party has filed a patent application to the same subject matter as we have, we may not be entitled to the protection sought by the patent application. We also cannot be certain whether the claims included in a patent application will ultimately be allowed in the applicable issued patent. Further, the scope of protection of issued patent claims is often difficult to determine. As a result, we cannot be certain that the patent applications that we file will issue, or that our issued patents will afford protection against competitors with similar technology. In addition, our competitors may design around our issued patents, which may adversely affect our business, prospects, financial condition and operating results.
In addition to patented technology, we rely on our unpatented proprietary technology, trade secrets, processes and know-how.
We rely on proprietary information (such as trade secrets, know-how and confidential information) to protect intellectual property that may not be patentable or subject to copyright, trademark, trade dress or service mark protection, or that we believe is best protected by means that do not require public disclosure. We generally seek to protect this proprietary information by
28

entering into confidentiality agreements, or consulting services or employment agreements that contain non-disclosure and non-use provisions with our employees, consultants, contractors and third parties. However, we may fail to enter into the necessary agreements, and even if entered into, these agreements may be breached or may otherwise fail to prevent disclosure, third-party infringement or misappropriation of our proprietary information, may be limited as to their term and may not provide an adequate remedy in the event of unauthorized disclosure or use of proprietary information. We have limited control over the protection of trade secrets used by our current or future manufacturing partners and suppliers and could lose future trade secret protection if any unauthorized disclosure of such information occurs. In addition, our proprietary information may otherwise become known or be independently developed by our competitors or other third parties. To the extent that our employees, consultants, contractors, advisors and other third parties use intellectual property owned by others in their work for us, disputes may arise as to the rights in related or resulting know-how and inventions. Costly and time-consuming litigation could be necessary to enforce and determine the scope of our proprietary rights, and failure to obtain or maintain protection for our proprietary information could adversely affect our competitive business position. Furthermore, laws regarding trade secret rights in certain markets where we operate may afford little or no protection to our trade secrets.
We also rely on physical and electronic security measures to protect our proprietary information, but we cannot provide assurance that these security measures will not be breached or provide adequate protection for our property. There is a risk that third parties may obtain and improperly utilize our proprietary information to our competitive disadvantage. We may not be able to detect or prevent the unauthorized use of such information or take appropriate and timely steps to enforce our intellectual property rights.
We may be subject to damages resulting from claims that we or our employees have wrongfully used or disclosed alleged trade secrets of our employees’ former employers.
We may be subject to claims that we or our employees have inadvertently or otherwise used or disclosed trade secrets or other proprietary information of an employee’s former employers. Litigation may be necessary to defend against these claims. If we fail in defending such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. A loss of key personnel or their work product could hamper or prevent our ability to commercialize our products, which could severely harm our business. Even if we are successful in defending against these claims, litigation could result in substantial costs and demand on management resources.
We use certain software and data governed by open-source licenses, which under certain circumstances could adversely affect our business, results of operations and financial condition.
Certain of our software and data, as well as that of our customers and vendors, may be derived from or otherwise incorporate so-called “open source” software and data that is generally made available to the public by its authors and/or other third parties. Some open-source software is made available under licenses that impose certain obligations on us regarding modifications or derivative works we create based upon the open-source software. These obligations may require us to make source code for the derivative works available to the public and/or license such derivative works under a particular type of license, rather than the forms of license we customarily use to protect our intellectual property. Additionally, if we combine our proprietary software with open-source software in certain manners we could be required to release the source code of our proprietary software or to make our proprietary software available under open-source licenses to third parties at little or no cost or on unfavorable license terms. In the event that the copyright holder of, or other third party that distributes, open-source software alleges that we have not complied with the terms of an open-source license, we could incur significant legal costs defending ourselves against such allegations. If such claims are successful, we could be subject to significant damages, required to release the source code that we developed using that open-source software to the public, enjoined from distributing our software and/or required to take other actions that could adversely affect our business, results of operations and financial condition.
While we take steps to monitor the use of open-source software in our solutions, processes and technology and try to ensure that no open-source software is used in such a way as to require us to disclose the source code to the related product, processes, or technology when we do not wish to do so, such use could inadvertently occur. Additionally, if a third-party software provider has incorporated certain types of open source software into software we license from such third party for our solutions, processes, or technology, we could, under certain circumstances, be required to disclose the source code to our solutions, processes, or technology. This could harm our intellectual property position and adversely affect our business, results of operations and financial condition.
Further, the use of open-source software can lead to vulnerabilities that may make our software susceptible to attack, and although some open-source vendors provide warranty and support agreements, it is common for such software to be available “as is” with no warranty, indemnity, or support. Although we monitor our use of such open-source code to avoid subjecting our solutions to unintended conditions, such use, under certain circumstances, could materially adversely affect our business, financial condition and operating results and cash flow, including if we are required to take remedial action that may divert resources away from our development efforts.
29

Risks Related to Ownership of Our Shares
Our Second Amended and Restated Certificate of Incorporation provides, subject to limited exceptions, that the Court of Chancery of the State of Delaware (the “Chancery Court”) will be the sole and exclusive forum for certain stockholder litigation matters, which could limit our stockholders’ ability to obtain a chosen judicial forum for disputes with us or our directors, officers, employees or stockholders.
Our Second Amended and Restated Certificate of Incorporation requires, to the fullest extent permitted by law, that derivative actions brought in our name, actions against directors, officers and employees for breach of fiduciary duty and other similar actions may be brought in the Chancery Court or, if that court lacks subject matter jurisdiction, another federal or state court situated in the State of Delaware. Any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock will be deemed to have notice of and consented to the forum provisions in our Second Amended and Restated Certificate of Incorporation. In addition, our Second Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws provide that the federal district courts of the United States shall be the exclusive forum for the resolution of any suit brought to enforce a duty or liability created by the Securities Act or the Exchange Act or any other claim for which the U.S. federal courts have exclusive jurisdiction. The Second Amended and Restated Certificate of Incorporation further provides that, unless we consent in writing to the selection of an alternative forum, to the fullest extent permitted by law, the federal district courts of the United States of America will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act.
In March 2020, the Delaware Supreme Court issued a decision in Salzburg et al. v. Sciabacucchi, which found that an exclusive forum provision providing for claims under the Securities Act to be brought in federal court is facially valid under Delaware law. We intend to enforce this forum provision, but we do not know whether courts in other jurisdictions will agree with this decision or enforce it.
The choice of forum providing that a state or federal court located within the state of Delaware will be the exclusive forum for substantially all disputes between us and our stockholders may limit a stockholder’s ability to bring a claim in a judicial forum of its choosing for disputes with us or any of our directors, officers, other employees or stockholders, which may discourage lawsuits with respect to such claims. If any other court were to find the choice of forum provision contained in our Second Amended and Restated Certificate of Incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, operating results and financial condition.
Our charter documents and Delaware law could prevent a takeover that stockholders consider favorable and could also reduce the market price of our stock.
Our Second Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws contain provisions that could delay or prevent a change in control. These provisions could also make it more difficult for stockholders to elect directors and take other corporate actions. These provisions include:
providing for a classified board of directors with staggered, three-year terms;
authorizing our Board to issue Preferred Stock with voting or other rights or preferences that could discourage a takeover attempt or delay changes in control;
prohibiting cumulative voting in the election of directors;
providing that vacancies on our Board may be filled only by a majority of directors then in office, even though less than a quorum;
prohibiting the adoption, amendment or repeal of the Amended and Restated Bylaws or the repeal of the provisions of our Second Amended and Restated Certificate of Incorporation regarding the election and removal of directors without the required approval of at least two-thirds of the shares entitled to vote at an election of directors;
prohibiting stockholder action by written consent;
limiting the persons who may call special meetings of stockholders; and
requiring advance notification of stockholder nominations and proposals.
These provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our Board, which is responsible for appointing the members of our management. In addition, we are governed by the provisions of Section 203 of the Delaware General Corporation Law (the “DGCL”). These provisions may prohibit large stockholders, in particular those owning 15% or more of our outstanding voting stock, from merging or combining with us for a certain period of time without the consent of our Board.
30

These and other provisions in our Second Amended and Restated Certificate of Incorporation and our Amended and Restated Bylaws and under Delaware law could discourage potential takeover attempts, reduce the price investors might be willing to pay in the future for shares of Class A common stock and result in the market price of Class A common stock being lower than it would be without these provisions.
Claims for indemnification by our directors and officers may reduce our available funds to satisfy successful third-party claims against us and may reduce the amount of money available to us.
Our Second Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws provide that we will indemnify our directors and officers, in each case to the fullest extent permitted by Delaware law.
In addition, as permitted by Section 145 of the DGCL, the Amended and Restated Bylaws and the indemnification agreements that we have entered into with our directors and officers provide that:
we will indemnify our directors and officers for serving us in those capacities or for serving other business enterprises at our request, to the fullest extent permitted by Delaware law. Delaware law provides that a corporation may indemnify such person if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the registrant and, with respect to any criminal proceeding, had no reasonable cause to believe such person’s conduct was unlawful;
we may, in our discretion, indemnify employees and agents in those circumstances where indemnification is permitted by applicable law;
we will be required to advance expenses, as incurred, to our directors and officers in connection with defending a proceeding, except that such directors or officers shall undertake to repay such advances if we are ultimately determined that such person is not entitled to indemnification;
we will not be obligated pursuant to our Amended and Restated Bylaws to indemnify a person with respect to proceedings initiated by that person against us or our other indemnitees, except with respect to proceedings authorized by our Board or brought to enforce a right to indemnification;
the rights conferred in the Amended and Restated Bylaws are not exclusive, and we are authorized to enter into indemnification agreements with our directors, officers, employees and agents and to obtain insurance to indemnify such persons; and
we may not retroactively amend our Amended and Restated Bylaw provisions to reduce our indemnification obligations to directors, officers, employees and agents.
The dual class structure of our Common Stock has the effect of concentrating voting control with Austin Russell, our Founder, President and Chief Executive Officer. This will limit or preclude your ability to influence corporate matters, including the outcome of important transactions, including a change in control.
Shares of our Class B common stock, $0.0001 par value per share (“Class B common stock”), have 10 votes per share, while shares of Class A common stock have one vote per share. Austin Russell, our Founder, President and Chief Executive Officer, holds all of the issued and outstanding shares of Class B common stock. Accordingly, Mr. Russell held approximately 78.3% of the voting power of our outstanding capital stock as of December 31, 2022 and will be able to control matters submitted to our stockholders for approval, including the election of directors, amendments of our organizational documents and any merger, consolidation, sale of all or substantially all of our assets or other major corporate transactions. Mr. Russell may have interests that differ from the interests of other stockholders of the Company and may vote in a way with which other stockholders of the Company disagree and which may be adverse to other stockholders’ interests. This concentrated control may have the effect of delaying, preventing or deterring a change in control of us, could deprive our stockholders of an opportunity to receive a premium for their capital stock as part of a sale of us, and might ultimately affect the market price of shares of Class A common stock.
In connection with the execution of the Merger Agreement, Austin Russell entered into a voting agreement, dated as of August 24, 2020, with Gores (the “Voting Agreement”). Under the Voting Agreement, Mr. Russell agreed that, following the consummation of the prior business combination between Legacy Luminar and Gores Metropoulos, Inc., solely if he is involuntarily terminated from his position as the Chief Executive Officer of the Company as a result of his conviction of, or pleading guilty or nolo contendere to, a felony that has a material negative impact on the Company, at any meeting of the stockholders of the Company at which directors are to be elected following the consummation of the Business Combination, Mr. Russell, or any of his permitted successors or assigns, will not vote more than 10% of the Class B common stock he or they beneficially own in any director election.
31

We are a controlled company within the meaning of The Nasdaq Stock Market listing standards, and, as a result, qualify for exemptions from certain corporate governance requirements that provide protection to stockholders of other companies. To the extent we utilize any of these exemptions, you will not have the same protections afforded to stockholders of companies that are subject to such requirements. We do not currently intend to rely on the exemptions afforded to controlled companies at this time.
So long as more than 50% of the voting power for the election of our directors is held by an individual, a group or another company, we will qualify as a “controlled company” under The Nasdaq Stock Market listing requirements. Austin Russell controls a majority of the voting power of our outstanding capital stock. As a result, we are a “controlled company” under the Nasdaq Stock Market rules. As a controlled company, we are exempt from certain Nasdaq corporate governance requirements, including those that would otherwise require our Board to have a majority of independent directors and require that we establish a compensation committee comprised entirely of independent directors, or otherwise ensure that the compensation of our executive officers and nominees for directors are determined or recommended to our Board by the independent members of our Board. While we do not currently rely on any of these exemptions, we will be entitled to do so for as long as we are considered a “controlled company,” and to the extent we rely on one or more of these exemptions, holders of our capital stock will not have the same protections afforded to stockholders of companies that are subject to all of Nasdaq’s corporate governance requirements.
Our dual class structure may depress the trading price of the Class A common stock.
Our dual class structure may result in a lower or more volatile market price of the Class A common stock or in adverse publicity or other adverse consequences due to disfavor of a dual class structure by certain organizations. For example, certain index providers have announced restrictions on including companies with multiple-class share structures in certain of their indexes. S&P Dow Jones and FTSE Russell had previously announced changes to their eligibility criteria for inclusion of shares of public companies on certain indices, including the S&P 500, pursuant to which companies with multiple classes of shares of common stock are excluded. In addition, several stockholder advisory firms have policies that oppose the use of multiple class structures. As a result, the dual class structure of our Common Stock may cause stockholder advisory firms to publish negative commentary about our corporate governance practices or otherwise seek to cause us to change our capital structure. Any such exclusion from indices or any actions or publications by stockholder advisory firms critical of our corporate governance practices or capital structure could adversely affect the value and trading market of the Class A common stock.
The market price and trading volume of Class A common stock is volatile and could decline significantly.
The market price of our Class A common stock has been and is expected to continue to be volatile and has recently experienced declines. In addition, the trading volume of our Class A common stock may fluctuate and cause significant price variations to occur. We cannot assure you that the market price of Class A common stock will not fluctuate widely or decline significantly in the future in response to a number of factors, including, among others, the following:
the realization of any of the risk factors presented in this Annual Report;
actual or anticipated differences in our estimates, or in the estimates of analysts, for our revenues, Adjusted EBITDA, results of operations, level of indebtedness, liquidity or financial condition;
additions and departures of key personnel;
failure to comply with the requirements of Nasdaq, Sarbanes-Oxley Act or other laws or regulations;
future issuances, sales, resales or repurchases or anticipated issuances, sales, resales or repurchases, of our securities;
publication of research reports about us;
the performance and market valuations of other similar companies;
commencement of, or involvement in, litigation involving us;
broad disruptions in the financial markets, including sudden disruptions in the credit markets;
speculation in the press or investment community;
actual, potential or perceived control, accounting or reporting problems;
changes in accounting principles, policies and guidelines; and
other events or factors, including those resulting from infectious diseases, health epidemics and pandemics (including the ongoing COVID-19 public health emergency), natural disasters, war, acts of terrorism or responses to these events.
32

In the past, securities class-action litigation has often been instituted against companies following periods of volatility in the market price of their shares. This type of litigation could result in substantial costs and divert our management’s attention and resources, which could have a material adverse effect on us.
If securities or industry analysts do not publish or cease publishing research or reports about us, our business, or our market, or if they change their recommendations regarding our Class A common stock adversely, then the price and trading volume of our Class A common stock could decline.
The trading market for our Class A common stock will be influenced by the research and reports that industry or securities analysts may publish about us, our business, our market, or our competitors. Securities and industry analysts do not currently, and may never, publish research on us. If no securities or industry analysts commence coverage of us, our stock price and trading volume would likely be negatively impacted. If any of the analysts who may cover us change their recommendation regarding our stock adversely, or provide more favorable relative recommendations about our competitors, the price of our Class A common stock would likely decline. If any analyst who may cover us were to cease coverage of us or fail to regularly publish reports on us, we could lose visibility in the financial markets, which could cause our stock price or trading volume to decline.
Future issuances of debt securities and equity securities, including from the exercise of warrants for our Class A common stock, and issuances to customers, vendors or partners, may adversely affect us, including the market price of the Class A common stock and may be dilutive to existing stockholders.
In the future, we may require additional capital to respond to technological advancements, competitive dynamics or technologies, customer demands, business opportunities, challenges, acquisitions or unforeseen circumstances and we may determine to engage in equity or debt financings or enter into credit facilities for other reasons. Securities and agreements involving the issuance of debt will generally rank senior to the Class A common stock and have priority upon liquidation. Such securities also may be governed by an indenture or other instrument containing covenants restricting the Company’s operating flexibility. Additionally, any equity securities or convertible or exchangeable securities that we issue in the future may have rights, preferences and privileges more favorable than those of the Class A common stock. In addition, in order to further business relationships with current or potential customers, vendors or partners, we may issue equity or equity-linked securities to such current or potential customers, vendors or partners. Because our decision to issue debt or equity in the future will depend on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing, nature or success of our future capital raising efforts. Sales of shares of Class A common stock in the public market or the perception that these sales or conversions might occur may depress the market price of Class A common stock and could impair our ability to raise capital through the sale of additional equity securities.
In addition, as of December 31, 2022, we had warrants to purchase an aggregate of 5.8 million shares of our Class A common stock outstanding. To the extent remaining warrants are exercised, additional shares of Class A common stock will be issued, which will result in dilution to the then-existing holders of Class A common stock and increase the number of shares eligible for resale in the public market. Sales of substantial numbers of such shares in the public market or the fact that such warrants may be exercised could adversely affect the market price of our Class A common stock.
Our failure to meet the continued listing requirements of Nasdaq could result in a delisting of our securities.
If we fail to satisfy the continued listing requirements of Nasdaq such as the corporate governance requirements or the minimum closing bid price requirement, Nasdaq may take steps to delist our securities. Such a delisting would likely have a negative effect on the price of the securities and would impair the ability of stockholders to sell or purchase their securities. In the event of a delisting, we can provide no assurance that any action taken by us to restore compliance with listing requirements would allow our securities to become listed again, stabilize the market price or improve the liquidity of our securities, prevent our securities from dropping below the Nasdaq minimum bid price requirement or prevent future non-compliance with Nasdaq’s listing requirements. Additionally, if our securities are not listed on, or become delisted from, Nasdaq for any reason, and are quoted on an inter-dealer automated quotation system for equity securities that is not a national securities exchange, the liquidity and price of our securities may be more limited than if we were quoted or listed on Nasdaq or another national securities exchange. You may be unable to sell your securities unless a market can be established or sustained.
Risks Related to Our Indebtedness
Our indebtedness and liabilities could limit the cash flow available for our operations, expose us to risks that could adversely affect our business, financial condition and results of operations and impair our ability to satisfy our obligations under the notes.
As of December 31, 2022, our total consolidated indebtedness was $612.2 million, representing the Convertible Senior Notes, net of unamortized debt discount and issuance costs, finance leases and certain secured equipment loans. We may also
33

incur additional indebtedness to meet future financing needs. Our indebtedness could have significant negative consequences for our security holders and our business, results of operations and financial condition by, among other things:
increasing our vulnerability to adverse economic and industry conditions;
limiting our ability to obtain additional financing;
requiring the dedication of a substantial portion of our cash flow from operations to service our indebtedness, which will reduce the amount of cash available for other purposes;
limiting our flexibility to plan for, or react to, changes in our business;
diluting the interests of our existing stockholders as a result of issuing shares of our Class A common stock upon conversion of the notes; and
placing us at a possible competitive disadvantage with competitors that are less leveraged than us or have better access to capital.
Our business may not generate sufficient funds, and we may otherwise be unable to maintain sufficient cash reserves, to pay amounts due under our indebtedness, including the notes, and our cash needs may increase in the future. In addition, any future indebtedness that we may incur may contain, financial and other restrictive covenants that limit our ability to operate our business, raise capital or make payments under our other indebtedness. If we fail to comply with these covenants or to make payments under our indebtedness when due, then we would be in default under that indebtedness, which could, in turn, result in that and our other indebtedness becoming immediately payable in full.
We may be unable to raise the funds necessary to repurchase the notes for cash following a fundamental change, or to pay any cash amounts due upon conversion, and our other indebtedness may limit our ability to repurchase the notes or pay cash upon their conversion.
Noteholders may, subject to a limited exception, require us to repurchase their notes following a fundamental change at a cash repurchase price generally equal to the principal amount of the notes to be repurchased, plus accrued and unpaid interest, if any. In addition, upon conversion, we will satisfy part or all of our conversion obligation in cash unless we elect to settle conversions solely in shares of our Class A common stock. We may not have enough available cash or be able to obtain financing at the time we are required to repurchase the notes or pay any cash amounts due upon conversion. In addition, applicable law, regulatory authorities and the agreements governing any future indebtedness may restrict our ability to repurchase the notes or pay any cash amounts due upon conversion. Our failure to repurchase notes or to pay any cash amounts due upon conversion or when otherwise required will constitute a default under the indenture. A default under the indenture or the fundamental change itself could also lead to a default under agreements governing other indebtedness which we have incurred or may incur, which may result in that other indebtedness becoming immediately payable in full. We may not have sufficient funds to satisfy all amounts due under the other indebtedness and the notes.
The accounting method for the notes could adversely affect our reported financial condition and results.
In August 2020, the Financial Accounting Standards Board published an Accounting Standards Update, which we refer to as ASU 2020-06, to reduce the number of accounting models for convertible debt instruments. We early adopted ASU 2020-06, effective January 1, 2021. The elimination of the separate accounting described above to reduce the interest expense that we have recognized and expect to recognize in the future for the notes for accounting purposes. Under ASU 2020-06, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, or that do not result in substantial premiums accounted for as paid-in capital. Consequently, the notes are accounted for as a single liability measured at amortized cost. Further, ASU 2020-06 eliminates the use of the treasury stock method for convertible instruments that can be settled in whole or in part with equity, and instead requires application of the “if-converted” method. Under that method, diluted earnings per share would generally be calculated assuming that all the notes were converted solely into shares of Class A common stock at the beginning of the reporting period, unless the result would be anti-dilutive. The application of the if-converted method may reduce our reported diluted earnings per share.
Furthermore, if any of the conditions to the convertibility of the notes is satisfied, then we may be required under applicable accounting standards to reclassify the liability carrying value of the notes as a current, rather than a long-term, liability. This reclassification could be required even if no noteholders convert their notes and could materially reduce our reported working capital.
The capped call transactions may affect the value of the notes and our Class A common stock.
In connection with the Convertible Senior Notes, we entered into privately negotiated capped call transactions with the option counterparties. The capped call transactions are expected generally to reduce the potential dilution to our Class A
34

common stock upon any conversion of the notes and/or offset any potential cash payments we are required to make in excess of the principal amount of converted notes, as the case may be, with such reduction and/or offset subject to a cap.
We have been advised that, in connection with establishing their initial hedges of the capped call transactions, the option counterparties or their respective affiliates entered into various derivative transactions with respect to our Class A common stock and/or purchased shares of our Class A common stock.
In addition, the option counterparties and/or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to our Class A common stock and/or purchasing or selling our Class A common stock or other securities of ours in secondary market transactions following the pricing of the notes and from time to time prior to the maturity of the notes (and are likely to do so following any conversion of the notes, any repurchase of the notes by us on any fundamental change repurchase date, any redemption date or any other date on which the notes are retired by us, in each case if we exercise the relevant election to terminate the corresponding portion of the capped call transactions). This activity could also cause or avoid an increase or a decrease in the market price of our Class A common stock.
We are subject to counterparty risk with respect to the capped call transactions and an accelerated share repurchase program (the “ASR program”), and the capped call transactions and ASR program may not operate as planned.
The option counterparties are, and the ASR counterparty will be, financial institutions, and we will be subject to the risk that they might default under the capped call transactions or the ASR program. Our exposure to the credit risk of the option counterparties or ASR counterparty will not be secured by any collateral. Global economic conditions have from time to time resulted in the actual or perceived failure or financial difficulties of many financial institutions, including the bankruptcy filing by Lehman Brothers Holdings Inc. and its various affiliates. If an option counterparty or ASR counterparty becomes subject to insolvency proceedings, we will become an unsecured creditor in those proceedings with a claim equal to our exposure at that time under our transactions with that option counterparty or the ASR counterparty. Our exposure will depend on many factors, but, generally, the increase in our exposure will be correlated with increases in the market price or the volatility of our Class A common stock. In addition, upon a default by an option counterparty or the ASR counterparty, we may suffer more dilution than we currently anticipate with respect to our Class A common stock. We can provide no assurances as to the financial stability or viability of any option counterparty or ASR counterparty.
In addition, the capped call transactions are complex, and they may not operate as planned. For example, the terms of the capped call transactions may be subject to adjustment, modification or, in some cases, renegotiation if certain corporate or other transactions occur. Accordingly, these transactions may not operate as we intend if we are required to adjust their terms as a result of transactions in the future or upon unanticipated developments that may adversely affect the functioning of the capped call transactions.
General Risks
Unanticipated changes in effective tax rates or adverse outcomes resulting from examination of our income or other tax returns could adversely affect our financial condition and results of operations.
We will be subject to income taxes in the United States and other jurisdictions, and our tax liabilities will be subject to the allocation of expenses in differing jurisdictions. Our future effective tax rates could be subject to volatility or adversely affected by a number of factors, including:
changes in the valuation of our deferred tax assets and liabilities;
expected timing and amount of the release of any tax valuation allowances;
tax effects of stock-based compensation;
costs related to intercompany restructurings;
changes in tax laws, regulations or interpretations thereof;
changes in accounting and tax standards or practices;
changes in the composition of operating income by the taxing jurisdiction; or
lower than anticipated future earnings in jurisdictions where we have lower statutory tax rates and higher than anticipated future earnings in jurisdictions where we have higher statutory tax rates.
In addition, we may be subject to audits of our income, sales and other transaction taxes by taxing authorities. Outcomes from these audits could have an adverse effect on our financial condition and results of operations.
35

We are subject to U.S. and foreign anti-corruption and anti-money laundering laws and regulations. We can face criminal liability and other serious consequences for violations, which can harm our business.
We are subject to the U.S. Foreign Corrupt Practices Act of 1977, as amended, the U.S. domestic bribery statute contained in 18 U.S.C. § 201, the U.S. Travel Act, the USA PATRIOT Act and possibly other anti-bribery and anti-money laundering laws in countries in which we conduct activities. Anti-corruption laws are interpreted broadly and prohibit companies and their employees, agents, contractors and other collaborators from authorizing, promising, offering or providing, directly or indirectly, improper payments or anything else of value to recipients in the public or private sector. We can be held liable for the corrupt or other illegal activities of our employees, agents, contractors and other collaborators, even if we do not explicitly authorize or have actual knowledge of such activities. Any violations of the laws and regulations described above may result in substantial civil and criminal fines and penalties, imprisonment, the loss of export or import privileges, debarment, tax reassessments, breach of contract and fraud litigation, reputational harm and other consequences.
On December 22, 2017, the Tax Cuts and Jobs Act of 2017 (the “Tax Act”) was signed into law making significant changes to the U.S. Tax Code. In particular, sweeping changes were made to the U.S. taxation of foreign operations. Changes include, but are not limited to, a reduction to the corporate income tax rate, limiting interest deductions, adopting elements of a territorial tax system, assessing a repatriation tax or “toll-charge” on undistributed earnings and profits of U.S.-owned foreign corporations, and introducing certain anti-base erosion provisions, including a new minimum tax on global intangible low-taxed income (“GILTI”) and base erosion and anti-abuse tax (“BEAT”). The new legislation did not have a material impact on our provision for income taxes for 2020 and 2019, because we generated net tax losses and offset our deferred tax assets on the balance sheet with a full valuation allowance due to our current loss position and forecasted losses for the near future. The overall impact of this tax reform is uncertain, and our business and financial condition, including with respect to our non-U.S. operations, could be adversely affected.
In addition to the impact of the Tax Act on our federal taxes, the Tax Act may impact our taxation in other jurisdictions, including state income taxes. Additionally, other foreign governing bodies may enact changes to their tax laws in reaction to the Tax Act that could result in changes to our global tax position and materially adversely affect our business, results of operations and financial condition. Additionally, the Internal Revenue Service, (the “IRS”) and several foreign tax authorities have increasingly focused attention on intercompany transfer pricing with respect to sales of products and services and the use of intangibles. Tax authorities could disagree with our future intercompany charges, cross-jurisdictional transfer pricing or other matters and assess additional taxes. If we do not prevail in any such disagreements, our profitability may be affected.
The current conflict between Ukraine and Russia has exacerbated market instability and disrupted the global economy and may adversely affect our business, results of operations and financial condition.
The current conflict between Ukraine and Russia has caused uncertainty about economic and political stability, increasing volatility in the credit and financial markets and disrupting the global economy. The United States, the European Union, and several other countries are imposing far-reaching sanctions and export control restrictions on Russian entities and individuals. These sanctions and export controls may also contribute to higher oil and gas prices and inflation, which could reduce demand in the global automotive sector and therefore reduce demand for our solutions. There is also a risk that Russia launches sanctions and other retaliatory actions. Additional consequences of the conflict may include diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, and various shortages and supply chain disruptions. While we do not currently directly rely on goods or services sourced in Russia or Ukraine and thus have not experienced any direct disruptions, we may experience indirect disruptions in our supply chain. Any of the foregoing factors, including developments or effects that we cannot yet predict, may adversely affect our business, results of operations and financial condition.
Our business is subject to the risks of earthquakes, fire, floods and other natural catastrophic events, global pandemics, and interruptions by man-made problems, such as terrorism. Material disruptions of our business or information systems resulting from these events could adversely affect our operating results.
A significant natural disaster, such as an earthquake, fire, flood, hurricane or significant power outage or other similar events, such as infectious disease outbreaks or pandemic events, could have an adverse effect on our business and operating results. One of our offices is located in the San Francisco Bay Area, a region known for seismic activity. In addition, natural disasters, acts of terrorism or war could cause disruptions in our remaining manufacturing operations, our or our customers’ or channel partners’ businesses, our suppliers’ or the economy as a whole. We also rely on information technology systems to communicate among our workforce and with third parties. Any disruption to our communications, whether caused by a natural disaster or by man made problems, such as power disruptions, could adversely affect our business. We do not have a formal disaster recovery plan or policy in place and do not currently require that our suppliers’ partners have such plans or policies in place. To the extent that any such disruptions result in delays or cancellations of orders or impede our suppliers’ ability to timely deliver product components, or the deployment of our products, our business, operating results and financial condition would be adversely affected.
36

ITEM 1B. UNRESOLVED STAFF COMMENTS.
None.
ITEM 2. PROPERTIES.
Our corporate headquarters is located in Orlando, Florida, where we lease a complex of three buildings with 170,294 square feet pursuant to leases that expire between June 2026 and September 2028. The Orlando facilities contain manufacturing, engineering, research and development, and administrative functions. We also lease 25,617 square feet of office and engineering space in two facilities in Palo Alto, California, 12,900 square feet of office and engineering space in a facility in Colorado Springs, Colorado, 7,573 square feet of office and engineering space in a facility in Boston, Massachusetts, and 20,337 square feet of office and engineering space in a facility in Santa Barbara, California. The Company believes its existing facilities are adequate for its current requirements.
ITEM 3. LEGAL PROCEEDINGS.
From time to time, we may become involved in actions, claims, suits, and other legal proceedings in the ordinary course of our business, including assertions by third parties relating to intellectual property infringement, breaches of contract or warranties or employment-related matters. We are not currently a party to any actions, claims, suits or other legal proceedings the outcome of which, if determined adversely to us, would individually or in the aggregate have a material adverse effect on our business, financial condition and results of operations.
ITEM 4. MINE SAFETY DISCLOSURES.
Not applicable.
37


PART II
ITEM 5. MARKET FOR THE REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.
Market Information
Our shares of Class A common stock have traded on the Nasdaq Global Select Market under the symbol “LAZR,” since December 3, 2020. Prior to that date, our common stock traded on the Nasdaq Global Select Market under the symbol “GMHI,” since March 25, 2019. There is no public trading market for our Class B common stock.
Holders
As of February 17, 2023, there were 339 holders of record of our Class A common stock and one holder of record of our Class B common stock. The number of record holders is based upon the actual number of holders registered on our books at such date and does not include holders of shares in street name or persons, partnerships, associations, corporations or other entities identified in security position listings maintained by depository trust companies.
Dividend Policy
We have never declared or paid any cash dividends on our common stock. We currently intend to retain any future earnings and do not expect to pay any dividends in the foreseeable future. Any future determination to declare cash dividends will be made at the discretion of our board of directors, subject to applicable laws, and will depend on a number of factors, including our financial condition, results of operations, capital requirements, contractual restrictions, including under any future loan facilities, general business conditions and other factors that our board of directors may deem relevant.
Recent Sales of Unregistered Securities
In connection with our investment in Class A ordinary shares of ECARX Holdings Inc. (“ECARX”), on December 20, 2022, we issued 2,030,374 shares of Class A common stock to ECARX pursuant to a private placement exempt from registration under the Securities Act of 1933, as amended, in reliance on Section 4(a)(2) thereof.

38

Stock Performance Graph
The graph below compares the cumulative total return on our common stock with that of the NASDAQ Composite Index and the Russell 2000 Index. The period shown commences on December 3, 2020, the date our common stock commenced trading on the Nasdaq Global Select Market, and ends on December 31, 2022. The graph assumes $100 was invested at the close of market on December 3, 2020 in the common stock of Luminar, the NASDAQ Composite Index and the Russell 2000 Index, and assumes the reinvestment of any dividends. The stock price performance on the following graph is not intended to forecast or be indicative of future stock price performance of our common stock.
lazr-20221231_g1.jpg
This performance graph shall not be deemed “soliciting material” or to be “filed” with the SEC for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities under that Section, and shall not be deemed to be incorporated by reference into any filing of Luminar Technologies, Inc. under the Securities Act of 1933, as amended, or the Securities Act of 1934 Exchange, as amended.
$100 investment in stock or index12/3/202012/31/202003/31/202106/30/202109/30/202112/31/202103/31/202206/30/202209/30/202212/31/2022
Luminar Technologies, Inc.$100.00 $147.95 $105.79 $95.52 $67.89 $75.15 $68.02 $25.81 $31.70 $21.54 
NASDAQ Composite Index100.00 104.13 107.03 117.18 116.74 127.18 114.89 89.11 85.44 84.56 
Russell 2000 Index100.00 106.82 120.11 124.98 119.24 121.64 111.98 92.39 90.05 95.27 
ITEM 6. RESERVED.

39

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
The following discussion and analysis provides information that Luminar’s management believes is relevant to an assessment and understanding of Luminar’s consolidated results of operations and financial condition. The discussion should be read together with “Selected Historical Consolidated Financial and Operating Data of Luminar” and the historical audited annual consolidated financial statements as of and for the years ended December 31, 2022 and 2021, and the related notes thereto, included elsewhere in this Annual Report on Form 10-K. This discussion may contain forward-looking statements based upon Luminar’s current expectations, estimates and projections that involve risks and uncertainties. Actual results could differ materially from those anticipated in these forward-looking statements due to, among other considerations, the matters discussed under “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements.” Unless the context otherwise requires, all references in this subsection to “Luminar” refer to the business of Luminar Technologies, Inc., a Delaware corporation, and its subsidiaries prior to the consummation of the Business Combination, which is the business of the post-Business Combination Company and its subsidiaries following the consummation of the Business Combination.
Discussion regarding our financial condition and results of operations for the year ended December 31, 2021 as compared to the year ended December 31, 2020 is included in Item 7 of our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, filed with the SEC on March 1, 2022.
Overview
We are a global automotive technology company ushering a new era of vehicle safety and autonomy. We are enabling solutions for series production passenger cars and commercial trucks as well as other targeted markets.
We have built a new type of lidar sensor which we believe meets the demanding performance, safety, and cost requirements for autonomous vehicles in production, while also enabling Advanced Driving Assistance Systems (“ADAS”).
Our lidar hardware and software products help set the standard for safety in the industry, and are designed to enable accurate and reliable detections of some of the most challenging “edge cases” autonomous vehicles can encounter on a regular basis. This is achieved by advancing existing lidar range and resolution to new levels, ensuring hard-to-see objects like a tire on the road ahead or a child that runs into the street are not missed, as well as by developing our software to interpret the data needed to inform autonomous and assisted driving decisions.
Business Combinations
Solfice Assets Purchase
On June 15, 2022, we completed our purchase of certain assets from Solfice Research, Inc. (“Solfice”). These assets are expected to advance our software development capabilities. The transaction was determined to be an asset acquisition under ASC 805, Business Combinations, with substantially all of the fair value attributable to acquired technology.
Freedom Photonics Acquisition
On April 13, 2022, we completed our acquisition of Freedom Photonics LLC (“Freedom Photonics”), a designer and manufacturer of high-performance lasers and related photonic products. The Freedom Photonics acquisition is expected to help us secure intellectual property and the supply of a key enabling component as part of our vertical integration strategy.
Optogration Acquisition
On August 3, 2021, we completed our acquisition of Optogration, Inc. (“Optogration”). The Optogration acquisition helps us secure intellectual property and supply of Indium Gallium Arsenide (“InGaAs”) photodetector semiconductor chips, which are used to convert optical power into an electrical current. The acquisition of Optogration is part of our vertical integration strategy, which will secure supply of a key component of our sensor technology.
Reverse Merger with Gores
On December 2, 2020 (the “Closing Date”), we merged with Gores Metropoulos, Inc. (“Gores”), at which time First Merger Sub, a newly formed subsidiary of Gores, merged with and into Luminar Technologies, Inc. (the “Company” or “Luminar”), with Luminar being the surviving corporation (the “First Merger”). Immediately following the consummation of the First Merger and as part of the same overall transaction as the First Merger, Luminar, merged with and into Dawn Merger Sub II, LLC (“Second Merger Sub”), a newly formed subsidiary of Gores, with Second Merger Sub continuing as the surviving entity (the “Second Merger” and, in combination with the First Merger and the other related transactions, the “Business Combination”). Luminar was deemed the accounting predecessor and the post-combination Company is the successor SEC registrant, which means that Luminar’s financial statements for previous periods will be disclosed in our future periodic reports
40

filed with the SEC, as appropriate. The Business Combination was accounted for as a reverse recapitalization. Under this method of accounting, Gores was treated as the acquired company for financial statement reporting purposes.
COVID-19 Impact
The coronavirus (COVID-19) pandemic has adversely affected our and some of our customers’ business operations. The extent of the continued impact of the coronavirus pandemic on our operational and financial performance will depend on various future developments, including the duration and spread of the outbreak, including the emergence of variants, and impact on our customers, suppliers, and employees, all of which is uncertain at this time. We expect the coronavirus (COVID-19) pandemic to adversely impact our business, including product development and industrialization initiatives, timing of shipment of products and provision of services to customers, supply chain, and may impact our financial position and results of operations. We are unable to predict at this time the potential adverse impact. For more information on our operations and risks related to health epidemics, including the COVID-19 pandemic, see Item 1A. Risk Factors in this Form 10-K.
Basis of Presentation
Our consolidated financial statements include the accounts of our wholly-owned subsidiaries. We have eliminated intercompany accounts and transactions.
Components of Results of Operations
Revenue
Our business and revenue producing activities are organized in two operating segments: (i) Autonomy Solutions and (ii) Advanced Technologies and Services (“ATS”).
The Autonomy Solutions segment is engaged in design, manufacturing, and sale of lidar sensors catering mainly to the OEMs in the automobile, commercial vehicle, robo-taxi and adjacent industries. The Autonomy Solutions segment revenue also includes fees earned from non-recurring engineering services provided to customers in connection with customization of our sensor and software products, as well as revenue generated from licensing of certain information.
The ATS segment provides advanced semiconductors and related components, as well as design, test and consulting services to the Autonomy Solutions segment and to various third-party customers, including government agencies and defense contractors, in markets generally unrelated to autonomous vehicles.
Revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Fixed fee arrangements are satisfied over time and utilize the input method based on costs incurred. Accordingly, revenue for fixed fee arrangements is recognized on a percentage of completion basis. Certain customer contracts are also structured as time and materials and billed at cost of time incurred plus a markup. Such time and material contracts are recognized over time.
Two customers accounted for 21%, and 17% of our revenue for the year ended December 31, 2022. Two customers accounted for 42% and 17% of our revenue for the year ended December 31, 2021. One customer accounted for 64% of our revenue for the year ended December 31, 2020.
Cost of sales and gross profit (loss)
Cost of sales includes the fixed and variable manufacturing cost of our lidar sensors, which primarily consists of personnel-related costs including certain engineering personnel and stock-based compensation and material purchases from third-party contract manufacturers and suppliers which are directly associated with our manufacturing process. Cost of sales includes cost of providing services to customers, depreciation and amortization for manufacturing fixed assets or equipment, cost of components, product testing and launch-related costs, an allocated portion of overhead, facility and information technology (“IT”) costs, write downs for excess and obsolete inventory and shipping costs.
The ATS segment provides certain services and components to the Autonomy Solutions segment which are recorded as cost of goods sold or research and development costs depending on the nature and use of such services and components by the Autonomy Solutions segment. These inter-segment transactions are eliminated in the consolidated results.
Gross profit (loss) equals revenue less cost of sales.
Operating Expenses
Research and Development (R&D)
R&D costs are expensed as incurred. Design and development costs for products to be sold under long-term supply arrangements are expensed as incurred. Design and development costs for molds, dies, and other tools involved in developing new technology are expensed as incurred.
41

Our R&D efforts are focused on enhancing and developing additional functionality for our existing products and on new product development, including new releases and upgrades to our lidar sensors and integrated software solutions. R&D expenses consist primarily of:
Personnel-related expenses, including salaries, benefits, and stock-based compensation expense, for personnel in our research and engineering functions;
Expenses related to materials, software licenses, supplies and third-party services;
Prototype expenses; and
An allocated portion of facility and IT costs and depreciation.
The ATS segment provides certain services and components to the Autonomy Solutions segment which are recorded as cost of goods sold or research and development costs depending on the nature and use of such services and components by the Autonomy Solutions segment. These inter-segment transactions are eliminated in our consolidated results. We expect our R&D costs to increase for the foreseeable future as we continue to invest in research and development activities to achieve our product roadmap, and we expect to continue to incur operating losses for at least the foreseeable future due to continued R&D investments.
Sales and Marketing Expenses
Sales and marketing expenses consist of personnel and personnel-related expenses, including stock-based compensation of our business development team, as well as advertising and marketing expenses. These include the cost of marketing programs, trade shows, promotional materials, demonstration equipment, an allocated portion of facility and IT costs and depreciation.
We expect to increase our sales and marketing activities, mainly in order to continue to build out our geographic presence to be closer to our partners and better serve them. We also expect that our sales and marketing expenses will increase over time as we continue to hire additional personnel to scale our business.
General and Administrative Expenses
General and administrative expenses consist of personnel and personnel-related expenses, including stock-based compensation of our executive, finance, human resources, information systems and legal departments as well as legal and accounting fees for professional and contract services.
We expect our general and administrative expenses to increase for the foreseeable future as we scale headcount with the growth of our business, and as a result of operating as a public company, including compliance with the rules and regulations of the SEC, legal, audit, additional insurance expenses, investor relations activities, and other administrative and professional services.
Change in Fair Value of Warrants
The warrant liabilities are classified as marked-to-market liabilities and the corresponding increase or decrease in value is reflected in change in fair value of warrants.
Interest Income and Other, and Interest Expense and Other
Interest income and other consists primarily of income earned on our cash equivalents and marketable securities. These amounts will vary based on our cash, cash equivalents and marketable securities balances, and also with market rates. It also includes realized gains and losses related to the marketable securities, as well as impact of gains and losses related to foreign exchange transactions, and impairment of investments and certain other assets. Interest expense and other consisted primarily of interest on convertible senior notes issued in December 2021, finance leases and interest on our senior secured term loan facility, which was repaid upon consummation of the Business Combination.
42

Results of Operations
Comparison of the Years Ended December 31, 2022 and 2021
The results of operations presented below should be reviewed in conjunction with the consolidated financial statements and notes included elsewhere in this report. The following table sets forth our consolidated results of operations data for the periods presented (in thousands):
Year Ended December 31,ChangeChange
20222021$%
Revenue$40,698 $31,944 $8,754 27 %
Cost of sales100,983 46,092 54,891 119 %
Gross loss(60,285)(14,148)(46,137)326 %
Operating Expenses:
Research and development185,283 88,861 96,422 109 %
Sales and marketing38,672 17,858 20,814 117 %
General and administrative158,162 93,685 64,477 69 %
Total operating expenses382,117 200,404 181,713 91 %
Loss from operations(442,402)(214,552)(227,850)106 %
Other income (expense), net:
Change in fair value of warrants9,222 (26,126)35,348 (135)%
Impairment of investments and certain other assets(6,016)— (6,016)nm
Interest expense and other(11,095)(2,028)(9,067)447 %
Interest income and other5,024 3,458 1,566 45 %
Total other income (expense), net(2,865)(24,696)21,831 (88)%
Loss before provision for (benefit from) income taxes(445,267)(239,248)(206,019)86 %
Provision for (benefit from) income taxes672 (1,262)1,934 nm
Net loss$(445,939)$(237,986)$(207,953)87 %
Revenue
The following table sets forth a breakdown of our revenue by our segments for the periods presented (in thousands):
Year Ended December 31,
20222021
Revenue from sales to external customers:
Autonomy Solutions$24,353 $28,497 
ATS16,345 3,447 
Total$40,698 $31,944 
The increase in revenue of our ATS segment in 2022 compared to 2021 was primarily driven by the Optogration and Freedom Photonics acquisitions. The decrease in revenue of our Autonomy Solutions segment in 2022 compared to 2021 was primarily due to a decrease in revenue from non-recurring engineering services as certain projects were completed or approached completion, offset by an increase in sales of sensors and licensing of certain of our intellectual property.
Cost of Sales
The $54.9 million increase in our cost of sales in 2022 compared to 2021, was primarily due to costs associated with industrialization of Iris as we approach closer to series production readiness, increase in sales of sensors, accrual for loss on certain NRE arrangements and impairment of inventory.
Operating Expenses
Research and Development
The $96.4 million increase in research and development expenses in 2022 compared to 2021 was primarily due:
$35.8 million increase in personnel-related costs driven mainly by increased headcount and increased stock-based compensation expense;
43

$34.7 million increased contractor fees and external spend in relation to continued development and testing of our sensor and in-development software products, as well as development activities related to advanced manufacturing; and
$15.5 million increase due to spend on data labeling services and investments in ongoing software development.
Sales and Marketing
The $20.8 million increase in sales and marketing expenses for 2022 compared to 2021 was primarily due:
a $14.4 million increase in personnel related costs including stock-based compensation costs due to increase in headcount; and
a $5.1 million increase in marketing expenses related to trade shows and presentations in auto industry conventions as well as increased outside consultants costs related to business development activities.
General and Administrative
The $64.5 million increase in general and administrative expenses for 2022 compared to 2021 was primarily due to:
a $58.2 million increase in personnel costs including stock-based compensation costs, driven mainly by increased headcount;
a $4.9 million increase in legal and other costs associated with our M&A activity during the year including Freedom Photonics, Solfice etc.; and
a $2.3 million increase in travel related costs due to easing of pandemic related travel restrictions.
Change in Fair Value of Warrant Liabilities
The change in fair value of warrant liabilities is a non-cash benefit or charge due to the corresponding decrease or increase in the estimated fair value of public and private warrants assumed in connection with the Business Combination.
Impairment of investments and certain other assets
Impairment of investments and certain other assets in 2022 primarily related to an impairment charge of $6.0 million related to our investment in Robotic Research OpCo, LLC.
Segment Operating Loss
Segment profit or loss is defined as income or loss before taxes. Our segment loss breakdown is as follows (in thousands):
Year Ended December 31,ChangeChange
20222021$%
Segment operating loss
Autonomy Solutions$(412,673)$(214,133)$(198,540)93 %
ATS(29,394)(324)(29,070)8972 %
Liquidity and Capital Resources
Sources of Liquidity and Capital Requirements
Our capital requirements will depend on many factors, including volume, the timing and extent of spending to support R&D efforts, investments in manufacturing equipment and facilities, the expansion of sales and marketing activities, market adoption of new and enhanced products and features, and investments in information technology systems. Until we can generate sufficient revenue from sale of products and services to cover our operating expenses, working capital, and capital expenditures, we expect our cash, cash equivalents and marketable securities, and proceeds from debt and/or equity financings to fund our cash needs. If we are required to raise additional funds by issuing equity securities, dilution to stockholders would result. Any equity securities issued may also provide for rights, preferences or privileges senior to those of holders of our common stock. If we raise funds by issuing debt securities, these debt securities may have rights, preferences and privileges senior to those of holders of our common stock. The terms of debt securities or borrowings could impose significant restrictions on our operations. The credit market and financial services industry have in the past, and may in the future, experience periods of uncertainty that could impact the availability and cost of equity and debt financing.
We expect to continue to invest in our product and software development as well as incur efforts to build customer relations and markets. Further, we expect to invest in developing advanced manufacturing capabilities, both, internally as well as with our contract manufacturing partners. For example, in January 2022, we executed an arrangement with Celestica
44

committing approximately $26.9 million for purchase of capital equipment as well as engineering efforts related to manufacturing process. We expect to fund these product and business development initiatives, and capital expenditures either through our cash, cash equivalents and marketable securities or through issuance of shares of our Class A common stock (“Stock-in-lieu of Cash Program”).
As of December 31, 2022, we had cash and cash equivalents totaling $69.6 million and marketable securities of $419.3 million, totaling $488.9 million of total liquidity. To date, our principal sources of liquidity have been proceeds received from issuances of debt and equity. Market and economic conditions, such as increase in interest rates by federal agencies, may materially impact relative cost and mix of these sources of liquidity.
To date, we have not generated positive cash flows from operating activities and have incurred significant losses from operations in the past as reflected in our accumulated deficit of $1.3 billion as of December 31, 2022. We expect to continue to incur operating losses for at least the foreseeable future due to continued R&D investments that we intend to make in our business and, as a result, we may require additional capital resources to grow our business. We believe that current cash, cash equivalents, and marketable securities will be sufficient to continue to execute our business strategy in the next 12 months and until we expect to begin series production.
Cash Flow Summary
The following table summarizes Luminar’s cash flows for the periods presented:
Year ended December 31,
20222021
Net cash provided by (used in):
Operating activities$(208,232)$(148,421)
Investing activities27,986 (194,188)
Financing activities(79,351)463,592 
Operating Activities
Net cash used in operating activities was $208.2 million during the year ended December 31, 2022. Net cash used in operating activities was due to our net loss of $445.9 million adjusted for non-cash items of $225.3 million, primarily consisting of $162.4 million of stock-based compensation, $41.5 million of vendor payments in stock in lieu of cash, $12.2 million of inventory write-offs and write-downs, $9.2 million of change in fair value of warrant liabilities, $6.6 million of depreciation and amortization, and $6.0 million of impairment of investments and certain other assets, offset by cash provided by operating assets and liabilities of $5.9 million due to the timing of cash receipts from customers and cash payments to vendors.
Investing Activities
Net cash provided by in investing activities of $28.0 million in 2022 comprised of $367.4 million and $88.0 million, respectively, of cash proceeds from maturities and sales or redemptions of marketable securities, offset primarily by $404.6 million related to purchases of marketable securities and $15.6 million in capital expenditures.
Financing Activities
Net cash used in financing activities of $79.4 million in 2022 primarily related to $80.9 million of cash paid for repurchases of shares of Class A common stock and $3.7 million of cash paid for employee taxes related to stock-based awards, offset by $4.0 million of cash received from exercises of stock options and $1.3 million of proceeds from sale of Class A common stock under our employee stock purchase plan.
Critical Accounting Policies and Estimates
We prepare our consolidated financial statements in accordance with generally accepted accounting principles in the United States (“GAAP”). The preparation of these consolidated financial statements requires us to make estimates, assumptions and judgments that can significantly impact the amounts we report as assets, liabilities, revenue, costs and expenses and the related disclosures. We base our estimates on historical experience and other assumptions that we believe are reasonable under the circumstances. Our actual results could differ significantly from these estimates under different assumptions and conditions. We believe that the accounting policies and estimates discussed below are critical to understanding our historical and future performance as these policies involve a greater degree of judgment and complexity.
45

Revenue
Revenue from product sales is recognized upon transfer of control of promised products. Revenue for service projects is recognized as services are performed and amounts are earned in accordance with the terms of a contract. Revenue is recognized in an amount that reflects the consideration that we expect to receive in exchange for those products and services.
Revenues related to NRE projects are recognized over time using the cost input method. In using this input method, we generally apply the cost-to-cost method of accounting where sales and profits are recorded based on the ratio of costs incurred to estimated total costs at completion. Recognition of profit on the NRE contracts requires estimates of the total contract value, the total cost at completion, and the measurement of progress towards completion. During the year ended December 31, 2022, we recorded $19.2 million in cost of sales (services) estimated losses expected to be incurred on NRE projects with certain customers. Estimated contract losses in the year ended December 31, 2021 and 2020 were not material. The estimated contract losses recorded in 2022 were primarily a result of (a) changes in estimates related to costs expected to be incurred for contractual milestones based on actual experience on similar projects and (b) changes in scope of project deliverables agreed upon with the respective customers during the year. Significant judgment is required when estimating total contract costs and progress to completion on the arrangements, as well as whether a loss is expected to be incurred on the contract. In estimating total contract costs, we are also required to estimate the effort expected to be incurred to complete a NRE project. These estimates are subject to significant estimation uncertainty as actual time and effort incurred on completing a NRE project or actual rates of either internal or contracted personnel working on such NRE projects may differ from our estimates. If circumstances arise that change the original estimates of revenues, costs, or extent of progress toward completion, revisions to the estimates are made. These revisions may result in increases or decreases in estimated revenues or costs, and such revisions are reflected in income in the period in which the circumstances that gave rise to the revision become known to us. We perform ongoing profitability analysis of our contracts accounted for under this method to determine whether the latest estimates of revenues, costs, and profits require updating. If at any time these estimates indicate that the contract will be unprofitable, the entire estimated loss for the remainder of the contract is recorded immediately.
We enter into contracts that can include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations; however, determining whether products or services are considered distinct performance obligations that should be accounted for separately versus together may sometimes require significant judgment. Transaction price is allocated to each performance obligation on a relative standalone selling price (“SSP”) basis. Judgment is required to determine SSP for each distinct performance obligation. We use a range of sales prices from actual sales to customers to estimate SSP when products and services are sold separately. In instances where SSP is not directly observable, we determine SSP using information that may include other observable inputs available to it.
Changes in judgments with respect to these assumptions and estimates could impact the timing or amount of revenue recognition.
Recent Accounting Pronouncements
See Note 2 in Item 8. of this Form 10-K for information related to recent accounting pronouncements.
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
We are exposed to various market risks, which may result in potential losses arising from adverse changes in market rates, such as interest rates and foreign exchange rates. We do not enter into derivatives or other financial instruments for trading or speculative purposes and do not believe we are exposed to material market risk with respect to our cash, cash equivalents and marketable securities.
Interest Rate Risk. We had cash and cash equivalents, and marketable securities totaling $488.9 million as of December 31, 2022. Cash equivalents and marketable securities were invested primarily in U.S. treasury securities, commercial paper, corporate bonds, U.S. agency and government sponsored securities, equity investments and asset-backed securities. Our investment policy is focused on the preservation of capital and supporting our liquidity needs. Under the policy, we invest in highly rated securities, while limiting the amount of credit exposure to any one issuer other than the U.S. government. We do not invest in financial instruments for trading or speculative purposes, nor do we use leveraged financial instruments. We utilize external investment managers who adhere to the guidelines of our investment policy. A hypothetical 100 basis point change in interest rates is not expected to have a material impact on the value of our cash and cash equivalents or marketable investments.
As of December 31, 2022, the principal amount outstanding of our Convertible Senior Notes was $625.0 million. The fair value of the Convertible Senior Notes is subject to interest rate risk, market risk and other factors due to their conversion features. The fair value of the Convertible Senior Notes will generally increase or decrease as our common stock price increases or decreases. The interest and market value changes affect the fair value of the Convertible Senior Notes but do not impact our financial position, cash flows or results of operations due to the fixed nature of the debt obligations. We carry the Convertible Senior Notes at face value less unamortized discount on our consolidated balance sheets.
46

Our Convertible Senior Notes bear fixed interest rate, and therefore, are not subject to interest rate risk. We have not utilized derivative financial instruments, derivative commodity instruments or other market risk sensitive instruments, positions or transactions in any material fashion, except for the privately negotiated capped call transactions entered into in December 2021 related to the issuance of our Convertible Senior Notes.
Foreign Currency Exchange Risk. Our results of operations and cash flows are subject to fluctuations due to changes in foreign currency exchange rates. Currently, all of our revenue is generated in U.S. dollars. Our expenses are generally denominated in the currencies of the jurisdictions in which we conduct our operations, which are primarily in the U.S. and in Europe. Luminar’s results of operations and cash flows in the future may be adversely affected due to an expansion of non-U.S. dollar denominated contracts, growth of its international entities, and changes in foreign exchange rates. The effect of a hypothetical 10% change in foreign currency exchange rates applicable to our business would not have a material impact on our historical or current consolidated financial statements. To date, we have not engaged in any hedging strategies. As our international operations grow, we will continue to reassess our approach to manage the risk relating to fluctuations in currency rates.
47

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.
LUMINAR TECHNOLOGIES, INC.
INDEX TO THE CONSOLIDATED FINANCIAL STATEMENTS

48

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the stockholders and the Board of Directors of Luminar Technologies, Inc.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of Luminar Technologies, Inc. and subsidiaries (the “Company”) as of December 31, 2022 and 2021, the related consolidated statements of operations and comprehensive loss, convertible preferred stock and stockholders’ equity (deficit), and cash flows, for each of the three years in the period ended December 31, 2022, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022, in conformity with accounting principles generally accepted in the United States of America.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 28, 2023, expressed an unqualified opinion on the Company’s internal control over financial reporting.
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Revenue — Non-recurring Engineering (“NRE”) services — Refer to Notes 2 and 4 to the financial statements
Critical Audit Matter Description
The Company recognizes revenue from non-recurring engineering services under fixed fee arrangements (“NRE services”) to integrate Luminar lidar hardware for autonomy in vehicle platforms. NRE services are recognized over time using an input method based on contract costs incurred to date compared to total estimated contract costs. The accounting for these contracts involves judgment, particularly as it relates to estimating total contract costs.
Given the judgments necessary to determine total estimated contract costs used to recognize revenue for NRE services, auditing such estimates required extensive audit effort due to the high degree of auditor judgment required when performing audit procedures and evaluating the results of those procedures.
How the Critical Audit Matter Was Addressed in the Audit
Our audit procedures related to management’s estimates of total contract costs used to recognize revenue for NRE services included the following, among others:
We tested the effectiveness of controls over long-term engineering services contract revenue, including management’s controls over the total estimated contract costs.
We selected a sample of NRE service contracts and performed the following:
49

Evaluated the estimates of total contract costs by:
Inquiring with management to obtain an understanding of its key inputs and assumptions used to determine total cost estimates.
Evaluating management’s ability to achieve the estimates of total cost by performing corroborating inquiries with the Company’s project managers and engineers.
Comparing inputs and assumptions to management’s work plans, engineering specifications, supplier contracts, and payroll data.
Assessing management’s ability to estimate total costs accurately by comparing actual costs to management’s historical estimates for performance obligations that have been fulfilled.
Testing the mathematical accuracy of management’s calculation of estimated total contract cost.

/s/ Deloitte & Touche LLP
San Jose, California
February 28, 2023
We have served as the Company’s auditor since 2020.




50

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
Consolidated Balance Sheets
(In thousands, except share and per share data)
December 31,
20222021
ASSETS
Current assets:
Cash and cash equivalents$69,552 $329,977 
Restricted cash1,553 725 
Marketable securities (including $0 and $12,200 with a related party as of December 31, 2022 and 2021, see Note 17)
419,314 462,141 
Accounts receivable11,172 13,013 
Inventory8,792 10,342 
Prepaid expenses and other current assets44,203 29,195 
Total current assets554,586 845,393 
Property and equipment, net30,260 11,009 
Operating lease right-of-use assets21,244 9,145 
Intangible assets, net22,077 2,424 
Goodwill18,816 3,110 
Other non-current assets40,344 12,455 
Total assets$687,327 $883,536 
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities:
Accounts payable$18,626 $14,419 
Accrued and other current liabilities52,962 19,844 
Operating lease liabilities5,953 4,735 
Total current liabilities77,541 38,998 
Warrant liabilities3,005 31,230 
Convertible senior notes612,192 608,957 
Operating lease liabilities, non-current16,989 5,768 
Other non-current liabilities4,005 598 
Total liabilities713,732 685,551 
Commitments and contingencies (see Note 15)
Stockholders’ equity (deficit):
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no shares issued and outstanding as of December 31, 2022 and 2021
  
Class A common stock, $0.0001 par value; 715,000,000 shares authorized, 291,942,087 shares issued, 270,078,637 shares outstanding as of December 31, 2022; 715,000,000 shares authorized, 266,076,525 shares issued, 250,812,764 outstanding as of December 31, 2021
29 27 
Class B common stock, $0.0001 par value; 121,000,000 shares authorized, 97,088,670 shares issued and outstanding as of December 31, 2022 and 2021
10 10 
Additional paid-in capital1,558,685 1,257,214 
Accumulated other comprehensive loss(4,226)(908)
Treasury stock, at cost, 21,863,450 and 15,263,761 shares as of December 31, 2022 and 2021, respectively
(312,477)(235,871)
Accumulated deficit(1,268,426)(822,487)
Total stockholders’ equity (deficit)(26,405)197,985 
Total liabilities and stockholders’ equity (deficit)$687,327 $883,536 

The accompanying notes are an integral part of these consolidated financial statements.
51

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
Consolidated Statements of Operations and Comprehensive Loss
(In thousands, except share and per share data)
Year Ended December 31,
202220212020
Revenue:
Products$18,492 $10,118 $4,840 
Services22,206 21,826 9,111 
Total revenue40,698 31,944 13,951 
Cost of sales:
Products61,985 23,484 15,097 
Services38,998 22,608 9,855 
Total cost of sales100,983 46,092 24,952 
Gross loss(60,285)(14,148)(11,001)
Operating expenses:
Research and development185,283 88,861 38,651 
Sales and marketing38,672 17,858 7,948 
General and administrative158,162 93,685 29,275 
Total operating expenses382,117 200,404 75,874 
Loss from operations(442,402)(214,552)(86,875)
Other income (expense), net:
Change in fair value of warrant liabilities9,222 (26,126)(268,266)
Impairment of investments and certain other assets(6,016)  
Loss on extinguishment of debt  (3,996)
Interest expense and other(11,095)(2,028)(2,885)
Interest income and other5,024 3,458 (276)
Total other income (expense), net(2,865)(24,696)(275,423)
Loss before provision for (benefit from) income taxes(445,267)(239,248)(362,298)
Provision for (benefit from) income taxes672 (1,262) 
Net loss$(445,939)$(237,986)$(362,298)
Net loss attributable to common stockholders$(445,939)$(237,986)$(369,055)
Net loss per share attributable to common stockholders:
Basic and diluted$(1.25)$(0.69)$(2.54)
Shares used in computing net loss per share attributable to common stockholders:
Basic and diluted356,265,774 346,300,975 145,096,996 
Comprehensive Loss:
Net loss$(445,939)$(237,986)$(362,298)
Net unrealized gains (losses) on available-for-sale debt securities(3,318)(942)35 
Comprehensive loss$(449,257)$(238,928)$(362,263)
The accompanying notes are an integral part of these consolidated financial statements.
52

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit)
(In thousands, except share data)
Series A Convertible
Preferred Stock
Series X Convertible
Preferred Stock
Founders Convertible
Preferred Stock
Class A
Common Stock
Class B
Common Stock
Additional
Paid-in
Capital
Accumulated
Other
Comprehensive
Income Loss
Treasury StockAccumulated
Deficit
Total
Stockholders’
Equity (Deficit)
SharesAmountSharesAmountSharesAmountSharesAmountSharesAmount
Balance as of December 31, 201994,818,151 244,743   26,206,837 3 139,635,890 14   10,457 (1) (222,203)(211,730)
Issuance of Series X convertible preferred stock for cash, net of issuance costs of $5,790
— — 18,457,230 178,074 — — — — — — — — — — — 
Retirement of Class A shares— — — — — — (6,629,372)(1)— — — — — — (1)
Conversion of certain shares into Class B common stock— — — — (22,935,413)(3)(82,182,790)(8)105,118,203 11 3,000 — — — 3,000 
Merger recapitalization—Class A(94,818,151)(244,743)(18,457,230)(178,074)(3,271,424)— 116,546,805 12 — — 422,802 — — — 422,814 
Public and Private Warrants— — — — — — — — — — (102,396)— — — (102,396)
Issuance of Class A common stock upon exercise of warrants— — — — — — 1,466,155 — — — 30,112 — — — 30,112 
Gores shares recapitalized, net of redemptions and equity issuance costs of $17,226
— — — — — — 49,981,349 5 — — 363,455 — — 363,460 
Share-based compensation— — — — — — — — — — 5,745 — — — 5,745 
Other comprehensive income— — — — — — — — — — — 35 — — 35 
Net loss— — — — — — — — — — — — — (362,298)(362,298)
Balance as of December 31, 2020 $  $  $ 218,818,037 $22 105,118,203 $11 $733,175 $34 $ $(584,501)$148,741 
Purchases of capped call options related to the convertible senior notes— — — — — — — — — — (73,438)— — — (73,438)
Shares repurchased— — — — — — — — — — — — (235,871)— 
Issuance of Class A common stock upon exercise of Public and Private Warrants— — — — — — 15,574,037 2 — — 492,219 — — — 492,221 
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units— — — — — — 5,232,744  — — 6,176 — — — 6,176 
Retirement of unvested restricted common stock— — — — — — (71,894)— — — — — — —  
Vendor payments under the stock-in-lieu of cash program— — — — — — 291,940 — — — 10,743 — — — 10,743 
Acquisition of Optogration, Inc.— — — — — — 370,034 — — — 6,527 — — — 6,527 
Issuance of earn-out shares— — — — — — 10,242,703 1 6,970,467 1 (2)— — —  
Issuance of shares for investment in Robotic Research Opco, LLC — — — — — — 618,924 — — — 10,002 — — — 10,002 
53

Series A Convertible
Preferred Stock
Series X Convertible
Preferred Stock
Founders Convertible
Preferred Stock
Class A
Common Stock
Class B
Common Stock
Additional
Paid-in
Capital
Accumulated
Other
Comprehensive
Income Loss
Treasury StockAccumulated
Deficit
Total
Stockholders’
Equity (Deficit)
SharesAmountSharesAmountSharesAmountSharesAmountSharesAmount
Conversion of Class B common stock into Class A common stock— — — — — — 15,000,000 2 (15,000,000)(2) — — —  
Share-based compensation— — — — — — — — — — 70,983 — — — 70,983 
Expense related to Volvo Warrants— — — — — — — — — — 959 — — — 959 
Payments of employee taxes related to vested restricted stock units— — — — — — — — — — (140)— — — (140)
Cash received from Gores on settlement of recapitalization of escrow— — — — — — — — — — 10 — — — 10 
Other comprehensive loss— — — — — — — — — — — (942)— — (942)
Net loss— — — — — — — — — — — — — (237,986)(237,986)
Balance as of December 31, 2021— — — —   266,076,525 27 97,088,670 10 1,257,214 (908)(235,871)(822,487)197,985 
Shares repurchased— — — — — — — — — — — — (76,606)— (76,606)
Issuance of Class A common stock upon exercise of Private Warrants— — — — — — 405,752 — — — 19,003 — — — 19,003 
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units— — — — — — 9,177,748 1 — — 3,944 — — — 3,945 
Issuance of Class A common stock under ESPP— — — — — — 168,147 — — — 1,271 — — 1,271 
Retirement of unvested restricted common stock— — — — — — (48,298)— — — — — — — — 
Vendor payments under the stock-in-lieu of cash program— — — — — — 9,949,385 1 — — 80,254 — — — 80,255 
Investment in ECARX Holdings, Inc.— — — — — — 2,030,374 — — — 12,588 — — — 12,588 
Optogration milestone awards— — — — — — 1,632,056 — — — 11,751 — — — 11,751 
Acquisition of Freedom Photonics LLC— — — — — — 2,176,205 — — — 30,510 — — — 30,510 
Acquisition of certain assets from Solfice Research, Inc.— — — — — — 374,193 — — — 3,361 — — — 3,361 
Share-based compensation— — — — — — — — — — 142,519 — — — 142,519 
Payments of employee taxes related to stock-based awards— — — — — — — — — — (3,730)— — — (3,730)
Other comprehensive loss— — — — — — — — — — — (3,318)— — (3,318)
Net loss— — — — — — — — — — — — — (445,939)(445,939)
Balance as of December 31, 2022— $— — $—  $ 291,942,087 $29 97,088,670 $10 $1,558,685 $(4,226)$(312,477)$(1,268,426)$(26,405)
The accompanying notes are an integral part of these consolidated financial statements.
54

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(In thousands)
Year Ended December 31,
202220212020
Cash flows from operating activities:
Net loss$(445,939)$(237,986)$(362,298)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization6,566 4,162 2,517 
Amortization of operating lease right-of-use assets5,237 3,705  
Amortization of premium on marketable securities1,288 1,792 175 
Change in fair value of warrants(9,222)26,126 268,266 
Vendor stock-in-lieu of cash program41,459 10,817  
Amortization of debt discount and issuance costs3,236   
Inventory write-offs and write-downs12,154 2,918 4,407 
Loss on sale or disposal of property and equipment 752 525 
Loss on extinguishment of debt  3,996 
Share-based compensation162,405 77,684 8,711 
Impairment of investments and certain other assets6,016   
Expense related to Volvo Warrants 959  
Warranty related to sensors2,481 1,538  
Deferred taxes232 (1,262) 
Other 305  
Changes in operating assets and liabilities:
Accounts receivable5,144 (6,233)(4,294)
Inventories(10,477)(10,751)(4,018)
Prepaid expenses and other current assets(6,557)(24,340)(2,805)
Other non-current assets(3,289)(6)165 
Accounts payable5,301 3,838 2,620 
Accrued and other current liabilities17,768 3,578 6,693 
Other non-current liabilities(2,035)(6,017)(302)
Net cash used in operating activities(208,232)(148,421)(75,642)
Cash flows from investing activities:
Acquisition of Freedom Photonics LLC (net of cash acquired)(2,759)  
Acquisition of certain assets from Solfice Research, Inc.(2,001)  
Cash received from acquisition of Optogration, Inc. 358  
Purchases of marketable securities (including $17,846 and $16,423 with related parties in 2022 and 2021, respectively, see Note 17)
(404,598)(716,933)(315,920)
Proceeds from maturities of marketable securities367,367 366,857 16,755 
Proceeds from sales/redemptions of marketable securities (including $24,753 and $4,396 with related parties in 2022 and 2021, respectively, see Note 17)
88,041 161,910 28,974 
Proceeds from refundable security deposits  581 
Purchases of property and equipment(15,614)(6,433)(2,202)
Disposal of property and equipment 53 18 
Advances for capital projects and equipment(2,450)  
Net cash provided by (used in) investing activities27,986 (194,188)(271,794)
Cash flows from financing activities:
Proceeds from issuance of convertible senior notes, net of debt discounts of $15,625
 609,375  
Purchases of capped call options (73,438) 
Cash received from Gores on recapitalization  380,601 
Transaction costs related to merger with Gores  (17,226)
Proceeds from issuance of Series X convertible preferred stock  183,865 
Issuance cost paid for Series X convertible preferred stock  (5,790)
Proceeds from the issuance of debt  32,101 
Repayment of debt (112)(41,190)
Debt prepayment charges  (1,918)
Debt issuance costs  (361)
Principal payments on finance leases (capital leases prior to adoption of ASC 842) (289)(222)
Proceeds from exercise of warrants 153,927  
55

Year Ended December 31,
202220212020
Proceeds from exercise of stock options3,986 5,859  
Proceeds from sale of Class A common stock under ESPP1,271   
Payments of employee taxes related to stock-based awards(3,730)  
Repurchases of common stock and redemption of warrants(80,878)(231,600)(10)
Other financing activities (130) 
Net cash provided by (used in) financing activities(79,351)463,592 529,850 
Net increase (decrease) in cash, cash equivalents and restricted cash(259,597)120,983 182,414 
Beginning cash, cash equivalents and restricted cash330,702 209,719 27,305 
Ending cash, cash equivalents and restricted cash$71,105 $330,702 $209,719 
Supplemental disclosures of cash flow information:
Cash paid for interest$7,769 $215 $2,789 
Supplemental disclosures of noncash investing and financing activities:
Issuance of Class A common stock upon exercise of warrants19,003 338,293 30,112 
Conversion of Series A, Series X and Founders’ convertible preferred stock into Class A and Class B common stock  422,813 
Issuance of Class A common stock for investment in Robotic Research OpCo, LLC 10,002  
Issuance of Class A common stock to acquire Optogration, Inc. 6,527  
Operating lease right-of-use assets obtained in exchange for lease obligations upon adoption of ASC 842 10,849  
Operating lease right-of-use assets obtained in exchange for lease obligations16,749 2,876  
Assets acquired under finance leases (capital leases prior to adoption of ASC 842)  318 
Purchases of property and equipment recorded in accounts payable and accrued liabilities3,870 849 319 
Amounts payable for shares repurchased 4,273  
Vendor stock-in-lieu of cash program—advances for capital projects and equipment28,402   
Investment in ECARX Holdings, Inc.12,588   
The accompanying notes are an integral part of these consolidated financial statements.
56

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 1. Organization and Description of Business
Luminar Technologies, Inc. and its wholly-owned subsidiaries (the “Company” or “Luminar”) was originally incorporated in Delaware on August 28, 2018 under the name Gores Metropoulos, Inc. (“Gores”). The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. On December 2, 2020, the Company (at such time named Gores Metropoulos, Inc.) consummated the business combination (the “Business Combination”) pursuant to the Agreement and Plan of Merger, dated August 24, 2020 with the pre-Business Combination Luminar Technologies, Inc. (“Legacy Luminar”). Legacy Luminar was incorporated in Delaware on March 31, 2015. In connection with the consummation of the Business Combination, the Company changed its name from Gores Metropoulos, Inc. to Luminar Technologies, Inc. The Company’s common stock is listed on the NASDAQ under the symbol “LAZR.”
Unless the context otherwise requires, the “Company” refers to the combined company and its subsidiaries following the Business Combination, “Gores” refers to the Company prior to the Business Combination and “Legacy Luminar” refers to Luminar Technologies, Inc. prior to the Business Combination. Refer to Note 3 for further discussion of the Business Combination.
The Company is a developer of advanced sensor technologies and software for the autonomous vehicle industry, encompassing Laser Imaging, Detection and Ranging (lidar) technology. The Company manufactures and distributes commercial lidar sensors and certain components for the autonomous vehicle industry. The Company is headquartered in Orlando, Florida and has personnel that conducts the Company’s operations from various locations in the United States and internationally including Germany, Sweden, Mexico, China, India and Israel.
Note 2. Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation and Consolidation
The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding annual financial reporting. All intercompany transactions and balances have been eliminated in consolidation.
Use of Estimates
The preparation of consolidated financial statements in conformity with GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosures. The significant estimates made by management include inventory write-downs, valuation allowance for deferred tax assets, valuation of warrants, fair valuation of assets acquired in mergers and acquisitions including intangible assets, forecasted costs associated with non-recurring engineering (“NRE”) services, product warranty reserves, stock-based compensation expense and other loss contingencies. Management periodically evaluates such estimates and they are adjusted prospectively based upon such periodic evaluation. Actual results could differ from those estimates.
Segment Information
The Company has determined its operating segments using the same indicators which are used to evaluate its performance internally. The Company’s business activities are organized in two operating segments:
(i) “Autonomy Solutions” which includes manufacturing and distribution of lidar sensors that measure distance using laser light to generate a 3D map, non-recurring engineering services related to the Company’s lidar products, development of software products that enable autonomy capabilities for automotive applications, and licensing of the Company’s intellectual property (“IP”). In June 2022, the Company acquired certain assets from Solfice Research, Inc. (“Solfice” or “Civil Maps”). Operations of Civil Maps have been included in the Autonomy Solutions segment.
(ii) “Advanced Technologies and Services (“ATS”)” which includes development of application-specific integrated circuits, pixel-based sensors, advanced lasers, as well as designing, testing and providing consulting services for non-standard integrated circuits. In the second quarter of 2022, the Components segment was renamed as ATS. In August 2021 and in April 2022, the Company acquired Optogration, Inc. (“Optogration”) and Freedom Photonics LLC (“Freedom Photonics”), respectively. Operations of Optogration and Freedom Photonic have been included in the ATS segment.
57

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Concentration of Credit Risk
The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, debt securities and accounts receivable. The Company’s deposits exceed federally insured limits. Cash held by the foreign subsidiaries of the Company as of December 31, 2022 and 2021 was not material.
The Company’s revenue is derived from customers located in the United States and international markets. Three customers accounted for 23%, 27% and 11%, respectively, of the Company’s accounts receivable as of December 31, 2022. Two customers accounted for 39% and 31%, respectively, of the Company’s accounts receivable as of December 31, 2021.
Cash and Cash Equivalents
The Company’s cash and cash equivalents consist of investments with maturities of three months or less at the time of purchase. The Company’s cash equivalents include investments in money market funds, U.S. treasury securities and commercial paper.
Restricted Cash
Restricted cash consists of funds that are contractually restricted as to usage or withdrawal due to legal agreements. The Company determines current or non-current classification of restricted cash based on the expected duration of the restriction.
Debt Securities
The Company’s debt securities consist of U.S agency securities and government sponsored securities, U.S. treasury securities, corporate bonds, commercial paper and asset-backed securities. The Company classifies its debt securities as available-for-sale at the time of purchase and reevaluates such designation as of each balance sheet date. The Company considers all debt securities as available for use to support current operations, including those with maturity dates beyond one year and are classified as current assets under marketable securities in the accompanying consolidated balance sheets. Debt securities included in marketable securities on the consolidated balance sheets consist of securities with original maturities greater than three months at the time of purchase. Debt securities are carried at fair value, with the unrealized gains and losses reported as a component of accumulated other comprehensive income (loss) (“OCI”). Any realized gains or losses on the sale of debt securities are determined on a specific identification method, and such gains and losses are reflected as a component of other income (expense), net.
The Company reviews the fair value of debt securities and when the fair value of a debt security is below its amortized cost, the amortized cost should be written down to its fair value if (i) it is more likely than not that management will be required to sell the impaired security before recovery of its amortized basis; or (ii) management has the intention to sell the security. If neither of these conditions are met, the Company must determine whether the impairment is due to credit losses. To determine the amount of credit losses, the Company compares the present value of the expected cash flows of the security, derived by taking into account the issuer’s credit ratings and remaining payment terms, with its amortized cost basis. The amount of impairment recognized is limited to the excess of the amortized cost over the fair value of the security. An allowance for credit losses for the excess of amortized cost over the expected cash flows is recorded in other income (expense), net on the consolidated statements of operations. Non-credit related impairment losses are recorded in OCI.
Marketable Equity Investments
The Company holds marketable equity investments over which the Company does not have a controlling interest or significant influence. Marketable equity investments are measured using the quoted prices in active markets with changes recorded in other income (expense), net on the consolidated statement of operations.
Non-Marketable Equity Investments Measured Using the Measurement Alternative
The Company holds a non-marketable equity investment in a privately held company in which the Company does not own a controlling interest or have significant influence. The investment does not have a readily determinable fair value and the Company has elected the measurement alternative, and consequently, measures the investment at cost less any impairment, adjusted to fair value, if there are observable price changes for an identical or similar investment of the same issuer.
Accounts Receivable
Accounts receivables are recorded at the invoiced amount and do not bear interest. The Company reviews the need for an allowance for doubtful accounts quarterly based on historical experience with each customer and the specifics of each customer arrangement. The Company did not have material write-offs in any period presented, and as of December 31, 2022, the
58

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
allowance for doubtful accounts was not material. The Company did not record any allowance for doubtful accounts as of December 31, 2021.
Inventory
The Company values inventory at the lower of cost or net realizable value. The Company determines the cost of inventory using the standard-cost method, which approximates actual costs based on a first-in, first-out method. The Company assesses inventory of slow-moving products for potential impairment, and records write-downs of inventory to cost of sales.
Property and Equipment
Property and equipment are stated at cost less accumulated depreciation and amortization, and are depreciated using the straight-line method over the estimated useful lives of the assets as follows:
Asset CategoryEstimated useful lives
Machinery and equipment
1 to 7 years
Computer hardware and software
3 to 5 years
Demonstration fleet and demonstration units
2 to 5 years
Leasehold improvementsShorter of useful life or lease term
Vehicles5 years
Furniture and fixtures7 years
Design and development costs for molds, dies and other tools that will be used in producing the products under a long-term supply arrangement are capitalized as tooling which are included in machinery and equipment. The Company estimates useful lives for these tooling items to range between one to three years. The amount capitalized for tooling as of December 31, 2022 was not material. The Company had not capitalized any amount for tooling as of December 31, 2021. Maintenance and repairs are charged to expense as incurred, and improvements and betterments are capitalized. When assets are retired or otherwise disposed of, the cost and accumulated depreciation and amortization are removed from the consolidated balance sheet and any resulting gain or loss is reflected in the consolidated statements of operations and comprehensive loss in the period realized.
Intangible Assets
Intangible assets, consisting of acquired developed technology, customer relationships, customer backlog, assembled workforce, IPR&D and tradename are carried at cost less accumulated amortization. All intangible assets have been determined to have definite lives and are amortized on a straight-line basis over their estimated remaining economic lives, ranging from one to ten years. Amortization expense related to developed technology is included in cost of sales. Amortization expense related to customer relationships is included in sales and marketing expense. Amortization expense related to tradename is included in general and administrative expense. Intangible assets are reviewed for impairment whenever events or changes in circumstances indicate an asset’s carrying value may not be recoverable. There was no impairment of intangible assets experienced during the year ended December 31, 2022 or 2021.
Goodwill
The Company records goodwill when the consideration paid in a business combination exceeds the fair value of the net tangible assets and the identified intangible assets acquired. Goodwill is not amortized, but instead is required to be tested for impairment annually and whenever events or changes in circumstances indicate that the carrying value of goodwill may exceed its fair value.
The Company reviews goodwill for impairment annually in its fourth quarter by initially considering qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill, as a basis for determining whether it is necessary to perform a quantitative analysis. If it is determined that it is more likely than not that the fair value of reporting unit is less than its carrying amount, a quantitative analysis is performed to identify goodwill impairment. There was no impairment of goodwill experienced during the year ended December 31, 2022 or 2021.
Impairment of Long-Lived Assets
The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. When such an event occurs, management determines whether there has been impairment by comparing the anticipated undiscounted future net cash flows to the related asset group’s carrying value. If
59

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
an asset is considered impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending on the nature of the asset. There was no impairment experienced of long-lived assets during the years ended December 31, 2022 or 2021.
Convertible Senior Notes
The Company’s convertible senior notes issued in December 2021 are accounted for as a single liability instrument measured at its amortized cost, as no other embedded features require bifurcation and recognition as derivatives.
Product Warranties
Estimated future warranty costs are accrued and charged to cost of sales in the period that the related revenue is recognized. These estimates are based on historical warranty experience and any known or expected changes in warranty exposure, such as trends of product reliability and costs of repairing and replacing defective products. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the said estimates as necessary.
Public and Private Warrants
As part of Gores’ initial public offering on February 5, 2019, Gores issued to third party investors 40.0 million units, consisting of one share of Class A common stock of Gores and one-third of one warrant, at a price of $10.00 per unit. Each whole warrant entitled the holder to purchase one share of Class A common stock at an exercise price of $11.50 per share (the “Public Warrants”). Simultaneously with the closing of the IPO, Gores completed the private sale of 6.667 million warrants to Gore’s sponsor at a purchase price of $1.50 per warrant (the “Private Warrants”). Each Private Warrant allows the sponsor to purchase one share of Class A common stock at $11.50 per share. Subsequent to the Business Combination, 13,333,309 Public Warrants and 6,666,666 Private Warrants remained outstanding as of December 31, 2020.
The Private Warrants and the shares of common stock issuable upon the exercise of the Private Warrants were not transferable, assignable or salable until after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants are exercisable for cash or on a cashless basis, at the holder’s option, and are non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, said Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

The exercise of the Private Warrants may be settled in cash upon the occurrence of a tender offer or exchange that involves 50% or more of the Company’s Class A stockholders. Public Warrants contained the same feature. Since not all of the Company’s stockholders need to participate in such tender offer or exchange to trigger the potential cash settlement and the Company does not control the occurrence of such an event, the Company concluded that the Public Warrants and Private Warrants do not meet the conditions to be classified in equity per the guidance in ASC 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity. Since the Public and Private Warrants meet the definition of a derivative under ASC 815, the Company recorded these warrants as liabilities on the balance sheet at fair value upon the closing of the Business Combination, with subsequent changes in their respective fair values recognized in the consolidated statement of operations and comprehensive loss at each reporting date.
In the first quarter of 2021, 3,589,645 Private Warrants and 13,128,671 Public Warrants were exercised, and the Company received $153.9 million in cash proceeds from the exercise of these warrants. Pursuant to the terms of the agreements governing the rights of the holders of the Public Warrants, the Company redeemed the remaining unexercised and outstanding 204,638 Public Warrants for a redemption price of $0.01 per Public Warrant.
The Company had 3,077,021 Private Warrants and no Public Warrants, outstanding as of December 31, 2021.
In January 2022 and April 2022, 1,389,529 and 19,223 Private Warrants, respectively, were exercised on a cashless basis and the Company issued 401,365 and 4,387 shares of Class A common stock, respectively, pursuant to the exercises. The Company had 1,668,269 Private Warrants outstanding as of December 31, 2022. These Private Warrants expire on December 2, 2025.
Revenue Recognition
Under ASC 606, the Company determines revenue recognition through the following steps:
Identifying the contract, or contracts, with the customer; 
Identifying the performance obligations in the contract;
60

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Determining the transaction price;
Allocating the transaction price to performance obligations in the contract; and
Recognizing revenue when, or as, the Company satisfies performance obligations by transferring the promised goods or services.
Nature of Products and Services and Revenue Recognition
The Autonomy Solutions segment derives revenue primarily from (a) product sales of lidar sensors to customers and distributors, (b) NRE services to integrate Luminar lidar hardware for autonomy in vehicle platforms, and (c) licensing of certain IP.
The ATS segment derives revenue primarily from (a) product sales of application-specific integrated circuits, pixel-based sensors and advanced lasers, as well as (b) NRE services for designing and testing non-standard integrated circuits.
Revenue from product sales is recognized at a point in time when control of the goods is transferred to the customer, generally occurring upon shipment or delivery dependent upon the terms of the underlying contract. Certain customer arrangements involve NRE services to design and develop custom prototype products to customers. Revenue from NRE service arrangements is recognized over time.
For NRE services, the Company recognizes revenue over time using an input method based on contract cost incurred to date compared to total estimated contract costs (cost-to-cost). For NRE service projects, the Company contracts with customers based on hourly rates or on a fixed fee basis. For arrangements based on hourly rates, revenue is recognized as services are performed and amounts are earned in accordance with the terms of a contract at estimated collectible amounts. For arrangements based on a fixed fee, revenue is recognized based on the progress or the percentage of completion of the NRE service project. Expenses associated with performance of work may be reimbursed with a markup depending on contractual terms and are included in revenue.
Contract costs related to NRE arrangements are incurred over time, which can be several years, and the estimation of these costs requires management’s judgment. Significant judgment is required when estimating total contract costs and progress to completion on the arrangements, as well as whether a loss is expected to be incurred on the contract. In estimating total contract costs, the Company is also required to estimate the effort expected to be incurred to complete a NRE project. These estimates are subject to significant estimation uncertainty as actual time and effort incurred on completing a NRE project or actual rates of either internal or contracted personnel working on such NRE projects may differ from the Company’s estimates. Changes in circumstances may change the original estimates of revenues, costs, or extent of progress toward completion, revisions to the estimates are made which may result in increases or decreases in estimated revenues or costs, and such revisions are reflected in income in the period in which the circumstances that gave rise to the revision become known to us. We perform ongoing profitability analysis of our contracts accounted for under this method to determine whether the latest estimates of revenues, costs, and profits require updating. If at any time these estimates indicate that the contract will be unprofitable, the entire estimated loss for the remainder of the contract is recorded immediately.
The Company enters into term-based licenses that provide customers the right to use certain IP available with the Company. Revenue from these licenses is recognized at the point in time at which the customer is able to use and benefit from the licensed information, which is generally upon delivery of the information to the customer or upon commencement of the renewal term.
Amounts billed to customers for shipping and handling are included in revenue. Taxes collected from customers and remitted to governmental authorities are excluded from revenue on the net basis of accounting.
Arrangements with Multiple Performance Obligations
When a contract involves multiple performance obligations, the Company accounts for individual products and services separately if the customer can benefit from the product or service on its own or with other resources that are readily available to the customer and the product or service is separately identifiable from other promises in the arrangement. The consideration is allocated between separate performance obligations in proportion to their estimated standalone selling price. The transactions to which the Company had to estimate standalone selling prices and allocate the arrangement consideration to multiple performance obligations were immaterial.
The Company provides standard product warranties for a term of typically up to one year to ensure that its products comply with agreed-upon specifications. Standard warranties are considered to be assurance type warranties and are not accounted for as separate performance obligations. See Product Warranties for accounting policy on standard warranties.
61

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Other Policies, Judgments and Practical Expedients
Contract balances.  Contract assets and liabilities represent the differences in the timing of revenue recognition from the receipt of cash from the Company’s customers and billings. Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. Receivable represents right to consideration that is unconditional. Such rights are considered unconditional if only the passage of time is required before payment of that consideration is due.
Remaining performance obligations.  Revenue allocated to remaining performance obligations represents the transaction price allocated to the performance obligations that are unsatisfied, or partially unsatisfied. It includes unearned revenue and amounts that will be invoiced and recognized as revenue in future periods and does not include contracts where the customer is not committed. The customer is not considered committed where they are able to terminate for convenience without payment of a substantive penalty under the contract. The Company has elected the optional exemption, which allows for the exclusion of the amounts for remaining performance obligations that are part of contracts with an original expected duration of one year or less.
Significant financing component. In certain arrangements, the Company receives payment from a customer either before or after the performance obligation has been satisfied. Typically, the expected timing difference between the payment and satisfaction of performance obligations is one year or less; therefore, the Company applies a practical expedient and does not consider the effects of the time value of money. The Company’s contracts with customer prepayment terms do not include a significant financing component because the primary purpose is not to receive or provide financing from or to the customers.
Contract modifications. The Company may modify contracts to offer customers additional products or services. Each of the additional products and services are generally considered distinct from those products or services transferred to the customer before the modification. The Company evaluates whether the contract price for the additional products and services reflects the standalone selling price as adjusted for facts and circumstances applicable to that contract. In these cases, the Company accounts for the additional products or services as a separate contract. In other cases where the pricing in the modification does not reflect the standalone selling price as adjusted for facts and circumstances applicable to that contract, the Company accounts on a prospective basis where the remaining goods and services are distinct from the original items and on a cumulative catch-up basis when the remaining goods and services are not distinct from the original items.
Judgments and estimates. Accounting for contracts recognized over time involves the use of various techniques to estimate total contract revenue and costs. Due to uncertainties inherent in the estimation process, it is possible that estimates of costs to complete a performance obligation will be revised in the near term. The Company reviews and updates its contract-related estimates regularly, and records adjustments as needed. For those performance obligations for which revenue is recognized using a cost-to-cost input method, changes in total estimated costs, and related progress towards complete satisfaction of the performance obligation, are recognized on a cumulative catch-up basis in the period in which the revisions to the estimates are made.
Cost of Sales
The Company includes all manufacturing and sourcing costs incurred prior to the receipt of finished goods at its distribution facility in cost of sales. The cost of sales principally includes personnel-related costs (including certain engineering personnel), including stock-based compensation, directly associated with the Company’s manufacturing organization, direct costs, product costs, purchasing costs, allocation of overhead costs associated with manufacturing operations, inbound freight charges, insurance, inventory write-downs, warranty cost and depreciation and amortization expense associated with the manufacturing and sourcing operations. Cost of sales also includes the direct cost and appropriate allocation of overhead costs involved in execution of service contracts.
Research and Development (R&D)
R&D expenses consist primarily of personnel-related expenses, consulting and contractor expenses, tooling and prototype materials to the extent no future benefit is expected and allocated overhead costs. Substantially all of the Company’s R&D expenses are related to developing new products and services, improving existing products and services, and developing manufacturing processes. R&D expenses are expensed as incurred.
Design and development costs for products to be sold under long-term supply arrangements are expensed as incurred. Design and development costs for molds, dies, and other tools involved in new technologies are expensed as incurred. Design and development costs for molds, dies, and other tools that will be used in producing the products under a long-term supply arrangement are capitalized as part of the molds, dies, and other tools.
62

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Stock-based Compensation
Employee awards
For equity classified awards, the Company measures the cost of share-based awards granted to employees, non-employees and directors based on the grant-date fair value of the awards. The grant-date fair value of the stock options is calculated using a Black-Scholes option pricing model. The grant-date fair value of purchase rights under the Company’s 2020 Employee Stock Purchase Plan (“ESPP”) is calculated using a Black-Scholes option pricing model. The grant-date fair value of restricted stock is calculated based on the fair value of the underlying common stock less cash proceeds paid by the recipient to acquire the restricted stock, if any. The grant-date fair value of restricted stock unit is calculated based on the fair value of the underlying common stock. The grant-date fair value of stock-based awards with market conditions is calculated using a Monte Carlo simulation model. The fair value of the stock-based compensation is recognized on a straight-line basis over the requisite service period, which is generally the vesting period of the award. The Company has elected to recognize the effect of forfeitures in the period they occur.
The Company grants fixed value share-based awards to certain employees, wherein the awardee is entitled to a fixed dollar value compensation settled by issuing shares on the vesting date, with the number of shares determined based on the Company’s stock price on or close to the settlement date. These fixed value equity awards are considered as liability classified awards. The Company measures the cost of fixed value share-based awards granted to employees based on a fixed monetary amount that is known at the inception of the obligation. The Company records the compensation cost for the fixed dollar amount of the award over the vesting period, with a corresponding liability.
Stock-based payments to vendors / non-employees
The Company has entered into arrangements with certain vendors and other third parties wherein the Company at its discretion may elect to compensate the respective vendors for services provided in either cash or by issuing shares of the Company’s Class A common stock (“Stock-in-lieu of Cash Program”). Typically, the amounts owed under the Stock-in-lieu of Cash Program are settled by issuing shares, with the number of shares generally determined based on the Company’s stock price on or close to the settlement date. Payments owed under this program may be equity or liability classified depending upon fixed or variable number of shares issued for the amount owed to vendors. The Company measures the cost based on a fixed monetary amount that is known at the inception of the obligation.
Income Taxes
Income taxes are accounted for under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax bases of assets and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.
The Company recognizes deferred tax assets to the extent that these assets are more likely than not to be realized. In making such a determination, all available positive and negative evidence are considered, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If it is determined that deferred tax assets would be realized in the future, in excess of their net recorded amount, an adjustment would be made to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.
The Company records uncertain tax positions in accordance with ASC 740, Income Taxes, on the basis of a two-step process which includes (1) determining whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position, and (2) for those tax positions that meet the more-likely-than-not recognition threshold. Recognized income tax positions are measured at the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority.
The Company recognizes interest and penalties related to unrecognized tax benefits on the income tax expense line in the accompanying consolidated statement of operations. Accrued interest and penalties are included on the related tax liability line in the consolidated balance sheet.
The Tax Cuts and Jobs Act (“TCJA”) subjects a U.S. shareholder to tax on global intangible low-taxed income (“GILTI”) earned by certain foreign subsidiaries. Under GAAP, the Company can make an accounting policy election to either
63

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
treat taxes due on the GILTI inclusion as a current period expense or factor such amounts into the Company’s measurement of deferred taxes. The Company elected to treat the GILTI inclusion as a period expense.
Recently Adopted Accounting Pronouncements
In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (“ASU 2021-08”). ASU 2021-08 requires an acquirer to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. At the acquisition date, it requires an acquirer to account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts, which should generally result in an acquirer recognizing and measuring the acquired contract assets and contract liabilities consistent with how they were recognized and measured in the acquiree’s financial statements. The Company elected to early adopt ASU 2021-08 as of January 1, 2022. The adoption of ASU 2021-08 did not have a material impact on the Company’s consolidated financial position, operating results or cash flows.
Note 3. Business Combinations
Freedom Photonics Acquisition
On April 13, 2022 (the “Acquisition Date”), the Company completed its acquisition of Freedom Photonics, a designer and manufacturer of high-performance lasers and related photonic products. The Freedom Photonics acquisition is expected to help the Company secure intellectual property and the supply of a key enabling component as part of the Company’s vertical integration strategy.
Pursuant to the terms of the Merger Agreement between the Company and Freedom Photonics, the Company acquired all of the issued and outstanding units of capital of Freedom Photonics for an aggregate purchase price of approximately $34.6 million payable primarily in Class A common stock of the Company. The purchase price includes a $0.4 million adjustment to the preliminary estimates of working capital. In conjunction with the acquisition, the Company issued share-based compensation awards to certain employees and selling equity holders of Freedom Photonics, which may result in future stock-based compensation expense, subject to achievement of certain service and performance conditions, including certain technical and financial milestones. These post-combination shared-based awards were determined to be compensatory in nature and consequently are being expensed over the vesting period of these awards. The results of operations related to Freedom Photonics are included in the Company’s consolidated statements of operations beginning from the Acquisition Date. As part of the transaction, the Company incurred $1.4 million of acquisition-related costs, which were expensed and included in general and administrative expenses in the periods in which the costs were incurred.
Recording of Assets Acquired and Liabilities Assumed
Preliminary estimates of fair values included in the consolidated financial statements are expected to be finalized within a year following the Acquisition Date. These are related to certain working capital adjustments and finalization of the estimates relating to deferred tax balances which will occur after the filing of the current tax returns. After the measurement period, any subsequent adjustments will be reflected in the consolidated statements of operations.
64

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The following table summarizes the preliminary purchase price allocation to assets acquired and liabilities assumed, including identification of measurement period adjustments (in thousands):
Preliminary Recorded Value
Cash and cash equivalents$1,063 
Accounts receivable3,311 
Contract asset1,913 
Inventories, net127 
Prepaid expenses and other current assets70 
Property and equipment1,353 
Operating lease right-of-use assets449 
Other non-current assets22 
Intangible assets (1)15,600 
Goodwill (2)15,885 
Total assets acquired39,793 
Current and non-current liabilities(5,158)
Total liabilities assumed(5,158)
Net assets acquired$34,635 
(1) Tradename was measured using the relief-from-royalty method. The remaining identifiable intangible assets were measured using the income approach. Significant inputs used as part of the valuation of intangible assets include revenue forecasts, present value factors, expected product margins and costs to complete the IPR&D.
(2) Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected future economic benefits as a result of other assets acquired that could not be individually identified and separately recognized. Goodwill is not amortized. The factors that made up goodwill recognized included assembled workforce and component cost savings. The entire amount of goodwill is expected to be deductible for tax purposes and is allocated to the ATS segment, which is also deemed the reporting unit.
Identifiable intangible assets recognized (in thousands):
Useful LifePreliminary Recorded Value
Customer backlog2 years$650 
Customer relationships4 years2,950 
Developed technology8 years4,000 
In-process research and development (IPR&D) (1)7,500 
Tradename4 years500 
Total intangible assets$15,600 
(1) IPR&D intangibles are treated as indefinite-lived until the completion or abandonment of the associated R&D
project, at which time the appropriate useful lives will be determined.
Supplemental Unaudited Pro Forma Information
The following unaudited pro forma financial information summarizes the combined results of operations for the Company and Freedom Photonics as if the companies were combined as of the beginning of fiscal year 2021. The unaudited pro forma information includes adjustments to amortization and depreciation for intangible assets and property and equipment acquired, the purchase accounting effect on transaction costs, and stock-based compensation expense.
The table below reflects the impact of adjustments to the unaudited pro forma results for the years ended December 31, 2022 and 2021 that are directly attributable to the acquisition (in thousands):
65

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31,
20222021
(Unaudited)
(Decrease) / increase to expenses as a result of transaction costs$(2,582)$2,795 
(Decrease) / increase to expenses as a result of stock-based compensation expense4,119 19,593 
Nonrecurring pro forma adjustments include:
Transaction costs of $2.8 million are assumed to have occurred on January 1, 2021, and are recognized as if incurred in the first quarter of 2021;
Employee compensation in connection with the retention awards, incentive plan awards, sign-on bonuses, and deferred shares are assumed to have started on January 1, 2021, and recognized as incurred based on their respective periods.
The unaudited pro forma information presented below is for informational purposes only and is not necessarily indicative of our consolidated results of operations of the combined business had the acquisition actually occurred at the beginning of fiscal year 2021 or the results of our future operations of the combined businesses (in thousands).
December 31,
20222021
(Unaudited)
Revenue$46,422 $49,804 
Net loss(447,736)(260,813)
Solfice Assets Acquisition
On June 15, 2022, the Company completed its acquisition from Solfice of certain assets for an aggregate consideration of $6.3 million, payable in Class A common stock of the Company, that are expected to advance Luminar’s mapping software development capabilities. The transaction was determined to be an asset acquisition under ASC 805, Business Combinations, with substantially all of the fair value attributable to acquired technology.
Optogration Acquisition
On August 3, 2021, (the “Optogration Acquisition Date”) the Company completed its acquisition of Optogration. The Optogration acquisition helps the Company secure intellectual property and supply of Indium Gallium Arsenide (“InGaAs”) photodetector semiconductor chips, which are used to convert optical power into an electrical current. The acquisition of Optogration is part of the Company’s vertical integration strategy, which helps to secure the supply of a key component of its sensor technology.
Pursuant to the terms of the Stock Purchase Agreement between the Company and Optogration, the Company acquired all of the issued and outstanding capital stock of Optogration for an aggregate purchase price of approximately $6.3 million payable in Class A common stock of the Company. Subsequent to the Optogration Acquisition Date, up to $22.0 million of post combination share-based awards may be payable to certain selling shareholders of Optogration, subject to certain service and performance conditions. These post combination shared-based awards were determined to be compensatory in nature and consequently are being expensed over the vesting period of these awards. In August 2022, the Company issued 1,632,056 shares of Class A common stock for $11.0 million of the Optogration Milestone Awards due to achievement of the service and performance conditions. As of December 31, 2022, it is probable that the service and performance conditions for the remaining $11.0 million obligation will be met.
The results of operations related to Optogration are included in the Company’s consolidated statements of operations beginning from the Optogration Acquisition Date. The impact of the acquisition on the consolidated financial results of the Company for the year ended December 31, 2021 was not material.
Recording of Assets Acquired and Liabilities Assumed
Estimates of fair value included in the consolidated financial statements, in conformity with ASC 820, Fair Value Measurement, represent the Company’s best estimates and valuations. In accordance with ASC 805, Business Combinations, the allocation of the consideration value is subject to adjustment until the Company has completed its analysis, but not to exceed one year after the Optogration Acquisition Date to provide the Company with the time to complete the valuation of its assets and liabilities.
66

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Settlement of a pre-existing agreement with Optogration
Prior to the acquisition, the Company had contracted with Optogration as a supplier. In assessing whether said pre-existing supply contract was at market, favorable or unfavorable from the Company’s perspective, the Company assessed whether the terms of the supply contract, including pricing, were consistent with what the Company would have required from another company that would have contracted for similar products and production volumes. The Company concluded that the supply agreement was at market, and thus no gain or loss was recognized upon effective settlement of the pre-existing supply agreement.
The following table summarizes the purchase price allocation to assets acquired and liabilities assumed, including identification of measurement period adjustments:
Recorded Value
Cash and cash equivalents$358 
Accounts receivable810 
Other current assets482 
Property and equipment1,248 
Other non-current assets384 
Intangible assets (1)2,650 
Goodwill (2)2,244 
     Total assets acquired8,176 
Current Liabilities(488)
Non-current liabilities(1,346)
     Total liabilities assumed(1,834)
      Net assets acquired$6,342 
(1) Identifiable intangible assets were measured using the income approach.
(2) Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected future economic benefits as a result of other assets acquired that could not be individually identified and separately recognized. Goodwill is not amortized. The factors that made up the goodwill recognized included assembled workforce and component cost savings. Goodwill is not expected to be deductible for tax purposes.
Identifiable intangible assets recognized:
Useful LifeRecorded Value
Customer relationships10 years$780 
Tradename
1 year
120 
Developed technology10 years1,750 
Total intangible assets$2,650 
Reverse Merger with Gores
On December 2, 2020, Gores consummated the Business Combination pursuant to that certain Agreement and Plan of Merger, dated August 24, 2020 (the “Merger Agreement”), by and among Gores, Dawn Merger Sub, Inc. (“First Merger Sub”), a wholly owned subsidiary of Gores, Dawn Merger Sub II, LLC (“Second Merger Sub”), a wholly owned subsidiary of Gores, and Legacy Luminar. In connection with the consummation of the Business Combination (the “Closing”), the registrant changed its name from Gores Metropoulos, Inc. to Luminar Technologies, Inc.
Immediately following the Business Combination, there were 323,936,240 shares of common stock, consisting of 218,818,037 shares of Class A common stock and 105,118,203 shares of Class B common stock with a par value of $0.0001 issued and outstanding, options to purchase an aggregate of 16,224,474 shares of Class A common stock and warrants to purchase, 4,089,280 shares of Class A common stock.
Pursuant to the Merger Agreement, the Company’s stockholders were entitled to receive an aggregate of up to 25,819,887 earn-out shares in the form of common stock (with respect to the Company’s Class A stockholders’ shares of Class A common stock and with respect to the Company’s Class B stockholders’ shares of Class B common stock). There were six
67

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
different triggering events that affect the number of earn-out shares that will be issued based upon the per share price of Class A common stock ranging from $13.00 to $28.00 per share. On August 11, 2021, the Company issued a total of 17,213,170 earn-out shares towards additional consideration in the form of common stock, consisting of 10,242,703 shares of Class A common stock and 6,970,467 shares of Class B common stock, upon meeting four of six triggering events. The shares issued were based upon the Class A common stock trading price exceeding $13.00, $16.00, $19.00 and $22.00 per share for a certain period of time. There are 5,121,484 shares of Class A common stock and 3,485,233 shares of Class B common stock remaining under the Merger Agreement, which will be issued in equal parts if the Class A common stock share price exceeds $25.00 and $28.00 per share for a certain period of time.
The Company accounts for the potential earn-out shares as a component of stockholders’ equity in accordance with the guidance in ASC 480, Distinguishing Liabilities from Equity, and ASC 815, Derivatives and Hedging. On December 2, 2020, the Company estimated the fair value of the potential earn-out shares to be $587.7 million, which was estimated using a Monte Carlo Model and Level 3 fair value inputs including volatility of 58.5% and a contractual term of 5.5 years. This was recorded as an increase in additional paid-in capital with an offsetting amount recorded in the same account, due to the absence of retained earnings.
The Business Combination was accounted for as a reverse recapitalization in accordance with GAAP as Legacy Luminar has been determined to be the accounting acquirer, primarily due to the fact that Legacy Luminar stockholders continue to control the post-combination Company. Under this method of accounting, while Gores was the legal acquirer, it has been treated as the “acquired” company for financial reporting purposes. Accordingly, the Business Combination was treated as the equivalent of Legacy Luminar issuing stock for the net assets of Gores, accompanied by a recapitalization. The net assets of Gores were stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Business Combination are those of Legacy Luminar. Reported shares and earnings per share available to holders of the Company’s common stock, prior to the Business Combination, have been retroactively restated as shares reflecting the exchange ratio established in the Business Combination (approximately 1 Gores shares to 13.63094 Luminar shares).
The Company incurred $17.2 million in transaction costs relating to the merger with Gores, which has been offset against additional paid-in capital in the Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit). On the date of the Business Combination, the Company recorded a liability related to the Public and Private Warrants of $102.4 million, with an offsetting entry to additional paid-in capital.
Upon closing of the Business Combination, the shareholders’ of Gores were issued 49,981,349 shares of Class A common stock. In connection with the Closing, holders of 18,651 shares of common stock of Gores were redeemed at a price per share of $10.16.
68

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 4. Revenue
The Company’s revenue is comprised of sales of lidar sensors hardware, components, NRE services and licensing of certain information available with the Company.
Disaggregation of Revenues
The Company disaggregates its revenue from contracts with customers by (1) geographic region based on customer’s billed to location, and (2) type of good or service and timing of transfer of goods or services to customers (point-in-time or over time), as it believes it best depicts how the nature, amount, timing and uncertainty of its revenue and cash flows are affected by economic factors. Total revenue based on the disaggregation criteria described above, as well as revenue by segment, are as follows (in thousands):
Year Ended December 31,
202220212020
Revenue% of RevenueRevenue% of RevenueRevenue% of Revenue
Revenue by primary geographical market:
North America$35,032 86 %$23,043 72 %$4,010 29 %
Asia Pacific3,703 9 %2,502 8 %906 6 %
Europe and Middle East1,963 5 %6,399 20 %9,035 65 %
Total40,698 100 %31,944 100 %13,951 100 %
Revenue by timing of recognition:
Recognized at a point in time17,595 43 %8,892 28 %2,639 19 %
Recognized over time23,103 57 %23,052 72 %11,312 81 %
Total40,698 100 %31,944 100 %13,951 100 %
Revenue by segment:
Autonomy Solutions24,353 60 %28,497 89 %11,387 82 %
ATS16,345 40 %3,447 11 %2,564 18 %
Total40,698 100 %31,944 100 %13,951 100 %
Volvo Stock Purchase Warrant
In March 2020, the Company issued a stock purchase warrant (“Volvo Warrants”) to Volvo Car Technology Fund AB (“VCTF”) in connection with an engineering services contract. The Volvo Warrants entitle VCTF to purchase up to 4,089,280 shares of Class A common stock, at a price of $3.1769 per share from the Company and were determined to be an equity classified award to VCTF. The Volvo Warrants vest and become exercisable in two tranches based on satisfaction of certain commercial milestones, upon reaching commercial production and delivery of production units. The grant date fair value of the Volvo Warrants, aggregating $2.9 million, represents consideration payable to VCTF and is being recognized as reduction in revenue consistent with the revenue recognition pattern when these warrants become probable of vesting. The Company’s management determined that the vesting of the first of the two tranches of the Volvo Warrants was probable as of December 31, 2021. As such, the Company had recognized a reduction in revenue in the amount of $1.0 million related to the said first tranche of the Volvo Warrants in the year ended December 31, 2021. The second tranche of the Volvo warrants will be recorded as a reduction in revenue upon achievement of sales of a certain number of the Company’s sensors to Volvo for use in their commercial vehicles. This threshold had not been achieved as of December 31, 2022.
Contract assets and liabilities
Contract assets primarily represent revenues recognized for performance obligations that have been satisfied but for which amounts have not been billed. The Company’s contract assets as of December 31, 2022 and 2021 were $18.0 million and $9.9 million. Contract liabilities consist of deferred revenue and customer advanced payments. Deferred revenue includes billings in excess of revenue recognized related to product sales and other services revenue and is recognized as revenue when the Company performs under the contract. Customer advanced payments represent required customer payments in advance of product shipments according to customer’s payment term. Customer advance payments are recognized as revenue when control of the performance obligation is transferred to the customer. The Company’s contract liabilities were $3.0 million and $0.9 million as of December 31, 2022 and 2021, respectively, and were included in accrued and other current and non-current liabilities in the consolidated balance sheets.
69

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The opening and closing balances of contract assets were as follows (in thousands):
December 31,
 20222021
Contract assets, current$15,395 $9,907 
Contract assets, non-current2,575  
Ending balance$17,970 $9,907 
The significant changes in contract assets balances consisted of the following (in thousands): 
 December 31,
 20222021
Beginning balance$9,907 $ 
Amounts billed that were included in the contract assets beginning balance(4,228) 
Revenue recognized for performance obligations that have been satisfied but for which amounts have not been billed12,291 9,907 
Ending balance$17,970 $9,907 
The opening and closing balances of contract liabilities were as follows (in thousands):
December 31,
 20222021
Contract liabilities, current$1,993 $898 
Contract liabilities, non-current1,015  
Ending balance$3,008 $898 
The significant changes in contract liabilities balances consisted of the following (in thousands): 
 December 31,
 20222021
Beginning balance$898 $2,284 
Revenue recognized that was included in the contract liabilities beginning balance(489)(1,792)
Increase due to cash received and not recognized as revenue and billings in excess of revenue recognized during the period2,599 406 
Ending balance$3,008 $898 
Remaining Performance Obligations
Revenue allocated to remaining performance obligations was $39.7 million as of December 31, 2022 and includes amounts within contract liabilities. The Company expects to recognize approximately 82% of this revenue over the next 12 months and the remainder thereafter.
70

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 5. Investments
Debt Securities
The Company’s investments in debt securities consisted of the following as of December 31, 2022 and 2021 (in thousands):
December 31, 2022
 CostGross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
U.S. treasury securities$191,075 $3 $(2,598)$188,480 
U.S. agency and government sponsored securities4,999  (75)4,924 
Commercial paper74,755  (232)74,523 
Corporate bonds111,123  (1,214)109,909 
Asset-backed securities11,945  (110)11,835 
Total debt securities$393,897 $3 $(4,229)$389,671 
Included in marketable securities$393,897 $3 $(4,229)$389,671 
December 31, 2021
 CostGross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
U.S. treasury securities$161,938 $1 $(474)$161,465 
U.S. agency and government sponsored securities4,995  (25)4,970 
Commercial paper40,788  (4)40,784 
Corporate bonds165,522 13 (345)165,190 
Asset-backed securities46,540  (74)46,466 
Total debt securities$419,783 $14 $(922)$418,875 
Included in cash and cash equivalents$950 $ $ $950 
Included in marketable securities$418,833 $14 $(922)$417,925 
The following table presents the gross unrealized losses and the fair value for those debt securities that were in an unrealized loss position for less than 12 months as of December 31, 2022 and 2021 (in thousands):
December 31, 2022December 31, 2021
Gross
Unrealized
Losses
Fair ValueGross
Unrealized
Losses
Fair Value
U.S. treasury securities$(2,598)$158,888 $(474)$146,454 
U.S. agency and government sponsored securities(75)4,924 (25)4,970 
Commercial paper(232)74,523 (4)30,285 
Corporate bonds(1,214)109,909 (345)145,522 
Asset-backed securities(110)11,835 (74)45,251 
Total$(4,229)$360,079 $(922)$372,482 
As of December 31, 2022, the total amortized cost basis of the Company’s available-for-sale securities exceeded its fair value by $4.2 million, which was primarily attributable to widening credit spreads and rising interest rates since purchase. The Company reviewed its available-for-sale securities and concluded that the decline in fair value was not related to credit losses and that it is more likely than not that the entire amortized cost of each security will be recoverable before the Company is required to sell them or when the security matures. Accordingly, during the year ended December 31, 2022, no allowance for credit losses was recorded and instead the unrealized losses are reported as a component of accumulated other comprehensive income (loss).
71

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Equity Investments
The Company’s equity investments consisted of the following as of December 31, 2022 and 2021 (in thousands):
December 31,
Consolidated Balance Sheets Location20222021
Money market funds(1)
Cash and cash equivalents$42,056 $25,654 
Marketable equity investments(1)
Marketable securities29,643 44,216 
Non-marketable equity investment measured using the measurement alternative(2)
Other non-current assets4,000 10,002 
$75,699 $79,872 
(1)    Investments with readily determinable fair values.
(2)    Investment in privately held company without readily determinable fair value.
In December 2021, the Company made an investment in 1,495 Class A Preferred Units of Robotic Research OpCo, LLC (“Robotic Research”) for consideration of $10.0 million, which was settled by issuing 618,924 shares of Class A common stock of the Company. The Company’s investment in Robotic Research represents less than 5% of Robotic Research’s capitalization. The Company neither has a significant influence over Robotic Research nor does its investment amount to a controlling financial interest in Robotic Research. As such, the Company measured the initial investment in Robotic Research at cost as provided under the guidance for measurement of equity investment using the measurement alternative. In the fourth quarter of 2022, the Company recorded an impairment charge of $6.0 million related to the investment in Robotic Research.
In December 2022, the Company made an investment in 1,500,000 Class A ordinary shares of ECARX Holdings Inc., (“ECARX”) for consideration of $15.0 million, which was settled by issuing 2,030,374 shares of Class A common stock of the Company. The Company’s investment in ECARX represents less than 5% of ECARX’s capitalization. The Company neither has a significant influence over ECARX nor does its investment amount to a controlling financial interest in ECARX. The Company measured the investment in ECARX using the quoted prices in active markets with changes recorded in other income (expense), net on the consolidated statement of operations. Jun Hong Heng is a director of ECARX. Mr. Heng is also a director of Luminar.
Note 6. Financial Statement Components
Cash and Cash Equivalents
Cash and cash equivalents consisted of the following (in thousands):
 December 31,
 20222021
Cash$27,496 $303,373 
Money market funds42,056 25,654 
Commercial paper 950 
Total cash and cash equivalents$69,552 $329,977 
Inventory
Inventory consisted of the following (in thousands):
 December 31,
 20222021
Raw materials$3,614 $5,866 
Work-in-process2,329 1,171 
Finished goods2,849 3,305 
Total inventory$8,792 $10,342 
The Company’s inventory write-offs and write-downs (primarily due to obsolescence, lower of cost or market assessment, and other adjustments) was $12.2 million, $2.9 million and $4.4 million during the years ended December 31, 2022, 2021 and 2020, respectively.
72

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following (in thousands):
 December 31,
 20222021
Prepaid expenses$15,653 $14,651 
Contract assets15,395 9,907 
Advance payments to vendors7,919 1,810 
Other receivables5,236 2,827 
Total prepaid expenses and other current assets$44,203 $29,195 
Property and Equipment
Property and equipment consisted of the following (in thousands):
 December 31,
 20222021
Machinery and equipment$14,047 $7,694 
Computer hardware and software6,797 2,854 
Land1,001  
Leasehold improvements885 869 
Vehicles, including demonstration fleet3,222 2,421 
Furniture and fixtures818 272 
Construction in progress13,642 3,677 
Total property and equipment40,412 17,787 
Accumulated depreciation and amortization(10,152)(6,778)
Total property and equipment, net$30,260 $11,009 
Property and equipment capitalized under finance lease (capital lease prior to adoption of ASC 842) were not material. Construction in progress increased due to increased capital expenditure related to capital projects to enable the Company to achieve series production readiness.
Depreciation and amortization associated with property and equipment was $4.3 million, $3.9 million and $2.5 million for the years ended December 31, 2022, 2021 and 2020, respectively.

Intangible Assets
The following table summarizes the activity in the Company’s intangible assets (in thousands):
December 31,
20222021
Beginning of the period$2,424 $ 
Additions21,890 2,650 
Amortization(2,237)(226)
End of the period$22,077 $2,424 
73

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Intangible assets were acquired in connection with the Company’s acquisition of Optogration in August 2021, Freedom Photonics in April 2022 and Solfice in June 2022. See Note 3 for further details of these acquisitions. The components of intangible assets were as follows (in thousands):
December 31, 2022December 31, 2021
Gross
Carrying
 Amount
Accumulated
Amortization
Net
Carrying
Amount
Weighted Average
Remaining Period
(Years)
Gross
Carrying
 Amount
Accumulated
Amortization
Net
Carrying
Amount
Weighted Average
Remaining Period
(Years)
Customer relationships$3,730 $(664)$3,066 4.4$780 $(33)$747 9.6
Customer backlog650 (292)358 0.9   — 
Tradename620 (214)406 3.3120 (120) — 
Assembled workforce130 (130) —    — 
Developed technology11,910 (1,163)10,747 7.51,750 (73)1,677 9.6
IPR&D7,500  7,500 —    — 
Total intangible assets$24,540 $(2,463)$22,077 6.6$2,650 $(226)$2,424 9.6
Amortization expense related to intangible assets was $2.2 million, $0.2 million and $0.0 million for the year ended December 31, 2022, 2021 and 2020, respectively.
As of December 31, 2022, the expected future amortization expense for intangible assets was as follows (in thousands):
PeriodExpected Future
Amortization Expense
2023$2,730 
20242,373 
20252,373 
20261,726 
20271,510 
Thereafter3,865 
IPR&D7,500 
Total$22,077 
Goodwill
The carrying amount of goodwill allocated to the Company’s reportable segments was as follows (in thousands):
 Autonomy SolutionsATSTotal
Balance as of December 31, 2021
$687 $2,423 $3,110 
Acquired goodwill related to Freedom Photonics in 2022 15,885 15,885 
Purchase accounting adjustments (179)(179)
Balance as of December 31, 2022
$687 $18,129 $18,816 
74

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Other Non-Current Assets
Other non-current assets consisted of the following (in thousands):
 December 31,
 20222021
Security deposits$5,495 $1,187 
Non-marketable equity investment4,000 10,002 
Advance payment for capital projects27,683  
Contract assets2,575  
Other non-current assets591 1,266 
Total other non-current assets$40,344 $12,455 
Accrued and Other Current Liabilities
Accrued and other current liabilities consisted of the following (in thousands): 
 December 31,
 20222021
Accrued compensation and benefits$16,682 $9,899 
Accrued expenses22,358 6,727 
Warranty reserves3,584 1,798 
Contract liabilities1,993 898 
Accrued interest payable359 316 
Contract losses7,526 115 
Other460 91 
Total accrued and other current liabilities$52,962 $19,844 
During the year ended December 31, 2022, the Company recorded $19.2 million in cost of sales (services) estimated losses expected to be incurred on NRE projects with certain customers. Estimated contract losses in the year ended December 31, 2021 and 2020 were not material. The estimated contract losses recorded in 2022 were primarily a result of (a) changes in estimates related to costs expected to be incurred for contractual milestones based on actual experience on similar projects and (b) changes in scope of project deliverables agreed upon with the respective customers during the year.
Note 7. Debt
Convertible Senior Notes and Capped Call Transactions
In December 2021, the Company issued $625.0 million aggregate principal amount of 1.25% Convertible Senior Notes due 2026 in a private placement, which included $75.0 million aggregate principal amount of such notes pursuant to the exercise in full of the option granted to the initial purchasers to purchase additional notes (collectively, the “Convertible Senior Notes”). The interest on the Convertible Senior Notes is payable semi-annually in arrears on June 15 and December 15 of each year, beginning on June 15, 2022. The Convertible Senior Notes will mature on December 15, 2026, unless earlier repurchased or redeemed by the Company or converted pursuant to their terms.
The total net proceeds from the debt offering, after deducting fees paid to the initial purchasers paid by the Company, was approximately $609.4 million.
Each $1,000 principal amount of the Convertible Senior Notes is initially convertible into 50.0475 shares of the Company’s Class A common stock, par value $0.0001, which is equivalent to an initial conversion price of approximately $19.98 per share. The conversion rate is subject to adjustment upon the occurrence of certain specified events prior to the maturity date but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date or if the Company delivers a notice of redemption in respect of some or all of the Convertible Senior Notes, the Company will, under certain circumstances, increase the conversion rate of the Convertible Senior Notes for a holder who elects to convert its Convertible Senior Notes in connection with such a corporate event or convert its Convertible Senior Notes called for redemption during the related redemption period, as the case may be. The Convertible Senior Notes are redeemable, in whole or in part (subject to certain limitations), at the Company’s option at any time, and from time to time, on or after December 20, 2024, and on or before the 40th scheduled trading day immediately before the maturity date, at a cash redemption price equal to the principal amount of the Convertible Senior Notes to be redeemed, plus accrued and unpaid
75

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
interest, if any, to, but excluding, the redemption date, but only if certain liquidity conditions are satisfied and the last reported sale price per share of the Class A common stock exceeds 130% of the conversion price on (1) each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice, and (2) the trading day immediately before the date the Company sends such notice. If the Company undergoes a fundamental change (as defined in the indenture governing the Convertible Senior Notes) prior to the maturity date, holders may require the Company to repurchase for cash all or any portion of their Convertible Senior Notes in principal amounts of $1,000 or a multiple thereof at a fundamental change repurchase price equal to 100% of the principal amount of the Convertible Senior Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.
Holders of the Convertible Senior Notes may convert their Convertible Senior Notes at their option at any time prior to the close of business on the business day immediately preceding December 15, 2026, in multiples of $1,000 principal amount, only under the following circumstances: (1) during any calendar quarter (and only during such calendar quarter) commencing after the calendar quarter ending on March 31, 2022, if the last reported sale price per share of the Class A common stock exceeds 130% of the conversion price for each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (2) during the five consecutive business days immediately after any 10 consecutive trading day period (such 10 consecutive trading day period, the “measurement period”) in which the trading price per $1,000 principal amount of Convertible Senior Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of the Class A common stock on such trading day and the conversion rate on such trading day; (3) upon the occurrence of specified corporate events or distributions on the Class A common stock; and (4) if the Convertible Senior Notes are called for redemption. On or after June 15, 2026, holders may convert all or any portion of their Convertible Senior Notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date, regardless of the foregoing circumstances. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of its Class A common stock or a combination of cash and shares of its Class A common stock, at the Company’s election. As of December 31, 2022, the conditions allowing holders of the Convertible Senior Notes to convert were not met.
It is the Company’s current intent to settle the principal amount of its outstanding Convertible Senior Notes in cash and any excess in shares of the Company’s Class A common stock.
The Convertible Senior Notes are senior unsecured obligations and will rank equal in right of payment with the Company’s future senior unsecured indebtedness; senior in right of payment to the Company’s future indebtedness that is expressly subordinated to the Convertible Senior Notes; effectively subordinated to the Company’s existing and future secured indebtedness, to the extent of the value of the collateral securing that indebtedness; and structurally subordinated to all existing and future indebtedness and other liabilities, including trade payables, and (to the extent the Company is not a holder thereof) preferred equity, if any, of the Company’s subsidiaries.
The Company has classified the Convertible Senior Notes as a non-current liability under the guidance in ASC 470-20, as amended by ASU 2020-06. Debt discount and issuance costs aggregating approximately $16.2 million were initially recorded as a reduction to the principal amount of the Convertible Senior Notes and is being amortized as interest expense on a straight line basis over the contractual terms of the notes. The Company estimates that the difference between amortizing the debt discounts and the issuance costs using the straight line method as compared to using effective interest rate method is immaterial.
The net carrying amount of the Convertible Senior Notes was as follows (in thousands):
December 31,
20222021
Principal$625,000 $625,000 
Unamortized debt discount and issuance costs(12,808)(16,043)
Net carrying amount$612,192 $608,957 
76

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The following table sets forth the interest expense recognized related to the Convertible Senior Notes (in thousands):
Year Ended December 31
20222021
Contractual interest expense$7,812 $316 
Amortization of debt discount and issuance costs3,236 135 
Total interest expense$11,048 $451 
The remaining term over which the debt discount and issuance costs will be amortized is 3.96 years. Interest expense of $7.8 million and $0.5 million is reflected as a component of interest (expense) income, net in the accompanying consolidated statement of operations for the years ended December 31, 2022 and 2021, respectively.
In connection with the offering of the Convertible Senior Notes, the Company entered into privately negotiated capped call option transactions with certain counterparties (the “Capped Calls”). The Capped Calls each have an initial strike price of approximately $19.98 per share, subject to certain adjustments, which corresponds to the initial conversion price of the Convertible Senior Notes. The Capped Calls have initial cap prices of $30.16 per share, subject to certain adjustment events. The Capped Calls are generally intended to reduce the potential dilution to the Class A common stock upon any conversion of the Convertible Senior Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of converted Convertible Senior Notes, as the case may be, with such reduction and/or offset subject to a cap based on the cap price. The Capped Calls expire on April 6, 2027, subject to earlier exercise. The Capped Calls are subject to either adjustment or termination upon the occurrence of specified extraordinary events affecting the Company, including a merger event, a tender offer, and a nationalization, insolvency or delisting involving the Company. In addition, the Capped Calls are subject to certain specified additional disruption events that may give rise to a termination of the Capped Calls, including changes in law, failure to deliver, and hedging disruptions. The net cost of $73.4 million incurred to purchase the Capped Calls was recorded as a reduction to additional paid-in capital in the accompanying consolidated balance sheet. The Capped Calls are not accounted for as derivatives.
Senior Secured Loan
Legacy Luminar had in August 2017 issued certain Senior Secured Promissory Notes (“Senior Secured Notes”). These Senior Secured Notes were subsequently amended, refinanced and partially repaid at various times through 2020. The Senior Secured Notes were repaid in full in December 2020 as required per the terms of the Merger Agreement. The Company had recorded loss on extinguishment of debt in connection with the Senior Secured Notes in the amount of approximately $4.0 million and interest expense in the amount of $2.5 million in 2020.
In connection with the issuance of Senior Secured Notes and its subsequent amendment, refinance and partial repayments at various times through 2020, Legacy Luminar had issued warrants in 2017, 2018 and 2019 (collectively “Legacy Warrants”). The Legacy Warrants were recorded at fair value with subsequent changes in fair value reflected in earnings. The change in fair value resulted in a loss of $27.3 million during the year ended December 31, 2020. Upon closing of the Business Combination, the Legacy Warrants were exercised for 1,466,155 shares of Class A common stock. No Legacy Warrants have been outstanding since December 31, 2020.
Note 8. Fair Value Measurements
As of December 31, 2022, the Company carried cash equivalents, marketable investments and Private Warrants that are measured at fair value on a recurring basis. The Company had previously carried Public Warrants which were exercised and redeemed in March 2021.
Fair value is based on the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:
Level 1 — Observable inputs, which include unadjusted quoted prices in active markets for identical assets or liabilities.
Level 2 — Observable inputs other than Level 1 inputs, such as quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 — Unobservable inputs that are supported by little or no market activity and that are based on management’s assumptions, including fair value measurements determined by using pricing models, discounted cash flow methodologies or similar techniques.
77

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The Company determined the fair value of its Level 1 financial instruments, which are traded in active markets, using quoted market prices for identical instruments.
Marketable investments classified within Level 2 of the fair value hierarchy are valued based on other observable inputs, including broker or dealer quotations, alternative pricing sources or U.S. Government Treasury yield of appropriate term. When quoted prices in active markets for identical assets or liabilities are not available, the Company relies on non-binding quotes from its investment managers, which are based on proprietary valuation models of independent pricing services. These models generally use inputs such as observable market data, quoted market prices for similar instruments, historical pricing trends of a security as relative to its peers. To validate the fair value determination provided by its investment managers, the Company reviews the pricing movement in the context of overall market trends and trading information from its investment managers. The Company performs routine procedures such as comparing prices obtained from independent source to ensure that appropriate fair values are recorded.
Given that the transfer of Private Warrants to anyone outside of a small group of individuals constituting the sponsors of Gores Metropoulos, Inc. would result in the Private Warrants having substantially the same terms as the Public Warrants, management determined that the fair value of each Private Warrant is the same as that of a Public Warrant, with an insignificant adjustment for short-term marketability restrictions, as of December 31, 2021. As of December 31, 2022, management determined the fair value of the Private Warrants using observable inputs in the Black-Scholes valuation model, which used the remaining term of warrants of 2.92 years, volatility of 85.0% and a risk-free rate of 4.23%. Accordingly, the Private Warrants are classified as Level 3 financial instruments.
The following table presents changes in Level 3 liabilities relating to Private Warrants measured at fair value (in thousands):
Private
Warrants
Balance as of December 31, 2021
$31,230 
Change in fair value prior to exercises4,713 
Reduction in liability due to exercises(19,003)
Change in fair value of outstanding warrants(13,935)
Balance as of December 31, 2022
$3,005 
The Company’s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used for such measurements were as follows (in thousands):
Fair Value (in thousands) Measured as of
December 31, 2022 Using:
Level 1Level 2Level 3Total
Assets:
Cash equivalents:
Money market funds$42,056 $ $ $42,056 
Total cash equivalents$42,056 $ $ $42,056 
Marketable investments:
U.S. treasury securities$188,480 $ $ $188,480 
U.S. agency and government sponsored securities 4,924  4,924 
Commercial paper 74,523  74,523 
Corporate bonds 109,909  109,909 
Asset-backed securities 11,835  11,835 
Marketable equity investments29,643   29,643 
Total marketable investments$218,123 $201,191 $ $419,314 
Liabilities:
Private Warrants  3,005 3,005 
Total warrant liabilities$ $ $3,005 $3,005 
78

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fair Value (in thousands) Measured as of
December 31, 2021 Using:
Level 1Level 2Level 3Total
Assets:
Cash equivalents:
Money market funds$25,654 $ $ $25,654 
Commercial paper 950  950 
Total cash equivalents$25,654 $950 $ $26,604 
Marketable investments:
U.S. treasury securities$161,465 $ $ $161,465 
U.S. agency and government sponsored securities 4,970  4,970 
Commercial paper 39,834  39,834 
Corporate bonds 165,190  165,190 
Asset-backed securities 46,466  46,466 
Marketable equity investments44,216   44,216 
Total marketable investments$205,681 $256,460 $ $462,141 
Liabilities:
Private Warrants  31,230 31,230 
Total warrant liabilities$ $ $31,230 $31,230 
The Company’s non-marketable equity investment, measured at fair value on a non-recurring basis, that has been remeasured during the period due to impairment is classified within Level 3 in the fair value hierarchy because the Company estimated the value based on valuation methods which included unobservable inputs including projections received from Robotic Research, market conditions, preference rights, etc. of the investment the Company holds. See Note 5 for further information on the Company’s non-marketable equity investment.
As of December 31, 2022 and 2021, the estimated fair value of the Company’s outstanding Convertible Senior Notes was $352.5 million and $669.4 million, respectively. The fair value was determined based on the quoted price of the Convertible Senior Notes in an inactive market on the last trading day of the reporting period and have been classified as Level 2 in the fair value hierarchy. See Note 7 for further information on the Company’s Convertible Senior Notes.
The Company’s other financial instruments’ fair value, including accounts receivable, accounts payable and other current liabilities, approximate its carrying value due to the relatively short maturity of those instruments. The carrying amounts of the Company’s finance leases approximate their fair value, which is the present value of expected future cash payments based on assumptions about current interest rates and the creditworthiness of the Company.
Note 9. Convertible Preferred Stock
Series A Convertible Preferred Stock
On June 24, 2019, Legacy Luminar had amended and restated its Certificate of Incorporation (“Certificate”), which authorized the issuance of up to 102,740,023 shares of Series A Convertible Preferred Stock with a par value of $0.00001. On June 24, 2019, Legacy Luminar entered into a Series A Convertible Preferred Stock Purchase Agreement to issue preferred stock to investors for cash and in settlement of outstanding SAFEs and Bridge Note.
Series X Convertible Preferred Stock
On August 24, 2020, Legacy Luminar had entered into the Series X Convertible Preferred Stock Purchase Agreement to offer shares of Legacy Luminar’s Series X Convertible Preferred Stock. In August 2020 and September of 2020, Legacy Luminar issued an aggregate of 17,065,536 convertible preferred stock for cash at a purchase price of $9.96 per share of preferred stock, which generated gross proceeds of $170.0 million. In October 2020, Legacy Luminar had issued an additional 1,391,694 shares of preferred stock for gross proceeds of $13.86 million. Accordingly, Legacy Luminar had amended and restated its certificate of incorporation, which authorized the issuance of up to 20,077,073 shares of Series X Convertible Preferred Stock with a par value of $0.00001.
Upon closing of the Business Combination on December 2, 2020, the outstanding shares of Series A and Series X Convertible Preferred Stock were automatically converted into 113,275,381 shares of the Company Class A common stock.
79

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Beneficial Conversion Features (“BCFs”)
The Company had assessed whether BCFs existed for the optional conversion rights that did not require bifurcation as derivatives. If the conversion option was in-the-money as of the commitment date, the preferred stock contained a BCF. The BCF was recognized as a deemed dividend against the carrying amount of the preferred stock. The Company had monitored for the issuance of additional shares below the conversion price, which could have resulted in a contingent BCF. The Company had recorded a total BCF of $12.0 million from the issuance of preferred stock prior to the close of the Business Combination. Because the preferred stock was convertible at any time pursuant to the optional conversion feature, the Company recognized a dividend equal to the BCF at the applicable commitment date. As the Company had an accumulated deficit as of the end of all periods presented, the BCF resulted in an increase and decrease in additional paid-in capital by the same amount.
Furthermore, the preferred stock contained a down-round protection provision that reduced the conversion price if the Company issues shares at less than the conversion price or for no consideration. This provision was not triggered upon consummation of the Business Combination and no contingent BCF was recorded during the year ended December 31, 2020.
Note 10. Earnings (Loss) Per Share
Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares of common stock during the period plus, common stock equivalents, as calculated under the treasury stock method, outstanding during the period. If the Company reports a net loss, the computation of diluted loss per share excludes the effect of dilutive common stock equivalents, as their effect would be antidilutive. The Company computes earnings (loss) per share using the two-class method for its Class A and Class B common stock. Earnings (loss) per share is same for both Class A and Class B common stock since they are entitled to the same liquidation and dividend rights. Earnings (loss) per share calculations for all periods prior to the Business Combination have been retrospectively restated to the equivalent number of shares reflecting the exchange ratio established in the reverse capitalization.
The following table sets forth the computation of basic and diluted loss for the years ended December 31, 2022, 2021, and 2020 as follows: (in thousands, except for share and per share amounts):
December 31,
202220212020
Numerator:
Net loss$(445,939)$(237,986)$(362,298)
Deemed dividend attributable to BCF accretion  (6,757)
Net loss attributable to common shareholders$(445,939)$(237,986)$(369,055)
Denominator:
Weighted average Common shares outstanding- Basic356,265,774 346,300,975 145,096,996 
Weighted average Common shares outstanding- Diluted356,265,774 346,300,975 145,096,996 
Net loss per shares attributable to Common shareholders- Basic and Diluted$(1.25)$(0.69)$(2.54)
The following table presents the potential shares of common stock outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive:
December 31,
202220212020
Warrants5,757,549 7,166,301 24,089,255 
Stock-based awards—Equity classified33,372,534 24,156,973 18,003,962 
Stock-based awards—Liability classified14,302,723 2,401,648  
Vendor stock-in-lieu of cash program3,162,879 1,659,510  
Convertible Senior Notes31,279,716 31,279,716  
Earn-out shares8,606,717 8,606,717 25,818,744 
Total96,482,118 75,270,865 67,911,961 
The Company uses the if converted method for calculating the dilutive effect of the Convertible Senior Notes using the initial conversion price of $19.981 per share. The closing price of Class A common stock as of December 31, 2022 was less than the initial conversion price.
80

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 11. Stockholders’ Equity (Deficit)
Class A and Class B Common Stock
The Company’s Board of Directors has authorized two classes of common stock, Class A and Class B. As of December 31, 2022, the Company had authorized 715,000,000 and 121,000,000 shares of Class A and Class B common stock with a par value of $0.0001 per share for each class. As of December 31, 2022, the Company had 291,942,087 shares issues and 270,078,637 shares outstanding shares of Class A common stock, and 97,088,670 shares of issued and outstanding Class B common stock. Holders of the Class A and Class B common stock have identical rights, except that holders of the Class A common stock are entitled to one vote per share and the holder of the Class B common stock is entitled to ten votes per share. Shares of Class B common stock can be converted to shares of Class A common stock at any time at the option of the stockholder and automatically convert upon sale or transfer, except for certain transfers specified in the Company’s amended and restated certificate of incorporation. During 2021, 15,000,000 shares of Class B common stock were converted into Class A common stock on a one-for-one basis.
In connection with the merger with Gores on December 2, 2020, the Company’s Chief Executive Officer exchanged 22,935,412 shares of Founders Preferred Stock and 82,182,791 shares of Class A common stock, which were entitled to one vote per share, into the same number of shares of Class B common stock, which are entitled to ten votes per share. The Company recorded the incremental value of $3.0 million associated with this transaction as stock-based compensation in general and administrative expenses.
Treasury Stock
In December 2021, the Company’s Board of Directors authorized share repurchases up to $312.5 million of the Company’s Class A common stock. The Company’s share repurchase program does not obligate the Company to acquire any specific number of shares. Under the program, shares could be repurchased in privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). In the fourth quarter of 2021, the Company repurchased 15,263,761 shares Class A common stock for $235.9 million through negotiated and market purchase transactions. In the first and second quarters of 2022, the Company repurchased 2,682,548 and 3,917,141 shares of Class A common stock for $39.7 million and $36.9 million, respectively. As of December 31, 2022, no amount remained available for stock repurchases pursuant to our stock repurchase program. The repurchased shares have been recorded as Treasury Stock on the Balance Sheet as of December 31, 2022 and 2021.
Founders Preferred Stock
26,206,837 shares of Founders Preferred Stock were issued in 2015. The compensation expense associated with the Founders Preferred Stock was immaterial to the financial statements. The Founders Preferred Stock was substantively the same as common stock, as they share identical rights and features. The Founders Preferred Stock was convertible into common stock on a one-to-one basis at any time. The Founders Preferred Stock is presented as a component of the Company’s permanent equity. Upon closing of the Business Combination, Founders Preferred Stock was converted into shares of Class A and Class B common stock. No Founders Preferred Stock have been outstanding since the closing of the Business Combination.
Public and Private Warrants
In March 2021, 3,589,645 Private Warrants and 13,128,671 Public Warrants were exercised, and the Company received $153.9 million in cash proceeds from the exercise of these warrants. Pursuant to the terms of the agreements governing the rights of the holders of the Public Warrants, the Company redeemed the remaining unexercised and outstanding 204,638 Public Warrants after March 2021 for a redemption price of $0.01 per Public Warrant.
As of December 31, 2021, the Company had no Public Warrants and 3,077,021 Private Warrants outstanding.
In January 2022 and April 2022, 1,389,529 and 19,223 Private Warrants, respectively, were exercised on a cashless basis and the Company issued 401,365 and 4,387 shares of Class A common stock, respectively, pursuant to the exercises. The Company had 1,668,269 Private Warrants outstanding as of December 31, 2022. These Private Warrants expire on December 2, 2025. Each Private Warrant allows the holder to purchase one share of Class A common stock at $11.50 per share.
Stock-in-lieu of Cash Program
The Company has entered into arrangements with certain vendors and other third parties wherein the Company at its discretion may elect to pay amounts owed to the respective vendors or third parties for services provided either in cash or by issuing shares of the Company’s Class A common stock (“Stock-in-lieu of Cash Program”). During the year ended December 31, 2022, the Company issued 8,824,385 shares of Class A common stock, as part of the Stock-in-lieu of Cash
81

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Program. The Company considers the shares issuable under the Stock-in-lieu of Cash Program as liability classified awards when the arrangement with the vendors requires the Company to issue a variable number of shares to settle amounts owed. As of December 31, 2022, the Company had a total of $15.2 million in prepaid expenses and other current and non-current assets related to its Stock-in-lieu of Cash Program.
In November 2021, the Company entered into an agreement with Daimler North America Corporation (“Daimler”) wherein Daimler is providing certain data and other services to the Company. To compensate Daimler for these services, the Company agreed to issue 1.5 million shares of Class A common stock to Daimler. These shares are subject to certain vesting conditions and vest over a period of two years. The Company recorded costs related to these shares as research and development expense of $7.9 million during the year ended December 31, 2022. During the year ended December 31, 2022, the Company issued 1,125,000 shares of Class A common stock related to this arrangement. The unamortized cost relating to the shares issued to Daimler under this agreement was recorded as $9.2 million in prepaid expenses and other current and non-current assets as of December 31, 2022.
The Company’s vendor Stock-in-lieu of Cash Program activity for the year ended December 31, 2022 was as follows:
SharesWeighted Average
Grant Date Fair Value
per Share
Outstanding as of December 31, 20211,500,000 $15.72 
Granted8,824,385 9.93 
Vested(9,277,234)10.65 
Outstanding as of December 31, 20221,047,151 11.90 
Note 12. Stock-based Compensation
Prior to becoming a publicly traded entity, the Company issued incentive stock options, non-qualified stock options, and restricted stock to employees and non-employee consultants under its 2015 Stock Plan (the “2015 Plan”). Since the closing of the Business Combination, the Company has not issued any new stock-based awards under the 2015 Plan.
In December 2020, the Board adopted, and the Company’s stockholders approved the 2020 Equity Incentive Plan (the “2020 Plan”). The 2020 Plan became effective upon the closing of the Business Combination. Under the 2020 Plan, the Company was originally authorized to issue a maximum number of 36,588,278 shares of Class A common stock.
In June 2022, the Company’s stockholders approved an amendment and restatement of the Company’s 2020 Plan (the “Amended 2020 Plan”) to increase the number of shares of Class A common stock authorized for issuance by 36,000,000 additional shares and added an evergreen provision under which the number of shares of Class A common stock available for issuance under the Amended 2020 Plan will be increased on the first day of each fiscal year of the Company beginning with the 2023 fiscal year and ending on (and including) the first day of the 2030 fiscal year, in an amount equal to the lesser of (i) 5% of the outstanding shares of common stock on the last day of the immediately preceding fiscal year, (ii) 40,000,000 shares or (iii) such number of shares determined by the Board. Pursuant to the evergreen provision, 18,358,365 additional shares of Class A common stock were added to the Amended 2020 Plan on January 1, 2023.
Stock Options
Under the terms of the 2015 Plan, incentive stock options had an exercise price at or above the fair market value of the stock on the date of the grant, while non-qualified stock options were permitted to be granted below fair market value of the stock on the date of grant. Stock options granted had service-based vesting conditions only. The service-based vesting conditions varied, though typically, stock options vest over four years with 25% of stock options vesting on the first anniversary of the grant and the remaining 75% vesting monthly over the remaining 36 months. Option holders have a 10-year period to exercise the options before they expire. Forfeitures are recognized in the period of occurrence.
82

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
A summary of the Company’s stock option activity for the year ended December 31, 2022 was as follows (in thousands, except years and per share data):
Number of
Stock Options
Weighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Life (Years)
Aggregate
Intrinsic Value
Outstanding as of December 31, 2021
11,507,643 $1.72 
Exercised(2,370,989)1.67 
Cancelled/Forfeited(973,804)1.67 
Outstanding as of December 31, 2022
8,162,850 1.74 7.03$26,763 
Vested and exercisable as of December 31, 20225,472,821 1.73 6.95$17,654 
Vested and expected to vest as of December 31, 20228,162,850 1.74 7.03$26,763 
No stock options were granted by the Company in 2022 or 2021. The weighted-average grant date fair value per share of options granted during the year ended December 31, 2020 was $0.98. The total grant-date fair value of options that vested during the year ended December 31, 2022, 2021 and 2020 was $2.9 million, $7.1 million and $1.4 million, respectively.
The aggregate intrinsic value of stock options exercised during the year ended December 31, 2022 was $20.6 million. The intrinsic value is calculated as the difference between the exercise price and the fair value of the common stock on the exercise date.
As of December 31, 2022, the Company had $2.7 million of unrecognized stock-based compensation expense related to stock options. This cost is expected to be recognized over a weighted-average period of 0.63 years.
Restricted Stock Awards
Prior to June 30, 2019, the Company granted restricted stock awards (“RSAs”) to employees. Recipients purchased the restricted stock on the grant date and the Company has the right to repurchase the restricted shares at the same price recipients paid to obtain those shares. The restrictions lapse solely based on continued service, and generally lapse over 4 years —25% on the first anniversary of the date of issuance, and the remaining 75% monthly over the remaining 36 months. At the grant date of the award, recipients of restricted stock were granted voting rights and right to receive dividends on unvested shares. No restricted stock awards have been granted after June 30, 2019.
The Company’s RSAs activity for the year ended December 31, 2022 was as follows:
SharesWeighted Average
Grant Date Fair Value
per Share
Outstanding as of December 31, 2021666,298 1.21 
Forfeited(18,476)1.23 
Vested(583,336)1.20 
Outstanding as of December 31, 202264,486 1.29 
The total grant-date fair value of restricted stock awards vested during the year ended December 31, 2022, 2021 and 2020 was $0.7 million, $1.0 million and $2.2 million, respectively.
As of December 31, 2022, the Company had $0.1 million of unrecognized stock-based compensation expense related to restricted stock awards, which is expected to be recognized in the first quarter of 2023.
Restricted Stock Units
Since the closing of the Business Combination, the Company has granted restricted stock units (“RSUs”) under the Amended 2020 Plan (and prior to its amendment and restatement, under the 2020 Plan). Each RSU granted under the Amended 2020 Plan represents a right to receive one share of the Company’s Class A common stock when the RSU vests. RSUs generally vest over a period up to six years. The Company has granted certain performance-based equity awards that vest upon achievement of certain performance milestones. The fair value of RSU is equal to the fair value of the Company’s common stock on the date of grant.
83

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The Company’s RSUs activity for the year ended December 31, 2022 was as follows:
SharesWeighted Average
Grant Date Fair
Value per Share
Outstanding as of December 31, 202111,983,032 19.56 
Granted23,213,889 10.29 
Forfeited(2,069,915)16.15 
Vested(7,532,971)15.40 
Outstanding as of December 31, 202225,594,035 12.66 
The total fair value of RSUs vested during the year ended December 31, 2022 and 2021was $116.0 million and $32.8 million, respectively.
As of December 31, 2022, the Company had $277.7 million of unrecognized stock-based compensation expense related to RSUs. This cost is expected to be recognized over a weighted-average period of 1.53 years.
Fixed Value Equity Awards
The Company issues fixed value equity awards to certain employees as a part of their compensation package. These awards are issued as RSUs out of the Amended 2020 Plan (and prior to its amendment and restatement, under the 2020 Plan) and are accounted for as liability classified awards under ASC 718 — Stock Compensation. Fixed value equity awards granted have service-based conditions only and vest quarterly over a period a period up to four years. These awards represent a fixed dollar amount settled in a variable number of shares determined at each vesting date. For the year ended December 31, 2022, the Company recorded $7.6 million in stock-based compensation expense related to these awards.
Employee Stock Purchase Plan
In December 2020, the Board and the Company’s stockholders adopted the 2020 Employee Stock Purchase Plan (“ESPP”) under which 7,317,655 shares were authorized for issuance. The 2020 ESPP became effective on February 26, 2021.
The ESPP permits eligible employees to purchase the Company’s Class A common stock through payroll deduction with up to 15% of their pre-tax earnings subject to certain Internal Revenue Code limitations. The purchase price of shares is 85% of the lower of the fair market value of the Company’s common stock on the first day of a six-month offering period, or the relevant purchase date. In addition, no participant may purchase more than 5,000 shares of common stock in each purchase period.
During 2022, 168,147 shares were purchased at a weighted average price of $7.56 per share.
The assumptions used to value purchase rights under the ESPP during the year ended December 31, 2022 were as follows:
May 16, 2022November 16, 2022
Expect term (years)0.50.5
Volatility82.3%93.5%
Risk-free interest rate1.54%4.54%
Dividend yield%%
Optogration Milestone Awards
As discussed in Note 3, as part of the Optogration acquisition in August 2021, the Company owed up to $22.0 million of post combination compensation related to certain service and performance conditions (“Optogration Milestone Awards”). In August 2022, the Company issued 1,632,056 shares of Class A common stock for $11.0 million of the Optogration Milestone Awards due to achievement of the service and performance conditions. As of December 31, 2022, it is probable that the service and performance conditions for the remaining $11.0 million obligation will be met. The Company recorded $16.5 million in stock-based compensation expense from inception to December 31, 2022 for Optogration Milestone Awards.
Freedom Photonics Awards
As part of the Freedom Photonics acquisition in April 2022, the Company owes up to $28.3 million of post combination compensation related to certain service and performance conditions including achievement of certain technical and financial
84

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
milestones. As of December 31, 2022, Freedom Photonics did not achieve a portion of its stipulated financial milestone. As of December 31, 2022, it is probable that the remaining conditions will be met, and as a result, the Company recorded $7.6 million in stock-based compensation expense through December 31, 2022.
Solfice Awards
The Company owes up to $0.7 million in compensation related to certain service and performance conditions. As of December 31, 2022, it is probable that the conditions will be met, and as a result, the Company recorded $0.4 million in stock-based compensation expense through December 31, 2022.
Executive Officer Awards
On May 2, 2022, the Board granted an award of 10.8 million RSUs to Austin Russell, the Company’s Chief Executive Officer. The grant date fair value per share was $8.70 per share. This award represents Mr. Russell’s total compensation from the Company. On August 19, 2022, the Board granted 500,000 RSUs to each of Thomas Fennimore, the Company’s Chief Financial Officer and Alan Prescott, the Company’s Chief Legal Officer. The grant date fair value per share was $6.12 per share.
The Company measured compensation cost for the above executive officer awards using a Monte Carlo simulation model and recorded $14.7 million in stock-based compensation expense related to these awards in the year ended December 31, 2022. These awards to the executive officers are subject to all of the following vesting conditions:
Public Market condition: Achievement of three stock price milestones: $50 or more, $60 or more, and $70 or more. The stock price will be measured based on the volume-weighted average price per share for 90 consecutive trading days;
Service condition: Approximately 7-years of vesting; and
Performance condition: Start of production for at least one series production program.
As of December 31, 2022, the Company had $85.3 million of unrecognized stock-based compensation expense related to RSUs. This cost is expected to be recognized over a weighted-average period of 6.36 years.
85

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Compensation expense
Stock-based compensation expense by type of award was as follows (in thousands):
Year Ended December 31,
202220212020
Equity Classified Awards:
Stock options$2,666 $5,137 $3,179 
RSAs293 1,682 5,532 
RSUs129,992 60,191  
ESPP714   
Liability Classified Awards:
Equity settled fixed value7,545 3,826  
Optogration10,894 6,114  
Freedom Photonics7,633   
Solfice410   
Other2,258 734  
Total$162,405 $77,684 $8,711 
Stock-based compensation expense by function was as follows (in thousands):
Year Ended December 31,
202220212020
Cost of sales$7,680 $6,422 $309 
Research and development40,898 20,216 2,098 
Sales and marketing15,814 4,546 414 
General and administrative98,013 46,500 5,890 
Total$162,405 $77,684 $8,711 
Note 13. Leases
The Company leases office and manufacturing facilities under non-cancelable operating leases expiring at various dates through September 2028. In October 2021, the Company entered into a lease agreement commencing on April 1, 2022 for a term of 65 months through August 31, 2027. In September 2022, the Company entered into a lease agreement for a term of 66 months through February 2028. Some of the Company’s leases include one or more options to renew, with renewal terms that if exercised by the Company, extend the lease term from one to six years. The exercise of these renewal options is at the Company’s discretion. The Company’s lease agreements do not contain any material terms and conditions of residual value guarantees or material restrictive covenants. The Company’s short-term leases and sublease income were not material.
The Company adopted ASC 842 using the modified retrospective method on January 1, 2021 and elected the available package of practical expedients upon adoption. The most significant impact of the adoption of ASC 842 was the recognition of right-of-use, or ROU, assets and lease liabilities for operating leases of $10.8 million and $12.0 million, respectively, and a reversal of deferred rent of $1.2 million on January 1, 2021. The Company’s accounting for finance leases remained substantially unchanged. The adoption of ASC 842 did not have any impact on the Company’s operating results or cash flows.
The components of lease expenses were as follows (in thousands):
Year Ended
December 31, 2022December 31, 2021
Operating lease cost$6,533 $4,654 
Variable lease cost2,230 1,703 
Total operating lease cost$8,763 $6,357 
86

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Supplemental cash flow information related to leases was as follows (in thousands):
Year Ended
December 31, 2022December 31, 2021
Cash paid for amounts included in the measurement of lease liabilities:
Cash paid for operating leases included in operating activities$(6,070)$(4,609)
Right of use assets obtained in exchange for lease obligations:
Operating leases16,749 2,876 
Supplemental balance sheet information related to leases was as follows (in thousands):
December 31, 2022December 31, 2021
Operating leases:
Operating lease right-of-use assets$21,244 $9,145 
Operating lease liabilities:
Operating lease liabilities, current$5,953 $4,735 
Operating lease liabilities, non-current16,989 5,768 
Total operating lease liabilities$22,942 $10,503 
Weighted average remaining terms were as follows (in years):
December 31, 2022December 31, 2021
Weighted average remaining lease term
Operating leases4.432.95
Weighted average discount rates were as follows:
December 31, 2022December 31, 2021
Weighted average discount rate
Operating leases5.45 %2.80 %
Maturities of lease liabilities were as follows (in thousands):
Year Ending December 31,Operating Leases
2023$6,190 
20245,123 
20255,193 
20264,732 
20273,927 
Thereafter1,149 
Total lease payments26,314 
Less: imputed interest(3,372)
Total leases liabilities$22,942 
Note 14. Income Taxes
The following table presents components of loss before provision for (benefit from) income taxes for the periods presented (in thousands):
Year Ended December 31,
202220212020
United States$(445,720)$(239,855)$(362,338)
International453 607 40 
Loss before provision for (benefit from) income taxes$(445,267)$(239,248)$(362,298)
87

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Provision for (benefit from) income taxes for the periods presented consisted of (in thousands):
Year Ended December 31,
202220212020
Current:
Foreign440   
Total current:440   
Deferred:
U.S. federal204 (1,262) 
U.S. state28   
Total deferred:232 (1,262) 
Total provision for (benefit from) income taxes$672 $(1,262)$ 
The reconciliation between the U.S. federal statutory income tax rate of 21% to the Company’s effective tax for the periods presented is as follows:
Year Ended December 31,
202220212020
U.S. federal provision at statutory rate21.0 %21.0 %21.0 %
State income taxes5.7 4.4 0.7 
Tax credits2.4 1.5 0.6 
Fair value of financial instruments0.4 (2.3)(15.6)
Stock-based compensation expense(3.4)2.0 (0.4)
Executive compensation(0.8)(1.1)0.0 
Other permanent items0.2 (0.3)0.0 
Uncertain tax benefits(1.4)(0.8)(0.3)
Change in valuation allowance(24.3)(24.0)(6.0)
Effective tax rate(0.2 %)0.4 %0.0 %
The Company’s effective tax rates differ from the federal statutory rate primarily due to the change in valuation allowance, non-deductible stock-based compensation expense net of excess windfall stock compensation deductions, nondeductible executive compensation, R&D tax credits, state income taxes and the fluctuation of fair value on instruments treated as debt for GAAP and equity for tax purposes, which is not taxable/deductible for income tax purposes, for 2022, 2021 and 2020.
88

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The Company’s deferred income tax assets and liabilities as of December 31, 2022 and 2021 were as follows (in thousands):
Year Ended December 31,
20222021
Deferred tax assets:
Net operating loss carry forward$161,881 $120,544 
Tax credits16,322 6,296 
Accruals and reserves3,309  
Stock-based compensation expense14,535 6,944 
Lease liability (ASC 842)6,268 2,622 
Section 174 R&D capitalization43,240  
Inventory reserves1,961 617 
Depreciation and amortization2,170  
Other20 15 
Total deferred tax assets249,706 137,038 
Valuation allowance(243,811)(130,569)
Total deferred tax asset5,895 6,469 
Deferred tax liabilities:
Depreciation and amortization 1,185 
Prepaid expenses 2,983 
Other162  
ROU asset (ASC 842)5,801 2,301 
Total deferred tax liabilities5,963 6,469 
Net deferred tax assets (liabilities)$(68)$ 
The Company assesses the realizability of deferred tax assets based on the available evidence, including a history of taxable income and estimates of future taxable income. In assessing the realizability of deferred tax assets, the Company considers whether it is more likely than not that all or some portion of deferred tax assets will not be realized. Due to the history of losses incurred by the Company, management believes it is not more likely than not that substantially all of the deferred tax assets can be realized. Accordingly, the Company established and recorded a full valuation allowance on its net deferred tax assets of $243.8 million and $130.6 million as of December 31, 2022 and 2021, respectively. The valuation allowance increased by $113.2 million in 2022.
No deferred tax liabilities for foreign withholding taxes have been recorded relating to the earnings of the Company’s foreign subsidiaries since all such earnings are intended to be indefinitely reinvested. The amount of the unrecognized deferred tax liability associated with these earnings is immaterial.
Utilization of the net operating loss and tax credit carryforwards is subject to a substantial annual limitation due to the “ownership change” limitations provided by Sections 382 and 383 of the Internal Revenue Code of 1986, as amended (“IRC”) and other similar state provisions. Any annual limitation may result in the expiration of net operating loss and tax credit carryforwards before utilization. As of December 31, 2022, the Company had $597.0 million of U.S. federal net operating loss carryforwards available to reduce future taxable income, of which $553.8 million will be carried forward indefinitely for U.S. federal tax purposes and $43.2 million will expire beginning in 2035 to 2037. The Company also has $547.8 million of U.S. state net operating loss carryforwards that will expire beginning in 2036.
The Company also has federal and state research and development (“R&D”) tax credit carryforwards of $21.1 million and $3.9 million, respectively, as of December 31, 2022. The federal research credit carryforwards will begin expiring in 2035 and although a small portion, less than $0.05 million, of the state research credit carryforwards will begin expiring in 2023, $4.3 million of the state research credit carryforwards do not expire.
Under the Tax Cuts and Jobs Act (“TCJA”), for tax years beginning after December 31, 2021, taxpayers are required to capitalize and amortize all R&D expenditures that are paid or incurred in connection with their trade or business which represent costs in the experimental or laboratory sense. Specifically, costs for U.S.-based R&D activities must be amortized over 5 years and costs for foreign R&D activities must be amortized over 15 years. As of December 31, 2022, there is
89

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
insufficient Internal Revenue Service guidance on how to treat capitalizable R&D expenditures. The Company will continue to monitor the status of any new guidance that might be issued and will update its estimated capitalized R&D, accordingly.
Beginning January 1, 2022, the TCJA eliminated the option to deduct research and development expenditures in the current year and requires taxpayers to capitalize such expenses pursuant to IRC Section 174. The capitalized expenses are amortized over a 5-year period for domestic expenses and a 15-year period for foreign expenses. As a result of this provision of the TCJA, deferred tax assets related to capitalized research expenses increased by $43.2 million.

Unrecognized Tax Benefits
The Company reports income tax related interest and penalties within its provision for income tax in its consolidated statements of operations. The Company had no interest and penalties accrued through December 31, 2022. The Company does not expect the total amount of unrecognized tax benefits will significantly increase or decrease within 12 months of the reporting date.
The following is a tabular reconciliation of the total amounts of unrecognized tax benefits (in thousands):
Year Ended December 31,
202220212020
Unrecognized tax benefits as of the beginning of the year$6,296 $3,975 $2,397 
Increases related to prior year tax positions 535 327 
Decreases related to prior year tax provisions(3,723)  
Increase related to current year tax positions6,031 1,786 1,251 
Unrecognized tax benefits as of the end of the year$8,604 $6,296 $3,975 
None of the Company’s unrecognized tax benefits, if recognized, would affect the effective tax rate since the tax benefits would increase a deferred tax asset that is currently fully offset by a full valuation allowance. The Company and its subsidiaries file federal, state and foreign income tax returns. In the normal course of business, the Company is subject to examination by taxing authorities, for which the Company’s major tax jurisdictions are the United States and various states. The Company’s federal, state and foreign income tax returns from inception to December 31, 2022 remain subject to examination.
Note 15. Commitments and Contingencies
Purchase Obligations
The Company purchases goods and services from a variety of suppliers in the ordinary course of business. Purchase obligations are defined as agreements that are enforceable and legally binding and that specify all significant terms, including fixed or minimum quantities to be purchased, fixed, minimum, or variable price provisions, and the approximate timing of the transaction. The Company had purchase obligations primarily for purchases of inventory, R&D, and general and administrative activities totaling $96.0 million as of December 31, 2022.
Legal Matters
From time to time, the Company is involved in actions, claims, suits and other proceedings in the ordinary course of business, including assertions by third parties relating to intellectual property infringement, breaches of contract or warranties or employment-related matters. When it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated, the Company records a liability for such loss contingencies. The Company’s estimates regarding potential losses and materiality are based on the Company’s judgment and assessment of the claims utilizing currently available information. Although the Company will continue to reassess its reserves and estimates based on future developments, the Company’s objective assessment of the legal merits of such claims may not always be predictive of the outcome and actual results may vary from the Company’s current estimates. The Company’s current legal accrual is not material to the financial statements.
Note 16. Segment and Customer Concentration Information
Reportable segments are (i) Autonomy Solutions and (ii) ATS. These segments reflect the way the chief operating decision maker (“CODM”) evaluates the Company’s business performance and manages its operations. Each segment has distinct product offerings, customers and market penetration. The Chief Executive Officer is the CODM of the Company.
90

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Autonomy Solutions
This segment manufactures and distributes commercial lidar sensors that measure distance using laser light for automotive mobility applications. This segment is impacted by trends in the autonomous vehicles and associated infrastructure/technology sector.
ATS
This segment is in the business of development of semiconductor technology based lasers and sensors. This segment also designs, tests and provides consulting services for development of integrated circuits. This segment is impacted by trends in and the strength of the automobile and aeronautics sector as well as government spending in military and defense activities.
The accounting policies of the operating segments are the same as those described in Note 2. Segment operating results and reconciliations to the Company’s consolidated balances are as follows (in thousands):
Year ended December 31, 2022
Autonomy
Solutions
ATSTotal
reportable
segments
Eliminations (1)Total
Consolidated
Revenue:
Revenues from external customers$24,353 $16,345 $40,698 $— $40,698 
Revenues from internal customer14,748 12,485 27,233 (27,233)— 
Total Revenue$39,101 $28,830 $67,931 $(27,233)$40,698 
Depreciation and amortization$4,110 $2,456 $6,566 $ $6,566 
Operating gain (loss)(412,673)(29,394)(442,067)(335)(442,402)
Other significant items:
Segment assets752,088 60,529 812,617 (125,290)687,327 
Inventories, net8,664 474 9,138 (346)8,792 
Year ended December 31, 2021
Autonomy
Solutions
ATSTotal
reportable
segments
Eliminations (1)Total
Consolidated
Revenue:
Revenues from external customers$28,497 $3,447 $31,944 $— $31,944 
Revenues from internal customer8,098 5,929 14,027 (14,027)— 
Total Revenue$36,595 $9,376 $45,971 $(14,027)$31,944 
Depreciation and amortization$3,723 $439 $4,162 $ $4,162 
Operating gain (loss)(214,133)(324)(214,457)(95)(214,552)
Other significant items:
Segment assets882,704 9,771 892,475 (8,939)883,536 
Inventories, net10,179 163 10,342  10,342 
91

LUMINAR TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Year ended December 31, 2020
Autonomy
Solutions
ATSTotal
reportable
segments
Eliminations (1)Total
Consolidated
Revenue:
Revenues from external customers$11,387 $2,564 $13,951 $— $13,951 
Revenues from internal customer1,516 3,248 4,764 (4,764)— 
Total Revenue$12,903 $5,812 $18,715 $(4,764)$13,951 
Depreciation and amortization$2,395 $128 $2,523 $(6)$2,517 
Operating gain (loss)(86,661)(316)(86,977)102 (86,875)
Other significant items:
Segment assets511,676 2,975 514,651 (4,300)510,351 
Inventories, net3,604 9 3,613  3,613 
(1) Represent the eliminations of all intercompany balances and transactions during the period presented.
Two customers accounted for 21%, and 17% of the Company’s revenue for the year ended December 31, 2022. Two customers accounted for 42% and 17% of the Company’s revenue for the year ended December 31, 2021. One customer accounted for 64% of the Company’s revenue for the year ended December 31, 2020.
Note 17. Related Party Transactions
Equity Investments
In February 2021, the Company invested $15.0 million in a special purpose acquisition company, of which Mr. Jun Hong Heng, was the Chairman and Chief Executive Officer, and a principal shareholder. Mr. Heng became a director of the Company in June 2021. The terms of such investment were no less favorable to the Company than to other third party investors. During 2021, the Company sold $2.9 million of this investment and had a remaining balance of $12.1 million as of December 31, 2021. The fair value of this investment as of December 31, 2021 was $12.2 million, which was included in marketable securities in the balance sheet. The Company sold this investment in its entirety in the second quarter of 2022. The special purpose acquisition company merged with ECARX on December 20, 2022 and Mr. Heng continues to be a director of the merged company.
In June 2022, the Company invested in a special purpose acquisition company through open market purchases, of which Mr. Alec Gores was the Chairman and Chief Executive Officer, and a principal shareholder. The special purpose acquisition company merged with Polestar Automotive Holdings UK PLC on June 24, 2022 and Mr. Gores continues to be a director of the merged company. Mr. Gores is a director of Luminar as well. The balance of this investment as of December 31, 2022 was not material.
Note 18. Subsequent Events
In preparing the audited consolidated financial statements as of December 31, 2022, the Company has evaluated subsequent events through February 28, 2023.
In January 2023, the Company executed an asset purchase agreement with Seagate Technology LLC and Seagate Singapore International Headquarters Pte. Ltd. (individually and collectively, “Seagate”) and concurrently completed the acquisition of certain fixed assets, inventory and intellectual property related to Seagate’s lidar-related projects and obtained a license to certain patents and other intangibles for an aggregate cash consideration of $12.6 million. Additionally, the Company hired certain former employees of Seagate who had been working on the above projects.
In February 2023, the Company executed an agreement with Swiss Re Solutions Ltd (“Swiss Re”) for use of certain of Swiss Re’s tools and services for assessment of the Company’s technology for purposes of potentially developing an insurance product and Swiss Re potentially providing reinsurance and other services. The Company agreed to pay Swiss Re $4.0 million in consideration for these services over 4 years, of which $1.0 million is non-cancelable. The Company may at its sole discretion pay the consideration owed to Swiss Re either in cash or shares of Class A common stock.
92

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.
None.
ITEM 9A. CONTROLS AND PROCEDURES.
Evaluation of Disclosure Controls and Procedures
We have established disclosure controls and procedures that are designed to ensure that the information required to be disclosed by us in the reports that we file or submit under the Exchange Act and other securities laws is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and that such information is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decision making and timely required disclosure to investors.
Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we have evaluated the effectiveness of our disclosure controls and procedures as required under Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of December 31, 2022. Based on this evaluation, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures were effective as of December 31, 2022.
Management’s Report on Internal Control Over Financial Reporting
Management, including our CEO and CFO, is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a- 15(f) and 15d-15(f) under the Exchange Act and based upon the criteria established in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“the COSO framework”). Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of our financial statements for external purposes in accordance with U.S. GAAP.
Management’s internal control system provides reasonable assurance with respect to the preparation and fair presentation of financial statements, but has inherent limitations that may not prevent or detect all misstatements, including the possibility of human error, circumvention of controls, or fraud.
Under the supervision and with the participation of our management, including our CEO and CFO, we have conducted an evaluation of the effectiveness of our internal control over financial reporting based on the COSO framework. Based on evaluation under these criteria, management has concluded that our internal control over financial reporting was effective as of December 31, 2022 to provide reasonable assurance regarding the reliability of financial reporting and preparation of consolidated financial statements in accordance with U.S. GAAP.
Our evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2022, did not include the internal controls of Freedom Photonics. We excluded Freedom Photonics from our assessment of internal control over financial reporting as of December 31, 2022 because it was acquired in a business combination on April 13, 2022. Freedom Photonics is a wholly owned subsidiary whose total assets represent approximately 5%, total operating expenses represent approximately 5% and revenue represents 28% of the related consolidated financial statement amounts as of and for the year ended December 31, 2022.
The effectiveness of our internal control over financial reporting as of December 31, 2022 has been audited by Deloitte & Touche LLP, an independent registered public accounting firm, and their opinion is stated in their report which is included in this Annual Report on Form 10-K.
Remediation of Prior Year Material Weaknesses
The material weaknesses as previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2021, have been remediated. Since that time, our management, with the oversight of the audit committee of our Board of Directors, engaged in efforts to remediate the material weaknesses by implementing new and enhanced procedures and controls, including:
An oversight mechanism was established to define responsibilities to achieve control objectives and hold individuals accountable for their internal control responsibilities. A number of qualified personnel, including a new Chief Accounting Officer, Corporate Controller, and Assistant Corporate Controller, within the accounting function were hired and effectively leading their respective functions for sufficient period to ensure GAAP principles are appropriately applied to the recording of accounting transactions.
93

An internal audit function was established in-house with a new VP and Director, Internal Audit to strengthen oversight of the team and improve the design, implementation, execution and supervision of internal controls within the organization.
The design of the controls was enhanced, new controls were implemented to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements, training was provided, and documentation and supervisory reviews were strengthened by management. Policies were updated and reviewed to establish expectations and procedures. Controls were implemented to monitor adherence to policies.
User access controls related to the general ledger, automated business controls, and service organization controls were redesigned and enhanced to provide reasonable assurance over the information used in the control.
An appropriate monitoring framework was designed to periodically evaluate the Company’s internal control over financial reporting.
Access and segregation of duties related to Information Technology General Controls were enhanced. Standardization and automations were implemented within the accounting processes to improve the reliability of information.
Training was provided and new controls were implemented along with strengthening existing controls to enhance oversight over review and approval of manual journal entries.
These controls are adequately designed and have operated effectively for a sufficient period during 2022. Accordingly, the material weaknesses were determined to be remediated as of December 31, 2022.
Inherent Limitations on Effectiveness of Controls
Our management, including our principal executive officer and our principal financial officer, has determined that our internal controls are reasonably designed and implemented to assure reliable financial reporting and preparation of our financial statements. However, no control system can prevent and detect all errors and fraud. The design of any system of controls is based in part on certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of the effectiveness of controls to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.
Changes in Internal Control Over Financial Reporting
Other than the remediation of the material weaknesses in the internal controls described above, there were no changes in our internal control over financial reporting during the quarter ended December 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the stockholders and the Board of Directors of Luminar Technologies, Inc.
Opinion on Internal Control over Financial Reporting
We have audited the internal control over financial reporting of Luminar Technologies, Inc. and subsidiaries (the “Company”) as of December 31, 2022, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control — Integrated Framework (2013) issued by COSO.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2022, of the Company and our report dated February 28, 2023, expressed an unqualified opinion on those financial statements.
As described in Management’s Report on Internal Control Over Financial Reporting, management excluded from its assessment the internal control over financial reporting at Freedom Photonics, which was acquired on April 13, 2022, and whose financial statements constitute 5% of total assets, 28% of revenues, and 5% of operating expenses, respectively of the consolidated financial statement amounts as of and for the year ended December 31, 2022. Accordingly, our audit did not include the internal control over financial reporting at Freedom Photonics.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control
94

over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/ Deloitte & Touche LLP
San Jose, California
February 28, 2023
ITEM 9B. OTHER INFORMATION.
The information below is reported in lieu of information that would be reported under Items 1.01 and 8.01 under Form 8-K.
On February 28, 2023, the Company entered into a Financing Agreement (the “Sales Agreement”) with Virtu Americas LLC (the “Agent”) under which the Company may offer and sell, from time to time in its sole discretion, shares (the “Shares”) of the Company’s Class A common stock, par value $0.0001 per share (the “Class A Common Stock”), with aggregate gross sales proceeds of up to $75,000,000 through an “at the market” equity offering program under which Virtu Americas LLC will act as sales agent.
Under the Sales Agreement, the Company will set the parameters for the sale of the Shares, including the number of Shares to be issued, the time period during which sales are requested to be made, limitations on the number of Shares that may be sold in any one trading day and any minimum price below which sales may not be made. Subject to the terms and conditions of the Sales Agreement, the Agent has agreed to use its commercially reasonable efforts, consistent with its normal trading and sales practices, to sell the Shares by methods deemed to be an “at the market” offering as defined in Rule 415 promulgated under the Securities Act of 1933, as amended, including sales made through The Nasdaq Global Select Market.
The Sales Agreement provides that the Agent will be entitled to compensation for its services equal to up to 2% of the gross proceeds of any shares of Class A Common Stock sold through the Agent under the Sales Agreement and the Company will reimburse the Agent for certain expenses incurred in connection with its services under the Sales Agreement, including reasonable legal fees in connection with the establishment of the at the market offering. The Company has no obligation to sell any Shares under the Sales Agreement, and may at any time suspend solicitation and offers under the Sales Agreement. The offering of Shares pursuant to the Sales Agreement will terminate upon the earlier of (i) the sale of all Shares subject to the Sales Agreement or (ii) termination of the Sales Agreement in accordance with its terms.
The shares will be issued pursuant to the Company’s shelf registration statement on Form S-3 (File No. 333-262250), as amended by that certain Amendment No. 1 filed on February 1, 2022, which was declared effective by the Securities and Exchange Commission (the “SEC”) on February 3, 2022. The Company will file a prospectus supplement with the SEC in connection with the offer and sale of the Shares pursuant to the Sales Agreement.
95

The foregoing description of the Sales Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Sales Agreement. A copy of the Sales Agreement is filed with this Annual Report on Form 10-K as Exhibit 10.4 and is incorporated herein by reference.
A copy of the legal opinion of Orrick, Herrington & Sutcliffe LLP, relating to the validity of the Shares that may be sold pursuant to the Sales Agreement, is filed with this Annual Report on Form 10-K as Exhibit 5.1.
This information set forth under this Item 9B shall not constitute an offer to sell or the solicitation of any offer to buy the securities discussed herein, nor shall there be any offer, solicitation or sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS.
Not applicable.
96

PART III
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.
The information required by this item will be included under the captions “Board of Directors and Corporate Governance,” “Proposal One: Election of Directors” and “Executive Officers” in our Proxy Statement for the 2023 Annual Meeting of Stockholders to be filed with the SEC within 120 days of the year ended December 31, 2022 and is incorporated herein by reference.
Code of Business Conduct and Ethics
We have adopted a Code of Business Conduct and Ethics that applies to all of the members of our board of directors, officers and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. Our Code of Business Conduct and Ethics is posted on the Investor Relations section of our website, which is located at https://investors.luminartech.com by clicking on “Governance Documents” in the “Governance” section of our website. We intend to satisfy the disclosure requirement under Item 5.05 of Form 8-K regarding amendment to, or waiver from, a provision of our Code of Business Conduct and Ethics by posting such information on our website at the location specified above.
ITEM 11. EXECUTIVE COMPENSATION.
The information required by this item will be included under the captions “Board of Directors and Corporate Governance” and “Executive Compensation” in our Proxy Statement for the 2023 Annual Meeting of Stockholders to be filed with the SEC within 120 days of the year ended December 31, 2022 and is incorporated herein by reference.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.
The information required by this item will be included under the captions “Equity Compensation Plan Information” and “Security Ownership of Certain Beneficial Owners and Management” in our Proxy Statement for the 2023 Annual Meeting of Stockholders to be filed with the SEC within 120 days of the year ended December 31, 2022 and is incorporated herein by reference.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE.
The information required by this item will be included under the captions “Board of Directors and Corporate Governance” and “Certain Relationships and Related Party Transactions” in our Proxy Statement for the 2023 Annual Meeting of Stockholders to be filed with the SEC within 120 days of the year ended December 31, 2022 and is incorporated herein by reference.
ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES.
The information required by this item will be included under the caption “Proposal Two: Ratification of Appointment of Independent Registered Public Accounting Firm” in our Proxy Statement for the 2023 Annual Meeting of Stockholders to be filed with the SEC within 120 days of the year ended December 31, 2022 and is incorporated herein by reference.
97

PART IV
ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES.

The following documents are filed as part of this report:
1.Financial Statements. The financial statements included in “Index to the Consolidated Financial Statements” in Part II, Item 8 are filed as part of this Annual Report on Form 10-K.
2.Financial Statement Schedules. None.
3.Exhibits. Exhibits listed in the accompanying index to exhibits are filed or incorporated by reference as part of this Annual Report on Form 10-K.
EXHIBIT INDEX
Incorporation by Reference
Exhibit NumberDescriptionFormFile NumberExhibit/Appendix ReferenceFiling DateFiled Herewith
2.1*8-K/A001-387912.112/8/20
3.18-K/A001-387913.112/8/20
12/8/20
3.28-K/A001-387913.212/8/20
12/8/20
4.18-K/A001-387914.112/8/20
12/8/20
4.28-K/A001-387914.212/8/20
12/8/20
4.38-K/A001-387914.312/8/20
12/8/20
4.410-K001-387914.403/1/22
4.58-K001-387914.112/17/21
4.610-K001-387914.703/1/22
5.1X
10.18-K/A001-3879110.112/8/20
12/8/20
10.28-K/A001-3879110.412/8/20
12/8/20
10.38-K/A001-3879110.512/8/20
10.4X
12/8/20
10.5†8-K/A001-3879110.612/8/20
10.6†X
12/8/20
98

10.7†8-K/A001-3879110.812/8/20
12/8/20
10.8†8-K/A001-3879110.912/8/20
10.98-K/A001-3879110.1012/8/20
10.10S-1/A333-25165710.1001/29/21
10.1110-K001-3879110.1404/14/21
12/8/20
10.128-K001-387914.112/17/21
10.13S-4/A333-24879410.810/23/20
10.1410-Q001-3879110.108/13/21
10.15†10-Q001-3879110.111/15/21
10.16S-4/A333-24879410.910/23/20
21.1X
23.1X
23.2
Consent of Orrick, Herrington & Sutcliffe LLP (included in Exhibit 5.1).
X
24.1X
31.1X
31.2X
32.1Furnished
herewith
101.INSXBRL Instance Document.X
99

101.SCHXBRL Taxonomy Extension Schema Document.X
101.CALXBRL Taxonomy Extension Calculation Linkbase Document.X
101.DEFXBRL Taxonomy Extension Definition Linkbase Document.X
101.LABXBRL Taxonomy Extension Label Linkbase Document.X
101.PREXBRL Taxonomy Extension Presentation Linkbase Document.X
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).X
*The schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(b)(2). The Company agrees to furnish supplementally a copy of any omitted schedule to the Securities and Exchange Commission upon its request.
Indicates a management contract or compensatory plan, contract or arrangement.
ITEM 16. FORM 10-K SUMMARY.
None provided.
100

SIGNATURES.
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Luminar Technologies, Inc.
Date: February 28, 2023
By:/s/ Thomas J. Fennimore
Thomas J. Fennimore
Chief Financial Officer
(Principal Financial Officer)
POWER OF ATTORNEY.
KNOW ALL PERSONS BY THESE PRESENTS that each individual whose signature appears below constitutes and appoints Austin Russell and Thomas J. Fennimore, and each of them, severally, as his or her true and lawful attorneys-in-fact and agents with the power to act, with or without the other, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in his or her capacity as a director or officer or both, as the case may be, of the Company, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that each of said attorneys-in-fact and agents, or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
SignatureTitleDate
/s/ Austin RussellPresident, Chief Executive Officer and Chairman of the Board of DirectorsFebruary 28, 2023
Austin Russell(Principal Executive Officer)
/s/ Thomas J. FennimoreChief Financial Officer February 28, 2023
Thomas J. Fennimore(Principal Financial and Accounting Officer)
/s/ Alec E. GoresDirectorFebruary 28, 2023
Alec E. Gores
/s/ Jun Hong HengDirectorFebruary 28, 2023
Jun Hong Heng
/s/ Mary Lou Jepsen, PhDDirectorFebruary 28, 2023
Mary Lou Jepsen, PhD
/s/ Shaun Maguire, PhDDirectorFebruary 28, 2023
Shaun Maguire, PhD
/s/ Katharine A. MartinDirectorFebruary 28, 2023
Katharine A. Martin
/s/ Matthew J. SimonciniDirectorFebruary 28, 2023
Matthew J. Simoncini
/s/ Daniel D. TempestaDirectorFebruary 28, 2023
Daniel D. Tempesta
101
EX-5.1 2 exhibit51orricksopinion202.htm EX-5.1 Document
Exhibit 5.1
image_0a.jpg
Orrick, Herrington & Sutcliffe LLP
631 WILSHIRE BOULEVARD
SUITE 2C
SANTA MONICA, CA 90401
+1-310-633-2800
orrick.com

February 28, 2023
Luminar Technologies, Inc.
2603 Discovery Drive, Suite 100
Orlando, CA 32826
Re:    Luminar Technologies, Inc.    
Registration Statement on Form S-3

Ladies and Gentlemen:
We have acted as counsel to Luminar Technologies, Inc., a Delaware corporation (the “Company”), in connection with the offer and sale by the Company of up to $75,000,000 of shares of the Company’s Class A common stock, par value $0.0001 (the “Shares”), pursuant to a registration statement on Form S-3 (Registration Statement No. 333-262250) filed with the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Act”) on January 20, 2022, as amended on February 1, 2022 and declared effective on February 3, 2022 (the “Registration Statement”), the prospectus dated February 3, 2022 (the “Base Prospectus”), and a prospectus supplement to be filed with the Commission pursuant to Rule 424(b) of the rules and regulations of the Act (the “Prospectus Supplement”). The Base Prospectus and the Prospectus Supplement are collectively referred to as the “Prospectus.” The Shares are to be sold by the Company pursuant to the Financing Agreement (the “Sales Agreement”) dated February 28, 2023, by and between the Company and Virtu Americas LLC.

In connection with rendering this opinion, we have examined and relied upon originals or copies, certified or otherwise identified to our satisfaction, of (i) the Second Amended and Restated Certificate of Incorporation of the Company, as amended through the date hereof, (ii) the Amended and Restated Bylaws of the Company, as amended through the date hereof, (iii) certain resolutions of the Board of Directors of the Company relating to the issuance, sale and registration of the Shares, (iv) the Registration Statement, (v) the Base Prospectus and a substantially final form of Prospectus Supplement, (vi) the Sales Agreement, and (vii) such corporate records of the Company, certificates of public officials, officers of the Company and other persons, and such other documents, agreements and instruments as we have deemed relevant and necessary or appropriate as a basis for the opinion set forth below.

In our examination, we have assumed the legal capacity of all natural persons, the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as facsimile, electronic, certified or photostatic copies, and the authenticity of the originals of such copies. In making our examination of documents executed or to be executed, we have assumed that the parties thereto, other than the Company, had or will have the power, corporate or other, to enter into and perform all obligations thereunder and have also assumed the due authorization by all requisite action, corporate or other, and the execution and delivery by such parties of such documents and the validity and binding effect thereof on such parties. As to any facts material to the opinions expressed herein that we did not independently establish or verify, we have relied upon statements and representations of officers and other representatives of the Company and others and of public officials.

Based upon the foregoing and subject to the limitations, qualifications and assumptions set forth herein, we are of the opinion that the Shares have been duly authorized and, upon issuance, delivery and payment therefor in accordance with the Sales Agreement, will be validly issued, fully paid and non-assessable.



Luminar Technologies, Inc.
February 28, 2023
Page 2

The opinion expressed herein is limited to the General Corporation Law of the State of Delaware and the federal laws of the United States of America, and we express no opinion as to the effect on the matters covered by this letter of the laws of any other jurisdictions.

We hereby consent to the filing of this opinion letter as an exhibit to the Company’s Annual Report on Form 10-K filed on or about March 1, 2023 for incorporation by reference into the Registration Statement. In giving such consent, we do not hereby admit that we are included in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission promulgated thereunder.


Very truly yours,
/s/ Orrick, Herrington & Sutcliffe LLP
Orrick, Herrington & Sutcliffe LLP


EX-10.4 3 exhibit104vendorequityfina.htm EX-10.4 Document




LUMINAR TECHNOLOGIES, INC.
Class A Common Stock
(par value $0.0001 per share)
Financing Agreement
    February 28, 2023
Virtu Americas LLC
1633 Broadway
New York, NY 10019

Ladies and Gentlemen:

Luminar Technologies, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Virtu Americas LLC (the “Agent”) as set forth below, for the purpose of establishing a financing program (the “Program”):
1.Issuance and Sale of Shares. The Company agrees that, from time to time during
the term of this Agreement, on the terms and subject to the conditions set forth herein, it may issue and sell through or to the Agent, as sales agent or principal, shares (the “Placement Shares”) of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”); provided however, that in no event shall the Company issue or sell through the Agent such number of Placement Shares that (a) exceeds the number of shares or dollar amount of Common Stock registered on the effective Registration Statement (as defined below) pursuant to which the offering is being made or (b) exceeds the number of shares or dollar amount registered on the Prospectus Supplement (as defined below) (the lesser of (a) or (b) the “Maximum Amount”) and provided further, however, that in no event shall the aggregate number of Placement Shares sold pursuant to this Agreement exceed the number of authorized but unissued shares of Common Stock. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitations set forth in this Section 1 on the number of Placement Shares issued and sold under this Agreement shall be the sole responsibility of the Company and that the Agent shall have no obligation in connection with such compliance. The issuance and sale of Placement Shares through the Agent will be effected pursuant to the Registration Statement (as defined below), although nothing in this Agreement shall be construed as requiring the Company to use the Registration Statement to issue any Placement Shares.
The Company has filed, in accordance with the provisions of the Securities Act of 1933, as amended and the rules and regulations thereunder (the “Securities Act”), with the Securities and Exchange Commission (the “Commission”), a registration statement on Form S-3 (File No. 333-262250), including a base prospectus, relating to certain securities including the Placement Shares to be issued from time to time by the Company, and which incorporates by reference



documents that the Company has filed or will file in accordance with the provisions of the Securities Exchange Act of 1934, as amended and the rules and regulations thereunder (the “Exchange Act”). The Company has prepared a prospectus or prospectus supplement to the base prospectus to be included as part of such registration statement specifically relating to the Placement Shares and to be filed pursuant to Rule 424(b) under the Securities Act (the “Prospectus Supplement”). The Company will furnish to the Agent, for use by the Agent, copies of the base prospectus included as part of such registration statement, as supplemented by the Prospectus Supplement, relating to the Placement Shares. Except where the context otherwise requires, such registration statement, and any post-effective amendment thereto, including all documents filed as part thereof or incorporated by reference therein, and including any information contained in a Prospectus (as defined below) subsequently filed with the Commission pursuant to Rule 424(b) under the Securities Act or deemed to be a part of such registration statement pursuant to Rule 430B of the Securities Act, or any subsequent registration statement on Form S-3 filed pursuant to Rule 415(a)(6) under the Securities Act by the Company to cover any Placement Shares, is herein called the “Registration Statement.” The base prospectus, including all documents incorporated or deemed incorporated therein by reference to the extent such information has not been superseded or modified in accordance with Rule 412 under the Securities Act (as qualified by Rule 430B(g) of the Securities Act), included in the Registration Statement, as it may be supplemented by the Prospectus Supplement, in the form in which such base prospectus and/or Prospectus Supplement have most recently been filed by the Company with the Commission pursuant to Rule 424(b) under the Securities Act is herein called the “Prospectus.” Any reference herein to the Registration Statement, the Prospectus or any amendment or supplement thereto shall be deemed to refer to and include the documents incorporated by reference therein, and any reference herein to the terms “amend,” “amendment” or “supplement” with respect to the Registration Statement or the Prospectus shall be deemed to refer to and include the filing after the execution hereof of any document with the Commission incorporated by reference therein (the “Incorporated Documents”).
For purposes of this Agreement, all references to the Registration Statement, the Prospectus or to any amendment or supplement thereto shall be deemed to include the most recent copy filed with the Commission pursuant to its Electronic Data Gathering Analysis and Retrieval System, or if applicable, the Interactive Data Electronic Application system when used by the Commission (collectively, “EDGAR”).
2.Placements. Each time that the Company wishes to issue and sell Placement Shares hereunder (each, a “Placement”), it will notify the Agent by electronic mail (or other method mutually agreed to in writing by the parties) of the number of Placement Shares, the time period during which sales are requested to be made, any limitation on the number of Placement Shares that may be sold in any one day and any minimum price below which sales may not be made (a “Placement Notice”), the form of which is attached hereto as Schedule 1. The Placement Notice shall originate from any of the individuals from the Company set forth on Schedule 3 (with a copy to each of the other individuals from the Company listed on such schedule), and shall be addressed to each of the individuals from the Agent set forth on Schedule 3, as such Schedule 3 may be amended from time to time. The Placement Notice shall be effective immediately upon receipt by the Agent unless and until (i) the Agent declines to accept the terms
2


contained therein for any reason, in its sole discretion, (ii) the entire amount of the Placement Shares thereunder has been sold, (iii) the Company suspends or terminates the Placement Notice, which suspension and termination rights may be exercised by the Company in its sole discretion, or (iv) this Agreement has been terminated under the provisions of Section 13. The amount of any discount, commission or other compensation to be paid by the Company to the Agent in connection with the sale of the Placement Shares shall be calculated in accordance with the terms set forth in Schedule 2. It is expressly acknowledged and agreed that neither the Company nor the Agent will have any obligation whatsoever with respect to a Placement or any Placement Shares unless and until the Company delivers a Placement Notice to the Agent and the Agent does not decline such Placement Notice pursuant to the terms set forth above, and then only upon the terms specified therein and herein. In the event of a conflict between the terms of Sections 2 or 3 of this Agreement and the terms of a Placement Notice, the terms of the Placement Notice will control.
3.Sale of Placement Shares by the Agent. Subject to the terms and conditions of this Agreement, for the period specified in a Placement Notice, the Agent will use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable state and federal laws, rules and regulations and the rules of the Nasdaq Stock Market (the “Exchange”), to sell the Placement Shares up to the amount specified in, and otherwise in accordance with the terms of, such Placement Notice. The Agent will provide written confirmation to the Company no later than the opening of the Trading Day (as defined below) immediately following the Trading Day on which it has made sales of Placement Shares hereunder setting forth the number of Placement Shares sold on such day, the compensation payable by the Company to the Agent pursuant to Section 2 with respect to such sales, and the Net Proceeds (as defined below) payable to the Company, with an itemization of the deductions made by the Agent (as set forth in Section 5(b)) from the gross proceeds that it receives from such sales. Subject to the terms of a Placement Notice, the Agent may sell Placement Shares by any method permitted by law deemed to be an “at the market offering” as defined in Rule 415 of the Securities Act. “Trading Day” means any day on which shares of Common Stock are purchased and sold on the Exchange.
4.Suspension of Sales. The Company or the Agent may, upon notice to the other party in writing (including by email correspondence to each of the individuals of the other party set forth on Schedule 3, if receipt of such correspondence is actually acknowledged by any of the individuals to whom the notice is sent, other than via auto-reply) or by telephone (confirmed immediately by verifiable facsimile transmission or email correspondence to each of the individuals of the other party set forth on Schedule 3), suspend any sale of Placement Shares (a “Suspension”); provided, however, that such suspension shall not affect or impair any party’s obligations with respect to any Placement Shares sold hereunder prior to the receipt of such notice. While a Suspension is in effect, any obligation under Sections 7(l), 7(m), and 7(n) with respect to the delivery of certificates, opinions, or comfort letters to the Agent, shall be waived. Each of the parties agrees that no such notice under this Section 4 shall be effective against any
3


other party unless it is made to one of the individuals named on Schedule 3 hereto, as such Schedule may be amended from time to time.
5.Sale and Delivery to the Agent; Settlement.
a.Sale of Placement Shares. On the basis of the representations and warranties herein contained and subject to the terms and conditions herein set forth, upon the Agent’s acceptance of the terms of a Placement Notice, and unless the sale of the Placement Shares described therein has been declined, suspended, or otherwise terminated in accordance with the terms of this Agreement, the Agent, for the period specified in the Placement Notice, will use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable state and federal laws, rules and regulations and the rules of the Exchange to sell such Placement Shares up to the amount specified in, and otherwise in accordance with the terms of, such Placement Notice. The Company acknowledges and agrees that (i) there can be no assurance that the Agent will be successful in selling Placement Shares, (ii) the Agent will incur no liability or obligation to the Company or any other person or entity if it does not sell Placement Shares for any reason other than a failure by the Agent to use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable state and federal laws, rules and regulations and the rules of the Exchange to sell such Placement Shares as required under this Agreement and (iii) the Agent shall be under no obligation to purchase Placement Shares on a principal basis pursuant to this Agreement, except as otherwise agreed by the Agent and the Company.
b.Settlement of Placement Shares. Unless otherwise specified in the applicable Placement Notice, settlement for sales of Placement Shares will occur on the second (2nd) Trading Day (or such earlier day as is industry practice for regular-way trading) following the date on which such sales are made (each, a “Settlement Date”). The Agent shall notify the Company of each sale of Placement Shares no later than opening day following the Trading Day that the Agent sold Placement Shares. The amount of proceeds to be delivered to the Company on a Settlement Date against receipt of the Placement Shares sold (the “Net Proceeds”) will be equal to the aggregate sales price received by the Agent, after deduction for (i) the Agent’s commission, discount or other compensation for such sales payable by the Company pursuant to Section 2 hereof, and (ii) any transaction fees imposed by any governmental or self-regulatory organization in respect of such sales.
c.Delivery of Placement Shares. On or before each Settlement Date, the Company will, or will cause its transfer agent to, electronically transfer the Placement Shares being sold by crediting the Agent’s or its designee’s account (provided the Agent shall have given the Company written notice of such designee and such designee’s account information at least one Trading Day prior to the Settlement Date) at The Depository Trust Company through its Deposit and Withdrawal at Custodian System or by such other means of delivery as may be mutually agreed upon by the parties hereto which in all cases shall be freely tradable, transferable, registered shares in good deliverable form. On each Settlement Date, the Agent will deliver the related Net Proceeds in same day funds to an account designated by the Company on, or prior to, the Settlement Date. The Company agrees that if the Company, or its transfer agent (if applicable), defaults in its obligation to deliver Placement Shares on a Settlement Date
4


through no fault of the Agent, then in addition to and in no way limiting the rights and obligations set forth in Section 11(a) hereto, it will (i) hold the Agent harmless against any reasonably incurred and documented loss, claim, damage or expense (including reasonable and documented legal fees and expenses), as incurred, arising out of or in connection with such default by the Company or its transfer agent (if applicable) and (ii) pay to the Agent (without duplication) any commission, discount, or other compensation to which it would otherwise have been entitled absent such default.
d.Limitations on Offering Size. Under no circumstances shall the Company cause or request the offer or sale of any Placement Shares if, after giving effect to the sale of such Placement Shares, the aggregate number of Placement Shares sold pursuant to this Agreement would exceed the lesser of (A) together with all sales of Placement Shares under this Agreement, the Maximum Amount, (B) the amount available for offer and sale under the currently effective Registration Statement and (C) the amount authorized from time to time to be issued and sold under this Agreement by the Company’s board of directors, a duly authorized committee thereof or a duly authorized executive committee, and notified to the Agent in writing. Under no circumstances shall the Company cause or request the offer or sale of any Placement Shares pursuant to this Agreement at a price lower than the minimum price authorized from time to time by the Company’s board of directors, a duly authorized committee thereof or a duly authorized executive committee, and notified to the Agent in writing.
6.Representations and Warranties of the Company. Except as disclosed in the Registration Statement or Prospectus (including the Incorporated Documents), the Company represents and warrants to, and agrees with the Agent that as of the date of this Agreement and as of each Applicable Time (as defined below), unless such representation, warranty or agreement specifies a different date or time:
a.Registration Statement and Prospectus. The transactions contemplated by this Agreement meet the requirements for and comply with the conditions for the use of Form S-3 under the Securities Act. The Registration Statement has been filed with the Commission and has been declared effective under the Securities Act. The Prospectus Supplement will name the Agent as the agent in the section entitled “Plan of Distribution.” The Company has not received, and has no notice of, any order of the Commission preventing or suspending the use of the Registration Statement, or threatening or instituting proceedings for that purpose. The Registration Statement and the offer and sale of Placement Shares as contemplated hereby meet the requirements of Rule 415 under the Securities Act and comply in all material respects with said Rule. Any statutes, regulations, contracts or other documents that are required to be described in the Registration Statement or the Prospectus or to be filed as exhibits to the Registration Statement have been so described or filed, as applicable. Copies of the Registration Statement, the Prospectus, and any such amendments or supplements and all documents incorporated by reference therein that were filed with the Commission on or prior to the date of this Agreement have been delivered, or are available through EDGAR, to the Agent and its counsel. The Company has not distributed and, prior to the later to occur of each Settlement Date and completion of the distribution of the Placement Shares, will not distribute any offering material in connection with the offering or sale of the Placement Shares other than
5


the Registration Statement and the Prospectus and any Issuer Free Writing Prospectus (as defined below) to which the Agent has consented, which consent will not be unreasonably withheld or delayed, or that is required by applicable law or the listing maintenance requirements of the Exchange. The Common Stock is currently quoted on the Exchange under the trading symbol “LAZR.” The Company has not, in the 12 months preceding the date hereof, received notice from the Exchange to the effect that the Company is not in compliance with the listing or maintenance requirements of the Exchange. To the Company’s knowledge, it is in compliance with all such listing and maintenance requirements.
b.No Misstatement or Omission. At each Settlement Date, the Registration Statement and the Prospectus, as of such date, will conform in all material respects with the requirements of the Securities Act. The Registration Statement, when it became or becomes effective, did not, and will not, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. The Prospectus and any amendment and supplement thereto, on the date thereof and at each Applicable Time (defined below), did not or will not include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. The documents incorporated by reference in the Prospectus or any Prospectus Supplement did not, and any further documents filed and incorporated by reference therein will not, when filed with the Commission, contain an untrue statement of a material fact or omit to state a material fact required to be stated in such document or necessary to make the statements in such document, in light of the circumstances under which they were made, not misleading. The foregoing shall not apply to statements in, or omissions from, any such document made in reliance upon, and in conformity with, information furnished to the Company by the Agent specifically for use in the preparation thereof.
c.Conformity with Securities Act and Exchange Act. The Registration Statement, the Prospectus, any Issuer Free Writing Prospectus or any amendment or supplement thereto, and the Incorporated Documents, when such documents were or are filed with the Commission under the Securities Act or the Exchange Act or became or become effective under the Securities Act, as the case may be, conformed or will conform in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable.
d.Financial Information. The consolidated financial statements of the Company included or incorporated by reference in the Registration Statement and the Prospectus, together with the related notes and schedules, present fairly, in all material respects, the consolidated financial position of the Company and the Subsidiaries (as defined below) as of the dates indicated and the consolidated results of operations, cash flows and changes in stockholders’ equity of the Company and the Subsidiaries for the periods specified (subject, in the case of unaudited statements, to normal year-end audit adjustments which will not be material, either individually or in the aggregate) and have been prepared in compliance with the published requirements of the Securities Act and Exchange Act, as applicable, and in conformity with generally accepted accounting principles in the United States (“GAAP”) applied on a consistent basis (except (i) for such adjustments to accounting standards and practices as are noted therein and (ii) in the case of unaudited interim statements, to the extent they may exclude
6


footnotes or may be condensed or summary statements) during the periods involved; the other financial and statistical data with respect to the Company and the Subsidiaries contained or incorporated by reference in the Registration Statement and the Prospectus, are accurately and fairly presented and prepared on a basis consistent with the financial statements and books and records of the Company; there are no financial statements (historical or pro forma) that are required to be included or incorporated by reference in the Registration Statement, or the Prospectus that are not included or incorporated by reference as required; the Company and the Subsidiaries do not have any material liabilities or obligations, direct or contingent (including any off balance sheet obligations), not described in the Registration Statement, and the Prospectus which are required to be described in the Registration Statement or Prospectus; and all disclosures contained or incorporated by reference in the Registration Statement and the Prospectus, if any, regarding “non-GAAP financial measures” (as such term is defined by the rules and regulations of the Commission) comply in all material respects with Regulation G of the Exchange Act and Item 10 of Regulation S-K under the Securities Act, to the extent applicable.
e.Conformity with EDGAR Filing. The Prospectus delivered to the Agent for use in connection with the sale of the Placement Shares pursuant to this Agreement will be identical to the versions of the Prospectus created to be transmitted to the Commission for filing via EDGAR, except to the extent permitted by Regulation S-T.
f.Organization. The Company and any subsidiary that is a significant subsidiary (as such term is defined in Rule 1-02 of Regulation S-X promulgated by the Commission) (each, a “Subsidiary,” collectively, the “Subsidiaries”), are, and will be, duly organized, validly existing as a corporation and in good standing under the laws of their respective jurisdictions of organization. The Company and the Subsidiaries are duly licensed or qualified as a foreign corporation for transaction of business and in good standing under the laws of each other jurisdiction in which their respective ownership or lease of property or the conduct of their respective businesses requires such license or qualification, and have all corporate power and authority necessary to own or hold their respective properties and to conduct their respective businesses as described in the Registration Statement and the Prospectus, except where the failure to be so qualified or in good standing or have such power or authority would not, individually or in the aggregate, have a material adverse effect on the assets, business, operations, earnings, properties, condition (financial or otherwise), prospects, stockholders’ equity or results of operations of the Company and the Subsidiaries taken as a whole, or prevent the consummation of the transactions contemplated hereby (a “Material Adverse Effect”).
g.Subsidiaries. The Company owns directly or indirectly, all of the equity interests of the Subsidiaries free and clear of any lien, charge, security interest, encumbrance, right of first refusal or other restriction, and all the equity interests of the Subsidiaries are validly issued and are fully paid, nonassessable and free of preemptive and similar rights. The Company does not own or control, directly or indirectly, any corporation, association or other entity other than the subsidiaries listed in Exhibit 21.1 to the Company’s Annual Report on Form 10-K for the most recently ended fiscal year and other than (i) those subsidiaries not required to be listed
7


on Exhibit 21.1 by Item 601 of Regulation S-K under the Exchange Act and (ii) those subsidiaries formed since the last day of the most recently ended fiscal year.
h.No Violation or Default. Neither the Company nor any Subsidiary is (i) in violation of its charter or by-laws or similar organizational documents; (ii) in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance or observance of any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or other similar agreement or instrument to which the Company or any Subsidiary is a party or by which the Company or any Subsidiary is bound or to which any of the property or assets of the Company or any Subsidiary is subject; or (iii) in violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority, except, in the case of each of clauses (ii) and (iii) above, for any such violation or default that would not, individually or in the aggregate, have a Material Adverse Effect. To the Company’s knowledge, no other party under any material contract or other agreement to which it or any Subsidiary is a party is in default in any respect thereunder where such default would have a Material Adverse Effect.
i.No Material Adverse Effect. Since the date of the most recent financial statements of the Company included or incorporated by reference in the Registration Statement and Prospectus, there has not been (i) any Material Adverse Effect, or any development that would result in a Material Adverse Effect, (ii) any transaction which is material to the Company and the Subsidiaries taken as a whole, (iii) any obligation or liability, direct or contingent (including any off-balance sheet obligations), incurred by the Company or the Subsidiaries, which is material to the Company and the Subsidiaries taken as a whole, (iv) any material change in the capital stock (other than (A) the grant of additional options under the Company’s existing stock option plans, (B) changes in the number of outstanding Common Stock of the Company due to the issuance of shares upon the exercise or conversion of securities exercisable for, or convertible into, Common Stock outstanding on the date hereof, (C) as a result of the issuance of Placement Shares, (D) any repurchases of capital stock of the Company, (E) as described in a proxy statement filed on Schedule 14A or a Registration Statement on Form S-4, or (F) otherwise publicly announced) or outstanding long-term indebtedness of the Company or the Subsidiaries or (v) any dividend or distribution of any kind declared, paid or made on the capital stock of the Company or any Subsidiary, other than in each case above in the ordinary course of business or as otherwise disclosed in the Registration Statement or Prospectus (including any document incorporated by reference therein).
j.Capitalization. The issued and outstanding shares of capital stock of the Company have been validly issued, are fully paid and non-assessable and, other than as disclosed in the Registration Statement or the Prospectus, are not subject to any preemptive rights, rights of first refusal or similar rights. The Company has an authorized, issued and outstanding capitalization as set forth in the Registration Statement and the Prospectus as of the dates referred to therein (other than (i) the grant of additional options under the Company’s existing stock option plans, (ii) changes in the number of outstanding Common Stock of the Company due to the issuance of shares upon the exercise or conversion of securities exercisable for, or convertible into, Common Stock outstanding on the date hereof, (iii) as a result of the issuance of Placement
8


Shares, or (iv) any repurchases of capital stock of the Company) and such authorized capital stock conforms to the description thereof set forth in the Registration Statement and the Prospectus. The description of the Common Stock in the Registration Statement and the Prospectus is complete and accurate in all material respects. Except as disclosed in or contemplated by the Registration Statement or the Prospectus, the Company did not have outstanding any options to purchase, or any rights or warrants to subscribe for, or any securities or obligations convertible into, or exchangeable for, or any contracts or commitments to issue or sell, any shares of capital stock or other securities.
k.S-3 Eligibility. (i) At the time of filing the Registration Statement and (ii) at the time of the most recent amendment thereto for the purposes of complying with Section 10(a)(3) of the Securities Act (whether such amendment was by post-effective amendment, incorporated report filed pursuant to Section 13 or 15(d) of the Exchange Act or form of prospectus), the Company met the then applicable requirements for use of Form S-3 under the Securities Act, including compliance with General Instruction I.B.1 of Form S-3, as applicable. The Company is not a shell company (as defined in Rule 405 under the Securities Act) and has not been a shell company for at least 12 calendar months previously and if it has been a shell company at any time previously, has filed current Form 10 information (as defined in General Instruction I.B.6 of Form S-3) or an equivalent thereof with the Commission at least 12 calendar months previously reflecting its status as an entity that is not a shell company.
l.Authorization; Enforceability. The Company has full legal right, power and authority to enter into this Agreement and perform the transactions contemplated hereby. This Agreement has been duly authorized, executed and delivered by the Company and is a legal, valid and binding agreement of the Company enforceable against the Company in accordance with its terms, except to the extent that (i) enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ rights generally and by general equitable principles and (ii) the indemnification and contribution provisions of Section 11 hereof may be limited by federal or state securities laws and public policy considerations in respect thereof.
m.Authorization of Placement Shares. The Placement Shares, when issued and delivered pursuant to the terms approved by the board of directors of the Company or a duly authorized committee thereof, or a duly authorized executive committee, against payment therefor as provided herein, will be duly and validly authorized and issued and fully paid and nonassessable, free and clear of any pledge, lien, encumbrance, security interest or other claim (other than any pledge, lien, encumbrance, security interest or other claim arising from an act or omission of the Agent or a purchaser), including any statutory or contractual preemptive rights, resale rights, rights of first refusal or other similar rights, and will be registered pursuant to Section 12 of the Exchange Act. The Placement Shares, when issued, will conform in all material respects to the description thereof set forth in or incorporated into the Prospectus.
n.No Consents Required. No consent, approval, authorization, order, registration or qualification of or with any court or arbitrator or any governmental or regulatory authority is required for the execution, delivery and performance by the Company of this Agreement, and the issuance and sale by the Company of the Placement Shares as contemplated
9


hereby, except for such consents, approvals, authorizations, orders and registrations or qualifications (i) as may be required under applicable state securities laws or by the by-laws and rules of the Financial Industry Regulatory Authority (“FINRA”) or the Exchange, including any notices that may be required by the Exchange, in connection with the sale of the Placement Shares by the Agent, (ii) as may be required under the Securities Act and (iii) as have been previously obtained by the Company.
o.No Preferential Rights. (i) No person, as such term is defined in Rule 1-02 of Regulation S-X promulgated under the Securities Act (each, a “Person”), has the right, contractual or otherwise, to cause the Company to issue or sell to such Person any Common Stock or shares of any other capital stock or other securities of the Company (other than upon the exercise of options or warrants to purchase Common Stock or upon the exercise of options that may be granted from time to time under the Company’s stock option plan), (ii) no Person has any preemptive rights, rights of first refusal, or any other rights (whether pursuant to a “poison pill” provision or otherwise) to purchase any Common Stock or shares of any other capital stock or other securities of the Company from the Company which have not been duly waived with respect to the offering contemplated hereby, (iii) no Person has the right to act as an underwriter or as a financial advisor to the Company in connection with the offer and sale of the Common Stock, and (iv) no Person has the right, contractual or otherwise, to require the Company to register under the Securities Act any Common Stock or shares of any other capital stock or other securities of the Company, or to include any such shares or other securities in the Registration Statement or the offering contemplated thereby, whether as a result of the filing or effectiveness of the Registration Statement or the sale of the Placement Shares as contemplated thereby or otherwise, except in each case for such rights as have been waived on or prior to the date hereof.
p.Independent Public Accountant. Deloitte & Touche LLP (the “Accountant”), whose report on the consolidated financial statements of the Company is filed with the Commission as part of the Company’s most recent Annual Report on Form 10-K filed with the Commission and incorporated into the Registration Statement, are and, during the periods covered by their report, were independent public accountants within the meaning of the Securities Act and the Public Company Accounting Oversight Board (United States). To the Company’s knowledge, the Accountant is not in violation of the auditor independence requirements of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”) with respect to the Company.
q.Enforceability of Agreements. All agreements between the Company and third parties expressly referenced in the Prospectus, other than such agreements that have expired by their terms or whose termination is disclosed in documents filed by the Company on EDGAR, are legal, valid and binding obligations of the Company and, to the Company’s knowledge, enforceable in accordance with their respective terms, except to the extent that (i) enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ rights generally and by general equitable principles and (ii) the indemnification provisions of certain agreements may be limited by federal or state securities laws or public policy considerations in respect thereof, and except for any unenforceability that, individually or in the aggregate, would not have a Material Adverse Effect.
10


r.No Litigation. There are no legal or governmental proceedings pending or threatened to which the Company or any Subsidiary is a party or to which any of the properties of the Company or any Subsidiary is subject (i) other than proceedings accurately described in all material respects in the Prospectus and proceedings that would not have a Material Adverse Effect on the Company and its subsidiaries, taken as a whole, or on the power or ability of the Company to perform its obligations under this Agreement or to consummate the transactions contemplated by the Prospectus or (ii) that are required to be described in the Registration Statement or the Prospectus and are not so described; and there are no contracts or other documents that are required to be described in the Registration Statement or the Prospectus or to be filed as exhibits to the Registration Statement that are not described or filed as required.
s.Licenses and Permits. The Company and the Subsidiaries possess or have obtained, all licenses, certificates, consents, orders, approvals, permits and other authorizations issued by, and have made all declarations and filings with, the appropriate federal, state, local or foreign governmental or regulatory authorities that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as currently conducted, as described in the Registration Statement and the Prospectus (the “Permits”), except where the failure to possess, obtain or make the same would not, individually or in the aggregate, have a Material Adverse Effect. Neither the Company nor any Subsidiary has received written notice of any proceeding relating to revocation or modification of any such Permit or has any reason to believe that such Permit will not be renewed in the ordinary course, except where the failure to obtain any such renewal would not, individually or in the aggregate, have a Material Adverse Effect.
t.No Material Defaults. Neither the Company nor any Subsidiary has defaulted on any installment on indebtedness for borrowed money or on any rental on one or more long-term leases, which defaults, individually or in the aggregate, would have a Material Adverse Effect. The Company has not filed a report pursuant to Section 13(a) or 15(d) of the Exchange Act since the filing of its last Annual Report on Form 10-K, indicating that it (i) has failed to pay any dividend or sinking fund installment on preferred stock or (ii) has defaulted on any installment on indebtedness for borrowed money or on any rental on one or more long-term leases, which defaults, individually or in the aggregate, would have a Material Adverse Effect.
u.Certain Market Activities. Neither the Company, nor any Subsidiary, nor, to the knowledge of the Company, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or would cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
v.Broker/Dealer Relationships. Neither the Company nor any Subsidiary or any related entities (i) is required to register as a “broker” or “dealer” in accordance with the provisions of the Exchange Act or (ii) directly or indirectly through one or more intermediaries, controls or is a “person associated with a member” or “associated person of a member” (within the meaning set forth in the FINRA Manual).
11


w.No Reliance. The Company has not relied upon the Agent or legal counsel for the Agent for any legal, tax or accounting advice in connection with the offering and sale of the Placement Shares.
x.Taxes. The Company and the Subsidiaries have filed all federal, state, local and foreign tax returns which have been required to be filed and paid all taxes shown thereon through the date hereof, to the extent that such taxes have become due and are not being contested in good faith, except where the failure to do so would not have a Material Adverse Effect. Except as otherwise disclosed in or contemplated by the Registration Statement or the Prospectus, no tax deficiency has been determined adversely to the Company or any Subsidiary which has had, or would have, individually or in the aggregate, a Material Adverse Effect. The Company has no knowledge of any federal, state or other governmental tax deficiency, penalty or assessment which has been or might be asserted or threatened against it which would have a Material Adverse Effect.
y.Title to Real and Personal Property. The Company and the Subsidiaries have good and marketable title to all items of real property and good and valid title to all personal property described in the Registration Statement or Prospectus as being owned by them that are material to the businesses of the Company or such Subsidiary, in each case free and clear of all liens, encumbrances and claims, except those that (i) do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries or (ii) would not, individually or in the aggregate, have a Material Adverse Effect. Any real property described in the Registration Statement or Prospectus as being leased by the Company and the Subsidiaries is held by them under valid, existing and enforceable leases, except those that (A) do not materially interfere with the use made or proposed to be made of such property by the Company or the Subsidiaries or (B) would not, individually or in the aggregate, have a Material Adverse Effect.
z.Intellectual Property. The Company and the Subsidiary own or possess adequate enforceable rights to use all patents, patent applications, trademarks (both registered and unregistered), trade names, trademark registrations, service marks, service mark registrations, Internet domain name registrations, copyrights, copyright registrations, licenses and know-how (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures) (collectively, the “Intellectual Property”), necessary for the conduct of their respective businesses as conducted as of the date hereof, except to the extent that the failure to own or possess adequate rights to use such Intellectual Property would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company and the Subsidiaries have not received any written notice of any claim of infringement or conflict which asserted Intellectual Property rights of others, which infringement or conflict, if the subject of an unfavorable decision, would result in a Material Adverse Effect. There are no pending, or to the Company’s knowledge, threatened judicial proceedings or interference proceedings challenging the Company’s or any Subsidiary’s rights in or to or the validity of the scope of any of the Company’s or its Subsidiaries’ patents, patent applications or proprietary information. To the Company’s knowledge, there are no third parties who have established rights or have any claim in any of the Company’s or any of its
12


Subsidiary’s patents, patent applications or any patent to be issued therefrom by virtue of any contract, license or other agreement entered into between such entity or individual and the Company or any Subsidiary or by any non-contractual obligation, other than by written licenses granted by the Company or any Subsidiary. The Company has not received any written notice of any claim challenging the rights of the Company or its Subsidiaries in or to any Intellectual Property owned, licensed or optioned by the Company or any Subsidiary which claim, if the subject of an unfavorable decision, would result in a Material Adverse Effect.
aa.Compliance with Applicable Laws. The Company has not been advised, and has no reason to believe, that it and each of its subsidiaries are not conducting business in compliance with all applicable laws, rules and regulations of the jurisdictions in which it is conducting business, except where failure to be so in compliance would not result in a Material Adverse Effect.
bb.    Environmental Laws. The Company and the Subsidiaries (i) are in compliance with any and all applicable federal, state, local and foreign laws, rules, regulations, decisions and orders relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (collectively, “Environmental Laws”); (ii) have received and are in compliance with all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses as described in the Registration Statement and the Prospectus; and (iii) have not received notice of any actual or potential liability for the investigation or remediation of any disposal or release of hazardous or toxic substances or wastes, pollutants or contaminants, except, in the case of any of clauses (i), (ii) or (iii) above, for any such failure to comply or failure to receive required permits, licenses, other approvals or liability as would not, individually or in the aggregate, have a Material Adverse Effect.
cc.    Compliance Program. The Company has established and administers a compliance program applicable to the Company, to assist the Company and the directors, officers and employees of the Company in complying with applicable regulatory guidelines (including, without limitation, if applicable, those administered by the FDA, the EMA, and any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA or EMA); except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.
dd.    Disclosure Controls. The Company maintains a system of internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability; (iii) access to assets is permitted only in accordance with management’s general or specific authorization; and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company is not aware of any material weaknesses in its internal control over financial reporting (other than as set forth in the Registration Statement or the Prospectus). Since the date of the latest audited financial statements of the Company included in the Prospectus, there has been no change in the Company’s internal control over financial
13


reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting (other than as set forth in the Registration Statement or the Prospectus). The Company has established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 and 15d-15) that comply with the requirements of the Exchange Act. The Company’s certifying officers have evaluated the effectiveness of the Company’s controls and procedures as of a date within 90 days prior to the filing date of the Form 10-K for the fiscal year most recently ended (such date, the “Evaluation Date”). The Company presented in its Form 10-K for the fiscal year most recently ended the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the most recent Evaluation Date.
ee.    Sarbanes-Oxley Act. There is and has been no failure on the part of the Company or, to the knowledge of the Company, any of the Company’s directors or officers, in their capacities as such, to comply in all material respects with any applicable provisions of the Sarbanes-Oxley Act and the rules and regulations promulgated thereunder. Each of the principal executive officer and the principal financial officer of the Company (or each former principal executive officer of the Company and each former principal financial officer of the Company as applicable) has made all certifications required by Sections 302 and 906 of the Sarbanes-Oxley Act with respect to all reports, schedules, forms, statements and other documents required to be filed by it or furnished by it to the Commission during the past 12 months. For purposes of the preceding sentence, “principal executive officer” and “principal financial officer” shall have the meanings given to such terms in the Exchange Act Rules 13a-15 and 15d-15.
ff. Finder’s Fees. Neither the Company nor any Subsidiary has incurred any liability for any finder’s fees, brokerage commissions or similar payments in connection with the transactions herein contemplated, except as may otherwise exist with respect to the Agent pursuant to this Agreement.
gg. Labor Disputes. No labor disturbance by or dispute with employees of the Company or any Subsidiary exists or, to the knowledge of the Company, is threatened which would result in a Material Adverse Effect.
hh.    Investment Company Act. Neither the Company nor any Subsidiary is or, after giving effect to the offering and sale of the Placement Shares, will be required to register as an “investment company” or an entity “controlled” by an “investment company,” as such terms are defined in the Investment Company Act of 1940, as amended (the “Investment Company Act”).
ii.    Operations. The operations of the Company and the Subsidiaries are and have been conducted at all times in compliance with applicable financial record keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all jurisdictions to which the Company or the Subsidiaries are subject, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency having jurisdiction over the Company (collectively, the “Money Laundering Laws”), except where the failure to be in such compliance would not result in a Material Adverse Effect; and no action,
14


suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.
jj.    Off-Balance Sheet Arrangements. There are no transactions, arrangements and other relationships between and/or among the Company, and/or, to the knowledge of the Company, any of its affiliates and any unconsolidated entity, including, but not limited to, any structured finance, special purpose or limited purpose entity (each, an “Off Balance Sheet Transaction”) that would affect materially the Company’s liquidity or the availability of or requirements for its capital resources, including those Off Balance Sheet Transactions described in the Commission’s Statement about Management’s Discussion and Analysis of Financial Conditions and Results of Operations (Release Nos. 33-8056; 34-45321; FR-61), required to be described in the Registration Statement or the Prospectus which have not been described as required.
kk.    Underwriter Agreements. Other than with respect to this Agreement, the Company is not a party to any agreement with an agent or underwriter for any other “at the market” or continuous equity transaction.
ll.    ERISA. To the knowledge of the Company, (i) each material employee benefit plan, within the meaning of Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”) that is maintained, administered or contributed to by the Company or any of its affiliates for employees or former employees of the Company and the Subsidiaries has been maintained in material compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations, including but not limited to ERISA and the Internal Revenue Code of 1986, as amended (the “Code”); (ii) no prohibited transaction, within the meaning of Section 406 of ERISA or Section 4975 of the Code, has occurred which would result in a material liability to the Company with respect to any such plan excluding transactions effected pursuant to a statutory or administrative exemption; and (iii) for each such plan that is subject to the funding rules of Section 412 of the Code or Section 302 of ERISA, no “accumulated funding deficiency” as defined in Section 412 of the Code has been incurred, whether or not waived, and the fair market value of the assets of each such plan (excluding for these purposes accrued but unpaid contributions) equals or exceeds the present value of all benefits accrued under such plan determined using reasonable actuarial assumptions, other than, in the case of (i), (ii) and (iii) above, as would not have a Material Adverse Effect.
mm.    Forward-Looking Statements. No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act) (a “Forward-Looking Statement”) contained in the Registration Statement and the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.
nn.    Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System.
15


oo.    Insurance. The Company and the Subsidiaries carry, or are covered by, insurance in such amounts and covering such risks as the Company and the Subsidiaries reasonably believe are adequate for the conduct of their business.
pp.    No Improper Practices. (i) Neither the Company nor, to the Company’s knowledge, the Subsidiaries, nor to the Company’s knowledge, any of their respective executive officers has, in the past five years, made any unlawful contributions to any candidate for any political office (or failed fully to disclose any contribution in violation of law) or made any contribution or other payment to any official of, or candidate for, any federal, state, municipal, or foreign office or other person charged with similar public or quasi-public duty in violation of any law or of the character required to be disclosed in the Prospectus; (ii) no relationship, direct or indirect, exists between or among the Company or, to the Company’s knowledge, the Subsidiaries or any affiliate of any of them, on the one hand, and the directors, officers and stockholders of the Company or, to the Company’s knowledge, the Subsidiaries, on the other hand, that is required by the Securities Act to be described in the Registration Statement and the Prospectus that is not so described; (iii) no relationship, direct or indirect, exists between or among the Company or the Subsidiaries or any affiliate of them, on the one hand, and the directors, officers, stockholders or directors of the Company or, to the Company’s knowledge, the Subsidiaries, on the other hand, that is required by the rules of FINRA to be described in the Registration Statement and the Prospectus that is not so described; (iv) there are no material outstanding loans or advances or material guarantees of indebtedness by the Company or, to the Company’s knowledge, the Subsidiaries to or for the benefit of any of their respective officers or directors or any of the members of the families of any of them; and (v) the Company has not offered, or caused any placement agent to offer, Common Stock to any person with the intent to influence unlawfully (A) a customer or supplier of the Company or the Subsidiaries to alter the customer’s or supplier’s level or type of business with the Company or the Subsidiaries or (B) a trade journalist or publication to write or publish favorable information about the Company or the Subsidiaries or any of their respective products or services, and, (vi) neither the Company nor the Subsidiaries nor, to the Company’s knowledge, any employee or agent of the Company or the Subsidiaries has made any payment of funds of the Company or the Subsidiaries or received or retained any funds in violation of any law, rule or regulation (including, without limitation, the Foreign Corrupt Practices Act of 1977), which payment, receipt or retention of funds is of a character required to be disclosed in the Registration Statement or the Prospectus.
qq.    Status Under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Shares.
rr.    No Misstatement or Omission in an Issuer Free Writing Prospectus. Each Issuer Free Writing Prospectus, as of its issue date and as of each Applicable Time (as defined in Section 25 below), did not, does not and will not, through the completion of the Placement or Placements for which such Issuer Free Writing Prospectus is issued, include any information that conflicted, conflicts or will conflict with the information contained in the Registration Statement or the Prospectus, including any incorporated document deemed to be a part thereof that has not
16


been superseded or modified. The foregoing sentence does not apply to statements in or omissions from any Issuer Free Writing Prospectus based upon and in conformity with written information furnished to the Company by the Agent specifically for use therein.
ss.    No Conflicts. Neither the execution of this Agreement, nor the issuance, offering or sale of the Placement Shares, nor the consummation of any of the transactions contemplated herein, nor the compliance by the Company with the terms and provisions hereof will conflict with, or will result in a breach of, any of the terms and provisions of, or has constituted or will constitute a default under, or has resulted in or will result in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the Company pursuant to the terms of any contract or other agreement to which the Company may be bound or to which any of the property or assets of the Company is subject, except (i) such conflicts, breaches or defaults as may have been waived and (ii) such conflicts, breaches and defaults that would not have a Material Adverse Effect; nor will such action result (x) in any violation of the provisions of the organizational or governing documents of the Company, or (y) in any material violation of the provisions of any statute or any order, rule or regulation applicable to the Company or of any court or of any federal, state or other regulatory authority or other government body having jurisdiction over the Company, except where such violation would not have a Material Adverse Effect.
tt.    OFAC.
(i)Neither the Company nor any Subsidiary (collectively, the “Entity”) nor, to the Company’s knowledge, any director, officer, employee, agent, affiliate or representative of the Entity, is a government, individual, or entity (in this paragraph (ss), “Person”) that is, or is owned or controlled by a Person that is:
(a)the subject of any sanctions administered or enforced by the U.S. Department of Treasury’s Office of Foreign Assets Control (“OFAC”), the United Nations Security Council (“UNSC”), the European Union (“EU”), Her Majesty’s Treasury (“HMT”), or other relevant sanctions authority (collectively, “Sanctions”), nor
(b)located, organized or resident in a country or territory that is the subject of Sanctions.
(ii)The Entity will not, directly or indirectly, knowingly use the proceeds of the offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other Person:
(a)to fund or facilitate any activities or business of or with any Person or in any country or territory that, at the time of such funding or facilitation, is the subject of Sanctions; or
(b)in any other manner that will result in a violation of Sanctions by any Person (including any Person participating in the offering, whether as underwriter, advisor, investor or otherwise).
17


(iii)The Entity represents and covenants that, except as detailed in the Registration Statement and the Prospectus, for the past 5 years, it has not knowingly engaged in and is not now knowingly engaged in any dealing or transactions with any Person, or in any country or territory, that at the time of the dealing or transaction is or was the subject of Sanctions.
uu.    Stock Transfer Taxes. On each Settlement Date, all material stock transfer or other taxes (other than income taxes) which are required to be paid in connection with the sale and transfer of the Placement Shares to be sold hereunder will be, or will have been, fully paid or provided for by the Company and all laws imposing such taxes will be or will have been fully complied with by the Company in all material respects.
vv.    IT Systems. (i)(x) To the knowledge of Company, there has been no security breach or other compromise of any Company’s information technology and computer systems, networks, hardware, software, data (including the data of their respective customers, employees, suppliers, vendors and any third party data maintained by or on behalf of them), equipment or technology (collectively, “IT Systems and Data”) and (y) the Company has not been notified of, and has no knowledge of any event or condition that would reasonably be expected to result in, any security breach or other compromise to their IT Systems and Data; (ii) the Company is presently in material compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, in the case of this clause (ii), individually or in the aggregate, have a Material Adverse Effect; and (iii) the Company has implemented backup and disaster recovery technology consistent with industry standards and practices.
        Any certificate signed by an officer of the Company and delivered to the Agent or to counsel for the Agent pursuant to or in connection with this Agreement shall be deemed to be a representation and warranty by the Company, as applicable, to the Agent as to the matters set forth therein.
7.Covenants of the Company. The Company covenants and agrees with the Agent that:
a.Registration Statement Amendments. After the date of this Agreement and during any period in which a prospectus relating to any Placement Shares is required to be delivered by the Agent under the Securities Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act) (the “Prospectus Delivery Period”) (i) the Company will notify the Agent promptly of the time when any subsequent amendment to the Registration Statement, other than documents incorporated by reference or amendments not related to any Placement, has been filed with the Commission and/or has become effective or any subsequent supplement to the Prospectus has been filed and of any request by the Commission for any amendment or supplement to the Registration Statement or Prospectus related to the Placement or for additional information related to the Placement, (ii)
18


the Company will prepare and file with the Commission, promptly upon the Agent’s request, any amendments or supplements to the Registration Statement or Prospectus that, upon the advice of the Company’s legal counsel, may be necessary or advisable in connection with the distribution of the Placement Shares by the Agent (provided, however, that the failure of the Agent to make such request shall not relieve the Company of any obligation or liability hereunder, or affect the Agent’s right to rely on the representations and warranties made by the Company in this Agreement and provided, further, that the only remedy the Agent shall have with respect to the failure to make such filing shall be to cease making sales under this Agreement until such amendment or supplement is filed); (iii) the Company will not file any amendment or supplement to the Registration Statement or Prospectus relating to the Placement Shares or a security convertible into the Placement Shares (other than an Incorporated Document) unless a copy thereof has been submitted to the Agent within a reasonable period of time before the filing and the Agent has not reasonably objected thereto (provided, however, that (A) the failure of the Agent to make such objection shall not relieve the Company of any obligation or liability hereunder, or affect the Agent’s right to rely on the representations and warranties made by the Company in this Agreement and (B) the Company has no obligation to provide the Agent any advance copy of such filing or to provide the Agent an opportunity to object to such filing if the filing does not name the Agent or does not relate to the transaction herein provided; and provided, further, that the only remedy the Agent shall have with respect to the failure by the Company to obtain such consent shall be to cease making sales under this Agreement) and the Company will furnish to the Agent at the time of filing thereof a copy of any document that upon filing is deemed to be incorporated by reference into the Registration Statement or Prospectus, except for those documents available via EDGAR; and (iv) the Company will cause each amendment or supplement to the Prospectus to be filed with the Commission as required pursuant to the applicable paragraph of Rule 424(b) of the Securities Act or, in the case of any document to be incorporated therein by reference, to be filed with the Commission as required pursuant to the Exchange Act, within the time period prescribed (the determination to file or not file any amendment or supplement with the Commission under this Section 7(a), based on the Company’s reasonable opinion or reasonable objections, shall be made exclusively by the Company).
b.Notice of Commission Stop Orders. The Company will advise the Agent, promptly after it receives notice or obtains knowledge thereof, of the issuance or threatened issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement, of the suspension of the qualification of the Placement Shares for offering or sale in any jurisdiction, or of the initiation or threatening of any proceeding for any such purpose; and it will use its commercially reasonable efforts to prevent the issuance of any stop order or to obtain its withdrawal if such a stop order should be issued. The Company will advise the Agent promptly after it receives any request by the Commission for any amendments to the Registration Statement or any amendment or supplements to the Prospectus or any Issuer Free Writing Prospectus or for additional information related to the offering of the Placement Shares or for additional information related to the Registration Statement, the Prospectus or any Issuer Free Writing Prospectus.
19


c.Delivery of Prospectus; Subsequent Changes. During the Prospectus Delivery Period, the Company will comply with all requirements imposed upon it by the Securities Act, as from time to time in force, and to file on or before their respective due dates all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Sections 13(a), 13(c), 14, 15(d) or any other provision of or under the Exchange Act. If the Company has omitted any information from the Registration Statement pursuant to Rule 430A under the Securities Act, it will use its commercially reasonable efforts to comply with the provisions of and make all requisite filings with the Commission pursuant to said Rule 430A and to notify the Agent promptly of all such filings. If during the Prospectus Delivery Period any event occurs as a result of which the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances then existing, not misleading, or if during such Prospectus Delivery Period it is necessary to amend or supplement the Registration Statement or Prospectus to comply with the Securities Act, the Company will promptly notify the Agent to suspend the offering of Placement Shares during such period and the Company will promptly amend or supplement the Registration Statement or Prospectus (at the expense of the Company) so as to correct such statement or omission or effect such compliance; provided, however, that the Company may delay the filing of any amendment or supplement, if in the judgment of the Company, it is in the best interest of the Company.
d.Listing of Placement Shares. During the Prospectus Delivery Period, the Company will use its commercially reasonable efforts to cause the Placement Shares to be listed on the Exchange and to qualify the Placement Shares for sale under the securities laws of such jurisdictions in the United States as the Agent reasonably designates and to continue such qualifications in effect so long as required for the distribution of the Placement Shares; provided, however, that the Company shall not be required in connection therewith to qualify as a foreign corporation or dealer in securities, file a general consent to service of process, or subject itself to taxation in any jurisdiction if it is not otherwise so subject.
e.Delivery of Registration Statement and Prospectus. The Company will furnish to the Agent and its counsel (at the reasonable expense of the Company) copies of the Registration Statement, the Prospectus (including all documents incorporated by reference therein) and all amendments and supplements to the Registration Statement or Prospectus that are filed with the Commission during the Prospectus Delivery Period (including all documents filed with the Commission during such period that are deemed to be incorporated by reference therein), in each case as soon as reasonably practicable and in such quantities as the Agent may from time to time reasonably request and, at the Agent’s request, will also furnish copies of the Prospectus to each exchange or market on which sales of the Placement Shares may be made; provided, however, that the Company shall not be required to furnish any document (other than the Prospectus) to the Agent to the extent such document is available on EDGAR.
f.Earnings Statement. The Company will make generally available to its security holders as soon as practicable, but in any event not later than 15 months after the end of
20


the Company’s current fiscal quarter, an earnings statement covering a 12-month period that satisfies the provisions of Section 11(a) and Rule 158 of the Securities Act.
g.Use of Proceeds. The Company will use the Net Proceeds as described in the Prospectus in the section entitled “Use of Proceeds.”
h.Notice of Other Sales. Without the prior notice to the Agent, the Company will not, directly or indirectly, offer to sell, sell, contract to sell, grant any option to sell or otherwise dispose of any Common Stock (other than the Placement Shares offered pursuant to this Agreement) or securities convertible into or exchangeable for Common Stock, warrants or any rights to purchase or acquire, Common Stock during the period beginning on the date on which any Placement Notice is delivered to the Agent hereunder and ending on the third (3rd) Trading Day immediately following the final Settlement Date with respect to Placement Shares sold pursuant to such Placement Notice (or, if the Placement Notice has been terminated or suspended prior to the sale of all Placement Shares covered by a Placement Notice, the date of such suspension or termination); and will not directly or indirectly in any other “at the market” or continuous equity transaction offer to sell, sell, contract to sell, grant any option to sell or otherwise dispose of any Common Stock (other than the Placement Shares offered pursuant to this Agreement) or securities convertible into or exchangeable for Common Stock, warrants or any rights to purchase or acquire, Common Stock prior to the termination of this Agreement; provided, however, that such restrictions will not apply in connection with the Company’s issuance, grant or sale of (i) Common Stock, options to purchase Common Stock or Common Stock issuable upon the exercise of options or other equity awards including restricted stock units, pursuant to any stock option, or benefits plan, stock ownership plan or dividend reinvestment plan (but not Common Stock subject to a waiver to exceed plan limits in its dividend reinvestment plan), stock bonus or other stock plan or arrangement of the Company whether now in effect or hereafter implemented; (ii) Common Stock issuable upon conversion of securities or the exercise of warrants, options, restricted stock units or other rights in effect or outstanding, and disclosed in filings by the Company available on EDGAR or otherwise in writing to the Agent, (iii) Common Stock, or securities convertible into or exercisable for Common Stock, offered and sold in a privately negotiated transaction to vendors, customers, strategic partners or potential strategic partners or other investors conducted in a manner so as not to be integrated with the offering of Common Stock hereby, (iv) any shares of Common Stock issuable upon the exchange, conversion or redemption of securities or the exercise of warrants, options or other rights in effect or outstanding; (v) Common Stock or securities convertible into or exercisable for Common Stock in connection with any acquisition, strategic investment or other similar transaction (including any joint venture, strategic alliance or partnership); and (vi) Common Stock issuable pursuant to any earnouts or contingent consideration, including any earn-out shares issuable in connection with the business combination or “De-SPAC” transaction between Luminar Technologies, Inc. and Gores Metropoulos.
i.Change of Circumstances. The Company will, at any time during the pendency of a Placement Notice advise the Agent promptly after it shall have received notice or obtained knowledge thereof, of any information or fact that would alter or affect in any material
21


respect any opinion, certificate, letter or other document required to be provided to the Agent pursuant to this Agreement.
j.Due Diligence Cooperation. During the term of this Agreement, the Company will cooperate with any reasonable due diligence review conducted by the Agent or its representatives in connection with the transactions contemplated hereby, including, without limitation, providing information and making available documents and senior corporate officers, during regular business hours and at the Company’s principal offices, as the Agent may reasonably request.
k.Required Filings Relating to Placement of Placement Shares. The Company agrees that on such dates as the Securities Act shall require, the Company will (i) file a prospectus supplement with the Commission under the applicable paragraph of Rule 424(b) under the Securities Act (each and every date a filing under Rule 424(b) is made, a “Filing Date”), which prospectus supplement will set forth, within the relevant period, the amount of Placement Shares sold through the Agent, the Net Proceeds to the Company and the compensation payable by the Company to the Agent with respect to such Placement Shares, and (ii) deliver such number of copies of each such prospectus supplement to each exchange or market on which such sales were effected as may be required by the rules or regulations of such exchange or market.
l.Representation Dates; Certificate. Each time during the term of this Agreement that the Company:
(i)amends or supplements (other than a prospectus supplement relating solely to an offering of securities other than the Placement Shares) the Registration Statement or the Prospectus relating to the Placement Shares by means of a post-effective amendment, sticker, or supplement but not by means of incorporation of documents by reference into the Registration Statement or the Prospectus relating to the Placement Shares;
(ii)files an annual report on Form 10-K under the Exchange Act (including any Form 10-K/A containing amended audited financial information or a material amendment to the previously filed Form 10-K);
(iii)files its quarterly reports on Form 10-Q under the Exchange Act; or
(iv)files a current report on Form 8-K containing amended financial information (other than information “furnished” pursuant to Items 2.02 or 7.01 of Form 8-K or to provide disclosure pursuant to Item 8.01 of Form 8-K relating to the reclassification of certain properties as discontinued operations in accordance with Statement of Financial Accounting Standards No. 144) under the Exchange Act;
(Each date of filing of one or more of the documents referred to in clauses (i) through (iv) shall be a “Representation Date.”)
22


the Company shall furnish the Agent (but in the case of clause (iv) above only if the Agent reasonably determines that the information contained in such Form 8-K is material) with a certificate, in the form attached hereto as Exhibit 7(1). The requirement to provide a certificate under this Section 7(1) shall be waived for any Representation Date occurring at a time at which no Placement Notice is pending, which waiver shall continue until the earlier to occur of the date the Company delivers a Placement Notice hereunder (which for such calendar quarter shall be considered a Representation Date) and the next occurring Representation Date on which the Company files its annual report on Form 10-K. Notwithstanding the foregoing, (i) upon the delivery of the first Placement Notice hereunder and (ii) if the Company subsequently decides to sell Placement Shares following a Representation Date when the Company relied on such waiver and did not provide the Agent with a certificate under this Section 7(1), then before the Agent sells any Placement Shares, the Company shall provide the Agent with a certificate, in the form attached hereto as Exhibit 7(1), dated the date of the Placement Notice.
m.Legal Opinion. On or prior to the date of the first Placement Notice given hereunder the Company shall cause to be furnished to the Agent a written opinion and a negative assurance letter of Orrick, Herrington & Sutcliffe LLP (“Company Counsel”), or other counsel reasonably satisfactory to the Agent, each in form and substance reasonably satisfactory to the Agent. Thereafter, within five (5) Trading Days of each Representation Date with respect to which the Company is obligated to deliver a certificate in the form attached hereto as Exhibit 7(l) for which no waiver is applicable, the Company shall cause to be furnished to the Agent a negative assurance letter of Company Counsel in form and substance reasonably satisfactory to the Agent; provided that, in lieu of such negative assurance for subsequent periodic filings under the Exchange Act, counsel may furnish the Agent with a letter (a “Reliance Letter”) to the effect that the Agent may rely on the negative assurance letter previously delivered under this Section 7(m) to the same extent as if it were dated the date of such letter (except that statements in such prior letter shall be deemed to relate to the Registration Statement and the Prospectus as amended or supplemented as of the date of the Reliance Letter).
n.Comfort Letter. On or prior to the date of the first Placement Notice given hereunder and within five (5) Trading Days after each subsequent Representation Date, other than pursuant to Section 7(l)(iii), the Company shall cause its independent accountants to furnish the Agent letters (the “Comfort Letters”), dated the date the Comfort Letter is delivered, which shall meet the requirements set forth in this Section 7(n). The Comfort Letter from the Company’s independent accountants shall be in a form and substance reasonably satisfactory to the Agent, (i) confirming that they are an independent public accounting firm within the meaning of the Securities Act and the Public Company Accounting Oversight Board (the “PCAOB”), (ii) stating, as of such date, the conclusions and findings of such firm with respect to the financial information and other matters ordinarily covered by accountants’ “comfort letters” to underwriters in connection with registered public offerings (the first such letter, the “Initial Comfort Letter”) and (iii) updating the Initial Comfort Letter with any information that would have been included in the Initial Comfort Letter had it been given on such date and modified as necessary to relate to the Registration Statement and the Prospectus, as amended and supplemented to the date of such letter.
23


o.Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
p.Investment Company Act. The Company will conduct its affairs in such a manner so as to reasonably ensure that neither it nor the Subsidiaries will be or become, at any time prior to the termination of this Agreement, an “investment company,” as such term is defined in the Investment Company Act.
q.No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunder pursuant to Section 23, neither of the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
r.Sarbanes-Oxley Act. The Company will maintain and keep accurate books and records reflecting its assets and maintain internal accounting controls in a manner designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP and including those policies and procedures that (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company, (ii) provide reasonable assurance that transactions are recorded as necessary to permit the preparation of the Company’s consolidated financial statements in accordance with GAAP, (iii) that receipts and expenditures of the Company are being made only in accordance with management’s and the Company’s directors’ authorization, and (iv) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on its financial statements. The Company will maintain disclosure controls and procedures that comply with the requirements of the Exchange Act.
8.Representations and Covenants of the Agent. The Agent represents and warrants that it is duly registered as a broker-dealer under FINRA, the Exchange Act and the applicable statutes and regulations of each state in which the Placement Shares will be offered and sold, except such states in which the Agent is exempt from registration or such registration is not otherwise required. The Agent shall continue, for the term of this Agreement, to be duly registered as a broker-dealer under FINRA, the Exchange Act and the applicable statutes and regulations of each state in which the Placement Shares will be offered and sold, except such states in which it is exempt from registration or such registration is not otherwise required, during the term of this Agreement. The Agent shall comply with all applicable law and regulations in connection with the transactions contemplated by this Agreement, including the issuance and sale through the Agent of the Placement Shares.
24


9.Payment of Expenses. The Company will pay all expenses incident to the performance of its obligations under this Agreement, including (i) the preparation, filing, including any fees required by the Commission, and printing of the Registration Statement (including financial statements and exhibits) as originally filed and of each amendment and supplement thereto and each Free Writing Prospectus, in such number as the Agent shall deem reasonably necessary, (ii) the printing and delivery to the Agent of this Agreement and such other documents as may be required in connection with the offering, purchase, sale, issuance or delivery of the Placement Shares, (iii) the preparation, issuance and delivery of the certificates, if any, for the Placement Shares to the Agent, including any stock or other transfer taxes and any capital duties, stamp duties or other duties or taxes payable upon the sale, issuance or delivery of the Placement Shares to the Agent, (iv) the fees and disbursements of the counsel, accountants and other advisors to the Company, (v) the reasonable and documented out-of-pocket fees and disbursements of counsel to the Agent not to exceed $50,000 in the aggregate; (vi) the fees and expenses of the transfer agent and registrar for the Common Stock, (vii) the filing fees incident to any review by FINRA of the terms of the sale of the Placement Shares not to exceed $5,000, and (viii) the fees and expenses incurred in connection with the listing of the Placement Shares on the Exchange.
10.Conditions to the Agent’s Obligations. The obligations of the Agent hereunder with respect to a Placement will be subject to the continuing accuracy and completeness of the representations and warranties made by the Company herein (other than those representations and warranties made as of a specified date or time), to the due performance in all material respects by the Company of its obligations hereunder, to the completion by the Agent of a due diligence review satisfactory to it in its reasonable judgment, and to the continuing reasonable satisfaction (or waiver by the Agent in its sole discretion) of the following additional conditions:
a.Registration Statement Effective. The Registration Statement shall remain effective and shall be available for the sale of all Placement Shares contemplated to be issued by any Placement Notice.
b.No Material Notices. None of the following events shall have occurred and be continuing: (i) receipt by the Company of any request for additional information from the Commission or any other federal or state governmental authority during the period of effectiveness of the Registration Statement, the response to which would require any post-effective amendments or supplements to the Registration Statement or the Prospectus; (ii) the issuance by the Commission or any other federal or state governmental authority of any stop order suspending the effectiveness of the Registration Statement or receipt by the Company of notification of the initiation of any proceedings for that purpose; (iii) receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Placement Shares for sale in any jurisdiction or receipt by the Company of notification of the initiation of, or a threat to initiate, any proceeding for such purpose; or (iv) the occurrence of any event that makes any material statement made in the Registration Statement or the Prospectus or any material Incorporated Document untrue in any material respect or that requires the making of any changes in the Registration Statement, the Prospectus or any material Incorporated Document so that, in the case of the Registration
25


Statement, it will not contain any materially untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading and, that in the case of the Prospectus or any material Incorporated Document, it will not contain any materially untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.
c.No Misstatement or Material Omission. The Agent shall not have advised the Company that the Registration Statement or Prospectus, or any amendment or supplement thereto, contains an untrue statement of fact that in the Agent’s reasonable opinion is material, or omits to state a fact that in the Agent’s reasonable opinion is material and is required to be stated therein or is necessary to make the statements therein not misleading.
d.Material Changes. Except as contemplated in the Prospectus, or disclosed in the Company’s reports filed with the Commission, there shall not have been any Material Adverse Effect, or any development that would cause a Material Adverse Effect, or a downgrading in or withdrawal of the rating assigned to any of the Company’s securities (other than asset backed securities) by any “nationally recognized statistical rating organization,” as such term is defined by the Commission for purposes of Rule 436(g)(2) under the Securities Act (a “Rating Organization”), or a public announcement by any Rating Organization that it has under surveillance or review its rating of any of the Company’s securities (other than asset backed securities), the effect of which, in the case of any such action by a Rating Organization described above, in the reasonable judgment of the Agent (without relieving the Company of any obligation or liability it may otherwise have), is so material as to make it impracticable or inadvisable to proceed with the offering of the Placement Shares on the terms and in the manner contemplated in the Prospectus.
e.Company Counsel Legal Opinion. The Agent shall have received the opinion and negative assurance letter of Company Counsel required to be delivered pursuant to Section 7(m) on or before the date on which such delivery of such opinion and negative assurance letter are required pursuant to Section 7(m).
f.Agent Counsel Legal Opinion. Agent shall have received from Duane Morris LLP, counsel for the Agent, such opinion or opinions, on or before the date on which the delivery of the Company Counsel legal opinion is required pursuant to Section 7(m), with respect to such matters as the Agent may reasonably require, and the Company shall have furnished to such counsel such documents as they request for enabling them to pass upon such matters.
g.Comfort Letter. The Agent shall have received the Comfort Letter required to be delivered pursuant Section 7(n) on or before the date on which such delivery of such letter is required pursuant to Section 7(n).
h.Representation Certificate. The Agent shall have received the certificate required to be delivered pursuant to Section 7(1) on or before the date on which delivery of such certificate is required pursuant to Section 7(1).
26


i.Secretary’s Certificate. On or prior to the first Representation Date, the Agent shall have received a certificate, signed on behalf of the Company by its corporate Secretary, in form and substance satisfactory to the Agent and its counsel.
j.No Suspension. Trading in the Common Stock shall not have been suspended on the Exchange and the Common Stock shall not have been delisted from the Exchange.
k.Other Materials. On each date on which the Company is required to deliver a certificate pursuant to Section 7(1), the Company shall have furnished to the Agent such appropriate further information, certificates and documents as the Agent may reasonably request and which are usually and customarily furnished by an issuer of securities in connection with a securities offering of the type contemplated hereby. All such opinions, certificates, letters and other documents will be in compliance with the provisions hereof.
l.Securities Act Filings Made. All filings with the Commission required by Rule 424 under the Securities Act to have been filed prior to the issuance of any Placement Notice hereunder shall have been made within the applicable time period prescribed for such filing by Rule 424.
m.Approval for Listing. The Placement Shares shall either have been approved for listing on the Exchange, subject only to notice of issuance, or the Company shall have filed an application for listing of the Placement Shares on the Exchange at, or prior to, the issuance of any Placement Notice.
n.No Termination Event. There shall not have occurred any event that would permit the Agent to terminate this Agreement pursuant to Section 13(a).
11.Indemnification and Contribution.
(a)    Company Indemnification. The Company agrees to indemnify and hold harmless the Agent, its partners, members, directors, officers, employees and agents and each person, if any, who controls the Agent within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act as follows:
(i)against any and all loss, liability, claim, damage and expense whatsoever, as incurred, joint or several, arising out of or based upon any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or any amendment thereto), or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements therein not misleading, or arising out of any untrue statement or alleged untrue statement of a material fact included in any related Issuer Free Writing Prospectus or the Prospectus (or any amendment or supplement thereto), or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading;
(ii)against any and all loss, liability, claim, damage and expense whatsoever, as incurred, joint or several, to the extent of the aggregate amount paid in settlement
27


of any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or of any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission; provided that (subject to Section 11(d) below) any such settlement is effected with the written consent of the Company, which consent shall not unreasonably be delayed or withheld; and
(iii)against any and all expense whatsoever, as incurred (including the reasonable and documented out-of-pocket fees and disbursements of counsel), reasonably incurred in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission, to the extent that any such expense is not paid under (i) or (ii) above,
provided, however, that this indemnity agreement shall not apply to any loss, liability, claim, damage or expense to the extent arising out of any untrue statement or omission or alleged untrue statement or omission made solely in reliance upon and in conformity with written information furnished to the Company by the Agent expressly for use in the Registration Statement (or any amendment thereto), or in any related Issuer Free Writing Prospectus or the Prospectus (or any amendment or supplement thereto).
(b)    Indemnification by the Agent. The Agent agrees to indemnify and hold harmless the Company and its directors and officers, and each person, if any, who (i) controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act or (ii) is controlled by or is under common control with the Company against any and all loss, liability, claim, damage and expense described in the indemnity contained in Section 11(a), as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in the Registration Statement (or any amendments thereto) or in any related Issuer Free Writing Prospectus or the Prospectus (or any amendment or supplement thereto) in reliance upon and in conformity with information relating to the Agent and furnished to the Company in writing by the Agent expressly for use therein.
(c)    Procedure. Any party that proposes to assert the right to be indemnified under this Section 11 will, promptly after receipt of notice of commencement of any action against such party in respect of which a claim is to be made against an indemnifying party or parties under this Section 11, notify each such indemnifying party of the commencement of such action, enclosing a copy of all papers served, but the omission so to notify such indemnifying party will not relieve the indemnifying party from (i) any liability that it might have to any indemnified party otherwise than under this Section 11 and (ii) any liability that it may have to any indemnified party under the foregoing provisions of this Section 11 unless, and only to the extent that, such omission results in the forfeiture of substantive rights or defenses by the indemnifying party. If any such action is brought against any indemnified party and it notifies the indemnifying party of its commencement, the indemnifying party will be entitled to participate in and, to the extent that it elects by delivering written notice to the indemnified party promptly after receiving notice of the commencement of the action from the indemnified party, jointly with any other indemnifying party similarly notified, to assume the defense of the action, with
28


counsel reasonably satisfactory to the indemnified party, and after notice from the indemnifying party to the indemnified party of its election to assume the defense, the indemnifying party will not be liable to the indemnified party for any legal or other expenses except as provided below and except for the reasonable costs of investigation subsequently incurred by the indemnified party in connection with the defense. The indemnified party will have the right to employ its own counsel in any such action, but the fees, expenses and other charges of such counsel will be at the expense of such indemnified party unless (1) the employment of counsel by the indemnified party has been authorized in writing by the indemnifying party, (2) the indemnified party has reasonably concluded (based on advice of counsel) that there may be legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying party, (3) a conflict or potential conflict of interest exists (based on advice of counsel to the indemnified party) between the indemnified party and the indemnifying party (in which case the indemnifying party will not have the right to direct the defense of such action on behalf of the indemnified party) or (4) the indemnifying party has not in fact employed counsel to assume the defense of such action within a reasonable time after receiving notice of the commencement of the action, in each of which cases the reasonable and documented out-of-pocket fees, disbursements and other charges of counsel will be at the expense of the indemnifying party or parties. It is understood that the indemnifying party or parties shall not, in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable and documented out-of-pocket fees, disbursements and other charges of more than one separate firm admitted to practice in such jurisdiction at any one time for all such indemnified party or parties. All such reasonable and documented out-of-pocket fees, disbursements and other charges will be reimbursed by the indemnifying party promptly after the indemnifying party receives a written invoice relating to fees, disbursements and other charges in reasonable detail. An indemnifying party will not, in any event, be liable for any settlement of any action or claim effected without its written consent. No indemnifying party shall, without the prior written consent of each indemnified party, settle or compromise or consent to the entry of any judgment in any pending or threatened claim, action or proceeding relating to the matters contemplated by this Section 11 (whether or not any indemnified party is a party thereto), unless such settlement, compromise or consent (1) includes an unconditional release of each indemnified party from all liability arising out of such litigation, investigation, proceeding or claim and (2) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party.
(d)    Contribution. In order to provide for just and equitable contribution in circumstances in which the indemnification provided for in the foregoing paragraphs of this Section 11 is applicable in accordance with its terms but for any reason is held to be unavailable from the Company or the Agent, the Company and the Agent will contribute to the total losses, claims, liabilities, expenses and damages (including any investigative, legal and other expenses reasonably incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claim asserted, but after deducting any contribution received by the Company from persons other than the Agent, such as persons who control the Company within the meaning of the Securities Act or the Exchange Act, officers of the Company who signed the Registration Statement and directors of the Company, who also may be liable for contribution) to which the Company and the Agent may be subject in such proportion as shall be appropriate to
29


reflect the relative benefits received by the Company on the one hand and the Agent on the other hand. The relative benefits received by the Company on the one hand and the Agent on the other hand shall be deemed to be in the same proportion as the total Net Proceeds from the sale of the Placement Shares (before deducting expenses) received by the Company bear to the total compensation received by the Agent (before deducting expenses) from the sale of Placement Shares on behalf of the Company. If, but only if, the allocation provided by the foregoing sentence is not permitted by applicable law, the allocation of contribution shall be made in such proportion as is appropriate to reflect not only the relative benefits referred to in the foregoing sentence but also the relative fault of the Company, on the one hand, and the Agent, on the other hand, with respect to the statements or omission that resulted in such loss, claim, liability, expense or damage, or action in respect thereof, as well as any other relevant equitable considerations with respect to such offering. Such relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or the Agent, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and the Agent agree that it would not be just and equitable if contributions pursuant to this Section 11(d) were to be determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, liability, expense, or damage, or action in respect thereof, referred to above in this Section 11(d) shall be deemed to include, for the purpose of this Section 11(d), any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim to the extent consistent with Section 11(c) hereof. Notwithstanding the foregoing provisions of this Section 11(d), the Agent shall not be required to contribute any amount in excess of the commissions received by it under this Agreement and no person found guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section 11(d), any person who controls a party to this Agreement within the meaning of the Securities Act or the Exchange Act, and any officers, directors, partners, employees or agents of the Agent, will have the same rights to contribution as that party, and each officer who signed the Registration Statement and director of the Company will have the same rights to contribution as the Company, subject in each case to the provisions hereof. Any party entitled to contribution, promptly after receipt of notice of commencement of any action against such party in respect of which a claim for contribution may be made under this Section 11(d), will notify any such party or parties from whom contribution may be sought, but the omission to so notify will not relieve that party or parties from whom contribution may be sought from any other obligation it or they may have under this Section 11(d) except to the extent that the failure to so notify such other party materially prejudiced the substantive rights or defenses of the party from whom contribution is sought. Except for a settlement entered into pursuant to the last sentence of Section 11(c) hereof, no party will be liable for contribution with respect to any action or claim settled without its written consent if such consent is required pursuant to Section 11(c) hereof.
30


12.Representations and Agreements to Survive Delivery. The indemnity and contribution agreements contained in Section 11 of this Agreement and all representations and warranties of the Company herein or in certificates delivered pursuant hereto shall survive, as of their respective dates, regardless of (i) any investigation made by or on behalf of the Agent, any controlling persons, or the Company (or any of their respective officers, directors or controlling persons), (ii) delivery and acceptance of the Placement Shares and payment therefor or (iii) any termination of this Agreement.
13.Termination.
a.The Agent may terminate this Agreement, by notice to the Company, as hereinafter specified at any time (1) if there has been, since the time of execution of this Agreement or since the date as of which information is given in the Prospectus, any Material Adverse Effect, or any development that would have a Material Adverse Effect that, in the sole judgment of the Agent, is material and adverse and makes it impractical or inadvisable to market the Placement Shares or to enforce contracts for the sale of the Placement Shares, (2) if there has occurred any material adverse change in the financial markets in the United States or the international financial markets, any outbreak of hostilities or escalation thereof or other calamity or crisis or any change or development involving a prospective change in national or international political, financial or economic conditions, in each case the effect of which is such as to make it, in the judgment of the Agent, impracticable or inadvisable to market the Placement Shares or to enforce contracts for the sale of the Placement Shares, (3) if trading in the Common Stock has been suspended or limited by the Commission or the Exchange, or if trading generally on the Exchange has been suspended or limited, or minimum prices for trading have been fixed on the Exchange, (4) if any suspension of trading of any securities of the Company on any exchange or in the over-the-counter market shall have occurred and be continuing, (5) if a major disruption of securities settlements or clearance services in the United States shall have occurred and be continuing, or (6) if a banking moratorium has been declared by either U.S. Federal or New York authorities. Any such termination shall be without liability of any party to any other party except that the provisions of Section 9 (Payment of Expenses), Section 11 (Indemnification and Contribution), Section 12 (Representations and Agreements to Survive Delivery), Section 18 (Governing Law and Time; Waiver of Jury Trial),Section 19 (Consent to Jurisdiction) and Section 25 ( Confidentiality) hereof shall remain in full force and effect notwithstanding such termination. If the Agent elects to terminate this Agreement as provided in this Section 13(a), the Agent shall provide the required notice as specified in Section 14 (Notices).
b.The Company shall have the right, by giving five (5) days’ notice as hereinafter specified to terminate this Agreement in its sole discretion at any time after the date of this Agreement. Any such termination shall be without liability of any party to any other party except that the provisions of Section 9 (Payment of Expenses), Section 11 (Indemnification and Contribution), Section 12 (Representations and Agreements to Survive Delivery), Section 18 (Governing Law and Time; Waiver of Jury Trial), Section 19 (Consent to Jurisdiction) and Section 25 (Confidentiality) hereof shall remain in full force and effect notwithstanding such termination.
31


c.The Agent shall have the right, by giving five (5) days’ notice as hereinafter specified to terminate this Agreement in its sole discretion at any time after the date of this Agreement. Any such termination shall be without liability of any party to any other party except that the provisions of Section 9 (Payment of Expenses), Section 11 (Indemnification and Contribution), Section 12 (Representations and Agreements to Survive Delivery), Section 18 (Governing Law and Time; Waiver of Jury Trial), Section 19 (Consent to Jurisdiction) and Section 25 (Confidentiality) hereof shall remain in full force and effect notwithstanding such termination.
d.Unless earlier terminated pursuant to this Section 13, this Agreement shall automatically terminate upon the issuance and sale of all of the Placement Shares through the Agent on the terms and subject to the conditions set forth herein except that the provisions of Section 9 (Payment of Expenses), Section 11 (Indemnification and Contribution), Section 12 (Representations and Agreements to Survive Delivery), Section 18 (Governing Law and Time; Waiver of Jury Trial), Section 19 (Consent to Jurisdiction) and Section 25 (Confidentiality) hereof shall remain in full force and effect notwithstanding such termination.
e.This Agreement shall remain in full force and effect unless terminated pursuant to Sections 13(a), (b), (c), or (d) above or otherwise by mutual agreement of the parties; provided, however, that any such termination by mutual agreement shall in all cases be deemed to provide that Section 9 (Payment of Expenses), Section 11 (Indemnification and Contribution), Section 12 (Representations and Agreements to Survive Delivery), Section 18 (Governing Law and Time; Waiver of Jury Trial), Section 19 (Consent to Jurisdiction) and Section 25 (Confidentiality) shall remain in full force and effect. Upon termination of this Agreement, the Company shall not have any liability to the Agent for any discount, commission or other compensation with respect to any Placement Shares not otherwise sold by the Agent under this Agreement.
f.Any termination of this Agreement shall be effective on the date specified in such notice of termination; provided, however, that such termination shall not be effective until the close of business on the date of receipt of such notice by the Agent or the Company, as the case may be. If such termination shall occur prior to the Settlement Date for any sale of Placement Shares, such Placement Shares shall settle in accordance with the provisions of this Agreement.
14.Notices. All notices or other communications required or permitted to be given by any party to any other party pursuant to the terms of this Agreement shall be in writing, unless otherwise specified, and if sent to the Agent, shall be delivered to:

Virtu Americas LLC
One Liberty Plaza
165 Broadway
New York, NY 10006
Attention: Virtu Capital Markets
Email:
32


with a copy to:

Duane Morris LLP
1540 Broadway
New York, NY 10036
Attention:     James T. Seery
Telephone:
Email:     
and if to the Company, shall be delivered to:

Luminar Technologies, Inc.
2603 Discovery Drive
Suite 100
Orlando, FL 32826
Attention:        
Telephone:
Email:        

with a copy to:

Orrick, Herrington & Sutcliffe LLP
631 Wilshire Boulevard
Santa Monica, CA 90401
Attention: Daniel S. Kim
Telephone:
Email:
Each party to this Agreement may change such address for notices by sending to the parties to this Agreement written notice of a new address for such purpose. Each such notice or other communication shall be deemed given (i) when delivered personally, by email, or by verifiable facsimile transmission on or before 4:30 p.m., New York City time, on a Business Day or, if such day is not a Business Day, on the next succeeding Business Day, (ii) on the next Business Day after timely delivery to a nationally-recognized overnight courier and (iii) on the Business Day actually received if deposited in the U.S. mail (certified or registered mail, return receipt requested, postage prepaid). For purposes of this Agreement, “Business Day” shall mean any day on which the Exchange and commercial banks in the City of New York are open for business.
15.Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the Company and the Agent and their respective successors and the affiliates, controlling persons, officers and directors referred to in Section 11 hereof. References to any of the parties contained in this Agreement shall be deemed to include the successors and permitted assigns of such party. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and permitted assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as
33


expressly provided in this Agreement. Neither the Company nor the Agent may assign its rights or obligations under this Agreement without the prior written consent of the other party.
16.Adjustments for Stock Splits. The parties acknowledge and agree that all share-related numbers contained in this Agreement shall be adjusted to take into account any share consolidation, stock split, stock dividend, corporate domestication or similar event effected with respect to the Placement Shares.
17.Entire Agreement; Amendment; Severability. This Agreement (including all schedules and exhibits attached hereto and Placement Notices issued pursuant hereto) constitutes the entire agreement and supersedes all other prior and contemporaneous agreements and undertakings, both written and oral, among the parties hereto with regard to the subject matter hereof. Neither this Agreement nor any term hereof may be amended except pursuant to a written instrument executed by the Company and the Agent. In the event that any one or more of the provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable as written by a court of competent jurisdiction, then such provision shall be given full force and effect to the fullest possible extent that it is valid, legal and enforceable, and the remainder of the terms and provisions herein shall be construed as if such invalid, illegal or unenforceable term or provision was not contained herein, but only to the extent that giving effect to such provision and the remainder of the terms and provisions hereof shall be in accordance with the intent of the parties as reflected in this Agreement.
18.GOVERNING LAW AND TIME; WAIVER OF JURY TRIAL. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAWS. SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME. THE COMPANY AND THE AGENT EACH HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.
19.CONSENT TO JURISDICTION. EACH PARTY HEREBY IRREVOCABLY SUBMITS TO THE NON-EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH ANY TRANSACTION CONTEMPLATED HEREBY, AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT, THAT SUCH SUIT, ACTION OR PROCEEDING IS BROUGHT IN AN INCONVENIENT FORUM OR THAT THE VENUE OF SUCH SUIT, ACTION OR PROCEEDING IS IMPROPER. EACH PARTY HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO PROCESS BEING SERVED IN ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF (CERTIFIED OR REGISTERED MAIL, RETURN RECEIPT REQUESTED) TO SUCH PARTY AT THE ADDRESS IN EFFECT FOR NOTICES TO IT UNDER THIS AGREEMENT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND
34


SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED BY LAW.
20.Use of Information. The Agent may not use any information gained in connection with this Agreement and the transactions contemplated by this Agreement, including due diligence, to advise any party with respect to transactions not expressly approved by the Company.
21.Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery of an executed Agreement by one party to the other may be made by facsimile transmission or email of a .pdf attachment.
22.Effect of Headings. The section, Schedule and Exhibit headings herein are for convenience only and shall not affect the construction hereof.
23.Permitted Free Writing Prospectuses. The Company represents, warrants and agrees that, unless it obtains the prior consent of the Agent, and the Agent represents, warrants and agrees that, unless it obtains the prior consent of the Company, it has not made and will not make any offer relating to the Placement Shares that would constitute an Issuer Free Writing Prospectus, or that would otherwise constitute a “free writing prospectus,” as defined in Rule 405, required to be filed with the Commission. Any such free writing prospectus consented to by the Agent or by the Company, as the case may be, is hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company represents and warrants that it has treated and agrees that it will treat each Permitted Free Writing Prospectus as an “issuer free writing prospectus,” as defined in Rule 433, and has complied and will comply with the requirements of Rule 433 applicable to any Permitted Free Writing Prospectus, including timely filing with the Commission where required, legending and record keeping. For the purposes of clarity, the parties hereto agree that all free writing prospectuses, if any, listed in Exhibit 23 hereto are Permitted Free Writing Prospectuses.
24.Absence of Fiduciary Relationship. The Company acknowledges and agrees that:
a.The Agent is acting solely as agent in connection with the public offering of the Placement Shares and in connection with each transaction contemplated by this Agreement and the process leading to such transactions, and no fiduciary or advisory relationship between the Company or any of its respective affiliates, stockholders (or other equity holders), creditors or employees or any other party, on the one hand, and the Agent, on the other hand, has been or will be created in respect of any of the transactions contemplated by this Agreement, irrespective of whether or not the Agent has advised or is advising the Company on other matters, and the Agent has no obligation to the Company with respect to the transactions contemplated by this Agreement except the obligations expressly set forth in this Agreement;
b.it is capable of evaluating and understanding, and understands and accepts, the terms, risks and conditions of the transactions contemplated by this Agreement;
35


c.the Agent has not provided any legal, accounting, regulatory or tax advice with respect to the transactions contemplated by this Agreement and it has consulted its own legal, accounting, regulatory and tax advisors to the extent it has deemed appropriate;
d.it is aware that the Agent and its affiliates are engaged in a broad range of transactions which may involve interests that differ from those of the Company and the Agent has no obligation to disclose such interests and transactions to the Company by virtue of any fiduciary, advisory or agency relationship or otherwise; and
e.it waives, to the fullest extent permitted by law, any claims it may have against the Agent for breach of fiduciary duty or alleged breach of fiduciary duty in connection with the sale of Placement Shares under this Agreement and agrees that the Agent shall not have any liability (whether direct or indirect, in contract, tort or otherwise) to it in respect of such a fiduciary duty claim or to any person asserting a fiduciary duty claim on its behalf or in right of it or the Company, employees or creditors of Company, other than in respect of the Agent’s obligations under this Agreement and to keep information provided by the Company to the Agent and its counsel confidential to the extent not otherwise publicly-available as set forth in Section 25 below.

25.Confidentiality. Each party hereto (“Discloser”) may disclose to the other party (“Recipient”) Confidential Information (defined herein). Recipient shall keep strictly confidential and shall not disclose to any third party any Confidential Information of the Discloser made available to the Recipient by the Discloser, whether made available before, on or after the date hereof, and shall use such Confidential Information solely for the purposes of performing the services hereunder or for the Program; provided, however, that such Confidential Information shall not include any information (i) available to or in possession of the Recipient prior to the time of its disclosure to the Recipient by the Discloser as demonstrated by files in existence at the time of disclosure; (ii) generally available to the public through no fault of the Recipient; or (iii) which becomes available to the Recipient on a non-confidential basis from any third party who is not bound by a confidentiality obligation to the Discloser without breach of this Agreement by the Recipient; and provided, further, that such Confidential Information may be disclosed (i) to the Recipient’s Representatives (as defined herein) who (A) need to know such information in connection with the performance by the Recipient of its services hereunder and (B) have been informed of the confidential nature of such information and that the disclosure thereof is subject to the restrictions contained in this Agreement; provided further that the Recipient shall remain liable for any breach of such restrictions by any of the Recipient’s Representatives; (ii) to any person with the prior written consent of the Discloser; or (iii) pursuant to the order or requirement of a court, administrative agency, or other governmental body; provided, however, that the Recipient shall provide prompt notice of such court order or requirement to the Discloser to enable the Discloser to seek a protective order or otherwise prevent or restrict such disclosure, and in the event that the Discloser is unable to obtain a protective order or other appropriate remedy, or if it so directs the Recipient, the Recipient shall furnish only that portion of the confidential information that the Recipient is advised by written opinion of its counsel is legally required to be furnished by it and shall exercise its reasonable best efforts to obtain reliable assurance that confidential treatment shall be accorded such
36


confidential information. Notwithstanding anything to the contrary set forth in this Agreement, the Company and the Agent each acknowledges and agrees that any breach by it of this Section 25 shall cause the other party irreparable harm which may not be adequately compensable by money damages. Accordingly, in the event of a breach or threatened breach by either party of this Section 25, the other party shall be entitled to seek the remedies of specific performance, injunction or other preliminary or equitable relief, without having to prove irreparable harm or actual damages and without the need for such other party to post a bond or other security. The foregoing right shall be in addition to such other rights or remedies as may be available to such other party for such breach or threatened breach, including but not limited to the recovery of money damages. The foregoing commitments of the Company and the Agent shall survive any termination of this Agreement and shall remain in effect for a period of five (5) years following termination of this Agreement, except that any of Discloser’s Confidential Information qualifying as a trade secret under applicable law shall be subject to the terms of this Agreement for so long as such Confidential Information is protectable as a trade secret. Within ten (10) business days after receipt of Discloser’s written request, Recipient shall return to Discloser any requested materials containing Discloser’s Confidential Information including all copies, and shall destroy all of Discloser’s Confidential Information stored in electronic format as well as any Notes (defined herein). Notwithstanding the foregoing, Confidential Information stored on backup systems that are not readily accessible need not be destroyed.
26.Definitions. As used in this Agreement, the following terms have the respective meanings set forth below:
“Affiliates” or “affiliates” of a party hereto are those entities that (i) control, (ii) are controlled by, or (iii) are under common control with such party, where “control” means ownership of more than 50% of an entity’s voting securities.
Applicable Time” means (i) each Representation Date and (ii) the time of each sale of any Placement Shares pursuant to this Agreement.
Confidential Information” shall mean any information disclosed by or on behalf of Discloser to Recipient or its Representatives (defined herein) in connection with the Program that (i) is designated in writing to be confidential or proprietary, or (ii) if given orally, is confirmed in writing as having been disclosed as confidential or proprietary within thirty (30) days after the oral disclosure, (iii) is provided or described under circumstances by which Recipient knows or should reasonably understand such information is to be treated as confidential, whether or not so marked, or (iv) is learned by Recipient as a result of visiting the facilities of the Discloser. Confidential Information includes, without limitation, technical data, trade secrets, research, plans, software, inventions, patent applications, notebooks, processes, formulas, techniques, mask works, designs, drawings, hardware configurations, third party agreements, materials, samples, methodologies, test results, specifications, supply sources, customer information, supplier data, financial data, marketing data, licenses, contract information, or materials generated by Recipient or its Representatives that contain or are derived from Discloser’s Confidential Information (“Notes”).
37


Issuer Free Writing Prospectus” means any “issuer free writing prospectus,” as defined in Rule 433, relating to the Placement Shares that (1) is required to be filed with the Commission by the Company, (2) is a “road show” that is a “written communication” within the meaning of Rule 433(d)(8)(i) whether or not required to be filed with the Commission, or (3) is exempt from filing pursuant to Rule 433(d)(5)(i) because it contains a description of the Placement Shares or of the offering that does not reflect the final terms, in each case in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company’s records pursuant to Rule 433(g) under the Securities Act.
Representative” shall mean either the Company’s or the Agent’s (as applicable) directors, officers, employees, members, consultants, affiliates, and agents, and those of such party’s affiliates.
Rule 172,” “Rule 405,” “Rule 415,” “Rule 424,” “Rule 424(b),” “Rule 430B,” and “Rule 433” refer to such rules under the Securities Act.
All references in this Agreement to financial statements and schedules and other information that is “contained,” “included” or “stated” in the Registration Statement or the Prospectus (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information that is incorporated by reference in the Registration Statement or the Prospectus, as the case may be.
All references in this Agreement to the Registration Statement, the Prospectus or any amendment or supplement to any of the foregoing shall be deemed to include the copy filed with the Commission pursuant to EDGAR; all references in this Agreement to any Issuer Free Writing Prospectus (other than any Issuer Free Writing Prospectuses that, pursuant to Rule 433, are not required to be filed with the Commission) shall be deemed to include the copy thereof filed with the Commission pursuant to EDGAR; and all references in this Agreement to “supplements” to the Prospectus shall include, without limitation, any supplements, “wrappers” or similar materials prepared in connection with any offering, sale or private placement of any Placement Shares by the Agent outside of the United States.
[Remainder of the page intentionally left blank]

38


If the foregoing correctly sets forth the understanding between the Company and the Agent, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Company and the Agent.
Very truly yours,
LUMINAR TECHNOLOGIES, INC.
By:    /s/ Thomas J. Fennimore
image_0b.jpg
Name: Thomas J. Fennimore
Title: Chief Financial Officer
ACCEPTED as of the date first-above written:

VIRTU AMERICAS LLC
By:    /s/ Joshua R. Feldman
image_0b.jpg
Name: Joshua R. Feldman
Title: Managing Director


39


SCHEDULE 1
image_2.jpg
FORM OF PLACEMENT NOTICE
image_2.jpg
From:    Luminar Technologies, Inc.
To:    Virtu Americas LLC
Attention:     Virtu Capital Markets
Subject:     Equity Financing -- Placement Notice

Ladies and Gentlemen:
Pursuant to the terms and subject to the conditions contained in the Financing Agreement between Luminar Technologies, Inc., a Delaware corporation (the “Company”), and Virtu Americas LLC (the “Agent”), dated February 28, 2023, the Company hereby requests that the Agent sell up to [____] of the Company’s Class A common stock, par value $0.0001 per share (the “Shares”), at a minimum market price of $    per Share, during the time period beginning [month, day, time] and ending [month, day, time].
[In addition, the following limitation applies to sales of Shares on any single day during the period specified above: [INSERT LIMITATION, IF ANY].]


40


SCHEDULE 2
________________________
Compensation
________________________

The Company shall pay to the Agent in cash, upon each sale of Placement Shares pursuant to this Agreement, an amount equal to up to 2.0% of the gross proceeds from each sale of Placement Shares.

41


SCHEDULE 3

________________________

Notice Parties
________________________

The Company
Austin Russell*        
Chief Executive Officer
(*Does not receive notices)
Thomas J. Fennimore        
Chief Financial Officer

The Agent

Jeffrey Lumby            

Joshua Feldman        

Conor Lumby            

With a copy to atm@virtu.com

42


EXHIBIT 7(1)
Form of Representation Date Certificate
___________, 20___
This Representation Date Certificate (this “Certificate”) is executed and delivered in connection with Section 7(1) of the Financing Agreement (the “Agreement”), dated February 28, 2023, and entered into between Luminar Technologies, Inc. (the “Company”) and Virtu Americas LLC. All capitalized terms used but not defined herein shall have the meanings given to such terms in the Agreement.
The Company hereby certifies as follows:
1.As of the date of this Certificate (i) the Registration Statement does not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading and (ii) neither the Registration Statement nor the Prospectus contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading and (iii) no event has occurred as a result of which it is necessary to amend or supplement the Prospectus in order to make the statements therein not untrue or misleading for this paragraph 1 to be true.
2.Each of the representations and warranties of the Company contained in the Agreement were, when originally made, and are, as of the date of this Certificate, true and correct in all material respects.
3.Except as waived by the Agent in writing, each of the covenants required to be performed by the Company in the Agreement on or prior to the date of the Agreement, this Representation Date, and each such other date prior to the date hereof as set forth in the Agreement, has been duly, timely and fully performed in all material respects and each condition required to be complied with by the Company on or prior to the date of the Agreement, this Representation Date, and each such other date prior to the date hereof as set forth in the Agreement has been duly, timely and fully complied with in all material respects.
4.Subsequent to the date of the most recent financial statements in the Prospectus, and except as described in the Prospectus, including Incorporated Documents, there has been no Material Adverse Effect.
5.No stop order suspending the effectiveness of the Registration Statement or of any part thereof has been issued, and no proceedings for that purpose have been instituted or are pending or threatened by any securities or other governmental authority (including, without limitation, the Commission).
6.No order suspending the effectiveness of the Registration Statement or the qualification or registration of the Placement Shares under the securities or Blue Sky laws of any
43


jurisdiction are in effect and no proceeding for such purpose is pending before, or threatened, to the Company’s knowledge or in writing by, any securities or other governmental authority (including, without limitation, the Commission).
The undersigned has executed this Representation Date Certificate as of the date first written above.
LUMINAR TECHNOLOGIES, INC.
By:    
Name:image_4a.jpg    
Title:
image_4a.jpg


    


EXHIBIT 23

Permitted Issuer Free Writing Prospectuses

None.



EX-10.6 4 exhibit106amendedandrestat.htm EX-10.6 Document

Exhibit 10.4

LUMINAR TECHNOLOGIES, INC.
AMENDED AND RESTATED 2020 EQUITY INCENTIVE PLAN
1. Purposes of the Plan. The purposes of this Plan are (a) to attract and retain the best available personnel to ensure the Company’s success and accomplish the Company’s goals; (b) to incentivize Employees, Directors and Independent Contractors with long-term equity-based compensation to align their interests with the Company’s stockholders, and (c) to promote the success of the Company’s business. This Plan, as amended and restated, was approved by the Board on May 5, 2022 and approved by the stockholders of the Company on _________.
The Plan permits the grant of Incentive Stock Options, Nonstatutory Stock Options, Restricted Stock, Restricted Stock Units, Stock Appreciation Rights, Performance Units and Performance Shares.
2. Definitions. As used herein, the following definitions will apply:
(a) “Administrator” means the Board or any of its Committees as will be administering the Plan, in accordance with Section 4 of the Plan.
(b) “Affiliate” means (i) an entity other than a Subsidiary which, together with the Company, is under common control of a third person or entity and (ii) an entity other than a Subsidiary in which the Company and/or one or more Subsidiaries own a controlling interest.
(c) “Applicable Laws” means all applicable laws, rules, regulations and requirements, including, but not limited to, all applicable U.S. federal or state laws, rules and regulations, the rules and regulations of any stock exchange or quotation system on which the Common Stock is listed or quoted, and the applicable laws, rules and regulations of any other country or jurisdiction where Awards are, or will be, granted under the Plan or Participants reside or provide services to the Company or any Parent or Subsidiary of the Company, as such laws, rules, and regulations shall be in effect from time to time.
(d) “Award” means, individually or collectively, a grant under the Plan of Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Units or Performance Shares.
(e) “Award Agreement” means the written or electronic agreement setting forth the terms and provisions applicable to each Award granted under the Plan. The Award Agreement is subject to the terms and conditions of the Plan.
(f) “Board” means the Board of Directors of the Company.
(g) “Cause” means, with respect to the termination of a Participant’s status as a Service Provider, except as otherwise defined in an Award Agreement, (i) in the case where there is no employment agreement, consulting agreement, change in control agreement or similar agreement in effect between the Company or an Affiliate of the Company and the Participant at the time of the grant of the Award (or where there is such an agreement but it does not define “cause” (or words of like import) or where it only applies upon the occurrence of a change in control and one has not yet taken place): (A) any material breach by Participant of any material written agreement between Participant and the Company; (B) any failure by Participant to comply with the Company’s material written policies or rules as they may be in effect from time to time; (C) neglect or persistent unsatisfactory performance of Participant’s duties; (D) Participant’s repeated failure to follow reasonable and lawful instructions from the Board or Chief Executive Officer; (E) Participant’s indictment for, conviction of, or plea of guilty or nolo contendre to, any felony or crime that results in, or is reasonably expected to result in, a material adverse effect on the business or reputation of the Company; (F) Participant’s commission of or participation in an act of fraud against the Company; (G) Participant’s intentional material damage to the Company’s business, property or reputation; or (H) Participant’s unauthorized use or disclosure of any proprietary information or trade secrets of the Company or any other party to whom the Participant owes an obligation of nondisclosure as a result of his or her relationship with the Company; or (ii) in the case where there is an employment agreement, consulting agreement, change in control agreement or similar agreement in effect between the Company or an Affiliate and the Participant at the time of the grant of the Award that defines “cause” (or words of like import), “cause” as defined under such agreement; provided,



however, that with regard to any agreement under which the definition of “cause” only applies on occurrence of a change in control, such definition of “cause” shall not apply until a change in control actually takes place and then only with regard to a termination thereafter. For purposes of clarity, a termination without “Cause” does not include any termination that occurs solely as a result of Participant’s death or Disability. The determination as to whether a Participant’s status as a Service Provider for purposes of the Plan has been terminated for Cause shall be made in good faith by the Company and shall be final and binding on the Participant. The foregoing definition does not in any way limit the Company’s ability (or that of any Parent or Subsidiary or any successor thereto, as appropriate) to terminate a Participant’s employment or consulting relationship at any time, subject to Applicable Laws.
(h) “Change in Control” except as may otherwise be provided in an Award Agreement or other applicable agreement, means the occurrence of any of the following:
(i) The consummation of a merger or consolidation of the Company with or into another entity or any other corporate reorganization, if the Company’s stockholders immediately prior to such merger, consolidation or reorganization cease to directly or indirectly own immediately after such merger, consolidation or reorganization at least a majority of the combined voting power of the continuing or surviving entity’s securities outstanding immediately after such merger, consolidation or reorganization;
(ii) The consummation of the sale, transfer or other disposition of all or substantially all of the Company’s assets (other than (x) to a corporation or other entity of which at least a majority of its combined voting power is owned directly or indirectly by the Company, (y) to a corporation or other entity owned directly or indirectly by the shareholders of the Company in substantially the same proportions as their ownership of Common Stock or (z) to a continuing or surviving entity described in Section 2(h)(i) in connection with a merger, consolidation or reorganization which does not result in a Change in Control under Section 2(h)(i));
(iii) A change in the effective control of the Company which occurs on the date that a majority of members of the Board is replaced during any twelve (12) month period by Directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election; or
(iv) The consummation of any transaction as a result of which any Person becomes the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing at least fifty percent (50%) of the total voting power represented by the Company’s then outstanding voting securities. For purposes of this Section 2(h), the term “Person” shall have the same meaning as when used in Sections 13(d) and 14(d) of the Exchange Act but shall exclude:
(1) a trustee or other fiduciary holding securities under an employee benefit plan of the Company or an affiliate of the Company;
(2) a corporation or other entity owned directly or indirectly by the stockholders of the Company in substantially the same proportions as their ownership of Common Stock;
(3) the Company; and
(4) a corporation or other entity of which at least a majority of its combined voting power is owned directly or indirectly by the Company.
A transaction shall not constitute a Change in Control if its sole purpose is to change the state of the Company’s incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company’s securities immediately before such transactions. In addition, if any Person (as defined above) is considered to be in effective control of the Company, the acquisition of additional control of the Company by the same Person will not be considered to cause a Change in Control. If required for compliance with Code Section 409A, in no event will a Change in Control be deemed to have occurred if such transaction is not also a “change in the ownership or effective control of” the Company or “a change in the ownership of a substantial portion of the assets of” the Company as determined under Treasury Regulation Section 1.409A-3(i)(5) (without regard to any alternative definition thereunder).



(i) “Code” means the Internal Revenue Code of 1986, as amended. Reference to a specific section of the Code or regulation thereunder shall include such section or regulation, any valid regulation promulgated under such section, and any comparable provision of any future legislation or regulation amending, supplementing or superseding such section or regulation.
(j) “Code Section 409A” means Code Section 409A, as amended from time to time, including the guidance and regulations promulgated thereunder and successor provisions, guidance and regulations thereto.
(k) “Committee” means a committee of Directors or of other individuals satisfying Applicable Laws appointed by the Board in accordance with Section 4 hereof.
(l) “Common Stock” means the Class A common stock of the Company.
(m) “Company” means Luminar Technologies, Inc., a Delaware corporation, or any successor thereto.
(n) “Director” means a member of the Board.
(o) “Disability” means total and permanent disability as defined in Section 22(e)(3) of the Code, provided that in the case of Awards other than Incentive Stock Options, the Administrator in its discretion may determine whether a permanent and total disability exists in accordance with uniform and non-discriminatory standards adopted by the Administrator from time to time.
(p) “Effective Date” means December 2, 2020.
(q) “Employee” means any person, including Officers and Directors, employed by the Company or any Parent or Subsidiary of the Company. Neither service as a Director nor payment of a director’s fee by the Company will be sufficient to constitute “employment” by the Company.
(r) “Exchange Act” means the Securities Exchange Act of 1934, as amended.
(s) “Exchange Program” means a program under which outstanding Awards are amended to provide for a lower exercise price or surrendered or cancelled in exchange for (i) Awards with a lower exercise price, (ii) a different type of Award or awards under a different equity incentive plan, (iii) cash, or (iv) a combination of (i), (ii) and/or (iii). Notwithstanding the preceding, the term Exchange Program does not include (A) any action described in Section 14 or any action taken in connection with a Change in Control transaction nor (B) any transfer or other disposition permitted under Section 13. For the purpose of clarity, each of the actions described in the prior sentence, none of which constitute an Exchange Program, may be undertaken (or authorized) by the Administrator in its sole discretion without approval by the Company’s stockholders.
(t) “Fair Market Value” means, as of any date, the value of Common Stock determined as follows:
(i) If the Common Stock is listed on any established stock exchange or a national market system, its Fair Market Value will be the closing sales price for such stock as quoted on such exchange or system on the day of determination, as reported in such source as the Administrator deems reliable (or the closing price on the most recent prior trading day, if no sales were reported on the day of determination);
(ii) If the Common Stock is regularly quoted by a recognized securities dealer but selling prices are not reported, the Fair Market Value of a Share will be the mean between the high bid and low asked prices for the Common Stock on the day of determination, as reported in such source as the Administrator deems reliable; or
(iii) In the absence of an established market for the Common Stock, the Fair Market Value will be determined in good faith by the Administrator in compliance with Applicable Laws and regulations and in a manner that complies with Code Section 409A.
(u) “Fiscal Year” means the fiscal year of the Company.
(v) “Incentive Stock Option” means an Option that by its terms qualifies and is intended to qualify as an incentive stock option within the meaning of Section 422 of the Code and the regulations promulgated thereunder.
(w) “Independent Contractor” means any person, including an advisor, consultant or agent, engaged by the Company or a Parent or Subsidiary to render services to such entity or who



renders, or has rendered, services to the Company, or any Parent, Subsidiary or Affiliate and is compensated for such services, in each case, other than an Employee.
(x) “Inside Director” means a Director who is an Employee.
(y) “Nonstatutory Stock Option” means an Option that by its terms does not qualify or is not intended to qualify as an Incentive Stock Option.
(z) “Officer” means a person who is an officer of the Company within the meaning of Section 16 of the Exchange Act and the rules and regulations promulgated thereunder.
(aa) “Option” means a stock option granted pursuant to the Plan.
(bb) “Outside Director means a Director who is not an Employee.
(cc) “Parent” means any corporation (other than the Company) in an unbroken chain of corporations ending with the Company if each of the corporations other than the Company owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain. A corporation that attains the status of a Parent on a date after the adoption of the Plan shall be considered a Parent commencing as of such date.
(dd) “Participant” means the holder of an outstanding Award.
(ee) “Performance Goal” means a formula or standard determined by the Administrator with respect to each Performance Period based on one or more of the following criteria and any adjustment(s) thereto established by the Administrator: (1) sales or non-sales revenue; (2) return on revenues; (3) operating income; (4) income or earnings including operating income; (5) income or earnings before or after taxes, interest, depreciation and/or amortization; (6) income or earnings from continuing operations; (7) net income; (8) pre-tax income or after-tax income; (9) net income excluding amortization of intangible assets, depreciation and impairment of goodwill and intangible assets and/or excluding charges attributable to the adoption of new accounting pronouncements; (10) raising of financing or fundraising; (11) project financing; (12) revenue backlog; (13) gross margin; (14) operating margin or profit margin; (15) capital expenditures, cost targets, reductions and savings and expense management; (16) return on assets (gross or net), return on investment, return on capital, or return on stockholder equity; (17) cash flow, free cash flow, cash flow return on investment (discounted or otherwise), net cash provided by operations, or cash flow in excess of cost of capital; (18) performance warranty and/or guarantee claims; (19) stock price or total stockholder return; (20) earnings or book value per share (basic or diluted); (21) economic value created; (22) pre-tax profit or after-tax profit; (23) strategic business criteria, consisting of one or more objectives based on meeting specified market penetration or market share, completion of strategic agreements such as licenses, joint ventures, acquisitions, and the like, geographic business expansion, objective customer satisfaction or information technology goals, intellectual property asset metrics; (24) objective goals relating to divestitures, joint ventures, mergers, acquisitions and similar transactions; (25) objective goals relating to staff management, results from staff attitude and/or opinion surveys, staff satisfaction scores, staff safety, staff accident and/or injury rates, compliance, headcount, performance management, completion of critical staff training initiatives; (26) objective goals relating to projects, including project completion, timing and/or achievement of milestones, project budget, technical progress against work plans; and (27) enterprise resource planning. Awards issued to Participants may take into account other criteria (including subjective criteria). Performance Goals may differ from Participant to Participant, Performance Period to Performance Period and from Award to Award. Any criteria used may be measured, as applicable, (i) in absolute terms, (ii) in relative terms (including, but not limited to, any increase (or decrease) over the passage of time and/or any measurement against other companies or financial or business or stock index metrics particular to the Company), (iii) on a per share and/or share per capita basis, (iv) against the performance of the Company as a whole or against any affiliate(s), or a particular segment(s), a business unit(s) or a product(s) of the Company or individual project company, (v) on a pre-tax or after-tax basis, and/or (vi) using an actual foreign exchange rate or on a foreign exchange neutral basis.
(ff) “Performance Period” means the time period during which the Performance Goals or other vesting provisions must be satisfied for Performance Shares or Performance Units.



(gg) “Performance Share” means an Award denominated in Shares which may be earned in whole or in part upon attainment of Performance Goals or other vesting criteria as the Administrator may determine pursuant to Section 10.
(hh) “Performance Unit” means an Award which may be earned in whole or in part upon attainment of Performance Goals or other vesting criteria as the Administrator may determine and which may be settled for cash, Shares or other securities or a combination of the foregoing pursuant to Section 10.
(ii) “Period of Restriction” means the period during which the transfer of Shares of Restricted Stock are subject to restrictions and therefore, the Shares are subject to a substantial risk of forfeiture. Such restrictions may be based on the passage of time, the achievement of target levels of performance, or the occurrence of other events as determined by the Administrator.
(jj) “Plan” means this Amended and Restated 2020 Equity Incentive Plan.
(kk) “Restricted Stock” means Shares issued pursuant to a Restricted Stock award under Section 7 of the Plan.
(ll) “Restricted Stock Unit” means a bookkeeping entry representing an amount equal to the Fair Market Value of one Share, granted pursuant to Section 8. Each Restricted Stock Unit represents an unfunded and unsecured obligation of the Company.
(mm) “Rule 16b-3” means Rule 16b-3 of the Exchange Act or any successor to Rule 16b-3, as in effect when discretion is being exercised with respect to the Plan.
(nn) “Section 16(b)” means Section 16(b) of the Exchange Act.
(oo) “Service Provider” means an Employee, Director or Independent Contractor.
(pp) “Share” means a share of the Common Stock, as adjusted in accordance with Section 14 of the Plan.
(qq) “Stock Appreciation Right” means an Award, granted alone or in connection with an Option, that pursuant to Section 9 is designated as a Stock Appreciation Right.
(rr) “Subsidiary” means any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company if each of the corporations other than the last corporation in the unbroken chain owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain. A corporation that attains the status of a Subsidiary on a date after the adoption of the Plan shall be considered a Subsidiary commencing as of such date.
(ss) “Tax-Related Items” means income tax, social insurance or other social contributions, national insurance, social security, payroll tax, fringe benefits tax, payment on account or other tax-related items.
3. Stock Subject to the Plan.
(a) Stock Subject to the Plan. Subject to the provisions of Section 14 of the Plan, the maximum aggregate number of Shares that may be issued under the Plan shall be 72,588,278 Shares. The Shares may be authorized, but unissued, or reacquired Common Stock. Notwithstanding the foregoing, subject to the provisions of Section 14 below, in no event shall the maximum aggregate number of Shares that may be issued under the Plan pursuant to Incentive Stock Options exceed the number set forth in this Section 3(a) plus, to the extent allowable under Section 422 of the Code and the regulations promulgated thereunder, any Shares that again become available for issuance pursuant to Sections 3(b) and 3(c).
(b) Automatic Share Reserve Increase. The number of Shares available for issuance under the Plan will be increased on the first day of each Fiscal Year beginning with the 2023 Fiscal Year and ending on (and including) the first day of the 2030 Fiscal Year, in an amount equal to the lesser of (i) 5% of the outstanding shares of Company common stock on the last day of the immediately preceding Fiscal Year, (ii) 40,000,000 Shares or (iii) such number of Shares determined by the Board.
(c) Lapsed Awards. To the extent an Award should expire or be forfeited or become unexercisable for any reason without having been exercised in full, the unissued Shares that were subject thereto shall, unless the Plan shall have been terminated, continue to be available under the Plan for



issuance pursuant to future Awards. Shares issued under the Plan and later forfeited to the Company due to the failure to vest or repurchased by the Company at the original purchase price paid to the Company for the Shares (including, without limitation, upon forfeiture to or repurchase by the Company in connection with a Participant ceasing to be a Service Provider) shall again be available for future grant under the Plan. Notwithstanding anything to the contrary contained herein, the following Shares shall not be added to the Shares authorized for grant under Section 3(a) and shall not be available for future grants of Awards: (i) Shares tendered by a Participant or withheld by the Company in payment of the exercise price of an Option;
(ii) Shares tendered by a Participant or withheld by the Company to satisfy any tax withholding obligation with respect to an Award; (iii) Shares subject to a Stock Appreciation Right that are not issued in connection with the stock settlement of the Stock Appreciation Right on exercise thereof; and (iv) Shares purchased on the open market with the cash proceeds from the exercise of Options.
4. Administration of the Plan.
(a) Procedure.
(i) Multiple Administrative Bodies. Different Committees with respect to different groups of Service Providers may administer the Plan, as may be determined from time to time by the Board.
(ii) Rule 16b-3. To the extent determined desirable by the Board to qualify transactions hereunder as exempt under Rule 16b-3, the transactions contemplated hereunder will be structured to satisfy the requirements for exemption under Rule 16b-3.
(iii) Other Administration. Other than as provided above, the Plan will be administered by the Board or, to the extent determined by the Board, a Committee, which committee will be constituted to satisfy Applicable Laws.
(b) Powers of the Administrator. Subject to the provisions of the Plan, the Administrator will have the authority, in its discretion:
(i) to determine the Fair Market Value in accordance with Section 2(c);
(ii) to select the Service Providers to whom Awards may be granted hereunder;
(iii) to determine the number of Shares to be covered by each Award granted hereunder;
(iv) to approve forms of Award Agreements for use under the Plan;
(v) to determine the terms and conditions, not inconsistent with the terms of the Plan, of any Award granted hereunder; such terms and conditions include, but are not limited to, the exercise price, the time or times when Awards may be exercised (which may be based on performance criteria), any vesting acceleration or waiver of forfeiture restrictions, and any restriction or limitation regarding any Award or the Shares relating thereto, based in each case on such factors as the Administrator will determine;
(vi) to institute and determine the terms and conditions of an Exchange Program; provided, however, that the Administrator shall not implement an Exchange Program without the approval of the holders of a majority of the Shares that are present in person or by proxy and entitled to vote at any annual or special meeting of Company’s stockholders;
(vii) to construe and interpret the terms of the Plan and Awards granted pursuant to the Plan;
(viii) to prescribe, amend and rescind rules and regulations relating to the Plan, including rules and regulations established for the purpose of satisfying applicable non-U.S. laws, for qualifying for favorable tax treatment under applicable non-U.S. laws or facilitating compliance with non-U.S. laws (sub-plans may be created for any of these purposes);
(ix) to modify or amend each Award (subject to Section 21 of the Plan), including but not limited to the discretionary authority to extend the post-termination exercisability period of Awards, to accelerate vesting and to extend the maximum term of an Option (subject to Section 6(b) of the Plan regarding Incentive Stock Options);



(x) to allow Participants to satisfy tax withholding obligations in such manner as prescribed in Section 15 of the Plan;
(xi) to authorize any person to execute on behalf of the Company any instrument required to effect the grant of an Award previously granted by the Administrator;
(xii) to allow a Participant to defer the receipt of the payment of cash or the delivery of Shares that would otherwise be due to such Participant under an Award; and
(xiii) to make all other determinations deemed necessary or advisable for administering the Plan.
(c) Effect of Administrator’s Decision. The Administrator’s decisions, determinations and interpretations will be final and binding on all Participants and any other holders of Awards.
(d) Delegation by the Administrator. To the extent permitted by Applicable Laws, the Administrator, in its sole discretion and on such terms and conditions as it may provide, may delegate all or any part of its authority and powers under the Plan to one or more Directors or officers of the Company.
5. Award Eligibility. Nonstatutory Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Shares and Performance Units may be granted to Service Providers. Incentive Stock Options may be granted only to Employees.
6. Stock Options.
(a) Limitations. Each Option will be designated in the Award Agreement as either an Incentive Stock Option or a Nonstatutory Stock Option. However, notwithstanding such designation, to the extent that the aggregate Fair Market Value of the Shares with respect to which Incentive Stock Options are exercisable for the first time by the Participant during any calendar year (under all plans of the Company and any Parent or Subsidiary) exceeds one hundred thousand dollars ($100,000), such Options will be treated as Nonstatutory Stock Options. For purposes of this Section 6(a), Incentive Stock Options will be taken into account in the order in which they were granted. The Fair Market Value of the Shares will be determined as of the date the Option with respect to such Shares is granted. With respect to the Committee’s authority in Section 4(b)(ix), if, at the time of any such extension, the exercise price per Share of the Option is less than the Fair Market Value of a Share, the extension shall, unless otherwise determined by the Committee, be limited to the earlier of (1) the maximum term of the Option as set by its original terms, or (2) ten (10) years from the grant date. Unless otherwise determined by the Committee, any extension of the term of an Option pursuant to Section 4(b)(ix) shall comply with Code Section 409A to the extent necessary to avoid taxation thereunder.
(b) Term of Option. The term of each Option will be stated in the Award Agreement. In the case of an Incentive Stock Option, the term will be ten (10) years from the date of grant or such shorter term as may be provided in the Award Agreement. Moreover, in the case of an Incentive Stock Option granted to a Participant who, at the time the Incentive Stock Option is granted, owns stock representing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or any Parent or Subsidiary, the term of the Incentive Stock Option will be five (5) years from the date of grant or such shorter term as may be provided in the Award Agreement.
(c) Option Exercise Price and Consideration.
(i) Exercise Price. The per share exercise price for the Shares to be issued pursuant to exercise of an Option will be determined by the Administrator, subject to the following:
(1) In the case of an Incentive Stock Option
(A) granted to an Employee who, at the time the Incentive Stock Option is granted, owns stock representing more than ten percent (10%) of the voting power of all classes of stock of the Company or any Parent or Subsidiary, the per Share exercise price will be no less than one hundred ten percent (110%) of the Fair Market Value per Share on the date of grant.
(B) granted to any Employee other than an Employee described in paragraph (A) immediately above, the per Share exercise price will be no less than one hundred percent (100%) of the Fair Market Value per Share on the date of grant.



(2) In the case of a Nonstatutory Stock Option, the per Share exercise price will be no less than one hundred percent (100%) of the Fair Market Value per Share on the date of grant.
(3) Notwithstanding the foregoing, Options may be granted with a per Share exercise price of less than one hundred percent (100%) of the Fair Market Value per Share on the date of grant pursuant to a transaction described in, and in a manner consistent with, Section 424(a) of the Code.
(ii) Waiting Period and Exercise Dates. At the time an Option is granted, the Administrator will fix the period within which the Option may be exercised and will determine any conditions that must be satisfied before the Option may be exercised.
(iii) Form of Consideration. The Administrator will determine the acceptable form of consideration for exercising an Option, including the method of payment. In the case of an Incentive Stock Option, the Administrator will determine the acceptable form of consideration at the time of grant. Such consideration for both types of Options may consist entirely of: (1) cash; (2) check; (3) promissory note (to the extent permitted by Applicable Laws and the Administrator); (4) other Shares, provided that such Shares have a Fair Market Value on the date of surrender equal to the aggregate exercise price of the Shares as to which such Option will be exercised and provided that accepting such Shares will not result in any adverse accounting consequences to the Company, as the Administrator determines in its sole discretion; (5) consideration received by the Company under a broker-assisted (or other) cashless exercise program (whether through a broker or otherwise) implemented by the Company in connection with the Plan; (6) by net exercise; (7) such other consideration and method of payment for the issuance of Shares to the extent permitted by Applicable Laws; or (8) any combination of the foregoing methods of payment.
(d) Exercise of Option.
(i) Procedure for Exercise; Rights as a Stockholder. Any Option granted hereunder will be exercisable according to the terms of the Plan and at such times and under such conditions as determined by the Administrator and set forth in the Award Agreement. An Option may not be exercised for a fraction of a Share.
An Option will be deemed exercised when the Company receives: (i) a notice of exercise (in such form as the Administrator may specify from time to time) from the person entitled to exercise the Option, and (ii) full payment for the Shares with respect to which the Option is exercised (together with full payment of any applicable taxes or other amounts required to be withheld or deducted with respect to the Option). Full payment may consist of any consideration and method of payment authorized by the Administrator and permitted by the Award Agreement and the Plan. Shares issued upon exercise of an Option will be issued in the name of the Participant or, if requested by the Participant, in the name of the Participant and his or her spouse. Until the Shares are issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a stockholder will exist with respect to the Shares subject to an Option, notwithstanding the exercise of the Option. The Company will issue (or cause to be issued) such Shares promptly after the Option is exercised. No adjustment will be made for a dividend or other right for which the record date is prior to the date the Shares are issued, except as provided in Section 14 of the Plan.
(ii) Termination of Relationship as a Service Provider. If a Participant ceases to be a Service Provider, other than upon the Participant’s termination as the result of the Participant’s death, Disability or Cause, the Participant may exercise his or her Option within such period of time as is specified in the Award Agreement to the extent that the Option is vested on the date of termination (but in no event later than the expiration of the term of such Option as set forth in the Award Agreement). In the absence of a specified time in the Award Agreement, the Option will remain exercisable for three (3) months following the Participant’s termination. Unless otherwise provided by the Administrator, if on the date of termination the Participant is not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option will revert to the Plan. If after termination the



Participant does not exercise his or her Option within the time specified by the Administrator, the Option will terminate, and the Shares covered by such Option will revert to the Plan.
(iii) Disability of Participant. If a Participant ceases to be a Service Provider as a result of the Participant’s Disability, the Participant may exercise his or her Option within such period of time as is specified in the Award Agreement to the extent the Option is vested on the date of termination (but in no event later than the expiration of the term of such Option as set forth in the Award Agreement). In the absence of a specified time in the Award Agreement, the Option will remain exercisable for twelve (12) months following the Participant’s termination as a result of the Participant’s Disability. Unless otherwise provided by the Administrator, if on the date of termination the Participant is not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option will revert to the Plan. If after termination the Participant does not exercise his or her Option within the time specified herein, the Option will terminate, and the Shares covered by such Option will revert to the Plan.
(iv) Death of Participant. If a Participant dies while a Service Provider, the Option may be exercised following the Participant’s death within such period of time as is specified in the Award Agreement to the extent that the Option is vested on the date of death (but in no event may the Option be exercised later than the expiration of the term of such Option as set forth in the Award Agreement), by the Participant’s designated beneficiary, provided such beneficiary has been designated prior to Participant’s death in a form acceptable to the Administrator. If no such beneficiary has been designated by the Participant, then such Option may be exercised by the personal representative of the Participant’s estate or by the person(s) to whom the Option is transferred pursuant to the Participant’s will or in accordance with the laws of descent and distribution. In the absence of a specified time in the Award Agreement, the Option will remain exercisable for twelve (12) months following the Participant’s death. Unless otherwise provided by the Administrator, if on the date of termination the Participant is not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option will revert to the Plan. If the Option is not so exercised within the time specified herein, the Option will terminate, and the Shares covered by such Option will revert to the Plan.
(v) Termination for Cause. If a Participant ceases to be a Service Provider as a result of being terminated for Cause, any outstanding Option (including any vested portion thereof) held by such Participant shall immediately terminate in its entirety upon the Participant being first notified of his or her termination for Cause and the Participant will be prohibited from exercising his or her Option from and after the date of such termination. All the Participant’s rights under any Option, including the right to exercise the Option, may be suspended pending an investigation of whether Participant will be terminated for Cause.
7. Restricted Stock.
(a) Grant of Restricted Stock. Subject to the terms and provisions of the Plan, the Administrator, at any time and from time to time, may grant Shares of Restricted Stock to Service Providers in such amounts as the Administrator, in its sole discretion, will determine.
(b) Restricted Stock Agreement. Each Award of Restricted Stock will be evidenced by an Award Agreement that will specify the Period of Restriction, the number of Shares granted, and such other terms and conditions as the Administrator, in its sole discretion, will determine. Unless the Administrator determines otherwise, the Company as escrow agent will hold Shares of Restricted Stock until the restrictions on such Shares have lapsed.
(c) Transferability. Except as provided in this Section 7 or the Award Agreement, Shares of Restricted Stock may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated until the end of the applicable Period of Restriction.
(d) Other Restrictions. The Administrator, in its sole discretion, may impose such other restrictions on Shares of Restricted Stock as it may deem advisable or appropriate.
(e) Removal of Restrictions. Except as otherwise provided in this Section 7, Shares of Restricted Stock covered by each Restricted Stock grant made under the Plan will be released from escrow as soon as practicable after the last day of the Period of Restriction or at such other time as the



Administrator may determine. The Administrator, in its discretion, may accelerate the time at which any restrictions will lapse or be removed.
(f) Voting Rights. During the Period of Restriction, Service Providers holding Shares of Restricted Stock granted hereunder may exercise full voting rights with respect to those Shares, unless the Administrator determines otherwise.
(g) Dividends and Other Distributions. During the Period of Restriction, any dividends or distributions paid with respect to Shares of Restricted Stock will be subject to the same restrictions, including without limitation restrictions on transferability and forfeitability, as the Shares of Restricted Stock with respect to which they were paid.
(h) Return of Restricted Stock to Company. On the date set forth in the Award Agreement, the Restricted Stock for which restrictions have not lapsed will be cancelled and returned as unissued shares to the Company and again will become available for grant under the Plan.
8. Restricted Stock Units.
(a) Grant. Restricted Stock Units may be granted at any time and from time to time as determined by the Administrator. After the Administrator determines that it will grant Restricted Stock Units under the Plan, it will advise the Participant in an Award Agreement of the terms, conditions, and restrictions (if any) related to the grant, including the number of Restricted Stock Units.
(b) Vesting Criteria and Other Terms. The Administrator will set vesting criteria in its discretion, which, depending on the extent to which the criteria are met, will determine the number of Restricted Stock Units that will be paid out to the Participant. The Administrator may set vesting criteria based upon the achievement of Company-wide, business unit, or individual goals (including, but not limited to, continued employment), or any other basis (including the passage of time) determined by the Administrator in its discretion.
(c) Earning Restricted Stock Units. Upon meeting the applicable vesting criteria, the Participant will be entitled to receive a payout as determined by the Administrator. Notwithstanding the foregoing, at any time after the grant of Restricted Stock Units, the Administrator, in its sole discretion, may reduce or waive any vesting criteria that must be met to receive a payout.
(d) Dividend Equivalents. The Administrator may, in its sole discretion, award dividend equivalents in connection with the grant of Restricted Stock Units that may be settled in cash, in Shares of equivalent value, or in some combination thereof. Any such dividend equivalents awarded with respect to Restricted Stock Units will be subject to the same restrictions, including without limitation restrictions on transferability and forfeitability, as the Restricted Stock Units with respect to which they were paid.
(e) Form and Timing of Payment. Payment of earned Restricted Stock Units will be made upon the date(s) determined by the Administrator and set forth in the Award Agreement, which shall specify whether earned Restricted Stock Units may be settled in cash, Shares, or a combination of both.
(f) Cancellation. On the date set forth in the Award Agreement, all Shares underlying any unvested, unlapsed unearned Restricted Stock Units will be forfeited to the Company for future issuance.
9. Stock Appreciation Rights.
(a) Grant of Stock Appreciation Rights. Subject to the terms and conditions of the Plan, a Stock Appreciation Right may be granted to Service Providers at any time and from time to time as will be determined by the Administrator, in its sole discretion.
(b) Number of Shares. The Administrator will have complete discretion to determine the number of Stock Appreciation Rights granted to any Service Provider.
(c) Exercise Price and Other Terms. The per share exercise price for the Shares to be issued pursuant to exercise of a Stock Appreciation Right will be determined by the Administrator and will be no less than one hundred percent (100%) of the Fair Market Value per Share on the date of grant. Otherwise, the Administrator, subject to the provisions of the Plan, will have complete discretion to determine the terms and conditions of Stock Appreciation Rights granted under the Plan.
(d) Stock Appreciation Right Agreement. Each Stock Appreciation Right grant will be evidenced by an Award Agreement that will specify the exercise price, the term of the Stock Appreciation



Right, the conditions of exercise, and such other terms and conditions as the Administrator, in its sole discretion, will determine.
(e) Expiration of Stock Appreciation Rights. A Stock Appreciation Right granted under the Plan will expire upon the date determined by the Administrator, in its sole discretion, and set forth in the Award Agreement. Notwithstanding the foregoing, the rules of Section 6(b) relating to the maximum term and Section 6(d) relating to exercise also will apply to Stock Appreciation Rights.
(f) Payment of Stock Appreciation Right Amount. Upon exercise of a Stock Appreciation Right, a Participant will be entitled to receive payment from the Company in an amount determined by multiplying:
(i) The difference between the Fair Market Value of a Share on the date of exercise over the exercise price; times
(ii) The number of Shares with respect to which the Stock Appreciation Right is exercised.
At the discretion of the Administrator, the payment upon Stock Appreciation Right exercise may be in cash, in Shares of equivalent value, or in some combination thereof.

10. Performance Units and Performance Shares.
(a) Grant of Performance Units/Shares. Performance Units and Performance Shares may be granted to Service Providers at any time and from time to time, as will be determined by the Administrator, in its sole discretion. The Administrator will have complete discretion in determining the number of Performance Units and Performance Shares granted to each Participant.
(b) Value of Performance Units/Shares. Each Performance Unit will have an initial value that is established by the Administrator on or before the date of grant. Each Performance Share will have an initial value equal to the Fair Market Value of a Share on the date of grant.
(c) Performance Goals and Other Terms. The Administrator will set Performance Goals or other vesting provisions (including, without limitation, continued status as a Service Provider) in its discretion which, depending on the extent to which they are met, will determine the number or value of Performance Units/Shares that will be paid out to the Service Providers. Each Award of Performance Units/Shares will be evidenced by an Award Agreement that will specify the Performance Period, and such other terms and conditions as the Administrator, in its sole discretion, will determine. Without limiting the foregoing, the Administrator shall adjust any Performance Goals or other feature of an Award that relates to or is wholly or partially based on the number of, or the value of, any stock of the Company, to reflect any stock dividend or split, repurchase, recapitalization, combination, or exchange of shares or other similar changes in such stock.
(d) Earning of Performance Units/Shares. After the applicable Performance Period has ended, the holder of Performance Units/Shares will be entitled to receive a payout of the number of Performance Units/Shares earned by the Participant over the Performance Period, to be determined as a function of the extent to which the corresponding Performance Goals or other vesting provisions have been achieved. After the grant of a Performance Unit/Share, the Administrator, in its sole discretion, may reduce or waive any Performance Goals or other vesting provisions for such Performance Unit/Share.
(e) Form and Timing of Payment of Performance Units/Shares. Payment of earned Performance Units/Shares will be made upon the time set forth in the applicable Award Agreement. The Administrator, in its sole discretion, may pay earned Performance Units/Shares in the form of cash, in Shares (which have an aggregate Fair Market Value equal to the value of the earned Performance Units/Shares at the close of the applicable Performance Period) or in a combination thereof.
(f) Cancellation of Performance Units/Shares. On the date set forth in the Award Agreement, all unearned or unvested Performance Units/Shares will be forfeited to the Company, and again will be available for grant under the Plan.
11. Outside Director Limitations. No Outside Director may receive Awards under the Plan with a total grant date fair value that, when combined with cash compensation received for service as an Outside Director, exceeds $750,000 in a calendar year, increased to $1,000,000 in the calendar year of



his or her initial services as an Outside Director. Grant date fair value for purposes of Awards to Outside Directors under the Plan will be determined as follows: (a) for Options and Stock Appreciation Rights, grant date fair value will be calculated using the Black-Scholes valuation methodology on the date of grant of such Option or Stock Appreciation Right and (b) for all other Awards other than Options and Stock Appreciation Rights, grant date fair value will be determined by either (i) calculating the product of the Fair Market Value per Share on the date of grant and the aggregate number of Shares subject to the Award or (ii) calculating the product using an average of the Fair Market Value over a number of trading days and the aggregate number of Shares subject to the Award. Awards granted to an individual while he or she was serving in the capacity as an Employee or while he or she was an Independent Contractor but not an Outside Director will not count for purposes of the limitations set forth in this Section 11.
12. Leaves of Absence/Transfer Between Locations. The Administrator shall have the discretion to determine at any time whether and to what extent the vesting of Awards shall be suspended during any leave of absence; provided, however, that in the absence of such determination, vesting of Awards shall continue during any paid leave and shall be suspended during any unpaid leave (unless otherwise required by Applicable Laws). A Participant will not cease to be an Employee in the case of (a) any leave of absence approved by the Participant’s employer or (b) transfers between locations of the Company or between the Company, its Parent, or any Subsidiary. If an Employee is holding an Incentive Stock Option and such leave exceeds three (3) months then, for purposes of Incentive Stock Option status only, such Employee’s service as an Employee shall be deemed terminated on the first (1st) day following such three (3) month period and the Incentive Stock Option shall thereafter automatically treated for tax purposes as a Nonstatutory Stock Option in accordance with Applicable Laws, unless reemployment upon the expiration of such leave is guaranteed by contract or statute, or unless provided otherwise pursuant to a written Company policy.
13. Transferability of Awards. Unless determined otherwise by the Administrator, an Award may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by will or by the laws of descent or distribution and may be exercised, during the lifetime of the Participant, only by the Participant. If the Administrator makes an Award transferable, such Award will contain such additional terms and conditions as the Administrator deems appropriate.
14. Adjustments; Dissolution or Liquidation; Merger or Change in Control.
(a) Adjustments. In the event of a stock split, reverse stock split, stock dividend, combination, consolidation, recapitalization (including a recapitalization through a large nonrecurring cash dividend) or reclassification of the Shares, subdivision of the Shares, a rights offering, a reorganization, merger, spin-off, split-up, repurchase, or exchange of Common Stock or other securities of the Company or other significant corporate transaction, or other change affecting the Common Stock occurs, the Administrator, in order to prevent dilution, diminution or enlargement of the benefits or potential benefits intended to be made available under the Plan, will, in such manner as it may deem equitable, adjust the number, kind and class of securities that may be delivered under the Plan and/or the number, class, kind and price of securities covered by each outstanding Award. Notwithstanding the forgoing, all adjustments under this Section 14 shall be made in a manner that does not result in taxation under Code Section 409A.
(b) Dissolution or Liquidation. In the event of the proposed winding up, dissolution or liquidation of the Company, the Administrator will notify each Participant as soon as practicable prior to the effective date of such proposed transaction. To the extent it has not been previously exercised or settled, an Award will terminate immediately prior to the consummation of such proposed action.
(c) Change in Control. In the event of a Change in Control, each outstanding Award (vested or unvested) will be treated as the Administrator determines, which determination may be made without the consent of any Participant and need not treat all outstanding Awards (or portion thereof) in an identical manner. Such determination, without the consent of any Participant, may provide (without limitation) for one or more of the following in the event of a Change in Control: (A) the continuation of such outstanding Awards by the Company (if the Company is the surviving corporation); (B) the assumption of such outstanding Awards by the surviving corporation or its parent; (C) the substitution by the surviving



corporation or its parent of new options or other equity awards for such Awards; (D) the cancellation of such Awards in exchange for a payment to the Participants equal to the excess of (1) the Fair Market Value of the Shares subject to such Awards as of the closing date of such Change in Control over (2) the exercise price or purchase price paid or to be paid (if any) for the Shares subject to the Awards; provided that at the discretion of the Administrator, such payment may be subject to the same conditions that apply to the consideration that will be paid to holders of Shares in connection with the transaction; provided, however, that any payout in connection with a terminated award shall comply with Code Section 409A to the extent necessary to avoid taxation thereunder; or (E) the opportunity for Participants to exercise the Options prior to the occurrence of the Change in Control and the termination (for no consideration) upon the consummation of such Change in Control of any Options not exercised prior thereto. An Award may be subject to additional acceleration of vesting and exercisability upon or after a Change in Control as may be provided in the Award Agreement for such Award or as may be provided in any other written agreement between the Company or any Affiliate and the Participant.
15. Tax.
(a) Withholding Requirements. Prior to the delivery of any Shares or cash pursuant to an Award (or exercise thereof) or prior to any time the Award or Shares are subject to taxation or other Tax-Related Items, the Company and/or the Participant’s employer will have the power and the right to deduct or withhold, or require a Participant to remit to the Company, an amount sufficient to satisfy any Tax-Related Items or other items that are required to be withheld or deducted or otherwise applicable with respect to such Award.
(b) Withholding Arrangements. The Administrator, in its sole discretion and pursuant to such procedures as it may specify from time to time, may permit a Participant to satisfy such withholding or deduction obligations or any other Tax-Related Items, in whole or in part by (without limitation) (i) paying cash, (ii) electing to have the Company withhold otherwise deliverable cash or Shares, or (iii) delivering to the Company already-owned Shares; provided that, unless specifically permitted by the Company, any proceeds derived from a cashless exercise must be an approved broker-assisted cashless exercise or the cash or Shares withheld or delivered must be limited to avoid financial accounting charges under applicable accounting guidance or Shares must have been previously held for the minimum duration required to avoid financial accounting charges under applicable accounting guidance. Except as otherwise determined by the Administrator, the Fair Market Value of the Shares to be withheld or delivered will be determined as of the date that the amounts are required to be withheld or deducted.
(c) Compliance With Code Section 409A. Awards will be designed and operated in such a manner that they are either exempt from the application of, or comply with, the requirements of Code Section 409A such that the grant, payment, settlement or deferral will not be subject to the additional tax or interest applicable under Code Section 409A. The Plan and each Award Agreement under the Plan is intended to meet the requirements of Code Section 409A (or an exemption therefrom) and will be construed and interpreted in accordance with such intent, except as otherwise determined in the sole discretion of the Administrator. To the extent that an Award or payment, or the settlement or deferral thereof, is subject to Code Section 409A the Award will be granted, paid, settled or deferred in a manner that will meet the requirements of Code Section 409A (or an exemption therefrom), such that the grant, payment, settlement or deferral will not be subject to the additional tax or interest applicable under Code Section 409A. In no event will the Company be responsible for or reimburse a Participant for any taxes or other penalties incurred as a result of the application of Code Section 409A.
16. No Effect on Employment or Service. Neither the Plan nor any Award will confer upon a Participant any right with respect to continuing the Participant’s relationship as a Service Provider with the Company or any Subsidiary or Affiliate, nor will they interfere in any way with the Participant’s right or the Company’s or any Subsidiary or Affiliate’s right to terminate such relationship at any time, with or without cause, to the extent permitted by Applicable Laws.
17. Date of Grant. The date of grant of an Award will be, for all purposes, the date on which the Administrator makes the determination granting such Award, or such other later date as is determined by



the Administrator. Notice of the determination will be provided to each Participant within a reasonable time after the date of such grant.
18. Corporate Records Control. In the event that the corporate records (e.g., Board consents, resolutions or minutes) documenting the corporate action constituting the grant contain terms (e.g., exercise price, vesting schedule or number of shares) that are inconsistent with those in the Award Agreement or related grant documents as a result of a clerical error in the papering of the Award Agreement or related grant documents, the corporate records will control and the Participant will have no legally binding right to the incorrect term in the Award Agreement or related grant documents.
19. Clawback/Recovery. All Awards granted under the Plan will be subject to recoupment in accordance with any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company’s securities are listed or as is otherwise required by the U.S. Dodd-Frank Wall Street Reform and Consumer Protection Act or other Applicable Laws. In addition, the Board may impose such other clawback, recovery or recoupment provisions in an Award Agreement as the Board determines necessary or appropriate, including but not limited to a reacquisition right in respect of previously acquired Shares or other cash or property upon the occurrence of an event constituting Cause. No recovery of compensation under such a clawback policy will be an event giving rise to a right to resign for “good reason” or “constructive termination” (or similar term) under any agreement with the Company.
20. Term of Plan. Subject to Section 24 of the Plan, this Plan will become effective as of the Effective Date. The Plan will continue in effect for a term of ten (10) years measured from the earlier of the date the Board approves this Plan or the approval of this Plan by the Company’s stockholders, unless terminated earlier under Section 21 of the Plan.
21. Amendment and Termination of the Plan.
(a) Amendment and Termination. The Administrator may at any time amend, alter, suspend or terminate the Plan.
(b) Stockholder Approval. The Company will obtain stockholder approval of any Plan amendment to the extent necessary and desirable to comply with Applicable Laws.
(c) Effect of Amendment or Termination. No amendment, alteration, suspension or termination of the Plan will materially impair the rights of any Participant, unless mutually agreed otherwise between the Participant and the Administrator, which agreement must be in writing and signed by the Participant and the Company. Termination of the Plan will not affect the Administrator’s ability to exercise the powers granted to it hereunder with respect to Awards granted under the Plan prior to the date of such termination.
22. Conditions Upon Issuance of Shares.
(a) Legal Compliance. Shares will not be issued pursuant to the exercise or vesting (as applicable) of an Award unless the exercise or vesting of such Award and the issuance and delivery of such Shares will comply with Applicable Laws and will be further subject to the approval of counsel for the Company with respect to such compliance.
(b) Investment Representations. As a condition to the exercise of an Award, the Company may require the person exercising such Award to represent and warrant at the time of any such exercise that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such a representation is required.
23. Inability to Obtain Authority. The inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company’s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, will relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority will not have been obtained.
24. Stockholder Approval. The Plan will be subject to approval by the stockholders of the Company within twelve (12) months after the date the Plan is adopted by the Board. Such stockholder approval will be obtained in the manner and to the degree required under Applicable Laws.



25. Governing Law. The Plan and all Awards hereunder shall be construed in accordance with and governed by the laws of the State of Delaware, but without regard to its conflict of law provisions.




LUMINAR TECHNOLOGIES, INC.
2020 EQUITY INCENTIVE PLAN
STOCK OPTION AWARD AGREEMENT
Unless otherwise defined herein, the terms defined in the Luminar Technologies, Inc. 2020 Equity Incentive Plan (the “Plan”) will have the same defined meanings in this Stock Option Award Agreement (the “Award Agreement”).
NOTICE OF STOCK OPTION GRANT
Participant Name:
You have been granted an Option to purchase Class A Common Stock of Luminar Technologies, Inc. (the “Company”), subject to the terms and conditions of the Plan and this Award Agreement, as follows:
 
Grant Number               
Date of Grant               
Vesting Commencement Date               
Exercise Price per Share  USD $
Total Number of Shares               
Total Exercise Price  USD $
Type of Option:                   U.S. Incentive Stock Option
                   Nonstatutory Stock Option
Term/Expiration Date:               
Vesting Schedule:               




Subject to Section 2 of this Award Agreement, this Option may be exercised, in whole or in part, in accordance with the following schedule:
 
             
             
             
Termination Period:
This Option will be exercisable for three (3) months after Participant ceases to be a Service Provider, unless such termination is due to Participant’s death, Disability or Cause. If Participant’s relationship as a Service Provider is terminated as a result of the Service Provider’s death or Disability, this Option will be exercisable for twelve (12) months after Participant ceases to be a Service Provider. If Participant’s relationship as a Service Provider is terminated for Cause, this Option (including any vested portion thereof) shall immediately terminate in its entirety upon Participant being first notified such termination for Cause and Participant will be prohibited from exercising this Option from and after the date of such termination. Notwithstanding the foregoing, in no event may this Option be exercised after the Term/Expiration Date as provided above and may be subject to earlier termination as provided in Section 14 of the Plan.
By Participant’s signature and the signature of the Company’s representative below, or by Participant otherwise accepting or exercising this Option, Participant and the Company agree that this Option is granted under and governed by the terms and conditions of the Plan and this Award Agreement, including the Terms and Conditions of Stock Option Grant, attached hereto as Exhibit A, all of which are made a part of this document. Participant has reviewed the Plan and this Award Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Award Agreement and fully understands all provisions of the Plan and Award Agreement. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator on any questions relating to the Plan and Award Agreement.
 
PARTICIPANT:
 
                    
  
LUMINAR TECHNOLOGIES, INC.
                             
Signature
   
By
                             
Print Name
   
Title
 




EXHIBIT A
TERMS AND CONDITIONS OF STOCK OPTION GRANT
1. Grant of Option. The Company hereby grants to Participant named in the Notice of Stock Option Grant attached as Part I of this Award Agreement (the “Participant”) an option (the “Option”) to purchase the number of Shares set forth in the Notice of Stock Option Grant, at the exercise price per Share set forth in the Notice of Stock Option Grant (the “Exercise Price”), subject to all of the terms and conditions set forth in the Notice of Stock Option Grant and in this Award Agreement and the Plan, which is incorporated herein by reference. Subject to Section 21 of the Plan, if there is a conflict between the terms and conditions of the Plan and the terms and conditions of this Award Agreement, the terms and conditions of the Plan will prevail.
If designated in the Notice of Stock Option Grant as an Incentive Stock Option (“ISO”), this Option is intended to qualify as an ISO to the maximum extent permitted under Section 422 of the U.S. Internal Revenue Code of 1986, as amended (the “Code”). However, if this Option is intended to be an ISO, to the extent that it exceeds the USD $100,000 rule of Code Section 422(d) it will be treated as a Nonstatutory Stock Option (“NSO”). Further, if for any reason this Option (or portion thereof) will not qualify as an ISO, then, to the extent of such non- qualification, such Option (or portion thereof) shall be regarded as an NSO granted under the Plan. In no event will the Administrator, the Company or any Parent or Subsidiary or any of their respective employees or directors have any liability to Participant (or any other person) due to the failure of the Option to qualify for any reason as an ISO.
2. Vesting Schedule. Except as provided in Section 3, the Option awarded by this Award Agreement will vest in accordance with the vesting provisions set forth in the Notice of Stock Option Grant. Options scheduled to vest on a certain date or upon the occurrence of a certain condition will not vest in accordance with any of the provisions of this Award Agreement, unless Participant will have been continuously a Service Provider from the Date of Grant until the date such vesting occurs. Service Provider status for purposes of this Award will end on the day that Participant is no longer actively providing services as an Employee, Director, or Independent Contractor and will not be extended by any notice period or “garden leave” that may be required contractually or under any Applicable Laws. Notwithstanding the foregoing, the Administrator (or any delegate) shall have the sole and absolute discretion to determine when Participant is no longer providing active service for purposes of Service Provider status and participation in the Plan.
3. Exercise of Option.
(a) Right to Exercise. This Option may be exercised only to the extent vested and only within the term set forth in the Notice of Stock Option Grant and may be exercised during such term only in accordance with the Plan and the terms of this Award Agreement.
(b) Method of Exercise. This Option is exercisable to the extent vested by delivery of an exercise notice, in the form attached as Exhibit B (the “Exercise Notice”) or in a manner and pursuant to such procedures as the Administrator may determine, which will state the election to exercise the Option, the number of Shares in respect of which the Option is being exercised (the “Exercised Shares”), and such other representations and agreements as may be required by the Company pursuant to the provisions of the Plan. The Exercise Notice will be completed by Participant and delivered to the Company. The Exercise Notice will be accompanied by payment of the aggregate Exercise Price as to all Exercised Shares together with any Tax-Related Items (as defined below) required to be withheld, paid or provided pursuant to any Applicable Laws. This Option will be deemed to be exercised upon receipt by the Company of such fully executed Exercise Notice accompanied by such aggregate Exercise Price and any other requirements or restrictions that may be imposed by the Company to comply with Applicable Laws or facilitate administration of the Plan. Notwithstanding the above, Participant understands that the Applicable Laws of the country in which Participant is residing or working at the time of grant, vesting, and/or exercise of this Option (including any rules or regulations governing securities, foreign exchange, tax, labor or other matters) may restrict or prevent exercise of this Option, and neither the Company nor any Parent or Subsidiary assumes any liability in relation to this Option in such case.



4. Method of Payment. Payment of the aggregate Exercise Price will be by any of the following, or a combination thereof, at the election of Participant unless otherwise specified by the Company in its sole discretion:
(a) cash (U.S. dollars); or
(b) check (denominated in U.S. dollars); or
(c) consideration received by the Company under a formal cashless exercise program adopted by the Company in connection with the Plan; or
(d) if Participant is subject to Section 16 of the Exchange Act, Participant may direct the Company to withhold Shares to be issued upon exercise of the Option to pay the aggregate Exercise Price and any such disposition of Shares to the Company shall be exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3(e).
Participant understands and agrees that, unless otherwise permitted by the Company, any cross-border remittance made to exercise this Option or transfer proceeds received upon the sale of Shares must be made through a locally authorized financial institution or registered foreign exchange agency and may require Participant to provide such entity with certain information regarding the transaction.
5. Tax Obligations.
(a) Withholding Taxes. Regardless of any action the Company or Participant’s employer (the “Employer”) takes with respect to any or all applicable national, local, or other tax or social contribution, withholding, required deductions, or other payments, if any, that arise upon the grant, vesting, or exercise of this Option, the holding or subsequent sale of Shares, and the receipt of dividends, if any, or otherwise in connection with this Option or the Shares (“Tax-Related Items”), Participant acknowledges and agrees that the ultimate liability for all Tax-Related Items legally due by Participant is and remains Participant’s responsibility and may exceed any amount actually withheld by the Company or the Employer. Participant further acknowledges and agrees that Participant is solely responsible for filing all relevant documentation that may be required in relation to this Option or any Tax-Related Items (other than filings or documentation that is the specific obligation of the Company or a Parent, Subsidiary, or Employer pursuant to Applicable Laws) such as but not limited to personal income tax returns or reporting statements in relation to the grant, vesting or exercise of this Option, the holding of Shares or any bank or brokerage account, the subsequent sale of Shares, and the receipt of any dividends. Participant further acknowledges that the Company and the Employer (a) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Option, including the grant, vesting, or exercise of the Option, the subsequent sale of Shares acquired under the Plan and the receipt of dividends, if any; and (b) does not commit to and is under no obligation to structure the terms of the Option or any aspect of the Option to reduce or eliminate Participant’s liability for Tax-Related Items, or achieve any particular tax result. Participant also understands that Applicable Laws may require varying Share or Option valuation methods for purposes of calculating Tax-Related Items, and the Company assumes no responsibility or liability in relation to any such valuation or for any calculation or reporting of income or Tax-Related Items that may be required of Participant under Applicable Laws. Further, if Participant has become subject to tax in more than one jurisdiction between the Date of Grant and the date of any relevant taxable event, Participant acknowledges that the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.
(b) Satisfaction of Tax-Related Items. As a condition to the grant, vesting and exercise of this Option and as set forth in Section 15 of the Plan, Participant hereby agrees to make adequate provision for the satisfaction of (and will indemnify the Company and any Parent or Subsidiary for) any Tax-Related Items. No payment will be made to Participant (or his or her estate or beneficiary) related to an Option, and no Shares will be issued pursuant to an Option, unless and until satisfactory arrangements (as determined by the Company) have been made by Participant with respect to the payment of any Tax-Related Items obligations of the Company and/or any Parent, Subsidiary, or Employer with respect to the grant, vesting or exercise of the Option.    In this regard, Participant authorizes the Company and/or any Parent, Subsidiary, or Employer, or their respective agents, at their discretion, to



satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following, in each case to the extent permitted by applicable law:
(i) withholding from Participant’s wages or other cash compensation paid to Participant by the Company or the Employer; or
(ii) withholding from proceeds of the sale of Shares acquired upon exercise of the Option, either through a voluntary sale or through a mandatory sale arranged by the Company (on Participant’s behalf pursuant to this authorization); or
(iii) withholding in Shares to be issued upon exercise of the Option.
 
Notwithstanding the foregoing, if Participant is subject to Section 16 of the Exchange Act, Participant may direct the Company to withhold Shares to be issued upon exercise of the Option to satisfy Participant’s obligations with regard to all Tax-Related Items and any such disposition of Shares to the Company shall be exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3(e).
If the obligation for Tax-Related Items is satisfied by withholding Shares, Participant is deemed to have been issued the full number of Shares purchased for tax purposes, notwithstanding that a number of Shares is held back solely for the purpose of paying the Tax-Related Items due as a result of Participant’s participation in the Plan. Participant shall pay to the Company or a Parent, Subsidiary, or Employer any amount of Tax-Related Items that the Company may be required to withhold, pay or otherwise provide for as a result of Participant’s participation in the Plan that cannot be satisfied by one or more of the means previously described in this Section 5. Participant acknowledges and agrees that the Company may refuse to honor the exercise and refuse to issue or deliver the Shares or the proceeds of the sale of Shares if Participant fails to comply with his or her obligations in connection with the Tax-Related Items.
(c) Notice of Disqualifying Disposition of ISO Shares. If the Option granted to Participant herein is an ISO, and if Participant sells or otherwise disposes of any of the Shares acquired pursuant to the ISO on or before the later of (i) the date two (2) years after the Date of Grant, or (ii) the date one (1) year after the date of exercise, Participant will immediately notify the Company in writing of such disposition.
(d) Code Section 409A (Applicable Only to Participants Subject to U.S. Taxes). Under Code Section 409A, an option that is granted with a per Share exercise price that is determined by the Internal Revenue Service (the “IRS”) to be less than the Fair Market Value of a Share on the Date of Grant (a “Discount Option”) may be considered “deferred compensation.” A Discount Option may result in (i) income recognition by Participant prior to the exercise of the option, (ii) an additional twenty percent (20%) federal income tax, and (iii) potential penalty and interest charges. The Discount Option may also result in additional state income, penalty and interest charges to Participant. Participant acknowledges that the Company cannot and has not guaranteed that the IRS will agree that the per Share exercise price of this Option equals or exceeds the Fair Market Value of a Share on the Date of Grant in a later examination. Participant agrees that if the IRS determines that the Option was granted with a per Share exercise price that was less than the Fair Market Value of a Share on the Date of Grant, Participant will be solely responsible for Participant’s costs related to such a determination.
6. Rights as Stockholder.    Neither Participant nor any person claiming under or through Participant will have any of the rights or privileges of a stockholder of the Company in respect of any Shares unless and until such Shares will have been issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company).    After such issuance, Participant will have all the rights of a stockholder of the Company with respect to voting such Shares and receipt of dividends and distributions on such Shares, but prior to such issuance, Participant will not have any rights to dividends and/or distributions on such Shares.
 
7. No Guarantee of Continued Service or Grants. PARTICIPANT ACKNOWLEDGES AND AGREES THAT THE VESTING OF SHARES PURSUANT TO THE VESTING SCHEDULE HEREOF SHALL OCCUR ONLY BY CONTINUING AS A SERVICE PROVIDER AT THE WILL OF THE EMPLOYER OR CONTRACTING ENTITY (AS APPLICABLE) AND NOT THROUGH THE ACT OF BEING HIRED, BEING



GRANTED THE OPTION OR ACQUIRING SHARES HEREUNDER.PARTICIPANT FURTHER ACKNOWLEDGES AND AGREES THAT THIS AWARD AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH HEREIN DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS A SERVICE PROVIDER FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND WILL NOT INTERFERE IN ANY WAY WITH PARTICIPANT’S RIGHT OR THE RIGHT OF THE EMPLOYER OR THE COMPANY, PARENT, OR SUBSIDIARY TO TERMINATE PARTICIPANT’S RELATIONSHIP AS A SERVICE PROVIDER AT ANY TIME, WITH OR WITHOUT CAUSE (SUBJECT TO APPLICABLE LOCAL LAWS).
8. Nature of Grant. In accepting the Option, Participant acknowledges, understands and agrees that:
(a) the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time;
(b) the grant of the Option is voluntary and occasional and does not create any contractual or other right to receive future grants of Options, or benefits in lieu of Options even if Options have been granted repeatedly in the past;
(c) all decisions with respect to future awards of Options, if any, will be at the sole discretion of the Company;
(d) Participant’s participation in the Plan is voluntary;
(e) the Option and the Shares subject to the Option are extraordinary items that do not constitute regular compensation for services rendered to the Company or the Employer, and that are outside the scope of Participant’s employment contract, if any;
(f) the Option and the Shares subject to the Option are not intended to replace any pension rights or compensation;
(g) the Option and the Shares subject to the Option are not part of normal or expected compensation or salary for any purposes, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, or end of service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company or the Employer, subject to Applicable Laws;
 
(h) the future value of the underlying Shares is unknown and cannot be predicted with certainty; further, if Participant exercises the Option and obtains Shares, the value of the Shares acquired upon exercise may increase or decrease in value, even below the Exercise Price;
(i) Participant also understands that neither the Company nor any affiliate is responsible for any foreign exchange fluctuation between local currency and the United States Dollar or the selection by the Company or any affiliate in its sole discretion of an applicable foreign currency exchange rate that may affect the value of the Option (or the calculation of income or Tax-Related Items thereunder);
(j) in consideration of the grant of the Option, no claim or entitlement to compensation or damages shall arise from forfeiture of the Option resulting from termination of employment by the Employer (for any reason whatsoever and whether or not in breach of Applicable Laws, including, without limitation, applicable local labor laws), and Participant irrevocably releases the Employer from any such claim that may arise; if, notwithstanding the foregoing, any such claim is found by a court of competent jurisdiction to have arisen, Participant shall be deemed irrevocably to have waived his or her entitlement to pursue such claim; and
(k) the Option and the benefits under the Plan, if any, will not without the Administrator’s consent transfer to another company in the case of a merger, take-over or transfer of liability.
9. No Advice Regarding Grant. The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding Participant’s participation in the Plan, or Participant’s acquisition



or sale of the underlying Shares. Participant is hereby advised to consult with his or her own personal tax, legal and financial advisors regarding Participant’s participation in the Plan before taking any action related to the Plan.
10. Data Privacy. Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of Participant’s Personal Data (as described below) by and among, as applicable, the Company, any Parent, Subsidiary, or affiliate, or third parties as may be selected by the Company for the exclusive purpose of implementing, administering and managing Participant’s participation in the Plan. Participant understands that refusal or withdrawal of consent will affect Participant’s ability to participate in the Plan; without providing consent, Participant will not be able to participate in the Plan or realize benefits (if any) from the Option.
Participant understands that the Company and any Parent, Subsidiary, affiliate, or designated third parties may hold personal information about Participant, including, but not limited to, Participant’s name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company or any Parent, Subsidiary, or affiliate, details of all Options or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in Participant’s favor (“Personal Data”). Participant understands that Personal Data may be transferred to any Parent, Subsidiary, affiliate, or third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in the United States, Participant’s country (if different than the United States), or elsewhere, and that the recipient’s country may have different data privacy laws and protections than Participant’s country. In particular, the Company may transfer Personal Data to the broker or stock plan administrator assisting with the Plan, to its legal counsel and tax/accounting advisor, and to the affiliate or entity that is Participant’s employer and its payroll provider.
Participant should also refer to any data privacy policy implemented by the Company (which will be available to Participant separately and may be updated from time to time) for more information regarding the collection, use, storage, and transfer of Participant’s Personal Data.
11. Address for Notices. Any notice to be given to the Company under the terms of this Award Agreement will be addressed to the Company, in care of its Secretary at Luminar Technologies, Inc., 12601 Research Parkway, Orlando, FL 32826, or at such other address as the Company may hereafter designate in writing.
12. Non-Transferability of Option. This Option may not be transferred in any manner otherwise than by will or by the laws of descent or distribution and may be exercised during the lifetime of Participant only by Participant.
13. Binding Agreement. Subject to the limitation on the transferability of this Option contained herein, this Award Agreement will be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors and assigns of the parties hereto.
14. Additional Conditions to Issuance of Stock. If at any time the Company will determine, in its discretion, that the listing, registration, qualification or compliance of the Shares upon or with any securities exchange or under any Applicable Laws, the tax code and related regulations or the consent or approval of any governmental regulatory authority is necessary or desirable as a condition to the grant or vesting of the Option or purchase by, or issuance of Shares to, Participant (or his or her estate) hereunder, such purchase or issuance will not occur unless and until such listing, registration, qualification, compliance, consent or approval will have been completed, effected or obtained free of any conditions not acceptable to the Company. The Company will make all reasonable efforts to meet the requirements of any Applicable Laws. Assuming such compliance, for purposes of the Tax-Related Items, the Exercised Shares will be considered transferred to Participant on the date the Option is exercised with respect to such Exercised Shares. The Company shall not be obligated to issue any Shares pursuant to this Option at any time if the issuance of Shares, or the exercise of an Option by Participant, violates or is not in compliance with any Applicable Laws.
15. Lock-Up Agreement. If so requested by the Company (or any successor thereof) or the underwriters in connection with any transaction pursuant to which the securities of the Company will be exchanged for securities of



the Company (or any successor or parent thereof), registered under the Securities Act of 1933, as amended, including, without limitation, through a transaction with a publicly-listed blank check company then registered under the Securities Act (a “SPAC Transaction”), Participant shall not sell, make any short sale of, loan, grant any option for the purchase of, or otherwise dispose of any securities of the Company (or any successor thereof) however or whenever acquired (except for those being registered) without the prior written consent of the Company or such underwriters, as the case may be, for 180 days from the effective date of the registration statement or becoming a listed security (including, without limitation, pursuant to a SPAC Transaction), and Participant shall execute an agreement reflecting the foregoing as may be requested by the Company (or any successor or parent thereof) or the underwriters at the time of such offering or listing.
16. Plan Governs. This Award Agreement is subject to all terms and provisions of the Plan. If there is a conflict between one or more provisions of this Award Agreement and one or more provisions of the Plan, the provisions of the Plan will govern. Capitalized terms used and not defined in this Award Agreement will have the meaning set forth in the Plan.
17. Administrator Authority. The Administrator will have the power to interpret the Plan and this Award Agreement and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith and to interpret or revoke any such rules (including, but not limited to, the determination regarding whether any Shares subject to the Option have vested).    All actions taken, and all interpretations and determinations made, by the Administrator in good faith will be final and binding upon Participant, the Company and all other interested persons.    No member of the Administrator will be personally liable for any action, determination or interpretation made in good faith with respect to the Plan or this Award Agreement.
18. Electronic Delivery and Acceptance. The Company may, in its sole discretion, decide to deliver any documents related to Participant’s current or future participation in the Plan, this Option, the Shares subject to this Option, any other securities of the Company or any other Company-related documents, by electronic means. By accepting this Option, whether electronically or otherwise, Participant hereby (a) consents to receive such documents by electronic means, (b) consents to the use of electronic signatures, and (c) agrees to participate in the Plan and/or receive any such documents through an on-line or electronic system established and maintained by the Company or a third party designated by the Company, including but not limited to the use of electronic signatures or click-through electronic acceptance of terms and conditions.
19. Translation. If Participant has received this Award Agreement, including appendices, or any other document related to the Plan translated into a language other than English, and the meaning of the translated version is different than the English version, the English version will control.
20. Imposition of Other Requirements. The Company reserves the right to impose other requirements on Participant’s participation in the Plan, on the Option and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable in order to comply with any Applicable Laws or facilitate the administration of the Plan, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing. Furthermore, Participant understands that the Applicable Laws of the country in which he or she is resident at the time of grant, vesting, and/or exercise of this Option or the holding or disposition of Shares (including any rules or regulations governing securities, foreign exchange, tax, labor or other matters) may restrict or prevent exercise of this Option or may subject Participant to additional procedural or regulatory requirements he or she is solely responsible for and will have to independently fulfill in relation to this Option or the Shares. Participant also understands and agrees that if he works, resides, moves to, or otherwise is or becomes subject to Applicable Laws or company policies of another jurisdiction at any time, certain country-specific notices, disclaimers and/or terms and conditions may apply to Participant as from the Date of Grant, unless otherwise determined by the Company in its sole discretion.
21. Captions. Captions provided herein are for convenience only and are not to serve as a basis for interpretation or construction of this Award Agreement.



22. Agreement Severable. If any provision in this Award Agreement will be held invalid or unenforceable, such provision will be severable from, and such invalidity or unenforceability will not be construed to have any effect on, the remaining provisions of this Award Agreement.
23. Modifications to this Award Agreement. This Award Agreement and the Plan constitute the entire understanding of the parties on the subjects covered. Participant expressly warrants that he or she is not accepting this Award Agreement in reliance on any promises, representations, or inducements other than those contained herein. Modifications to this Award Agreement or the Plan can be made only in an express written contract executed by a duly authorized officer of the Company. Notwithstanding anything to the contrary in the Plan or this Award Agreement, the Company reserves the right to revise this Award Agreement as it deems necessary or advisable, in its sole discretion and without the consent of Participant, to comply with Code Section 409A or to otherwise avoid imposition of any additional tax or income recognition under Code Section 409A in connection to this Option.
24. Amendment, Suspension or Termination of the Plan. By accepting this Award, Participant expressly warrants that he or she has received an Option under the Plan, and has received, read and understood a description of the Plan. Participant understands that the Plan is discretionary in nature and may be amended, suspended or terminated by the Company at any time.
25. Governing Law and Venue. This Award Agreement will be governed by the laws of the State of Delaware, without giving effect to the conflict of law principles thereof.    For purposes of litigating any dispute that arises under this Award Agreement, the parties hereby submit to and consent to the jurisdiction of the State of Florida and agree that such litigation will be conducted in the courts of Orange County, Florida, or the federal courts for the United States for the Middle District of Florida, and no other courts.
***
 




EXHIBIT B
LUMINAR TECHNOLOGIES, INC.
2020 EQUITY INCENTIVE PLAN
EXERCISE NOTICE
 
Luminar Technologies, Inc.
                                                             
                                                             
Attention:                                              
1. Exercise of Option. Effective as of today,                                 , the undersigned (“Purchaser”) hereby elects to purchase,                 , shares (the “Shares”) of the Class A Common Stock of Luminar Technologies, Inc. (the “Company”) under and pursuant to the 2020 Equity Incentive Plan (the “Plan”) and the Stock Option Award Agreement dated                                  (the “Award Agreement). The purchase price for the Shares will be USD $                 , as required by the Award Agreement.
2. Delivery of Payment. Purchaser herewith delivers to the Company, or otherwise makes adequate arrangements satisfactory to the Company, the full purchase price of the Shares and any Tax-Related Items (as defined in the Agreement) to be paid in connection with the exercise of the Option.
3. Representations of Purchaser. Purchaser acknowledges that Purchaser has received, read and understood the Plan and the Award Agreement and agrees to abide by and be bound by their terms and conditions.
4. Rights as Stockholder. Until the issuance (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company) of the Shares, no right to vote or receive dividends or any other rights as a stockholder will exist with respect to the Shares subject to the Option, notwithstanding the exercise of the Option. The Shares so acquired will be issued to Purchaser as soon as practicable after exercise of the Option. No adjustment will be made for a dividend or other right for which the record date is prior to the date of issuance, except as provided in Section 14 of the Plan.
5. Tax Consultation.    Purchaser understands that Purchaser may suffer adverse tax consequences as a result of Purchaser’s purchase or disposition of the Shares. Purchaser represents that Purchaser has consulted with any tax consultants Purchaser deems advisable in connection with the purchase or disposition of the Shares and that Purchaser is not relying on the Company for any tax advice.
 
6. Entire Agreement; Governing Law. The Plan and Award Agreement are incorporated herein by reference. This Exercise Notice, the Plan and the Award Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and Purchaser with respect to the subject matter hereof, and may not be modified adversely to the Purchaser’s interest except by means of a writing signed by the Company and Purchaser. This agreement is governed by the internal substantive laws, but not the choice of law rules, of the State of Delaware.
 



            Submitted by:              Accepted by:
            PURCHASER:              LUMINAR TECHNOLOGIES, INC.
                                                                                                                                                                          
            Signature              By
                                                                                                                                                                          
            Print Name              Title
 



LUMINAR TECHNOLOGIES, INC.
2020 EQUITY INCENTIVE PLAN
RESTRICTED STOCK UNIT AWARD AGREEMENT
1. Unless otherwise defined herein, the terms defined in the Luminar Technologies, Inc. 2020 Equity Incentive Plan (the “Plan”) will have the same defined meanings in this Restricted Stock Unit Award Agreement (this “Award Agreement”).
26. NOTICE OF RESTRICTED STOCK UNIT GRANT
Participant Name:
2. You have been granted the right to receive an Award of Restricted Stock Units, subject to the terms and conditions of the Plan and this Award Agreement, as follows:
Grant Number                                                                          
3. Date of Grant                                                                              
4. Vesting Commencement Date                                                      
Number of Restricted Stock Units                                                      
Vesting Schedule                                                                          
Subject to Section 3 of this Award Agreement, the Restricted Stock Units will vest in accordance with the following schedule:
 
(a)   
 
 
(b) If Participant ceases to be a Service Provider for any or no reason before Participant vests in the Restricted Stock Unit, the Restricted Stock Unit and Participant’s right to acquire any Shares hereunder will terminate in accordance with Section 3 of this Award Agreement.

By Participant’s signature and the signature of the representative of Luminar Technologies, Inc. (the “Company”) below, or by Participant otherwise accepting this Award, Participant and the Company agree that this Award of Restricted Stock Units is granted under and governed by the terms and conditions of the Plan and this Award Agreement, including the terms and conditions of Restricted Stock Unit Grant, attached hereto as Exhibit A, all of which are made a part of this document. Participant has reviewed the Plan and this Award Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Award Agreement and fully understands all provisions of the Plan and Award Agreement. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator on any questions relating to the Plan and Award Agreement.
 



PARTICIPANT:  LUMINAR TECHNOLOGIES, INC.
  
Signature  By
  
Print Name  Title
 





EXHIBIT A
TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT GRANT
1. Grant. The Company hereby grants to the individual named in the Notice of Grant attached as Part I of this Award Agreement (the “Participant”) under the Plan an Award of Restricted Stock Units, subject to all of the terms and conditions in this Award Agreement and the Plan, which is incorporated herein by reference. Subject to Section 21 of the Plan, if there is a conflict between the terms and conditions of the Plan and the terms and conditions of this Award Agreement, the terms and conditions of the Plan will prevail.
2. Company’s Obligation to Pay. Each Restricted Stock Unit represents the right to receive a Share on the date it vests. Unless and until the Restricted Stock Units will have vested in the manner set forth in Section 3, Participant will have no right to receive Shares pursuant to any such Restricted Stock Units. Prior to actual payment of any vested Restricted Stock Units, such Restricted Stock Units will represent an unsecured obligation of the Company. Any Restricted Stock Units that vest in accordance with Section 3 will be settled by delivery of whole Shares as set forth herein to Participant (or in the event of Participant’s death, to his or her estate), subject to Participant satisfying any Tax-Related Items as set forth in Section 7. Subject to the provisions of Section 4, such vested Restricted Stock Units will be settled by delivery of whole Shares as soon as practicable after vesting, but in each such case within the period ending no later than the date that is two and one-half (212) months from the end of the Company’s tax year that includes the vesting date. In no event will Participant be permitted, directly or indirectly, to specify the taxable year in which Shares will be issued upon payment of any Restricted Stock Units under this Award Agreement.
3. Vesting Schedule. The Restricted Stock Units awarded by this Award Agreement will vest in accordance with the vesting provisions set forth in the Notice of Grant. Restricted Stock Units scheduled to vest on a certain date or upon the occurrence of a certain condition will not vest in accordance with any of the provisions of this Award Agreement, unless Participant will have been continuously a Service Provider from the Date of Grant until the date such vesting occurs. Service Provider status for purposes of this Award will end on the day that Participant is no longer actively providing services as an Employee, Director, or Independent Contractor and will not be extended by any notice period or “garden leave” that may be required contractually or under Applicable Laws. Notwithstanding the foregoing, the Administrator (or any delegate) shall have the sole and absolute discretion to determine when Participant is no longer providing active service for purposes of Service Provider status and participation in the Plan.
4. Administrator Discretion. Notwithstanding anything in the Plan or this Award Agreement to the contrary, if the vesting of the balance, or some lesser portion of the balance, of the Restricted Stock Units is accelerated in connection with Participant’s termination as a Service Provider (provided that such termination is a “separation from service” within the meaning of Code Section 409A, as determined by the Company), other than due to death, and if (x) Participant is a “specified employee” within the meaning of Code Section 409A at the time of such termination as a Service Provider and (y) the payment of such accelerated Restricted Stock Units will result in the imposition of additional tax under Code Section 409A if paid to Participant on or within the six (6) month period following Participant’s termination as a Service Provider, then the payment of such accelerated Restricted Stock Units will not be made until the date six (6) months and one (1) day following the date of Participant’s termination as a Service Provider, unless Participant dies following his or her termination as a Service Provider, in which case, the Restricted Stock Units will be settled in Shares to Participant’s estate as soon as practicable following his or her death. It is the intent of this Award Agreement that it and all payments and benefits hereunder be exempt from, or comply with, the requirements of Code Section 409A so that none of the Restricted Stock Units provided under this Award Agreement or Shares issuable thereunder will be subject to the additional tax imposed under Code Section 409A, and any ambiguities herein will be interpreted to be so exempt or so comply. Each payment payable under this Award Agreement is intended to constitute a separate payment for purposes of U.S. Treasury Regulation Section 1.409A-2(b)(2). Notwithstanding the foregoing, the Company makes no representations that the payments and benefits provided under this Award Agreement are exempt from or compliant with Code Section 409A.



5. Forfeiture upon Termination of Status as a Service Provider. Notwithstanding any contrary provision of this Award Agreement, any Restricted Stock Units that have not vested will be forfeited and will return to the Plan on the date that is thirty (30) days following the termination of Participant’s status as a Service Provider. No additional Restricted Stock Units shall vest during such thirty (30) day period unless approved by the Administrator.
6. Death of Participant. Any distribution or delivery to be made to Participant under this Award Agreement will, if Participant is then deceased, be made to Participant’s designated beneficiary, if so allowed by the Administrator in its sole discretion, or if no beneficiary survives Participant, the administrator or executor of Participant’s estate. Any such transferee must furnish the Company with (a) written notice of his or her status as transferee, and (b) evidence satisfactory to the Company to establish the validity of the transfer and compliance with any Applicable Laws or regulations pertaining to said transfer.
7. Withholding of Taxes. Regardless of any action the Company or Participant’s employer (the “Employer”) takes with respect to any or all applicable national, local, or other tax or social contribution, withholding, required deductions, or other payments, if any, that arise upon the grant or vesting of the Restricted Stock Units or the holding or subsequent sale of Shares, and the receipt of dividends, if any, or otherwise in connection with the Restricted Stock Units or the Shares (“Tax-Related Items”), Participant acknowledges and agrees that the ultimate liability for all Tax-Related Items legally due by Participant is and remains Participant’s responsibility and may exceed any amount actually withheld by the Company or the Employer. Participant further acknowledges and agrees that Participant is solely responsible for filing all relevant documentation that may be required in relation to the Restricted Stock Units or any Tax-Related Items (other than filings or documentation that is the specific obligation of the Company or a Parent, Subsidiary, or Employer pursuant to Applicable Laws) such as but not limited to personal income tax returns or reporting statements in relation to the grant, vesting or payment of the Restricted Stock Units, the holding of Shares or any bank or brokerage account, the subsequent sale of Shares, and the receipt of any dividends. Participant further acknowledges that the Company and the Employer (a) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Restricted Stock Units, including the grant or vesting of the Restricted Stock Units, the subsequent sale of Shares acquired under the Plan, and the receipt of dividends, if any; and (b) do not commit to and are under no obligation to structure the terms of the Restricted Stock Units or any aspect of the Restricted Stock Units to reduce or eliminate Participant’s liability for Tax-Related Items, or achieve any particular tax result. Participant also understands that Applicable Laws may require varying Share or Restricted Stock Unit valuation methods for purposes of calculating Tax-Related Items, and the Company assumes no responsibility or liability in relation to any such valuation or for any calculation or reporting of income or Tax-Related Items that may be required of Participant under Applicable Laws. Further, if Participant has become subject to tax in more than one jurisdiction between the Date of Grant and the date of any relevant taxable event, Participant acknowledges that the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction. Notwithstanding any contrary provision of this Award Agreement, no certificate representing the Shares will be issued to Participant, unless and until satisfactory arrangements (as determined by the Administrator) will have been made by Participant with respect to the payment of any Tax-Related Items which the Company determines must be withheld with respect to such Shares.
As a condition to the grant and vesting of the Restricted Stock Units and as set forth in Section 15 of the Plan, Participant hereby agrees to make adequate provision for the satisfaction of (and will indemnify the Company and any Parent or Subsidiary for) any Tax-Related Items. In this regard, Participant authorizes the Company and/or the Employer or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following, in each case to the extent permitted by Applicable Laws: (i) by receipt of a cash payment from Participant; (ii) by withholding from Participant’s wages or other cash compensation paid to Participant by the Company or the Employer; (iii) withholding Shares that otherwise would be issued to Participant upon payment of the vested Restricted Stock Units (provided that amounts withheld shall not exceed the amount permitted under Applicable Laws); (iv) by withholding from proceeds of the sale of Shares acquired upon payment of the vested Restricted Stock Units through a voluntary sale or a mandatory sale arranged by the Company (on Participant’s behalf pursuant to this authorization); or (v) by any other arrangement approved by the Administrator.



Notwithstanding the foregoing, if Participant is subject to Section 16 of the Exchange Act, Participant’s obligations with respect to all Tax-Related Items shall be satisfied by the Company withholding Shares that otherwise would be issued to Participant upon payment of the vested Restricted Stock Units; provided that amounts withheld shall not exceed the amount permitted under Applicable Laws. Any Shares withheld pursuant to this Section 7 shall be valued based on the Fair Market Value as of the date the withholding obligations are satisfied. Furthermore, Participant agrees to pay the Company or any Parent, Subsidiary, or Employer any Tax-Related Items that cannot be satisfied by the foregoing methods.
8. Rights as Stockholder. Neither Participant nor any person claiming under or through Participant will have any of the rights or privileges of a stockholder of the Company in respect of any Shares deliverable hereunder unless and until such Shares will have been issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company). After such issuance, Participant will have all the rights of a stockholder of the Company with respect to voting such Shares and receipt of dividends and distributions on such Shares, but prior to such issuance, Participant will not have any rights to dividends and/or distributions on such Shares.
 
9. No Guarantee of Continued Service or Grants. PARTICIPANT ACKNOWLEDGES AND AGREES THAT THE VESTING OF THE RESTRICTED STOCK UNITS PURSUANT TO THE VESTING SCHEDULE HEREOF SHALL OCCUR ONLY BY CONTINUING AS A SERVICE PROVIDER AT THE WILL OF THE EMPLOYER OR CONTRACTING ENTITY (AS APPLICABLE) AND NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS AWARD OF RESTRICTED STOCK UNITS OR ACQUIRING SHARES HEREUNDER. PARTICIPANT FURTHER ACKNOWLEDGES AND AGREES THAT THIS AWARD AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH HEREIN DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS A SERVICE PROVIDER FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND WILL NOT INTERFERE IN ANY WAY WITH PARTICIPANT’S RIGHT OR THE RIGHT OF THE EMPLOYER OR THE COMPANY (OR ANY PARENT OR SUBSIDIARY) TO TERMINATE PARTICIPANT’S RELATIONSHIP AS A SERVICE PROVIDER AT ANY TIME, WITH OR WITHOUT CAUSE, SUBJECT TO APPLICABLE LAWS.
Participant also acknowledges and agrees that: (a) the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time; (b) the grant of Restricted Stock Units is voluntary and occasional and does not create any contractual or other right to receive future grants of Restricted Stock Units, or benefits in lieu of Restricted Stock Units even if Restricted Stock Units have been granted repeatedly in the past; (c) all decisions with respect to future awards of Restricted Stock Units, if any, will be at the sole discretion of the Company; (d) Participant’s participation in the Plan is voluntary; (e) the Restricted Stock Units and the Shares subject to the Restricted Stock Units are extraordinary items that do not constitute regular compensation for services rendered to the Company or the Employer, and that are outside the scope of Participant’s employment contract, if any; (f) the Restricted Stock Units and the Shares subject to the Restricted Stock Units are not intended to replace any pension rights or compensation; or (g) the Restricted Stock Units and the Shares subject to the Restricted Stock Units are not part of normal or expected compensation or salary for any purposes, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, or end of service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company or the Employer, subject to Applicable Laws.
10. Address for Notices. Any notice to be given to the Company under the terms of this Award Agreement will be addressed to the Company, in care of its Secretary at Luminar Technologies, Inc., 12601 Research Parkway, Orlando, FL 32826, or at such other address as the Company may hereafter designate in writing.
11. Grant is Not Transferable. Except to the limited extent provided in Section 6, this grant and the rights and privileges conferred hereby may not be transferred, assigned, pledged or hypothecated in any way (whether by operation of Applicable Laws or otherwise) and may not be subject to sale under execution, attachment or similar



process. Upon any attempt to transfer, assign, pledge, hypothecate or otherwise dispose of this grant, or any right or privilege conferred hereby, or upon any attempted sale under any execution, attachment or similar process, this grant and the rights and privileges conferred hereby immediately will become null and void.
 
12. Binding Agreement. Subject to the limitation on the transferability of this grant contained herein, this Award Agreement will be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors and assigns of the parties hereto.
13. Additional Conditions to Issuance of Stock and Imposition of Other Requirements. If at any time the Company will determine, in its discretion, that the listing, registration, qualification or compliance of the Shares upon or with any securities exchange or under any Applicable Laws, the tax code and related regulations or the consent or approval of any governmental regulatory authority is necessary or desirable as a condition to the issuance of Shares to Participant (or his or her estate) hereunder, such issuance will not occur unless and until such listing, registration, qualification, compliance, consent or approval will have been completed, effected or obtained free of any conditions not acceptable to the Company. Where the Company determines that the delivery of any Shares will violate any state, federal or foreign securities or exchange laws or other Applicable Laws, the Company will defer delivery until the earliest date at which the Company reasonably anticipates that the delivery of Shares will no longer cause such violation. The Company will make all reasonable efforts to meet the requirements of any Applicable Laws or securities exchange and to obtain any such consent or approval of any such governmental authority or securities exchange. The Company shall not be obligated to issue any Shares pursuant to the Restricted Stock Units at any time if the issuance of Shares violates or is not in compliance with any Applicable Laws.
Furthermore, the Company reserves the right to impose other requirements on Participant’s participation in the Plan, on the Restricted Stock Units and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable in order to comply with any Applicable Laws or facilitate the administration of the Plan, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing. Furthermore, Participant understands that the Applicable Laws of the country in which he or she is resident at the time of grant or vesting of the Restricted Stock Units or the holding or disposition of Shares (including any rules or regulations governing securities, foreign exchange, tax, labor or other matters) may restrict or prevent the issuance of Shares or may subject Participant to additional procedural or regulatory requirements he or she is solely responsible for and will have to independently fulfill in relation to the Restricted Stock Units or the Shares. Participant also understands and agrees that if he works, resides, moves to, or otherwise is or becomes subject to Applicable Laws or company policies of another jurisdiction at any time, certain country-specific notices, disclaimers and/or terms and conditions may apply to Participant as from the Date of Grant, unless otherwise determined by the Company in its sole discretion.
14. Lock-Up Agreement. If so requested by the Company (or any successor thereof) or the underwriters in connection with any transaction pursuant to which the securities of the Company will be exchanged for securities of the Company (or any successor or parent thereof), registered under the Securities Act of 1933, as amended, including, without limitation, through a transaction with a publicly-listed blank check company then registered under the Securities Act (a “SPAC Transaction”), Participant shall not sell, make any short sale of, loan, grant any option for the purchase of, or otherwise dispose of any securities of the Company (or any successor thereof) however or whenever acquired (except for those being registered) without the prior written consent of the Company or such underwriters, as the case may be, for 180 days from the effective date of the registration statement or becoming a listed security (including, without limitation, pursuant to a SPAC Transaction), and Participant shall execute an agreement reflecting the foregoing as may be requested by the Company (or any successor or parent thereof) or the underwriters at the time of such offering or listing.
15. Plan Governs. This Award Agreement is subject to all terms and provisions of the Plan. If there is a conflict between one or more provisions of this Award Agreement and one or more provisions of the Plan, the provisions of the Plan will govern. Capitalized terms used and not defined in this Award Agreement will have the meaning set forth in the Plan.



16. Administrator Authority. The Administrator will have the power to interpret the Plan and this Award Agreement and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith and to interpret or revoke any such rules (including, but not limited to, the determination regarding whether any Restricted Stock Units have vested). All actions taken, and all interpretations and determinations made, by the Administrator in good faith will be final and binding upon Participant, the Company and all other interested persons. No member of the Administrator will be personally liable for any action, determination or interpretation made in good faith with respect to the Plan or this Award Agreement.
17. Electronic Delivery and Acceptance; Translation. The Company may, in its sole discretion, decide to deliver any documents related to Participant’s current or future participation in the Plan, this Award, the Shares subject to this Award, any other securities of the Company or any other Company-related documents, by electronic means. By accepting this Award, whether electronically or otherwise, Participant hereby (a) consents to receive such documents by electronic means, (b) consents to the use of electronic signatures, and (c) agrees to participate in the Plan and/or receive any such documents through an on-line or electronic system established and maintained by the Company or a third party designated by the Company, including but not limited to the use of electronic signatures or click-through electronic acceptance of terms and conditions.
18. Translation. If Participant has received this Award Agreement, including appendices, or any other document related to the Plan translated into a language other than English, and the meaning of the translated version is different than the English version, the English version will control.
19. Captions. Captions provided herein are for convenience only and are not to serve as a basis for interpretation or construction of this Award Agreement.
19. Agreement Severable. If any provision in this Award Agreement will be held invalid or unenforceable, such provision will be severable from, and such invalidity or unenforceability will not be construed to have any effect on, the remaining provisions of this Award Agreement.
 
20. Modifications to this Award Agreement. This Award Agreement and the Plan constitute the entire understanding of the parties on the subjects covered. Participant expressly warrants that he or she is not accepting this Award Agreement in reliance on any promises, representations, or inducements other than those contained herein. Modifications to this Award Agreement or the Plan can be made only in an express written contract executed by a duly authorized officer of the Company. Notwithstanding anything to the contrary in the Plan or this Award Agreement, the Company reserves the right to revise this Award Agreement as it deems necessary or advisable, in its sole discretion and without the consent of Participant, to comply with Code Section 409A or to otherwise avoid imposition of any additional tax or income recognition under Code Section 409A in connection to this Award of Restricted Stock Units.
21. Data Privacy. Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of Participant’s Personal Data (as described below) by and among, as applicable, the Company, any Parent, Subsidiary, or affiliate, or third parties as may be selected by the Company for the exclusive purpose of implementing, administering and managing Participant’s participation in the Plan. Participant understands that refusal or withdrawal of consent will affect Participant’s ability to participate in the Plan; without providing consent, Participant will not be able to participate in the Plan or realize benefits (if any) from the Restricted Stock Units.
Participant understands that the Company and any Parent, Subsidiary, affiliate, or designated third parties may hold personal information about Participant, including, but not limited to, Participant’s name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company or any Parent, Subsidiary, or affiliate, details of all Restricted Stock Units or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in Participant’s favor (“Personal Data”). Participant understands that Personal Data may be transferred to any Parent, Subsidiary, affiliate, or third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in the United States, Participant’s country (if



different than the United States), or elsewhere, and that the recipient’s country may have different data privacy laws and protections than Participant’s country. In particular, the Company may transfer Personal Data to the broker or stock plan administrator assisting with the Plan, to its legal counsel and tax/accounting advisor, and to the affiliate or entity that is Participant’s employer and its payroll provider.
Participant should also refer to any data privacy policy implemented by the Company (which will be available to Participant separately and may be updated from time to time) for more information regarding the collection, use, storage, and transfer of Participant’s Personal Data.
22. Foreign Exchange Fluctuations and Restrictions. Participant understands and agrees that the future value of the underlying Shares is unknown and cannot be predicted with certainty and may decrease. Participant also understands that neither the Company, nor any affiliate is responsible for any foreign exchange fluctuation between local currency and the United States Dollar or the selection by the Company or any affiliate in its sole discretion of an applicable foreign currency exchange rate that may affect the value of the Restricted Stock Units or Shares received (or the calculation of income or Tax-Related Items thereunder). Participant understands and agrees that any cross-border remittance made to transfer proceeds received upon the sale of Shares must be made through a locally authorized financial institution or registered foreign exchange agency and may require Participant to provide such entity with certain information regarding the transaction.
 
23. Amendment, Suspension or Termination of the Plan. By accepting this Award, Participant expressly warrants that he or she has received an Award of Restricted Stock Units under the Plan, and has received, read and understood a description of the Plan. Participant understands that the Plan is discretionary in nature and may be amended, suspended or terminated by the Company at any time.
24. Governing Law and Venue. This Award Agreement will be governed by the laws of the State of Delaware, without giving effect to the conflict of law principles thereof. For purposes of litigating any dispute that arises under this Award of Restricted Stock Units or this Award Agreement, the parties hereby submit to and consent to the jurisdiction of the State of Florida, and agree that such litigation will be conducted in the courts of Orange County, Florida, or the federal courts for the United States for the Middle District of Florida, and no other courts.
***
 


EX-21.1 5 exhibit211202210-k.htm EX-21.1 Document

Exhibit 21.1
Subsidiaries of Luminar Technologies, Inc.

Name of SubsidiaryJurisdiction of Organization
Luminar, LLCDelaware
Luminar Semiconductor, Inc.Delaware
BFE Acquisition Sub II, LLC (dba Black Forest Engineering)Delaware
OptoGration, Inc.Delaware
Freedom Photonics, LLCCalifornia
Condor Acquisition Sub I, Inc.Delaware
Condor Acquisition Sub II, Inc.Delaware
Luminar LimitedCayman Islands
Luminar Technologies (Shanghai) Co., Ltd.China
Luminar GmbHGermany
Luminar Hong Kong LimitedHong Kong
Luminar Technology Services (India) Private LimitedIndia
Luminar LTC Israel Ltd.Israel
Luminartech Mexico, S. DE R.L. DE C.V.Mexico
Luminar Sweden ABSweden



EX-23.1 6 q4-2022exhibit231.htm EX-23.1 Document
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


We consent to the incorporation by reference in Registration Statement No. 333-253658 on Form S-8, Registration Statement No. 333-262250 on Form S-3, Registration Statement No. 333-257989 on Form S-3, Registration Statement No. 333-251657 on Form S-3, Registration Statement No. 333-263745 on Form S-3, and Registration Statement No. 333-265752 on Form S- 8 of our reports dated February 28, 2023, relating to the financial statements of Luminar Technologies, Inc. and the effectiveness of Luminar Technologies, Inc.'s internal control over financial reporting appearing in this Annual Report on December 31, 2022.


/s/ Deloitte & Touche LLP

San Jose, California
February 28, 2023

EX-31.1 7 q4-2022exhibit311.htm EX-31.1 Document



Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Austin Russell, certify that:

1.I have reviewed this annual report on Form 10-K of Luminar Technologies, Inc. for the year ended December 31, 2022;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: February 28, 2023
By:By: /s/ Austin Russell
Austin Russell
Chief Executive Officer
(Principal Executive Officer)

EX-31.2 8 q4-2022exhibit312.htm EX-31.2 Document



Exhibit 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Thomas J. Fennimore, certify that:

1.I have reviewed this annual report on Form 10-K of Luminar Technologies, Inc. for the year ended December 31, 2022;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: February 28, 2023
By:/s/ Thomas J. Fennimore
Thomas J. Fennimore
Chief Financial Officer
(Principal Financial and Accounting Officer)

EX-32.1 9 q4-2022exhibit321.htm EX-32.1 Document

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


I, Austin Russell, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Luminar Technologies, Inc. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2022 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that information contained in such Annual Report on Form 10-K fairly presents in all material respects the financial condition and results of operations of the Company.
Date: February 28, 2023
By:/s/ Austin Russell
Austin Russell
Chief Executive Officer
(Principal Executive Officer)

I, Thomas J. Fennimore, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Luminar Technologies, Inc. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2022 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that information contained in such Annual Report on Form 10-K fairly presents in all material respects the financial condition and results of operations of the Company.

Date: February 28, 2023
By:/s/ Thomas J. Fennimore
Thomas J. Fennimore
Chief Financial Officer
(Principal Financial and Accounting Officer)

This certification accompanies the Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Luminar Technologies, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing.

EX-101.SCH 10 lazr-20221231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 0000002 - Document - Audit Information link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - Consolidated Statements of Operations and Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000008 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 0000009 - Statement - Consolidated Statements of Cash Flows (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Organization and Description of Business link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Business Combinations link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Revenue link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Investments link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Financial Statement Components link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Convertible Preferred Stock link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Earnings (Loss) Per Share link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Stockholders’ Equity (Deficit) link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Stock-based Compensation link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - Commitment and Contingencies link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - Segment and Customer Concentration Information link:presentationLink link:calculationLink link:definitionLink 0000026 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 0000027 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 0000028 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 0000029 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 0000030 - Disclosure - Business Combinations (Tables) link:presentationLink link:calculationLink link:definitionLink 0000031 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 0000032 - Disclosure - Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 0000033 - Disclosure - Financial Statement Components (Tables) link:presentationLink link:calculationLink link:definitionLink 0000034 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 0000035 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 0000036 - Disclosure - Earnings (Loss) Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 0000037 - Disclosure - Stockholders’ Equity (Deficit) (Tables) link:presentationLink link:calculationLink link:definitionLink 0000038 - Disclosure - Stock-based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 0000039 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 0000040 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 0000041 - Disclosure - Segment and Customer Concentration Information (Tables) link:presentationLink link:calculationLink link:definitionLink 0000042 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Segment Information (Details) link:presentationLink link:calculationLink link:definitionLink 0000043 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Concentration of Credit Risk (Details) link:presentationLink link:calculationLink link:definitionLink 0000044 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 0000045 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Intangible Assets and Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 0000046 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Impairment of Long-Lived Assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000047 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Public and Private Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 0000048 - Disclosure - Business Combinations - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000049 - Disclosure - Business Combinations - Schedule of Recognized Identified Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000050 - Disclosure - Business Combinations - Components of Intangible Assets and Estimated Useful Lives (Details) link:presentationLink link:calculationLink link:definitionLink 0000051 - Disclosure - Business Combinations - Impact of Adjustments to the Unaudited Pro Forma (Details) link:presentationLink link:calculationLink link:definitionLink 0000052 - Disclosure - Business Combinations - Unaudited Pro Forma (Details) link:presentationLink link:calculationLink link:definitionLink 0000053 - Disclosure - Revenue - Schedule of Disaggregation of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 0000054 - Disclosure - Revenue - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000055 - Disclosure - Revenue - Schedule of Opening and Closing Balances of Contract Assets and Contract Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000056 - Disclosure - Revenue - Schedule of Significant Changes in Contract Assets and Contract Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000057 - Disclosure - Revenue - Remaining Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 0000057 - Disclosure - Revenue - Remaining Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 0000058 - Disclosure - Investments - Amortized Cost (Details) link:presentationLink link:calculationLink link:definitionLink 0000059 - Disclosure - Investments - Continuous Loss Position (Details) link:presentationLink link:calculationLink link:definitionLink 0000060 - Disclosure - Investments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000061 - Disclosure - Investments - Schedule of Equity Investments (Details) link:presentationLink link:calculationLink link:definitionLink 0000062 - Disclosure - Financial Statement Components - Cash and Cash Equivalents (Details) link:presentationLink link:calculationLink link:definitionLink 0000063 - Disclosure - Financial Statement Components - Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 0000064 - Disclosure - Financial Statement Components - Prepaid Expenses and Other Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000065 - Disclosure - Financial Statement Components - Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 0000066 - Disclosure - Financial Statement Components - Schedule of Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000067 - Disclosure - Financial Statement Components - Future Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 0000068 - Disclosure - Financial Statement Components - Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 0000069 - Disclosure - Financial Statement Components - Other Noncurrent Assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000070 - Disclosure - Financial Statement Components - Accrued and Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000071 - Disclosure - Debt - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 0000072 - Disclosure - Debt - Schedule of Net Carrying Amount (Details) link:presentationLink link:calculationLink link:definitionLink 0000073 - Disclosure - Debt - Schedule of Interest Expense (Details) link:presentationLink link:calculationLink link:definitionLink 0000074 - Disclosure - Fair Value Measurements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000075 - Disclosure - Fair Value Measurements - Schedule of Changes in Level 3 Liabilities Measured at Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 0000076 - Disclosure - Fair Value Measurements - Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements on a Recurring Basis and the Level of Inputs Used (Details) link:presentationLink link:calculationLink link:definitionLink 0000077 - Disclosure - Convertible Preferred Stock (Details) link:presentationLink link:calculationLink link:definitionLink 0000078 - Disclosure - Earnings (Loss) Per Share - Basic and Diluted Loss Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 0000079 - Disclosure - Earnings (Loss) Per Share - Antidilutive Securities (Details) link:presentationLink link:calculationLink link:definitionLink 0000080 - Disclosure - Earnings (Loss) Per Share - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000081 - Disclosure - Stockholders’ Equity (Deficit) (Details) link:presentationLink link:calculationLink link:definitionLink 0000082 - Disclosure - Stockholders’ Equity (Deficit) - Stock-in-lieu of Cash Program Activity (Details) link:presentationLink link:calculationLink link:definitionLink 0000083 - Disclosure - Stock-based Compensation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000084 - Disclosure - Stock-based Compensation - Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 0000085 - Disclosure - Stock-based Compensation - Restricted Stock Activity (Details) link:presentationLink link:calculationLink link:definitionLink 0000086 - Disclosure - Stock-based Compensation - Employee Stock Purchase Plan, Valuation Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 0000087 - Disclosure - Stock-based Compensation - Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 0000088 - Disclosure - Leases - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000089 - Disclosure - Leases - Components of Lease Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 0000090 - Disclosure - Leases - Supplemental Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 0000091 - Disclosure - Leases - Supplemental Balance Sheet Information, Weighted Average Remaining Terms, and Weighted Average Discount Rates (Details) link:presentationLink link:calculationLink link:definitionLink 0000092 - Disclosure - Leases - Maturities of Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000092 - Disclosure - Leases - Maturities of Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000093 - Disclosure - Income Taxes - Components of Loss Before Provision for (Benefit from) Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 0000094 - Disclosure - Income Taxes - Provision for (benefit from) income taxes (Details) link:presentationLink link:calculationLink link:definitionLink 0000095 - Disclosure - Income Taxes - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000096 - Disclosure - Income Taxes - Effective Income Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 0000097 - Disclosure - Income Taxes - Deferred Income Tax Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000098 - Disclosure - Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details) link:presentationLink link:calculationLink link:definitionLink 0000099 - Disclosure - Commitment and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 0000100 - Disclosure - Segment and Customer Concentration Information - Segment Operating Results and Reconciliation to the Consolidated Balances (Details) link:presentationLink link:calculationLink link:definitionLink 0000101 - Disclosure - Segment and Customer Concentration Information - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000102 - Disclosure - Related Party Disclosures (Details) link:presentationLink link:calculationLink link:definitionLink 0000103 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 11 lazr-20221231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 12 lazr-20221231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 13 lazr-20221231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Geographic Concentration Risk Geographic Concentration Risk [Member] Business Acquisition [Axis] Business Acquisition [Axis] Beneficial conversion feature Temporary Equity, Convertible, Beneficial Conversion Feature Temporary Equity, Convertible, Beneficial Conversion Feature Foreign Current Foreign Tax Expense (Benefit) Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Related Party Transactions [Abstract] Other non-current liabilities Increase (Decrease) in Other Noncurrent Liabilities Schedule of Gross Unrealized Losses and the Fair Value for Marketable Investments Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block] Equity Classified Awards [Axis] Equity Classified Awards [Axis] Equity Classified Awards Increase due to cash received and not recognized as revenue and billings in excess of revenue recognized during the period Contract With Customer, Liability, Increase Due To Cash Received Billings In Excess Of Revenue Contract With Customer, Liability, Increase Due To Cash Received Billings In Excess Of Revenue Deferred: Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Preferred stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Preferred Stock, Shares Outstanding Debt instrument, convertible, threshold consecutive trading days Debt Instrument, Convertible, Threshold Consecutive Trading Days Debt Instrument [Axis] Debt Instrument [Axis] Total property and equipment Property, Plant and Equipment, Gross Stock option, capped calls, initial strike price (in dollars per share) Stock Option, Capped Calls, Initial Strike Price Stock Option, Capped Calls, Initial Strike Price Additional paid-in capital Additional Paid in Capital Financial Instruments [Domain] Financial Instruments [Domain] Depreciation and amortization Depreciation Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Net deferred tax assets (liabilities) Deferred Tax Assets, Net Operating leases (as a percent) Operating Lease, Weighted Average Discount Rate, Percent Interest rate (as a percent) Debt Instrument, Interest Rate, Stated Percentage Acquisition (in shares) Shares issued to acquiree shareholders (in shares) Stock Issued During Period, Shares, Acquisitions Other Other Noncash Income (Expense) Assets acquired under finance leases (capital leases prior to adoption of ASC 842) Assets Acquired On Capital Leases Assets Acquired On Capital Leases Beginning balance (in shares) Ending balance (in shares) Temporary Equity, Shares Outstanding Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Measurement Input Type [Domain] Measurement Input Type [Domain] Asset acquisition, consideration transferred, non-cancelable amount Asset Acquisition, Consideration Transferred, Non-Cancelable Amount Asset Acquisition, Consideration Transferred, Non-Cancelable Amount Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Total (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Document Information [Line Items] Document Information [Line Items] Lessee, Operating Lease, Liability, Payment, Due [Abstract] Lessee, Operating Lease, Liability, to be Paid [Abstract] Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Equity Component [Domain] Equity Component [Domain] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Increase related to current year tax positions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Period of Time, Five Share Price Triggering Event Five [Member] Share Price Triggering Event Five Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Related Party [Domain] Related Party [Domain] Earn-out shares remaining (in shares) Business Acquisition, Equity Interest Issued or Issuable, Number of Shares, Remaining Business Acquisition, Equity Interest Issued or Issuable, Number of Shares, Remaining Fair Value Marketable investments Debt Securities, Available-for-Sale Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward, Name [Domain] Right of use assets obtained in exchange for lease obligations: Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract] Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract] Common stock, votes per share Common Stock, Voting Rights, Votes Per Common Share Common Stock, Voting Rights, Votes Per Common Share Cancelled/Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Unrecognized stock-based compensation expense for restricted stock Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Plan Name [Domain] Plan Name [Domain] Amounts payable for shares repurchased Amounts Payable For Shares Repurchased Amounts Payable For Shares Repurchased Entity Address, State or Province Entity Address, State or Province ESPP Employee Stock [Member] Outstanding balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Award Type [Axis] Award Type [Axis] Aggregate cash consideration Asset Acquisition, Consideration Transferred, Other Assets Operating lease liabilities Operating lease liabilities, current Operating Lease, Liability, Current Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Supplemental Balance Sheet Information Assets And Liabilities, Lessee [Table Text Block] Assets And Liabilities, Lessee Accounts receivable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Property and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Total liabilities Liabilities Operating leases (in years) Operating Lease, Weighted Average Remaining Lease Term Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Purchase accounting adjustments Goodwill, Purchase Accounting Adjustments Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Shares converted (in shares) Conversion of Stock, Shares Converted Period of Time, One Share Price Triggering Event One [Member] Share Price Triggering Event One Advances for capital projects and equipment Advances for Capital Projects and Equipment Advances for Capital Projects and Equipment Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Current: Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Document Type Document Type Weighted Average Grant Date Fair Value per Share Weighted- Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Remaining warrants redeemed (in shares) Class Of Warrant Or Right, Warrants Redeemed During Period Class Of Warrant Or Right, Warrants Redeemed During Period Estimated useful life (in years) Property, Plant and Equipment, Useful Life Assets: Assets, Fair Value Disclosure [Abstract] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Outstanding at beginning of period (in dollars per share) Outstanding at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Asset Acquisition [Axis] Asset Acquisition [Axis] Deferred taxes Total deferred: Deferred Income Tax Expense (Benefit) Purchases of capped call options Payments for Derivative Instrument, Financing Activities Portion of investment sold Investment Sold, Related Party Investment Sold, Related Party Developed technology Developed Technology Rights [Member] Proceeds from exercise of warrants Proceeds from Warrant Exercises Non-current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities Cash received from Gores on settlement of recapitalization of escrow Adjustments To Additional Paid In Capital, Increase From Settlement Of Recapitalization Of Escrow Adjustments To Additional Paid In Capital, Increase From Settlement Of Recapitalization Of Escrow Schedule of Opening and Closing Balances of Contract Liabilities and Significant Changes in Contract Liabilities Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Tranche One Share-Based Payment Arrangement, Tranche One [Member] Liability Classified Awards [Domain] Liability Classified Awards [Domain] Liability Classified Awards [Domain] Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-Sale [Table] Net assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Amended 2020 Plan Amended 2020 Plan [Member] Amended 2020 Plan Debt Disclosure [Abstract] Payments to purchase capped calls Payments To Purchase Capped Calls Payments To Purchase Capped Calls Accounts Receivable Accounts Receivable [Policy Text Block] Income Statement Location [Axis] Income Statement Location [Axis] Sale of stock, number of shares of common stock per unit (in shares) Sale Of Stock, Number Of Shares Of Common Stock Per Unit Sale Of Stock, Number Of Shares Of Common Stock Per Unit RSU vesting, market condition, stock price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Market Vesting Condition, Stock Price Share-based Compensation Arrangement by Share-based Payment Award, Market Vesting Condition, Stock Price Tranche Three Share-Based Payment Arrangement, Tranche Three [Member] Segment Concentration Risk Segment Concentration Risk [Member] Segment Concentration Risk Accrued and other current liabilities Total accrued and other current liabilities Accrued Liabilities, Current Acquisition-related Costs Acquisition-related Costs [Member] Numerator: Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Additions Finite-Lived Intangible Assets Acquired Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Accounting Policies [Abstract] Accrued interest repaid Interest Expense, Debt Variable lease cost Variable Lease, Cost Beginning balance Ending balance Temporary Equity, Carrying Amount, Attributable to Parent Stockholders’ equity (deficit): Stockholders' Equity Attributable to Parent [Abstract] Prepaid expenses and other current assets Total prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Customer [Axis] Customer [Axis] Equity Classified Awards [Domain] Equity Classified Awards [Domain] Equity Classified Awards [Domain] Financial Statement Components Supplemental Balance Sheet Disclosures [Text Block] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Schedule of Provision for Benefit From Income Taxes Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Change in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Conversion of warrants into securities (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Unrecognized compensation expense, period for recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Conversion of certain shares into Class B common stock Stockholders Equity, Exchange Of Common Stock, Value Stockholders Equity, Exchange Of Common Stock, Value Schedule of Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Acquisitions Payments to Acquire Businesses, Gross Gross loss Gross Profit Entity Registrant Name Entity Registrant Name Subsequent Events Subsequent Events [Text Block] Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Investment in Robotic Research, percentage of capitalization (percent, less than) Investment, Ownership Percentage Investment, Ownership Percentage Aggregate Intrinsic Value Share-based Compensation Arrangement By Share-based Payment Award, Aggregate Intrinsic Value [Abstract] Share-based Compensation Arrangement By Share-based Payment Award, Aggregate Intrinsic Value Leases [Abstract] Expected Term Measurement Input, Expected Term [Member] Net operating loss carry forward Deferred Tax Assets, Operating Loss Carryforwards Share-based Payment Arrangement, Employee Share-Based Payment Arrangement, Employee [Member] Asset Class [Domain] Asset Class [Domain] Included in marketable securities Marketable securities Marketable Securities [Member] Marketable Securities Minimum Minimum [Member] Entity Emerging Growth Company Entity Emerging Growth Company Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Inventory write-offs and write-downs Inventory write-downs Inventory Write-down Total intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Commitments and Contingencies Disclosure [Abstract] Fair Value Measurements Fair Value Disclosures [Text Block] 2017, 2018, And 2020 Warrants 2017, 2018, And 2020 Warrants [Member] 2017, 2018, And 2020 Warrants Trading Symbol Trading Symbol Entity File Number Entity File Number 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Four Accrued interest payable Interest Payable, Current Purchase price includes working capital adjustments Business Combination, Purchase Price Includes Working Capital Adjustments Business Combination, Purchase Price Includes Working Capital Adjustments Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Title of Individual [Axis] Title of Individual [Axis] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Effective tax rate Effective Income Tax Rate Reconciliation, Percent Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Use of Estimates Use of Estimates, Policy [Policy Text Block] Issuance of shares for investment in Robotic Research Opco, LLC (in shares) Issuance of Shares for Investment in Shares Issuance of Shares for Investment in Shares Business Combinations Business Combination Disclosure [Text Block] Accounts payable Increase (Decrease) in Accounts Payable Balance at beginning of period Balance at end of period Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Percentage of accounts receivable (as percent) Percentage of revenue (as percent) Concentration Risk, Percentage Capitalized expenses, amortization period Capitalized Contract Cost, Amortization Period Contingent stock consideration Business Combination, Consideration Transferred, Liabilities Incurred Net loss Business Acquisition, Pro Forma Net Income (Loss) Income Taxes Income Tax Disclosure [Text Block] Finished goods Inventory, Finished Goods, Net of Reserves Intangible assets, gross Intangible Assets, Gross (Excluding Goodwill) Basic (in dollars per share) Net loss per share attributable to common shareholders- Basic (in dollars per share) Earnings Per Share, Basic Service period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period Fair value of restricted stock vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Schedule of Vendor Stock-in-lieu of Cash Program Vendor Stock-in-lieu of Cash Program [Table Text Block] Vendor Stock-in-lieu of Cash Program Conversion of certain shares into Class B common stock (in shares) Stockholders Equity, Exchange Of Common Stock, Shares Stockholders Equity, Exchange Of Common Stock, Shares Revenue Recognition Timing Concentration Risk Revenue Recognition Timing Concentration Risk [Member] Revenue Recognition Timing Concentration Risk Other Other Awards [Member] Other Awards Entity Interactive Data Current Entity Interactive Data Current Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Uncertain tax benefits Effective Income Tax Rate Reconciliation, Tax Contingency, Percent Money market funds Money Market Funds [Member] Current and non-current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current and Noncurrent Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current and Noncurrent Liabilities Advance payment for capital projects Advances payment For Capital Projects Advances payment For Capital Projects Schedule of Stock-based Compensation Expense by Function Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Other comprehensive (loss) income Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Optogration milestone awards Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Class of Stock [Axis] Class of Stock [Axis] Income Taxes Income Tax, Policy [Policy Text Block] Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Debt Securities Marketable Equity Investments Marketable Securities, Policy [Policy Text Block] Merger recapitalization (in shares) Merger recapitalization (in shares) Temporary Equity, Elimination As Part Of Reorganization, Shares Temporary Equity, Elimination As Part Of Reorganization, Shares Deferred tax assets, deferred expense, capitalized research and development costs increase (decrease) Deferred Tax Assets, Deferred Expense, Capitalized Research and Development Costs Increase (Decrease) Deferred Tax Assets, Deferred Expense, Capitalized Research and Development Costs Increase (Decrease) Renewal lease term (in years) Lessee, Operating Lease, Renewal Term Commercial paper Commercial Paper, Not Included with Cash and Cash Equivalents [Member] Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Current assets: Assets, Current [Abstract] Par value (in dollars per share) Temporary Equity, Par or Stated Value Per Share Asset Acquisition [Domain] Asset Acquisition [Domain] Contract assets, non-current Contract assets Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent Accumulated deficit Retained Earnings (Accumulated Deficit) Proceeds from issuance of convertible senior notes, net of debt discounts of $15,625 Proceeds from convertible debt Proceeds from Convertible Debt Threshold stock price trigger (in dollars per share) Business Combination, Threshold Stock Price Trigger Business Combination, Threshold Stock Price Trigger Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Fair Value, Recurring Fair Value, Recurring [Member] Related Party Transactions Related Party Transactions Disclosure [Text Block] Business Acquisition, Pro Forma Information Business Acquisition, Pro Forma Information [Table Text Block] Fair Value Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months Document Fiscal Year Focus Document Fiscal Year Focus Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Warrants term (in years) Warrants and Rights Outstanding, Term Principal payments on finance leases (capital leases prior to adoption of ASC 842) Finance Lease, Principal Payments Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Proceeds from the issuance of debt Proceeds from Issuance of Other Long-Term Debt Section 174 R&D capitalization Deferred Tax Assets, in Process Research and Development Optogration, Inc. Optogration, Inc. [Member] Optogration, Inc. Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Number of triggering events Business Combination, Number Of Triggering Events Business Combination, Number Of Triggering Events Total current: Current Income Tax Expense (Benefit) Products Product [Member] Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Principal payments on finance leases (capital leases prior to adoption of ASC 842) Repayments of Long-Term Capital Lease Obligations Share per warrant (in shares) Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Vested and expected to vest (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Stock-based compensation expense Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent Inventories Increase (Decrease) in Inventories Non-marketable equity investment Equity Securities without Readily Determinable Fair Value, Amount Document Information [Table] Document Information [Table] Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Goodwill Balance as of December 31, 2021 Balance as of December 31, 2022 Goodwill Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Public Warrants Public Warrants [Member] Public Warrants Provision for (benefit from) income taxes Total provision for (benefit from) income taxes Income Tax Expense (Benefit) Geographical [Domain] Geographical [Domain] Valuation allowance Valuation allowance Deferred Tax Assets, Valuation Allowance Convertible Senior Notes Due 2026 Convertible Senior Notes Due 2026 [Member] Convertible Senior Notes Due 2026 Lease liability (ASC 842) Deferred Tax Assets, Lease liability Deferred Tax Assets, Lease liability Entity Public Float Entity Public Float Balance Sheet Location [Domain] Balance Sheet Location [Domain] Number of tranches Class Of Warrant Or Right, Number Of Tranches Class Of Warrant Or Right, Number Of Tranches Accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table] Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table] Shares of common stock in each purchase period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee Net carrying amount Convertible Debt, Noncurrent Accounts Receivable Accounts Receivable [Member] Period of Time, Four Share Price Triggering Event Four [Member] Share Price Triggering Event Four Common stock Common Stock, Value, Issued Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Assembled workforce Assembled Workforce [Member] Assembled Workforce Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Preferred Stock Preferred Stock [Member] Senior Notes Senior Notes [Member] Conversion price (in dollars per share) Debt Instrument, Convertible, Conversion Price Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Number of renewal options Lessee, Operating Lease, Number Of Renewal Options Lessee, Operating Lease, Number Of Renewal Options RSAs Restricted Stock Awards [Member] Restricted Stock Awards Revenue recognized for performance obligations that have been satisfied but for which amounts have not been billed Contract with Customer, Asset, Credit Loss Expense (Reversal) Beginning cash, cash equivalents and restricted cash Ending cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents International Income (Loss) from Continuing Operations before Income Taxes, Foreign Warrants outstanding, measurement input Warrants and Rights Outstanding, Measurement Input Current liabilities: Liabilities, Current [Abstract] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Proceeds from exercise of stock options Proceeds from Stock Options Exercised Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Contract liabilities, current Contract liabilities Contract with Customer, Liability, Current Accounting Standards Update 2016-02 Accounting Standards Update 2016-02 [Member] Purchase obligations Purchase Obligation, to be Paid, Year One Warrant liabilities Fair value of warrants outstanding Warrants and Rights Outstanding Income Statement Location [Domain] Income Statement Location [Domain] Public and Private Warrants Warrants And Rights Policy Disclosure [Policy Text Block] Warrants And Rights Policy Disclosure Amendment Flag Amendment Flag Useful life Weighted Average Remaining Period (Years) Finite-Lived Intangible Asset, Useful Life Operating lease cost Operating Lease, Cost Sale of stock (in shares) Investment in Equity Securities, FV-NI, Shares Investment in Equity Securities, FV-NI, Shares Acquired goodwill related to Freedom Photonics in 2022 Goodwill, Acquired During Period Revenue Business Acquisition, Pro Forma Revenue Total liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Other significant items: Segment Reporting, Other Significant Reconciling Item, Consolidated [Abstract] Construction in progress Construction in Progress [Member] Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Transaction costs related to merger with Gores Payments of Merger Related Costs, Financing Activities Deferred tax assets: Components of Deferred Tax Assets [Abstract] Other non-current assets Other non-current assets Other Assets, Noncurrent Weighted- Average Remaining Contractual Life (Years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Depreciation and amortization Depreciation and amortization Depreciation, Depletion and Amortization Percentage of purchase price of shares Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Thereafter Finite-Lived Intangible Asset, Expected Amortization, after Year Five Issuance of Class A common stock upon exercise of Public and Private Warrants (in shares) Shares issued for exercise of warrants (in shares) Stock Issued During Period, Shares, Warrants Exercised Stock Issued During Period, Shares, Warrants Exercised Term of lease (in moths) Lessee, Operating Lease, Term of Contract Beginning of the period End of the period Intangible Assets, Net (Including Goodwill) Debt instrument, convertible, threshold percent of conversion price triggering convertible feature Debt Instrument, Convertible, Threshold Percent Of Conversion Price Triggering Convertible Feature Debt Instrument, Convertible, Threshold Percent Of Conversion Price Triggering Convertible Feature Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Cash paid for operating leases included in operating activities Operating Lease, Payments Repayment of debt Repayments of Long-Term Debt Issuance of Class A common stock upon exercise of warrants Conversion Of Warrants, Amount Issued Conversion Of Warrants, Amount Issued Stock options Share-Based Payment Arrangement, Option [Member] Volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Optogration Optogration Awards [Member] Optogration Awards Net unrealized gains (losses) on available-for-sale debt securities OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax Stock-based awards—Liability classified Share-Based Payment Arrangement, Liability Classified Awards [Member] Share-Based Payment Arrangement, Liability Classified Awards Common stock, shares authorized (in shares) Common Stock, Shares Authorized Stock redeemed (in shares) Business Combination, Stock Redeemed, Shares Business Combination, Stock Redeemed, Shares Total operating expenses Operating Expenses Maximum Maximum [Member] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Retirement of Class A shares Stock Repurchased and Retired During Period, Value Cash and cash equivalents Total cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Weighted average remaining lease term Weighted Average Remaining Lease Term [Abstract] Weighted Average Remaining Lease Term [Abstract] Investment in ECARX Holdings, Inc. (ECX) (in shares) Stock Issued During Period, Shares, Investment Stock Issued During Period, Shares, Investment Shares used in computing net loss per share attributable to common stockholders: Earnings Per Share, Basic and Diluted EPS [Abstract] Earnings Per Share, Basic and Diluted EPS Chief Legal Officer Chief Legal Officer [Member] Chief Legal Officer Business Acquisition [Line Items] Business Acquisition [Line Items] Measurement Frequency [Domain] Measurement Frequency [Domain] Stockholders’ Equity (Deficit) Stockholders' Equity Note Disclosure [Text Block] Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Purchases of marketable securities (including $17,846 and $16,423 with related parties in 2022 and 2021, respectively, see Note 17) Payments to Acquire Debt Securities, Available-for-Sale Cost of Sales Cost of Goods and Service [Policy Text Block] Debt instrument, convertible, threshold trading days Debt Instrument, Convertible, Threshold Trading Days Sublease income Sublease Income Retirement of Class A shares (in shares) Repurchase of Class A shares (in shares) Stock Repurchased and Retired During Period, Shares Accounts receivable Increase (Decrease) in Accounts Receivable Title of 12(b) Security Title of 12(b) Security Contract with Customer, Liability [Roll Forward] Contract with Customer, Liability [Roll Forward] Contract with Customer, Liability Schedule of Reconciliation of the Total Amounts of Unrecognized Tax Benefits Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Subsequent Event [Line Items] Subsequent Event [Line Items] Length of offering period (in months) Employee Stock Purchase Plan, Length of Offering Period Employee Stock Purchase Plan, Length of Offering Period Gross Unrealized Losses Available-for-sale securities in excess of fair value Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss Segment and Customer Concentration Information Segment Reporting Disclosure [Text Block] Price Volatility Measurement Input, Price Volatility [Member] Amortization of premium on marketable securities Accretion (Amortization) of Discounts and Premiums, Investments Net deferred tax assets (liabilities) Deferred Tax Liabilities, Net LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) Liabilities and Equity [Abstract] Research and development activities, amortized over period Research and Development Activities, Amortized Over Period Research and Development Activities, Amortized Over Period U.S. treasury securities US Treasury Securities [Member] Change in fair value of warrants Fair Value Adjustment Of Warrants And Financial Instruments Subject to Mandatory Redemption Fair Value Adjustment Of Warrants And Financial Instruments Subject to Mandatory Redemption Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Inventory Total inventory Inventories, net Inventory, Net Accounts payable Accounts Payable, Current Income Tax Authority [Axis] Income Tax Authority [Axis] Proceeds from issuance of convertible senior notes, net of debt discounts Debt Instrument, Unamortized Discount Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Debt instrument, convertible, threshold percentage of stock price trigger Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger Proceeds from sale of Class A common stock under ESPP Proceeds from Issuance of Common Stock Basic (in shares) Weighted average Common shares outstanding- Basic (in shares) Weighted Average Number of Shares Outstanding, Basic Stock redeemed, redemption price (in dollars per share) Business Combination, Stock Redeemed, Redemption Price Per Share Business Combination, Stock Redeemed, Redemption Price Per Share Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Preferred stock Preferred Stock, Value, Issued Restricted cash Restricted Cash, Current Restricted Stock Stock-based awards—Liability classified Restricted Stock [Member] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] General and administrative General and Administrative Expense [Member] Corporate bonds Corporate Bond Securities [Member] Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Customer One Customer One [Member] Customer One Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Level 3 Fair Value, Inputs, Level 3 [Member] Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract] Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract] Percentage of outstanding stock maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum Estimated contract losses Contract with Customer, Asset, Allowance for Credit Loss Stock-based Compensation Share-Based Payment Arrangement [Text Block] Stock Based Compensation Costs Stock Based Compensation Costs [Member] Stock Based Compensation Costs Work-in-process Inventory, Work in Process, Net of Reserves Purchases of capped call options related to the convertible senior notes Purchases of Capped Call Options Related to the Convertible Senior Notes Value Purchases of Capped Call Options Related to the Convertible Senior Notes Value Merger recapitalization—Class A Temporary Equity, Elimination as Part of Reorganization Note term (in months) Debt Instrument, Term Schedule of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Issuance of Series X convertible preferred stock for cash, net of issuance costs Issuance cost paid for Series X convertible preferred stock Payments For Temporary Equity Issuance Costs Payments For Temporary Equity Issuance Costs Goodwill [Roll Forward] Goodwill [Roll Forward] Related Party [Axis] Related Party [Axis] Timing of Transfer of Good or Service [Domain] Timing of Transfer of Good or Service [Domain] Land Land [Member] Organization, Consolidation and Presentation of Financial Statements [Abstract] Level 2 Fair Value, Inputs, Level 2 [Member] Period of Time, Two Share Price Triggering Event Two [Member] Share Price Triggering Event Two Convertible Senior Notes Debt, Policy [Policy Text Block] Debt Instrument, Redemption, Period One Debt Instrument, Redemption, Period One [Member] Private Warrants Private Warrants [Member] Private Warrants Other Other Accrued Liabilities, Miscellaneous, Current Other Accrued Liabilities, Miscellaneous, Current Current Fiscal Year End Date Current Fiscal Year End Date Other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Intangible assets, net Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Tranche Two Share-Based Payment Arrangement, Tranche Two [Member] Loss on sale or disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Share-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Change in fair value of warrant liabilities Change in fair value of warrant liabilities Fair Value Adjustment of Warrants Concentration Risk Type [Axis] Concentration Risk Type [Axis] Total current liabilities Liabilities, Current Customer Concentration Risk Customer Concentration Risk [Member] Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items] Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items] Unrecognized tax benefits that would impact effective tax rate, if recognized Unrecognized Tax Benefits that Would Impact Effective Tax Rate Vendor payments under the stock-in-lieu of cash program (in shares) Shares issued for services (in shares) Stock Issued During Period, Shares, Issued for Services Revenue, remaining performance obligation, amount Revenue, Remaining Performance Obligation, Amount Award expiration period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Swiss Re Swiss Re [Member] Swiss Re Revenue from contract with customer benchmark Revenue from Contract with Customer Benchmark [Member] Income Tax Authority [Domain] Income Tax Authority [Domain] Total cost of sales Cost of Revenue Other financing activities Proceeds from (Payments for) Other Financing Activities Europe and Middle East Europe And Middle East [Member] Europe And Middle East Valuation allowance, increase (decrease), amount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Fair Value Disclosures [Abstract] Issuance of Series X convertible preferred stock for cash, net of issuance costs Gross proceeds from stock issuance Temporary Equity, Stock Issued During Period, Value, New Issues Vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value U.S. agency and government sponsored securities U.S. agency securities US Government Corporations and Agencies Securities [Member] Equity [Abstract] Subsequent Event [Table] Subsequent Event [Table] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Other receivables Other Receivables, Net, Current Exchange ratio (in dollars per share) Business Combination, Exchange Ratio, Per Acquiree Share Business Combination, Exchange Ratio, Per Acquiree Share Issuance of earn-out shares Stock Issued During Period, Contingent Consideration, Equity, Value Stock Issued During Period, Contingent Consideration, Equity, Value Entity Tax Identification Number Entity Tax Identification Number Shares authorized for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Stock-based compensation expense Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits Deemed dividend attributable to BCF accretion Temporary Equity, Accretion to Redemption Value, Adjustment Schedule of Effective Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Net increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Entity Central Index Key Entity Central Index Key Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Payments of employee taxes related to vested restricted stock units Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Aggregate consideration transferred Business Combination, Consideration Transferred Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Stock option, capped calls, initial cap price (in dollars per share) Stock Option, Capped Calls, Initial Cap Price Stock Option, Capped Calls, Initial Cap Price Measurement Input Type [Axis] Measurement Input Type [Axis] Entity [Domain] Entity [Domain] City Area Code City Area Code Issuance of shares for investment in Robotic Research Opco, LLC Issuance of Shares for Investment in Values Issuance of Shares for Investment in Values ASSETS Assets [Abstract] Prepaid expenses and other current assets Increase (Decrease) in Other Current Assets ECARX Holdings Inc., ECARX Holdings Inc., [Member] ECARX Holdings Inc., Sale of Stock [Axis] Sale of Stock [Axis] Prepaid expenses Other Prepaid Expense, Current Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Capitalized costs Capitalized Costs, Support Equipment and Facilities Solfice Solfice Awards [Member] Solfice Awards Optogration milestone awards, remaining obligations Share-Based Compensation Arrangement by Share-Based Payment Award, Remaining Milestone Obligations Share-Based Compensation Arrangement by Share-Based Payment Award, Remaining Milestone Obligations Asset Class [Axis] Asset Class [Axis] Share-based compensation Share-Based Payment Arrangement, Noncash Expense Weighted-average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Redemption price per warrant (in dollars per share) Class Of Warrant Or Right, Redemption Price Per Warrant Class Of Warrant Or Right, Redemption Price Per Warrant Warrants outstanding (in shares) Class of Warrant or Right, Outstanding Other non-current liabilities Other Liabilities, Noncurrent Private and Public Warrants Private And Public Warrants [Member] Private And Public Warrants Advance payments to vendors Prepaid Supplies Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment 2023 Finite-Lived Intangible Asset, Expected Amortization, Year One Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Operating lease right-of-use assets obtained in exchange for lease obligations Operating leases Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Short-term leases Short-Term Lease Payments Customer [Domain] Customer [Domain] Other permanent items Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Total lease payments Lessee, Operating Lease, Liability, to be Paid (Decrease) / increase to expenses as a result of transaction costs and stock-based compensation expense Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Entity Address, Postal Zip Code Entity Address, Postal Zip Code Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Proceeds from issuance of Series X convertible preferred stock Proceeds from Issuance of Convertible Preferred Stock Total marketable investments Investments, Fair Value Disclosure Vendor stock-in-lieu of cash program Payments To Vendors For Services, Noncash, Operating Activities Payments To Vendors For Services, Noncash, Operating Activities Freedom Photonics Freedom Photonics [Member] Freedom Photonics Vendor payments in shares in lieu of cash (in shares) Vendor Payments In Stock in Lieu Of Cash, Shares Vendor Payments In Stock in Lieu Of Cash, Shares Incremental number of shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Incremental Number of Shares Authorized Share-Based Compensation Arrangement by Share-Based Payment Award, Incremental Number of Shares Authorized Income Tax Disclosure [Abstract] Robotic Research OpCo, LLC Robotic Research OpCo, LLC [Member] Robotic Research OpCo, LLC Accrued compensation and benefits Accrued Employee Benefits, Current Market One Member Market One Member [Member] Market One Member Statistical Measurement [Domain] Statistical Measurement [Domain] Contractual interest expense Interest Expense, Debt, Excluding Amortization Share-Based Payment Arrangement [Abstract] Conversion of SAFE into Series A common stock and Issuance of Class A common stock upon exercise of warrants Stock Issued During Period, Value, Conversion of Convertible Securities Debt Instrument, Redemption, Period Three Debt Instrument, Redemption, Period Three [Member] Schedule of Business Acquisitions, by Acquisition Schedule of Business Acquisitions, by Acquisition [Table Text Block] United States Domestic Tax Authority [Member] Property and equipment, net Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Purchase transaction Treasury Stock, Value, Acquired, Cost Method Amounts billed that were included in the contract assets beginning balance Contract with Customer, Asset, Reclassified to Receivable Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Net loss Net loss Net loss Net Income (Loss) Attributable to Parent Schedule of Employee Stock Purchase Plan, Valuation Assumptions Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Leases Lessee, Finance Leases [Text Block] Series X Convertible Preferred Stock Series X Convertible Preferred Stock [Member] Series X Convertible Preferred Stock Subsequent Event Type [Axis] Subsequent Event Type [Axis] Temporary Equity [Line Items] Temporary Equity [Line Items] Debt instrument, redemption price, percentage Debt Instrument, Redemption Price, Percentage Computer hardware and software Computer hardware and software Computer Hardware And Software [Member] Computer Hardware And Software Award vesting percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Earn out shares, measurement input Business Combination, Contingent Equity, Equity Interests Issuable, Measurement Input Business Combination, Contingent Equity, Equity Interests Issuable, Measurement Input Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Leases Lessee, Operating Leases [Text Block] Treasury stock, at cost, 21,863,450 and 15,263,761 shares as of December 31, 2022 and 2021, respectively Treasury Stock, Common, Value Plan Name [Axis] Plan Name [Axis] Contract assets Contract with customer, asset, total Beginning balance Ending balance Contract with Customer, Asset, after Allowance for Credit Loss Contract With Customer Asset [Roll Forward] Contract With Customer Asset [Roll Forward] Contract With Customer Asset Supplemental disclosures of cash flow information: Supplemental Cash Flow Elements [Abstract] Executive Officer Executive Officer [Member] Revenue: Segment Reporting Information, Revenue for Reportable Segment [Abstract] Number of operating segments Number of Operating Segments Cash received from Gores on recapitalization Cash Acquired From Acquisition, Financing Activities Cash Acquired From Acquisition, Financing Activities Goodwill [Line Items] Goodwill [Line Items] Statement of Cash Flows [Abstract] Level 1 Fair Value, Inputs, Level 1 [Member] Expense related to Volvo Warrants Adjustment of Warrants Granted for Services Customer Three Customer Three [Member] Customer Three Denominator: Weighted Average Number of Shares Outstanding, Basic [Abstract] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Fair value of financial instruments Effective Income Tax Rate Reconciliation, Fair Value Of Financial Instruments, Percent Effective Income Tax Rate Reconciliation, Fair Value Of Financial Instruments, Percent Contract asset Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contract Asset Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contract Asset Market Two Member Market Two Member [Member] Market Two Member Schedule of Restricted Stock Activity Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Debt Securities, Available-for-sale Debt Securities, Available-for-Sale [Table Text Block] Reduction in liability due to exercises Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements IPR&D In Process Research and Development [Member] Stock-based awards—Equity classified Share-Based Payment Arrangement, Equity Classified Awards [Member] Share-Based Payment Arrangement, Equity Classified Awards Cancelled/Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Document Annual Report Document Annual Report Liability Class [Axis] Liability Class [Axis] Legal Entity [Axis] Legal Entity [Axis] Liability recorded related to warrants from business combination Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Warrants Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Warrants Intangible Assets (Including Goodwill) [Roll Forward] Intangible Assets (Including Goodwill) [Roll Forward] Intangible Assets (Including Goodwill) Asset acquisition, consideration service, period Asset Acquisition, Consideration Service, Period Asset Acquisition, Consideration Service, Period Public and Private Warrants Adjustments to Additional Paid in Capital, Warrants Adjustments to Additional Paid in Capital, Warrants Solfice Solfice [Member] Solfice Geographical [Axis] Geographical [Axis] Cash and cash equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units Stock Issued During Period, Value, New Issues Schedule of Property and Equipment Property, Plant and Equipment [Table Text Block] Marketable securities (including $0 and $12,200 with a related party as of December 31, 2022 and 2021, see Note 17) Marketable securities, related party Debt Securities, Available-for-Sale, Current Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Recognized at a point in time Transferred at Point in Time [Member] Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Number of shares issued for each vested RSU (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Issued for Each Vested RSU Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Issued for Each Vested RSU Segments [Axis] Segments [Axis] Debt Debt Disclosure [Text Block] Audit Information [Abstract] Audit Information Product and Service [Domain] Product and Service [Domain] Entity Shell Company Entity Shell Company Class B Common Stock Common Class B [Member] Accrued and other current liabilities Increase (Decrease) in Accrued Liabilities Decreases related to prior year tax provisions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions ATS ATS Advanced Technologies and Services Segment [Member] Advanced Technologies and Services Segment Period of Time, Six Share Price Triggering Event Six [Member] Share Price Triggering Event Six Investment in ECARX Holdings, Inc. Stock Issued During Period, Value, Investment Stock Issued During Period, Value, Investment Gores Metropoulos Gores Metropoulos [Member] Gores Metropoulos Concentration Risk [Table] Concentration Risk [Table] 2023 Lessee, Operating Lease, Liability, to be Paid, Year One Earn-out shares issued (in shares) Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Financial Instrument [Axis] Financial Instrument [Axis] Aggregate number of Class A and Class B Common Stock shares entitled to stockholders (in shares) Business Combination, Contingent Equity, Shares Business Combination, Contingent Equity, Shares Purchases of marketable securities with related parties Payments to Acquire Debt Securities, Available-for-sale, Related Party Payments to Acquire Debt Securities, Available-for-sale, Related Party Deferred tax liabilities: Components of Deferred Tax Liabilities [Abstract] Vehicles, including demonstration fleet Vehicles [Member] Related Party Affiliated Entity [Member] Consolidation Items [Domain] Consolidation Items [Domain] Subsequent Event Subsequent Event [Member] Share-based Payment Arrangement, Nonemployee Share-Based Payment Arrangement, Nonemployee [Member] Document Period End Date Document Period End Date Market Three Member Market Three Member [Member] Market Three Member Warranty reserves Product Warranty Accrual, Current Series A Convertible Preferred Stock Series A Convertible Preferred Stock [Member] Series A Convertible Preferred Stock Total assets Segment assets Assets Net loss per share attributable to common stockholders: Earnings Per Share [Abstract] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Marketable equity investments Equity Securities, FV-NI, Current Issuance of earn-out shares (in shares) Stock Issued During Period, Contingent Consideration, Equity, Shares Stock Issued During Period, Contingent Consideration, Equity, Shares Repurchases of common stock and redemption of warrants Payments For Repurchase Of Common Stock And Warrants Payments For Repurchase Of Common Stock And Warrants 2027 Lessee, Operating Lease, Liability, to be Paid, Year Five Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Conversion of Series A, Series X and Founders’ convertible preferred stock into Class A and Class B common stock Conversion Of Temporary Equity, Amount Issued Conversion Of Temporary Equity, Amount Issued Shares repurchased Stock Repurchase Program, Authorized Amount Asset-backed securities Asset-Backed Securities [Member] Loss before provision for (benefit from) income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Segments [Domain] Segments [Domain] Share price (in dollars per share) Business Acquisition, Contingent Consideration, Share Price Trigger Business Acquisition, Contingent Consideration, Share Price Trigger Schedule of Goodwill [Table] Schedule of Goodwill [Table] Amortization of debt discount and issuance costs Amortization of Debt Issuance Costs and Discounts Earnings (Loss) Per Share Earnings Per Share [Text Block] Other Deferred Tax Liabilities, Other Earn-out shares Earn-Out Shares [Member] Earn-Out Shares Schedule of the impact of Adjustments to the Unaudited Pro Forma Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table Text Block] Fair value of options vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Award Type [Domain] Award Type [Domain] Grantee Status [Axis] Grantee Status [Axis] Loss on extinguishment of debt Loss on extinguishment of debt Gain (Loss) on Extinguishment of Debt Executive compensation Effective Income Tax Rate Reconciliation, Executive Compensation, Percent Effective Income Tax Rate Reconciliation, Executive Compensation, Percent Schedule of Other Noncurrent Assets Schedule of Other Assets, Noncurrent [Table Text Block] Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units (in Shares) Stock Issued During Period, Shares, New Issues Shares authorized (in shares) Temporary Equity, Shares Authorized Intangible Assets and Goodwill Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Inventories, net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Tranche Four Share-Based Payment Arrangement, Tranche Four [Member] Share-Based Payment Arrangement, Tranche Four Investment, fair value Investments, Related Party, Fair Value Investments, Related Party, Fair Value Customer relationships Customer Relationships [Member] Entity Address, City or Town Entity Address, City or Town Operating expenses: Operating Expenses [Abstract] Eliminations Intersegment Eliminations [Member] Conversion ratio Common Stock, Convertible, Conversion Ratio Common Stock, Convertible, Conversion Ratio Statement of Financial Position [Abstract] Raw materials Inventory, Raw Materials, Net of Reserves Debt issuance costs, net Debt Issuance Costs, Net Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Treasury Stock Treasury Stock, Common [Member] Auditor Name Auditor Name Accounting Standards Update [Axis] Accounting Standards Update [Axis] Net operating loss carryforwards Operating Loss Carryforwards Convertible Senior Notes Convertible Debt Securities [Member] ECARX Holdings, Inc. (ECX) ECARX Holdings, Inc. (ECX) [Member] ECARX Holdings, Inc. (ECX) Transaction costs Business Acquisition, Transaction Costs Treasury stock, at cost (in shares) Treasury stock, shares outstanding (in shares) Treasury Stock, Common, Shares Contract liabilities, non-current Contract with Customer, Liability, Noncurrent Research and development Research and Development Expense Increases related to prior year tax positions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Depreciation and amortization Deferred Tax Liabilities, Property, Plant and Equipment And Intangibles, Depreciation And Amortization Deferred Tax Liabilities, Property, Plant and Equipment And Intangibles, Depreciation And Amortization Research Tax Credit Carryforward Research Tax Credit Carryforward [Member] RSUs Restricted Stock Units (RSUs) [Member] Risk Free Interest Rate Measurement Input, Risk Free Interest Rate [Member] Machinery and equipment Other Machinery and Equipment [Member] Vested and expected to vest (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Total cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Subsequent Events [Abstract] Additional shares authorized for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Sale of stock, number of warrants per unit (in shares) Sale Of Stock, Number Of Warrants Per Unit Sale Of Stock, Number Of Warrants Per Unit Investments Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Proceeds from sales/redemptions of marketable securities with related parties Proceeds from Debt Securities, Available-for-Sale, Related Party Proceeds from Debt Securities, Available-for-Sale, Related Party Net operating loss carryforwards, subject to expiration Operating Loss Carryforwards, Subject To Expiration Operating Loss Carryforwards, Subject To Expiration Debt prepayment charges Payment for Debt Extinguishment or Debt Prepayment Cost U.S. state Deferred State and Local Income Tax Expense (Benefit) Number of triggering events Business Acquisition, Number Of Triggering Events Business Acquisition, Number Of Triggering Events Amortization Amortization of Intangible Assets Stock price of warrants (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Schedule of Goodwill Schedule of Goodwill [Table Text Block] Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Operating lease right-of-use assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-Use Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-Use Assets 2025 Lessee, Operating Lease, Liability, to be Paid, Year Three Inventory Inventory, Policy [Policy Text Block] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Sales and marketing Selling and Marketing Expense Total stockholders’ equity (deficit) Beginning balance Ending balance Stockholders' Equity Attributable to Parent Research and development tax credit carryforwards Tax Credit Carryforward, Amount Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Vesting [Domain] Vesting [Domain] Issuance of Series X convertible preferred stock for cash, net of issuance costs (in shares) Preferred stock issued (in shares) Temporary Equity, Stock Issued During Period, Shares, New Issues Temporary Equity, Stock Issued During Period, Shares, New Issues Tax credits Deferred Tax Assets, Tax Credit Carryforwards Other Deferred Tax Assets, Other Mr Alec Gores Mr Alec Gores [Member] Mr Alec Gores Series A And Series X Convertible Preferred Stock Series A And Series X Convertible Preferred Stock [Member] Series A And Series X Convertible Preferred Stock Sale of stock (in shares) Sale of Stock, Number of Shares Issued in Transaction Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Tooling Tooling [Member] Tooling 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Three Schedule of Changes in Level 3 Liabilities Measured at Fair Value Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Other non-current assets Other Assets, Miscellaneous, Noncurrent Proceeds from sales/redemptions of marketable securities (including $24,753 and $4,396 with related parties in 2022 and 2021, respectively, see Note 17) Proceeds from Sale of Debt Securities, Available-for-Sale Accumulated Deficit Retained Earnings [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Unrecognized stock-based compensation expense Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Total operating lease cost Lease, Cost Common Stock Common Stock [Member] Money market funds Money Market Funds, at Carrying Value Schedule of Components of Lease Expenses, Supplemental Cash Flow Information, Weighted Average Remaining Terms, and Weighted Average Discount Rates Lease, Cost [Table Text Block] Statement [Table] Statement [Table] Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Debt instrument, convertible, shares issuable (in shares) Debt Instrument, Convertible, Shares Issuable Debt Instrument, Convertible, Shares Issuable Acquisitions Stock Issued During Period, Value, Acquisitions Cash held in foreign entities Intercompany Foreign Currency Balance, Amount Furniture and fixtures Furniture and fixtures Furniture and Fixtures [Member] Operating lease liabilities, non-current Operating lease liabilities, non-current Operating Lease, Liability, Noncurrent Statistical Measurement [Axis] Statistical Measurement [Axis] IPR&D Indefinite-Lived Intangible Assets (Excluding Goodwill) Leasehold improvements Leasehold Improvements [Member] Grantee Status [Domain] Grantee Status [Domain] Change in fair value of outstanding warrants Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Convertible senior notes, fair value Convertible Debt, Fair Value Disclosures Equity Components [Axis] Equity Components [Axis] Timing of Transfer of Good or Service [Axis] Timing of Transfer of Good or Service [Axis] Number of triggering events met Business Acquisition, Number Of Triggering Events Met Business Acquisition, Number Of Triggering Events Met Segment Information Segment Reporting, Policy [Policy Text Block] Tax Credit Carryforward [Axis] Tax Credit Carryforward [Axis] Statement [Line Items] Statement [Line Items] Outstanding at beginning of period (in shares) Outstanding at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Total other income (expense), net Nonoperating Income (Expense) Recorded Value Gross Carrying Amount Finite-Lived Intangible Assets, Gross Weighted average purchase price (in dollars per share) Employee Stock Ownership Plan (ESOP), Weighted Average Purchase Price of Shares Purchased Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Operating lease right-of-use assets Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Shares repurchased Stock Repurchased During Period, Value Accumulated Other Comprehensive Income Loss AOCI Attributable to Parent [Member] Non-Marketable Equity Investments Measured Using the Measurement Alternative Equity Securities without Readily Determinable Fair Value [Policy Text Block] Auditor Firm ID Auditor Firm ID Merger recapitalization—Class A Stock Issued During Period, Value, Reverse Recapitalization Stock Issued During Period, Value, Reverse Recapitalization Document Transition Report Document Transition Report Foreign Tax Authority Foreign Tax Authority [Member] Local Phone Number Local Phone Number Schedule of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Loss from operations Operating gain (loss) Operating Income (Loss) Inventory reserves Deferred Tax Assets, Inventory Recently Adopted Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Net operating loss carryforwards, not subject to expiration Operating Loss Carryforwards, Not Subject To Expiration Operating Loss Carryforwards, Not Subject To Expiration U.S. State State and Local Jurisdiction [Member] Services Service [Member] 2015 Plan 2015 Plan [Member] 2015 Plan Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share 2026 Lessee, Operating Lease, Liability, to be Paid, Year Four Income Statement [Abstract] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross U.S. federal Deferred Federal Income Tax Expense (Benefit) Impairment of long-lived assets Impairment, Long-Lived Asset, Held-for-Use Additional Paid-in Capital Additional Paid-in Capital [Member] Document Fiscal Period Focus Document Fiscal Period Focus Intrinsic value of stock options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Prepaid expenses Deferred Tax Liabilities, Prepaid Expenses Cash and Cash Equivalents Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block] Diluted (in shares) Weighted average Common shares outstanding- Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Seagate Seagate [Member] Seagate Change in fair value prior to exercises Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings, Prior to Exercise Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings, Prior to Exercise Expect term (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Marketable equity investments Equity Securities, FV-NI Non-marketable equity investment measured using the measurement alternative Equity Securities, FV-NI, Noncurrent Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Warranty related to sensors Product Warranty Expense ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Current Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Issuance of Class A common stock upon exercise of Public and Private Warrants Stock Issued During Period, Value, Warrants Exercised Stock Issued During Period, Value, Warrants Exercised Tax credit carryforward, not subject to expiration Tax Credit Carryforward, Not Subject To Expiration Tax Credit Carryforward, Not Subject To Expiration Freedom Photonics Freedom Photonics Awards [Member] Freedom Photonics Awards Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Asia Pacific Asia Pacific [Member] Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements on a Recurring Basis and the Level of Inputs Used Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Reportable Segments Operating Segments [Member] Convertible Debt Convertible Debt [Member] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Private Placement Private Placement [Member] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Stock consideration Increase (Decrease) in Equity Securities, FV-NI Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Expense related to Volvo Warrants Adjustments to Additional Paid in Capital, Warrant Issued Proceeds from the issuance of debt Proceeds from Issuance of Long-Term Debt Net loss attributable to common stockholders Net loss attributable to common shareholders Net Income (Loss) Available to Common Stockholders, Basic Common stock, shares issued (in shares) Common Stock, Shares, Issued Concentration Risk [Line Items] Concentration Risk [Line Items] Security deposits Deposits Assets, Noncurrent Purchases of property and equipment recorded in accounts payable and accrued liabilities Capital Expenditures Incurred but Not yet Paid Schedule of Equity Investments Included in Marketable Securities Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block] Recognized over time Transferred over Time [Member] Merger related expenses incurred Business Combination, Acquisition Related Costs Convertible senior notes Convertible Notes Payable, Noncurrent Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Temporary Equity, by Class of Stock [Table] Temporary Equity, by Class of Stock [Table] Principal Debt Instrument, Face Amount Issuance of Class A common stock under ESPP Stock Issued During Period, Value, Employee Stock Purchase Plan Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent VCTF warrant Volvo Car Technology Fund Warrant [Member] Volvo Car Technology Fund Warrant Schedule of Segment Operating Results and Reconciliations to the Consolidated Balances Schedule of Segment Reporting Information, by Segment [Table Text Block] Entity Current Reporting Status Entity Current Reporting Status Autonomy Solutions Autonomy Solutions Autonomy Solutions Segment [Member] Autonomy Solutions Segment 2020 Plan 2020 Plan [Member] 2020 Plan Nonrecurring Adjustment [Axis] Nonrecurring Adjustment [Axis] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Chief Executive Officer Chief Executive Officer [Member] Statutory tax rate U.S. federal provision at statutory rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Issuance of Class A common stock under ESPP (in shares) Weighted average purchase price (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Outstanding at beginning of period (in shares) Outstanding at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Warrants exercised (in shares) Class Of Warrant Or Right, Exercised Class Of Warrant Or Right, Exercised IPO IPO [Member] State income taxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Customer backlog Customer Backlog [Member] Customer Backlog Mr. Heng Mr. Heng [Member] Mr. Heng Total property and equipment, net Property, Plant and Equipment, Net Basis of Presentation and Consolidation Basis of Accounting, Policy [Policy Text Block] Liabilities [Abstract] Liabilities [Abstract] Weighted average discount rate Leases, Weighted Average Discount Rate [Abstract] Leases, Weighted Average Discount Rate [Abstract] Vendor stock-in-lieu of cash program Vendor Stock-In-Lieu Of Cash Program [Member] Vendor Stock-In-Lieu Of Cash Program Schedule of Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] Sales and marketing Selling and Marketing Expense [Member] Other non-current assets Increase (Decrease) in Other Noncurrent Assets Title of Individual [Domain] Title of Individual [Domain] Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Balance Sheet Location [Axis] Balance Sheet Location [Axis] Sale of stock, price per share (in dollars per share) Sale of Stock, Price Per Share Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Investment Investments, Related Party Investments, Related Party Class A Common Stock Common Class A [Member] Depreciation and amortization Deferred Tax Assets, Property, Plant and Equipment And Intangibles, Depreciation And Amortization Deferred Tax Assets, Property, Plant and Equipment And Intangibles, Depreciation And Amortization Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Total current assets Assets, Current Revenue recognized that was included in the contract liabilities beginning balance Contract with Customer, Liability, Revenue Recognized Entity Small Business Entity Small Business Issuance of Class A common stock for investment in Robotic Research OpCo, LLC Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable Amortization of operating lease right-of-use assets Operating Lease, Right-of-Use Asset, Amortization Expense Shares issued in period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Net Carrying Amount Finite-Lived Intangible Assets, Net Percentage of Class A shareholders Class Of Warrant Or Right, Cash Settlement, Transaction Threshold Percentage Of Shareholders Class Of Warrant Or Right, Cash Settlement, Transaction Threshold Percentage Of Shareholders Revenue, remaining performance obligation, period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Basis of Presentation and Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Shares Number of Stock Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Amortization of debt discount and issuance costs Amortization of Debt Discount (Premium) Interest income and other Interest Income (Expense) And Other, Nonoperating, Net Interest Income (Expense) And Other, Nonoperating, Net Nonrecurring Adjustment [Domain] Nonrecurring Adjustment [Domain] Convertible Preferred Stock Temporary Equity [Text Block] Temporary Equity Outstanding balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Schedule of Interest Expense Schedule of Interest Expense [Table Text Block] Schedule of Interest Expense Consecutive trading days Consecutive Trading Days Consecutive Trading Days Shares issued upon conversion (in shares) Conversion of Stock, Shares Issued Debt Instrument [Line Items] Debt Instrument [Line Items] Business Combination and Asset Acquisition [Abstract] Class of Warrant or Right [Table] Class of Warrant or Right [Table] Class of Stock [Line Items] Class of Stock [Line Items] Optogration milestone awards (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Debt issuance costs Payments of Debt Issuance Costs Operating lease liabilities Total operating lease liabilities Total leases liabilities Operating Lease, Liability Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Investments, Debt and Equity Securities [Abstract] 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Two Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Common stock, shares issued (in shares) Stock Issued During Period, Shares, Purchase of Assets Cost Debt Securities, Available-for-Sale, Amortized Cost Accruals and reserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals Comprehensive Loss: Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Auditor Location Auditor Location Organization and Description of Business Nature of Operations [Text Block] Warrants Warrant [Member] Entity Filer Category Entity Filer Category Purchase price (in dollars per share) Temporary Equity, Stock issued During Period, Value, New Issues, Price Per Share Temporary Equity, Stock issued During Period, Value, New Issues, Price Per Share Demonstration fleet and demonstration units Demonstration Fleet And Demonstration Units [Member] Demonstration Fleet And Demonstration Units Vested and exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Liabilities: Liabilities, Fair Value Disclosure [Abstract] Compensation expense Compensation cost Share-Based Payment Arrangement, Expense Supplemental disclosures of noncash investing and financing activities: Noncash Investing and Financing Items [Abstract] Commitments and contingencies (see Note 15) Commitments and Contingencies Contract losses Contract with Customer, Asset, Allowance for Credit Loss, Current Security Exchange Name Security Exchange Name Outstanding as of Beginning Balance Outstanding as of Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Merger recapitalization—Class A (in shares) Stock Issued During Period, Shares, Reverse Recapitalization Stock Issued During Period, Shares, Reverse Recapitalization Vendor stock-in-lieu of cash program—advances for capital projects and equipment Stock Issued Vendor payments under the stock-in-lieu of cash program Stock Issued During Period, Value, Issued for Services Liability Classified Awards [Axis] Liability Classified Awards [Axis] Liability Classified Awards Total revenue Revenue Revenue from Contract with Customer, Excluding Assessed Tax Conversion of SAFE into Series A common stock and Issuance of Class A common stock upon exercise of warrants (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Issuance of Class A common stock to acquire Optogration, Inc. Stock consideration Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Included in cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents [Member] Cover [Abstract] Entity Voluntary Filers Entity Voluntary Filers Tax credit carryforward, subject to expiration Tax Credit Carryforward, Subject To Expiration Tax Credit Carryforward, Subject To Expiration Impairment of goodwill Goodwill, Impairment Loss Tax credits Effective Income Tax Rate Reconciliation, Tax Credit, Percent Revenue Revenue from Contract with Customer [Text Block] Prepaid expenses and other current assets Prepaid Expenses And Other Current Assets Related To Stock-In-Lieu of Cash Program Prepaid Expenses And Other Current Assets Related To Stock-In-Lieu of Cash Program Schedule of Prepaid Expenses and Other Current Assets Schedule of Other Current Assets [Table Text Block] Segment Reporting [Abstract] Cash received from acquisition of Optogration, Inc. Cash Acquired from Acquisition Debt Instrument, Redemption, Period Two Debt Instrument, Redemption, Period Two [Member] Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Payments of employee taxes related to stock-based awards Payment, Tax Withholding, Share-Based Payment Arrangement Total liabilities and stockholders’ equity (deficit) Liabilities and Equity Equity settled fixed value Fixed Value Equity Awards [Member] Fixed Value Equity Awards Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Stock repurchase program, remaining authorized repurchase amount Stock Repurchase Program, Remaining Authorized Repurchase Amount Cash Cash Product Warranties Standard Product Warranty, Policy [Policy Text Block] Total deferred tax assets Deferred Tax Assets, Gross Schedule of Loss Before Provision for (Benefit from) Income Taxes Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Operating leases: Operating Lease, Assets And Liabilities, Lessee [Abstract] Operating Lease, Assets And Liabilities, Lessee [Abstract] Marketable equity investments Equity Method Investments [Member] Investment in ECARX Holdings, Inc. Payments to Acquire Investments Percentage of pre-tax earnings Share-Based Compensation Arrangement By Share-Based Payment Award, Pre-Tax Earnings, Percent Share-Based Compensation Arrangement By Share-Based Payment Award, Pre-Tax Earnings, Percent Interest and penalties accrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Vesting [Axis] Vesting [Axis] Diluted (in dollars per share) Net loss per share attributable to common shareholders- Diluted (in dollars per share) Earnings Per Share, Diluted Sale of Stock [Domain] Sale of Stock [Domain] Temporary Equity Disclosure [Abstract] Disposal of property and equipment Proceeds from Sale of Property, Plant, and Equipment Award vesting period (in years and in months) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Gores shares recapitalized, net of redemptions and equity issuance costs Payments of Stock Issuance Costs Consolidation Items [Axis] Consolidation Items [Axis] 2024 Lessee, Operating Lease, Liability, to be Paid, Year Two Proceeds from refundable security deposits Proceeds From Refundable Security Deposits Proceeds From Refundable Security Deposits Unrecognized tax benefits as of the beginning of the year Unrecognized tax benefits as of the end of the year Unrecognized Tax Benefits Total deferred tax asset Deferred Tax Assets, Net of Valuation Allowance Customer Two Customer Two [Member] Customer Two Impairment of investments and certain other assets Impairment of investments and certain other assets Other Asset Impairment Charges United States Income (Loss) from Continuing Operations before Income Taxes, Domestic Vested and exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Commercial paper Commercial Paper, at Carrying Value Schedule of Maturities of Lease Liabilities Lessee, Operating Lease, Liability, Maturity [Table Text Block] Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Address Line One Entity Address, Address Line One Contract liabilities Contract with customer, liability, total Beginning balance Ending balance Contract with Customer, Liability Product and Service [Axis] Product and Service [Axis] Class of Stock [Domain] Class of Stock [Domain] Other non-current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Interest expense and other Total interest expense Interest Expense Tradename Trade Names [Member] Schedule of Accrued and Other Current Liabilities Schedule of Accrued Liabilities [Table Text Block] Estimated fair value of the potential earn-out shares Business Combination, Contingent Equity, Equity Interests Issuable Business Combination, Contingent Equity, Equity Interests Issuable Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Machinery and equipment Machinery and Equipment [Member] ROU asset (ASC 842) Deferred Tax Liabilities, Leasing Arrangements Grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Intrinsic Value, Amount Per Share Unamortized debt discount and issuance costs Unamortized Debt Issuance Expense Other non-current assets Other Noncurrent Assets [Member] Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Total deferred tax liabilities Deferred Tax Liabilities, Gross Revenue from Contract with Customer [Abstract] Contract assets, current Contract with Customer, Asset, after Allowance for Credit Loss, Current Reversal of deferred rent Deferred Rent Asset, Net, Current Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Daimler North America Corporation Daimler North America Corporation [Member] Daimler North America Corporation Period of Time, Three Share Price Triggering Event Three [Member] Share Price Triggering Event Three Cash paid for amounts included in the measurement of lease liabilities: Cash Flow, Lessee [Abstract] Cash Flow, Lessee [Abstract] Commercial paper Commercial Paper [Member] 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Five Business Acquisition, Contingent Consideration Triggering Event [Domain] Business Acquisition, Contingent Consideration Triggering Event [Domain] Business Acquisition, Contingent Consideration Triggering Event Measurement Frequency [Axis] Measurement Frequency [Axis] Research and Development (R&D) Research and Development Expense, Policy [Policy Text Block] Weighted Average Grant Date Fair Value per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Accrued expenses Other Accrued Liabilities, Current Business Acquisition, Contingent Consideration Triggering Event [Axis] Business Acquisition, Contingent Consideration Triggering Event [Axis] Business Acquisition, Contingent Consideration Triggering Event Optogration Milestone Awards Optogration Milestone Awards [Member] Optogration Milestone Awards Accounting Standards Update [Domain] Accounting Standards Update [Domain] General and administrative General and Administrative Expense Impairment of intangible assets Impairment of Intangible Assets (Excluding Goodwill) Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Statement of Stockholders' Equity [Abstract] Proceeds from maturities of marketable securities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale Revenue, remaining performance obligation, percentage Revenue, Remaining Performance Obligation, Percentage Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Class A Preferred Units Class A Preferred Units [Member] Class A Preferred Units North America North America [Member] Impairment charges Asset Impairment Charges Research and development Research and Development Expense [Member] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Vendor payments under the stock-in-lieu of cash program Vendor Payments In Stock In Lieu Of Cash, Liability Vendor Payments In Stock In Lieu Of Cash, Liability Cost of sales Cost of Sales [Member] Non-Marketable Equity Investment Non-Marketable Equity Investment [Member] Non-Marketable Equity Investment Schedule of Net Carrying Amount Convertible Debt [Table Text Block] EX-101.PRE 14 lazr-20221231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 15 image_0a.jpg begin 644 image_0a.jpg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end GRAPHIC 16 image_0b.jpg begin 644 image_0b.jpg MB5!.1PT*&@H -24A$4@ !5( !" ( "S \+7 'DE$051X7NW! J01$ P"(/N7UO GRAPHIC 17 image_2.jpg begin 644 image_2.jpg MB5!.1PT*&@H -24A$4@ !5\ !" ( !&_4EG '4E$051X7NW! I,0$ P"(/N7UGL9!B0 # ,[T&AZ8.\F'(: 4 245.1*Y"8((! end GRAPHIC 18 image_4a.jpg begin 644 image_4a.jpg MB5!.1PT*&@H -24A$4@ !3\ !" ( "7&DT7 'DE$051X7NW! J,0$ P"(/N7U@ KL -( @$]Z#+H3$>^)S@7* $E%3D2N0F"" end GRAPHIC 19 lazr-20221231_g1.jpg begin 644 lazr-20221231_g1.jpg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
XML 21 R2.htm IDEA: XBRL DOCUMENT v3.22.4
Audit Information
12 Months Ended
Dec. 31, 2022
Audit Information [Abstract]  
Auditor Name Deloitte & Touche LLP
Auditor Location San Jose, CA
Auditor Firm ID 34
XML 22 R3.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 69,552 $ 329,977
Restricted cash 1,553 725
Marketable securities (including $0 and $12,200 with a related party as of December 31, 2022 and 2021, see Note 17) 419,314 462,141
Accounts receivable 11,172 13,013
Inventory 8,792 10,342
Prepaid expenses and other current assets 44,203 29,195
Total current assets 554,586 845,393
Property and equipment, net 30,260 11,009
Operating lease right-of-use assets 21,244 9,145
Intangible assets, net 22,077 2,424
Goodwill 18,816 3,110
Other non-current assets 40,344 12,455
Total assets 687,327 883,536
Current liabilities:    
Accounts payable 18,626 14,419
Accrued and other current liabilities 52,962 19,844
Operating lease liabilities 5,953 4,735
Total current liabilities 77,541 38,998
Warrant liabilities 3,005 31,230
Convertible senior notes 612,192 608,957
Operating lease liabilities, non-current 16,989 5,768
Other non-current liabilities 4,005 598
Total liabilities 713,732 685,551
Commitments and contingencies (see Note 15)
Stockholders’ equity (deficit):    
Additional paid-in capital 1,558,685 1,257,214
Accumulated other comprehensive loss (4,226) (908)
Treasury stock, at cost, 21,863,450 and 15,263,761 shares as of December 31, 2022 and 2021, respectively (312,477) (235,871)
Accumulated deficit (1,268,426) (822,487)
Total stockholders’ equity (deficit) (26,405) 197,985
Total liabilities and stockholders’ equity (deficit) 687,327 883,536
Preferred Stock    
Stockholders’ equity (deficit):    
Preferred stock 0 0
Class A Common Stock    
Stockholders’ equity (deficit):    
Common stock 29 27
Class B Common Stock    
Stockholders’ equity (deficit):    
Common stock $ 10 $ 10
XML 23 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Stockholders’ equity (deficit):    
Marketable securities, related party $ 419,314 $ 462,141
Preferred stock, shares outstanding (in shares) 0  
Treasury stock, at cost (in shares) 21,863,450 15,263,761
Related Party    
Stockholders’ equity (deficit):    
Marketable securities, related party $ 0 $ 12,200
Preferred Stock    
Stockholders’ equity (deficit):    
Preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized (in shares) 10,000,000 10,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Class A Common Stock    
Stockholders’ equity (deficit):    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 715,000,000 715,000,000
Common stock, shares issued (in shares) 291,942,087 266,076,525
Common stock, shares outstanding (in shares) 270,078,637 250,812,764
Treasury stock, at cost (in shares)   15,263,761
Class B Common Stock    
Stockholders’ equity (deficit):    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 121,000,000 121,000,000
Common stock, shares issued (in shares) 97,088,670 97,088,670
Common stock, shares outstanding (in shares) 97,088,670 97,088,670
XML 24 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Total revenue $ 40,698 $ 31,944 $ 13,951
Total cost of sales 100,983 46,092 24,952
Gross loss (60,285) (14,148) (11,001)
Operating expenses:      
Research and development 185,283 88,861 38,651
Sales and marketing 38,672 17,858 7,948
General and administrative 158,162 93,685 29,275
Total operating expenses 382,117 200,404 75,874
Loss from operations (442,402) (214,552) (86,875)
Change in fair value of warrant liabilities 9,222 (26,126) (268,266)
Impairment of investments and certain other assets (6,016) 0 0
Loss on extinguishment of debt 0 0 (3,996)
Interest expense and other (11,095) (2,028) (2,885)
Interest income and other 5,024 3,458 (276)
Total other income (expense), net (2,865) (24,696) (275,423)
Loss before provision for (benefit from) income taxes (445,267) (239,248) (362,298)
Provision for (benefit from) income taxes 672 (1,262) 0
Net loss (445,939) (237,986) (362,298)
Net loss attributable to common stockholders $ (445,939) $ (237,986) $ (369,055)
Net loss per share attributable to common stockholders:      
Basic (in dollars per share) $ (1.25) $ (0.69) $ (2.54)
Diluted (in dollars per share) $ (1.25) $ (0.69) $ (2.54)
Shares used in computing net loss per share attributable to common stockholders:      
Basic (in shares) 356,265,774 346,300,975 145,096,996
Diluted (in shares) 356,265,774 346,300,975 145,096,996
Comprehensive Loss:      
Net loss $ (445,939) $ (237,986) $ (362,298)
Net unrealized gains (losses) on available-for-sale debt securities (3,318) (942) 35
Comprehensive loss (449,257) (238,928) (362,263)
Products      
Total revenue 18,492 10,118 4,840
Total cost of sales 61,985 23,484 15,097
Services      
Total revenue 22,206 21,826 9,111
Total cost of sales $ 38,998 $ 22,608 $ 9,855
XML 25 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Optogration, Inc.
ECARX Holdings, Inc. (ECX)
Freedom Photonics
Solfice
Preferred Stock
Additional Paid-in Capital
Additional Paid-in Capital
Optogration, Inc.
Additional Paid-in Capital
ECARX Holdings, Inc. (ECX)
Additional Paid-in Capital
Freedom Photonics
Additional Paid-in Capital
Solfice
Accumulated Other Comprehensive Income Loss
Treasury Stock
Accumulated Deficit
Series A Convertible Preferred Stock
Series X Convertible Preferred Stock
Class A Common Stock
Class A Common Stock
Common Stock
Class A Common Stock
Common Stock
Optogration, Inc.
Class A Common Stock
Common Stock
ECARX Holdings, Inc. (ECX)
Class A Common Stock
Common Stock
Freedom Photonics
Class A Common Stock
Common Stock
Solfice
Class B Common Stock
Class B Common Stock
Common Stock
Beginning balance (in shares) at Dec. 31, 2019                             94,818,151 0                
Beginning balance at Dec. 31, 2019                             $ 244,743 $ 0                
Increase (Decrease) in Temporary Equity [Roll Forward]                                                
Issuance of Series X convertible preferred stock for cash, net of issuance costs (in shares)                               18,457,230                
Issuance of Series X convertible preferred stock for cash, net of issuance costs                               $ 178,074                
Merger recapitalization (in shares)                             (94,818,151) (18,457,230)                
Merger recapitalization—Class A                             $ (244,743) $ (178,074)                
Ending balance (in shares) at Dec. 31, 2020                             0 0                
Ending balance at Dec. 31, 2020                             $ 0 $ 0                
Beginning balance (in shares) at Dec. 31, 2019           26,206,837                                    
Beginning balance at Dec. 31, 2019 $ (211,730)         $ 3 $ 10,457         $ (1) $ 0 $ (222,203)       $ 14           $ 0
Beginning balance (in shares) at Dec. 31, 2019                                   139,635,890           0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                
Retirement of Class A shares (in shares)                                   (6,629,372)            
Retirement of Class A shares (1)                                 $ (1)            
Conversion of certain shares into Class B common stock (in shares)           (22,935,413)                       (82,182,790)           105,118,203
Conversion of certain shares into Class B common stock 3,000         $ (3) 3,000                     $ (8)           $ 11
Merger recapitalization—Class A (in shares)           (3,271,424)                       116,546,805            
Merger recapitalization—Class A 422,814           422,802                     $ 12            
Public and Private Warrants (102,396)           (102,396)                                  
Conversion of SAFE into Series A common stock and Issuance of Class A common stock upon exercise of warrants (in shares)                                   1,466,155            
Conversion of SAFE into Series A common stock and Issuance of Class A common stock upon exercise of warrants 30,112           30,112                                  
Acquisition (in shares)                                   49,981,349            
Acquisitions 363,460           363,455                     $ 5            
Share-based compensation 5,745           5,745                                  
Other comprehensive (loss) income 35                     35                        
Net loss (362,298)                         (362,298)                    
Ending balance (in shares) at Dec. 31, 2020           0                                    
Ending balance at Dec. 31, 2020 148,741         $ 0 733,175         34 0 (584,501)       $ 22           $ 11
Ending balance (in shares) at Dec. 31, 2020                                   218,818,037           105,118,203
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                
Retirement of Class A shares (in shares)                                   (71,894)            
Retirement of Class A shares 0                                              
Expense related to Volvo Warrants 959                                              
Purchases of capped call options related to the convertible senior notes (73,438)           (73,438)                                  
Shares repurchased                       (235,871)                      
Issuance of Class A common stock upon exercise of Public and Private Warrants (in shares)                                   15,574,037            
Issuance of Class A common stock upon exercise of Public and Private Warrants 492,221           492,219                     $ 2            
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units (in Shares)                                   5,232,744            
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units 6,176           6,176                     $ 0            
Vendor payments under the stock-in-lieu of cash program (in shares)                                   291,940            
Vendor payments under the stock-in-lieu of cash program 10,743           10,743                                  
Issuance of shares for investment in Robotic Research Opco, LLC (in shares)                                   618,924            
Issuance of shares for investment in Robotic Research Opco, LLC 10,002           10,002                                  
Conversion of SAFE into Series A common stock and Issuance of Class A common stock upon exercise of warrants (in shares)                                   15,000,000           (15,000,000)
Conversion of SAFE into Series A common stock and Issuance of Class A common stock upon exercise of warrants 0           0                     $ 2           $ (2)
Acquisition (in shares)                                     370,034          
Acquisitions   $ 6,527           $ 6,527                                
Issuance of earn-out shares (in shares)                                   10,242,703           6,970,467
Issuance of earn-out shares 0           (2)                     $ 1           $ 1
Share-based compensation 70,983           70,983                                  
Payments of employee taxes related to vested restricted stock units (140)           (140)                                  
Cash received from Gores on settlement of recapitalization of escrow 10           10                                  
Other comprehensive (loss) income (942)                     (942)                        
Net loss (237,986)                         (237,986)                    
Ending balance (in shares) at Dec. 31, 2021           0                                    
Ending balance at Dec. 31, 2021 197,985         $ 0 1,257,214         (908) (235,871) (822,487)       $ 27           $ 10
Ending balance (in shares) at Dec. 31, 2021                                 250,812,764 266,076,525         97,088,670 97,088,670
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                
Retirement of Class A shares (in shares)                                   (48,298)            
Shares repurchased (76,606)                       (76,606)                      
Issuance of Class A common stock upon exercise of Public and Private Warrants (in shares)                                   405,752            
Issuance of Class A common stock upon exercise of Public and Private Warrants 19,003           19,003                                  
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units (in Shares)                                   9,177,748            
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units 3,945           3,944                     $ 1            
Issuance of Class A common stock under ESPP (in shares)                                   168,147            
Issuance of Class A common stock under ESPP 1,271           1,271                                  
Vendor payments under the stock-in-lieu of cash program (in shares)                                   9,949,385            
Vendor payments under the stock-in-lieu of cash program 80,255           80,254                     $ 1            
Investment in ECARX Holdings, Inc. (ECX) (in shares)                                       2,030,374        
Investment in ECARX Holdings, Inc.     $ 12,588           $ 12,588                              
Optogration milestone awards (in shares)                                   1,632,056            
Optogration milestone awards 11,751           11,751                                  
Acquisition (in shares)                                         2,176,205 374,193    
Acquisitions       $ 30,510 $ 3,361         $ 30,510 $ 3,361                          
Share-based compensation 142,519           142,519                                  
Payments of employee taxes related to vested restricted stock units (3,730)           (3,730)                                  
Other comprehensive (loss) income (3,318)                     (3,318)                        
Net loss $ (445,939)                         (445,939)                    
Ending balance (in shares) at Dec. 31, 2022 0         0                                    
Ending balance at Dec. 31, 2022 $ (26,405)         $ 0 $ 1,558,685         $ (4,226) $ (312,477) $ (1,268,426)       $ 29           $ 10
Ending balance (in shares) at Dec. 31, 2022                                 270,078,637 291,942,087         97,088,670 97,088,670
XML 26 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) (Parenthetical)
$ in Thousands
12 Months Ended
Dec. 31, 2020
USD ($)
Issuance of Series X convertible preferred stock for cash, net of issuance costs $ 5,790
Gores shares recapitalized, net of redemptions and equity issuance costs 17,226
Series X Convertible Preferred Stock  
Issuance of Series X convertible preferred stock for cash, net of issuance costs $ 5,790
XML 27 R8.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net loss $ (445,939) $ (237,986) $ (362,298)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 6,566 4,162 2,517
Amortization of operating lease right-of-use assets 5,237 3,705 0
Amortization of premium on marketable securities 1,288 1,792 175
Change in fair value of warrants (9,222) 26,126 268,266
Vendor stock-in-lieu of cash program 41,459 10,817 0
Amortization of debt discount and issuance costs 3,236 0 0
Inventory write-offs and write-downs 12,154 2,918 4,407
Loss on sale or disposal of property and equipment 0 752 525
Loss on extinguishment of debt 0 0 3,996
Share-based compensation 162,405 77,684 8,711
Impairment of investments and certain other assets 6,016 0 0
Expense related to Volvo Warrants 0 959 0
Warranty related to sensors 2,481 1,538 0
Deferred taxes 232 (1,262) 0
Other 0 305 0
Changes in operating assets and liabilities:      
Accounts receivable 5,144 (6,233) (4,294)
Inventories (10,477) (10,751) (4,018)
Prepaid expenses and other current assets (6,557) (24,340) (2,805)
Other non-current assets (3,289) (6) 165
Accounts payable 5,301 3,838 2,620
Accrued and other current liabilities 17,768 3,578 6,693
Other non-current liabilities (2,035) (6,017) (302)
Net cash used in operating activities (208,232) (148,421) (75,642)
Cash flows from investing activities:      
Cash received from acquisition of Optogration, Inc. 0 358 0
Purchases of marketable securities (including $17,846 and $16,423 with related parties in 2022 and 2021, respectively, see Note 17) (404,598) (716,933) (315,920)
Proceeds from maturities of marketable securities 367,367 366,857 16,755
Proceeds from sales/redemptions of marketable securities (including $24,753 and $4,396 with related parties in 2022 and 2021, respectively, see Note 17) 88,041 161,910 28,974
Proceeds from refundable security deposits 0 0 581
Purchases of property and equipment (15,614) (6,433) (2,202)
Disposal of property and equipment 0 53 18
Advances for capital projects and equipment (2,450) 0 0
Net cash provided by (used in) investing activities 27,986 (194,188) (271,794)
Cash flows from financing activities:      
Proceeds from issuance of convertible senior notes, net of debt discounts of $15,625 0 609,375 0
Purchases of capped call options 0 (73,438) 0
Cash received from Gores on recapitalization 0 0 380,601
Transaction costs related to merger with Gores 0 0 (17,226)
Issuance cost paid for Series X convertible preferred stock 0 0 (5,790)
Proceeds from the issuance of debt 0 0 32,101
Repayment of debt 0 (112) (41,190)
Debt prepayment charges 0 0 (1,918)
Debt issuance costs 0 0 (361)
Principal payments on finance leases (capital leases prior to adoption of ASC 842)   (289) (222)
Principal payments on finance leases (capital leases prior to adoption of ASC 842) 0    
Proceeds from exercise of warrants 0 153,927 0
Proceeds from exercise of stock options 3,986 5,859 0
Proceeds from sale of Class A common stock under ESPP 1,271 0 0
Payments of employee taxes related to stock-based awards (3,730) 0 0
Repurchases of common stock and redemption of warrants (80,878) (231,600) (10)
Other financing activities 0 (130) 0
Net cash provided by (used in) financing activities (79,351) 463,592 529,850
Net increase (decrease) in cash, cash equivalents and restricted cash (259,597) 120,983 182,414
Beginning cash, cash equivalents and restricted cash 330,702 209,719 27,305
Ending cash, cash equivalents and restricted cash 71,105 330,702 209,719
Supplemental disclosures of cash flow information:      
Cash paid for interest 7,769 215 2,789
Supplemental disclosures of noncash investing and financing activities:      
Issuance of Class A common stock upon exercise of warrants 19,003 338,293 30,112
Conversion of Series A, Series X and Founders’ convertible preferred stock into Class A and Class B common stock 0 0 422,813
Issuance of Class A common stock for investment in Robotic Research OpCo, LLC 0 10,002 0
Issuance of Class A common stock to acquire Optogration, Inc. 0 6,527 0
Operating lease right-of-use assets obtained in exchange for lease obligations 16,749 2,876 0
Assets acquired under finance leases (capital leases prior to adoption of ASC 842) 0 0 318
Purchases of property and equipment recorded in accounts payable and accrued liabilities 3,870 849 319
Amounts payable for shares repurchased 0 4,273 0
Vendor stock-in-lieu of cash program—advances for capital projects and equipment 28,402 0 0
Investment in ECARX Holdings, Inc. 12,588 0 0
Accounting Standards Update 2016-02      
Supplemental disclosures of noncash investing and financing activities:      
Operating lease right-of-use assets obtained in exchange for lease obligations 0 10,849 0
Series X Convertible Preferred Stock      
Cash flows from financing activities:      
Proceeds from issuance of Series X convertible preferred stock 0 0 183,865
Issuance cost paid for Series X convertible preferred stock     (5,790)
Freedom Photonics      
Cash flows from investing activities:      
Acquisitions (2,759) 0 0
Solfice      
Cash flows from investing activities:      
Acquisitions $ (2,001) $ 0 $ 0
XML 28 R9.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows (Parenthetical) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Statement of Cash Flows [Abstract]    
Purchases of marketable securities with related parties $ 17,846 $ 16,423
Proceeds from sales/redemptions of marketable securities with related parties $ 24,753 4,396
Proceeds from issuance of convertible senior notes, net of debt discounts   $ 15,625
XML 29 R10.htm IDEA: XBRL DOCUMENT v3.22.4
Organization and Description of Business
12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Description of Business Organization and Description of Business
Luminar Technologies, Inc. and its wholly-owned subsidiaries (the “Company” or “Luminar”) was originally incorporated in Delaware on August 28, 2018 under the name Gores Metropoulos, Inc. (“Gores”). The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. On December 2, 2020, the Company (at such time named Gores Metropoulos, Inc.) consummated the business combination (the “Business Combination”) pursuant to the Agreement and Plan of Merger, dated August 24, 2020 with the pre-Business Combination Luminar Technologies, Inc. (“Legacy Luminar”). Legacy Luminar was incorporated in Delaware on March 31, 2015. In connection with the consummation of the Business Combination, the Company changed its name from Gores Metropoulos, Inc. to Luminar Technologies, Inc. The Company’s common stock is listed on the NASDAQ under the symbol “LAZR.”
Unless the context otherwise requires, the “Company” refers to the combined company and its subsidiaries following the Business Combination, “Gores” refers to the Company prior to the Business Combination and “Legacy Luminar” refers to Luminar Technologies, Inc. prior to the Business Combination. Refer to Note 3 for further discussion of the Business Combination.
The Company is a developer of advanced sensor technologies and software for the autonomous vehicle industry, encompassing Laser Imaging, Detection and Ranging (lidar) technology. The Company manufactures and distributes commercial lidar sensors and certain components for the autonomous vehicle industry. The Company is headquartered in Orlando, Florida and has personnel that conducts the Company’s operations from various locations in the United States and internationally including Germany, Sweden, Mexico, China, India and Israel.
XML 30 R11.htm IDEA: XBRL DOCUMENT v3.22.4
Basis of Presentation and Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation and Consolidation
The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding annual financial reporting. All intercompany transactions and balances have been eliminated in consolidation.
Use of Estimates
The preparation of consolidated financial statements in conformity with GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosures. The significant estimates made by management include inventory write-downs, valuation allowance for deferred tax assets, valuation of warrants, fair valuation of assets acquired in mergers and acquisitions including intangible assets, forecasted costs associated with non-recurring engineering (“NRE”) services, product warranty reserves, stock-based compensation expense and other loss contingencies. Management periodically evaluates such estimates and they are adjusted prospectively based upon such periodic evaluation. Actual results could differ from those estimates.
Segment Information
The Company has determined its operating segments using the same indicators which are used to evaluate its performance internally. The Company’s business activities are organized in two operating segments:
(i) “Autonomy Solutions” which includes manufacturing and distribution of lidar sensors that measure distance using laser light to generate a 3D map, non-recurring engineering services related to the Company’s lidar products, development of software products that enable autonomy capabilities for automotive applications, and licensing of the Company’s intellectual property (“IP”). In June 2022, the Company acquired certain assets from Solfice Research, Inc. (“Solfice” or “Civil Maps”). Operations of Civil Maps have been included in the Autonomy Solutions segment.
(ii) “Advanced Technologies and Services (“ATS”)” which includes development of application-specific integrated circuits, pixel-based sensors, advanced lasers, as well as designing, testing and providing consulting services for non-standard integrated circuits. In the second quarter of 2022, the Components segment was renamed as ATS. In August 2021 and in April 2022, the Company acquired Optogration, Inc. (“Optogration”) and Freedom Photonics LLC (“Freedom Photonics”), respectively. Operations of Optogration and Freedom Photonic have been included in the ATS segment.
Concentration of Credit Risk
The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, debt securities and accounts receivable. The Company’s deposits exceed federally insured limits. Cash held by the foreign subsidiaries of the Company as of December 31, 2022 and 2021 was not material.
The Company’s revenue is derived from customers located in the United States and international markets. Three customers accounted for 23%, 27% and 11%, respectively, of the Company’s accounts receivable as of December 31, 2022. Two customers accounted for 39% and 31%, respectively, of the Company’s accounts receivable as of December 31, 2021.
Cash and Cash Equivalents
The Company’s cash and cash equivalents consist of investments with maturities of three months or less at the time of purchase. The Company’s cash equivalents include investments in money market funds, U.S. treasury securities and commercial paper.
Restricted Cash
Restricted cash consists of funds that are contractually restricted as to usage or withdrawal due to legal agreements. The Company determines current or non-current classification of restricted cash based on the expected duration of the restriction.
Debt Securities
The Company’s debt securities consist of U.S agency securities and government sponsored securities, U.S. treasury securities, corporate bonds, commercial paper and asset-backed securities. The Company classifies its debt securities as available-for-sale at the time of purchase and reevaluates such designation as of each balance sheet date. The Company considers all debt securities as available for use to support current operations, including those with maturity dates beyond one year and are classified as current assets under marketable securities in the accompanying consolidated balance sheets. Debt securities included in marketable securities on the consolidated balance sheets consist of securities with original maturities greater than three months at the time of purchase. Debt securities are carried at fair value, with the unrealized gains and losses reported as a component of accumulated other comprehensive income (loss) (“OCI”). Any realized gains or losses on the sale of debt securities are determined on a specific identification method, and such gains and losses are reflected as a component of other income (expense), net.
The Company reviews the fair value of debt securities and when the fair value of a debt security is below its amortized cost, the amortized cost should be written down to its fair value if (i) it is more likely than not that management will be required to sell the impaired security before recovery of its amortized basis; or (ii) management has the intention to sell the security. If neither of these conditions are met, the Company must determine whether the impairment is due to credit losses. To determine the amount of credit losses, the Company compares the present value of the expected cash flows of the security, derived by taking into account the issuer’s credit ratings and remaining payment terms, with its amortized cost basis. The amount of impairment recognized is limited to the excess of the amortized cost over the fair value of the security. An allowance for credit losses for the excess of amortized cost over the expected cash flows is recorded in other income (expense), net on the consolidated statements of operations. Non-credit related impairment losses are recorded in OCI.
Marketable Equity Investments
The Company holds marketable equity investments over which the Company does not have a controlling interest or significant influence. Marketable equity investments are measured using the quoted prices in active markets with changes recorded in other income (expense), net on the consolidated statement of operations.
Non-Marketable Equity Investments Measured Using the Measurement Alternative
The Company holds a non-marketable equity investment in a privately held company in which the Company does not own a controlling interest or have significant influence. The investment does not have a readily determinable fair value and the Company has elected the measurement alternative, and consequently, measures the investment at cost less any impairment, adjusted to fair value, if there are observable price changes for an identical or similar investment of the same issuer.
Accounts Receivable
Accounts receivables are recorded at the invoiced amount and do not bear interest. The Company reviews the need for an allowance for doubtful accounts quarterly based on historical experience with each customer and the specifics of each customer arrangement. The Company did not have material write-offs in any period presented, and as of December 31, 2022, the
allowance for doubtful accounts was not material. The Company did not record any allowance for doubtful accounts as of December 31, 2021.
Inventory
The Company values inventory at the lower of cost or net realizable value. The Company determines the cost of inventory using the standard-cost method, which approximates actual costs based on a first-in, first-out method. The Company assesses inventory of slow-moving products for potential impairment, and records write-downs of inventory to cost of sales.
Property and Equipment
Property and equipment are stated at cost less accumulated depreciation and amortization, and are depreciated using the straight-line method over the estimated useful lives of the assets as follows:
Asset CategoryEstimated useful lives
Machinery and equipment
1 to 7 years
Computer hardware and software
3 to 5 years
Demonstration fleet and demonstration units
2 to 5 years
Leasehold improvementsShorter of useful life or lease term
Vehicles5 years
Furniture and fixtures7 years
Design and development costs for molds, dies and other tools that will be used in producing the products under a long-term supply arrangement are capitalized as tooling which are included in machinery and equipment. The Company estimates useful lives for these tooling items to range between one to three years. The amount capitalized for tooling as of December 31, 2022 was not material. The Company had not capitalized any amount for tooling as of December 31, 2021. Maintenance and repairs are charged to expense as incurred, and improvements and betterments are capitalized. When assets are retired or otherwise disposed of, the cost and accumulated depreciation and amortization are removed from the consolidated balance sheet and any resulting gain or loss is reflected in the consolidated statements of operations and comprehensive loss in the period realized.
Intangible Assets
Intangible assets, consisting of acquired developed technology, customer relationships, customer backlog, assembled workforce, IPR&D and tradename are carried at cost less accumulated amortization. All intangible assets have been determined to have definite lives and are amortized on a straight-line basis over their estimated remaining economic lives, ranging from one to ten years. Amortization expense related to developed technology is included in cost of sales. Amortization expense related to customer relationships is included in sales and marketing expense. Amortization expense related to tradename is included in general and administrative expense. Intangible assets are reviewed for impairment whenever events or changes in circumstances indicate an asset’s carrying value may not be recoverable. There was no impairment of intangible assets experienced during the year ended December 31, 2022 or 2021.
Goodwill
The Company records goodwill when the consideration paid in a business combination exceeds the fair value of the net tangible assets and the identified intangible assets acquired. Goodwill is not amortized, but instead is required to be tested for impairment annually and whenever events or changes in circumstances indicate that the carrying value of goodwill may exceed its fair value.
The Company reviews goodwill for impairment annually in its fourth quarter by initially considering qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill, as a basis for determining whether it is necessary to perform a quantitative analysis. If it is determined that it is more likely than not that the fair value of reporting unit is less than its carrying amount, a quantitative analysis is performed to identify goodwill impairment. There was no impairment of goodwill experienced during the year ended December 31, 2022 or 2021.
Impairment of Long-Lived Assets
The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. When such an event occurs, management determines whether there has been impairment by comparing the anticipated undiscounted future net cash flows to the related asset group’s carrying value. If
an asset is considered impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending on the nature of the asset. There was no impairment experienced of long-lived assets during the years ended December 31, 2022 or 2021.
Convertible Senior Notes
The Company’s convertible senior notes issued in December 2021 are accounted for as a single liability instrument measured at its amortized cost, as no other embedded features require bifurcation and recognition as derivatives.
Product Warranties
Estimated future warranty costs are accrued and charged to cost of sales in the period that the related revenue is recognized. These estimates are based on historical warranty experience and any known or expected changes in warranty exposure, such as trends of product reliability and costs of repairing and replacing defective products. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the said estimates as necessary.
Public and Private Warrants
As part of Gores’ initial public offering on February 5, 2019, Gores issued to third party investors 40.0 million units, consisting of one share of Class A common stock of Gores and one-third of one warrant, at a price of $10.00 per unit. Each whole warrant entitled the holder to purchase one share of Class A common stock at an exercise price of $11.50 per share (the “Public Warrants”). Simultaneously with the closing of the IPO, Gores completed the private sale of 6.667 million warrants to Gore’s sponsor at a purchase price of $1.50 per warrant (the “Private Warrants”). Each Private Warrant allows the sponsor to purchase one share of Class A common stock at $11.50 per share. Subsequent to the Business Combination, 13,333,309 Public Warrants and 6,666,666 Private Warrants remained outstanding as of December 31, 2020.
The Private Warrants and the shares of common stock issuable upon the exercise of the Private Warrants were not transferable, assignable or salable until after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants are exercisable for cash or on a cashless basis, at the holder’s option, and are non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, said Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

The exercise of the Private Warrants may be settled in cash upon the occurrence of a tender offer or exchange that involves 50% or more of the Company’s Class A stockholders. Public Warrants contained the same feature. Since not all of the Company’s stockholders need to participate in such tender offer or exchange to trigger the potential cash settlement and the Company does not control the occurrence of such an event, the Company concluded that the Public Warrants and Private Warrants do not meet the conditions to be classified in equity per the guidance in ASC 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity. Since the Public and Private Warrants meet the definition of a derivative under ASC 815, the Company recorded these warrants as liabilities on the balance sheet at fair value upon the closing of the Business Combination, with subsequent changes in their respective fair values recognized in the consolidated statement of operations and comprehensive loss at each reporting date.
In the first quarter of 2021, 3,589,645 Private Warrants and 13,128,671 Public Warrants were exercised, and the Company received $153.9 million in cash proceeds from the exercise of these warrants. Pursuant to the terms of the agreements governing the rights of the holders of the Public Warrants, the Company redeemed the remaining unexercised and outstanding 204,638 Public Warrants for a redemption price of $0.01 per Public Warrant.
The Company had 3,077,021 Private Warrants and no Public Warrants, outstanding as of December 31, 2021.
In January 2022 and April 2022, 1,389,529 and 19,223 Private Warrants, respectively, were exercised on a cashless basis and the Company issued 401,365 and 4,387 shares of Class A common stock, respectively, pursuant to the exercises. The Company had 1,668,269 Private Warrants outstanding as of December 31, 2022. These Private Warrants expire on December 2, 2025.
Revenue Recognition
Under ASC 606, the Company determines revenue recognition through the following steps:
Identifying the contract, or contracts, with the customer; 
Identifying the performance obligations in the contract;
Determining the transaction price;
Allocating the transaction price to performance obligations in the contract; and
Recognizing revenue when, or as, the Company satisfies performance obligations by transferring the promised goods or services.
Nature of Products and Services and Revenue Recognition
The Autonomy Solutions segment derives revenue primarily from (a) product sales of lidar sensors to customers and distributors, (b) NRE services to integrate Luminar lidar hardware for autonomy in vehicle platforms, and (c) licensing of certain IP.
The ATS segment derives revenue primarily from (a) product sales of application-specific integrated circuits, pixel-based sensors and advanced lasers, as well as (b) NRE services for designing and testing non-standard integrated circuits.
Revenue from product sales is recognized at a point in time when control of the goods is transferred to the customer, generally occurring upon shipment or delivery dependent upon the terms of the underlying contract. Certain customer arrangements involve NRE services to design and develop custom prototype products to customers. Revenue from NRE service arrangements is recognized over time.
For NRE services, the Company recognizes revenue over time using an input method based on contract cost incurred to date compared to total estimated contract costs (cost-to-cost). For NRE service projects, the Company contracts with customers based on hourly rates or on a fixed fee basis. For arrangements based on hourly rates, revenue is recognized as services are performed and amounts are earned in accordance with the terms of a contract at estimated collectible amounts. For arrangements based on a fixed fee, revenue is recognized based on the progress or the percentage of completion of the NRE service project. Expenses associated with performance of work may be reimbursed with a markup depending on contractual terms and are included in revenue.
Contract costs related to NRE arrangements are incurred over time, which can be several years, and the estimation of these costs requires management’s judgment. Significant judgment is required when estimating total contract costs and progress to completion on the arrangements, as well as whether a loss is expected to be incurred on the contract. In estimating total contract costs, the Company is also required to estimate the effort expected to be incurred to complete a NRE project. These estimates are subject to significant estimation uncertainty as actual time and effort incurred on completing a NRE project or actual rates of either internal or contracted personnel working on such NRE projects may differ from the Company’s estimates. Changes in circumstances may change the original estimates of revenues, costs, or extent of progress toward completion, revisions to the estimates are made which may result in increases or decreases in estimated revenues or costs, and such revisions are reflected in income in the period in which the circumstances that gave rise to the revision become known to us. We perform ongoing profitability analysis of our contracts accounted for under this method to determine whether the latest estimates of revenues, costs, and profits require updating. If at any time these estimates indicate that the contract will be unprofitable, the entire estimated loss for the remainder of the contract is recorded immediately.
The Company enters into term-based licenses that provide customers the right to use certain IP available with the Company. Revenue from these licenses is recognized at the point in time at which the customer is able to use and benefit from the licensed information, which is generally upon delivery of the information to the customer or upon commencement of the renewal term.
Amounts billed to customers for shipping and handling are included in revenue. Taxes collected from customers and remitted to governmental authorities are excluded from revenue on the net basis of accounting.
Arrangements with Multiple Performance Obligations
When a contract involves multiple performance obligations, the Company accounts for individual products and services separately if the customer can benefit from the product or service on its own or with other resources that are readily available to the customer and the product or service is separately identifiable from other promises in the arrangement. The consideration is allocated between separate performance obligations in proportion to their estimated standalone selling price. The transactions to which the Company had to estimate standalone selling prices and allocate the arrangement consideration to multiple performance obligations were immaterial.
The Company provides standard product warranties for a term of typically up to one year to ensure that its products comply with agreed-upon specifications. Standard warranties are considered to be assurance type warranties and are not accounted for as separate performance obligations. See Product Warranties for accounting policy on standard warranties.
Other Policies, Judgments and Practical Expedients
Contract balances.  Contract assets and liabilities represent the differences in the timing of revenue recognition from the receipt of cash from the Company’s customers and billings. Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. Receivable represents right to consideration that is unconditional. Such rights are considered unconditional if only the passage of time is required before payment of that consideration is due.
Remaining performance obligations.  Revenue allocated to remaining performance obligations represents the transaction price allocated to the performance obligations that are unsatisfied, or partially unsatisfied. It includes unearned revenue and amounts that will be invoiced and recognized as revenue in future periods and does not include contracts where the customer is not committed. The customer is not considered committed where they are able to terminate for convenience without payment of a substantive penalty under the contract. The Company has elected the optional exemption, which allows for the exclusion of the amounts for remaining performance obligations that are part of contracts with an original expected duration of one year or less.
Significant financing component. In certain arrangements, the Company receives payment from a customer either before or after the performance obligation has been satisfied. Typically, the expected timing difference between the payment and satisfaction of performance obligations is one year or less; therefore, the Company applies a practical expedient and does not consider the effects of the time value of money. The Company’s contracts with customer prepayment terms do not include a significant financing component because the primary purpose is not to receive or provide financing from or to the customers.
Contract modifications. The Company may modify contracts to offer customers additional products or services. Each of the additional products and services are generally considered distinct from those products or services transferred to the customer before the modification. The Company evaluates whether the contract price for the additional products and services reflects the standalone selling price as adjusted for facts and circumstances applicable to that contract. In these cases, the Company accounts for the additional products or services as a separate contract. In other cases where the pricing in the modification does not reflect the standalone selling price as adjusted for facts and circumstances applicable to that contract, the Company accounts on a prospective basis where the remaining goods and services are distinct from the original items and on a cumulative catch-up basis when the remaining goods and services are not distinct from the original items.
Judgments and estimates. Accounting for contracts recognized over time involves the use of various techniques to estimate total contract revenue and costs. Due to uncertainties inherent in the estimation process, it is possible that estimates of costs to complete a performance obligation will be revised in the near term. The Company reviews and updates its contract-related estimates regularly, and records adjustments as needed. For those performance obligations for which revenue is recognized using a cost-to-cost input method, changes in total estimated costs, and related progress towards complete satisfaction of the performance obligation, are recognized on a cumulative catch-up basis in the period in which the revisions to the estimates are made.
Cost of Sales
The Company includes all manufacturing and sourcing costs incurred prior to the receipt of finished goods at its distribution facility in cost of sales. The cost of sales principally includes personnel-related costs (including certain engineering personnel), including stock-based compensation, directly associated with the Company’s manufacturing organization, direct costs, product costs, purchasing costs, allocation of overhead costs associated with manufacturing operations, inbound freight charges, insurance, inventory write-downs, warranty cost and depreciation and amortization expense associated with the manufacturing and sourcing operations. Cost of sales also includes the direct cost and appropriate allocation of overhead costs involved in execution of service contracts.
Research and Development (R&D)
R&D expenses consist primarily of personnel-related expenses, consulting and contractor expenses, tooling and prototype materials to the extent no future benefit is expected and allocated overhead costs. Substantially all of the Company’s R&D expenses are related to developing new products and services, improving existing products and services, and developing manufacturing processes. R&D expenses are expensed as incurred.
Design and development costs for products to be sold under long-term supply arrangements are expensed as incurred. Design and development costs for molds, dies, and other tools involved in new technologies are expensed as incurred. Design and development costs for molds, dies, and other tools that will be used in producing the products under a long-term supply arrangement are capitalized as part of the molds, dies, and other tools.
Stock-based Compensation
Employee awards
For equity classified awards, the Company measures the cost of share-based awards granted to employees, non-employees and directors based on the grant-date fair value of the awards. The grant-date fair value of the stock options is calculated using a Black-Scholes option pricing model. The grant-date fair value of purchase rights under the Company’s 2020 Employee Stock Purchase Plan (“ESPP”) is calculated using a Black-Scholes option pricing model. The grant-date fair value of restricted stock is calculated based on the fair value of the underlying common stock less cash proceeds paid by the recipient to acquire the restricted stock, if any. The grant-date fair value of restricted stock unit is calculated based on the fair value of the underlying common stock. The grant-date fair value of stock-based awards with market conditions is calculated using a Monte Carlo simulation model. The fair value of the stock-based compensation is recognized on a straight-line basis over the requisite service period, which is generally the vesting period of the award. The Company has elected to recognize the effect of forfeitures in the period they occur.
The Company grants fixed value share-based awards to certain employees, wherein the awardee is entitled to a fixed dollar value compensation settled by issuing shares on the vesting date, with the number of shares determined based on the Company’s stock price on or close to the settlement date. These fixed value equity awards are considered as liability classified awards. The Company measures the cost of fixed value share-based awards granted to employees based on a fixed monetary amount that is known at the inception of the obligation. The Company records the compensation cost for the fixed dollar amount of the award over the vesting period, with a corresponding liability.
Stock-based payments to vendors / non-employees
The Company has entered into arrangements with certain vendors and other third parties wherein the Company at its discretion may elect to compensate the respective vendors for services provided in either cash or by issuing shares of the Company’s Class A common stock (“Stock-in-lieu of Cash Program”). Typically, the amounts owed under the Stock-in-lieu of Cash Program are settled by issuing shares, with the number of shares generally determined based on the Company’s stock price on or close to the settlement date. Payments owed under this program may be equity or liability classified depending upon fixed or variable number of shares issued for the amount owed to vendors. The Company measures the cost based on a fixed monetary amount that is known at the inception of the obligation.
Income Taxes
Income taxes are accounted for under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax bases of assets and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.
The Company recognizes deferred tax assets to the extent that these assets are more likely than not to be realized. In making such a determination, all available positive and negative evidence are considered, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If it is determined that deferred tax assets would be realized in the future, in excess of their net recorded amount, an adjustment would be made to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.
The Company records uncertain tax positions in accordance with ASC 740, Income Taxes, on the basis of a two-step process which includes (1) determining whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position, and (2) for those tax positions that meet the more-likely-than-not recognition threshold. Recognized income tax positions are measured at the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority.
The Company recognizes interest and penalties related to unrecognized tax benefits on the income tax expense line in the accompanying consolidated statement of operations. Accrued interest and penalties are included on the related tax liability line in the consolidated balance sheet.
The Tax Cuts and Jobs Act (“TCJA”) subjects a U.S. shareholder to tax on global intangible low-taxed income (“GILTI”) earned by certain foreign subsidiaries. Under GAAP, the Company can make an accounting policy election to either
treat taxes due on the GILTI inclusion as a current period expense or factor such amounts into the Company’s measurement of deferred taxes. The Company elected to treat the GILTI inclusion as a period expense.
Recently Adopted Accounting Pronouncements
In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (“ASU 2021-08”). ASU 2021-08 requires an acquirer to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. At the acquisition date, it requires an acquirer to account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts, which should generally result in an acquirer recognizing and measuring the acquired contract assets and contract liabilities consistent with how they were recognized and measured in the acquiree’s financial statements. The Company elected to early adopt ASU 2021-08 as of January 1, 2022. The adoption of ASU 2021-08 did not have a material impact on the Company’s consolidated financial position, operating results or cash flows.
XML 31 R12.htm IDEA: XBRL DOCUMENT v3.22.4
Business Combinations
12 Months Ended
Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]  
Business Combinations Business Combinations
Freedom Photonics Acquisition
On April 13, 2022 (the “Acquisition Date”), the Company completed its acquisition of Freedom Photonics, a designer and manufacturer of high-performance lasers and related photonic products. The Freedom Photonics acquisition is expected to help the Company secure intellectual property and the supply of a key enabling component as part of the Company’s vertical integration strategy.
Pursuant to the terms of the Merger Agreement between the Company and Freedom Photonics, the Company acquired all of the issued and outstanding units of capital of Freedom Photonics for an aggregate purchase price of approximately $34.6 million payable primarily in Class A common stock of the Company. The purchase price includes a $0.4 million adjustment to the preliminary estimates of working capital. In conjunction with the acquisition, the Company issued share-based compensation awards to certain employees and selling equity holders of Freedom Photonics, which may result in future stock-based compensation expense, subject to achievement of certain service and performance conditions, including certain technical and financial milestones. These post-combination shared-based awards were determined to be compensatory in nature and consequently are being expensed over the vesting period of these awards. The results of operations related to Freedom Photonics are included in the Company’s consolidated statements of operations beginning from the Acquisition Date. As part of the transaction, the Company incurred $1.4 million of acquisition-related costs, which were expensed and included in general and administrative expenses in the periods in which the costs were incurred.
Recording of Assets Acquired and Liabilities Assumed
Preliminary estimates of fair values included in the consolidated financial statements are expected to be finalized within a year following the Acquisition Date. These are related to certain working capital adjustments and finalization of the estimates relating to deferred tax balances which will occur after the filing of the current tax returns. After the measurement period, any subsequent adjustments will be reflected in the consolidated statements of operations.
The following table summarizes the preliminary purchase price allocation to assets acquired and liabilities assumed, including identification of measurement period adjustments (in thousands):
Preliminary Recorded Value
Cash and cash equivalents$1,063 
Accounts receivable3,311 
Contract asset1,913 
Inventories, net127 
Prepaid expenses and other current assets70 
Property and equipment1,353 
Operating lease right-of-use assets449 
Other non-current assets22 
Intangible assets (1)15,600 
Goodwill (2)15,885 
Total assets acquired39,793 
Current and non-current liabilities(5,158)
Total liabilities assumed(5,158)
Net assets acquired$34,635 
(1) Tradename was measured using the relief-from-royalty method. The remaining identifiable intangible assets were measured using the income approach. Significant inputs used as part of the valuation of intangible assets include revenue forecasts, present value factors, expected product margins and costs to complete the IPR&D.
(2) Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected future economic benefits as a result of other assets acquired that could not be individually identified and separately recognized. Goodwill is not amortized. The factors that made up goodwill recognized included assembled workforce and component cost savings. The entire amount of goodwill is expected to be deductible for tax purposes and is allocated to the ATS segment, which is also deemed the reporting unit.
Identifiable intangible assets recognized (in thousands):
Useful LifePreliminary Recorded Value
Customer backlog2 years$650 
Customer relationships4 years2,950 
Developed technology8 years4,000 
In-process research and development (IPR&D) (1)7,500 
Tradename4 years500 
Total intangible assets$15,600 
(1) IPR&D intangibles are treated as indefinite-lived until the completion or abandonment of the associated R&D
project, at which time the appropriate useful lives will be determined.
Supplemental Unaudited Pro Forma Information
The following unaudited pro forma financial information summarizes the combined results of operations for the Company and Freedom Photonics as if the companies were combined as of the beginning of fiscal year 2021. The unaudited pro forma information includes adjustments to amortization and depreciation for intangible assets and property and equipment acquired, the purchase accounting effect on transaction costs, and stock-based compensation expense.
The table below reflects the impact of adjustments to the unaudited pro forma results for the years ended December 31, 2022 and 2021 that are directly attributable to the acquisition (in thousands):
December 31,
20222021
(Unaudited)
(Decrease) / increase to expenses as a result of transaction costs$(2,582)$2,795 
(Decrease) / increase to expenses as a result of stock-based compensation expense4,119 19,593 
Nonrecurring pro forma adjustments include:
Transaction costs of $2.8 million are assumed to have occurred on January 1, 2021, and are recognized as if incurred in the first quarter of 2021;
Employee compensation in connection with the retention awards, incentive plan awards, sign-on bonuses, and deferred shares are assumed to have started on January 1, 2021, and recognized as incurred based on their respective periods.
The unaudited pro forma information presented below is for informational purposes only and is not necessarily indicative of our consolidated results of operations of the combined business had the acquisition actually occurred at the beginning of fiscal year 2021 or the results of our future operations of the combined businesses (in thousands).
December 31,
20222021
(Unaudited)
Revenue$46,422 $49,804 
Net loss(447,736)(260,813)
Solfice Assets Acquisition
On June 15, 2022, the Company completed its acquisition from Solfice of certain assets for an aggregate consideration of $6.3 million, payable in Class A common stock of the Company, that are expected to advance Luminar’s mapping software development capabilities. The transaction was determined to be an asset acquisition under ASC 805, Business Combinations, with substantially all of the fair value attributable to acquired technology.
Optogration Acquisition
On August 3, 2021, (the “Optogration Acquisition Date”) the Company completed its acquisition of Optogration. The Optogration acquisition helps the Company secure intellectual property and supply of Indium Gallium Arsenide (“InGaAs”) photodetector semiconductor chips, which are used to convert optical power into an electrical current. The acquisition of Optogration is part of the Company’s vertical integration strategy, which helps to secure the supply of a key component of its sensor technology.
Pursuant to the terms of the Stock Purchase Agreement between the Company and Optogration, the Company acquired all of the issued and outstanding capital stock of Optogration for an aggregate purchase price of approximately $6.3 million payable in Class A common stock of the Company. Subsequent to the Optogration Acquisition Date, up to $22.0 million of post combination share-based awards may be payable to certain selling shareholders of Optogration, subject to certain service and performance conditions. These post combination shared-based awards were determined to be compensatory in nature and consequently are being expensed over the vesting period of these awards. In August 2022, the Company issued 1,632,056 shares of Class A common stock for $11.0 million of the Optogration Milestone Awards due to achievement of the service and performance conditions. As of December 31, 2022, it is probable that the service and performance conditions for the remaining $11.0 million obligation will be met.
The results of operations related to Optogration are included in the Company’s consolidated statements of operations beginning from the Optogration Acquisition Date. The impact of the acquisition on the consolidated financial results of the Company for the year ended December 31, 2021 was not material.
Recording of Assets Acquired and Liabilities Assumed
Estimates of fair value included in the consolidated financial statements, in conformity with ASC 820, Fair Value Measurement, represent the Company’s best estimates and valuations. In accordance with ASC 805, Business Combinations, the allocation of the consideration value is subject to adjustment until the Company has completed its analysis, but not to exceed one year after the Optogration Acquisition Date to provide the Company with the time to complete the valuation of its assets and liabilities.
Settlement of a pre-existing agreement with Optogration
Prior to the acquisition, the Company had contracted with Optogration as a supplier. In assessing whether said pre-existing supply contract was at market, favorable or unfavorable from the Company’s perspective, the Company assessed whether the terms of the supply contract, including pricing, were consistent with what the Company would have required from another company that would have contracted for similar products and production volumes. The Company concluded that the supply agreement was at market, and thus no gain or loss was recognized upon effective settlement of the pre-existing supply agreement.
The following table summarizes the purchase price allocation to assets acquired and liabilities assumed, including identification of measurement period adjustments:
Recorded Value
Cash and cash equivalents$358 
Accounts receivable810 
Other current assets482 
Property and equipment1,248 
Other non-current assets384 
Intangible assets (1)2,650 
Goodwill (2)2,244 
     Total assets acquired8,176 
Current Liabilities(488)
Non-current liabilities(1,346)
     Total liabilities assumed(1,834)
      Net assets acquired$6,342 
(1) Identifiable intangible assets were measured using the income approach.
(2) Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected future economic benefits as a result of other assets acquired that could not be individually identified and separately recognized. Goodwill is not amortized. The factors that made up the goodwill recognized included assembled workforce and component cost savings. Goodwill is not expected to be deductible for tax purposes.
Identifiable intangible assets recognized:
Useful LifeRecorded Value
Customer relationships10 years$780 
Tradename
≤ 1 year
120 
Developed technology10 years1,750 
Total intangible assets$2,650 
Reverse Merger with Gores
On December 2, 2020, Gores consummated the Business Combination pursuant to that certain Agreement and Plan of Merger, dated August 24, 2020 (the “Merger Agreement”), by and among Gores, Dawn Merger Sub, Inc. (“First Merger Sub”), a wholly owned subsidiary of Gores, Dawn Merger Sub II, LLC (“Second Merger Sub”), a wholly owned subsidiary of Gores, and Legacy Luminar. In connection with the consummation of the Business Combination (the “Closing”), the registrant changed its name from Gores Metropoulos, Inc. to Luminar Technologies, Inc.
Immediately following the Business Combination, there were 323,936,240 shares of common stock, consisting of 218,818,037 shares of Class A common stock and 105,118,203 shares of Class B common stock with a par value of $0.0001 issued and outstanding, options to purchase an aggregate of 16,224,474 shares of Class A common stock and warrants to purchase, 4,089,280 shares of Class A common stock.
Pursuant to the Merger Agreement, the Company’s stockholders were entitled to receive an aggregate of up to 25,819,887 earn-out shares in the form of common stock (with respect to the Company’s Class A stockholders’ shares of Class A common stock and with respect to the Company’s Class B stockholders’ shares of Class B common stock). There were six
different triggering events that affect the number of earn-out shares that will be issued based upon the per share price of Class A common stock ranging from $13.00 to $28.00 per share. On August 11, 2021, the Company issued a total of 17,213,170 earn-out shares towards additional consideration in the form of common stock, consisting of 10,242,703 shares of Class A common stock and 6,970,467 shares of Class B common stock, upon meeting four of six triggering events. The shares issued were based upon the Class A common stock trading price exceeding $13.00, $16.00, $19.00 and $22.00 per share for a certain period of time. There are 5,121,484 shares of Class A common stock and 3,485,233 shares of Class B common stock remaining under the Merger Agreement, which will be issued in equal parts if the Class A common stock share price exceeds $25.00 and $28.00 per share for a certain period of time.
The Company accounts for the potential earn-out shares as a component of stockholders’ equity in accordance with the guidance in ASC 480, Distinguishing Liabilities from Equity, and ASC 815, Derivatives and Hedging. On December 2, 2020, the Company estimated the fair value of the potential earn-out shares to be $587.7 million, which was estimated using a Monte Carlo Model and Level 3 fair value inputs including volatility of 58.5% and a contractual term of 5.5 years. This was recorded as an increase in additional paid-in capital with an offsetting amount recorded in the same account, due to the absence of retained earnings.
The Business Combination was accounted for as a reverse recapitalization in accordance with GAAP as Legacy Luminar has been determined to be the accounting acquirer, primarily due to the fact that Legacy Luminar stockholders continue to control the post-combination Company. Under this method of accounting, while Gores was the legal acquirer, it has been treated as the “acquired” company for financial reporting purposes. Accordingly, the Business Combination was treated as the equivalent of Legacy Luminar issuing stock for the net assets of Gores, accompanied by a recapitalization. The net assets of Gores were stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Business Combination are those of Legacy Luminar. Reported shares and earnings per share available to holders of the Company’s common stock, prior to the Business Combination, have been retroactively restated as shares reflecting the exchange ratio established in the Business Combination (approximately 1 Gores shares to 13.63094 Luminar shares).
The Company incurred $17.2 million in transaction costs relating to the merger with Gores, which has been offset against additional paid-in capital in the Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit). On the date of the Business Combination, the Company recorded a liability related to the Public and Private Warrants of $102.4 million, with an offsetting entry to additional paid-in capital.
Upon closing of the Business Combination, the shareholders’ of Gores were issued 49,981,349 shares of Class A common stock. In connection with the Closing, holders of 18,651 shares of common stock of Gores were redeemed at a price per share of $10.16.
XML 32 R13.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue
12 Months Ended
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
The Company’s revenue is comprised of sales of lidar sensors hardware, components, NRE services and licensing of certain information available with the Company.
Disaggregation of Revenues
The Company disaggregates its revenue from contracts with customers by (1) geographic region based on customer’s billed to location, and (2) type of good or service and timing of transfer of goods or services to customers (point-in-time or over time), as it believes it best depicts how the nature, amount, timing and uncertainty of its revenue and cash flows are affected by economic factors. Total revenue based on the disaggregation criteria described above, as well as revenue by segment, are as follows (in thousands):
Year Ended December 31,
202220212020
Revenue% of RevenueRevenue% of RevenueRevenue% of Revenue
Revenue by primary geographical market:
North America$35,032 86 %$23,043 72 %$4,010 29 %
Asia Pacific3,703 %2,502 %906 %
Europe and Middle East1,963 %6,399 20 %9,035 65 %
Total40,698 100 %31,944 100 %13,951 100 %
Revenue by timing of recognition:
Recognized at a point in time17,595 43 %8,892 28 %2,639 19 %
Recognized over time23,103 57 %23,052 72 %11,312 81 %
Total40,698 100 %31,944 100 %13,951 100 %
Revenue by segment:
Autonomy Solutions24,353 60 %28,497 89 %11,387 82 %
ATS16,345 40 %3,447 11 %2,564 18 %
Total40,698 100 %31,944 100 %13,951 100 %
Volvo Stock Purchase Warrant
In March 2020, the Company issued a stock purchase warrant (“Volvo Warrants”) to Volvo Car Technology Fund AB (“VCTF”) in connection with an engineering services contract. The Volvo Warrants entitle VCTF to purchase up to 4,089,280 shares of Class A common stock, at a price of $3.1769 per share from the Company and were determined to be an equity classified award to VCTF. The Volvo Warrants vest and become exercisable in two tranches based on satisfaction of certain commercial milestones, upon reaching commercial production and delivery of production units. The grant date fair value of the Volvo Warrants, aggregating $2.9 million, represents consideration payable to VCTF and is being recognized as reduction in revenue consistent with the revenue recognition pattern when these warrants become probable of vesting. The Company’s management determined that the vesting of the first of the two tranches of the Volvo Warrants was probable as of December 31, 2021. As such, the Company had recognized a reduction in revenue in the amount of $1.0 million related to the said first tranche of the Volvo Warrants in the year ended December 31, 2021. The second tranche of the Volvo warrants will be recorded as a reduction in revenue upon achievement of sales of a certain number of the Company’s sensors to Volvo for use in their commercial vehicles. This threshold had not been achieved as of December 31, 2022.
Contract assets and liabilities
Contract assets primarily represent revenues recognized for performance obligations that have been satisfied but for which amounts have not been billed. The Company’s contract assets as of December 31, 2022 and 2021 were $18.0 million and $9.9 million. Contract liabilities consist of deferred revenue and customer advanced payments. Deferred revenue includes billings in excess of revenue recognized related to product sales and other services revenue and is recognized as revenue when the Company performs under the contract. Customer advanced payments represent required customer payments in advance of product shipments according to customer’s payment term. Customer advance payments are recognized as revenue when control of the performance obligation is transferred to the customer. The Company’s contract liabilities were $3.0 million and $0.9 million as of December 31, 2022 and 2021, respectively, and were included in accrued and other current and non-current liabilities in the consolidated balance sheets.
The opening and closing balances of contract assets were as follows (in thousands):
December 31,
 20222021
Contract assets, current$15,395 $9,907 
Contract assets, non-current2,575 — 
Ending balance$17,970 $9,907 
The significant changes in contract assets balances consisted of the following (in thousands): 
 December 31,
 20222021
Beginning balance$9,907 $— 
Amounts billed that were included in the contract assets beginning balance(4,228)— 
Revenue recognized for performance obligations that have been satisfied but for which amounts have not been billed12,291 9,907 
Ending balance$17,970 $9,907 
The opening and closing balances of contract liabilities were as follows (in thousands):
December 31,
 20222021
Contract liabilities, current$1,993 $898 
Contract liabilities, non-current1,015 — 
Ending balance$3,008 $898 
The significant changes in contract liabilities balances consisted of the following (in thousands): 
 December 31,
 20222021
Beginning balance$898 $2,284 
Revenue recognized that was included in the contract liabilities beginning balance(489)(1,792)
Increase due to cash received and not recognized as revenue and billings in excess of revenue recognized during the period2,599 406 
Ending balance$3,008 $898 
Remaining Performance Obligations
Revenue allocated to remaining performance obligations was $39.7 million as of December 31, 2022 and includes amounts within contract liabilities. The Company expects to recognize approximately 82% of this revenue over the next 12 months and the remainder thereafter.
XML 33 R14.htm IDEA: XBRL DOCUMENT v3.22.4
Investments
12 Months Ended
Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]  
Investments Investments
Debt Securities
The Company’s investments in debt securities consisted of the following as of December 31, 2022 and 2021 (in thousands):
December 31, 2022
 CostGross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
U.S. treasury securities$191,075 $$(2,598)$188,480 
U.S. agency and government sponsored securities4,999 — (75)4,924 
Commercial paper74,755 — (232)74,523 
Corporate bonds111,123 — (1,214)109,909 
Asset-backed securities11,945 — (110)11,835 
Total debt securities$393,897 $$(4,229)$389,671 
Included in marketable securities$393,897 $$(4,229)$389,671 
December 31, 2021
 CostGross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
U.S. treasury securities$161,938 $$(474)$161,465 
U.S. agency and government sponsored securities4,995 — (25)4,970 
Commercial paper40,788 — (4)40,784 
Corporate bonds165,522 13 (345)165,190 
Asset-backed securities46,540 — (74)46,466 
Total debt securities$419,783 $14 $(922)$418,875 
Included in cash and cash equivalents$950 $— $— $950 
Included in marketable securities$418,833 $14 $(922)$417,925 
The following table presents the gross unrealized losses and the fair value for those debt securities that were in an unrealized loss position for less than 12 months as of December 31, 2022 and 2021 (in thousands):
December 31, 2022December 31, 2021
Gross
Unrealized
Losses
Fair ValueGross
Unrealized
Losses
Fair Value
U.S. treasury securities$(2,598)$158,888 $(474)$146,454 
U.S. agency and government sponsored securities(75)4,924 (25)4,970 
Commercial paper(232)74,523 (4)30,285 
Corporate bonds(1,214)109,909 (345)145,522 
Asset-backed securities(110)11,835 (74)45,251 
Total$(4,229)$360,079 $(922)$372,482 
As of December 31, 2022, the total amortized cost basis of the Company’s available-for-sale securities exceeded its fair value by $4.2 million, which was primarily attributable to widening credit spreads and rising interest rates since purchase. The Company reviewed its available-for-sale securities and concluded that the decline in fair value was not related to credit losses and that it is more likely than not that the entire amortized cost of each security will be recoverable before the Company is required to sell them or when the security matures. Accordingly, during the year ended December 31, 2022, no allowance for credit losses was recorded and instead the unrealized losses are reported as a component of accumulated other comprehensive income (loss).
Equity Investments
The Company’s equity investments consisted of the following as of December 31, 2022 and 2021 (in thousands):
December 31,
Consolidated Balance Sheets Location20222021
Money market funds(1)
Cash and cash equivalents$42,056 $25,654 
Marketable equity investments(1)
Marketable securities29,643 44,216 
Non-marketable equity investment measured using the measurement alternative(2)
Other non-current assets4,000 10,002 
$75,699 $79,872 
(1)    Investments with readily determinable fair values.
(2)    Investment in privately held company without readily determinable fair value.
In December 2021, the Company made an investment in 1,495 Class A Preferred Units of Robotic Research OpCo, LLC (“Robotic Research”) for consideration of $10.0 million, which was settled by issuing 618,924 shares of Class A common stock of the Company. The Company’s investment in Robotic Research represents less than 5% of Robotic Research’s capitalization. The Company neither has a significant influence over Robotic Research nor does its investment amount to a controlling financial interest in Robotic Research. As such, the Company measured the initial investment in Robotic Research at cost as provided under the guidance for measurement of equity investment using the measurement alternative. In the fourth quarter of 2022, the Company recorded an impairment charge of $6.0 million related to the investment in Robotic Research.
In December 2022, the Company made an investment in 1,500,000 Class A ordinary shares of ECARX Holdings Inc., (“ECARX”) for consideration of $15.0 million, which was settled by issuing 2,030,374 shares of Class A common stock of the Company. The Company’s investment in ECARX represents less than 5% of ECARX’s capitalization. The Company neither has a significant influence over ECARX nor does its investment amount to a controlling financial interest in ECARX. The Company measured the investment in ECARX using the quoted prices in active markets with changes recorded in other income (expense), net on the consolidated statement of operations. Jun Hong Heng is a director of ECARX. Mr. Heng is also a director of Luminar.
XML 34 R15.htm IDEA: XBRL DOCUMENT v3.22.4
Financial Statement Components
12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Financial Statement Components Financial Statement Components
Cash and Cash Equivalents
Cash and cash equivalents consisted of the following (in thousands):
 December 31,
 20222021
Cash$27,496 $303,373 
Money market funds42,056 25,654 
Commercial paper— 950 
Total cash and cash equivalents$69,552 $329,977 
Inventory
Inventory consisted of the following (in thousands):
 December 31,
 20222021
Raw materials$3,614 $5,866 
Work-in-process2,329 1,171 
Finished goods2,849 3,305 
Total inventory$8,792 $10,342 
The Company’s inventory write-offs and write-downs (primarily due to obsolescence, lower of cost or market assessment, and other adjustments) was $12.2 million, $2.9 million and $4.4 million during the years ended December 31, 2022, 2021 and 2020, respectively.
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following (in thousands):
 December 31,
 20222021
Prepaid expenses$15,653 $14,651 
Contract assets15,395 9,907 
Advance payments to vendors7,919 1,810 
Other receivables5,236 2,827 
Total prepaid expenses and other current assets$44,203 $29,195 
Property and Equipment
Property and equipment consisted of the following (in thousands):
 December 31,
 20222021
Machinery and equipment$14,047 $7,694 
Computer hardware and software6,797 2,854 
Land1,001 — 
Leasehold improvements885 869 
Vehicles, including demonstration fleet3,222 2,421 
Furniture and fixtures818 272 
Construction in progress13,642 3,677 
Total property and equipment40,412 17,787 
Accumulated depreciation and amortization(10,152)(6,778)
Total property and equipment, net$30,260 $11,009 
Property and equipment capitalized under finance lease (capital lease prior to adoption of ASC 842) were not material. Construction in progress increased due to increased capital expenditure related to capital projects to enable the Company to achieve series production readiness.
Depreciation and amortization associated with property and equipment was $4.3 million, $3.9 million and $2.5 million for the years ended December 31, 2022, 2021 and 2020, respectively.

Intangible Assets
The following table summarizes the activity in the Company’s intangible assets (in thousands):
December 31,
20222021
Beginning of the period$2,424 $— 
Additions21,890 2,650 
Amortization(2,237)(226)
End of the period$22,077 $2,424 
Intangible assets were acquired in connection with the Company’s acquisition of Optogration in August 2021, Freedom Photonics in April 2022 and Solfice in June 2022. See Note 3 for further details of these acquisitions. The components of intangible assets were as follows (in thousands):
December 31, 2022December 31, 2021
Gross
Carrying
 Amount
Accumulated
Amortization
Net
Carrying
Amount
Weighted Average
Remaining Period
(Years)
Gross
Carrying
 Amount
Accumulated
Amortization
Net
Carrying
Amount
Weighted Average
Remaining Period
(Years)
Customer relationships$3,730 $(664)$3,066 4.4$780 $(33)$747 9.6
Customer backlog650 (292)358 0.9— — — — 
Tradename620 (214)406 3.3120 (120)— — 
Assembled workforce130 (130)— — — — — — 
Developed technology11,910 (1,163)10,747 7.51,750 (73)1,677 9.6
IPR&D7,500 — 7,500 — — — — — 
Total intangible assets$24,540 $(2,463)$22,077 6.6$2,650 $(226)$2,424 9.6
Amortization expense related to intangible assets was $2.2 million, $0.2 million and $0.0 million for the year ended December 31, 2022, 2021 and 2020, respectively.
As of December 31, 2022, the expected future amortization expense for intangible assets was as follows (in thousands):
PeriodExpected Future
Amortization Expense
2023$2,730 
20242,373 
20252,373 
20261,726 
20271,510 
Thereafter3,865 
IPR&D7,500 
Total$22,077 
Goodwill
The carrying amount of goodwill allocated to the Company’s reportable segments was as follows (in thousands):
 Autonomy SolutionsATSTotal
Balance as of December 31, 2021
$687 $2,423 $3,110 
Acquired goodwill related to Freedom Photonics in 2022— 15,885 15,885 
Purchase accounting adjustments— (179)(179)
Balance as of December 31, 2022
$687 $18,129 $18,816 
Other Non-Current Assets
Other non-current assets consisted of the following (in thousands):
 December 31,
 20222021
Security deposits$5,495 $1,187 
Non-marketable equity investment4,000 10,002 
Advance payment for capital projects27,683 — 
Contract assets2,575 — 
Other non-current assets591 1,266 
Total other non-current assets$40,344 $12,455 
Accrued and Other Current Liabilities
Accrued and other current liabilities consisted of the following (in thousands): 
 December 31,
 20222021
Accrued compensation and benefits$16,682 $9,899 
Accrued expenses22,358 6,727 
Warranty reserves3,584 1,798 
Contract liabilities1,993 898 
Accrued interest payable359 316 
Contract losses7,526 115 
Other460 91 
Total accrued and other current liabilities$52,962 $19,844 
During the year ended December 31, 2022, the Company recorded $19.2 million in cost of sales (services) estimated losses expected to be incurred on NRE projects with certain customers. Estimated contract losses in the year ended December 31, 2021 and 2020 were not material. The estimated contract losses recorded in 2022 were primarily a result of (a) changes in estimates related to costs expected to be incurred for contractual milestones based on actual experience on similar projects and (b) changes in scope of project deliverables agreed upon with the respective customers during the year.
XML 35 R16.htm IDEA: XBRL DOCUMENT v3.22.4
Debt
12 Months Ended
Dec. 31, 2022
Debt Disclosure [Abstract]  
Debt Debt
Convertible Senior Notes and Capped Call Transactions
In December 2021, the Company issued $625.0 million aggregate principal amount of 1.25% Convertible Senior Notes due 2026 in a private placement, which included $75.0 million aggregate principal amount of such notes pursuant to the exercise in full of the option granted to the initial purchasers to purchase additional notes (collectively, the “Convertible Senior Notes”). The interest on the Convertible Senior Notes is payable semi-annually in arrears on June 15 and December 15 of each year, beginning on June 15, 2022. The Convertible Senior Notes will mature on December 15, 2026, unless earlier repurchased or redeemed by the Company or converted pursuant to their terms.
The total net proceeds from the debt offering, after deducting fees paid to the initial purchasers paid by the Company, was approximately $609.4 million.
Each $1,000 principal amount of the Convertible Senior Notes is initially convertible into 50.0475 shares of the Company’s Class A common stock, par value $0.0001, which is equivalent to an initial conversion price of approximately $19.98 per share. The conversion rate is subject to adjustment upon the occurrence of certain specified events prior to the maturity date but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date or if the Company delivers a notice of redemption in respect of some or all of the Convertible Senior Notes, the Company will, under certain circumstances, increase the conversion rate of the Convertible Senior Notes for a holder who elects to convert its Convertible Senior Notes in connection with such a corporate event or convert its Convertible Senior Notes called for redemption during the related redemption period, as the case may be. The Convertible Senior Notes are redeemable, in whole or in part (subject to certain limitations), at the Company’s option at any time, and from time to time, on or after December 20, 2024, and on or before the 40th scheduled trading day immediately before the maturity date, at a cash redemption price equal to the principal amount of the Convertible Senior Notes to be redeemed, plus accrued and unpaid
interest, if any, to, but excluding, the redemption date, but only if certain liquidity conditions are satisfied and the last reported sale price per share of the Class A common stock exceeds 130% of the conversion price on (1) each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice, and (2) the trading day immediately before the date the Company sends such notice. If the Company undergoes a fundamental change (as defined in the indenture governing the Convertible Senior Notes) prior to the maturity date, holders may require the Company to repurchase for cash all or any portion of their Convertible Senior Notes in principal amounts of $1,000 or a multiple thereof at a fundamental change repurchase price equal to 100% of the principal amount of the Convertible Senior Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.
Holders of the Convertible Senior Notes may convert their Convertible Senior Notes at their option at any time prior to the close of business on the business day immediately preceding December 15, 2026, in multiples of $1,000 principal amount, only under the following circumstances: (1) during any calendar quarter (and only during such calendar quarter) commencing after the calendar quarter ending on March 31, 2022, if the last reported sale price per share of the Class A common stock exceeds 130% of the conversion price for each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (2) during the five consecutive business days immediately after any 10 consecutive trading day period (such 10 consecutive trading day period, the “measurement period”) in which the trading price per $1,000 principal amount of Convertible Senior Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of the Class A common stock on such trading day and the conversion rate on such trading day; (3) upon the occurrence of specified corporate events or distributions on the Class A common stock; and (4) if the Convertible Senior Notes are called for redemption. On or after June 15, 2026, holders may convert all or any portion of their Convertible Senior Notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date, regardless of the foregoing circumstances. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of its Class A common stock or a combination of cash and shares of its Class A common stock, at the Company’s election. As of December 31, 2022, the conditions allowing holders of the Convertible Senior Notes to convert were not met.
It is the Company’s current intent to settle the principal amount of its outstanding Convertible Senior Notes in cash and any excess in shares of the Company’s Class A common stock.
The Convertible Senior Notes are senior unsecured obligations and will rank equal in right of payment with the Company’s future senior unsecured indebtedness; senior in right of payment to the Company’s future indebtedness that is expressly subordinated to the Convertible Senior Notes; effectively subordinated to the Company’s existing and future secured indebtedness, to the extent of the value of the collateral securing that indebtedness; and structurally subordinated to all existing and future indebtedness and other liabilities, including trade payables, and (to the extent the Company is not a holder thereof) preferred equity, if any, of the Company’s subsidiaries.
The Company has classified the Convertible Senior Notes as a non-current liability under the guidance in ASC 470-20, as amended by ASU 2020-06. Debt discount and issuance costs aggregating approximately $16.2 million were initially recorded as a reduction to the principal amount of the Convertible Senior Notes and is being amortized as interest expense on a straight line basis over the contractual terms of the notes. The Company estimates that the difference between amortizing the debt discounts and the issuance costs using the straight line method as compared to using effective interest rate method is immaterial.
The net carrying amount of the Convertible Senior Notes was as follows (in thousands):
December 31,
20222021
Principal$625,000 $625,000 
Unamortized debt discount and issuance costs(12,808)(16,043)
Net carrying amount$612,192 $608,957 
The following table sets forth the interest expense recognized related to the Convertible Senior Notes (in thousands):
Year Ended December 31
20222021
Contractual interest expense$7,812 $316 
Amortization of debt discount and issuance costs3,236 135 
Total interest expense$11,048 $451 
The remaining term over which the debt discount and issuance costs will be amortized is 3.96 years. Interest expense of $7.8 million and $0.5 million is reflected as a component of interest (expense) income, net in the accompanying consolidated statement of operations for the years ended December 31, 2022 and 2021, respectively.
In connection with the offering of the Convertible Senior Notes, the Company entered into privately negotiated capped call option transactions with certain counterparties (the “Capped Calls”). The Capped Calls each have an initial strike price of approximately $19.98 per share, subject to certain adjustments, which corresponds to the initial conversion price of the Convertible Senior Notes. The Capped Calls have initial cap prices of $30.16 per share, subject to certain adjustment events. The Capped Calls are generally intended to reduce the potential dilution to the Class A common stock upon any conversion of the Convertible Senior Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of converted Convertible Senior Notes, as the case may be, with such reduction and/or offset subject to a cap based on the cap price. The Capped Calls expire on April 6, 2027, subject to earlier exercise. The Capped Calls are subject to either adjustment or termination upon the occurrence of specified extraordinary events affecting the Company, including a merger event, a tender offer, and a nationalization, insolvency or delisting involving the Company. In addition, the Capped Calls are subject to certain specified additional disruption events that may give rise to a termination of the Capped Calls, including changes in law, failure to deliver, and hedging disruptions. The net cost of $73.4 million incurred to purchase the Capped Calls was recorded as a reduction to additional paid-in capital in the accompanying consolidated balance sheet. The Capped Calls are not accounted for as derivatives.
Senior Secured Loan
Legacy Luminar had in August 2017 issued certain Senior Secured Promissory Notes (“Senior Secured Notes”). These Senior Secured Notes were subsequently amended, refinanced and partially repaid at various times through 2020. The Senior Secured Notes were repaid in full in December 2020 as required per the terms of the Merger Agreement. The Company had recorded loss on extinguishment of debt in connection with the Senior Secured Notes in the amount of approximately $4.0 million and interest expense in the amount of $2.5 million in 2020.
In connection with the issuance of Senior Secured Notes and its subsequent amendment, refinance and partial repayments at various times through 2020, Legacy Luminar had issued warrants in 2017, 2018 and 2019 (collectively “Legacy Warrants”). The Legacy Warrants were recorded at fair value with subsequent changes in fair value reflected in earnings. The change in fair value resulted in a loss of $27.3 million during the year ended December 31, 2020. Upon closing of the Business Combination, the Legacy Warrants were exercised for 1,466,155 shares of Class A common stock. No Legacy Warrants have been outstanding since December 31, 2020.
XML 36 R17.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value Measurements
12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
As of December 31, 2022, the Company carried cash equivalents, marketable investments and Private Warrants that are measured at fair value on a recurring basis. The Company had previously carried Public Warrants which were exercised and redeemed in March 2021.
Fair value is based on the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:
Level 1 — Observable inputs, which include unadjusted quoted prices in active markets for identical assets or liabilities.
Level 2 — Observable inputs other than Level 1 inputs, such as quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 — Unobservable inputs that are supported by little or no market activity and that are based on management’s assumptions, including fair value measurements determined by using pricing models, discounted cash flow methodologies or similar techniques.
The Company determined the fair value of its Level 1 financial instruments, which are traded in active markets, using quoted market prices for identical instruments.
Marketable investments classified within Level 2 of the fair value hierarchy are valued based on other observable inputs, including broker or dealer quotations, alternative pricing sources or U.S. Government Treasury yield of appropriate term. When quoted prices in active markets for identical assets or liabilities are not available, the Company relies on non-binding quotes from its investment managers, which are based on proprietary valuation models of independent pricing services. These models generally use inputs such as observable market data, quoted market prices for similar instruments, historical pricing trends of a security as relative to its peers. To validate the fair value determination provided by its investment managers, the Company reviews the pricing movement in the context of overall market trends and trading information from its investment managers. The Company performs routine procedures such as comparing prices obtained from independent source to ensure that appropriate fair values are recorded.
Given that the transfer of Private Warrants to anyone outside of a small group of individuals constituting the sponsors of Gores Metropoulos, Inc. would result in the Private Warrants having substantially the same terms as the Public Warrants, management determined that the fair value of each Private Warrant is the same as that of a Public Warrant, with an insignificant adjustment for short-term marketability restrictions, as of December 31, 2021. As of December 31, 2022, management determined the fair value of the Private Warrants using observable inputs in the Black-Scholes valuation model, which used the remaining term of warrants of 2.92 years, volatility of 85.0% and a risk-free rate of 4.23%. Accordingly, the Private Warrants are classified as Level 3 financial instruments.
The following table presents changes in Level 3 liabilities relating to Private Warrants measured at fair value (in thousands):
Private
Warrants
Balance as of December 31, 2021
$31,230 
Change in fair value prior to exercises4,713 
Reduction in liability due to exercises(19,003)
Change in fair value of outstanding warrants(13,935)
Balance as of December 31, 2022
$3,005 
The Company’s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used for such measurements were as follows (in thousands):
Fair Value (in thousands) Measured as of
December 31, 2022 Using:
Level 1Level 2Level 3Total
Assets:
Cash equivalents:
Money market funds$42,056 $— $— $42,056 
Total cash equivalents$42,056 $— $— $42,056 
Marketable investments:
U.S. treasury securities$188,480 $— $— $188,480 
U.S. agency and government sponsored securities— 4,924 — 4,924 
Commercial paper— 74,523 — 74,523 
Corporate bonds— 109,909 — 109,909 
Asset-backed securities— 11,835 — 11,835 
Marketable equity investments29,643 — — 29,643 
Total marketable investments$218,123 $201,191 $— $419,314 
Liabilities:
Private Warrants— — 3,005 3,005 
Total warrant liabilities$— $— $3,005 $3,005 
Fair Value (in thousands) Measured as of
December 31, 2021 Using:
Level 1Level 2Level 3Total
Assets:
Cash equivalents:
Money market funds$25,654 $— $— $25,654 
Commercial paper— 950 — 950 
Total cash equivalents$25,654 $950 $— $26,604 
Marketable investments:
U.S. treasury securities$161,465 $— $— $161,465 
U.S. agency and government sponsored securities— 4,970 — 4,970 
Commercial paper— 39,834 — 39,834 
Corporate bonds— 165,190 — 165,190 
Asset-backed securities— 46,466 — 46,466 
Marketable equity investments44,216 — — 44,216 
Total marketable investments$205,681 $256,460 $— $462,141 
Liabilities:
Private Warrants— — 31,230 31,230 
Total warrant liabilities$— $— $31,230 $31,230 
The Company’s non-marketable equity investment, measured at fair value on a non-recurring basis, that has been remeasured during the period due to impairment is classified within Level 3 in the fair value hierarchy because the Company estimated the value based on valuation methods which included unobservable inputs including projections received from Robotic Research, market conditions, preference rights, etc. of the investment the Company holds. See Note 5 for further information on the Company’s non-marketable equity investment.
As of December 31, 2022 and 2021, the estimated fair value of the Company’s outstanding Convertible Senior Notes was $352.5 million and $669.4 million, respectively. The fair value was determined based on the quoted price of the Convertible Senior Notes in an inactive market on the last trading day of the reporting period and have been classified as Level 2 in the fair value hierarchy. See Note 7 for further information on the Company’s Convertible Senior Notes.
The Company’s other financial instruments’ fair value, including accounts receivable, accounts payable and other current liabilities, approximate its carrying value due to the relatively short maturity of those instruments. The carrying amounts of the Company’s finance leases approximate their fair value, which is the present value of expected future cash payments based on assumptions about current interest rates and the creditworthiness of the Company.
XML 37 R18.htm IDEA: XBRL DOCUMENT v3.22.4
Convertible Preferred Stock
12 Months Ended
Dec. 31, 2022
Temporary Equity Disclosure [Abstract]  
Convertible Preferred Stock Convertible Preferred Stock
Series A Convertible Preferred Stock
On June 24, 2019, Legacy Luminar had amended and restated its Certificate of Incorporation (“Certificate”), which authorized the issuance of up to 102,740,023 shares of Series A Convertible Preferred Stock with a par value of $0.00001. On June 24, 2019, Legacy Luminar entered into a Series A Convertible Preferred Stock Purchase Agreement to issue preferred stock to investors for cash and in settlement of outstanding SAFEs and Bridge Note.
Series X Convertible Preferred Stock
On August 24, 2020, Legacy Luminar had entered into the Series X Convertible Preferred Stock Purchase Agreement to offer shares of Legacy Luminar’s Series X Convertible Preferred Stock. In August 2020 and September of 2020, Legacy Luminar issued an aggregate of 17,065,536 convertible preferred stock for cash at a purchase price of $9.96 per share of preferred stock, which generated gross proceeds of $170.0 million. In October 2020, Legacy Luminar had issued an additional 1,391,694 shares of preferred stock for gross proceeds of $13.86 million. Accordingly, Legacy Luminar had amended and restated its certificate of incorporation, which authorized the issuance of up to 20,077,073 shares of Series X Convertible Preferred Stock with a par value of $0.00001.
Upon closing of the Business Combination on December 2, 2020, the outstanding shares of Series A and Series X Convertible Preferred Stock were automatically converted into 113,275,381 shares of the Company Class A common stock.
Beneficial Conversion Features (“BCFs”)
The Company had assessed whether BCFs existed for the optional conversion rights that did not require bifurcation as derivatives. If the conversion option was in-the-money as of the commitment date, the preferred stock contained a BCF. The BCF was recognized as a deemed dividend against the carrying amount of the preferred stock. The Company had monitored for the issuance of additional shares below the conversion price, which could have resulted in a contingent BCF. The Company had recorded a total BCF of $12.0 million from the issuance of preferred stock prior to the close of the Business Combination. Because the preferred stock was convertible at any time pursuant to the optional conversion feature, the Company recognized a dividend equal to the BCF at the applicable commitment date. As the Company had an accumulated deficit as of the end of all periods presented, the BCF resulted in an increase and decrease in additional paid-in capital by the same amount.
Furthermore, the preferred stock contained a down-round protection provision that reduced the conversion price if the Company issues shares at less than the conversion price or for no consideration. This provision was not triggered upon consummation of the Business Combination and no contingent BCF was recorded during the year ended December 31, 2020.
XML 38 R19.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings (Loss) Per Share
12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Earnings (Loss) Per Share Earnings (Loss) Per Share
Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares of common stock during the period plus, common stock equivalents, as calculated under the treasury stock method, outstanding during the period. If the Company reports a net loss, the computation of diluted loss per share excludes the effect of dilutive common stock equivalents, as their effect would be antidilutive. The Company computes earnings (loss) per share using the two-class method for its Class A and Class B common stock. Earnings (loss) per share is same for both Class A and Class B common stock since they are entitled to the same liquidation and dividend rights. Earnings (loss) per share calculations for all periods prior to the Business Combination have been retrospectively restated to the equivalent number of shares reflecting the exchange ratio established in the reverse capitalization.
The following table sets forth the computation of basic and diluted loss for the years ended December 31, 2022, 2021, and 2020 as follows: (in thousands, except for share and per share amounts):
December 31,
202220212020
Numerator:
Net loss$(445,939)$(237,986)$(362,298)
Deemed dividend attributable to BCF accretion— — (6,757)
Net loss attributable to common shareholders$(445,939)$(237,986)$(369,055)
Denominator:
Weighted average Common shares outstanding- Basic356,265,774 346,300,975 145,096,996 
Weighted average Common shares outstanding- Diluted356,265,774 346,300,975 145,096,996 
Net loss per shares attributable to Common shareholders- Basic and Diluted$(1.25)$(0.69)$(2.54)
The following table presents the potential shares of common stock outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive:
December 31,
202220212020
Warrants5,757,549 7,166,301 24,089,255 
Stock-based awards—Equity classified33,372,534 24,156,973 18,003,962 
Stock-based awards—Liability classified14,302,723 2,401,648 — 
Vendor stock-in-lieu of cash program3,162,879 1,659,510 — 
Convertible Senior Notes31,279,716 31,279,716 — 
Earn-out shares8,606,717 8,606,717 25,818,744 
Total96,482,118 75,270,865 67,911,961 
The Company uses the if converted method for calculating the dilutive effect of the Convertible Senior Notes using the initial conversion price of $19.981 per share. The closing price of Class A common stock as of December 31, 2022 was less than the initial conversion price.
XML 39 R20.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders’ Equity (Deficit)
12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Stockholders’ Equity (Deficit) Stockholders’ Equity (Deficit)
Class A and Class B Common Stock
The Company’s Board of Directors has authorized two classes of common stock, Class A and Class B. As of December 31, 2022, the Company had authorized 715,000,000 and 121,000,000 shares of Class A and Class B common stock with a par value of $0.0001 per share for each class. As of December 31, 2022, the Company had 291,942,087 shares issues and 270,078,637 shares outstanding shares of Class A common stock, and 97,088,670 shares of issued and outstanding Class B common stock. Holders of the Class A and Class B common stock have identical rights, except that holders of the Class A common stock are entitled to one vote per share and the holder of the Class B common stock is entitled to ten votes per share. Shares of Class B common stock can be converted to shares of Class A common stock at any time at the option of the stockholder and automatically convert upon sale or transfer, except for certain transfers specified in the Company’s amended and restated certificate of incorporation. During 2021, 15,000,000 shares of Class B common stock were converted into Class A common stock on a one-for-one basis.
In connection with the merger with Gores on December 2, 2020, the Company’s Chief Executive Officer exchanged 22,935,412 shares of Founders Preferred Stock and 82,182,791 shares of Class A common stock, which were entitled to one vote per share, into the same number of shares of Class B common stock, which are entitled to ten votes per share. The Company recorded the incremental value of $3.0 million associated with this transaction as stock-based compensation in general and administrative expenses.
Treasury Stock
In December 2021, the Company’s Board of Directors authorized share repurchases up to $312.5 million of the Company’s Class A common stock. The Company’s share repurchase program does not obligate the Company to acquire any specific number of shares. Under the program, shares could be repurchased in privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). In the fourth quarter of 2021, the Company repurchased 15,263,761 shares Class A common stock for $235.9 million through negotiated and market purchase transactions. In the first and second quarters of 2022, the Company repurchased 2,682,548 and 3,917,141 shares of Class A common stock for $39.7 million and $36.9 million, respectively. As of December 31, 2022, no amount remained available for stock repurchases pursuant to our stock repurchase program. The repurchased shares have been recorded as Treasury Stock on the Balance Sheet as of December 31, 2022 and 2021.
Founders Preferred Stock
26,206,837 shares of Founders Preferred Stock were issued in 2015. The compensation expense associated with the Founders Preferred Stock was immaterial to the financial statements. The Founders Preferred Stock was substantively the same as common stock, as they share identical rights and features. The Founders Preferred Stock was convertible into common stock on a one-to-one basis at any time. The Founders Preferred Stock is presented as a component of the Company’s permanent equity. Upon closing of the Business Combination, Founders Preferred Stock was converted into shares of Class A and Class B common stock. No Founders Preferred Stock have been outstanding since the closing of the Business Combination.
Public and Private Warrants
In March 2021, 3,589,645 Private Warrants and 13,128,671 Public Warrants were exercised, and the Company received $153.9 million in cash proceeds from the exercise of these warrants. Pursuant to the terms of the agreements governing the rights of the holders of the Public Warrants, the Company redeemed the remaining unexercised and outstanding 204,638 Public Warrants after March 2021 for a redemption price of $0.01 per Public Warrant.
As of December 31, 2021, the Company had no Public Warrants and 3,077,021 Private Warrants outstanding.
In January 2022 and April 2022, 1,389,529 and 19,223 Private Warrants, respectively, were exercised on a cashless basis and the Company issued 401,365 and 4,387 shares of Class A common stock, respectively, pursuant to the exercises. The Company had 1,668,269 Private Warrants outstanding as of December 31, 2022. These Private Warrants expire on December 2, 2025. Each Private Warrant allows the holder to purchase one share of Class A common stock at $11.50 per share.
Stock-in-lieu of Cash Program
The Company has entered into arrangements with certain vendors and other third parties wherein the Company at its discretion may elect to pay amounts owed to the respective vendors or third parties for services provided either in cash or by issuing shares of the Company’s Class A common stock (“Stock-in-lieu of Cash Program”). During the year ended December 31, 2022, the Company issued 8,824,385 shares of Class A common stock, as part of the Stock-in-lieu of Cash
Program. The Company considers the shares issuable under the Stock-in-lieu of Cash Program as liability classified awards when the arrangement with the vendors requires the Company to issue a variable number of shares to settle amounts owed. As of December 31, 2022, the Company had a total of $15.2 million in prepaid expenses and other current and non-current assets related to its Stock-in-lieu of Cash Program.
In November 2021, the Company entered into an agreement with Daimler North America Corporation (“Daimler”) wherein Daimler is providing certain data and other services to the Company. To compensate Daimler for these services, the Company agreed to issue 1.5 million shares of Class A common stock to Daimler. These shares are subject to certain vesting conditions and vest over a period of two years. The Company recorded costs related to these shares as research and development expense of $7.9 million during the year ended December 31, 2022. During the year ended December 31, 2022, the Company issued 1,125,000 shares of Class A common stock related to this arrangement. The unamortized cost relating to the shares issued to Daimler under this agreement was recorded as $9.2 million in prepaid expenses and other current and non-current assets as of December 31, 2022.
The Company’s vendor Stock-in-lieu of Cash Program activity for the year ended December 31, 2022 was as follows:
SharesWeighted Average
Grant Date Fair Value
per Share
Outstanding as of December 31, 20211,500,000 $15.72 
Granted8,824,385 9.93 
Vested(9,277,234)10.65 
Outstanding as of December 31, 20221,047,151 11.90 
XML 40 R21.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-based Compensation
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Stock-based Compensation Stock-based Compensation
Prior to becoming a publicly traded entity, the Company issued incentive stock options, non-qualified stock options, and restricted stock to employees and non-employee consultants under its 2015 Stock Plan (the “2015 Plan”). Since the closing of the Business Combination, the Company has not issued any new stock-based awards under the 2015 Plan.
In December 2020, the Board adopted, and the Company’s stockholders approved the 2020 Equity Incentive Plan (the “2020 Plan”). The 2020 Plan became effective upon the closing of the Business Combination. Under the 2020 Plan, the Company was originally authorized to issue a maximum number of 36,588,278 shares of Class A common stock.
In June 2022, the Company’s stockholders approved an amendment and restatement of the Company’s 2020 Plan (the “Amended 2020 Plan”) to increase the number of shares of Class A common stock authorized for issuance by 36,000,000 additional shares and added an evergreen provision under which the number of shares of Class A common stock available for issuance under the Amended 2020 Plan will be increased on the first day of each fiscal year of the Company beginning with the 2023 fiscal year and ending on (and including) the first day of the 2030 fiscal year, in an amount equal to the lesser of (i) 5% of the outstanding shares of common stock on the last day of the immediately preceding fiscal year, (ii) 40,000,000 shares or (iii) such number of shares determined by the Board. Pursuant to the evergreen provision, 18,358,365 additional shares of Class A common stock were added to the Amended 2020 Plan on January 1, 2023.
Stock Options
Under the terms of the 2015 Plan, incentive stock options had an exercise price at or above the fair market value of the stock on the date of the grant, while non-qualified stock options were permitted to be granted below fair market value of the stock on the date of grant. Stock options granted had service-based vesting conditions only. The service-based vesting conditions varied, though typically, stock options vest over four years with 25% of stock options vesting on the first anniversary of the grant and the remaining 75% vesting monthly over the remaining 36 months. Option holders have a 10-year period to exercise the options before they expire. Forfeitures are recognized in the period of occurrence.
A summary of the Company’s stock option activity for the year ended December 31, 2022 was as follows (in thousands, except years and per share data):
Number of
Stock Options
Weighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Life (Years)
Aggregate
Intrinsic Value
Outstanding as of December 31, 2021
11,507,643 $1.72 
Exercised(2,370,989)1.67 
Cancelled/Forfeited(973,804)1.67 
Outstanding as of December 31, 2022
8,162,850 1.74 7.03$26,763 
Vested and exercisable as of December 31, 20225,472,821 1.73 6.95$17,654 
Vested and expected to vest as of December 31, 20228,162,850 1.74 7.03$26,763 
No stock options were granted by the Company in 2022 or 2021. The weighted-average grant date fair value per share of options granted during the year ended December 31, 2020 was $0.98. The total grant-date fair value of options that vested during the year ended December 31, 2022, 2021 and 2020 was $2.9 million, $7.1 million and $1.4 million, respectively.
The aggregate intrinsic value of stock options exercised during the year ended December 31, 2022 was $20.6 million. The intrinsic value is calculated as the difference between the exercise price and the fair value of the common stock on the exercise date.
As of December 31, 2022, the Company had $2.7 million of unrecognized stock-based compensation expense related to stock options. This cost is expected to be recognized over a weighted-average period of 0.63 years.
Restricted Stock Awards
Prior to June 30, 2019, the Company granted restricted stock awards (“RSAs”) to employees. Recipients purchased the restricted stock on the grant date and the Company has the right to repurchase the restricted shares at the same price recipients paid to obtain those shares. The restrictions lapse solely based on continued service, and generally lapse over 4 years —25% on the first anniversary of the date of issuance, and the remaining 75% monthly over the remaining 36 months. At the grant date of the award, recipients of restricted stock were granted voting rights and right to receive dividends on unvested shares. No restricted stock awards have been granted after June 30, 2019.
The Company’s RSAs activity for the year ended December 31, 2022 was as follows:
SharesWeighted Average
Grant Date Fair Value
per Share
Outstanding as of December 31, 2021666,298 1.21 
Forfeited(18,476)1.23 
Vested(583,336)1.20 
Outstanding as of December 31, 202264,486 1.29 
The total grant-date fair value of restricted stock awards vested during the year ended December 31, 2022, 2021 and 2020 was $0.7 million, $1.0 million and $2.2 million, respectively.
As of December 31, 2022, the Company had $0.1 million of unrecognized stock-based compensation expense related to restricted stock awards, which is expected to be recognized in the first quarter of 2023.
Restricted Stock Units
Since the closing of the Business Combination, the Company has granted restricted stock units (“RSUs”) under the Amended 2020 Plan (and prior to its amendment and restatement, under the 2020 Plan). Each RSU granted under the Amended 2020 Plan represents a right to receive one share of the Company’s Class A common stock when the RSU vests. RSUs generally vest over a period up to six years. The Company has granted certain performance-based equity awards that vest upon achievement of certain performance milestones. The fair value of RSU is equal to the fair value of the Company’s common stock on the date of grant.
The Company’s RSUs activity for the year ended December 31, 2022 was as follows:
SharesWeighted Average
Grant Date Fair
Value per Share
Outstanding as of December 31, 202111,983,032 19.56 
Granted23,213,889 10.29 
Forfeited(2,069,915)16.15 
Vested(7,532,971)15.40 
Outstanding as of December 31, 202225,594,035 12.66 
The total fair value of RSUs vested during the year ended December 31, 2022 and 2021was $116.0 million and $32.8 million, respectively.
As of December 31, 2022, the Company had $277.7 million of unrecognized stock-based compensation expense related to RSUs. This cost is expected to be recognized over a weighted-average period of 1.53 years.
Fixed Value Equity Awards
The Company issues fixed value equity awards to certain employees as a part of their compensation package. These awards are issued as RSUs out of the Amended 2020 Plan (and prior to its amendment and restatement, under the 2020 Plan) and are accounted for as liability classified awards under ASC 718 — Stock Compensation. Fixed value equity awards granted have service-based conditions only and vest quarterly over a period a period up to four years. These awards represent a fixed dollar amount settled in a variable number of shares determined at each vesting date. For the year ended December 31, 2022, the Company recorded $7.6 million in stock-based compensation expense related to these awards.
Employee Stock Purchase Plan
In December 2020, the Board and the Company’s stockholders adopted the 2020 Employee Stock Purchase Plan (“ESPP”) under which 7,317,655 shares were authorized for issuance. The 2020 ESPP became effective on February 26, 2021.
The ESPP permits eligible employees to purchase the Company’s Class A common stock through payroll deduction with up to 15% of their pre-tax earnings subject to certain Internal Revenue Code limitations. The purchase price of shares is 85% of the lower of the fair market value of the Company’s common stock on the first day of a six-month offering period, or the relevant purchase date. In addition, no participant may purchase more than 5,000 shares of common stock in each purchase period.
During 2022, 168,147 shares were purchased at a weighted average price of $7.56 per share.
The assumptions used to value purchase rights under the ESPP during the year ended December 31, 2022 were as follows:
May 16, 2022November 16, 2022
Expect term (years)0.50.5
Volatility82.3%93.5%
Risk-free interest rate1.54%4.54%
Dividend yield—%—%
Optogration Milestone Awards
As discussed in Note 3, as part of the Optogration acquisition in August 2021, the Company owed up to $22.0 million of post combination compensation related to certain service and performance conditions (“Optogration Milestone Awards”). In August 2022, the Company issued 1,632,056 shares of Class A common stock for $11.0 million of the Optogration Milestone Awards due to achievement of the service and performance conditions. As of December 31, 2022, it is probable that the service and performance conditions for the remaining $11.0 million obligation will be met. The Company recorded $16.5 million in stock-based compensation expense from inception to December 31, 2022 for Optogration Milestone Awards.
Freedom Photonics Awards
As part of the Freedom Photonics acquisition in April 2022, the Company owes up to $28.3 million of post combination compensation related to certain service and performance conditions including achievement of certain technical and financial
milestones. As of December 31, 2022, Freedom Photonics did not achieve a portion of its stipulated financial milestone. As of December 31, 2022, it is probable that the remaining conditions will be met, and as a result, the Company recorded $7.6 million in stock-based compensation expense through December 31, 2022.
Solfice Awards
The Company owes up to $0.7 million in compensation related to certain service and performance conditions. As of December 31, 2022, it is probable that the conditions will be met, and as a result, the Company recorded $0.4 million in stock-based compensation expense through December 31, 2022.
Executive Officer Awards
On May 2, 2022, the Board granted an award of 10.8 million RSUs to Austin Russell, the Company’s Chief Executive Officer. The grant date fair value per share was $8.70 per share. This award represents Mr. Russell’s total compensation from the Company. On August 19, 2022, the Board granted 500,000 RSUs to each of Thomas Fennimore, the Company’s Chief Financial Officer and Alan Prescott, the Company’s Chief Legal Officer. The grant date fair value per share was $6.12 per share.
The Company measured compensation cost for the above executive officer awards using a Monte Carlo simulation model and recorded $14.7 million in stock-based compensation expense related to these awards in the year ended December 31, 2022. These awards to the executive officers are subject to all of the following vesting conditions:
Public Market condition: Achievement of three stock price milestones: $50 or more, $60 or more, and $70 or more. The stock price will be measured based on the volume-weighted average price per share for 90 consecutive trading days;
Service condition: Approximately 7-years of vesting; and
Performance condition: Start of production for at least one series production program.
As of December 31, 2022, the Company had $85.3 million of unrecognized stock-based compensation expense related to RSUs. This cost is expected to be recognized over a weighted-average period of 6.36 years.
Compensation expense
Stock-based compensation expense by type of award was as follows (in thousands):
Year Ended December 31,
202220212020
Equity Classified Awards:
Stock options$2,666 $5,137 $3,179 
RSAs293 1,682 5,532 
RSUs129,992 60,191 — 
ESPP714 — — 
Liability Classified Awards:
Equity settled fixed value7,545 3,826 — 
Optogration10,894 6,114 — 
Freedom Photonics7,633 — — 
Solfice410 — — 
Other2,258 734 — 
Total$162,405 $77,684 $8,711 
Stock-based compensation expense by function was as follows (in thousands):
Year Ended December 31,
202220212020
Cost of sales$7,680 $6,422 $309 
Research and development40,898 20,216 2,098 
Sales and marketing15,814 4,546 414 
General and administrative98,013 46,500 5,890 
Total$162,405 $77,684 $8,711 
XML 41 R22.htm IDEA: XBRL DOCUMENT v3.22.4
Leases
12 Months Ended
Dec. 31, 2022
Leases [Abstract]  
Leases Leases
The Company leases office and manufacturing facilities under non-cancelable operating leases expiring at various dates through September 2028. In October 2021, the Company entered into a lease agreement commencing on April 1, 2022 for a term of 65 months through August 31, 2027. In September 2022, the Company entered into a lease agreement for a term of 66 months through February 2028. Some of the Company’s leases include one or more options to renew, with renewal terms that if exercised by the Company, extend the lease term from one to six years. The exercise of these renewal options is at the Company’s discretion. The Company’s lease agreements do not contain any material terms and conditions of residual value guarantees or material restrictive covenants. The Company’s short-term leases and sublease income were not material.
The Company adopted ASC 842 using the modified retrospective method on January 1, 2021 and elected the available package of practical expedients upon adoption. The most significant impact of the adoption of ASC 842 was the recognition of right-of-use, or ROU, assets and lease liabilities for operating leases of $10.8 million and $12.0 million, respectively, and a reversal of deferred rent of $1.2 million on January 1, 2021. The Company’s accounting for finance leases remained substantially unchanged. The adoption of ASC 842 did not have any impact on the Company’s operating results or cash flows.
The components of lease expenses were as follows (in thousands):
Year Ended
December 31, 2022December 31, 2021
Operating lease cost$6,533 $4,654 
Variable lease cost2,230 1,703 
Total operating lease cost$8,763 $6,357 
Supplemental cash flow information related to leases was as follows (in thousands):
Year Ended
December 31, 2022December 31, 2021
Cash paid for amounts included in the measurement of lease liabilities:
Cash paid for operating leases included in operating activities$(6,070)$(4,609)
Right of use assets obtained in exchange for lease obligations:
Operating leases16,749 2,876 
Supplemental balance sheet information related to leases was as follows (in thousands):
December 31, 2022December 31, 2021
Operating leases:
Operating lease right-of-use assets$21,244 $9,145 
Operating lease liabilities:
Operating lease liabilities, current$5,953 $4,735 
Operating lease liabilities, non-current16,989 5,768 
Total operating lease liabilities$22,942 $10,503 
Weighted average remaining terms were as follows (in years):
December 31, 2022December 31, 2021
Weighted average remaining lease term
Operating leases4.432.95
Weighted average discount rates were as follows:
December 31, 2022December 31, 2021
Weighted average discount rate
Operating leases5.45 %2.80 %
Maturities of lease liabilities were as follows (in thousands):
Year Ending December 31,Operating Leases
2023$6,190 
20245,123 
20255,193 
20264,732 
20273,927 
Thereafter1,149 
Total lease payments26,314 
Less: imputed interest(3,372)
Total leases liabilities$22,942 
Leases Leases
The Company leases office and manufacturing facilities under non-cancelable operating leases expiring at various dates through September 2028. In October 2021, the Company entered into a lease agreement commencing on April 1, 2022 for a term of 65 months through August 31, 2027. In September 2022, the Company entered into a lease agreement for a term of 66 months through February 2028. Some of the Company’s leases include one or more options to renew, with renewal terms that if exercised by the Company, extend the lease term from one to six years. The exercise of these renewal options is at the Company’s discretion. The Company’s lease agreements do not contain any material terms and conditions of residual value guarantees or material restrictive covenants. The Company’s short-term leases and sublease income were not material.
The Company adopted ASC 842 using the modified retrospective method on January 1, 2021 and elected the available package of practical expedients upon adoption. The most significant impact of the adoption of ASC 842 was the recognition of right-of-use, or ROU, assets and lease liabilities for operating leases of $10.8 million and $12.0 million, respectively, and a reversal of deferred rent of $1.2 million on January 1, 2021. The Company’s accounting for finance leases remained substantially unchanged. The adoption of ASC 842 did not have any impact on the Company’s operating results or cash flows.
The components of lease expenses were as follows (in thousands):
Year Ended
December 31, 2022December 31, 2021
Operating lease cost$6,533 $4,654 
Variable lease cost2,230 1,703 
Total operating lease cost$8,763 $6,357 
Supplemental cash flow information related to leases was as follows (in thousands):
Year Ended
December 31, 2022December 31, 2021
Cash paid for amounts included in the measurement of lease liabilities:
Cash paid for operating leases included in operating activities$(6,070)$(4,609)
Right of use assets obtained in exchange for lease obligations:
Operating leases16,749 2,876 
Supplemental balance sheet information related to leases was as follows (in thousands):
December 31, 2022December 31, 2021
Operating leases:
Operating lease right-of-use assets$21,244 $9,145 
Operating lease liabilities:
Operating lease liabilities, current$5,953 $4,735 
Operating lease liabilities, non-current16,989 5,768 
Total operating lease liabilities$22,942 $10,503 
Weighted average remaining terms were as follows (in years):
December 31, 2022December 31, 2021
Weighted average remaining lease term
Operating leases4.432.95
Weighted average discount rates were as follows:
December 31, 2022December 31, 2021
Weighted average discount rate
Operating leases5.45 %2.80 %
Maturities of lease liabilities were as follows (in thousands):
Year Ending December 31,Operating Leases
2023$6,190 
20245,123 
20255,193 
20264,732 
20273,927 
Thereafter1,149 
Total lease payments26,314 
Less: imputed interest(3,372)
Total leases liabilities$22,942 
XML 42 R23.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The following table presents components of loss before provision for (benefit from) income taxes for the periods presented (in thousands):
Year Ended December 31,
202220212020
United States$(445,720)$(239,855)$(362,338)
International453 607 40 
Loss before provision for (benefit from) income taxes$(445,267)$(239,248)$(362,298)
Provision for (benefit from) income taxes for the periods presented consisted of (in thousands):
Year Ended December 31,
202220212020
Current:
Foreign440 — — 
Total current:440 — — 
Deferred:
U.S. federal204 (1,262)— 
U.S. state28 — — 
Total deferred:232 (1,262)— 
Total provision for (benefit from) income taxes$672 $(1,262)$— 
The reconciliation between the U.S. federal statutory income tax rate of 21% to the Company’s effective tax for the periods presented is as follows:
Year Ended December 31,
202220212020
U.S. federal provision at statutory rate21.0 %21.0 %21.0 %
State income taxes5.7 4.4 0.7 
Tax credits2.4 1.5 0.6 
Fair value of financial instruments0.4 (2.3)(15.6)
Stock-based compensation expense(3.4)2.0 (0.4)
Executive compensation(0.8)(1.1)0.0 
Other permanent items0.2 (0.3)0.0 
Uncertain tax benefits(1.4)(0.8)(0.3)
Change in valuation allowance(24.3)(24.0)(6.0)
Effective tax rate(0.2 %)0.4 %0.0 %
The Company’s effective tax rates differ from the federal statutory rate primarily due to the change in valuation allowance, non-deductible stock-based compensation expense net of excess windfall stock compensation deductions, nondeductible executive compensation, R&D tax credits, state income taxes and the fluctuation of fair value on instruments treated as debt for GAAP and equity for tax purposes, which is not taxable/deductible for income tax purposes, for 2022, 2021 and 2020.
The Company’s deferred income tax assets and liabilities as of December 31, 2022 and 2021 were as follows (in thousands):
Year Ended December 31,
20222021
Deferred tax assets:
Net operating loss carry forward$161,881 $120,544 
Tax credits16,322 6,296 
Accruals and reserves3,309 — 
Stock-based compensation expense14,535 6,944 
Lease liability (ASC 842)6,268 2,622 
Section 174 R&D capitalization43,240 — 
Inventory reserves1,961 617 
Depreciation and amortization2,170 — 
Other20 15 
Total deferred tax assets249,706 137,038 
Valuation allowance(243,811)(130,569)
Total deferred tax asset5,895 6,469 
Deferred tax liabilities:
Depreciation and amortization— 1,185 
Prepaid expenses— 2,983 
Other162 — 
ROU asset (ASC 842)5,801 2,301 
Total deferred tax liabilities5,963 6,469 
Net deferred tax assets (liabilities)$(68)$— 
The Company assesses the realizability of deferred tax assets based on the available evidence, including a history of taxable income and estimates of future taxable income. In assessing the realizability of deferred tax assets, the Company considers whether it is more likely than not that all or some portion of deferred tax assets will not be realized. Due to the history of losses incurred by the Company, management believes it is not more likely than not that substantially all of the deferred tax assets can be realized. Accordingly, the Company established and recorded a full valuation allowance on its net deferred tax assets of $243.8 million and $130.6 million as of December 31, 2022 and 2021, respectively. The valuation allowance increased by $113.2 million in 2022.
No deferred tax liabilities for foreign withholding taxes have been recorded relating to the earnings of the Company’s foreign subsidiaries since all such earnings are intended to be indefinitely reinvested. The amount of the unrecognized deferred tax liability associated with these earnings is immaterial.
Utilization of the net operating loss and tax credit carryforwards is subject to a substantial annual limitation due to the “ownership change” limitations provided by Sections 382 and 383 of the Internal Revenue Code of 1986, as amended (“IRC”) and other similar state provisions. Any annual limitation may result in the expiration of net operating loss and tax credit carryforwards before utilization. As of December 31, 2022, the Company had $597.0 million of U.S. federal net operating loss carryforwards available to reduce future taxable income, of which $553.8 million will be carried forward indefinitely for U.S. federal tax purposes and $43.2 million will expire beginning in 2035 to 2037. The Company also has $547.8 million of U.S. state net operating loss carryforwards that will expire beginning in 2036.
The Company also has federal and state research and development (“R&D”) tax credit carryforwards of $21.1 million and $3.9 million, respectively, as of December 31, 2022. The federal research credit carryforwards will begin expiring in 2035 and although a small portion, less than $0.05 million, of the state research credit carryforwards will begin expiring in 2023, $4.3 million of the state research credit carryforwards do not expire.
Under the Tax Cuts and Jobs Act (“TCJA”), for tax years beginning after December 31, 2021, taxpayers are required to capitalize and amortize all R&D expenditures that are paid or incurred in connection with their trade or business which represent costs in the experimental or laboratory sense. Specifically, costs for U.S.-based R&D activities must be amortized over 5 years and costs for foreign R&D activities must be amortized over 15 years. As of December 31, 2022, there is
insufficient Internal Revenue Service guidance on how to treat capitalizable R&D expenditures. The Company will continue to monitor the status of any new guidance that might be issued and will update its estimated capitalized R&D, accordingly.
Beginning January 1, 2022, the TCJA eliminated the option to deduct research and development expenditures in the current year and requires taxpayers to capitalize such expenses pursuant to IRC Section 174. The capitalized expenses are amortized over a 5-year period for domestic expenses and a 15-year period for foreign expenses. As a result of this provision of the TCJA, deferred tax assets related to capitalized research expenses increased by $43.2 million.

Unrecognized Tax Benefits
The Company reports income tax related interest and penalties within its provision for income tax in its consolidated statements of operations. The Company had no interest and penalties accrued through December 31, 2022. The Company does not expect the total amount of unrecognized tax benefits will significantly increase or decrease within 12 months of the reporting date.
The following is a tabular reconciliation of the total amounts of unrecognized tax benefits (in thousands):
Year Ended December 31,
202220212020
Unrecognized tax benefits as of the beginning of the year$6,296 $3,975 $2,397 
Increases related to prior year tax positions— 535 327 
Decreases related to prior year tax provisions(3,723)— — 
Increase related to current year tax positions6,031 1,786 1,251 
Unrecognized tax benefits as of the end of the year$8,604 $6,296 $3,975 
None of the Company’s unrecognized tax benefits, if recognized, would affect the effective tax rate since the tax benefits would increase a deferred tax asset that is currently fully offset by a full valuation allowance. The Company and its subsidiaries file federal, state and foreign income tax returns. In the normal course of business, the Company is subject to examination by taxing authorities, for which the Company’s major tax jurisdictions are the United States and various states. The Company’s federal, state and foreign income tax returns from inception to December 31, 2022 remain subject to examination.
XML 43 R24.htm IDEA: XBRL DOCUMENT v3.22.4
Commitment and Contingencies
12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Purchase Obligations
The Company purchases goods and services from a variety of suppliers in the ordinary course of business. Purchase obligations are defined as agreements that are enforceable and legally binding and that specify all significant terms, including fixed or minimum quantities to be purchased, fixed, minimum, or variable price provisions, and the approximate timing of the transaction. The Company had purchase obligations primarily for purchases of inventory, R&D, and general and administrative activities totaling $96.0 million as of December 31, 2022.
Legal Matters
From time to time, the Company is involved in actions, claims, suits and other proceedings in the ordinary course of business, including assertions by third parties relating to intellectual property infringement, breaches of contract or warranties or employment-related matters. When it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated, the Company records a liability for such loss contingencies. The Company’s estimates regarding potential losses and materiality are based on the Company’s judgment and assessment of the claims utilizing currently available information. Although the Company will continue to reassess its reserves and estimates based on future developments, the Company’s objective assessment of the legal merits of such claims may not always be predictive of the outcome and actual results may vary from the Company’s current estimates. The Company’s current legal accrual is not material to the financial statements.
XML 44 R25.htm IDEA: XBRL DOCUMENT v3.22.4
Segment and Customer Concentration Information
12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
Segment and Customer Concentration Information Segment and Customer Concentration InformationReportable segments are (i) Autonomy Solutions and (ii) ATS. These segments reflect the way the chief operating decision maker (“CODM”) evaluates the Company’s business performance and manages its operations. Each segment has distinct product offerings, customers and market penetration. The Chief Executive Officer is the CODM of the Company.
Autonomy Solutions
This segment manufactures and distributes commercial lidar sensors that measure distance using laser light for automotive mobility applications. This segment is impacted by trends in the autonomous vehicles and associated infrastructure/technology sector.
ATS
This segment is in the business of development of semiconductor technology based lasers and sensors. This segment also designs, tests and provides consulting services for development of integrated circuits. This segment is impacted by trends in and the strength of the automobile and aeronautics sector as well as government spending in military and defense activities.
The accounting policies of the operating segments are the same as those described in Note 2. Segment operating results and reconciliations to the Company’s consolidated balances are as follows (in thousands):
Year ended December 31, 2022
Autonomy
Solutions
ATSTotal
reportable
segments
Eliminations (1)Total
Consolidated
Revenue:
Revenues from external customers$24,353 $16,345 $40,698 $— $40,698 
Revenues from internal customer14,748 12,485 27,233 (27,233)— 
Total Revenue$39,101 $28,830 $67,931 $(27,233)$40,698 
Depreciation and amortization$4,110 $2,456 $6,566 $— $6,566 
Operating gain (loss)(412,673)(29,394)(442,067)(335)(442,402)
Other significant items:
Segment assets752,088 60,529 812,617 (125,290)687,327 
Inventories, net8,664 474 9,138 (346)8,792 
Year ended December 31, 2021
Autonomy
Solutions
ATSTotal
reportable
segments
Eliminations (1)Total
Consolidated
Revenue:
Revenues from external customers$28,497 $3,447 $31,944 $— $31,944 
Revenues from internal customer8,098 5,929 14,027 (14,027)— 
Total Revenue$36,595 $9,376 $45,971 $(14,027)$31,944 
Depreciation and amortization$3,723 $439 $4,162 $— $4,162 
Operating gain (loss)(214,133)(324)(214,457)(95)(214,552)
Other significant items:
Segment assets882,704 9,771 892,475 (8,939)883,536 
Inventories, net10,179 163 10,342 — 10,342 
Year ended December 31, 2020
Autonomy
Solutions
ATSTotal
reportable
segments
Eliminations (1)Total
Consolidated
Revenue:
Revenues from external customers$11,387 $2,564 $13,951 $— $13,951 
Revenues from internal customer1,516 3,248 4,764 (4,764)— 
Total Revenue$12,903 $5,812 $18,715 $(4,764)$13,951 
Depreciation and amortization$2,395 $128 $2,523 $(6)$2,517 
Operating gain (loss)(86,661)(316)(86,977)102 (86,875)
Other significant items:
Segment assets511,676 2,975 514,651 (4,300)510,351 
Inventories, net3,604 3,613 — 3,613 
(1) Represent the eliminations of all intercompany balances and transactions during the period presented.
Two customers accounted for 21%, and 17% of the Company’s revenue for the year ended December 31, 2022. Two customers accounted for 42% and 17% of the Company’s revenue for the year ended December 31, 2021. One customer accounted for 64% of the Company’s revenue for the year ended December 31, 2020.
XML 45 R26.htm IDEA: XBRL DOCUMENT v3.22.4
Related Party Transactions
12 Months Ended
Dec. 31, 2022
Related Party Transactions [Abstract]  
Related Party Transactions Related Party Transactions
Equity Investments
In February 2021, the Company invested $15.0 million in a special purpose acquisition company, of which Mr. Jun Hong Heng, was the Chairman and Chief Executive Officer, and a principal shareholder. Mr. Heng became a director of the Company in June 2021. The terms of such investment were no less favorable to the Company than to other third party investors. During 2021, the Company sold $2.9 million of this investment and had a remaining balance of $12.1 million as of December 31, 2021. The fair value of this investment as of December 31, 2021 was $12.2 million, which was included in marketable securities in the balance sheet. The Company sold this investment in its entirety in the second quarter of 2022. The special purpose acquisition company merged with ECARX on December 20, 2022 and Mr. Heng continues to be a director of the merged company.
In June 2022, the Company invested in a special purpose acquisition company through open market purchases, of which Mr. Alec Gores was the Chairman and Chief Executive Officer, and a principal shareholder. The special purpose acquisition company merged with Polestar Automotive Holdings UK PLC on June 24, 2022 and Mr. Gores continues to be a director of the merged company. Mr. Gores is a director of Luminar as well. The balance of this investment as of December 31, 2022 was not material.
XML 46 R27.htm IDEA: XBRL DOCUMENT v3.22.4
Subsequent Events
12 Months Ended
Dec. 31, 2022
Subsequent Events [Abstract]  
Subsequent Events Subsequent Events
In preparing the audited consolidated financial statements as of December 31, 2022, the Company has evaluated subsequent events through February 28, 2023.
In January 2023, the Company executed an asset purchase agreement with Seagate Technology LLC and Seagate Singapore International Headquarters Pte. Ltd. (individually and collectively, “Seagate”) and concurrently completed the acquisition of certain fixed assets, inventory and intellectual property related to Seagate’s lidar-related projects and obtained a license to certain patents and other intangibles for an aggregate cash consideration of $12.6 million. Additionally, the Company hired certain former employees of Seagate who had been working on the above projects.
In February 2023, the Company executed an agreement with Swiss Re Solutions Ltd (“Swiss Re”) for use of certain of Swiss Re’s tools and services for assessment of the Company’s technology for purposes of potentially developing an insurance product and Swiss Re potentially providing reinsurance and other services. The Company agreed to pay Swiss Re $4.0 million in consideration for these services over 4 years, of which $1.0 million is non-cancelable. The Company may at its sole discretion pay the consideration owed to Swiss Re either in cash or shares of Class A common stock.
XML 47 R28.htm IDEA: XBRL DOCUMENT v3.22.4
Basis of Presentation and Summary of Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Basis of Presentation and Consolidation
Basis of Presentation and Consolidation
The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding annual financial reporting. All intercompany transactions and balances have been eliminated in consolidation.
Use of Estimates
Use of Estimates
The preparation of consolidated financial statements in conformity with GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosures. The significant estimates made by management include inventory write-downs, valuation allowance for deferred tax assets, valuation of warrants, fair valuation of assets acquired in mergers and acquisitions including intangible assets, forecasted costs associated with non-recurring engineering (“NRE”) services, product warranty reserves, stock-based compensation expense and other loss contingencies. Management periodically evaluates such estimates and they are adjusted prospectively based upon such periodic evaluation. Actual results could differ from those estimates.
Segment Information
Segment Information
The Company has determined its operating segments using the same indicators which are used to evaluate its performance internally. The Company’s business activities are organized in two operating segments:
(i) “Autonomy Solutions” which includes manufacturing and distribution of lidar sensors that measure distance using laser light to generate a 3D map, non-recurring engineering services related to the Company’s lidar products, development of software products that enable autonomy capabilities for automotive applications, and licensing of the Company’s intellectual property (“IP”). In June 2022, the Company acquired certain assets from Solfice Research, Inc. (“Solfice” or “Civil Maps”). Operations of Civil Maps have been included in the Autonomy Solutions segment.
(ii) “Advanced Technologies and Services (“ATS”)” which includes development of application-specific integrated circuits, pixel-based sensors, advanced lasers, as well as designing, testing and providing consulting services for non-standard integrated circuits. In the second quarter of 2022, the Components segment was renamed as ATS. In August 2021 and in April 2022, the Company acquired Optogration, Inc. (“Optogration”) and Freedom Photonics LLC (“Freedom Photonics”), respectively. Operations of Optogration and Freedom Photonic have been included in the ATS segment.
Concentration of Credit Risk Concentration of Credit RiskThe Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, debt securities and accounts receivable. The Company’s deposits exceed federally insured limits.The Company’s revenue is derived from customers located in the United States and international markets.
Cash and Cash Equivalents
Cash and Cash Equivalents
The Company’s cash and cash equivalents consist of investments with maturities of three months or less at the time of purchase. The Company’s cash equivalents include investments in money market funds, U.S. treasury securities and commercial paper.
Restricted Cash
Restricted Cash
Restricted cash consists of funds that are contractually restricted as to usage or withdrawal due to legal agreements. The Company determines current or non-current classification of restricted cash based on the expected duration of the restriction.
Debt Securities Marketable Equity Investments
Debt Securities
The Company’s debt securities consist of U.S agency securities and government sponsored securities, U.S. treasury securities, corporate bonds, commercial paper and asset-backed securities. The Company classifies its debt securities as available-for-sale at the time of purchase and reevaluates such designation as of each balance sheet date. The Company considers all debt securities as available for use to support current operations, including those with maturity dates beyond one year and are classified as current assets under marketable securities in the accompanying consolidated balance sheets. Debt securities included in marketable securities on the consolidated balance sheets consist of securities with original maturities greater than three months at the time of purchase. Debt securities are carried at fair value, with the unrealized gains and losses reported as a component of accumulated other comprehensive income (loss) (“OCI”). Any realized gains or losses on the sale of debt securities are determined on a specific identification method, and such gains and losses are reflected as a component of other income (expense), net.
The Company reviews the fair value of debt securities and when the fair value of a debt security is below its amortized cost, the amortized cost should be written down to its fair value if (i) it is more likely than not that management will be required to sell the impaired security before recovery of its amortized basis; or (ii) management has the intention to sell the security. If neither of these conditions are met, the Company must determine whether the impairment is due to credit losses. To determine the amount of credit losses, the Company compares the present value of the expected cash flows of the security, derived by taking into account the issuer’s credit ratings and remaining payment terms, with its amortized cost basis. The amount of impairment recognized is limited to the excess of the amortized cost over the fair value of the security. An allowance for credit losses for the excess of amortized cost over the expected cash flows is recorded in other income (expense), net on the consolidated statements of operations. Non-credit related impairment losses are recorded in OCI.
Marketable Equity Investments
The Company holds marketable equity investments over which the Company does not have a controlling interest or significant influence. Marketable equity investments are measured using the quoted prices in active markets with changes recorded in other income (expense), net on the consolidated statement of operations.
Non-Marketable Equity Investments Measured Using the Measurement Alternative Non-Marketable Equity Investments Measured Using the Measurement AlternativeThe Company holds a non-marketable equity investment in a privately held company in which the Company does not own a controlling interest or have significant influence. The investment does not have a readily determinable fair value and the Company has elected the measurement alternative, and consequently, measures the investment at cost less any impairment, adjusted to fair value, if there are observable price changes for an identical or similar investment of the same issuer.
Accounts Receivable Accounts ReceivableAccounts receivables are recorded at the invoiced amount and do not bear interest. The Company reviews the need for an allowance for doubtful accounts quarterly based on historical experience with each customer and the specifics of each customer arrangement.
Inventory
Inventory
The Company values inventory at the lower of cost or net realizable value. The Company determines the cost of inventory using the standard-cost method, which approximates actual costs based on a first-in, first-out method. The Company assesses inventory of slow-moving products for potential impairment, and records write-downs of inventory to cost of sales.
Property and Equipment
Property and Equipment
Property and equipment are stated at cost less accumulated depreciation and amortization, and are depreciated using the straight-line method over the estimated useful lives of the assets as follows:
Asset CategoryEstimated useful lives
Machinery and equipment
1 to 7 years
Computer hardware and software
3 to 5 years
Demonstration fleet and demonstration units
2 to 5 years
Leasehold improvementsShorter of useful life or lease term
Vehicles5 years
Furniture and fixtures7 years
Design and development costs for molds, dies and other tools that will be used in producing the products under a long-term supply arrangement are capitalized as tooling which are included in machinery and equipment. The Company estimates useful lives for these tooling items to range between one to three years. The amount capitalized for tooling as of December 31, 2022 was not material. The Company had not capitalized any amount for tooling as of December 31, 2021. Maintenance and repairs are charged to expense as incurred, and improvements and betterments are capitalized. When assets are retired or otherwise disposed of, the cost and accumulated depreciation and amortization are removed from the consolidated balance sheet and any resulting gain or loss is reflected in the consolidated statements of operations and comprehensive loss in the period realized.
Intangible Assets and Goodwill
Intangible Assets
Intangible assets, consisting of acquired developed technology, customer relationships, customer backlog, assembled workforce, IPR&D and tradename are carried at cost less accumulated amortization. All intangible assets have been determined to have definite lives and are amortized on a straight-line basis over their estimated remaining economic lives, ranging from one to ten years. Amortization expense related to developed technology is included in cost of sales. Amortization expense related to customer relationships is included in sales and marketing expense. Amortization expense related to tradename is included in general and administrative expense. Intangible assets are reviewed for impairment whenever events or changes in circumstances indicate an asset’s carrying value may not be recoverable. There was no impairment of intangible assets experienced during the year ended December 31, 2022 or 2021.
Goodwill
The Company records goodwill when the consideration paid in a business combination exceeds the fair value of the net tangible assets and the identified intangible assets acquired. Goodwill is not amortized, but instead is required to be tested for impairment annually and whenever events or changes in circumstances indicate that the carrying value of goodwill may exceed its fair value.
The Company reviews goodwill for impairment annually in its fourth quarter by initially considering qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill, as a basis for determining whether it is necessary to perform a quantitative analysis. If it is determined that it is more likely than not that the fair value of reporting unit is less than its carrying amount, a quantitative analysis is performed to identify goodwill impairment. There was no impairment of goodwill experienced during the year ended December 31, 2022 or 2021.
Impairment of Long-Lived Assets
Impairment of Long-Lived Assets
The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. When such an event occurs, management determines whether there has been impairment by comparing the anticipated undiscounted future net cash flows to the related asset group’s carrying value. If
an asset is considered impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending on the nature of the asset.
Convertible Senior Notes
Convertible Senior Notes
The Company’s convertible senior notes issued in December 2021 are accounted for as a single liability instrument measured at its amortized cost, as no other embedded features require bifurcation and recognition as derivatives.
Product Warranties Product WarrantiesEstimated future warranty costs are accrued and charged to cost of sales in the period that the related revenue is recognized. These estimates are based on historical warranty experience and any known or expected changes in warranty exposure, such as trends of product reliability and costs of repairing and replacing defective products. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the said estimates as necessary.
Public and Private Warrants
Public and Private Warrants
As part of Gores’ initial public offering on February 5, 2019, Gores issued to third party investors 40.0 million units, consisting of one share of Class A common stock of Gores and one-third of one warrant, at a price of $10.00 per unit. Each whole warrant entitled the holder to purchase one share of Class A common stock at an exercise price of $11.50 per share (the “Public Warrants”). Simultaneously with the closing of the IPO, Gores completed the private sale of 6.667 million warrants to Gore’s sponsor at a purchase price of $1.50 per warrant (the “Private Warrants”). Each Private Warrant allows the sponsor to purchase one share of Class A common stock at $11.50 per share. Subsequent to the Business Combination, 13,333,309 Public Warrants and 6,666,666 Private Warrants remained outstanding as of December 31, 2020.
The Private Warrants and the shares of common stock issuable upon the exercise of the Private Warrants were not transferable, assignable or salable until after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants are exercisable for cash or on a cashless basis, at the holder’s option, and are non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, said Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

The exercise of the Private Warrants may be settled in cash upon the occurrence of a tender offer or exchange that involves 50% or more of the Company’s Class A stockholders. Public Warrants contained the same feature. Since not all of the Company’s stockholders need to participate in such tender offer or exchange to trigger the potential cash settlement and the Company does not control the occurrence of such an event, the Company concluded that the Public Warrants and Private Warrants do not meet the conditions to be classified in equity per the guidance in ASC 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity. Since the Public and Private Warrants meet the definition of a derivative under ASC 815, the Company recorded these warrants as liabilities on the balance sheet at fair value upon the closing of the Business Combination, with subsequent changes in their respective fair values recognized in the consolidated statement of operations and comprehensive loss at each reporting date.
In the first quarter of 2021, 3,589,645 Private Warrants and 13,128,671 Public Warrants were exercised, and the Company received $153.9 million in cash proceeds from the exercise of these warrants. Pursuant to the terms of the agreements governing the rights of the holders of the Public Warrants, the Company redeemed the remaining unexercised and outstanding 204,638 Public Warrants for a redemption price of $0.01 per Public Warrant.
The Company had 3,077,021 Private Warrants and no Public Warrants, outstanding as of December 31, 2021.
In January 2022 and April 2022, 1,389,529 and 19,223 Private Warrants, respectively, were exercised on a cashless basis and the Company issued 401,365 and 4,387 shares of Class A common stock, respectively, pursuant to the exercises. The Company had 1,668,269 Private Warrants outstanding as of December 31, 2022. These Private Warrants expire on December 2, 2025.
Revenue Recognition
Revenue Recognition
Under ASC 606, the Company determines revenue recognition through the following steps:
Identifying the contract, or contracts, with the customer; 
Identifying the performance obligations in the contract;
Determining the transaction price;
Allocating the transaction price to performance obligations in the contract; and
Recognizing revenue when, or as, the Company satisfies performance obligations by transferring the promised goods or services.
Nature of Products and Services and Revenue Recognition
The Autonomy Solutions segment derives revenue primarily from (a) product sales of lidar sensors to customers and distributors, (b) NRE services to integrate Luminar lidar hardware for autonomy in vehicle platforms, and (c) licensing of certain IP.
The ATS segment derives revenue primarily from (a) product sales of application-specific integrated circuits, pixel-based sensors and advanced lasers, as well as (b) NRE services for designing and testing non-standard integrated circuits.
Revenue from product sales is recognized at a point in time when control of the goods is transferred to the customer, generally occurring upon shipment or delivery dependent upon the terms of the underlying contract. Certain customer arrangements involve NRE services to design and develop custom prototype products to customers. Revenue from NRE service arrangements is recognized over time.
For NRE services, the Company recognizes revenue over time using an input method based on contract cost incurred to date compared to total estimated contract costs (cost-to-cost). For NRE service projects, the Company contracts with customers based on hourly rates or on a fixed fee basis. For arrangements based on hourly rates, revenue is recognized as services are performed and amounts are earned in accordance with the terms of a contract at estimated collectible amounts. For arrangements based on a fixed fee, revenue is recognized based on the progress or the percentage of completion of the NRE service project. Expenses associated with performance of work may be reimbursed with a markup depending on contractual terms and are included in revenue.
Contract costs related to NRE arrangements are incurred over time, which can be several years, and the estimation of these costs requires management’s judgment. Significant judgment is required when estimating total contract costs and progress to completion on the arrangements, as well as whether a loss is expected to be incurred on the contract. In estimating total contract costs, the Company is also required to estimate the effort expected to be incurred to complete a NRE project. These estimates are subject to significant estimation uncertainty as actual time and effort incurred on completing a NRE project or actual rates of either internal or contracted personnel working on such NRE projects may differ from the Company’s estimates. Changes in circumstances may change the original estimates of revenues, costs, or extent of progress toward completion, revisions to the estimates are made which may result in increases or decreases in estimated revenues or costs, and such revisions are reflected in income in the period in which the circumstances that gave rise to the revision become known to us. We perform ongoing profitability analysis of our contracts accounted for under this method to determine whether the latest estimates of revenues, costs, and profits require updating. If at any time these estimates indicate that the contract will be unprofitable, the entire estimated loss for the remainder of the contract is recorded immediately.
The Company enters into term-based licenses that provide customers the right to use certain IP available with the Company. Revenue from these licenses is recognized at the point in time at which the customer is able to use and benefit from the licensed information, which is generally upon delivery of the information to the customer or upon commencement of the renewal term.
Amounts billed to customers for shipping and handling are included in revenue. Taxes collected from customers and remitted to governmental authorities are excluded from revenue on the net basis of accounting.
Arrangements with Multiple Performance Obligations
When a contract involves multiple performance obligations, the Company accounts for individual products and services separately if the customer can benefit from the product or service on its own or with other resources that are readily available to the customer and the product or service is separately identifiable from other promises in the arrangement. The consideration is allocated between separate performance obligations in proportion to their estimated standalone selling price. The transactions to which the Company had to estimate standalone selling prices and allocate the arrangement consideration to multiple performance obligations were immaterial.
The Company provides standard product warranties for a term of typically up to one year to ensure that its products comply with agreed-upon specifications. Standard warranties are considered to be assurance type warranties and are not accounted for as separate performance obligations. See Product Warranties for accounting policy on standard warranties.
Other Policies, Judgments and Practical Expedients
Contract balances.  Contract assets and liabilities represent the differences in the timing of revenue recognition from the receipt of cash from the Company’s customers and billings. Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. Receivable represents right to consideration that is unconditional. Such rights are considered unconditional if only the passage of time is required before payment of that consideration is due.
Remaining performance obligations.  Revenue allocated to remaining performance obligations represents the transaction price allocated to the performance obligations that are unsatisfied, or partially unsatisfied. It includes unearned revenue and amounts that will be invoiced and recognized as revenue in future periods and does not include contracts where the customer is not committed. The customer is not considered committed where they are able to terminate for convenience without payment of a substantive penalty under the contract. The Company has elected the optional exemption, which allows for the exclusion of the amounts for remaining performance obligations that are part of contracts with an original expected duration of one year or less.
Significant financing component. In certain arrangements, the Company receives payment from a customer either before or after the performance obligation has been satisfied. Typically, the expected timing difference between the payment and satisfaction of performance obligations is one year or less; therefore, the Company applies a practical expedient and does not consider the effects of the time value of money. The Company’s contracts with customer prepayment terms do not include a significant financing component because the primary purpose is not to receive or provide financing from or to the customers.
Contract modifications. The Company may modify contracts to offer customers additional products or services. Each of the additional products and services are generally considered distinct from those products or services transferred to the customer before the modification. The Company evaluates whether the contract price for the additional products and services reflects the standalone selling price as adjusted for facts and circumstances applicable to that contract. In these cases, the Company accounts for the additional products or services as a separate contract. In other cases where the pricing in the modification does not reflect the standalone selling price as adjusted for facts and circumstances applicable to that contract, the Company accounts on a prospective basis where the remaining goods and services are distinct from the original items and on a cumulative catch-up basis when the remaining goods and services are not distinct from the original items.
Judgments and estimates. Accounting for contracts recognized over time involves the use of various techniques to estimate total contract revenue and costs. Due to uncertainties inherent in the estimation process, it is possible that estimates of costs to complete a performance obligation will be revised in the near term. The Company reviews and updates its contract-related estimates regularly, and records adjustments as needed. For those performance obligations for which revenue is recognized using a cost-to-cost input method, changes in total estimated costs, and related progress towards complete satisfaction of the performance obligation, are recognized on a cumulative catch-up basis in the period in which the revisions to the estimates are made.
Cost of Sales
Cost of Sales
The Company includes all manufacturing and sourcing costs incurred prior to the receipt of finished goods at its distribution facility in cost of sales. The cost of sales principally includes personnel-related costs (including certain engineering personnel), including stock-based compensation, directly associated with the Company’s manufacturing organization, direct costs, product costs, purchasing costs, allocation of overhead costs associated with manufacturing operations, inbound freight charges, insurance, inventory write-downs, warranty cost and depreciation and amortization expense associated with the manufacturing and sourcing operations. Cost of sales also includes the direct cost and appropriate allocation of overhead costs involved in execution of service contracts.
Research and Development (R&D)
Research and Development (R&D)
R&D expenses consist primarily of personnel-related expenses, consulting and contractor expenses, tooling and prototype materials to the extent no future benefit is expected and allocated overhead costs. Substantially all of the Company’s R&D expenses are related to developing new products and services, improving existing products and services, and developing manufacturing processes. R&D expenses are expensed as incurred.
Design and development costs for products to be sold under long-term supply arrangements are expensed as incurred. Design and development costs for molds, dies, and other tools involved in new technologies are expensed as incurred. Design and development costs for molds, dies, and other tools that will be used in producing the products under a long-term supply arrangement are capitalized as part of the molds, dies, and other tools.
Stock-Based Compensation
Stock-based Compensation
Employee awards
For equity classified awards, the Company measures the cost of share-based awards granted to employees, non-employees and directors based on the grant-date fair value of the awards. The grant-date fair value of the stock options is calculated using a Black-Scholes option pricing model. The grant-date fair value of purchase rights under the Company’s 2020 Employee Stock Purchase Plan (“ESPP”) is calculated using a Black-Scholes option pricing model. The grant-date fair value of restricted stock is calculated based on the fair value of the underlying common stock less cash proceeds paid by the recipient to acquire the restricted stock, if any. The grant-date fair value of restricted stock unit is calculated based on the fair value of the underlying common stock. The grant-date fair value of stock-based awards with market conditions is calculated using a Monte Carlo simulation model. The fair value of the stock-based compensation is recognized on a straight-line basis over the requisite service period, which is generally the vesting period of the award. The Company has elected to recognize the effect of forfeitures in the period they occur.
The Company grants fixed value share-based awards to certain employees, wherein the awardee is entitled to a fixed dollar value compensation settled by issuing shares on the vesting date, with the number of shares determined based on the Company’s stock price on or close to the settlement date. These fixed value equity awards are considered as liability classified awards. The Company measures the cost of fixed value share-based awards granted to employees based on a fixed monetary amount that is known at the inception of the obligation. The Company records the compensation cost for the fixed dollar amount of the award over the vesting period, with a corresponding liability.
Stock-based payments to vendors / non-employees
The Company has entered into arrangements with certain vendors and other third parties wherein the Company at its discretion may elect to compensate the respective vendors for services provided in either cash or by issuing shares of the Company’s Class A common stock (“Stock-in-lieu of Cash Program”). Typically, the amounts owed under the Stock-in-lieu of Cash Program are settled by issuing shares, with the number of shares generally determined based on the Company’s stock price on or close to the settlement date. Payments owed under this program may be equity or liability classified depending upon fixed or variable number of shares issued for the amount owed to vendors. The Company measures the cost based on a fixed monetary amount that is known at the inception of the obligation.
Income Taxes
Income Taxes
Income taxes are accounted for under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax bases of assets and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.
The Company recognizes deferred tax assets to the extent that these assets are more likely than not to be realized. In making such a determination, all available positive and negative evidence are considered, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If it is determined that deferred tax assets would be realized in the future, in excess of their net recorded amount, an adjustment would be made to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.
The Company records uncertain tax positions in accordance with ASC 740, Income Taxes, on the basis of a two-step process which includes (1) determining whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position, and (2) for those tax positions that meet the more-likely-than-not recognition threshold. Recognized income tax positions are measured at the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority.
The Company recognizes interest and penalties related to unrecognized tax benefits on the income tax expense line in the accompanying consolidated statement of operations. Accrued interest and penalties are included on the related tax liability line in the consolidated balance sheet.
The Tax Cuts and Jobs Act (“TCJA”) subjects a U.S. shareholder to tax on global intangible low-taxed income (“GILTI”) earned by certain foreign subsidiaries. Under GAAP, the Company can make an accounting policy election to either
treat taxes due on the GILTI inclusion as a current period expense or factor such amounts into the Company’s measurement of deferred taxes. The Company elected to treat the GILTI inclusion as a period expense.
Recently Adopted Accounting Pronouncements
Recently Adopted Accounting Pronouncements
In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (“ASU 2021-08”). ASU 2021-08 requires an acquirer to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. At the acquisition date, it requires an acquirer to account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts, which should generally result in an acquirer recognizing and measuring the acquired contract assets and contract liabilities consistent with how they were recognized and measured in the acquiree’s financial statements. The Company elected to early adopt ASU 2021-08 as of January 1, 2022. The adoption of ASU 2021-08 did not have a material impact on the Company’s consolidated financial position, operating results or cash flows.
Fair Value Measurements Fair Value Measurements
As of December 31, 2022, the Company carried cash equivalents, marketable investments and Private Warrants that are measured at fair value on a recurring basis. The Company had previously carried Public Warrants which were exercised and redeemed in March 2021.
Fair value is based on the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:
Level 1 — Observable inputs, which include unadjusted quoted prices in active markets for identical assets or liabilities.
Level 2 — Observable inputs other than Level 1 inputs, such as quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 — Unobservable inputs that are supported by little or no market activity and that are based on management’s assumptions, including fair value measurements determined by using pricing models, discounted cash flow methodologies or similar techniques.
The Company determined the fair value of its Level 1 financial instruments, which are traded in active markets, using quoted market prices for identical instruments.
Marketable investments classified within Level 2 of the fair value hierarchy are valued based on other observable inputs, including broker or dealer quotations, alternative pricing sources or U.S. Government Treasury yield of appropriate term. When quoted prices in active markets for identical assets or liabilities are not available, the Company relies on non-binding quotes from its investment managers, which are based on proprietary valuation models of independent pricing services. These models generally use inputs such as observable market data, quoted market prices for similar instruments, historical pricing trends of a security as relative to its peers. To validate the fair value determination provided by its investment managers, the Company reviews the pricing movement in the context of overall market trends and trading information from its investment managers. The Company performs routine procedures such as comparing prices obtained from independent source to ensure that appropriate fair values are recorded.
XML 48 R29.htm IDEA: XBRL DOCUMENT v3.22.4
Basis of Presentation and Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Schedule of Property and Equipment
Property and equipment are stated at cost less accumulated depreciation and amortization, and are depreciated using the straight-line method over the estimated useful lives of the assets as follows:
Asset CategoryEstimated useful lives
Machinery and equipment
1 to 7 years
Computer hardware and software
3 to 5 years
Demonstration fleet and demonstration units
2 to 5 years
Leasehold improvementsShorter of useful life or lease term
Vehicles5 years
Furniture and fixtures7 years
Property and equipment consisted of the following (in thousands):
 December 31,
 20222021
Machinery and equipment$14,047 $7,694 
Computer hardware and software6,797 2,854 
Land1,001 — 
Leasehold improvements885 869 
Vehicles, including demonstration fleet3,222 2,421 
Furniture and fixtures818 272 
Construction in progress13,642 3,677 
Total property and equipment40,412 17,787 
Accumulated depreciation and amortization(10,152)(6,778)
Total property and equipment, net$30,260 $11,009 
XML 49 R30.htm IDEA: XBRL DOCUMENT v3.22.4
Business Combinations (Tables)
12 Months Ended
Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]  
Schedule of Business Acquisitions, by Acquisition
The following table summarizes the preliminary purchase price allocation to assets acquired and liabilities assumed, including identification of measurement period adjustments (in thousands):
Preliminary Recorded Value
Cash and cash equivalents$1,063 
Accounts receivable3,311 
Contract asset1,913 
Inventories, net127 
Prepaid expenses and other current assets70 
Property and equipment1,353 
Operating lease right-of-use assets449 
Other non-current assets22 
Intangible assets (1)15,600 
Goodwill (2)15,885 
Total assets acquired39,793 
Current and non-current liabilities(5,158)
Total liabilities assumed(5,158)
Net assets acquired$34,635 
(1) Tradename was measured using the relief-from-royalty method. The remaining identifiable intangible assets were measured using the income approach. Significant inputs used as part of the valuation of intangible assets include revenue forecasts, present value factors, expected product margins and costs to complete the IPR&D.
(2) Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected future economic benefits as a result of other assets acquired that could not be individually identified and separately recognized. Goodwill is not amortized. The factors that made up goodwill recognized included assembled workforce and component cost savings. The entire amount of goodwill is expected to be deductible for tax purposes and is allocated to the ATS segment, which is also deemed the reporting unit.
The following table summarizes the purchase price allocation to assets acquired and liabilities assumed, including identification of measurement period adjustments:
Recorded Value
Cash and cash equivalents$358 
Accounts receivable810 
Other current assets482 
Property and equipment1,248 
Other non-current assets384 
Intangible assets (1)2,650 
Goodwill (2)2,244 
     Total assets acquired8,176 
Current Liabilities(488)
Non-current liabilities(1,346)
     Total liabilities assumed(1,834)
      Net assets acquired$6,342 
(1) Identifiable intangible assets were measured using the income approach.
(2) Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected future economic benefits as a result of other assets acquired that could not be individually identified and separately recognized. Goodwill is not amortized. The factors that made up the goodwill recognized included assembled workforce and component cost savings. Goodwill is not expected to be deductible for tax purposes.
Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination
Identifiable intangible assets recognized (in thousands):
Useful LifePreliminary Recorded Value
Customer backlog2 years$650 
Customer relationships4 years2,950 
Developed technology8 years4,000 
In-process research and development (IPR&D) (1)7,500 
Tradename4 years500 
Total intangible assets$15,600 
(1) IPR&D intangibles are treated as indefinite-lived until the completion or abandonment of the associated R&D
project, at which time the appropriate useful lives will be determined.
Identifiable intangible assets recognized:
Useful LifeRecorded Value
Customer relationships10 years$780 
Tradename
≤ 1 year
120 
Developed technology10 years1,750 
Total intangible assets$2,650 
Schedule of the impact of Adjustments to the Unaudited Pro Forma The table below reflects the impact of adjustments to the unaudited pro forma results for the years ended December 31, 2022 and 2021 that are directly attributable to the acquisition (in thousands):
December 31,
20222021
(Unaudited)
(Decrease) / increase to expenses as a result of transaction costs$(2,582)$2,795 
(Decrease) / increase to expenses as a result of stock-based compensation expense4,119 19,593 
Business Acquisition, Pro Forma Information
The unaudited pro forma information presented below is for informational purposes only and is not necessarily indicative of our consolidated results of operations of the combined business had the acquisition actually occurred at the beginning of fiscal year 2021 or the results of our future operations of the combined businesses (in thousands).
December 31,
20222021
(Unaudited)
Revenue$46,422 $49,804 
Net loss(447,736)(260,813)
XML 50 R31.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue (Tables)
12 Months Ended
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue Total revenue based on the disaggregation criteria described above, as well as revenue by segment, are as follows (in thousands):
Year Ended December 31,
202220212020
Revenue% of RevenueRevenue% of RevenueRevenue% of Revenue
Revenue by primary geographical market:
North America$35,032 86 %$23,043 72 %$4,010 29 %
Asia Pacific3,703 %2,502 %906 %
Europe and Middle East1,963 %6,399 20 %9,035 65 %
Total40,698 100 %31,944 100 %13,951 100 %
Revenue by timing of recognition:
Recognized at a point in time17,595 43 %8,892 28 %2,639 19 %
Recognized over time23,103 57 %23,052 72 %11,312 81 %
Total40,698 100 %31,944 100 %13,951 100 %
Revenue by segment:
Autonomy Solutions24,353 60 %28,497 89 %11,387 82 %
ATS16,345 40 %3,447 11 %2,564 18 %
Total40,698 100 %31,944 100 %13,951 100 %
Schedule of Opening and Closing Balances of Contract Liabilities and Significant Changes in Contract Liabilities
The opening and closing balances of contract assets were as follows (in thousands):
December 31,
 20222021
Contract assets, current$15,395 $9,907 
Contract assets, non-current2,575 — 
Ending balance$17,970 $9,907 
The significant changes in contract assets balances consisted of the following (in thousands): 
 December 31,
 20222021
Beginning balance$9,907 $— 
Amounts billed that were included in the contract assets beginning balance(4,228)— 
Revenue recognized for performance obligations that have been satisfied but for which amounts have not been billed12,291 9,907 
Ending balance$17,970 $9,907 
The opening and closing balances of contract liabilities were as follows (in thousands):
December 31,
 20222021
Contract liabilities, current$1,993 $898 
Contract liabilities, non-current1,015 — 
Ending balance$3,008 $898 
The significant changes in contract liabilities balances consisted of the following (in thousands): 
 December 31,
 20222021
Beginning balance$898 $2,284 
Revenue recognized that was included in the contract liabilities beginning balance(489)(1,792)
Increase due to cash received and not recognized as revenue and billings in excess of revenue recognized during the period2,599 406 
Ending balance$3,008 $898 
XML 51 R32.htm IDEA: XBRL DOCUMENT v3.22.4
Investments (Tables)
12 Months Ended
Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]  
Debt Securities, Available-for-sale
The Company’s investments in debt securities consisted of the following as of December 31, 2022 and 2021 (in thousands):
December 31, 2022
 CostGross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
U.S. treasury securities$191,075 $$(2,598)$188,480 
U.S. agency and government sponsored securities4,999 — (75)4,924 
Commercial paper74,755 — (232)74,523 
Corporate bonds111,123 — (1,214)109,909 
Asset-backed securities11,945 — (110)11,835 
Total debt securities$393,897 $$(4,229)$389,671 
Included in marketable securities$393,897 $$(4,229)$389,671 
December 31, 2021
 CostGross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
U.S. treasury securities$161,938 $$(474)$161,465 
U.S. agency and government sponsored securities4,995 — (25)4,970 
Commercial paper40,788 — (4)40,784 
Corporate bonds165,522 13 (345)165,190 
Asset-backed securities46,540 — (74)46,466 
Total debt securities$419,783 $14 $(922)$418,875 
Included in cash and cash equivalents$950 $— $— $950 
Included in marketable securities$418,833 $14 $(922)$417,925 
Schedule of Gross Unrealized Losses and the Fair Value for Marketable Investments
The following table presents the gross unrealized losses and the fair value for those debt securities that were in an unrealized loss position for less than 12 months as of December 31, 2022 and 2021 (in thousands):
December 31, 2022December 31, 2021
Gross
Unrealized
Losses
Fair ValueGross
Unrealized
Losses
Fair Value
U.S. treasury securities$(2,598)$158,888 $(474)$146,454 
U.S. agency and government sponsored securities(75)4,924 (25)4,970 
Commercial paper(232)74,523 (4)30,285 
Corporate bonds(1,214)109,909 (345)145,522 
Asset-backed securities(110)11,835 (74)45,251 
Total$(4,229)$360,079 $(922)$372,482 
Schedule of Equity Investments Included in Marketable Securities
The Company’s equity investments consisted of the following as of December 31, 2022 and 2021 (in thousands):
December 31,
Consolidated Balance Sheets Location20222021
Money market funds(1)
Cash and cash equivalents$42,056 $25,654 
Marketable equity investments(1)
Marketable securities29,643 44,216 
Non-marketable equity investment measured using the measurement alternative(2)
Other non-current assets4,000 10,002 
$75,699 $79,872 
(1)    Investments with readily determinable fair values.
(2)    Investment in privately held company without readily determinable fair value.
XML 52 R33.htm IDEA: XBRL DOCUMENT v3.22.4
Financial Statement Components (Tables)
12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Cash and Cash Equivalents Cash and cash equivalents consisted of the following (in thousands):
 December 31,
 20222021
Cash$27,496 $303,373 
Money market funds42,056 25,654 
Commercial paper— 950 
Total cash and cash equivalents$69,552 $329,977 
Schedule of Inventory
Inventory consisted of the following (in thousands):
 December 31,
 20222021
Raw materials$3,614 $5,866 
Work-in-process2,329 1,171 
Finished goods2,849 3,305 
Total inventory$8,792 $10,342 
Schedule of Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following (in thousands):
 December 31,
 20222021
Prepaid expenses$15,653 $14,651 
Contract assets15,395 9,907 
Advance payments to vendors7,919 1,810 
Other receivables5,236 2,827 
Total prepaid expenses and other current assets$44,203 $29,195 
Schedule of Property and Equipment
Property and equipment are stated at cost less accumulated depreciation and amortization, and are depreciated using the straight-line method over the estimated useful lives of the assets as follows:
Asset CategoryEstimated useful lives
Machinery and equipment
1 to 7 years
Computer hardware and software
3 to 5 years
Demonstration fleet and demonstration units
2 to 5 years
Leasehold improvementsShorter of useful life or lease term
Vehicles5 years
Furniture and fixtures7 years
Property and equipment consisted of the following (in thousands):
 December 31,
 20222021
Machinery and equipment$14,047 $7,694 
Computer hardware and software6,797 2,854 
Land1,001 — 
Leasehold improvements885 869 
Vehicles, including demonstration fleet3,222 2,421 
Furniture and fixtures818 272 
Construction in progress13,642 3,677 
Total property and equipment40,412 17,787 
Accumulated depreciation and amortization(10,152)(6,778)
Total property and equipment, net$30,260 $11,009 
Schedule of Intangible Assets
The following table summarizes the activity in the Company’s intangible assets (in thousands):
December 31,
20222021
Beginning of the period$2,424 $— 
Additions21,890 2,650 
Amortization(2,237)(226)
End of the period$22,077 $2,424 
The components of intangible assets were as follows (in thousands):
December 31, 2022December 31, 2021
Gross
Carrying
 Amount
Accumulated
Amortization
Net
Carrying
Amount
Weighted Average
Remaining Period
(Years)
Gross
Carrying
 Amount
Accumulated
Amortization
Net
Carrying
Amount
Weighted Average
Remaining Period
(Years)
Customer relationships$3,730 $(664)$3,066 4.4$780 $(33)$747 9.6
Customer backlog650 (292)358 0.9— — — — 
Tradename620 (214)406 3.3120 (120)— — 
Assembled workforce130 (130)— — — — — — 
Developed technology11,910 (1,163)10,747 7.51,750 (73)1,677 9.6
IPR&D7,500 — 7,500 — — — — — 
Total intangible assets$24,540 $(2,463)$22,077 6.6$2,650 $(226)$2,424 9.6
Schedule of Future Amortization Expense As of December 31, 2022, the expected future amortization expense for intangible assets was as follows (in thousands):
PeriodExpected Future
Amortization Expense
2023$2,730 
20242,373 
20252,373 
20261,726 
20271,510 
Thereafter3,865 
IPR&D7,500 
Total$22,077 
Schedule of Goodwill
The carrying amount of goodwill allocated to the Company’s reportable segments was as follows (in thousands):
 Autonomy SolutionsATSTotal
Balance as of December 31, 2021
$687 $2,423 $3,110 
Acquired goodwill related to Freedom Photonics in 2022— 15,885 15,885 
Purchase accounting adjustments— (179)(179)
Balance as of December 31, 2022
$687 $18,129 $18,816 
Schedule of Other Noncurrent Assets
Other non-current assets consisted of the following (in thousands):
 December 31,
 20222021
Security deposits$5,495 $1,187 
Non-marketable equity investment4,000 10,002 
Advance payment for capital projects27,683 — 
Contract assets2,575 — 
Other non-current assets591 1,266 
Total other non-current assets$40,344 $12,455 
Schedule of Accrued and Other Current Liabilities
Accrued and other current liabilities consisted of the following (in thousands): 
 December 31,
 20222021
Accrued compensation and benefits$16,682 $9,899 
Accrued expenses22,358 6,727 
Warranty reserves3,584 1,798 
Contract liabilities1,993 898 
Accrued interest payable359 316 
Contract losses7,526 115 
Other460 91 
Total accrued and other current liabilities$52,962 $19,844 
XML 53 R34.htm IDEA: XBRL DOCUMENT v3.22.4
Debt (Tables)
12 Months Ended
Dec. 31, 2022
Debt Disclosure [Abstract]  
Schedule of Net Carrying Amount The net carrying amount of the Convertible Senior Notes was as follows (in thousands):
December 31,
20222021
Principal$625,000 $625,000 
Unamortized debt discount and issuance costs(12,808)(16,043)
Net carrying amount$612,192 $608,957 
Schedule of Interest Expense The following table sets forth the interest expense recognized related to the Convertible Senior Notes (in thousands):
Year Ended December 31
20222021
Contractual interest expense$7,812 $316 
Amortization of debt discount and issuance costs3,236 135 
Total interest expense$11,048 $451 
XML 54 R35.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of Changes in Level 3 Liabilities Measured at Fair Value The following table presents changes in Level 3 liabilities relating to Private Warrants measured at fair value (in thousands):
Private
Warrants
Balance as of December 31, 2021
$31,230 
Change in fair value prior to exercises4,713 
Reduction in liability due to exercises(19,003)
Change in fair value of outstanding warrants(13,935)
Balance as of December 31, 2022
$3,005 
Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements on a Recurring Basis and the Level of Inputs Used The Company’s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used for such measurements were as follows (in thousands):
Fair Value (in thousands) Measured as of
December 31, 2022 Using:
Level 1Level 2Level 3Total
Assets:
Cash equivalents:
Money market funds$42,056 $— $— $42,056 
Total cash equivalents$42,056 $— $— $42,056 
Marketable investments:
U.S. treasury securities$188,480 $— $— $188,480 
U.S. agency and government sponsored securities— 4,924 — 4,924 
Commercial paper— 74,523 — 74,523 
Corporate bonds— 109,909 — 109,909 
Asset-backed securities— 11,835 — 11,835 
Marketable equity investments29,643 — — 29,643 
Total marketable investments$218,123 $201,191 $— $419,314 
Liabilities:
Private Warrants— — 3,005 3,005 
Total warrant liabilities$— $— $3,005 $3,005 
Fair Value (in thousands) Measured as of
December 31, 2021 Using:
Level 1Level 2Level 3Total
Assets:
Cash equivalents:
Money market funds$25,654 $— $— $25,654 
Commercial paper— 950 — 950 
Total cash equivalents$25,654 $950 $— $26,604 
Marketable investments:
U.S. treasury securities$161,465 $— $— $161,465 
U.S. agency and government sponsored securities— 4,970 — 4,970 
Commercial paper— 39,834 — 39,834 
Corporate bonds— 165,190 — 165,190 
Asset-backed securities— 46,466 — 46,466 
Marketable equity investments44,216 — — 44,216 
Total marketable investments$205,681 $256,460 $— $462,141 
Liabilities:
Private Warrants— — 31,230 31,230 
Total warrant liabilities$— $— $31,230 $31,230 
XML 55 R36.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings (Loss) Per Share (Tables)
12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted The following table sets forth the computation of basic and diluted loss for the years ended December 31, 2022, 2021, and 2020 as follows: (in thousands, except for share and per share amounts):
December 31,
202220212020
Numerator:
Net loss$(445,939)$(237,986)$(362,298)
Deemed dividend attributable to BCF accretion— — (6,757)
Net loss attributable to common shareholders$(445,939)$(237,986)$(369,055)
Denominator:
Weighted average Common shares outstanding- Basic356,265,774 346,300,975 145,096,996 
Weighted average Common shares outstanding- Diluted356,265,774 346,300,975 145,096,996 
Net loss per shares attributable to Common shareholders- Basic and Diluted$(1.25)$(0.69)$(2.54)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share The following table presents the potential shares of common stock outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive:
December 31,
202220212020
Warrants5,757,549 7,166,301 24,089,255 
Stock-based awards—Equity classified33,372,534 24,156,973 18,003,962 
Stock-based awards—Liability classified14,302,723 2,401,648 — 
Vendor stock-in-lieu of cash program3,162,879 1,659,510 — 
Convertible Senior Notes31,279,716 31,279,716 — 
Earn-out shares8,606,717 8,606,717 25,818,744 
Total96,482,118 75,270,865 67,911,961 
XML 56 R37.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders’ Equity (Deficit) (Tables)
12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Schedule of Vendor Stock-in-lieu of Cash Program
The Company’s vendor Stock-in-lieu of Cash Program activity for the year ended December 31, 2022 was as follows:
SharesWeighted Average
Grant Date Fair Value
per Share
Outstanding as of December 31, 20211,500,000 $15.72 
Granted8,824,385 9.93 
Vested(9,277,234)10.65 
Outstanding as of December 31, 20221,047,151 11.90 
XML 57 R38.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
A summary of the Company’s stock option activity for the year ended December 31, 2022 was as follows (in thousands, except years and per share data):
Number of
Stock Options
Weighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Life (Years)
Aggregate
Intrinsic Value
Outstanding as of December 31, 2021
11,507,643 $1.72 
Exercised(2,370,989)1.67 
Cancelled/Forfeited(973,804)1.67 
Outstanding as of December 31, 2022
8,162,850 1.74 7.03$26,763 
Vested and exercisable as of December 31, 20225,472,821 1.73 6.95$17,654 
Vested and expected to vest as of December 31, 20228,162,850 1.74 7.03$26,763 
Schedule of Restricted Stock Activity
The Company’s RSAs activity for the year ended December 31, 2022 was as follows:
SharesWeighted Average
Grant Date Fair Value
per Share
Outstanding as of December 31, 2021666,298 1.21 
Forfeited(18,476)1.23 
Vested(583,336)1.20 
Outstanding as of December 31, 202264,486 1.29 
The Company’s RSUs activity for the year ended December 31, 2022 was as follows:
SharesWeighted Average
Grant Date Fair
Value per Share
Outstanding as of December 31, 202111,983,032 19.56 
Granted23,213,889 10.29 
Forfeited(2,069,915)16.15 
Vested(7,532,971)15.40 
Outstanding as of December 31, 202225,594,035 12.66 
Schedule of Employee Stock Purchase Plan, Valuation Assumptions
The assumptions used to value purchase rights under the ESPP during the year ended December 31, 2022 were as follows:
May 16, 2022November 16, 2022
Expect term (years)0.50.5
Volatility82.3%93.5%
Risk-free interest rate1.54%4.54%
Dividend yield—%—%
Schedule of Stock-based Compensation Expense by Function
Stock-based compensation expense by type of award was as follows (in thousands):
Year Ended December 31,
202220212020
Equity Classified Awards:
Stock options$2,666 $5,137 $3,179 
RSAs293 1,682 5,532 
RSUs129,992 60,191 — 
ESPP714 — — 
Liability Classified Awards:
Equity settled fixed value7,545 3,826 — 
Optogration10,894 6,114 — 
Freedom Photonics7,633 — — 
Solfice410 — — 
Other2,258 734 — 
Total$162,405 $77,684 $8,711 
Stock-based compensation expense by function was as follows (in thousands):
Year Ended December 31,
202220212020
Cost of sales$7,680 $6,422 $309 
Research and development40,898 20,216 2,098 
Sales and marketing15,814 4,546 414 
General and administrative98,013 46,500 5,890 
Total$162,405 $77,684 $8,711 
XML 58 R39.htm IDEA: XBRL DOCUMENT v3.22.4
Leases (Tables)
12 Months Ended
Dec. 31, 2022
Leases [Abstract]  
Schedule of Components of Lease Expenses, Supplemental Cash Flow Information, Weighted Average Remaining Terms, and Weighted Average Discount Rates The components of lease expenses were as follows (in thousands):
Year Ended
December 31, 2022December 31, 2021
Operating lease cost$6,533 $4,654 
Variable lease cost2,230 1,703 
Total operating lease cost$8,763 $6,357 
Supplemental cash flow information related to leases was as follows (in thousands):
Year Ended
December 31, 2022December 31, 2021
Cash paid for amounts included in the measurement of lease liabilities:
Cash paid for operating leases included in operating activities$(6,070)$(4,609)
Right of use assets obtained in exchange for lease obligations:
Operating leases16,749 2,876 
Weighted average remaining terms were as follows (in years):
December 31, 2022December 31, 2021
Weighted average remaining lease term
Operating leases4.432.95
Weighted average discount rates were as follows:
December 31, 2022December 31, 2021
Weighted average discount rate
Operating leases5.45 %2.80 %
Schedule of Supplemental Balance Sheet Information
Supplemental balance sheet information related to leases was as follows (in thousands):
December 31, 2022December 31, 2021
Operating leases:
Operating lease right-of-use assets$21,244 $9,145 
Operating lease liabilities:
Operating lease liabilities, current$5,953 $4,735 
Operating lease liabilities, non-current16,989 5,768 
Total operating lease liabilities$22,942 $10,503 
Schedule of Maturities of Lease Liabilities
Maturities of lease liabilities were as follows (in thousands):
Year Ending December 31,Operating Leases
2023$6,190 
20245,123 
20255,193 
20264,732 
20273,927 
Thereafter1,149 
Total lease payments26,314 
Less: imputed interest(3,372)
Total leases liabilities$22,942 
XML 59 R40.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Loss Before Provision for (Benefit from) Income Taxes
The following table presents components of loss before provision for (benefit from) income taxes for the periods presented (in thousands):
Year Ended December 31,
202220212020
United States$(445,720)$(239,855)$(362,338)
International453 607 40 
Loss before provision for (benefit from) income taxes$(445,267)$(239,248)$(362,298)
Schedule of Provision for Benefit From Income Taxes Provision for (benefit from) income taxes for the periods presented consisted of (in thousands):
Year Ended December 31,
202220212020
Current:
Foreign440 — — 
Total current:440 — — 
Deferred:
U.S. federal204 (1,262)— 
U.S. state28 — — 
Total deferred:232 (1,262)— 
Total provision for (benefit from) income taxes$672 $(1,262)$— 
Schedule of Effective Tax Rate
The reconciliation between the U.S. federal statutory income tax rate of 21% to the Company’s effective tax for the periods presented is as follows:
Year Ended December 31,
202220212020
U.S. federal provision at statutory rate21.0 %21.0 %21.0 %
State income taxes5.7 4.4 0.7 
Tax credits2.4 1.5 0.6 
Fair value of financial instruments0.4 (2.3)(15.6)
Stock-based compensation expense(3.4)2.0 (0.4)
Executive compensation(0.8)(1.1)0.0 
Other permanent items0.2 (0.3)0.0 
Uncertain tax benefits(1.4)(0.8)(0.3)
Change in valuation allowance(24.3)(24.0)(6.0)
Effective tax rate(0.2 %)0.4 %0.0 %
Schedule of Deferred Tax Assets and Liabilities
The Company’s deferred income tax assets and liabilities as of December 31, 2022 and 2021 were as follows (in thousands):
Year Ended December 31,
20222021
Deferred tax assets:
Net operating loss carry forward$161,881 $120,544 
Tax credits16,322 6,296 
Accruals and reserves3,309 — 
Stock-based compensation expense14,535 6,944 
Lease liability (ASC 842)6,268 2,622 
Section 174 R&D capitalization43,240 — 
Inventory reserves1,961 617 
Depreciation and amortization2,170 — 
Other20 15 
Total deferred tax assets249,706 137,038 
Valuation allowance(243,811)(130,569)
Total deferred tax asset5,895 6,469 
Deferred tax liabilities:
Depreciation and amortization— 1,185 
Prepaid expenses— 2,983 
Other162 — 
ROU asset (ASC 842)5,801 2,301 
Total deferred tax liabilities5,963 6,469 
Net deferred tax assets (liabilities)$(68)$— 
Schedule of Reconciliation of the Total Amounts of Unrecognized Tax Benefits
The following is a tabular reconciliation of the total amounts of unrecognized tax benefits (in thousands):
Year Ended December 31,
202220212020
Unrecognized tax benefits as of the beginning of the year$6,296 $3,975 $2,397 
Increases related to prior year tax positions— 535 327 
Decreases related to prior year tax provisions(3,723)— — 
Increase related to current year tax positions6,031 1,786 1,251 
Unrecognized tax benefits as of the end of the year$8,604 $6,296 $3,975 
XML 60 R41.htm IDEA: XBRL DOCUMENT v3.22.4
Segment and Customer Concentration Information (Tables)
12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
Schedule of Segment Operating Results and Reconciliations to the Consolidated Balances
The accounting policies of the operating segments are the same as those described in Note 2. Segment operating results and reconciliations to the Company’s consolidated balances are as follows (in thousands):
Year ended December 31, 2022
Autonomy
Solutions
ATSTotal
reportable
segments
Eliminations (1)Total
Consolidated
Revenue:
Revenues from external customers$24,353 $16,345 $40,698 $— $40,698 
Revenues from internal customer14,748 12,485 27,233 (27,233)— 
Total Revenue$39,101 $28,830 $67,931 $(27,233)$40,698 
Depreciation and amortization$4,110 $2,456 $6,566 $— $6,566 
Operating gain (loss)(412,673)(29,394)(442,067)(335)(442,402)
Other significant items:
Segment assets752,088 60,529 812,617 (125,290)687,327 
Inventories, net8,664 474 9,138 (346)8,792 
Year ended December 31, 2021
Autonomy
Solutions
ATSTotal
reportable
segments
Eliminations (1)Total
Consolidated
Revenue:
Revenues from external customers$28,497 $3,447 $31,944 $— $31,944 
Revenues from internal customer8,098 5,929 14,027 (14,027)— 
Total Revenue$36,595 $9,376 $45,971 $(14,027)$31,944 
Depreciation and amortization$3,723 $439 $4,162 $— $4,162 
Operating gain (loss)(214,133)(324)(214,457)(95)(214,552)
Other significant items:
Segment assets882,704 9,771 892,475 (8,939)883,536 
Inventories, net10,179 163 10,342 — 10,342 
Year ended December 31, 2020
Autonomy
Solutions
ATSTotal
reportable
segments
Eliminations (1)Total
Consolidated
Revenue:
Revenues from external customers$11,387 $2,564 $13,951 $— $13,951 
Revenues from internal customer1,516 3,248 4,764 (4,764)— 
Total Revenue$12,903 $5,812 $18,715 $(4,764)$13,951 
Depreciation and amortization$2,395 $128 $2,523 $(6)$2,517 
Operating gain (loss)(86,661)(316)(86,977)102 (86,875)
Other significant items:
Segment assets511,676 2,975 514,651 (4,300)510,351 
Inventories, net3,604 3,613 — 3,613 
(1) Represent the eliminations of all intercompany balances and transactions during the period presented.
XML 61 R42.htm IDEA: XBRL DOCUMENT v3.22.4
Basis of Presentation and Summary of Significant Accounting Policies - Segment Information (Details)
12 Months Ended
Dec. 31, 2022
operating_segment
Accounting Policies [Abstract]  
Number of operating segments 2
XML 62 R43.htm IDEA: XBRL DOCUMENT v3.22.4
Basis of Presentation and Summary of Significant Accounting Policies - Concentration of Credit Risk (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Concentration Risk [Line Items]    
Cash held in foreign entities $ 0.0 $ 0.0
Customer One | Accounts Receivable | Customer Concentration Risk    
Concentration Risk [Line Items]    
Percentage of accounts receivable (as percent) 23.00% 39.00%
Customer Two | Accounts Receivable | Customer Concentration Risk    
Concentration Risk [Line Items]    
Percentage of accounts receivable (as percent) 27.00% 31.00%
Customer Three | Accounts Receivable | Customer Concentration Risk    
Concentration Risk [Line Items]    
Percentage of accounts receivable (as percent) 11.00%  
XML 63 R44.htm IDEA: XBRL DOCUMENT v3.22.4
Basis of Presentation and Summary of Significant Accounting Policies - Property and Equipment (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Machinery and equipment | Minimum    
Property, Plant and Equipment [Line Items]    
Estimated useful life (in years) 1 year  
Machinery and equipment | Maximum    
Property, Plant and Equipment [Line Items]    
Estimated useful life (in years) 7 years  
Computer hardware and software | Minimum    
Property, Plant and Equipment [Line Items]    
Estimated useful life (in years) 3 years  
Computer hardware and software | Maximum    
Property, Plant and Equipment [Line Items]    
Estimated useful life (in years) 5 years  
Demonstration fleet and demonstration units | Minimum    
Property, Plant and Equipment [Line Items]    
Estimated useful life (in years) 2 years  
Demonstration fleet and demonstration units | Maximum    
Property, Plant and Equipment [Line Items]    
Estimated useful life (in years) 5 years  
Vehicles, including demonstration fleet    
Property, Plant and Equipment [Line Items]    
Estimated useful life (in years) 5 years  
Furniture and fixtures    
Property, Plant and Equipment [Line Items]    
Estimated useful life (in years) 7 years  
Tooling    
Property, Plant and Equipment [Line Items]    
Capitalized costs $ 0 $ 0
Tooling | Minimum    
Property, Plant and Equipment [Line Items]    
Estimated useful life (in years) 1 year  
Tooling | Maximum    
Property, Plant and Equipment [Line Items]    
Estimated useful life (in years) 3 years  
XML 64 R45.htm IDEA: XBRL DOCUMENT v3.22.4
Basis of Presentation and Summary of Significant Accounting Policies - Intangible Assets and Goodwill (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]    
Impairment of intangible assets $ 0 $ 0
Impairment of goodwill $ 0 $ 0
Minimum    
Finite-Lived Intangible Assets [Line Items]    
Useful life 1 year  
Maximum    
Finite-Lived Intangible Assets [Line Items]    
Useful life 10 years  
XML 65 R46.htm IDEA: XBRL DOCUMENT v3.22.4
Basis of Presentation and Summary of Significant Accounting Policies - Impairment of Long-Lived Assets (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Accounting Policies [Abstract]    
Impairment of long-lived assets $ 0 $ 0
XML 66 R47.htm IDEA: XBRL DOCUMENT v3.22.4
Basis of Presentation and Summary of Significant Accounting Policies - Public and Private Warrants (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Feb. 05, 2019
Apr. 30, 2022
Jan. 31, 2022
Mar. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Class of Warrant or Right [Line Items]              
Percentage of Class A shareholders         50.00%    
Proceeds from exercise of warrants         $ 0 $ 153,927 $ 0
Private and Public Warrants              
Class of Warrant or Right [Line Items]              
Proceeds from exercise of warrants       $ 153,900      
Public Warrants              
Class of Warrant or Right [Line Items]              
Warrants outstanding (in shares)           0 13,333,309
Warrants exercised (in shares)       13,128,671      
Remaining warrants redeemed (in shares)       204,638      
Redemption price per warrant (in dollars per share)       $ 0.01      
Private Warrants              
Class of Warrant or Right [Line Items]              
Stock price of warrants (in dollars per share)         $ 11.50    
Share per warrant (in shares)         1    
Warrants outstanding (in shares)         1,668,269 3,077,021 6,666,666
Warrants exercised (in shares)   19,223 1,389,529 3,589,645      
Shares issued for exercise of warrants (in shares)   4,387 401,365        
Gores Metropoulos | Public Warrants | Class A Common Stock              
Class of Warrant or Right [Line Items]              
Stock price of warrants (in dollars per share) $ 11.50            
Share per warrant (in shares) 1            
Gores Metropoulos | Private Warrants | Class A Common Stock              
Class of Warrant or Right [Line Items]              
Stock price of warrants (in dollars per share) $ 11.50            
Share per warrant (in shares) 1            
IPO | Gores Metropoulos              
Class of Warrant or Right [Line Items]              
Sale of stock (in shares) 40,000,000            
Sale of stock, number of shares of common stock per unit (in shares) 1            
Sale of stock, number of warrants per unit (in shares) 0.3333            
Sale of stock, price per share (in dollars per share) $ 10.00            
Private Placement | Gores Metropoulos | Private Warrants              
Class of Warrant or Right [Line Items]              
Sale of stock (in shares) 6,667,000            
Sale of stock, price per share (in dollars per share) $ 1.50            
XML 67 R48.htm IDEA: XBRL DOCUMENT v3.22.4
Business Combinations - Narrative (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Jun. 15, 2022
USD ($)
Apr. 13, 2022
USD ($)
Aug. 11, 2021
triggeringEvent
$ / shares
shares
Aug. 03, 2021
USD ($)
Dec. 02, 2020
USD ($)
triggeringEvent
$ / shares
shares
Aug. 31, 2022
USD ($)
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
shares
Dec. 31, 2019
shares
Business Acquisition [Line Items]                    
Stock consideration | $             $ 0 $ 6,527 $ 0  
Optogration milestone awards | $             $ 11,751      
Common stock, shares outstanding (in shares)         323,936,240          
Estimated fair value of the potential earn-out shares | $         $ 587,700          
Level 3 | Price Volatility                    
Business Acquisition [Line Items]                    
Earn out shares, measurement input         0.585          
Level 3 | Expected Term                    
Business Acquisition [Line Items]                    
Earn out shares, measurement input         5.5          
Class A Common Stock                    
Business Acquisition [Line Items]                    
Common stock, shares issued (in shares)         218,818,037   291,942,087 266,076,525    
Common stock, shares outstanding (in shares)         218,818,037   270,078,637 250,812,764    
Common stock, par value (in dollars per share) | $ / shares         $ 0.0001   $ 0.0001 $ 0.0001    
Granted (in shares)         16,224,474          
Conversion of warrants into securities (in shares)         4,089,280          
Class A Common Stock | Common Stock                    
Business Acquisition [Line Items]                    
Optogration milestone awards (in shares)             1,632,056      
Common stock, shares outstanding (in shares)             291,942,087 266,076,525 218,818,037 139,635,890
Shares issued to acquiree shareholders (in shares)                 49,981,349  
Class A Common Stock | Minimum                    
Business Acquisition [Line Items]                    
Threshold stock price trigger (in dollars per share) | $ / shares         $ 13.00          
Class A Common Stock | Maximum                    
Business Acquisition [Line Items]                    
Threshold stock price trigger (in dollars per share) | $ / shares         $ 28.00          
Class B Common Stock                    
Business Acquisition [Line Items]                    
Common stock, shares issued (in shares)         105,118,203   97,088,670 97,088,670    
Common stock, shares outstanding (in shares)         105,118,203   97,088,670 97,088,670    
Common stock, par value (in dollars per share) | $ / shares         $ 0.0001   $ 0.0001 $ 0.0001    
Class B Common Stock | Common Stock                    
Business Acquisition [Line Items]                    
Common stock, shares outstanding (in shares)             97,088,670 97,088,670 105,118,203 0
Freedom Photonics                    
Business Acquisition [Line Items]                    
Stock consideration | $   $ 34,600                
Purchase price includes working capital adjustments | $   400                
Merger related expenses incurred | $   $ 1,400                
Freedom Photonics | Class A Common Stock | Common Stock                    
Business Acquisition [Line Items]                    
Shares issued to acquiree shareholders (in shares)             2,176,205      
Solfice                    
Business Acquisition [Line Items]                    
Aggregate consideration transferred | $ $ 6,300                  
Solfice | Class A Common Stock | Common Stock                    
Business Acquisition [Line Items]                    
Shares issued to acquiree shareholders (in shares)             374,193      
Optogration, Inc.                    
Business Acquisition [Line Items]                    
Stock consideration | $       $ 6,300            
Contingent stock consideration | $       22,000            
Optogration, Inc. | Class A Common Stock | Common Stock                    
Business Acquisition [Line Items]                    
Shares issued to acquiree shareholders (in shares)               370,034    
Optogration Milestone Awards                    
Business Acquisition [Line Items]                    
Contingent stock consideration | $       $ 22,000            
Optogration Milestone Awards | Class A Common Stock                    
Business Acquisition [Line Items]                    
Optogration milestone awards (in shares)           1,632,056        
Optogration milestone awards | $           $ 11,000        
Optogration milestone awards, remaining obligations | $             $ 11,000      
Gores Metropoulos                    
Business Acquisition [Line Items]                    
Transaction costs | $         $ 17,200          
Aggregate number of Class A and Class B Common Stock shares entitled to stockholders (in shares)         25,819,887          
Number of triggering events | triggeringEvent         6          
Earn-out shares issued (in shares)     17,213,170              
Number of triggering events met | triggeringEvent     4              
Number of triggering events | triggeringEvent     6              
Exchange ratio (in dollars per share) | $ / shares         $ 13.63094          
Stock redeemed (in shares)         18,651          
Stock redeemed, redemption price (in dollars per share) | $ / shares         $ 10.16          
Gores Metropoulos | Private and Public Warrants                    
Business Acquisition [Line Items]                    
Liability recorded related to warrants from business combination | $         $ 102,400          
Gores Metropoulos | Class A Common Stock                    
Business Acquisition [Line Items]                    
Earn-out shares issued (in shares)     10,242,703              
Earn-out shares remaining (in shares)     5,121,484              
Gores Metropoulos | Class A Common Stock | Common Stock                    
Business Acquisition [Line Items]                    
Shares issued to acquiree shareholders (in shares)         49,981,349          
Gores Metropoulos | Class A Common Stock | Period of Time, One                    
Business Acquisition [Line Items]                    
Share price (in dollars per share) | $ / shares     $ 13.00              
Gores Metropoulos | Class A Common Stock | Period of Time, Two                    
Business Acquisition [Line Items]                    
Share price (in dollars per share) | $ / shares     16.00              
Gores Metropoulos | Class A Common Stock | Period of Time, Three                    
Business Acquisition [Line Items]                    
Share price (in dollars per share) | $ / shares     19.00              
Gores Metropoulos | Class A Common Stock | Period of Time, Four                    
Business Acquisition [Line Items]                    
Share price (in dollars per share) | $ / shares     22.00              
Gores Metropoulos | Class A Common Stock | Period of Time, Five                    
Business Acquisition [Line Items]                    
Share price (in dollars per share) | $ / shares     25.00              
Gores Metropoulos | Class A Common Stock | Period of Time, Six                    
Business Acquisition [Line Items]                    
Share price (in dollars per share) | $ / shares     $ 28.00              
Gores Metropoulos | Class B Common Stock                    
Business Acquisition [Line Items]                    
Earn-out shares issued (in shares)     6,970,467              
Earn-out shares remaining (in shares)     3,485,233              
XML 68 R49.htm IDEA: XBRL DOCUMENT v3.22.4
Business Combinations - Schedule of Recognized Identified Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Apr. 13, 2022
Dec. 31, 2021
Aug. 03, 2021
Business Acquisition [Line Items]        
Goodwill $ 18,816   $ 3,110  
Freedom Photonics        
Business Acquisition [Line Items]        
Cash and cash equivalents   $ 1,063    
Accounts receivable   3,311    
Contract asset   1,913    
Inventories, net   127    
Other current assets   70    
Property and equipment   1,353    
Operating lease right-of-use assets   449    
Other non-current assets   22    
Total intangible assets   15,600    
Goodwill   15,885    
Total assets acquired   39,793    
Current and non-current liabilities   (5,158)    
Total liabilities assumed   (5,158)    
Net assets acquired   $ 34,635    
Optogration, Inc.        
Business Acquisition [Line Items]        
Cash and cash equivalents       $ 358
Accounts receivable       810
Other current assets       482
Property and equipment       1,248
Other non-current assets       384
Total intangible assets       2,650
Goodwill       2,244
Total assets acquired       8,176
Current Liabilities       (488)
Non-current liabilities       (1,346)
Total liabilities assumed       (1,834)
Net assets acquired       $ 6,342
XML 69 R50.htm IDEA: XBRL DOCUMENT v3.22.4
Business Combinations - Components of Intangible Assets and Estimated Useful Lives (Details) - USD ($)
$ in Thousands
12 Months Ended
Apr. 13, 2022
Aug. 03, 2021
Dec. 31, 2022
Dec. 31, 2021
Maximum        
Business Acquisition [Line Items]        
Weighted Average Remaining Period (Years)     10 years  
Freedom Photonics        
Business Acquisition [Line Items]        
Total intangible assets $ 15,600      
Freedom Photonics | Customer backlog        
Business Acquisition [Line Items]        
Recorded Value $ 650      
Freedom Photonics | Customer backlog | Maximum        
Business Acquisition [Line Items]        
Weighted Average Remaining Period (Years) 2 years      
Freedom Photonics | Customer relationships        
Business Acquisition [Line Items]        
Weighted Average Remaining Period (Years) 4 years      
Recorded Value $ 2,950      
Freedom Photonics | Developed technology        
Business Acquisition [Line Items]        
Weighted Average Remaining Period (Years) 8 years      
Recorded Value $ 4,000      
Freedom Photonics | IPR&D        
Business Acquisition [Line Items]        
Recorded Value $ 7,500      
Freedom Photonics | Tradename        
Business Acquisition [Line Items]        
Weighted Average Remaining Period (Years) 4 years      
Recorded Value $ 500      
Optogration, Inc.        
Business Acquisition [Line Items]        
Weighted Average Remaining Period (Years)     6 years 7 months 6 days 9 years 7 months 6 days
Total intangible assets   $ 2,650    
Optogration, Inc. | Customer backlog        
Business Acquisition [Line Items]        
Weighted Average Remaining Period (Years)     10 months 24 days  
Recorded Value     $ 650 $ 0
Optogration, Inc. | Customer relationships        
Business Acquisition [Line Items]        
Weighted Average Remaining Period (Years)   10 years 4 years 4 months 24 days 9 years 7 months 6 days
Recorded Value     $ 3,730 $ 780
Optogration, Inc. | Developed technology        
Business Acquisition [Line Items]        
Weighted Average Remaining Period (Years)   10 years 7 years 6 months 9 years 7 months 6 days
Recorded Value     $ 11,910 $ 1,750
Optogration, Inc. | Tradename        
Business Acquisition [Line Items]        
Weighted Average Remaining Period (Years)   1 year 3 years 3 months 18 days  
Recorded Value     $ 620 $ 120
XML 70 R51.htm IDEA: XBRL DOCUMENT v3.22.4
Business Combinations - Impact of Adjustments to the Unaudited Pro Forma (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Mar. 31, 2021
Acquisition-related Costs      
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]      
(Decrease) / increase to expenses as a result of transaction costs and stock-based compensation expense $ (2,582) $ 2,795  
Transaction costs     $ 2,800
Stock Based Compensation Costs      
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]      
(Decrease) / increase to expenses as a result of transaction costs and stock-based compensation expense $ 4,119 $ 19,593  
XML 71 R52.htm IDEA: XBRL DOCUMENT v3.22.4
Business Combinations - Unaudited Pro Forma (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Business Combination and Asset Acquisition [Abstract]    
Revenue $ 46,422 $ 49,804
Net loss $ (447,736) $ (260,813)
XML 72 R53.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue - Schedule of Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disaggregation of Revenue [Line Items]      
Revenue $ 40,698 $ 31,944 $ 13,951
Revenue from contract with customer benchmark | Geographic Concentration Risk      
Disaggregation of Revenue [Line Items]      
Percentage of revenue (as percent) 100.00% 100.00% 100.00%
Revenue from contract with customer benchmark | Revenue Recognition Timing Concentration Risk      
Disaggregation of Revenue [Line Items]      
Percentage of revenue (as percent) 100.00% 100.00% 100.00%
Revenue from contract with customer benchmark | Segment Concentration Risk      
Disaggregation of Revenue [Line Items]      
Percentage of revenue (as percent) 100.00% 100.00% 100.00%
Autonomy Solutions      
Disaggregation of Revenue [Line Items]      
Revenue $ 24,353 $ 28,497 $ 11,387
Autonomy Solutions | Revenue from contract with customer benchmark | Segment Concentration Risk      
Disaggregation of Revenue [Line Items]      
Percentage of revenue (as percent) 60.00% 89.00% 82.00%
ATS      
Disaggregation of Revenue [Line Items]      
Revenue $ 16,345 $ 3,447 $ 2,564
ATS | Revenue from contract with customer benchmark | Segment Concentration Risk      
Disaggregation of Revenue [Line Items]      
Percentage of revenue (as percent) 40.00% 11.00% 18.00%
Recognized at a point in time      
Disaggregation of Revenue [Line Items]      
Revenue $ 17,595 $ 8,892 $ 2,639
Recognized at a point in time | Revenue from contract with customer benchmark | Revenue Recognition Timing Concentration Risk      
Disaggregation of Revenue [Line Items]      
Percentage of revenue (as percent) 43.00% 28.00% 19.00%
Recognized over time      
Disaggregation of Revenue [Line Items]      
Revenue $ 23,103 $ 23,052 $ 11,312
Recognized over time | Revenue from contract with customer benchmark | Revenue Recognition Timing Concentration Risk      
Disaggregation of Revenue [Line Items]      
Percentage of revenue (as percent) 57.00% 72.00% 81.00%
North America      
Disaggregation of Revenue [Line Items]      
Revenue $ 35,032 $ 23,043 $ 4,010
North America | Revenue from contract with customer benchmark | Geographic Concentration Risk      
Disaggregation of Revenue [Line Items]      
Percentage of revenue (as percent) 86.00% 72.00% 29.00%
Asia Pacific      
Disaggregation of Revenue [Line Items]      
Revenue $ 3,703 $ 2,502 $ 906
Asia Pacific | Revenue from contract with customer benchmark | Geographic Concentration Risk      
Disaggregation of Revenue [Line Items]      
Percentage of revenue (as percent) 9.00% 8.00% 6.00%
Europe and Middle East      
Disaggregation of Revenue [Line Items]      
Revenue $ 1,963 $ 6,399 $ 9,035
Europe and Middle East | Revenue from contract with customer benchmark | Geographic Concentration Risk      
Disaggregation of Revenue [Line Items]      
Percentage of revenue (as percent) 5.00% 20.00% 65.00%
XML 73 R54.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue - Narrative (Details)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Dec. 02, 2020
shares
Mar. 31, 2020
USD ($)
tranche
$ / shares
shares
Class of Warrant or Right [Line Items]          
Fair value of warrants outstanding $ 3,005 $ 31,230      
Change in fair value of warrant liabilities (9,222) 26,126 $ 268,266    
Contract assets 17,970 9,907 0    
Contract liabilities $ 3,008 898 $ 2,284    
VCTF warrant          
Class of Warrant or Right [Line Items]          
Number of tranches | tranche         2
Fair value of warrants outstanding         $ 2,900
Change in fair value of warrant liabilities   $ (1,000)      
Class A Common Stock          
Class of Warrant or Right [Line Items]          
Conversion of warrants into securities (in shares) | shares       4,089,280  
Class A Common Stock | VCTF warrant          
Class of Warrant or Right [Line Items]          
Conversion of warrants into securities (in shares) | shares         4,089,280
Stock price of warrants (in dollars per share) | $ / shares         $ 3.1769
XML 74 R55.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue - Schedule of Opening and Closing Balances of Contract Assets and Contract Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Contract With Customer Asset [Roll Forward]      
Contract assets, current $ 15,395 $ 9,907  
Contract assets, non-current 2,575 0  
Contract with customer, asset, total 17,970 9,907 $ 0
Contract with Customer, Liability [Roll Forward]      
Contract liabilities, current 1,993 898  
Contract liabilities, non-current 1,015 0  
Contract with customer, liability, total $ 3,008 $ 898 $ 2,284
XML 75 R56.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue - Schedule of Significant Changes in Contract Assets and Contract Liabilities (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Contract With Customer Asset [Roll Forward]    
Beginning balance $ 9,907 $ 0
Amounts billed that were included in the contract assets beginning balance (4,228) 0
Revenue recognized for performance obligations that have been satisfied but for which amounts have not been billed 12,291 9,907
Ending balance 17,970 9,907
Contract with Customer, Liability [Roll Forward]    
Beginning balance 898 2,284
Revenue recognized that was included in the contract liabilities beginning balance (489) (1,792)
Increase due to cash received and not recognized as revenue and billings in excess of revenue recognized during the period 2,599 406
Ending balance $ 3,008 $ 898
XML 76 R57.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue - Remaining Performance Obligations (Details) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
$ in Millions
Dec. 31, 2022
USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Revenue, remaining performance obligation, amount $ 39.7
Revenue, remaining performance obligation, percentage 82.00%
Revenue, remaining performance obligation, period 12 months
XML 77 R58.htm IDEA: XBRL DOCUMENT v3.22.4
Investments - Amortized Cost (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Debt Securities, Available-for-sale [Line Items]    
Cost $ 393,897 $ 419,783
Gross Unrealized Gains 3 14
Gross Unrealized Losses (4,229) (922)
Fair Value 389,671 418,875
Included in cash and cash equivalents    
Debt Securities, Available-for-sale [Line Items]    
Cost   950
Gross Unrealized Gains   0
Gross Unrealized Losses   0
Fair Value   950
Included in marketable securities    
Debt Securities, Available-for-sale [Line Items]    
Cost 393,897 418,833
Gross Unrealized Gains 3 14
Gross Unrealized Losses (4,229) (922)
Fair Value 389,671 417,925
U.S. treasury securities    
Debt Securities, Available-for-sale [Line Items]    
Cost 191,075 161,938
Gross Unrealized Gains 3 1
Gross Unrealized Losses (2,598) (474)
Fair Value 188,480 161,465
U.S. agency and government sponsored securities    
Debt Securities, Available-for-sale [Line Items]    
Cost 4,999 4,995
Gross Unrealized Gains 0 0
Gross Unrealized Losses (75) (25)
Fair Value 4,924 4,970
Commercial paper    
Debt Securities, Available-for-sale [Line Items]    
Cost 74,755 40,788
Gross Unrealized Gains 0 0
Gross Unrealized Losses (232) (4)
Fair Value 74,523 40,784
Corporate bonds    
Debt Securities, Available-for-sale [Line Items]    
Cost 111,123 165,522
Gross Unrealized Gains 0 13
Gross Unrealized Losses (1,214) (345)
Fair Value 109,909 165,190
Asset-backed securities    
Debt Securities, Available-for-sale [Line Items]    
Cost 11,945 46,540
Gross Unrealized Gains 0 0
Gross Unrealized Losses (110) (74)
Fair Value $ 11,835 $ 46,466
XML 78 R59.htm IDEA: XBRL DOCUMENT v3.22.4
Investments - Continuous Loss Position (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Debt Securities, Available-for-sale [Line Items]    
Gross Unrealized Losses $ (4,229) $ (922)
Fair Value 360,079 372,482
U.S. treasury securities    
Debt Securities, Available-for-sale [Line Items]    
Gross Unrealized Losses (2,598) (474)
Fair Value 158,888 146,454
U.S. agency securities    
Debt Securities, Available-for-sale [Line Items]    
Gross Unrealized Losses (75) (25)
Fair Value 4,924 4,970
Commercial paper    
Debt Securities, Available-for-sale [Line Items]    
Gross Unrealized Losses (232) (4)
Fair Value 74,523 30,285
Corporate bonds    
Debt Securities, Available-for-sale [Line Items]    
Gross Unrealized Losses (1,214) (345)
Fair Value 109,909 145,522
Asset-backed securities    
Debt Securities, Available-for-sale [Line Items]    
Gross Unrealized Losses (110) (74)
Fair Value $ 11,835 $ 45,251
XML 79 R60.htm IDEA: XBRL DOCUMENT v3.22.4
Investments - Narrative (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Debt Securities, Available-for-sale [Line Items]      
Available-for-sale securities in excess of fair value $ 4,229 $ 922 $ 4,229
Robotic Research OpCo, LLC      
Debt Securities, Available-for-sale [Line Items]      
Investment in Robotic Research, percentage of capitalization (percent, less than)   5.00%  
Impairment charges     $ 6,000
ECARX Holdings Inc.,      
Debt Securities, Available-for-sale [Line Items]      
Investment in Robotic Research, percentage of capitalization (percent, less than) 5.00%   5.00%
Class A Preferred Units | Robotic Research OpCo, LLC      
Debt Securities, Available-for-sale [Line Items]      
Sale of stock (in shares)   1,495  
Class A Preferred Units | ECARX Holdings Inc.,      
Debt Securities, Available-for-sale [Line Items]      
Sale of stock (in shares) 1,500,000    
Class A Common Stock | Robotic Research OpCo, LLC      
Debt Securities, Available-for-sale [Line Items]      
Stock consideration   $ 10,000  
Common stock, shares issued (in shares)   618,924  
Class A Common Stock | ECARX Holdings Inc.,      
Debt Securities, Available-for-sale [Line Items]      
Stock consideration $ 15,000    
Common stock, shares issued (in shares) 2,030,374    
XML 80 R61.htm IDEA: XBRL DOCUMENT v3.22.4
Investments - Schedule of Equity Investments (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Debt Securities, Available-for-sale [Line Items]    
Marketable equity investments $ 75,699 $ 79,872
Money market funds | Cash and cash equivalents    
Debt Securities, Available-for-sale [Line Items]    
Marketable equity investments 42,056 25,654
Marketable equity investments | Marketable securities    
Debt Securities, Available-for-sale [Line Items]    
Marketable equity investments 29,643 44,216
Non-Marketable Equity Investment | Other non-current assets    
Debt Securities, Available-for-sale [Line Items]    
Non-marketable equity investment measured using the measurement alternative $ 4,000 $ 10,002
XML 81 R62.htm IDEA: XBRL DOCUMENT v3.22.4
Financial Statement Components - Cash and Cash Equivalents (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Cash $ 27,496 $ 303,373
Money market funds 42,056 25,654
Commercial paper 0 950
Total cash and cash equivalents $ 69,552 $ 329,977
XML 82 R63.htm IDEA: XBRL DOCUMENT v3.22.4
Financial Statement Components - Inventory (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Raw materials $ 3,614 $ 5,866  
Work-in-process 2,329 1,171  
Finished goods 2,849 3,305  
Total inventory 8,792 10,342 $ 3,613
Inventory write-downs $ 12,154 $ 2,918 $ 4,407
XML 83 R64.htm IDEA: XBRL DOCUMENT v3.22.4
Financial Statement Components - Prepaid Expenses and Other Current Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Prepaid expenses $ 15,653 $ 14,651
Contract assets, current 15,395 9,907
Advance payments to vendors 7,919 1,810
Other receivables 5,236 2,827
Total prepaid expenses and other current assets $ 44,203 $ 29,195
XML 84 R65.htm IDEA: XBRL DOCUMENT v3.22.4
Financial Statement Components - Property and Equipment (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Property, Plant and Equipment [Line Items]      
Total property and equipment $ 40,412 $ 17,787  
Accumulated depreciation and amortization (10,152) (6,778)  
Total property and equipment, net 30,260 11,009  
Depreciation and amortization 4,300 3,900 $ 2,500
Machinery and equipment      
Property, Plant and Equipment [Line Items]      
Total property and equipment 14,047 7,694  
Computer hardware and software      
Property, Plant and Equipment [Line Items]      
Total property and equipment 6,797 2,854  
Land      
Property, Plant and Equipment [Line Items]      
Total property and equipment 1,001 0  
Leasehold improvements      
Property, Plant and Equipment [Line Items]      
Total property and equipment 885 869  
Vehicles, including demonstration fleet      
Property, Plant and Equipment [Line Items]      
Total property and equipment 3,222 2,421  
Furniture and fixtures      
Property, Plant and Equipment [Line Items]      
Total property and equipment 818 272  
Construction in progress      
Property, Plant and Equipment [Line Items]      
Total property and equipment $ 13,642 $ 3,677  
XML 85 R66.htm IDEA: XBRL DOCUMENT v3.22.4
Financial Statement Components - Schedule of Intangible Assets (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Aug. 03, 2021
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Intangible Assets (Including Goodwill) [Roll Forward]          
Beginning of the period   $ 2,424 $ 2,424 $ 0  
Additions   2,650 21,890    
Amortization   $ (226) (2,237)    
End of the period     22,077 2,424 $ 0
Intangible assets, net     22,077 2,424  
Optogration, Inc.          
Intangible Assets (Including Goodwill) [Roll Forward]          
Amortization     (2,200) (200) $ 0
Accumulated Amortization     (2,463) $ (226)  
Net Carrying Amount     $ 22,077    
Weighted Average Remaining Period (Years)     6 years 7 months 6 days 9 years 7 months 6 days  
IPR&D     $ 7,500    
Intangible assets, gross     24,540 $ 2,650  
Intangible assets, net     22,077 2,424  
Optogration, Inc. | Customer relationships          
Intangible Assets (Including Goodwill) [Roll Forward]          
Gross Carrying Amount     3,730 780  
Accumulated Amortization     (664) (33)  
Net Carrying Amount     $ 3,066 $ 747  
Weighted Average Remaining Period (Years) 10 years   4 years 4 months 24 days 9 years 7 months 6 days  
Optogration, Inc. | Customer backlog          
Intangible Assets (Including Goodwill) [Roll Forward]          
Gross Carrying Amount     $ 650 $ 0  
Accumulated Amortization     (292) 0  
Net Carrying Amount     $ 358 0  
Weighted Average Remaining Period (Years)     10 months 24 days    
Optogration, Inc. | Tradename          
Intangible Assets (Including Goodwill) [Roll Forward]          
Gross Carrying Amount     $ 620 120  
Accumulated Amortization     (214) (120)  
Net Carrying Amount     $ 406 0  
Weighted Average Remaining Period (Years) 1 year   3 years 3 months 18 days    
Optogration, Inc. | Assembled workforce          
Intangible Assets (Including Goodwill) [Roll Forward]          
Gross Carrying Amount     $ 130 0  
Accumulated Amortization     (130) 0  
Net Carrying Amount     0 0  
Optogration, Inc. | Developed technology          
Intangible Assets (Including Goodwill) [Roll Forward]          
Gross Carrying Amount     11,910 1,750  
Accumulated Amortization     (1,163) (73)  
Net Carrying Amount     $ 10,747 $ 1,677  
Weighted Average Remaining Period (Years) 10 years   7 years 6 months 9 years 7 months 6 days  
Optogration, Inc. | IPR&D          
Intangible Assets (Including Goodwill) [Roll Forward]          
Accumulated Amortization     $ 0 $ 0  
IPR&D     $ 7,500 $ 0  
XML 86 R67.htm IDEA: XBRL DOCUMENT v3.22.4
Financial Statement Components - Future Amortization Expense (Details) - Optogration, Inc.
$ in Thousands
Dec. 31, 2022
USD ($)
Finite-Lived Intangible Assets [Line Items]  
2023 $ 2,730
2024 2,373
2025 2,373
2026 1,726
2027 1,510
Thereafter 3,865
IPR&D 7,500
Net Carrying Amount $ 22,077
XML 87 R68.htm IDEA: XBRL DOCUMENT v3.22.4
Financial Statement Components - Goodwill (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2022
USD ($)
Goodwill [Roll Forward]  
Balance as of December 31, 2021 $ 3,110
Purchase accounting adjustments (179)
Balance as of December 31, 2022 18,816
Freedom Photonics  
Goodwill [Roll Forward]  
Acquired goodwill related to Freedom Photonics in 2022 15,885
Autonomy Solutions  
Goodwill [Roll Forward]  
Balance as of December 31, 2021 687
Purchase accounting adjustments 0
Balance as of December 31, 2022 687
Autonomy Solutions | Freedom Photonics  
Goodwill [Roll Forward]  
Acquired goodwill related to Freedom Photonics in 2022 0
ATS  
Goodwill [Roll Forward]  
Balance as of December 31, 2021 2,423
Purchase accounting adjustments (179)
Balance as of December 31, 2022 18,129
ATS | Freedom Photonics  
Goodwill [Roll Forward]  
Acquired goodwill related to Freedom Photonics in 2022 $ 15,885
XML 88 R69.htm IDEA: XBRL DOCUMENT v3.22.4
Financial Statement Components - Other Noncurrent Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Security deposits $ 5,495 $ 1,187
Non-marketable equity investment 4,000 10,002
Advance payment for capital projects 27,683 0
Contract assets 2,575 0
Other non-current assets 591 1,266
Other non-current assets $ 40,344 $ 12,455
XML 89 R70.htm IDEA: XBRL DOCUMENT v3.22.4
Financial Statement Components - Accrued and Other Current Liabilities (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Accrued compensation and benefits $ 16,682,000 $ 9,899,000  
Accrued expenses 22,358,000 6,727,000  
Warranty reserves 3,584,000 1,798,000  
Contract liabilities 1,993,000 898,000  
Accrued interest payable 359,000 316,000  
Contract losses 7,526,000 115,000  
Other 460,000 91,000  
Total accrued and other current liabilities 52,962,000 19,844,000  
Estimated contract losses $ 19,200,000 $ 0 $ 0
XML 90 R71.htm IDEA: XBRL DOCUMENT v3.22.4
Debt - Additional Information (Details)
1 Months Ended 12 Months Ended
Dec. 31, 2021
USD ($)
$ / shares
Dec. 31, 2021
USD ($)
$ / shares
Dec. 31, 2021
USD ($)
trading_day
$ / shares
Dec. 31, 2021
USD ($)
consecutive_trading_day
$ / shares
Dec. 31, 2021
USD ($)
consecutive_business_day
$ / shares
Dec. 31, 2022
USD ($)
$ / shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
shares
Dec. 02, 2020
$ / shares
Debt Instrument [Line Items]                  
Proceeds from convertible debt           $ 0 $ 609,375,000 $ 0  
Stock option, capped calls, initial strike price (in dollars per share) | $ / shares $ 19.98 $ 19.98 $ 19.98 $ 19.98 $ 19.98   $ 19.98    
Stock option, capped calls, initial cap price (in dollars per share) | $ / shares 30.16 30.16 30.16 30.16 30.16   $ 30.16    
Loss on extinguishment of debt           0 $ 0 (3,996,000)  
Change in fair value of warrant liabilities           $ (9,222,000) $ 26,126,000 268,266,000  
2017, 2018, And 2020 Warrants                  
Debt Instrument [Line Items]                  
Change in fair value of warrant liabilities               $ 27,300,000  
Warrants outstanding (in shares) | shares               0  
Class A Common Stock                  
Debt Instrument [Line Items]                  
Common stock, par value (in dollars per share) | $ / shares $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001   $ 0.0001
Class A Common Stock | Common Stock                  
Debt Instrument [Line Items]                  
Conversion of SAFE into Series A common stock and Issuance of Class A common stock upon exercise of warrants (in shares) | shares             15,000,000 1,466,155  
Senior Notes                  
Debt Instrument [Line Items]                  
Accrued interest repaid               $ 2,500,000  
Loss on extinguishment of debt               $ 4,000,000  
Convertible Senior Notes Due 2026 | Convertible Debt                  
Debt Instrument [Line Items]                  
Principal $ 625,000,000 $ 625,000,000 $ 625,000,000 $ 625,000,000 $ 625,000,000 $ 625,000,000 $ 625,000,000    
Interest rate (as a percent) 1.25% 1.25% 1.25% 1.25% 1.25%   1.25%    
Proceeds from the issuance of debt $ 75,000,000                
Proceeds from convertible debt $ 609,400,000                
Debt instrument, convertible, shares issuable (in shares) | shares             50.0475    
Conversion price (in dollars per share) | $ / shares $ 19.98 $ 19.98 $ 19.98 $ 19.98 $ 19.98   $ 19.98    
Debt issuance costs, net $ 16,200,000 $ 16,200,000 $ 16,200,000 $ 16,200,000 $ 16,200,000   $ 16,200,000    
Note term (in months)           3 years 11 months 15 days      
Accrued interest repaid           $ 7,800,000 $ 500,000    
Payments to purchase capped calls           $ 73,400,000      
Convertible Senior Notes Due 2026 | Convertible Debt | Debt Instrument, Redemption, Period One                  
Debt Instrument [Line Items]                  
Debt instrument, convertible, threshold trading days | trading_day     20            
Debt instrument, convertible, threshold consecutive trading days | consecutive_trading_day       30          
Debt instrument, redemption price, percentage   100.00%              
Convertible Senior Notes Due 2026 | Convertible Debt | Debt Instrument, Redemption, Period Two                  
Debt Instrument [Line Items]                  
Debt instrument, convertible, threshold percentage of stock price trigger   130.00%              
Debt instrument, convertible, threshold trading days | trading_day     20            
Debt instrument, convertible, threshold consecutive trading days | consecutive_trading_day       30          
Convertible Senior Notes Due 2026 | Convertible Debt | Debt Instrument, Redemption, Period Three                  
Debt Instrument [Line Items]                  
Debt instrument, convertible, threshold trading days       10 5        
Debt instrument, convertible, threshold percent of conversion price triggering convertible feature   98.00%              
Convertible Senior Notes Due 2026 | Convertible Debt | Class A Common Stock                  
Debt Instrument [Line Items]                  
Common stock, par value (in dollars per share) | $ / shares $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001   $ 0.0001    
Convertible Senior Notes Due 2026 | Convertible Debt | Class A Common Stock | Debt Instrument, Redemption, Period One                  
Debt Instrument [Line Items]                  
Debt instrument, convertible, threshold percentage of stock price trigger   130.00%              
XML 91 R72.htm IDEA: XBRL DOCUMENT v3.22.4
Debt - Schedule of Net Carrying Amount (Details) - Convertible Senior Notes Due 2026 - Convertible Debt - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Debt Instrument [Line Items]    
Principal $ 625,000,000 $ 625,000,000
Unamortized debt discount and issuance costs (12,808,000) (16,043,000)
Net carrying amount $ 612,192,000 $ 608,957,000
XML 92 R73.htm IDEA: XBRL DOCUMENT v3.22.4
Debt - Schedule of Interest Expense (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Debt Instrument [Line Items]      
Total interest expense $ 11,095 $ 2,028 $ 2,885
Convertible Senior Notes Due 2026 | Convertible Debt      
Debt Instrument [Line Items]      
Contractual interest expense 7,812 316  
Amortization of debt discount and issuance costs 3,236 135  
Total interest expense $ 11,048 $ 451  
XML 93 R74.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value Measurements - Narrative (Details)
$ in Millions
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Level 3 | Expected Term | Private Warrants    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants term (in years) 2 years 11 months 1 day  
Level 3 | Price Volatility | Private Warrants    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants outstanding, measurement input 0.850  
Level 3 | Risk Free Interest Rate | Private Warrants    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants outstanding, measurement input 0.0423  
Level 2    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Convertible senior notes, fair value $ 352.5 $ 669.4
XML 94 R75.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value Measurements - Schedule of Changes in Level 3 Liabilities Measured at Fair Value (Details) - Private Warrants - Warrants
$ in Thousands
12 Months Ended
Dec. 31, 2022
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]  
Balance at beginning of period $ 31,230
Change in fair value prior to exercises 4,713
Reduction in liability due to exercises (19,003)
Change in fair value of outstanding warrants (13,935)
Balance at end of period $ 3,005
XML 95 R76.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value Measurements - Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements on a Recurring Basis and the Level of Inputs Used (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Assets:    
Marketable investments $ 389,671 $ 418,875
Liabilities:    
Warrant liabilities 3,005 31,230
U.S. treasury securities    
Assets:    
Marketable investments 188,480 161,465
U.S. agency and government sponsored securities    
Assets:    
Marketable investments 4,924 4,970
Corporate bonds    
Assets:    
Marketable investments 109,909 165,190
Asset-backed securities    
Assets:    
Marketable investments 11,835 46,466
Fair Value, Recurring    
Assets:    
Total cash equivalents 42,056 26,604
Marketable equity investments 29,643 44,216
Total marketable investments 419,314 462,141
Liabilities:    
Warrant liabilities 3,005 31,230
Fair Value, Recurring | Private Warrants    
Liabilities:    
Warrant liabilities 3,005 31,230
Fair Value, Recurring | U.S. treasury securities    
Assets:    
Marketable investments 188,480 161,465
Fair Value, Recurring | U.S. agency and government sponsored securities    
Assets:    
Marketable investments 4,924 4,970
Fair Value, Recurring | Commercial paper    
Assets:    
Marketable investments 74,523 39,834
Fair Value, Recurring | Corporate bonds    
Assets:    
Marketable investments 109,909 165,190
Fair Value, Recurring | Asset-backed securities    
Assets:    
Marketable investments 11,835 46,466
Fair Value, Recurring | Money market funds    
Assets:    
Total cash equivalents 42,056 25,654
Fair Value, Recurring | Commercial paper    
Assets:    
Total cash equivalents   950
Level 1 | Fair Value, Recurring    
Assets:    
Total cash equivalents 42,056 25,654
Marketable equity investments 29,643 44,216
Total marketable investments 218,123 205,681
Liabilities:    
Warrant liabilities 0 0
Level 1 | Fair Value, Recurring | Private Warrants    
Liabilities:    
Warrant liabilities 0 0
Level 1 | Fair Value, Recurring | U.S. treasury securities    
Assets:    
Marketable investments 188,480 161,465
Level 1 | Fair Value, Recurring | U.S. agency and government sponsored securities    
Assets:    
Marketable investments 0 0
Level 1 | Fair Value, Recurring | Commercial paper    
Assets:    
Marketable investments 0 0
Level 1 | Fair Value, Recurring | Corporate bonds    
Assets:    
Marketable investments 0 0
Level 1 | Fair Value, Recurring | Asset-backed securities    
Assets:    
Marketable investments 0 0
Level 1 | Fair Value, Recurring | Money market funds    
Assets:    
Total cash equivalents 42,056 25,654
Level 1 | Fair Value, Recurring | Commercial paper    
Assets:    
Total cash equivalents   0
Level 2 | Fair Value, Recurring    
Assets:    
Total cash equivalents 0 950
Marketable equity investments 0 0
Total marketable investments 201,191 256,460
Liabilities:    
Warrant liabilities 0 0
Level 2 | Fair Value, Recurring | Private Warrants    
Liabilities:    
Warrant liabilities 0 0
Level 2 | Fair Value, Recurring | U.S. treasury securities    
Assets:    
Marketable investments 0 0
Level 2 | Fair Value, Recurring | U.S. agency and government sponsored securities    
Assets:    
Marketable investments 4,924 4,970
Level 2 | Fair Value, Recurring | Commercial paper    
Assets:    
Marketable investments 74,523 39,834
Level 2 | Fair Value, Recurring | Corporate bonds    
Assets:    
Marketable investments 109,909 165,190
Level 2 | Fair Value, Recurring | Asset-backed securities    
Assets:    
Marketable investments 11,835 46,466
Level 2 | Fair Value, Recurring | Money market funds    
Assets:    
Total cash equivalents 0 0
Level 2 | Fair Value, Recurring | Commercial paper    
Assets:    
Total cash equivalents   950
Level 3 | Fair Value, Recurring    
Assets:    
Total cash equivalents 0 0
Marketable equity investments 0 0
Total marketable investments 0 0
Liabilities:    
Warrant liabilities 3,005 31,230
Level 3 | Fair Value, Recurring | Private Warrants    
Liabilities:    
Warrant liabilities 3,005 31,230
Level 3 | Fair Value, Recurring | U.S. treasury securities    
Assets:    
Marketable investments 0 0
Level 3 | Fair Value, Recurring | U.S. agency and government sponsored securities    
Assets:    
Marketable investments 0 0
Level 3 | Fair Value, Recurring | Commercial paper    
Assets:    
Marketable investments 0 0
Level 3 | Fair Value, Recurring | Corporate bonds    
Assets:    
Marketable investments 0 0
Level 3 | Fair Value, Recurring | Asset-backed securities    
Assets:    
Marketable investments 0 0
Level 3 | Fair Value, Recurring | Money market funds    
Assets:    
Total cash equivalents $ 0 0
Level 3 | Fair Value, Recurring | Commercial paper    
Assets:    
Total cash equivalents   $ 0
XML 96 R77.htm IDEA: XBRL DOCUMENT v3.22.4
Convertible Preferred Stock (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 2 Months Ended 12 Months Ended 17 Months Ended
Dec. 02, 2020
Oct. 31, 2020
Sep. 30, 2020
Dec. 31, 2020
Dec. 02, 2020
Jun. 24, 2019
Temporary Equity [Line Items]            
Beneficial conversion feature         $ 12,000  
Series A Convertible Preferred Stock            
Temporary Equity [Line Items]            
Shares authorized (in shares)           102,740,023
Par value (in dollars per share)           $ 0.00001
Merger recapitalization (in shares)       94,818,151    
Series X Convertible Preferred Stock            
Temporary Equity [Line Items]            
Shares authorized (in shares)   20,077,073        
Par value (in dollars per share)   $ 0.00001        
Preferred stock issued (in shares)   1,391,694 17,065,536 18,457,230    
Purchase price (in dollars per share)     $ 9.96      
Gross proceeds from stock issuance   $ 13,860 $ 170,000 $ 178,074    
Merger recapitalization (in shares)       18,457,230    
Series A And Series X Convertible Preferred Stock            
Temporary Equity [Line Items]            
Merger recapitalization (in shares) 113,275,381          
XML 97 R78.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings (Loss) Per Share - Basic and Diluted Loss Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Numerator:      
Net loss $ (445,939) $ (237,986) $ (362,298)
Deemed dividend attributable to BCF accretion 0 0 (6,757)
Net loss attributable to common shareholders $ (445,939) $ (237,986) $ (369,055)
Denominator:      
Weighted average Common shares outstanding- Basic (in shares) 356,265,774 346,300,975 145,096,996
Weighted average Common shares outstanding- Diluted (in shares) 356,265,774 346,300,975 145,096,996
Net loss per share attributable to common shareholders- Basic (in dollars per share) $ (1.25) $ (0.69) $ (2.54)
Net loss per share attributable to common shareholders- Diluted (in dollars per share) $ (1.25) $ (0.69) $ (2.54)
XML 98 R79.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings (Loss) Per Share - Antidilutive Securities (Details) - shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Total (in shares) 96,482,118 75,270,865 67,911,961
Warrants      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Total (in shares) 5,757,549 7,166,301 24,089,255
Stock-based awards—Equity classified      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Total (in shares) 33,372,534 24,156,973 18,003,962
Stock-based awards—Liability classified      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Total (in shares) 14,302,723 2,401,648 0
Vendor stock-in-lieu of cash program      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Total (in shares) 3,162,879 1,659,510 0
Convertible Senior Notes      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Total (in shares) 31,279,716 31,279,716 0
Earn-out shares      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Total (in shares) 8,606,717 8,606,717 25,818,744
XML 99 R80.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings (Loss) Per Share - Narrative (Details)
Dec. 31, 2022
$ / shares
Convertible Senior Notes  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Conversion price (in dollars per share) $ 19.981
XML 100 R81.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders’ Equity (Deficit) (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Dec. 02, 2020
USD ($)
vote
$ / shares
shares
Apr. 30, 2022
shares
Jan. 31, 2022
shares
Nov. 30, 2021
shares
Mar. 31, 2021
USD ($)
$ / shares
shares
Jun. 30, 2022
USD ($)
shares
Mar. 31, 2022
USD ($)
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
vote
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
shares
Dec. 21, 2021
Jul. 01, 2021
Dec. 31, 2019
shares
Dec. 31, 2015
shares
Class of Stock [Line Items]                              
Common stock, shares outstanding (in shares) 323,936,240                            
Compensation expense | $                 $ 162,405,000 $ 77,684,000 $ 8,711,000        
Treasury stock, shares outstanding (in shares)               15,263,761 21,863,450 15,263,761          
Stock repurchase program, remaining authorized repurchase amount | $                 $ 0            
Preferred stock, shares outstanding (in shares)                 0            
Proceeds from exercise of warrants | $                 $ 0 $ 153,927,000 0        
Vendor payments in shares in lieu of cash (in shares)                 8,824,385            
Vendor payments under the stock-in-lieu of cash program | $                 $ 15,200,000            
Research and development                              
Class of Stock [Line Items]                              
Compensation expense | $                 40,898,000 $ 20,216,000 $ 2,098,000        
Daimler North America Corporation                              
Class of Stock [Line Items]                              
Prepaid expenses and other current assets | $                 9,200,000            
Daimler North America Corporation | Research and development                              
Class of Stock [Line Items]                              
Compensation expense | $                 $ 7,900,000            
Private and Public Warrants                              
Class of Stock [Line Items]                              
Proceeds from exercise of warrants | $         $ 153,900,000                    
Public Warrants                              
Class of Stock [Line Items]                              
Warrants exercised (in shares)         13,128,671                    
Remaining warrants redeemed (in shares)         204,638                    
Redemption price per warrant (in dollars per share) | $ / shares         $ 0.01                    
Warrants outstanding (in shares)               0   0 13,333,309        
Private Warrants                              
Class of Stock [Line Items]                              
Warrants exercised (in shares)   19,223 1,389,529   3,589,645                    
Warrants outstanding (in shares)               3,077,021 1,668,269 3,077,021 6,666,666        
Shares issued for exercise of warrants (in shares)   4,387 401,365                        
Share per warrant (in shares)                 1            
Stock price of warrants (in dollars per share) | $ / shares                 $ 11.50            
Preferred Stock                              
Class of Stock [Line Items]                              
Conversion ratio                             1
Preferred stock, shares issued (in shares)                             26,206,837
Preferred stock, shares outstanding (in shares)               0 0 0 0     26,206,837  
Chief Executive Officer | Gores Metropoulos                              
Class of Stock [Line Items]                              
Compensation expense | $ $ 3,000,000                            
Chief Executive Officer | Gores Metropoulos | Preferred Stock                              
Class of Stock [Line Items]                              
Shares converted (in shares) 22,935,412                            
Class A Common Stock                              
Class of Stock [Line Items]                              
Common stock, shares authorized (in shares)               715,000,000 715,000,000 715,000,000          
Common stock, par value (in dollars per share) | $ / shares $ 0.0001             $ 0.0001 $ 0.0001 $ 0.0001          
Common stock, shares issued (in shares) 218,818,037             266,076,525 291,942,087 266,076,525          
Common stock, shares outstanding (in shares) 218,818,037             250,812,764 270,078,637 250,812,764          
Common stock, votes per share | vote                 1            
Shares converted (in shares)                   15,000,000          
Shares repurchased | $               $ 312,500,000   $ 312,500,000          
Treasury stock, shares outstanding (in shares)               15,263,761   15,263,761          
Purchase transaction | $           $ 36,900,000 $ 39,700,000 $ 235,900,000              
Repurchase of Class A shares (in shares)           3,917,141 2,682,548                
Class A Common Stock | Daimler North America Corporation                              
Class of Stock [Line Items]                              
Shares issued for services (in shares)       1,500,000                      
Award vesting period (in years and in months)       2 years                      
Shares issued in period (in shares)                 1,125,000            
Class A Common Stock | Common Stock                              
Class of Stock [Line Items]                              
Common stock, shares outstanding (in shares)               266,076,525 291,942,087 266,076,525 218,818,037     139,635,890  
Repurchase of Class A shares (in shares)                 48,298 71,894 6,629,372        
Shares issued for exercise of warrants (in shares)                 405,752 15,574,037          
Shares issued for services (in shares)                 9,949,385 291,940          
Class A Common Stock | Chief Executive Officer | Gores Metropoulos                              
Class of Stock [Line Items]                              
Common stock, votes per share | vote 1                            
Class A Common Stock | Chief Executive Officer | Gores Metropoulos | Common Stock                              
Class of Stock [Line Items]                              
Shares converted (in shares) 82,182,791                            
Class B Common Stock                              
Class of Stock [Line Items]                              
Common stock, shares authorized (in shares)               121,000,000 121,000,000 121,000,000          
Common stock, par value (in dollars per share) | $ / shares $ 0.0001             $ 0.0001 $ 0.0001 $ 0.0001          
Common stock, shares issued (in shares) 105,118,203             97,088,670 97,088,670 97,088,670          
Common stock, shares outstanding (in shares) 105,118,203             97,088,670 97,088,670 97,088,670          
Common stock, votes per share | vote                 10            
Shares issued upon conversion (in shares)                   15,000,000          
Class B Common Stock | Common Stock                              
Class of Stock [Line Items]                              
Common stock, shares outstanding (in shares)               97,088,670 97,088,670 97,088,670 105,118,203     0  
Class B Common Stock | Chief Executive Officer | Gores Metropoulos                              
Class of Stock [Line Items]                              
Common stock, votes per share | vote 10                            
Common Stock                              
Class of Stock [Line Items]                              
Conversion ratio                       1 1    
XML 101 R82.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders’ Equity (Deficit) - Stock-in-lieu of Cash Program Activity (Details)
12 Months Ended
Dec. 31, 2022
$ / shares
shares
Shares  
Outstanding at beginning of period (in shares) | shares 11,507,643
Outstanding at end of period (in shares) | shares 8,162,850
Weighted Average Grant Date Fair Value per Share  
Outstanding as of Beginning Balance | $ / shares $ 1.72
Outstanding as of Ending Balance | $ / shares $ 1.74
Vendor stock-in-lieu of cash program  
Shares  
Outstanding at beginning of period (in shares) | shares 1,500,000
Granted (in shares) | shares 8,824,385
Vested (in shares) | shares (9,277,234)
Outstanding at end of period (in shares) | shares 1,047,151
Weighted Average Grant Date Fair Value per Share  
Outstanding as of Beginning Balance | $ / shares $ 15.72
Granted (in dollars per share) | $ / shares 9.93
Vested (in dollars per share) | $ / shares 10.65
Outstanding as of Ending Balance | $ / shares $ 11.90
XML 102 R83.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-based Compensation - Narrative (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 6 Months Ended 12 Months Ended 17 Months Ended 42 Months Ended
Jan. 01, 2023
shares
Aug. 19, 2022
$ / shares
shares
May 02, 2022
$ / shares
shares
Aug. 03, 2021
USD ($)
Aug. 31, 2022
USD ($)
shares
Jun. 30, 2022
USD ($)
shares
Apr. 30, 2022
USD ($)
Dec. 31, 2020
shares
Jun. 30, 2021
Jun. 30, 2019
Dec. 31, 2022
USD ($)
trading_day
$ / shares
shares
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2020
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
shares
Dec. 31, 2022
USD ($)
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Weighted-average grant date fair value (in dollars per share) | $ / shares                         $ 0.98    
Fair value of options vested                     $ 2,900 $ 7,100 $ 1,400    
Intrinsic value of stock options exercised                     20,600        
Unrecognized stock-based compensation expense                     2,700     $ 2,700 $ 2,700
Compensation cost                     162,405 77,684 $ 8,711    
Optogration milestone awards                     11,751        
Optogration Milestone Awards                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Compensation cost                           16,500  
Contingent stock consideration       $ 22,000                      
Freedom Photonics                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Compensation cost                     7,600        
Contingent stock consideration             $ 28,300                
Solfice                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Compensation cost                     $ 400        
Contingent stock consideration           $ 700                  
ESPP                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Shares authorized for issuance (in shares) | shares               7,317,655         7,317,655    
Percentage of purchase price of shares               85.00%              
Length of offering period (in months)               6 months              
Shares of common stock in each purchase period (in shares) | shares               5,000              
Weighted average purchase price (in shares) | shares                     168,147        
Weighted average purchase price (in dollars per share) | $ / shares                     $ 7.56        
Stock options                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Unrecognized compensation expense, period for recognition                     7 months 17 days        
Stock options | Tranche One                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Award vesting period (in years and in months)                     1 year        
Restricted Stock | Share-based Payment Arrangement, Employee                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Award vesting period (in years and in months)                   4 years          
Granted (in shares) | shares                             0
Fair value of restricted stock vested                     $ 700 1,000 $ 2,200    
Unrecognized stock-based compensation expense for restricted stock                     $ 100     100 $ 100
Restricted Stock | Share-based Payment Arrangement, Nonemployee                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Granted (in shares) | shares                     23,213,889        
Unrecognized compensation expense, period for recognition                     1 year 6 months 10 days        
Fair value of restricted stock vested                     $ 116,000 $ 32,800      
Unrecognized stock-based compensation expense for restricted stock                     $ 277,700     277,700 277,700
Restricted Stock | Tranche One | Share-based Payment Arrangement, Employee                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Award vesting period (in years and in months)                 1 year            
Award vesting percentage                   25.00%          
Restricted Stock | Tranche Two | Share-based Payment Arrangement, Employee                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Award vesting period (in years and in months)                   36 months          
Award vesting percentage                   75.00%          
RSUs | Chief Executive Officer                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Granted (in shares) | shares   500,000 10,800,000                        
Grant date fair value (in dollars per share) | $ / shares   $ 6.12 $ 8.70                        
RSUs | Chief Legal Officer                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Granted (in shares) | shares   500,000                          
Grant date fair value (in dollars per share) | $ / shares   $ 6.12                          
RSUs | Executive Officer                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Unrecognized compensation expense, period for recognition                     6 years 4 months 9 days        
Unrecognized stock-based compensation expense for restricted stock                     $ 85,300     85,300 85,300
Compensation cost                     $ 14,700        
Consecutive trading days | trading_day                     90        
Service period (in years)                     7 years        
RSUs | Maximum                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Award vesting period (in years and in months)                     6 years        
Number of shares issued for each vested RSU (in shares) | shares                     1        
RSUs | Market One Member | Executive Officer                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
RSU vesting, market condition, stock price (in dollars per share) | $ / shares                     $ 50        
RSUs | Market Two Member | Executive Officer                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
RSU vesting, market condition, stock price (in dollars per share) | $ / shares                     60        
RSUs | Market Three Member | Executive Officer                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
RSU vesting, market condition, stock price (in dollars per share) | $ / shares                     $ 70        
Class A Common Stock | Optogration Milestone Awards                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Optogration milestone awards (in shares) | shares         1,632,056                    
Optogration milestone awards         $ 11,000                    
Optogration milestone awards, remaining obligations                     $ 11,000     $ 11,000 $ 11,000
Class A Common Stock | ESPP                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Percentage of pre-tax earnings               15.00%              
2020 Plan                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Shares authorized for issuance (in shares) | shares                     36,588,278     36,588,278 36,588,278
2020 Plan | Equity settled fixed value | Share-based Payment Arrangement, Employee                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Award vesting period (in years and in months)                     4 years        
Compensation cost                     $ 7,600        
2020 Plan | Equity settled fixed value | Tranche One | Share-based Payment Arrangement, Employee                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Award vesting percentage                     25.00%        
2020 Plan | Equity settled fixed value | Tranche Two | Share-based Payment Arrangement, Employee                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Award vesting percentage                     25.00%        
2020 Plan | Equity settled fixed value | Tranche Three | Share-based Payment Arrangement, Employee                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Award vesting percentage                     25.00%        
2020 Plan | Equity settled fixed value | Tranche Four | Share-based Payment Arrangement, Employee                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Award vesting percentage                     25.00%        
Amended 2020 Plan                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Additional shares authorized for issuance (in shares) | shares           36,000,000                  
Percentage of outstanding stock maximum           5.00%                  
Incremental number of shares authorized (in shares) | shares           40,000,000                  
Amended 2020 Plan | Class A Common Stock | Subsequent Event                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Additional shares authorized for issuance (in shares) | shares 18,358,365                            
2015 Plan | Stock options                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Award vesting period (in years and in months)                     4 years        
Award expiration period (in years)                     10 years        
Granted (in shares) | shares                     0 0      
2015 Plan | Stock options | Tranche One                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Award vesting percentage                     25.00%        
2015 Plan | Stock options | Tranche Two                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Award vesting period (in years and in months)                     36 months        
Award vesting percentage                     75.00%        
XML 103 R84.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-based Compensation - Stock Option Activity (Details)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2022
USD ($)
$ / shares
shares
Number of Stock Options  
Outstanding at beginning of period (in shares) | shares 11,507,643
Exercised (in shares) | shares (2,370,989)
Cancelled/Forfeited (in shares) | shares (973,804)
Outstanding at end of period (in shares) | shares 8,162,850
Vested and exercisable (in shares) | shares 5,472,821
Vested and expected to vest (in shares) | shares 8,162,850
Weighted- Average Exercise Price  
Outstanding as of Beginning Balance | $ / shares $ 1.72
Exercised (in dollars per share) | $ / shares 1.67
Cancelled/Forfeited (in dollars per share) | $ / shares 1.67
Outstanding as of Ending Balance | $ / shares 1.74
Vested and exercisable (in dollars per share) | $ / shares 1.73
Vested and expected to vest (in dollars per share) | $ / shares $ 1.74
Weighted- Average Remaining Contractual Life (Years)  
Outstanding balance 7 years 10 days
Vested and exercisable 6 years 11 months 12 days
Vested and expected to vest 7 years 10 days
Aggregate Intrinsic Value  
Outstanding balance | $ $ 26,763
Vested and exercisable | $ 17,654
Vested and expected to vest | $ $ 26,763
XML 104 R85.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-based Compensation - Restricted Stock Activity (Details) - Stock-based awards—Liability classified - $ / shares
12 Months Ended 42 Months Ended
Dec. 31, 2022
Dec. 31, 2022
Share-based Payment Arrangement, Employee    
Shares    
Outstanding at beginning of period (in shares) 666,298  
Granted (in shares)   0
Forfeited (in shares) (18,476)  
Vested (in shares) (583,336)  
Outstanding at end of period (in shares) 64,486 64,486
Weighted Average Grant Date Fair Value per Share    
Outstanding at beginning of period (in dollars per share) $ 1.21  
Forfeited (in dollars per share) 1.23  
Vested (in dollars per share) 1.20  
Outstanding at end of period (in dollars per share) $ 1.29 $ 1.29
Share-based Payment Arrangement, Nonemployee    
Shares    
Outstanding at beginning of period (in shares) 11,983,032  
Granted (in shares) 23,213,889  
Forfeited (in shares) (2,069,915)  
Vested (in shares) (7,532,971)  
Outstanding at end of period (in shares) 25,594,035 25,594,035
Weighted Average Grant Date Fair Value per Share    
Outstanding at beginning of period (in dollars per share) $ 19.56  
Granted (in dollars per share) 10.29  
Forfeited (in dollars per share) 16.15  
Vested (in dollars per share) 15.40  
Outstanding at end of period (in dollars per share) $ 12.66 $ 12.66
XML 105 R86.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-based Compensation - Employee Stock Purchase Plan, Valuation Assumptions (Details) - ESPP
Nov. 16, 2022
May 16, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Expect term (years) 6 months 6 months
Volatility 93.50% 82.30%
Risk-free interest rate 4.54% 1.54%
Dividend yield 0.00% 0.00%
XML 106 R87.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-based Compensation - Compensation Expense (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense $ 162,405 $ 77,684 $ 8,711
Cost of sales      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense 7,680 6,422 309
Research and development      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense 40,898 20,216 2,098
Sales and marketing      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense 15,814 4,546 414
General and administrative      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense 98,013 46,500 5,890
Equity settled fixed value      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense 7,545 3,826 0
Optogration      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense 10,894 6,114 0
Freedom Photonics      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense 7,633 0 0
Solfice      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense 410 0 0
Other      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense 2,258 734 0
Stock options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense 2,666 5,137 3,179
RSAs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense 293 1,682 5,532
RSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense 129,992 60,191 0
ESPP      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense $ 714 $ 0 $ 0
XML 107 R88.htm IDEA: XBRL DOCUMENT v3.22.4
Leases - Narrative (Details)
12 Months Ended
Dec. 31, 2022
USD ($)
renewal_option
Sep. 30, 2022
Dec. 31, 2021
USD ($)
Oct. 31, 2021
Jan. 01, 2021
USD ($)
Lessee, Lease, Description [Line Items]          
Term of lease (in moths)   66 months   65 months  
Short-term leases $ 0        
Sublease income 0        
Operating lease right-of-use assets 21,244,000   $ 9,145,000    
Operating lease liabilities $ 22,942,000   $ 10,503,000    
Accounting Standards Update 2016-02          
Lessee, Lease, Description [Line Items]          
Operating lease right-of-use assets         $ 10,800,000
Operating lease liabilities         12,000,000
Reversal of deferred rent         $ (1,200,000)
Minimum          
Lessee, Lease, Description [Line Items]          
Number of renewal options | renewal_option 1        
Renewal lease term (in years) 1 year        
Maximum          
Lessee, Lease, Description [Line Items]          
Renewal lease term (in years) 6 years        
XML 108 R89.htm IDEA: XBRL DOCUMENT v3.22.4
Leases - Components of Lease Expenses (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Leases [Abstract]    
Operating lease cost $ 6,533 $ 4,654
Variable lease cost 2,230 1,703
Total operating lease cost $ 8,763 $ 6,357
XML 109 R90.htm IDEA: XBRL DOCUMENT v3.22.4
Leases - Supplemental Cash Flow Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash paid for amounts included in the measurement of lease liabilities:      
Cash paid for operating leases included in operating activities $ (6,070) $ (4,609)  
Right of use assets obtained in exchange for lease obligations:      
Operating leases $ 16,749 $ 2,876 $ 0
XML 110 R91.htm IDEA: XBRL DOCUMENT v3.22.4
Leases - Supplemental Balance Sheet Information, Weighted Average Remaining Terms, and Weighted Average Discount Rates (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Operating leases:    
Operating lease right-of-use assets $ 21,244 $ 9,145
Operating lease liabilities, current 5,953 4,735
Operating lease liabilities, non-current 16,989 5,768
Total operating lease liabilities $ 22,942 $ 10,503
Weighted average remaining lease term    
Operating leases (in years) 4 years 5 months 4 days 2 years 11 months 12 days
Weighted average discount rate    
Operating leases (as a percent) 5.45% 2.80%
XML 111 R92.htm IDEA: XBRL DOCUMENT v3.22.4
Leases - Maturities of Lease Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Lessee, Operating Lease, Liability, Payment, Due [Abstract]    
2023 $ 6,190  
2024 5,123  
2025 5,193  
2026 4,732  
2027 3,927  
Thereafter 1,149  
Total lease payments 26,314  
Less: imputed interest (3,372)  
Total leases liabilities $ 22,942 $ 10,503
XML 112 R93.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Components of Loss Before Provision for (Benefit from) Income Taxes (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]      
United States $ (445,720) $ (239,855) $ (362,338)
International 453 607 40
Loss before provision for (benefit from) income taxes $ (445,267) $ (239,248) $ (362,298)
XML 113 R94.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Provision for (benefit from) income taxes (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Current:      
Foreign $ 440 $ 0 $ 0
Total current: 440 0 0
Deferred:      
U.S. federal 204 (1,262) 0
U.S. state 28 0 0
Total deferred: 232 (1,262) 0
Total provision for (benefit from) income taxes $ 672 $ (1,262) $ 0
XML 114 R95.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Narrative (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Jan. 01, 2022
Operating Loss Carryforwards [Line Items]        
Statutory tax rate 21.00% 21.00% 21.00%  
Valuation allowance $ 243,811,000 $ 130,569,000    
Valuation allowance, increase (decrease), amount 113,200,000      
Deferred tax assets, deferred expense, capitalized research and development costs increase (decrease)       $ 43,200,000
Interest and penalties accrued 0 $ 0    
Unrecognized tax benefits that would impact effective tax rate, if recognized 0      
United States        
Operating Loss Carryforwards [Line Items]        
Net operating loss carryforwards 597,000,000      
Net operating loss carryforwards, not subject to expiration 553,800,000      
Net operating loss carryforwards, subject to expiration $ 43,200,000      
Research and development activities, amortized over period 5 years      
Capitalized expenses, amortization period       5 years
United States | Research Tax Credit Carryforward        
Operating Loss Carryforwards [Line Items]        
Research and development tax credit carryforwards $ 21,100,000      
U.S. State        
Operating Loss Carryforwards [Line Items]        
Net operating loss carryforwards 547,800,000      
U.S. State | Research Tax Credit Carryforward        
Operating Loss Carryforwards [Line Items]        
Research and development tax credit carryforwards 3,900,000      
Tax credit carryforward, subject to expiration 50,000.00      
Tax credit carryforward, not subject to expiration $ 4,300,000      
Foreign Tax Authority        
Operating Loss Carryforwards [Line Items]        
Research and development activities, amortized over period 15 years      
Capitalized expenses, amortization period       15 years
XML 115 R96.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Effective Income Tax Rate (Details)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]      
U.S. federal provision at statutory rate 21.00% 21.00% 21.00%
State income taxes 5.70% 4.40% 0.70%
Tax credits 2.40% 1.50% 0.60%
Fair value of financial instruments 0.40% (2.30%) (15.60%)
Stock-based compensation expense (3.40%) 2.00% (0.40%)
Executive compensation (0.80%) (1.10%) 0.00%
Other permanent items 0.20% (0.30%) 0.00%
Uncertain tax benefits (1.40%) (0.80%) (0.30%)
Change in valuation allowance (24.30%) (24.00%) (6.00%)
Effective tax rate (0.20%) 0.40% 0.00%
XML 116 R97.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Deferred Income Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Deferred tax assets:    
Net operating loss carry forward $ 161,881 $ 120,544
Tax credits 16,322 6,296
Accruals and reserves 3,309 0
Stock-based compensation expense 14,535 6,944
Lease liability (ASC 842) 6,268 2,622
Section 174 R&D capitalization 43,240 0
Inventory reserves 1,961 617
Depreciation and amortization 2,170 0
Other 20 15
Total deferred tax assets 249,706 137,038
Valuation allowance (243,811) (130,569)
Total deferred tax asset 5,895 6,469
Deferred tax liabilities:    
Depreciation and amortization 0 1,185
Prepaid expenses 0 2,983
Other 162 0
ROU asset (ASC 842) 5,801 2,301
Total deferred tax liabilities 5,963 6,469
Net deferred tax assets (liabilities) $ (68)  
Net deferred tax assets (liabilities)   $ 0
XML 117 R98.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Unrecognized tax benefits as of the beginning of the year $ 6,296 $ 3,975 $ 2,397
Increases related to prior year tax positions 0 535 327
Decreases related to prior year tax provisions (3,723) 0 0
Increase related to current year tax positions 6,031 1,786 1,251
Unrecognized tax benefits as of the end of the year $ 8,604 $ 6,296 $ 3,975
XML 118 R99.htm IDEA: XBRL DOCUMENT v3.22.4
Commitment and Contingencies (Details)
$ in Millions
Dec. 31, 2022
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Purchase obligations $ 96.0
XML 119 R100.htm IDEA: XBRL DOCUMENT v3.22.4
Segment and Customer Concentration Information - Segment Operating Results and Reconciliation to the Consolidated Balances (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenue:      
Total revenue $ 40,698 $ 31,944 $ 13,951
Depreciation and amortization 6,566 4,162 2,517
Operating gain (loss) (442,402) (214,552) (86,875)
Other significant items:      
Segment assets 687,327 883,536 510,351
Inventories, net 8,792 10,342 3,613
Eliminations      
Revenue:      
Total revenue (27,233) (14,027) (4,764)
Depreciation and amortization 0 0 (6)
Operating gain (loss) (335) (95) 102
Other significant items:      
Segment assets (125,290) (8,939) (4,300)
Inventories, net (346) 0 0
Reportable Segments      
Revenue:      
Total revenue 67,931 45,971 18,715
Depreciation and amortization 6,566 4,162 2,523
Operating gain (loss) (442,067) (214,457) (86,977)
Other significant items:      
Segment assets 812,617 892,475 514,651
Inventories, net 9,138 10,342 3,613
Autonomy Solutions      
Revenue:      
Total revenue 24,353 28,497 11,387
Autonomy Solutions | Eliminations      
Revenue:      
Total revenue (14,748) (8,098) (1,516)
Autonomy Solutions | Reportable Segments      
Revenue:      
Total revenue 39,101 36,595 12,903
Depreciation and amortization 4,110 3,723 2,395
Operating gain (loss) (412,673) (214,133) (86,661)
Other significant items:      
Segment assets 752,088 882,704 511,676
Inventories, net 8,664 10,179 3,604
ATS      
Revenue:      
Total revenue 16,345 3,447 2,564
ATS | Eliminations      
Revenue:      
Total revenue (12,485) (5,929) (3,248)
ATS | Reportable Segments      
Revenue:      
Total revenue 28,830 9,376 5,812
Depreciation and amortization 2,456 439 128
Operating gain (loss) (29,394) (324) (316)
Other significant items:      
Segment assets 60,529 9,771 2,975
Inventories, net $ 474 $ 163 $ 9
XML 120 R101.htm IDEA: XBRL DOCUMENT v3.22.4
Segment and Customer Concentration Information - Narrative (Details) - Revenue from contract with customer benchmark - Customer Concentration Risk
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Customer One      
Concentration Risk [Line Items]      
Percentage of revenue (as percent) 21.00% 42.00% 64.00%
Customer Two      
Concentration Risk [Line Items]      
Percentage of revenue (as percent) 17.00% 17.00%  
XML 121 R102.htm IDEA: XBRL DOCUMENT v3.22.4
Related Party Disclosures (Details) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2022
Feb. 28, 2021
Mr. Heng      
Related Party Transaction [Line Items]      
Investment $ 12,100,000   $ 15,000,000
Portion of investment sold 2,900,000    
Investment, fair value $ 12,200,000    
Mr Alec Gores      
Related Party Transaction [Line Items]      
Investment   $ 0  
XML 122 R103.htm IDEA: XBRL DOCUMENT v3.22.4
Subsequent Events (Details) - Subsequent Event - USD ($)
$ in Millions
1 Months Ended
Feb. 28, 2023
Jan. 31, 2023
Seagate    
Subsequent Event [Line Items]    
Aggregate cash consideration   $ 12.6
Swiss Re    
Subsequent Event [Line Items]    
Aggregate cash consideration $ 4.0  
Asset acquisition, consideration service, period 4 years  
Asset acquisition, consideration transferred, non-cancelable amount $ 1.0  
XML 123 lazr-20221231_htm.xml IDEA: XBRL DOCUMENT 0001758057 2022-01-01 2022-12-31 0001758057 2022-06-30 0001758057 us-gaap:CommonClassAMember 2023-02-17 0001758057 us-gaap:CommonClassBMember 2023-02-17 0001758057 2022-12-31 0001758057 2021-12-31 0001758057 srt:AffiliatedEntityMember 2022-12-31 0001758057 srt:AffiliatedEntityMember 2021-12-31 0001758057 us-gaap:PreferredStockMember 2022-12-31 0001758057 us-gaap:PreferredStockMember 2021-12-31 0001758057 us-gaap:CommonClassAMember 2021-12-31 0001758057 us-gaap:CommonClassAMember 2022-12-31 0001758057 us-gaap:CommonClassBMember 2021-12-31 0001758057 us-gaap:CommonClassBMember 2022-12-31 0001758057 us-gaap:ProductMember 2022-01-01 2022-12-31 0001758057 us-gaap:ProductMember 2021-01-01 2021-12-31 0001758057 us-gaap:ProductMember 2020-01-01 2020-12-31 0001758057 us-gaap:ServiceMember 2022-01-01 2022-12-31 0001758057 us-gaap:ServiceMember 2021-01-01 2021-12-31 0001758057 us-gaap:ServiceMember 2020-01-01 2020-12-31 0001758057 2021-01-01 2021-12-31 0001758057 2020-01-01 2020-12-31 0001758057 lazr:SeriesAConvertiblePreferredStockMember 2019-12-31 0001758057 lazr:SeriesXConvertiblePreferredStockMember 2019-12-31 0001758057 us-gaap:PreferredStockMember 2019-12-31 0001758057 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2019-12-31 0001758057 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2019-12-31 0001758057 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001758057 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001758057 us-gaap:TreasuryStockCommonMember 2019-12-31 0001758057 us-gaap:RetainedEarningsMember 2019-12-31 0001758057 2019-12-31 0001758057 lazr:SeriesXConvertiblePreferredStockMember 2020-01-01 2020-12-31 0001758057 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001758057 us-gaap:PreferredStockMember 2020-01-01 2020-12-31 0001758057 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001758057 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001758057 lazr:SeriesAConvertiblePreferredStockMember 2020-01-01 2020-12-31 0001758057 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001758057 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001758057 lazr:SeriesAConvertiblePreferredStockMember 2020-12-31 0001758057 lazr:SeriesXConvertiblePreferredStockMember 2020-12-31 0001758057 us-gaap:PreferredStockMember 2020-12-31 0001758057 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-12-31 0001758057 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-12-31 0001758057 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001758057 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001758057 us-gaap:TreasuryStockCommonMember 2020-12-31 0001758057 us-gaap:RetainedEarningsMember 2020-12-31 0001758057 2020-12-31 0001758057 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001758057 us-gaap:TreasuryStockCommonMember 2021-01-01 2021-12-31 0001758057 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001758057 lazr:OptogrationIncMember us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001758057 lazr:OptogrationIncMember us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001758057 lazr:OptogrationIncMember 2021-01-01 2021-12-31 0001758057 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001758057 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001758057 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001758057 us-gaap:PreferredStockMember 2021-12-31 0001758057 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-12-31 0001758057 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001758057 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001758057 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001758057 us-gaap:TreasuryStockCommonMember 2021-12-31 0001758057 us-gaap:RetainedEarningsMember 2021-12-31 0001758057 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-12-31 0001758057 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001758057 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001758057 lazr:ECARXHoldingsIncECXMember us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001758057 lazr:ECARXHoldingsIncECXMember us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001758057 lazr:ECARXHoldingsIncECXMember 2022-01-01 2022-12-31 0001758057 lazr:FreedomPhotonicsMember us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001758057 lazr:FreedomPhotonicsMember us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001758057 lazr:FreedomPhotonicsMember 2022-01-01 2022-12-31 0001758057 lazr:SolficeMember us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001758057 lazr:SolficeMember us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001758057 lazr:SolficeMember 2022-01-01 2022-12-31 0001758057 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001758057 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001758057 us-gaap:PreferredStockMember 2022-12-31 0001758057 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-12-31 0001758057 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-12-31 0001758057 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001758057 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001758057 us-gaap:TreasuryStockCommonMember 2022-12-31 0001758057 us-gaap:RetainedEarningsMember 2022-12-31 0001758057 lazr:FreedomPhotonicsMember 2021-01-01 2021-12-31 0001758057 lazr:FreedomPhotonicsMember 2020-01-01 2020-12-31 0001758057 lazr:SolficeMember 2021-01-01 2021-12-31 0001758057 lazr:SolficeMember 2020-01-01 2020-12-31 0001758057 lazr:SeriesXConvertiblePreferredStockMember 2022-01-01 2022-12-31 0001758057 lazr:SeriesXConvertiblePreferredStockMember 2021-01-01 2021-12-31 0001758057 us-gaap:AccountingStandardsUpdate201602Member 2022-01-01 2022-12-31 0001758057 us-gaap:AccountingStandardsUpdate201602Member 2021-01-01 2021-12-31 0001758057 us-gaap:AccountingStandardsUpdate201602Member 2020-01-01 2020-12-31 0001758057 us-gaap:IPOMember lazr:GoresMetropoulosMember 2019-02-05 0001758057 lazr:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001758057 lazr:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001758057 lazr:CustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001758057 lazr:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001758057 lazr:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001758057 srt:MinimumMember us-gaap:OtherMachineryAndEquipmentMember 2022-01-01 2022-12-31 0001758057 srt:MaximumMember us-gaap:OtherMachineryAndEquipmentMember 2022-01-01 2022-12-31 0001758057 srt:MinimumMember lazr:ComputerHardwareAndSoftwareMember 2022-01-01 2022-12-31 0001758057 srt:MaximumMember lazr:ComputerHardwareAndSoftwareMember 2022-01-01 2022-12-31 0001758057 srt:MinimumMember lazr:DemonstrationFleetAndDemonstrationUnitsMember 2022-01-01 2022-12-31 0001758057 srt:MaximumMember lazr:DemonstrationFleetAndDemonstrationUnitsMember 2022-01-01 2022-12-31 0001758057 us-gaap:VehiclesMember 2022-01-01 2022-12-31 0001758057 us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-12-31 0001758057 srt:MinimumMember lazr:ToolingMember 2022-01-01 2022-12-31 0001758057 srt:MaximumMember lazr:ToolingMember 2022-01-01 2022-12-31 0001758057 lazr:ToolingMember 2022-12-31 0001758057 lazr:ToolingMember 2021-12-31 0001758057 srt:MinimumMember 2022-01-01 2022-12-31 0001758057 srt:MaximumMember 2022-01-01 2022-12-31 0001758057 us-gaap:IPOMember lazr:GoresMetropoulosMember 2019-02-05 2019-02-05 0001758057 lazr:PublicWarrantsMember us-gaap:CommonClassAMember lazr:GoresMetropoulosMember 2019-02-05 0001758057 lazr:PrivateWarrantsMember us-gaap:PrivatePlacementMember lazr:GoresMetropoulosMember 2019-02-05 2019-02-05 0001758057 lazr:PrivateWarrantsMember us-gaap:PrivatePlacementMember lazr:GoresMetropoulosMember 2019-02-05 0001758057 lazr:PrivateWarrantsMember us-gaap:CommonClassAMember lazr:GoresMetropoulosMember 2019-02-05 0001758057 lazr:PublicWarrantsMember 2020-12-31 0001758057 lazr:PrivateWarrantsMember 2020-12-31 0001758057 lazr:PrivateWarrantsMember 2021-03-31 0001758057 lazr:PublicWarrantsMember 2021-03-31 0001758057 lazr:PrivateAndPublicWarrantsMember 2021-03-01 2021-03-31 0001758057 lazr:PublicWarrantsMember 2021-03-01 2021-03-31 0001758057 lazr:PrivateWarrantsMember 2021-12-31 0001758057 lazr:PublicWarrantsMember 2021-12-31 0001758057 lazr:PrivateWarrantsMember 2022-01-31 0001758057 lazr:PrivateWarrantsMember 2022-04-30 0001758057 lazr:PrivateWarrantsMember 2022-01-01 2022-01-31 0001758057 lazr:PrivateWarrantsMember 2022-04-01 2022-04-30 0001758057 lazr:PrivateWarrantsMember 2022-12-31 0001758057 lazr:FreedomPhotonicsMember 2022-04-13 2022-04-13 0001758057 lazr:FreedomPhotonicsMember 2022-04-13 0001758057 srt:MaximumMember lazr:FreedomPhotonicsMember lazr:CustomerBacklogMember 2022-04-13 2022-04-13 0001758057 lazr:FreedomPhotonicsMember lazr:CustomerBacklogMember 2022-04-13 0001758057 lazr:FreedomPhotonicsMember us-gaap:CustomerRelationshipsMember 2022-04-13 2022-04-13 0001758057 lazr:FreedomPhotonicsMember us-gaap:CustomerRelationshipsMember 2022-04-13 0001758057 lazr:FreedomPhotonicsMember us-gaap:DevelopedTechnologyRightsMember 2022-04-13 2022-04-13 0001758057 lazr:FreedomPhotonicsMember us-gaap:DevelopedTechnologyRightsMember 2022-04-13 0001758057 lazr:FreedomPhotonicsMember us-gaap:InProcessResearchAndDevelopmentMember 2022-04-13 0001758057 lazr:FreedomPhotonicsMember us-gaap:TradeNamesMember 2022-04-13 2022-04-13 0001758057 lazr:FreedomPhotonicsMember us-gaap:TradeNamesMember 2022-04-13 0001758057 us-gaap:AcquisitionRelatedCostsMember 2022-01-01 2022-12-31 0001758057 us-gaap:AcquisitionRelatedCostsMember 2021-01-01 2021-12-31 0001758057 lazr:StockBasedCompensationCostsMember 2022-01-01 2022-12-31 0001758057 lazr:StockBasedCompensationCostsMember 2021-01-01 2021-12-31 0001758057 us-gaap:AcquisitionRelatedCostsMember 2021-03-31 0001758057 lazr:SolficeMember 2022-06-15 2022-06-15 0001758057 lazr:OptogrationIncMember 2021-08-03 2021-08-03 0001758057 lazr:OptogrationMilestoneAwardsMember us-gaap:CommonClassAMember 2022-08-01 2022-08-31 0001758057 lazr:OptogrationMilestoneAwardsMember us-gaap:CommonClassAMember 2022-12-31 0001758057 lazr:OptogrationIncMember 2021-08-03 0001758057 lazr:OptogrationIncMember us-gaap:CustomerRelationshipsMember 2021-08-03 2021-08-03 0001758057 lazr:OptogrationIncMember us-gaap:CustomerRelationshipsMember 2021-12-31 0001758057 lazr:OptogrationIncMember us-gaap:TradeNamesMember 2021-08-03 2021-08-03 0001758057 lazr:OptogrationIncMember us-gaap:TradeNamesMember 2021-12-31 0001758057 lazr:OptogrationIncMember us-gaap:DevelopedTechnologyRightsMember 2021-08-03 2021-08-03 0001758057 lazr:OptogrationIncMember us-gaap:DevelopedTechnologyRightsMember 2021-12-31 0001758057 2020-12-02 0001758057 us-gaap:CommonClassAMember 2020-12-02 0001758057 us-gaap:CommonClassBMember 2020-12-02 0001758057 us-gaap:CommonClassAMember 2020-12-02 2020-12-02 0001758057 lazr:GoresMetropoulosMember 2020-12-02 2020-12-02 0001758057 lazr:GoresMetropoulosMember 2020-12-02 0001758057 srt:MinimumMember us-gaap:CommonClassAMember 2020-12-02 0001758057 srt:MaximumMember us-gaap:CommonClassAMember 2020-12-02 0001758057 lazr:GoresMetropoulosMember 2021-08-11 2021-08-11 0001758057 lazr:GoresMetropoulosMember us-gaap:CommonClassAMember 2021-08-11 2021-08-11 0001758057 lazr:GoresMetropoulosMember us-gaap:CommonClassBMember 2021-08-11 2021-08-11 0001758057 lazr:GoresMetropoulosMember 2021-08-11 0001758057 lazr:GoresMetropoulosMember us-gaap:CommonClassAMember lazr:SharePriceTriggeringEventOneMember 2021-08-11 0001758057 lazr:GoresMetropoulosMember us-gaap:CommonClassAMember lazr:SharePriceTriggeringEventTwoMember 2021-08-11 0001758057 lazr:GoresMetropoulosMember us-gaap:CommonClassAMember lazr:SharePriceTriggeringEventThreeMember 2021-08-11 0001758057 lazr:GoresMetropoulosMember us-gaap:CommonClassAMember lazr:SharePriceTriggeringEventFourMember 2021-08-11 0001758057 lazr:GoresMetropoulosMember us-gaap:CommonClassAMember lazr:SharePriceTriggeringEventFiveMember 2021-08-11 0001758057 lazr:GoresMetropoulosMember us-gaap:CommonClassAMember lazr:SharePriceTriggeringEventSixMember 2021-08-11 0001758057 2020-12-02 2020-12-02 0001758057 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2020-12-02 0001758057 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember 2020-12-02 0001758057 lazr:GoresMetropoulosMember lazr:PrivateAndPublicWarrantsMember 2020-12-02 0001758057 lazr:GoresMetropoulosMember us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-12-02 2020-12-02 0001758057 srt:NorthAmericaMember 2022-01-01 2022-12-31 0001758057 srt:NorthAmericaMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2022-01-01 2022-12-31 0001758057 srt:NorthAmericaMember 2021-01-01 2021-12-31 0001758057 srt:NorthAmericaMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-12-31 0001758057 srt:NorthAmericaMember 2020-01-01 2020-12-31 0001758057 srt:NorthAmericaMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2020-01-01 2020-12-31 0001758057 srt:AsiaPacificMember 2022-01-01 2022-12-31 0001758057 srt:AsiaPacificMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2022-01-01 2022-12-31 0001758057 srt:AsiaPacificMember 2021-01-01 2021-12-31 0001758057 srt:AsiaPacificMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-12-31 0001758057 srt:AsiaPacificMember 2020-01-01 2020-12-31 0001758057 srt:AsiaPacificMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2020-01-01 2020-12-31 0001758057 lazr:EuropeAndMiddleEastMember 2022-01-01 2022-12-31 0001758057 lazr:EuropeAndMiddleEastMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2022-01-01 2022-12-31 0001758057 lazr:EuropeAndMiddleEastMember 2021-01-01 2021-12-31 0001758057 lazr:EuropeAndMiddleEastMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-12-31 0001758057 lazr:EuropeAndMiddleEastMember 2020-01-01 2020-12-31 0001758057 lazr:EuropeAndMiddleEastMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2020-01-01 2020-12-31 0001758057 us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2022-01-01 2022-12-31 0001758057 us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-12-31 0001758057 us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2020-01-01 2020-12-31 0001758057 us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-12-31 0001758057 us-gaap:RevenueFromContractWithCustomerMember lazr:RevenueRecognitionTimingConcentrationRiskMember us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-12-31 0001758057 us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-12-31 0001758057 us-gaap:RevenueFromContractWithCustomerMember lazr:RevenueRecognitionTimingConcentrationRiskMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-12-31 0001758057 us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-12-31 0001758057 us-gaap:RevenueFromContractWithCustomerMember lazr:RevenueRecognitionTimingConcentrationRiskMember us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-12-31 0001758057 us-gaap:TransferredOverTimeMember 2022-01-01 2022-12-31 0001758057 us-gaap:RevenueFromContractWithCustomerMember lazr:RevenueRecognitionTimingConcentrationRiskMember us-gaap:TransferredOverTimeMember 2022-01-01 2022-12-31 0001758057 us-gaap:TransferredOverTimeMember 2021-01-01 2021-12-31 0001758057 us-gaap:RevenueFromContractWithCustomerMember lazr:RevenueRecognitionTimingConcentrationRiskMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-12-31 0001758057 us-gaap:TransferredOverTimeMember 2020-01-01 2020-12-31 0001758057 us-gaap:RevenueFromContractWithCustomerMember lazr:RevenueRecognitionTimingConcentrationRiskMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-12-31 0001758057 us-gaap:RevenueFromContractWithCustomerMember lazr:RevenueRecognitionTimingConcentrationRiskMember 2022-01-01 2022-12-31 0001758057 us-gaap:RevenueFromContractWithCustomerMember lazr:RevenueRecognitionTimingConcentrationRiskMember 2021-01-01 2021-12-31 0001758057 us-gaap:RevenueFromContractWithCustomerMember lazr:RevenueRecognitionTimingConcentrationRiskMember 2020-01-01 2020-12-31 0001758057 lazr:AutonomySolutionsSegmentMember 2022-01-01 2022-12-31 0001758057 us-gaap:RevenueFromContractWithCustomerMember lazr:SegmentConcentrationRiskMember lazr:AutonomySolutionsSegmentMember 2022-01-01 2022-12-31 0001758057 lazr:AutonomySolutionsSegmentMember 2021-01-01 2021-12-31 0001758057 us-gaap:RevenueFromContractWithCustomerMember lazr:SegmentConcentrationRiskMember lazr:AutonomySolutionsSegmentMember 2021-01-01 2021-12-31 0001758057 lazr:AutonomySolutionsSegmentMember 2020-01-01 2020-12-31 0001758057 us-gaap:RevenueFromContractWithCustomerMember lazr:SegmentConcentrationRiskMember lazr:AutonomySolutionsSegmentMember 2020-01-01 2020-12-31 0001758057 lazr:AdvancedTechnologiesAndServicesSegmentMember 2022-01-01 2022-12-31 0001758057 us-gaap:RevenueFromContractWithCustomerMember lazr:SegmentConcentrationRiskMember lazr:AdvancedTechnologiesAndServicesSegmentMember 2022-01-01 2022-12-31 0001758057 lazr:AdvancedTechnologiesAndServicesSegmentMember 2021-01-01 2021-12-31 0001758057 us-gaap:RevenueFromContractWithCustomerMember lazr:SegmentConcentrationRiskMember lazr:AdvancedTechnologiesAndServicesSegmentMember 2021-01-01 2021-12-31 0001758057 lazr:AdvancedTechnologiesAndServicesSegmentMember 2020-01-01 2020-12-31 0001758057 us-gaap:RevenueFromContractWithCustomerMember lazr:SegmentConcentrationRiskMember lazr:AdvancedTechnologiesAndServicesSegmentMember 2020-01-01 2020-12-31 0001758057 us-gaap:RevenueFromContractWithCustomerMember lazr:SegmentConcentrationRiskMember 2022-01-01 2022-12-31 0001758057 us-gaap:RevenueFromContractWithCustomerMember lazr:SegmentConcentrationRiskMember 2021-01-01 2021-12-31 0001758057 us-gaap:RevenueFromContractWithCustomerMember lazr:SegmentConcentrationRiskMember 2020-01-01 2020-12-31 0001758057 lazr:VolvoCarTechnologyFundWarrantMember us-gaap:CommonClassAMember 2020-03-31 0001758057 lazr:VolvoCarTechnologyFundWarrantMember 2020-03-31 0001758057 lazr:VolvoCarTechnologyFundWarrantMember 2021-01-01 2021-12-31 0001758057 2023-01-01 2022-12-31 0001758057 us-gaap:USTreasurySecuritiesMember 2022-12-31 0001758057 us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2022-12-31 0001758057 us-gaap:CommercialPaperMember 2022-12-31 0001758057 us-gaap:CorporateBondSecuritiesMember 2022-12-31 0001758057 us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001758057 lazr:MarketableSecuritiesMember 2022-12-31 0001758057 us-gaap:USTreasurySecuritiesMember 2021-12-31 0001758057 us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2021-12-31 0001758057 us-gaap:CommercialPaperMember 2021-12-31 0001758057 us-gaap:CorporateBondSecuritiesMember 2021-12-31 0001758057 us-gaap:AssetBackedSecuritiesMember 2021-12-31 0001758057 us-gaap:CashAndCashEquivalentsMember 2021-12-31 0001758057 lazr:MarketableSecuritiesMember 2021-12-31 0001758057 us-gaap:CashAndCashEquivalentsMember us-gaap:MoneyMarketFundsMember 2022-12-31 0001758057 us-gaap:CashAndCashEquivalentsMember us-gaap:MoneyMarketFundsMember 2021-12-31 0001758057 lazr:MarketableSecuritiesMember us-gaap:EquityMethodInvestmentsMember 2022-12-31 0001758057 lazr:MarketableSecuritiesMember us-gaap:EquityMethodInvestmentsMember 2021-12-31 0001758057 us-gaap:OtherNoncurrentAssetsMember lazr:NonMarketableEquityInvestmentMember 2022-12-31 0001758057 us-gaap:OtherNoncurrentAssetsMember lazr:NonMarketableEquityInvestmentMember 2021-12-31 0001758057 lazr:RoboticResearchOpCoLLCMember lazr:ClassAPreferredUnitsMember 2021-12-01 2021-12-31 0001758057 lazr:RoboticResearchOpCoLLCMember us-gaap:CommonClassAMember 2021-12-01 2021-12-31 0001758057 lazr:RoboticResearchOpCoLLCMember 2021-12-31 0001758057 lazr:RoboticResearchOpCoLLCMember 2022-10-01 2022-12-31 0001758057 lazr:ECARXHoldingsIncMember lazr:ClassAPreferredUnitsMember 2022-12-01 2022-12-31 0001758057 lazr:ECARXHoldingsIncMember us-gaap:CommonClassAMember 2022-12-01 2022-12-31 0001758057 lazr:ECARXHoldingsIncMember 2022-12-31 0001758057 us-gaap:MachineryAndEquipmentMember 2022-12-31 0001758057 us-gaap:MachineryAndEquipmentMember 2021-12-31 0001758057 lazr:ComputerHardwareAndSoftwareMember 2022-12-31 0001758057 lazr:ComputerHardwareAndSoftwareMember 2021-12-31 0001758057 us-gaap:LandMember 2022-12-31 0001758057 us-gaap:LandMember 2021-12-31 0001758057 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001758057 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001758057 us-gaap:VehiclesMember 2022-12-31 0001758057 us-gaap:VehiclesMember 2021-12-31 0001758057 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001758057 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001758057 us-gaap:ConstructionInProgressMember 2022-12-31 0001758057 us-gaap:ConstructionInProgressMember 2021-12-31 0001758057 2022-01-01 2022-03-31 0001758057 lazr:OptogrationIncMember us-gaap:CustomerRelationshipsMember 2022-12-31 0001758057 lazr:OptogrationIncMember us-gaap:CustomerRelationshipsMember 2022-01-01 2022-12-31 0001758057 lazr:OptogrationIncMember us-gaap:CustomerRelationshipsMember 2021-01-01 2021-12-31 0001758057 lazr:OptogrationIncMember lazr:CustomerBacklogMember 2022-12-31 0001758057 lazr:OptogrationIncMember lazr:CustomerBacklogMember 2022-01-01 2022-12-31 0001758057 lazr:OptogrationIncMember lazr:CustomerBacklogMember 2021-12-31 0001758057 lazr:OptogrationIncMember us-gaap:TradeNamesMember 2022-12-31 0001758057 lazr:OptogrationIncMember us-gaap:TradeNamesMember 2022-01-01 2022-12-31 0001758057 lazr:OptogrationIncMember lazr:AssembledWorkforceMember 2022-12-31 0001758057 lazr:OptogrationIncMember lazr:AssembledWorkforceMember 2021-12-31 0001758057 lazr:OptogrationIncMember us-gaap:DevelopedTechnologyRightsMember 2022-12-31 0001758057 lazr:OptogrationIncMember us-gaap:DevelopedTechnologyRightsMember 2022-01-01 2022-12-31 0001758057 lazr:OptogrationIncMember us-gaap:DevelopedTechnologyRightsMember 2021-01-01 2021-12-31 0001758057 lazr:OptogrationIncMember us-gaap:InProcessResearchAndDevelopmentMember 2022-12-31 0001758057 lazr:OptogrationIncMember us-gaap:InProcessResearchAndDevelopmentMember 2021-12-31 0001758057 lazr:OptogrationIncMember 2022-12-31 0001758057 lazr:OptogrationIncMember 2022-01-01 2022-12-31 0001758057 lazr:OptogrationIncMember 2021-12-31 0001758057 lazr:OptogrationIncMember 2020-01-01 2020-12-31 0001758057 lazr:AutonomySolutionsSegmentMember 2021-12-31 0001758057 lazr:AdvancedTechnologiesAndServicesSegmentMember 2021-12-31 0001758057 lazr:FreedomPhotonicsMember lazr:AutonomySolutionsSegmentMember 2022-01-01 2022-12-31 0001758057 lazr:FreedomPhotonicsMember lazr:AdvancedTechnologiesAndServicesSegmentMember 2022-01-01 2022-12-31 0001758057 lazr:AutonomySolutionsSegmentMember 2022-12-31 0001758057 lazr:AdvancedTechnologiesAndServicesSegmentMember 2022-12-31 0001758057 lazr:ConvertibleSeniorNotesDue2026Member us-gaap:ConvertibleDebtMember 2021-12-31 0001758057 lazr:ConvertibleSeniorNotesDue2026Member us-gaap:ConvertibleDebtMember 2021-12-01 2021-12-31 0001758057 lazr:ConvertibleSeniorNotesDue2026Member us-gaap:ConvertibleDebtMember 2021-01-01 2021-12-31 0001758057 lazr:ConvertibleSeniorNotesDue2026Member us-gaap:ConvertibleDebtMember us-gaap:CommonClassAMember 2021-12-31 0001758057 lazr:ConvertibleSeniorNotesDue2026Member us-gaap:DebtInstrumentRedemptionPeriodOneMember us-gaap:ConvertibleDebtMember us-gaap:CommonClassAMember 2021-12-01 2021-12-31 0001758057 lazr:ConvertibleSeniorNotesDue2026Member us-gaap:DebtInstrumentRedemptionPeriodOneMember us-gaap:ConvertibleDebtMember 2021-12-01 2021-12-31 0001758057 lazr:ConvertibleSeniorNotesDue2026Member us-gaap:DebtInstrumentRedemptionPeriodTwoMember us-gaap:ConvertibleDebtMember 2021-12-01 2021-12-31 0001758057 lazr:ConvertibleSeniorNotesDue2026Member us-gaap:DebtInstrumentRedemptionPeriodThreeMember us-gaap:ConvertibleDebtMember 2021-12-01 2021-12-31 0001758057 lazr:ConvertibleSeniorNotesDue2026Member us-gaap:ConvertibleDebtMember 2022-12-31 0001758057 lazr:ConvertibleSeniorNotesDue2026Member us-gaap:ConvertibleDebtMember 2022-01-01 2022-12-31 0001758057 us-gaap:SeniorNotesMember 2020-01-01 2020-12-31 0001758057 lazr:A20172018And2020WarrantsMember 2020-01-01 2020-12-31 0001758057 lazr:A20172018And2020WarrantsMember 2020-12-31 0001758057 lazr:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember 2022-12-31 0001758057 lazr:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0001758057 lazr:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001758057 lazr:PrivateWarrantsMember us-gaap:WarrantMember 2021-12-31 0001758057 lazr:PrivateWarrantsMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001758057 lazr:PrivateWarrantsMember us-gaap:WarrantMember 2022-12-31 0001758057 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001758057 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001758057 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001758057 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001758057 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001758057 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001758057 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001758057 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001758057 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2022-12-31 0001758057 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2022-12-31 0001758057 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2022-12-31 0001758057 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2022-12-31 0001758057 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2022-12-31 0001758057 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2022-12-31 0001758057 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2022-12-31 0001758057 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2022-12-31 0001758057 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2022-12-31 0001758057 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2022-12-31 0001758057 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2022-12-31 0001758057 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2022-12-31 0001758057 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateBondSecuritiesMember 2022-12-31 0001758057 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateBondSecuritiesMember 2022-12-31 0001758057 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateBondSecuritiesMember 2022-12-31 0001758057 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateBondSecuritiesMember 2022-12-31 0001758057 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001758057 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001758057 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001758057 us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001758057 lazr:PrivateWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001758057 lazr:PrivateWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001758057 lazr:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001758057 lazr:PrivateWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001758057 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001758057 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001758057 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001758057 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001758057 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001758057 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001758057 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001758057 us-gaap:CommercialPaperMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001758057 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001758057 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001758057 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001758057 us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001758057 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2021-12-31 0001758057 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2021-12-31 0001758057 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2021-12-31 0001758057 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2021-12-31 0001758057 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2021-12-31 0001758057 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2021-12-31 0001758057 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2021-12-31 0001758057 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2021-12-31 0001758057 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2021-12-31 0001758057 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2021-12-31 0001758057 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2021-12-31 0001758057 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2021-12-31 0001758057 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateBondSecuritiesMember 2021-12-31 0001758057 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateBondSecuritiesMember 2021-12-31 0001758057 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateBondSecuritiesMember 2021-12-31 0001758057 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateBondSecuritiesMember 2021-12-31 0001758057 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2021-12-31 0001758057 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2021-12-31 0001758057 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2021-12-31 0001758057 us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2021-12-31 0001758057 lazr:PrivateWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001758057 lazr:PrivateWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001758057 lazr:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001758057 lazr:PrivateWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001758057 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001758057 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001758057 lazr:SeriesAConvertiblePreferredStockMember 2019-06-24 0001758057 lazr:SeriesXConvertiblePreferredStockMember 2020-08-01 2020-09-30 0001758057 lazr:SeriesXConvertiblePreferredStockMember 2020-09-30 0001758057 lazr:SeriesXConvertiblePreferredStockMember 2020-10-01 2020-10-31 0001758057 lazr:SeriesXConvertiblePreferredStockMember 2020-10-31 0001758057 lazr:SeriesAAndSeriesXConvertiblePreferredStockMember 2020-12-02 2020-12-02 0001758057 2019-06-24 2020-12-02 0001758057 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001758057 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001758057 us-gaap:WarrantMember 2020-01-01 2020-12-31 0001758057 lazr:ShareBasedPaymentArrangementEquityClassifiedAwardsMember 2022-01-01 2022-12-31 0001758057 lazr:ShareBasedPaymentArrangementEquityClassifiedAwardsMember 2021-01-01 2021-12-31 0001758057 lazr:ShareBasedPaymentArrangementEquityClassifiedAwardsMember 2020-01-01 2020-12-31 0001758057 lazr:ShareBasedPaymentArrangementLiabilityClassifiedAwardsMember 2022-01-01 2022-12-31 0001758057 lazr:ShareBasedPaymentArrangementLiabilityClassifiedAwardsMember 2021-01-01 2021-12-31 0001758057 lazr:ShareBasedPaymentArrangementLiabilityClassifiedAwardsMember 2020-01-01 2020-12-31 0001758057 lazr:VendorStockInLieuOfCashProgramMember 2022-01-01 2022-12-31 0001758057 lazr:VendorStockInLieuOfCashProgramMember 2021-01-01 2021-12-31 0001758057 lazr:VendorStockInLieuOfCashProgramMember 2020-01-01 2020-12-31 0001758057 us-gaap:ConvertibleDebtSecuritiesMember 2022-01-01 2022-12-31 0001758057 us-gaap:ConvertibleDebtSecuritiesMember 2021-01-01 2021-12-31 0001758057 us-gaap:ConvertibleDebtSecuritiesMember 2020-01-01 2020-12-31 0001758057 lazr:EarnOutSharesMember 2022-01-01 2022-12-31 0001758057 lazr:EarnOutSharesMember 2021-01-01 2021-12-31 0001758057 lazr:EarnOutSharesMember 2020-01-01 2020-12-31 0001758057 us-gaap:ConvertibleDebtSecuritiesMember 2022-12-31 0001758057 us-gaap:CommonClassAMember 2021-01-01 2021-12-31 0001758057 us-gaap:CommonClassBMember 2021-01-01 2021-12-31 0001758057 us-gaap:CommonStockMember 2021-07-01 0001758057 us-gaap:CommonStockMember 2021-12-21 0001758057 srt:ChiefExecutiveOfficerMember lazr:GoresMetropoulosMember us-gaap:PreferredStockMember 2020-12-02 2020-12-02 0001758057 srt:ChiefExecutiveOfficerMember lazr:GoresMetropoulosMember us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-12-02 2020-12-02 0001758057 srt:ChiefExecutiveOfficerMember lazr:GoresMetropoulosMember us-gaap:CommonClassAMember 2020-12-02 0001758057 srt:ChiefExecutiveOfficerMember lazr:GoresMetropoulosMember us-gaap:CommonClassBMember 2020-12-02 0001758057 srt:ChiefExecutiveOfficerMember lazr:GoresMetropoulosMember 2020-12-02 2020-12-02 0001758057 us-gaap:CommonClassAMember 2021-10-01 2021-12-31 0001758057 us-gaap:CommonClassAMember 2022-01-01 2022-03-31 0001758057 us-gaap:CommonClassAMember 2022-04-01 2022-06-30 0001758057 us-gaap:PreferredStockMember 2015-12-31 0001758057 lazr:DaimlerNorthAmericaCorporationMember us-gaap:CommonClassAMember 2021-11-01 2021-11-30 0001758057 us-gaap:ResearchAndDevelopmentExpenseMember lazr:DaimlerNorthAmericaCorporationMember 2022-01-01 2022-12-31 0001758057 lazr:DaimlerNorthAmericaCorporationMember us-gaap:CommonClassAMember 2022-01-01 2022-12-31 0001758057 lazr:DaimlerNorthAmericaCorporationMember 2022-12-31 0001758057 lazr:VendorStockInLieuOfCashProgramMember 2021-12-31 0001758057 lazr:VendorStockInLieuOfCashProgramMember 2022-12-31 0001758057 lazr:A2020PlanMember 2022-12-31 0001758057 lazr:Amended2020PlanMember 2022-06-01 2022-06-30 0001758057 lazr:Amended2020PlanMember us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2023-01-01 2023-01-01 0001758057 us-gaap:EmployeeStockOptionMember lazr:A2015PlanMember 2022-01-01 2022-12-31 0001758057 us-gaap:EmployeeStockOptionMember lazr:A2015PlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2022-01-01 2022-12-31 0001758057 us-gaap:EmployeeStockOptionMember lazr:A2015PlanMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2022-01-01 2022-12-31 0001758057 us-gaap:EmployeeStockOptionMember lazr:A2015PlanMember 2021-01-01 2021-12-31 0001758057 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001758057 us-gaap:RestrictedStockMember us-gaap:ShareBasedPaymentArrangementEmployeeMember 2019-01-01 2019-06-30 0001758057 us-gaap:RestrictedStockMember us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2019-01-01 2019-06-30 0001758057 us-gaap:RestrictedStockMember us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2019-01-01 2019-06-30 0001758057 us-gaap:RestrictedStockMember us-gaap:ShareBasedPaymentArrangementEmployeeMember 2019-07-01 2022-12-31 0001758057 us-gaap:RestrictedStockMember us-gaap:ShareBasedPaymentArrangementEmployeeMember 2021-12-31 0001758057 us-gaap:RestrictedStockMember us-gaap:ShareBasedPaymentArrangementEmployeeMember 2022-01-01 2022-12-31 0001758057 us-gaap:RestrictedStockMember us-gaap:ShareBasedPaymentArrangementEmployeeMember 2022-12-31 0001758057 us-gaap:RestrictedStockMember us-gaap:ShareBasedPaymentArrangementEmployeeMember 2021-01-01 2021-12-31 0001758057 us-gaap:RestrictedStockMember us-gaap:ShareBasedPaymentArrangementEmployeeMember 2020-01-01 2020-12-31 0001758057 srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001758057 us-gaap:RestrictedStockMember us-gaap:ShareBasedPaymentArrangementNonemployeeMember 2021-12-31 0001758057 us-gaap:RestrictedStockMember us-gaap:ShareBasedPaymentArrangementNonemployeeMember 2022-01-01 2022-12-31 0001758057 us-gaap:RestrictedStockMember us-gaap:ShareBasedPaymentArrangementNonemployeeMember 2022-12-31 0001758057 us-gaap:RestrictedStockMember us-gaap:ShareBasedPaymentArrangementNonemployeeMember 2021-01-01 2021-12-31 0001758057 lazr:FixedValueEquityAwardsMember us-gaap:ShareBasedPaymentArrangementEmployeeMember lazr:A2020PlanMember 2022-01-01 2022-12-31 0001758057 us-gaap:EmployeeStockMember 2020-12-31 0001758057 us-gaap:CommonClassAMember us-gaap:EmployeeStockMember 2020-12-01 2020-12-31 0001758057 us-gaap:EmployeeStockMember 2020-12-01 2020-12-31 0001758057 us-gaap:EmployeeStockMember 2022-01-01 2022-12-31 0001758057 us-gaap:EmployeeStockMember 2022-05-16 2022-05-16 0001758057 us-gaap:EmployeeStockMember 2022-11-16 2022-11-16 0001758057 lazr:OptogrationMilestoneAwardsMember 2021-08-03 2021-08-03 0001758057 lazr:OptogrationMilestoneAwardsMember 2021-08-01 2022-12-31 0001758057 lazr:FreedomPhotonicsAwardsMember 2022-04-01 2022-04-30 0001758057 lazr:FreedomPhotonicsAwardsMember 2022-01-01 2022-12-31 0001758057 lazr:SolficeAwardsMember 2022-06-01 2022-06-30 0001758057 lazr:SolficeAwardsMember 2022-01-01 2022-12-31 0001758057 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2022-05-02 2022-05-02 0001758057 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2022-08-19 2022-08-19 0001758057 lazr:ChiefLegalOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2022-08-19 2022-08-19 0001758057 srt:ExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001758057 srt:ExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember lazr:MarketOneMemberMember 2022-01-01 2022-12-31 0001758057 srt:ExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember lazr:MarketTwoMemberMember 2022-01-01 2022-12-31 0001758057 srt:ExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember lazr:MarketThreeMemberMember 2022-01-01 2022-12-31 0001758057 srt:ExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001758057 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001758057 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001758057 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0001758057 lazr:RestrictedStockAwardsMember 2022-01-01 2022-12-31 0001758057 lazr:RestrictedStockAwardsMember 2021-01-01 2021-12-31 0001758057 lazr:RestrictedStockAwardsMember 2020-01-01 2020-12-31 0001758057 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001758057 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001758057 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0001758057 us-gaap:EmployeeStockMember 2022-01-01 2022-12-31 0001758057 us-gaap:EmployeeStockMember 2021-01-01 2021-12-31 0001758057 us-gaap:EmployeeStockMember 2020-01-01 2020-12-31 0001758057 lazr:FixedValueEquityAwardsMember 2022-01-01 2022-12-31 0001758057 lazr:FixedValueEquityAwardsMember 2021-01-01 2021-12-31 0001758057 lazr:FixedValueEquityAwardsMember 2020-01-01 2020-12-31 0001758057 lazr:OptogrationAwardsMember 2022-01-01 2022-12-31 0001758057 lazr:OptogrationAwardsMember 2021-01-01 2021-12-31 0001758057 lazr:OptogrationAwardsMember 2020-01-01 2020-12-31 0001758057 lazr:FreedomPhotonicsAwardsMember 2022-01-01 2022-12-31 0001758057 lazr:FreedomPhotonicsAwardsMember 2021-01-01 2021-12-31 0001758057 lazr:FreedomPhotonicsAwardsMember 2020-01-01 2020-12-31 0001758057 lazr:SolficeAwardsMember 2022-01-01 2022-12-31 0001758057 lazr:SolficeAwardsMember 2021-01-01 2021-12-31 0001758057 lazr:SolficeAwardsMember 2020-01-01 2020-12-31 0001758057 lazr:OtherAwardsMember 2022-01-01 2022-12-31 0001758057 lazr:OtherAwardsMember 2021-01-01 2021-12-31 0001758057 lazr:OtherAwardsMember 2020-01-01 2020-12-31 0001758057 us-gaap:CostOfSalesMember 2022-01-01 2022-12-31 0001758057 us-gaap:CostOfSalesMember 2021-01-01 2021-12-31 0001758057 us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0001758057 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-12-31 0001758057 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-12-31 0001758057 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-12-31 0001758057 us-gaap:SellingAndMarketingExpenseMember 2022-01-01 2022-12-31 0001758057 us-gaap:SellingAndMarketingExpenseMember 2021-01-01 2021-12-31 0001758057 us-gaap:SellingAndMarketingExpenseMember 2020-01-01 2020-12-31 0001758057 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-12-31 0001758057 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-12-31 0001758057 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-12-31 0001758057 us-gaap:EmployeeStockOptionMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2022-01-01 2022-12-31 0001758057 us-gaap:RestrictedStockMember us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2021-01-01 2021-06-30 0001758057 lazr:FixedValueEquityAwardsMember us-gaap:ShareBasedPaymentArrangementEmployeeMember lazr:A2020PlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2022-01-01 2022-12-31 0001758057 lazr:FixedValueEquityAwardsMember us-gaap:ShareBasedPaymentArrangementEmployeeMember lazr:A2020PlanMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2022-01-01 2022-12-31 0001758057 lazr:FixedValueEquityAwardsMember us-gaap:ShareBasedPaymentArrangementEmployeeMember lazr:A2020PlanMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2022-01-01 2022-12-31 0001758057 lazr:FixedValueEquityAwardsMember us-gaap:ShareBasedPaymentArrangementEmployeeMember lazr:A2020PlanMember lazr:ShareBasedPaymentArrangementTrancheFourMember 2022-01-01 2022-12-31 0001758057 2021-10-31 0001758057 2022-09-30 0001758057 srt:MinimumMember 2022-12-31 0001758057 srt:MaximumMember 2022-12-31 0001758057 us-gaap:AccountingStandardsUpdate201602Member 2021-01-01 0001758057 us-gaap:DomesticCountryMember 2022-12-31 0001758057 us-gaap:StateAndLocalJurisdictionMember 2022-12-31 0001758057 us-gaap:DomesticCountryMember us-gaap:ResearchMember 2022-12-31 0001758057 us-gaap:StateAndLocalJurisdictionMember us-gaap:ResearchMember 2022-12-31 0001758057 us-gaap:DomesticCountryMember 2022-01-01 2022-12-31 0001758057 us-gaap:ForeignCountryMember 2022-01-01 2022-12-31 0001758057 us-gaap:DomesticCountryMember 2022-01-01 0001758057 us-gaap:ForeignCountryMember 2022-01-01 0001758057 2022-01-01 0001758057 us-gaap:IntersegmentEliminationMember lazr:AutonomySolutionsSegmentMember 2022-01-01 2022-12-31 0001758057 us-gaap:IntersegmentEliminationMember lazr:AdvancedTechnologiesAndServicesSegmentMember 2022-01-01 2022-12-31 0001758057 us-gaap:IntersegmentEliminationMember 2022-01-01 2022-12-31 0001758057 us-gaap:OperatingSegmentsMember lazr:AutonomySolutionsSegmentMember 2022-01-01 2022-12-31 0001758057 us-gaap:OperatingSegmentsMember lazr:AdvancedTechnologiesAndServicesSegmentMember 2022-01-01 2022-12-31 0001758057 us-gaap:OperatingSegmentsMember 2022-01-01 2022-12-31 0001758057 us-gaap:OperatingSegmentsMember lazr:AutonomySolutionsSegmentMember 2022-12-31 0001758057 us-gaap:OperatingSegmentsMember lazr:AdvancedTechnologiesAndServicesSegmentMember 2022-12-31 0001758057 us-gaap:OperatingSegmentsMember 2022-12-31 0001758057 us-gaap:IntersegmentEliminationMember 2022-12-31 0001758057 us-gaap:IntersegmentEliminationMember lazr:AutonomySolutionsSegmentMember 2021-01-01 2021-12-31 0001758057 us-gaap:IntersegmentEliminationMember lazr:AdvancedTechnologiesAndServicesSegmentMember 2021-01-01 2021-12-31 0001758057 us-gaap:IntersegmentEliminationMember 2021-01-01 2021-12-31 0001758057 us-gaap:OperatingSegmentsMember lazr:AutonomySolutionsSegmentMember 2021-01-01 2021-12-31 0001758057 us-gaap:OperatingSegmentsMember lazr:AdvancedTechnologiesAndServicesSegmentMember 2021-01-01 2021-12-31 0001758057 us-gaap:OperatingSegmentsMember 2021-01-01 2021-12-31 0001758057 us-gaap:OperatingSegmentsMember lazr:AutonomySolutionsSegmentMember 2021-12-31 0001758057 us-gaap:OperatingSegmentsMember lazr:AdvancedTechnologiesAndServicesSegmentMember 2021-12-31 0001758057 us-gaap:OperatingSegmentsMember 2021-12-31 0001758057 us-gaap:IntersegmentEliminationMember 2021-12-31 0001758057 us-gaap:IntersegmentEliminationMember lazr:AutonomySolutionsSegmentMember 2020-01-01 2020-12-31 0001758057 us-gaap:IntersegmentEliminationMember lazr:AdvancedTechnologiesAndServicesSegmentMember 2020-01-01 2020-12-31 0001758057 us-gaap:IntersegmentEliminationMember 2020-01-01 2020-12-31 0001758057 us-gaap:OperatingSegmentsMember lazr:AutonomySolutionsSegmentMember 2020-01-01 2020-12-31 0001758057 us-gaap:OperatingSegmentsMember lazr:AdvancedTechnologiesAndServicesSegmentMember 2020-01-01 2020-12-31 0001758057 us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0001758057 us-gaap:OperatingSegmentsMember lazr:AutonomySolutionsSegmentMember 2020-12-31 0001758057 us-gaap:OperatingSegmentsMember lazr:AdvancedTechnologiesAndServicesSegmentMember 2020-12-31 0001758057 us-gaap:OperatingSegmentsMember 2020-12-31 0001758057 us-gaap:IntersegmentEliminationMember 2020-12-31 0001758057 lazr:CustomerOneMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001758057 lazr:CustomerTwoMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001758057 lazr:CustomerOneMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001758057 lazr:CustomerTwoMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001758057 lazr:CustomerOneMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001758057 lazr:MrHengMember 2021-02-28 0001758057 lazr:MrHengMember 2021-01-01 2021-12-31 0001758057 lazr:MrHengMember 2021-12-31 0001758057 lazr:MrAlecGoresMember 2022-12-31 0001758057 lazr:SeagateMember us-gaap:SubsequentEventMember 2023-01-01 2023-01-31 0001758057 lazr:SwissReMember us-gaap:SubsequentEventMember 2023-02-01 2023-02-28 iso4217:USD shares iso4217:USD shares lazr:operating_segment pure lazr:triggeringEvent lazr:tranche lazr:trading_day lazr:consecutive_trading_day lazr:consecutive_business_day lazr:vote lazr:renewal_option Luminar Technologies, Inc./DE 0001758057 2022 FY false 0.3333 P1Y P1Y 0.3333 P1Y P1Y 0.25 0.25 0.25 0.25 P1Y 10-K true 2022-12-31 --12-31 false 001-38791 DE 83-1804317 2603 Discovery Drive Suite 100 Orlando FL 32826 407 900-5259 Class A common stock, par value of $0.0001 per share LAZR NASDAQ No No Yes Yes Large Accelerated Filer false false true false 1500000000 272176538 97088670 DOCUMENTS INCORPORATED BY REFERENCEPart III incorporates by reference certain information from the registrant’s definitive proxy statement (the “Proxy Statement”) relating to its 2023 Annual Meeting of Stockholders. The Proxy Statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates. Deloitte & Touche LLP San Jose, CA 34 69552000 329977000 1553000 725000 0 12200000 419314000 462141000 11172000 13013000 8792000 10342000 44203000 29195000 554586000 845393000 30260000 11009000 21244000 9145000 22077000 2424000 18816000 3110000 40344000 12455000 687327000 883536000 18626000 14419000 52962000 19844000 5953000 4735000 77541000 38998000 3005000 31230000 612192000 608957000 16989000 5768000 4005000 598000 713732000 685551000 0.0001 0.0001 10000000 10000000 0 0 0 0 0 0 0.0001 0.0001 715000000 715000000 291942087 270078637 715000000 715000000 266076525 250812764 29000 27000 0.0001 0.0001 121000000 121000000 97088670 97088670 97088670 97088670 10000 10000 1558685000 1257214000 -4226000 -908000 21863450 15263761 312477000 235871000 -1268426000 -822487000 -26405000 197985000 687327000 883536000 18492000 10118000 4840000 22206000 21826000 9111000 40698000 31944000 13951000 61985000 23484000 15097000 38998000 22608000 9855000 100983000 46092000 24952000 -60285000 -14148000 -11001000 185283000 88861000 38651000 38672000 17858000 7948000 158162000 93685000 29275000 382117000 200404000 75874000 -442402000 -214552000 -86875000 -9222000 26126000 268266000 6016000 0 0 0 0 -3996000 11095000 2028000 2885000 5024000 3458000 -276000 -2865000 -24696000 -275423000 -445267000 -239248000 -362298000 672000 -1262000 0 -445939000 -237986000 -362298000 -445939000 -237986000 -369055000 -1.25 -1.25 -0.69 -0.69 -2.54 -2.54 356265774 356265774 346300975 346300975 145096996 145096996 -445939000 -237986000 -362298000 -3318000 -942000 35000 -449257000 -238928000 -362263000 94818151 244743000 0 0 26206837 3000 139635890 14000 0 0 10457000 -1000 0 -222203000 -211730000 5790000 18457230 178074000 6629372 1000 1000 -22935413 -3000 -82182790 -8000 105118203 11000 3000000 3000000 94818151 244743000 18457230 178074000 -3271424 116546805 12000 422802000 422814000 102396000 102396000 1466155 30112000 30112000 17226000 49981349 5000 363455000 363460000 5745000 5745000 35000 35000 -362298000 -362298000 0 0 0 0 0 0 218818037 22000 105118203 11000 733175000 34000 0 -584501000 148741000 -73438000 -73438000 235871000 15574037 2000 492219000 492221000 5232744 0 6176000 6176000 71894 0 291940 10743000 10743000 370034 6527000 6527000 10242703 1000 6970467 1000 -2000 0 618924 10002000 10002000 15000000 2000 -15000000 -2000 0 0 70983000 70983000 959000 959000 140000 140000 10000 10000 -942000 -942000 -237986000 -237986000 0 0 266076525 27000 97088670 10000 1257214000 -908000 -235871000 -822487000 197985000 76606000 76606000 405752 19003000 19003000 9177748 1000 3944000 3945000 168147 1271000 1271000 48298 9949385 1000 80254000 80255000 2030374 12588000 12588000 1632056 11751000 11751000 2176205 30510000 30510000 374193 3361000 3361000 142519000 142519000 3730000 3730000 -3318000 -3318000 -445939000 -445939000 0 0 291942087 29000 97088670 10000 1558685000 -4226000 -312477000 -1268426000 -26405000 -445939000 -237986000 -362298000 6566000 4162000 2517000 5237000 3705000 0 -1288000 -1792000 -175000 -9222000 26126000 268266000 41459000 10817000 0 3236000 0 0 12154000 2918000 4407000 0 -752000 -525000 0 0 -3996000 162405000 77684000 8711000 6016000 0 0 0 959000 0 2481000 1538000 0 232000 -1262000 0 0 -305000 0 -5144000 6233000 4294000 10477000 10751000 4018000 6557000 24340000 2805000 3289000 6000 -165000 5301000 3838000 2620000 17768000 3578000 6693000 -2035000 -6017000 -302000 -208232000 -148421000 -75642000 2759000 0 0 2001000 0 0 0 358000 0 17846000 16423000 404598000 716933000 315920000 367367000 366857000 16755000 24753000 4396000 88041000 161910000 28974000 0 0 581000 15614000 6433000 2202000 0 53000 18000 2450000 0 0 27986000 -194188000 -271794000 15625000 0 609375000 0 0 73438000 0 0 0 380601000 0 0 17226000 0 0 183865000 0 0 5790000 0 0 32101000 0 112000 41190000 0 0 1918000 0 0 361000 0 289000 222000 0 153927000 0 3986000 5859000 0 1271000 0 0 3730000 0 0 80878000 231600000 10000 0 -130000 0 -79351000 463592000 529850000 -259597000 120983000 182414000 330702000 209719000 27305000 71105000 330702000 209719000 7769000 215000 2789000 19003000 338293000 30112000 0 0 422813000 0 10002000 0 0 6527000 0 0 10849000 0 16749000 2876000 0 0 0 318000 3870000 849000 319000 0 4273000 0 28402000 0 0 12588000 0 0 Organization and Description of Business<div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Luminar Technologies, Inc. and its wholly-owned subsidiaries (the “Company” or “Luminar”) was originally incorporated in Delaware on August 28, 2018 under the name Gores Metropoulos, Inc. (“Gores”). The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. On December 2, 2020, the Company (at such time named Gores Metropoulos, Inc.) consummated the business combination (the “Business Combination”) pursuant to the Agreement and Plan of Merger, dated August 24, 2020 with the pre-Business Combination Luminar Technologies, Inc. (“Legacy Luminar”). Legacy Luminar was incorporated in Delaware on March 31, 2015. In connection with the consummation of the Business Combination, the Company changed its name from Gores Metropoulos, Inc. to Luminar Technologies, Inc. The Company’s common stock is listed on the NASDAQ under the symbol “LAZR.”</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context otherwise requires, the “Company” refers to the combined company and its subsidiaries following the Business Combination, “Gores” refers to the Company prior to the Business Combination and “Legacy Luminar” refers to Luminar Technologies, Inc. prior to the Business Combination. Refer to Note 3 for further discussion of the Business Combination.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a developer of advanced sensor technologies and software for the autonomous vehicle industry, encompassing Laser Imaging, Detection and Ranging (lidar) technology. The Company manufactures and distributes commercial lidar sensors and certain components for the autonomous vehicle industry. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is headquartered in Orlando, Florida and has personnel that conducts the Company’s operations from various locations in the United States and internationally including Germany, Sweden, Mexico, China, India and Israel.</span></div> Basis of Presentation and Summary of Significant Accounting Policies<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation and Consolidation</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding annual financial reporting. All intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosures. The significant estimates made by management include inventory write-downs, valuation allowance for deferred tax assets, valuation of warrants, fair valuation of assets acquired in mergers and acquisitions including intangible assets, forecasted costs associated with non-recurring engineering (“NRE”) services, product warranty reserves, stock-based compensation expense and other loss contingencies. Management periodically evaluates such estimates and they are adjusted prospectively based upon such periodic evaluation. Actual results could differ from those estimates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined its operating segments using the same indicators which are used to evaluate its performance internally. The Company’s business activities are organized in two operating segments:</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) “Autonomy Solutions” which includes manufacturing and distribution of lidar sensors that measure distance using laser light to generate a 3D map, non-recurring engineering services related to the Company’s lidar products, development of software products that enable autonomy capabilities for automotive applications, and licensing of the Company’s intellectual property (“IP”). In June 2022, the Company acquired certain assets from Solfice Research, Inc. (“Solfice” or “Civil Maps”). Operations of Civil Maps have been included in the Autonomy Solutions segment.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) “Advanced Technologies and Services (“ATS”)” which includes development of application-specific integrated circuits, pixel-based sensors, advanced lasers, as well as designing, testing and providing consulting services for non-standard integrated circuits. In the second quarter of 2022, the Components segment was renamed as ATS. In August 2021 and in April 2022, the Company acquired Optogration, Inc. (“Optogration”) and Freedom Photonics LLC (“Freedom Photonics”), respectively. Operations of Optogration and Freedom Photonic have been included in the ATS segment.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, debt securities and accounts receivable. The Company’s d</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">eposits exceed federally insured limits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Cash held by the foreign subsidiaries of the Company as of December 31, 2022 and 2021 was not material. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s revenue is derived from customers located in the United States and international markets. Three customers accounted for 23%, 27% and 11%, respectively, of the Company’s accounts receivable as of December 31, 2022. Two customers accounted for 39% and 31%, respectively, of the Company’s accounts receivable as of December 31, 2021.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s cash and cash equivalents consist of investments with maturities of three months or less at the time of purchase. The Company’s cash equivalents include investments in money market funds, U.S. treasury securities and commercial paper.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash consists of funds that are contractually restricted as to usage or withdrawal due to legal agreements. The Company determines current or non-current classification of restricted cash based on the expected duration of the restriction.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Securities</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s debt securities consist of U.S agency securities and government sponsored securities, U.S. treasury securities, corporate bonds, commercial paper and asset-backed securities. The Company classifies its debt securities as available-for-sale at the time of purchase and reevaluates such designation as of each balance sheet date. The Company considers all debt securities as available for use to support current operations, including those with maturity dates beyond one year and are classified as current assets under marketable securities in the accompanying consolidated balance sheets. Debt securities included in marketable securities on the consolidated balance sheets consist of securities with original maturities greater than three months at the time of purchase. Debt securities are carried at fair value, with the unrealized gains and losses reported as a component of accumulated other comprehensive income (loss) (“OCI”). Any realized gains or losses on the sale of debt securities are determined on a specific identification method, and such gains and losses are reflected as a component of other income (expense), net.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews the fair value of debt securities and when the fair value of a debt security is below its amortized cost, the amortized cost should be written down to its fair value if (i) it is more likely than not that management will be required to sell the impaired security before recovery of its amortized basis; or (ii) management has the intention to sell the security. If neither of these conditions are met, the Company must determine whether the impairment is due to credit losses. To determine the amount of credit losses, the Company compares the present value of the expected cash flows of the security, derived by taking into account the issuer’s credit ratings and remaining payment terms, with its amortized cost basis. The amount of impairment recognized is limited to the excess of the amortized cost over the fair value of the security. An allowance for credit losses for the excess of amortized cost over the expected cash flows is recorded in other income (expense), net on the consolidated statements of operations. Non-credit related impairment losses are recorded in OCI.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketable Equity Investments</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds marketable equity investments over which the Company does not have a controlling interest or significant influence. Marketable equity investments are measured using the quoted prices in active markets with changes recorded in other income (expense), net on the consolidated statement of operations.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Marketable Equity Investments Measured Using the Measurement Alternative</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds a non-marketable equity investment in a privately held company in which the Company does not own a controlling interest or have significant influence. The investment does not have a readily determinable fair value and the Company has elected the measurement alternative, and consequently, measures the investment at cost less any impairment, adjusted to fair value, if there are observable price changes for an identical or similar investment of the same issuer. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivables are recorded at the invoiced amount and do not bear interest. The Company reviews the need for an allowance for doubtful accounts quarterly based on historical experience with each customer and the specifics of each customer arrangement. The Company did not have material write-offs in any period presented, and as of December 31, 2022, the </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">allowance for doubtful accounts was not material. The Company did not record any allowance for doubtful accounts as of December 31, 2021.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company values inventory at the lower of cost or net realizable value. The Company determines the cost of inventory using the standard-cost method, which approximates actual costs based on a first-in, first-out method. The Company assesses inventory of slow-moving products for potential impairment, and records write-downs of inventory to cost of sales.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost less accumulated depreciation and amortization, and are depreciated using the straight-line method over the estimated useful lives of the assets as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.825%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated useful lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 to 7 years</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Demonstration fleet and demonstration units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of useful life or lease term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Design and development costs for molds, dies and other tools that will be used in producing the products under a long-term supply arrangement are capitalized as tooling which are included in machinery and equipment. The Company estimates useful lives for these tooling items to range between <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEyYjdjMWI3NDE1ZDQ3ZjM4NzA1YjBjMmY3NjQ0YjRjL3NlYzoxMmI3YzFiNzQxNWQ0N2YzODcwNWIwYzJmNzY0NGI0Y185Ny9mcmFnOmUxNTE4YmIyZDFjNjQyMjc4NTgwNjkzYTQ4Y2I3NWMzL3RleHRyZWdpb246ZTE1MThiYjJkMWM2NDIyNzg1ODA2OTNhNDhjYjc1YzNfMzI5ODUzNDk2NzQ4Nw_c4028848-e976-46a7-ab6d-8f64b6b29b77">one</span> to three years. The amount capitalized for tooling as of December 31, 2022 was not material. The Company had not capitalized any amount for tooling as of December 31, 2021. Maintenance and repairs are charged to expense as incurred, and improvements and betterments are capitalized. When assets are retired or otherwise disposed of, the cost and accumulated depreciation and amortization are removed from the consolidated balance sheet and any resulting gain or loss is reflected in the consolidated statements of operations and comprehensive loss in the period realized.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, consisting of acquired developed technology, customer relationships, customer backlog, assembled workforce, IPR&amp;D and tradename are carried at cost less accumulated amortization. All intangible assets have been determined to have definite lives and are amortized on a straight-line basis over their estimated remaining economic lives, ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEyYjdjMWI3NDE1ZDQ3ZjM4NzA1YjBjMmY3NjQ0YjRjL3NlYzoxMmI3YzFiNzQxNWQ0N2YzODcwNWIwYzJmNzY0NGI0Y185Ny9mcmFnOmUxNTE4YmIyZDFjNjQyMjc4NTgwNjkzYTQ4Y2I3NWMzL3RleHRyZWdpb246ZTE1MThiYjJkMWM2NDIyNzg1ODA2OTNhNDhjYjc1YzNfODQyNw_a8c8f2aa-5b0f-4f39-acba-8a46d283859e">one</span> to ten years. Amortization expense related to developed technology is included in cost of sales. Amortization expense related to customer relationships is included in sales and marketing expense. Amortization expense related to tradename is included in general and administrative expense. Intangible assets are reviewed for impairment whenever events or changes in circumstances indicate an asset’s carrying value may not be recoverable. There was no impairment of intangible assets experienced during the year ended December 31, 2022 or 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records goodwill when the consideration paid in a business combination exceeds the fair value of the net tangible assets and the identified intangible assets acquired. Goodwill is not amortized, but instead is required to be tested for impairment annually and whenever events or changes in circumstances indicate that the carrying value of goodwill may exceed its fair value. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews goodwill for impairment annually in its fourth quarter by initially considering qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill, as a basis for determining whether it is necessary to perform a quantitative analysis. If it is determined that it is more likely than not that the fair value of reporting unit is less than its carrying amount, a quantitative analysis is performed to identify goodwill impairment. There was no impairment of goodwill experienced during the year ended December 31, 2022 or 2021.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. When such an event occurs, management determines whether there has been impairment by comparing the anticipated undiscounted future net cash flows to the related asset group’s carrying value. If </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an asset is considered impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending on the nature of the asset. There was no impairment experienced of long-lived assets during the years ended December 31, 2022 or 2021.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Convertible Senior Notes</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s convertible senior notes issued in December 2021 are accounted for as a single liability instrument measured at its amortized cost, as no other embedded features require bifurcation and recognition as derivatives.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Warranties</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated future warranty costs are accrued and charged to cost of sales in the period that the related revenue is recognized. These estimates are based on historical warranty experience and any known or expected changes in warranty exposure, such as trends of product reliability and costs of repairing and replacing defective products. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the said estimates as necessary. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Public and Private Warrants</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of Gores’ initial public offering on February 5, 2019, Gores issued to third party investors 40.0 million units, consisting of one share of Class A common stock of Gores and one-third of one warrant, at a price of $10.00 per unit. Each whole warrant entitled the holder to purchase one share of Class A common stock at an exercise price of $11.50 per share (the “Public Warrants”). Simultaneously with the closing of the IPO, Gores completed the private sale of 6.667 million warrants to Gore’s sponsor at a purchase price of $1.50 per warrant (the “Private Warrants”). Each Private Warrant allows the sponsor to purchase one share of Class A common stock at $11.50 per share. Subsequent to the Business Combination, 13,333,309 Public Warrants and 6,666,666 Private Warrants remained outstanding as of December 31, 2020.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Private Warrants and the shares of common stock issuable upon the exercise of the Private Warrants were not transferable, assignable or salable until after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants are exercisable for cash or on a cashless basis, at the holder’s option, and are non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, said Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exercise of the Private Warrants may be settled in cash upon the occurrence of a tender offer or exchange that involves 50% or more of the Company’s Class A stockholders. Public Warrants contained the same feature. Since not all of the Company’s stockholders need to participate in such tender offer or exchange to trigger the potential cash settlement and the Company does not control the occurrence of such an event, the Company concluded that the Public Warrants and Private Warrants do not meet the conditions to be classified in equity per the guidance in ASC 815-40, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging—Contracts in Entity’s Own Equity. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the Public and Private Warrants meet the definition of a derivative under ASC 815, the Company recorded these warrants as liabilities on the balance sheet at fair value upon the closing of the Business Combination, with subsequent changes in their respective fair values recognized in the consolidated statement of operations and comprehensive loss at each reporting date.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, 3,589,645 Private Warrants and 13,128,671 Public Warrants were exercised, and the Company received $153.9 million in cash proceeds from the exercise of these warrants. Pursuant to the terms of the agreements governing the rights of the holders of the Public Warrants, the Company redeemed the remaining unexercised and outstanding 204,638 Public Warrants for a redemption price of $0.01 per Public Warrant.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had 3,077,021 Private Warrants and no Public Warrants, outstanding as of December 31, 2021. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022 and April 2022, 1,389,529 and 19,223 Private Warrants, respectively, were exercised on a cashless basis and the Company issued 401,365 and 4,387 shares of Class A common stock, respectively, pursuant to the exercises. The Company had 1,668,269 Private Warrants outstanding as of December 31, 2022. These Private Warrants expire on December 2, 2025.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 606, the Company determines revenue recognition through the following steps:</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Identifying the contract, or contracts, with the customer; </span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Identifying the performance obligations in the contract;</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Determining the transaction price;</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Allocating the transaction price to performance obligations in the contract; and</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Recognizing revenue when, or as, the Company satisfies performance obligations by transferring the promised goods or services.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Nature of Products and Services and Revenue Recognition</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Autonomy Solutions segment derives revenue primarily from (a) product sales of lidar sensors to customers and distributors, (b) NRE services to integrate Luminar lidar hardware for autonomy in vehicle platforms, and (c) licensing of certain IP. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ATS segment derives revenue primarily from (a) product sales of application-specific integrated circuits, pixel-based sensors and advanced lasers, as well as (b) NRE services for designing and testing non-standard integrated circuits.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from product sales is recognized at a point in time when control of the goods is transferred to the customer, generally occurring upon shipment or delivery dependent upon the terms of the underlying contract. Certain customer arrangements involve NRE services to design and develop custom prototype products to customers. Revenue from NRE service arrangements is recognized over time.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For NRE services, the Company recognizes revenue over time using an input method based on contract cost incurred to date compared to total estimated contract costs (cost-to-cost). For NRE service projects, the Company contracts with customers based on hourly rates or on a fixed fee basis. For arrangements based on hourly rates, revenue is recognized as services are performed and amounts are earned in accordance with the terms of a contract at estimated collectible amounts. For arrangements based on a fixed fee, revenue is recognized based on the progress or the percentage of completion of the NRE service project. Expenses associated with performance of work may be reimbursed with a markup depending on contractual terms and are included in revenue.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract costs related to NRE arrangements are incurred over time, which can be several years, and the estimation of these costs requires management’s judgment. Significant judgment is required when estimating total contract costs and progress to completion on the arrangements, as well as whether a loss is expected to be incurred on the contract. In estimating total contract costs, the Company is also required to estimate the effort expected to be incurred to complete a NRE project. These estimates are subject to significant estimation uncertainty as actual time and effort incurred on completing a NRE project or actual rates of either internal or contracted personnel working on such NRE projects may differ from the Company’s estimates. Changes in circumstances may change the original estimates of revenues, costs, or extent of progress toward completion, revisions to the estimates are made which may result in increases or decreases in estimated revenues or costs, and such revisions are reflected in income in the period in which the circumstances that gave rise to the revision become known to us. We perform ongoing profitability analysis of our contracts accounted for under this method to determine whether the latest estimates of revenues, costs, and profits require updating. If at any time these estimates indicate that the contract will be unprofitable, the entire estimated loss for the remainder of the contract is recorded immediately. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into term-based licenses that provide customers the right to use certain IP available with the Company. Revenue from these licenses is recognized at the point in time at which the customer is able to use and benefit from the licensed information, which is generally upon delivery of the information to the customer or upon commencement of the renewal term.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts billed to customers for shipping and handling are included in revenue. Taxes collected from customers and remitted to governmental authorities are excluded from revenue on the net basis of accounting.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Arrangements with Multiple Performance Obligations</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When a contract involves multiple performance obligations, the Company accounts for individual products and services separately if the customer can benefit from the product or service on its own or with other resources that are readily available to the customer and the product or service is separately identifiable from other promises in the arrangement. The consideration is allocated between separate performance obligations in proportion to their estimated standalone selling price. The transactions to which the Company had to estimate standalone selling prices and allocate the arrangement consideration to multiple performance obligations were immaterial.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides standard product warranties for a term of typically up to one year to ensure that its products comply with agreed-upon specifications. Standard warranties are considered to be assurance type warranties and are not accounted for as separate performance obligations. See Product Warranties for accounting policy on standard warranties.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Other Policies, Judgments and Practical Expedients</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract balances.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets and liabilities represent the differences in the timing of revenue recognition from the receipt of cash from the Company’s customers and billings. Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. Receivable represents right to consideration that is unconditional. Such rights are considered unconditional if only the passage of time is required before payment of that consideration is due.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remaining performance obligations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Revenue allocated to remaining performance obligations represents the transaction price allocated to the performance obligations that are unsatisfied, or partially unsatisfied. It includes unearned revenue and amounts that will be invoiced and recognized as revenue in future periods and does not include contracts where the customer is not committed. The customer is not considered committed where they are able to terminate for convenience without payment of a substantive penalty under the contract. The Company has elected the optional exemption, which allows for the exclusion of the amounts for remaining performance obligations that are part of contracts with an original expected duration of one year or less.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Significant financing component. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain arrangements, the Company receives payment from a customer either before or after the performance obligation has been satisfied. Typically, the expected timing difference between the payment and satisfaction of performance obligations is one year or less; therefore, the Company applies a practical expedient and does not consider the effects of the time value of money. The Company’s contracts with customer prepayment terms do not include a significant financing component because the primary purpose is not to receive or provide financing from or to the customers.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract modifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company may modify contracts to offer customers additional products or services. Each of the additional products and services are generally considered distinct from those products or services transferred to the customer before the modification. The Company evaluates whether the contract price for the additional products and services reflects the standalone selling price as adjusted for facts and circumstances applicable to that contract. In these cases, the Company accounts for the additional products or services as a separate contract. In other cases where the pricing in the modification does not reflect the standalone selling price as adjusted for facts and circumstances applicable to that contract, the Company accounts on a prospective basis where the remaining goods and services are distinct from the original items and on a cumulative catch-up basis when the remaining goods and services are not distinct from the original items.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Judgments and estimates. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting for contracts recognized over time involves the use of various techniques to estimate total contract revenue and costs. Due to uncertainties inherent in the estimation process, it is possible that estimates of costs to complete a performance obligation will be revised in the near term. The Company reviews and updates its contract-related estimates regularly, and records adjustments as needed. For those performance obligations for which revenue is recognized using a cost-to-cost input method, changes in total estimated costs, and related progress towards complete satisfaction of the performance obligation, are recognized on a cumulative catch-up basis in the period in which the revisions to the estimates are made.</span></div><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of Sales</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company includes all manufacturing and sourcing costs incurred prior to the receipt of finished goods at its distribution facility in cost of sales. The cost of sales principally includes personnel-related costs (including certain engineering personnel), including stock-based compensation, directly associated with the Company’s manufacturing organization, direct costs, product costs, purchasing costs, allocation of overhead costs associated with manufacturing operations, inbound freight charges, insurance, inventory write-downs, warranty cost and depreciation and amortization expense associated with the manufacturing and sourcing operations. Cost of sales also includes the direct cost and appropriate allocation of overhead costs involved in execution of service contracts.</span></div><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development (R&amp;D)</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expenses consist primarily of personnel-related expenses, consulting and contractor expenses, tooling and prototype materials to the extent no future benefit is expected and allocated overhead costs. Substantially all of the Company’s R&amp;D expenses are related to developing new products and services, improving existing products and services, and developing manufacturing processes. R&amp;D expenses are expensed as incurred.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Design and development costs for products to be sold under long-term supply arrangements are expensed as incurred. Design and development costs for molds, dies, and other tools involved in new technologies are expensed as incurred. Design and development costs for molds, dies, and other tools that will be used in producing the products under a long-term supply arrangement are capitalized as part of the molds, dies, and other tools.</span></div><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-based Compensation</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee awards </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For equity classified awards, the Company measures the cost of share-based awards granted to employees, non-employees and directors based on the grant-date fair value of the awards. The grant-date fair value of the stock options is calculated using a Black-Scholes option pricing model. The grant-date fair value of purchase rights under the Company’s 2020 Employee Stock Purchase Plan (“ESPP”) is calculated using a Black-Scholes option pricing model. The grant-date fair value of restricted stock is calculated based on the fair value of the underlying common stock less cash proceeds paid by the recipient to acquire the restricted stock, if any. The grant-date fair value of restricted stock unit is calculated based on the fair value of the underlying common stock. The grant-date fair value of stock-based awards with market conditions is calculated using a Monte Carlo simulation model. The fair value of the stock-based compensation is recognized on a straight-line basis over the requisite service period, which is generally the vesting period of the award. The Company has elected to recognize the effect of forfeitures in the period they occur.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants fixed value share-based awards to certain employees, wherein the awardee is entitled to a fixed dollar value compensation settled by issuing shares on the vesting date, with the number of shares determined based on the Company’s stock price on or close to the settlement date. These fixed value equity awards are considered as liability classified awards. The Company measures the cost of fixed value share-based awards granted to employees based on a fixed monetary amount that is known at the inception of the obligation. The Company records the compensation cost for the fixed dollar amount of the award over the vesting period, with a corresponding liability.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based payments to vendors / non-employees</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into arrangements with certain vendors and other third parties wherein the Company at its discretion may elect to compensate the respective vendors for services provided in either cash or by issuing shares of the Company’s Class A common stock (“Stock-in-lieu of Cash Program”). Typically, the amounts owed under the Stock-in-lieu of Cash Program are </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">settled by issuing shares, with the number of shares generally determined based on the Company’s stock price on or close to the settlement date. Payments owed under this program may be equity or liability classified depending upon fixed or variable number of shares issued for the amount owed to vendors. The Company measures the cost based on a fixed monetary amount that is known at the inception of the obligation.</span></div><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax bases of assets and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes deferred tax assets to the extent that these assets are more likely than not to be realized. In making such a determination, all available positive and negative evidence are considered, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If it is determined that deferred tax assets would be realized in the future, in excess of their net recorded amount, an adjustment would be made to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records uncertain tax positions in accordance with ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the basis of a two-step process which includes (1) determining whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position, and (2) for those tax positions that meet the more-likely-than-not recognition threshold. Recognized income tax positions are measured at the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes interest and penalties related to unrecognized tax benefits on the income tax expense line in the accompanying consolidated statement of operations. Accrued interest and penalties are included on the related tax liability line in the consolidated balance sheet.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Tax Cuts and Jobs Act (“TCJA”) subjects a U.S. shareholder to tax on global intangible low-taxed income (“GILTI”) earned by certain foreign subsidiaries. Under GAAP, the Company can make an accounting policy election to either </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">treat taxes due on the GILTI inclusion as a current period expense or factor such amounts into the Company’s measurement of deferred taxes. The Company elected to treat the GILTI inclusion as a period expense.</span></div><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. ASU 2021-08,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(“ASU 2021-08”). ASU 2021-08 requires an acquirer to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. At the acquisition date, it requires an acquirer to account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts, which should generally result in an acquirer recognizing and measuring the acquired contract assets and contract liabilities consistent with how they were recognized and measured in the acquiree’s financial statements. The Company elected to early adopt ASU 2021-08 as of January 1, 2022. The adoption of ASU 2021-08 did not have a material impact on the Company’s consolidated financial position, operating results or cash flows.</span></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation and Consolidation</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding annual financial reporting. All intercompany transactions and balances have been eliminated in consolidation.</span></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosures. The significant estimates made by management include inventory write-downs, valuation allowance for deferred tax assets, valuation of warrants, fair valuation of assets acquired in mergers and acquisitions including intangible assets, forecasted costs associated with non-recurring engineering (“NRE”) services, product warranty reserves, stock-based compensation expense and other loss contingencies. Management periodically evaluates such estimates and they are adjusted prospectively based upon such periodic evaluation. Actual results could differ from those estimates.</span></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined its operating segments using the same indicators which are used to evaluate its performance internally. The Company’s business activities are organized in two operating segments:</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) “Autonomy Solutions” which includes manufacturing and distribution of lidar sensors that measure distance using laser light to generate a 3D map, non-recurring engineering services related to the Company’s lidar products, development of software products that enable autonomy capabilities for automotive applications, and licensing of the Company’s intellectual property (“IP”). In June 2022, the Company acquired certain assets from Solfice Research, Inc. (“Solfice” or “Civil Maps”). Operations of Civil Maps have been included in the Autonomy Solutions segment.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) “Advanced Technologies and Services (“ATS”)” which includes development of application-specific integrated circuits, pixel-based sensors, advanced lasers, as well as designing, testing and providing consulting services for non-standard integrated circuits. In the second quarter of 2022, the Components segment was renamed as ATS. In August 2021 and in April 2022, the Company acquired Optogration, Inc. (“Optogration”) and Freedom Photonics LLC (“Freedom Photonics”), respectively. Operations of Optogration and Freedom Photonic have been included in the ATS segment.</span></div> 2 Concentration of Credit Risk<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, debt securities and accounts receivable. The Company’s d</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">eposits exceed federally insured limits</span>.The Company’s revenue is derived from customers located in the United States and international markets. 0 0 0.23 0.27 0.11 0.39 0.31 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s cash and cash equivalents consist of investments with maturities of three months or less at the time of purchase. The Company’s cash equivalents include investments in money market funds, U.S. treasury securities and commercial paper.</span></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash consists of funds that are contractually restricted as to usage or withdrawal due to legal agreements. The Company determines current or non-current classification of restricted cash based on the expected duration of the restriction.</span></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Securities</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s debt securities consist of U.S agency securities and government sponsored securities, U.S. treasury securities, corporate bonds, commercial paper and asset-backed securities. The Company classifies its debt securities as available-for-sale at the time of purchase and reevaluates such designation as of each balance sheet date. The Company considers all debt securities as available for use to support current operations, including those with maturity dates beyond one year and are classified as current assets under marketable securities in the accompanying consolidated balance sheets. Debt securities included in marketable securities on the consolidated balance sheets consist of securities with original maturities greater than three months at the time of purchase. Debt securities are carried at fair value, with the unrealized gains and losses reported as a component of accumulated other comprehensive income (loss) (“OCI”). Any realized gains or losses on the sale of debt securities are determined on a specific identification method, and such gains and losses are reflected as a component of other income (expense), net.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews the fair value of debt securities and when the fair value of a debt security is below its amortized cost, the amortized cost should be written down to its fair value if (i) it is more likely than not that management will be required to sell the impaired security before recovery of its amortized basis; or (ii) management has the intention to sell the security. If neither of these conditions are met, the Company must determine whether the impairment is due to credit losses. To determine the amount of credit losses, the Company compares the present value of the expected cash flows of the security, derived by taking into account the issuer’s credit ratings and remaining payment terms, with its amortized cost basis. The amount of impairment recognized is limited to the excess of the amortized cost over the fair value of the security. An allowance for credit losses for the excess of amortized cost over the expected cash flows is recorded in other income (expense), net on the consolidated statements of operations. Non-credit related impairment losses are recorded in OCI.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketable Equity Investments</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds marketable equity investments over which the Company does not have a controlling interest or significant influence. Marketable equity investments are measured using the quoted prices in active markets with changes recorded in other income (expense), net on the consolidated statement of operations.</span></div> Non-Marketable Equity Investments Measured Using the Measurement AlternativeThe Company holds a non-marketable equity investment in a privately held company in which the Company does not own a controlling interest or have significant influence. The investment does not have a readily determinable fair value and the Company has elected the measurement alternative, and consequently, measures the investment at cost less any impairment, adjusted to fair value, if there are observable price changes for an identical or similar investment of the same issuer. Accounts ReceivableAccounts receivables are recorded at the invoiced amount and do not bear interest. The Company reviews the need for an allowance for doubtful accounts quarterly based on historical experience with each customer and the specifics of each customer arrangement. <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company values inventory at the lower of cost or net realizable value. The Company determines the cost of inventory using the standard-cost method, which approximates actual costs based on a first-in, first-out method. The Company assesses inventory of slow-moving products for potential impairment, and records write-downs of inventory to cost of sales.</span></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost less accumulated depreciation and amortization, and are depreciated using the straight-line method over the estimated useful lives of the assets as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.825%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated useful lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 to 7 years</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Demonstration fleet and demonstration units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of useful life or lease term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Design and development costs for molds, dies and other tools that will be used in producing the products under a long-term supply arrangement are capitalized as tooling which are included in machinery and equipment. The Company estimates useful lives for these tooling items to range between <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEyYjdjMWI3NDE1ZDQ3ZjM4NzA1YjBjMmY3NjQ0YjRjL3NlYzoxMmI3YzFiNzQxNWQ0N2YzODcwNWIwYzJmNzY0NGI0Y185Ny9mcmFnOmUxNTE4YmIyZDFjNjQyMjc4NTgwNjkzYTQ4Y2I3NWMzL3RleHRyZWdpb246ZTE1MThiYjJkMWM2NDIyNzg1ODA2OTNhNDhjYjc1YzNfMzI5ODUzNDk2NzQ4Nw_c4028848-e976-46a7-ab6d-8f64b6b29b77">one</span> to three years. The amount capitalized for tooling as of December 31, 2022 was not material. The Company had not capitalized any amount for tooling as of December 31, 2021. Maintenance and repairs are charged to expense as incurred, and improvements and betterments are capitalized. When assets are retired or otherwise disposed of, the cost and accumulated depreciation and amortization are removed from the consolidated balance sheet and any resulting gain or loss is reflected in the consolidated statements of operations and comprehensive loss in the period realized.</span></div> <div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost less accumulated depreciation and amortization, and are depreciated using the straight-line method over the estimated useful lives of the assets as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.825%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated useful lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 to 7 years</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Demonstration fleet and demonstration units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of useful life or lease term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,047 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,694 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,797 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,854 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,001 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">885 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles, including demonstration fleet</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,421 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,642 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,677 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,412 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,787 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,152)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,778)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,260 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,009 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> P1Y P7Y P3Y P5Y P2Y P5Y P5Y P7Y P3Y 0 0 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, consisting of acquired developed technology, customer relationships, customer backlog, assembled workforce, IPR&amp;D and tradename are carried at cost less accumulated amortization. All intangible assets have been determined to have definite lives and are amortized on a straight-line basis over their estimated remaining economic lives, ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEyYjdjMWI3NDE1ZDQ3ZjM4NzA1YjBjMmY3NjQ0YjRjL3NlYzoxMmI3YzFiNzQxNWQ0N2YzODcwNWIwYzJmNzY0NGI0Y185Ny9mcmFnOmUxNTE4YmIyZDFjNjQyMjc4NTgwNjkzYTQ4Y2I3NWMzL3RleHRyZWdpb246ZTE1MThiYjJkMWM2NDIyNzg1ODA2OTNhNDhjYjc1YzNfODQyNw_a8c8f2aa-5b0f-4f39-acba-8a46d283859e">one</span> to ten years. Amortization expense related to developed technology is included in cost of sales. Amortization expense related to customer relationships is included in sales and marketing expense. Amortization expense related to tradename is included in general and administrative expense. Intangible assets are reviewed for impairment whenever events or changes in circumstances indicate an asset’s carrying value may not be recoverable. There was no impairment of intangible assets experienced during the year ended December 31, 2022 or 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records goodwill when the consideration paid in a business combination exceeds the fair value of the net tangible assets and the identified intangible assets acquired. Goodwill is not amortized, but instead is required to be tested for impairment annually and whenever events or changes in circumstances indicate that the carrying value of goodwill may exceed its fair value. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews goodwill for impairment annually in its fourth quarter by initially considering qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill, as a basis for determining whether it is necessary to perform a quantitative analysis. If it is determined that it is more likely than not that the fair value of reporting unit is less than its carrying amount, a quantitative analysis is performed to identify goodwill impairment. There was no impairment of goodwill experienced during the year ended December 31, 2022 or 2021.</span></div> P10Y 0 0 0 0 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. When such an event occurs, management determines whether there has been impairment by comparing the anticipated undiscounted future net cash flows to the related asset group’s carrying value. If </span></div>an asset is considered impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending on the nature of the asset. 0 0 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Convertible Senior Notes</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s convertible senior notes issued in December 2021 are accounted for as a single liability instrument measured at its amortized cost, as no other embedded features require bifurcation and recognition as derivatives.</span></div> Product WarrantiesEstimated future warranty costs are accrued and charged to cost of sales in the period that the related revenue is recognized. These estimates are based on historical warranty experience and any known or expected changes in warranty exposure, such as trends of product reliability and costs of repairing and replacing defective products. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the said estimates as necessary. <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Public and Private Warrants</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of Gores’ initial public offering on February 5, 2019, Gores issued to third party investors 40.0 million units, consisting of one share of Class A common stock of Gores and one-third of one warrant, at a price of $10.00 per unit. Each whole warrant entitled the holder to purchase one share of Class A common stock at an exercise price of $11.50 per share (the “Public Warrants”). Simultaneously with the closing of the IPO, Gores completed the private sale of 6.667 million warrants to Gore’s sponsor at a purchase price of $1.50 per warrant (the “Private Warrants”). Each Private Warrant allows the sponsor to purchase one share of Class A common stock at $11.50 per share. Subsequent to the Business Combination, 13,333,309 Public Warrants and 6,666,666 Private Warrants remained outstanding as of December 31, 2020.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Private Warrants and the shares of common stock issuable upon the exercise of the Private Warrants were not transferable, assignable or salable until after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants are exercisable for cash or on a cashless basis, at the holder’s option, and are non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, said Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exercise of the Private Warrants may be settled in cash upon the occurrence of a tender offer or exchange that involves 50% or more of the Company’s Class A stockholders. Public Warrants contained the same feature. Since not all of the Company’s stockholders need to participate in such tender offer or exchange to trigger the potential cash settlement and the Company does not control the occurrence of such an event, the Company concluded that the Public Warrants and Private Warrants do not meet the conditions to be classified in equity per the guidance in ASC 815-40, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging—Contracts in Entity’s Own Equity. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the Public and Private Warrants meet the definition of a derivative under ASC 815, the Company recorded these warrants as liabilities on the balance sheet at fair value upon the closing of the Business Combination, with subsequent changes in their respective fair values recognized in the consolidated statement of operations and comprehensive loss at each reporting date.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, 3,589,645 Private Warrants and 13,128,671 Public Warrants were exercised, and the Company received $153.9 million in cash proceeds from the exercise of these warrants. Pursuant to the terms of the agreements governing the rights of the holders of the Public Warrants, the Company redeemed the remaining unexercised and outstanding 204,638 Public Warrants for a redemption price of $0.01 per Public Warrant.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had 3,077,021 Private Warrants and no Public Warrants, outstanding as of December 31, 2021. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022 and April 2022, 1,389,529 and 19,223 Private Warrants, respectively, were exercised on a cashless basis and the Company issued 401,365 and 4,387 shares of Class A common stock, respectively, pursuant to the exercises. The Company had 1,668,269 Private Warrants outstanding as of December 31, 2022. These Private Warrants expire on December 2, 2025.</span></div> 40000000 1 10.00 1 11.50 6667000 1.50 1 11.50 13333309 6666666 0.50 3589645 13128671 153900000 204638 0.01 3077021 0 1389529 19223 401365 4387 1668269 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 606, the Company determines revenue recognition through the following steps:</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Identifying the contract, or contracts, with the customer; </span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Identifying the performance obligations in the contract;</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Determining the transaction price;</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Allocating the transaction price to performance obligations in the contract; and</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Recognizing revenue when, or as, the Company satisfies performance obligations by transferring the promised goods or services.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Nature of Products and Services and Revenue Recognition</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Autonomy Solutions segment derives revenue primarily from (a) product sales of lidar sensors to customers and distributors, (b) NRE services to integrate Luminar lidar hardware for autonomy in vehicle platforms, and (c) licensing of certain IP. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ATS segment derives revenue primarily from (a) product sales of application-specific integrated circuits, pixel-based sensors and advanced lasers, as well as (b) NRE services for designing and testing non-standard integrated circuits.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from product sales is recognized at a point in time when control of the goods is transferred to the customer, generally occurring upon shipment or delivery dependent upon the terms of the underlying contract. Certain customer arrangements involve NRE services to design and develop custom prototype products to customers. Revenue from NRE service arrangements is recognized over time.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For NRE services, the Company recognizes revenue over time using an input method based on contract cost incurred to date compared to total estimated contract costs (cost-to-cost). For NRE service projects, the Company contracts with customers based on hourly rates or on a fixed fee basis. For arrangements based on hourly rates, revenue is recognized as services are performed and amounts are earned in accordance with the terms of a contract at estimated collectible amounts. For arrangements based on a fixed fee, revenue is recognized based on the progress or the percentage of completion of the NRE service project. Expenses associated with performance of work may be reimbursed with a markup depending on contractual terms and are included in revenue.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract costs related to NRE arrangements are incurred over time, which can be several years, and the estimation of these costs requires management’s judgment. Significant judgment is required when estimating total contract costs and progress to completion on the arrangements, as well as whether a loss is expected to be incurred on the contract. In estimating total contract costs, the Company is also required to estimate the effort expected to be incurred to complete a NRE project. These estimates are subject to significant estimation uncertainty as actual time and effort incurred on completing a NRE project or actual rates of either internal or contracted personnel working on such NRE projects may differ from the Company’s estimates. Changes in circumstances may change the original estimates of revenues, costs, or extent of progress toward completion, revisions to the estimates are made which may result in increases or decreases in estimated revenues or costs, and such revisions are reflected in income in the period in which the circumstances that gave rise to the revision become known to us. We perform ongoing profitability analysis of our contracts accounted for under this method to determine whether the latest estimates of revenues, costs, and profits require updating. If at any time these estimates indicate that the contract will be unprofitable, the entire estimated loss for the remainder of the contract is recorded immediately. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into term-based licenses that provide customers the right to use certain IP available with the Company. Revenue from these licenses is recognized at the point in time at which the customer is able to use and benefit from the licensed information, which is generally upon delivery of the information to the customer or upon commencement of the renewal term.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts billed to customers for shipping and handling are included in revenue. Taxes collected from customers and remitted to governmental authorities are excluded from revenue on the net basis of accounting.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Arrangements with Multiple Performance Obligations</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When a contract involves multiple performance obligations, the Company accounts for individual products and services separately if the customer can benefit from the product or service on its own or with other resources that are readily available to the customer and the product or service is separately identifiable from other promises in the arrangement. The consideration is allocated between separate performance obligations in proportion to their estimated standalone selling price. The transactions to which the Company had to estimate standalone selling prices and allocate the arrangement consideration to multiple performance obligations were immaterial.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides standard product warranties for a term of typically up to one year to ensure that its products comply with agreed-upon specifications. Standard warranties are considered to be assurance type warranties and are not accounted for as separate performance obligations. See Product Warranties for accounting policy on standard warranties.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Other Policies, Judgments and Practical Expedients</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract balances.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets and liabilities represent the differences in the timing of revenue recognition from the receipt of cash from the Company’s customers and billings. Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. Receivable represents right to consideration that is unconditional. Such rights are considered unconditional if only the passage of time is required before payment of that consideration is due.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remaining performance obligations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Revenue allocated to remaining performance obligations represents the transaction price allocated to the performance obligations that are unsatisfied, or partially unsatisfied. It includes unearned revenue and amounts that will be invoiced and recognized as revenue in future periods and does not include contracts where the customer is not committed. The customer is not considered committed where they are able to terminate for convenience without payment of a substantive penalty under the contract. The Company has elected the optional exemption, which allows for the exclusion of the amounts for remaining performance obligations that are part of contracts with an original expected duration of one year or less.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Significant financing component. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain arrangements, the Company receives payment from a customer either before or after the performance obligation has been satisfied. Typically, the expected timing difference between the payment and satisfaction of performance obligations is one year or less; therefore, the Company applies a practical expedient and does not consider the effects of the time value of money. The Company’s contracts with customer prepayment terms do not include a significant financing component because the primary purpose is not to receive or provide financing from or to the customers.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract modifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company may modify contracts to offer customers additional products or services. Each of the additional products and services are generally considered distinct from those products or services transferred to the customer before the modification. The Company evaluates whether the contract price for the additional products and services reflects the standalone selling price as adjusted for facts and circumstances applicable to that contract. In these cases, the Company accounts for the additional products or services as a separate contract. In other cases where the pricing in the modification does not reflect the standalone selling price as adjusted for facts and circumstances applicable to that contract, the Company accounts on a prospective basis where the remaining goods and services are distinct from the original items and on a cumulative catch-up basis when the remaining goods and services are not distinct from the original items.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Judgments and estimates. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting for contracts recognized over time involves the use of various techniques to estimate total contract revenue and costs. Due to uncertainties inherent in the estimation process, it is possible that estimates of costs to complete a performance obligation will be revised in the near term. The Company reviews and updates its contract-related estimates regularly, and records adjustments as needed. For those performance obligations for which revenue is recognized using a cost-to-cost input method, changes in total estimated costs, and related progress towards complete satisfaction of the performance obligation, are recognized on a cumulative catch-up basis in the period in which the revisions to the estimates are made.</span></div> <div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of Sales</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company includes all manufacturing and sourcing costs incurred prior to the receipt of finished goods at its distribution facility in cost of sales. The cost of sales principally includes personnel-related costs (including certain engineering personnel), including stock-based compensation, directly associated with the Company’s manufacturing organization, direct costs, product costs, purchasing costs, allocation of overhead costs associated with manufacturing operations, inbound freight charges, insurance, inventory write-downs, warranty cost and depreciation and amortization expense associated with the manufacturing and sourcing operations. Cost of sales also includes the direct cost and appropriate allocation of overhead costs involved in execution of service contracts.</span></div> <div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development (R&amp;D)</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expenses consist primarily of personnel-related expenses, consulting and contractor expenses, tooling and prototype materials to the extent no future benefit is expected and allocated overhead costs. Substantially all of the Company’s R&amp;D expenses are related to developing new products and services, improving existing products and services, and developing manufacturing processes. R&amp;D expenses are expensed as incurred.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Design and development costs for products to be sold under long-term supply arrangements are expensed as incurred. Design and development costs for molds, dies, and other tools involved in new technologies are expensed as incurred. Design and development costs for molds, dies, and other tools that will be used in producing the products under a long-term supply arrangement are capitalized as part of the molds, dies, and other tools.</span></div> <div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-based Compensation</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee awards </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For equity classified awards, the Company measures the cost of share-based awards granted to employees, non-employees and directors based on the grant-date fair value of the awards. The grant-date fair value of the stock options is calculated using a Black-Scholes option pricing model. The grant-date fair value of purchase rights under the Company’s 2020 Employee Stock Purchase Plan (“ESPP”) is calculated using a Black-Scholes option pricing model. The grant-date fair value of restricted stock is calculated based on the fair value of the underlying common stock less cash proceeds paid by the recipient to acquire the restricted stock, if any. The grant-date fair value of restricted stock unit is calculated based on the fair value of the underlying common stock. The grant-date fair value of stock-based awards with market conditions is calculated using a Monte Carlo simulation model. The fair value of the stock-based compensation is recognized on a straight-line basis over the requisite service period, which is generally the vesting period of the award. The Company has elected to recognize the effect of forfeitures in the period they occur.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants fixed value share-based awards to certain employees, wherein the awardee is entitled to a fixed dollar value compensation settled by issuing shares on the vesting date, with the number of shares determined based on the Company’s stock price on or close to the settlement date. These fixed value equity awards are considered as liability classified awards. The Company measures the cost of fixed value share-based awards granted to employees based on a fixed monetary amount that is known at the inception of the obligation. The Company records the compensation cost for the fixed dollar amount of the award over the vesting period, with a corresponding liability.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based payments to vendors / non-employees</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into arrangements with certain vendors and other third parties wherein the Company at its discretion may elect to compensate the respective vendors for services provided in either cash or by issuing shares of the Company’s Class A common stock (“Stock-in-lieu of Cash Program”). Typically, the amounts owed under the Stock-in-lieu of Cash Program are </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">settled by issuing shares, with the number of shares generally determined based on the Company’s stock price on or close to the settlement date. Payments owed under this program may be equity or liability classified depending upon fixed or variable number of shares issued for the amount owed to vendors. The Company measures the cost based on a fixed monetary amount that is known at the inception of the obligation.</span></div> <div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax bases of assets and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes deferred tax assets to the extent that these assets are more likely than not to be realized. In making such a determination, all available positive and negative evidence are considered, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If it is determined that deferred tax assets would be realized in the future, in excess of their net recorded amount, an adjustment would be made to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records uncertain tax positions in accordance with ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the basis of a two-step process which includes (1) determining whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position, and (2) for those tax positions that meet the more-likely-than-not recognition threshold. Recognized income tax positions are measured at the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes interest and penalties related to unrecognized tax benefits on the income tax expense line in the accompanying consolidated statement of operations. Accrued interest and penalties are included on the related tax liability line in the consolidated balance sheet.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Tax Cuts and Jobs Act (“TCJA”) subjects a U.S. shareholder to tax on global intangible low-taxed income (“GILTI”) earned by certain foreign subsidiaries. Under GAAP, the Company can make an accounting policy election to either </span></div>treat taxes due on the GILTI inclusion as a current period expense or factor such amounts into the Company’s measurement of deferred taxes. The Company elected to treat the GILTI inclusion as a period expense. <div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. ASU 2021-08,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(“ASU 2021-08”). ASU 2021-08 requires an acquirer to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. At the acquisition date, it requires an acquirer to account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts, which should generally result in an acquirer recognizing and measuring the acquired contract assets and contract liabilities consistent with how they were recognized and measured in the acquiree’s financial statements. The Company elected to early adopt ASU 2021-08 as of January 1, 2022. The adoption of ASU 2021-08 did not have a material impact on the Company’s consolidated financial position, operating results or cash flows.</span></div> Business Combinations<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Freedom Photonics Acquisition</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 13, 2022 (the “Acquisition Date”), the Company completed its acquisition of Freedom Photonics, a designer and manufacturer of high-performance lasers and related photonic products. The Freedom Photonics acquisition is expected to help the Company secure intellectual property and the supply of a key enabling component as part of the Company’s vertical integration strategy.</span></div><div style="margin-bottom:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the Merger Agreement between the Company and Freedom Photonics, the Company acquired all of the issued and outstanding units of capital of Freedom Photonics for an aggregate purchase price of approximately $34.6 million payable primarily in Class A common stock of the Company. The purchase price includes a $0.4 million adjustment to the preliminary estimates of working capital. In conjunction with the acquisition, the Company issued share-based compensation awards to certain employees and selling equity holders of Freedom Photonics, which may result in future stock-based compensation expense, subject to achievement of certain service and performance conditions, including certain technical and financial milestones. These post-combination shared-based awards were determined to be compensatory in nature and consequently are being expensed over the vesting period of these awards. The results of operations related to Freedom Photonics are included in the Company’s consolidated statements of operations beginning from the Acquisition Date. As part of the transaction, the Company incurred $1.4 million of acquisition-related costs, which were expensed and included in general and administrative expenses in the periods in which the costs were incurred.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recording of Assets Acquired and Liabilities Assumed</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Preliminary estimates of fair values included in the consolidated financial statements are expected to be finalized within a year following the Acquisition Date. These are related to certain working capital adjustments and finalization of the estimates relating to deferred tax balances which will occur after the filing of the current tax returns. After the measurement period, any subsequent adjustments will be reflected in the consolidated statements of operations.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the preliminary purchase price allocation to assets acquired and liabilities assumed, including identification of measurement period adjustments (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preliminary Recorded Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,063 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,311 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,913 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,353 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,600 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill (2)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,885 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,793 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,158)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,158)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,635 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Tradename was measured using the relief-from-royalty method. The remaining identifiable intangible assets were measured using the income approach. Significant inputs used as part of the valuation of intangible assets include revenue forecasts, present value factors, expected product margins and costs to complete the IPR&amp;D.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected future economic benefits as a result of other assets acquired that could not be individually identified and separately recognized. Goodwill is not amortized. The factors that made up goodwill recognized included assembled workforce and component cost savings. The entire amount of goodwill is expected to be deductible for tax purposes and is allocated to the ATS segment, which is also deemed the reporting unit.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable intangible assets recognized (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preliminary Recorded Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer backlog</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,950 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development (IPR&amp;D) (1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradename</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,600 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) IPR&amp;D intangibles are treated as indefinite-lived until the completion or abandonment of the associated R&amp;D</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> project, at which time the appropriate useful lives will be determined.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplemental Unaudited Pro Forma Information</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following unaudited pro forma financial information summarizes the combined results of operations for the Company and Freedom Photonics as if the companies were combined as of the beginning of fiscal year 2021. The unaudited pro forma information includes adjustments to amortization and depreciation for intangible assets and property and equipment acquired, the purchase accounting effect on transaction costs, and stock-based compensation expense. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below reflects the impact of adjustments to the unaudited pro forma results for the years ended December 31, 2022 and 2021 that are directly attributable to the acquisition (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) / increase to expenses as a result of transaction costs</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,582)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,795 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) / increase to expenses as a result of stock-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,119 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,593 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nonrecurring pro forma adjustments include:</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Transaction costs of $2.8 million are assumed to have occurred on January 1, 2021, and are recognized as if incurred in the first quarter of 2021;</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Employee compensation in connection with the retention awards, incentive plan awards, sign-on bonuses, and deferred shares are assumed to have started on January 1, 2021, and recognized as incurred based on their respective periods.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma information presented below is for informational purposes only and is not necessarily indicative of our consolidated results of operations of the combined business had the acquisition actually occurred at the beginning of fiscal year 2021 or the results of our future operations of the combined businesses (in thousands).</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,422 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,804 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(447,736)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(260,813)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Solfice Assets Acquisition</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 15, 2022, the Company completed its acquisition from Solfice of certain assets for an aggregate consideration of $6.3 million, payable in Class A common stock of the Company, that are expected to advance Luminar’s mapping software development capabilities. The transaction was determined to be an asset acquisition under ASC 805, Business Combinations, with substantially all of the fair value attributable to acquired technology. </span></div><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Optogration Acquisition</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 3, 2021, (the “Optogration Acquisition Date”) the Company completed its acquisition of Optogration. The Optogration acquisition helps the Company secure intellectual property and supply of Indium Gallium Arsenide (“InGaAs”) photodetector semiconductor chips, which are used to convert optical power into an electrical current. The acquisition of Optogration is part of the Company’s vertical integration strategy, which helps to secure the supply of a key component of its sensor technology.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the Stock Purchase Agreement between the Company and Optogration, the Company acquired all of the issued and outstanding capital stock of Optogration for an aggregate purchase price of approximately $6.3 million payable in Class A common stock of the Company. Subsequent to the Optogration Acquisition Date, up to $22.0 million of post combination share-based awards may be payable to certain selling shareholders of Optogration, subject to certain service and performance conditions. These post combination shared-based awards were determined to be compensatory in nature and consequently are being expensed over the vesting period of these awards. In August 2022, the Company issued 1,632,056 shares of Class A common stock for $11.0 million of the Optogration Milestone Awards due to achievement of the service and performance conditions. As of December 31, 2022, it is probable that the service and performance conditions for the remaining $11.0 million obligation will be met.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations related to Optogration are included in the Company’s consolidated statements of operations beginning from the Optogration Acquisition Date. The impact of the acquisition on the consolidated financial results of the Company for the year ended December 31, 2021 was not material.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recording of Assets Acquired and Liabilities Assumed</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimates of fair value included in the consolidated financial statements, in conformity with ASC 820, Fair Value Measurement, represent the Company’s best estimates and valuations. In accordance with ASC 805, Business Combinations, the allocation of the consideration value is subject to adjustment until the Company has completed its analysis, but not to exceed one year after the Optogration Acquisition Date to provide the Company with the time to complete the valuation of its assets and liabilities.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Settlement of a pre-existing agreement with Optogration</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the acquisition, the Company had contracted with Optogration as a supplier. In assessing whether said pre-existing supply contract was at market, favorable or unfavorable from the Company’s perspective, the Company assessed whether the terms of the supply contract, including pricing, were consistent with what the Company would have required from another company that would have contracted for similar products and production volumes. The Company concluded that the supply agreement was at market, and thus no gain or loss was recognized upon effective settlement of the pre-existing supply agreement.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the purchase price allocation to assets acquired and liabilities assumed, including identification of measurement period adjustments:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Recorded Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">810 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,248 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets (1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill (2)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,244 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Total assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,176 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(488)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,346)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Total liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,834)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">      Net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,342 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1) Identifiable intangible assets were measured using the income approach.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2) Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected future economic benefits as a result of other assets acquired that could not be individually identified and separately recognized. Goodwill is not amortized. The factors that made up the goodwill recognized included assembled workforce and component cost savings. Goodwill is not expected to be deductible for tax purposes.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable intangible assets recognized:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Recorded Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradename</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">≤ 1 year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reverse Merger with Gores</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 2, 2020, Gores consummated the Business Combination pursuant to that certain Agreement and Plan of Merger, dated August 24, 2020 (the “Merger Agreement”), by and among Gores, Dawn Merger Sub, Inc. (“First Merger Sub”), a wholly owned subsidiary of Gores, Dawn Merger Sub II, LLC (“Second Merger Sub”), a wholly owned subsidiary of Gores, and Legacy Luminar. In connection with the consummation of the Business Combination (the “Closing”), the registrant changed its name from Gores Metropoulos, Inc. to Luminar Technologies, Inc.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately following the Business Combination, there were 323,936,240 shares of common stock, consisting of 218,818,037 shares of Class A common stock and 105,118,203 shares of Class B common stock with a par value of $0.0001 issued and outstanding, options to purchase an aggregate of 16,224,474 shares of Class A common stock and warrants to purchase, 4,089,280 shares of Class A common stock.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, the Company’s stockholders were entitled to receive an aggregate of up to 25,819,887 earn-out shares in the form of common stock (with respect to the Company’s Class A stockholders’ shares of Class A common stock and with respect to the Company’s Class B stockholders’ shares of Class B common stock). There were six </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">different triggering events that affect the number of earn-out shares that will be issued based upon the per share price of Class A common stock ranging from $13.00 to $28.00 per share. On August 11, 2021, the Company issued a total of 17,213,170 earn-out shares towards additional consideration in the form of common stock, consisting of 10,242,703 shares of Class A common stock and 6,970,467 shares of Class B common stock, upon meeting four of six triggering events. The shares issued were based upon the Class A common stock trading price exceeding $13.00, $16.00, $19.00 and $22.00 per share for a certain period of time. There are 5,121,484 shares of Class A common stock and 3,485,233 shares of Class B common stock remaining under the Merger Agreement, which will be issued in equal parts if the Class A common stock share price exceeds $25.00 and $28.00 per share for a certain period of time.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for the potential earn-out shares as a component of stockholders’ equity in accordance with the guidance in ASC 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liabilities from Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On December 2, 2020, the Company estimated the fair value of the potential earn-out shares to be $587.7 million, which was estimated using a Monte Carlo Model and Level 3 fair value inputs including volatility of 58.5% and a contractual term of 5.5 years. This was recorded as an increase in additional paid-in capital with an offsetting amount recorded in the same account, due to the absence of retained earnings.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Business Combination was accounted for as a reverse recapitalization </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in accordance with GAAP as Legacy Luminar has been determined to be the accounting acquirer, primarily due to the fact that Legacy Luminar stockholders continue to control the post-combination Company. Under this method of accounting, while Gores was the legal acquirer, it has been treated as the “acquired” company for financial reporting purposes. Accordingly, the Business Combination was treated as the equivalent of Legacy Luminar issuing stock for the net assets of Gores, accompanied by a recapitalization. The net assets of Gores were stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Business Combination are those of Legacy Luminar. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reported shares and earnings per share available to holders of the Company’s common stock, prior to the Business Combination, have been retroactively restated as shares reflecting the exchange ratio established in the Business Combination (approximately 1 Gores shares to 13.63094 Luminar shares).</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred $17.2 million in transaction costs relating to the merger with Gores, which has been offset against additional paid-in capital in the Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit). On the date of the Business Combination, the Company recorded a liability related to the Public and Private Warrants of $102.4 million, with an offsetting entry to additional paid-in capital.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon closing of the Business Combination, the shareholders’ of Gores were issued 49,981,349 shares of Class A common stock. In connection with the Closing, holders of 18,651 shares of common stock of Gores were redeemed at a price per share of $10.16.</span></div> 34600000 400000 1400000 <div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the preliminary purchase price allocation to assets acquired and liabilities assumed, including identification of measurement period adjustments (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preliminary Recorded Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,063 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,311 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,913 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,353 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,600 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill (2)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,885 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,793 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,158)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,158)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,635 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Tradename was measured using the relief-from-royalty method. The remaining identifiable intangible assets were measured using the income approach. Significant inputs used as part of the valuation of intangible assets include revenue forecasts, present value factors, expected product margins and costs to complete the IPR&amp;D.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected future economic benefits as a result of other assets acquired that could not be individually identified and separately recognized. Goodwill is not amortized. The factors that made up goodwill recognized included assembled workforce and component cost savings. The entire amount of goodwill is expected to be deductible for tax purposes and is allocated to the ATS segment, which is also deemed the reporting unit.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the purchase price allocation to assets acquired and liabilities assumed, including identification of measurement period adjustments:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Recorded Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">810 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,248 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets (1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill (2)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,244 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Total assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,176 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(488)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,346)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Total liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,834)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">      Net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,342 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1) Identifiable intangible assets were measured using the income approach.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2) Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected future economic benefits as a result of other assets acquired that could not be individually identified and separately recognized. Goodwill is not amortized. The factors that made up the goodwill recognized included assembled workforce and component cost savings. Goodwill is not expected to be deductible for tax purposes.</span></div> 1063000 3311000 1913000 127000 70000 1353000 449000 22000 15600000 15885000 39793000 5158000 5158000 34635000 <div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable intangible assets recognized (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preliminary Recorded Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer backlog</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,950 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development (IPR&amp;D) (1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradename</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,600 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) IPR&amp;D intangibles are treated as indefinite-lived until the completion or abandonment of the associated R&amp;D</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> project, at which time the appropriate useful lives will be determined.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable intangible assets recognized:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Recorded Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradename</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">≤ 1 year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> P2Y 650000 P4Y 2950000 P8Y 4000000 7500000 P4Y 500000 15600000 The table below reflects the impact of adjustments to the unaudited pro forma results for the years ended December 31, 2022 and 2021 that are directly attributable to the acquisition (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) / increase to expenses as a result of transaction costs</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,582)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,795 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) / increase to expenses as a result of stock-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,119 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,593 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> -2582000 2795000 4119000 19593000 2800000 <div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma information presented below is for informational purposes only and is not necessarily indicative of our consolidated results of operations of the combined business had the acquisition actually occurred at the beginning of fiscal year 2021 or the results of our future operations of the combined businesses (in thousands).</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,422 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,804 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(447,736)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(260,813)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 46422000 49804000 -447736000 -260813000 6300000 6300000 22000000 1632056 11000000 11000000 358000 810000 482000 1248000 384000 2650000 2244000 8176000 488000 1346000 1834000 6342000 P10Y 780000 P1Y 120000 P10Y 1750000 2650000 323936240 218818037 218818037 105118203 105118203 0.0001 0.0001 16224474 4089280 25819887 6 13.00 28.00 17213170 10242703 6970467 4 6 13.00 16.00 19.00 22.00 5121484 3485233 25.00 28.00 587700000 0.585 5.5 13.63094 17200000 102400000 49981349 18651 10.16 Revenue<div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s revenue is comprised of sales of lidar sensors hardware, components, NRE services and licensing of certain information available with the Company.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenues</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disaggregates its revenue from contracts with customers by (1) geographic region based on customer’s billed to location, and (2) type of good or service and timing of transfer of goods or services to customers (point-in-time or over time), as it believes it best depicts how the nature, amount, timing and uncertainty of its revenue and cash flows are affected by economic factors. Total revenue based on the disaggregation criteria described above, as well as revenue by segment, are as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue by primary geographical market:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">North America</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,032 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,043 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,010 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,703 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,502 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">906 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Europe and Middle East</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,963 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,399 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,035 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,698 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,944 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,951 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue by timing of recognition:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Recognized at a point in time</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,595 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,892 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,639 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Recognized over time</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,103 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,052 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,312 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,698 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,944 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,951 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue by segment:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Autonomy Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,353 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,497 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,387 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ATS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,345 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,447 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,564 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,698 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,944 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,951 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Volvo Stock Purchase Warrant</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Company issued a stock purchase warrant (“Volvo Warrants”) to Volvo Car Technology Fund AB (“VCTF”) in connection with an engineering services contract. The Volvo Warrants entitle VCTF to purchase up to 4,089,280 shares of Class A common stock, at a price of $3.1769 per share from the Company and were determined to be an equity classified award to VCTF. The Volvo Warrants vest and become exercisable in two tranches based on satisfaction of certain commercial milestones, upon reaching commercial production and delivery of production units. The grant date fair value of the Volvo Warrants, aggregating $2.9 million, represents consideration payable to VCTF and is being recognized as reduction in revenue consistent with the revenue recognition pattern when these warrants become probable of vesting. The Company’s management determined that the vesting of the first of the two tranches of the Volvo Warrants was probable as of December 31, 2021. As such, the Company had recognized a reduction in revenue in the amount of $1.0 million related to the said first tranche of the Volvo Warrants in the year ended December 31, 2021. The second tranche of the Volvo warrants will be recorded as a reduction in revenue upon achievement of sales of a certain number of the Company’s sensors to Volvo for use in their commercial vehicles. This threshold had not been achieved as of December 31, 2022.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract assets and liabilities</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets primarily represent revenues recognized for performance obligations that have been satisfied but for which amounts have not been billed. The Company’s contract assets as of December 31, 2022 and 2021 were $18.0 million and $9.9 million. Contract liabilities consist of deferred revenue and customer advanced payments. Deferred revenue includes billings in excess of revenue recognized related to product sales and other services revenue and is recognized as revenue when the Company performs under the contract. Customer advanced payments represent required customer payments in advance of product shipments according to customer’s payment term. Customer advance payments are recognized as revenue when control of the performance obligation is transferred to the customer. The Company’s contract liabilities were $3.0 million and $0.9 million as of December 31, 2022 and 2021, respectively, and were included in accrued and other current and non-current liabilities in the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The opening and closing balances of contract assets were as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,395 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,907 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,575 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,970 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,907 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant changes in contract assets balances consisted of the following (in thousands): </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,907 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts billed that were included in the contract assets beginning balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,228)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized for performance obligations that have been satisfied but for which amounts have not been billed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,907 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,970 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,907 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The opening and closing balances of contract liabilities were as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,993 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,008 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant changes in contract liabilities balances consisted of the following (in thousands): </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,284 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized that was included in the contract liabilities beginning balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(489)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,792)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to cash received and not recognized as revenue and billings in excess of revenue recognized during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,599 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,008 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remaining Performance Obligations</span></div>Revenue allocated to remaining performance obligations was $39.7 million as of December 31, 2022 and includes amounts within contract liabilities. The Company expects to recognize approximately 82% of this revenue over the next 12 months and the remainder thereafter. Total revenue based on the disaggregation criteria described above, as well as revenue by segment, are as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue by primary geographical market:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">North America</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,032 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,043 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,010 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,703 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,502 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">906 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Europe and Middle East</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,963 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,399 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,035 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,698 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,944 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,951 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue by timing of recognition:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Recognized at a point in time</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,595 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,892 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,639 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Recognized over time</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,103 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,052 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,312 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,698 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,944 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,951 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue by segment:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Autonomy Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,353 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,497 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,387 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ATS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,345 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,447 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,564 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,698 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,944 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,951 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table> 35032000 0.86 23043000 0.72 4010000 0.29 3703000 0.09 2502000 0.08 906000 0.06 1963000 0.05 6399000 0.20 9035000 0.65 40698000 1 31944000 1 13951000 1 17595000 0.43 8892000 0.28 2639000 0.19 23103000 0.57 23052000 0.72 11312000 0.81 40698000 1 31944000 1 13951000 1 24353000 0.60 28497000 0.89 11387000 0.82 16345000 0.40 3447000 0.11 2564000 0.18 40698000 1 31944000 1 13951000 1 4089280 3.1769 2 2900000 -1000000 18000000 9900000 3000000 900000 <div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The opening and closing balances of contract assets were as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,395 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,907 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,575 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,970 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,907 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant changes in contract assets balances consisted of the following (in thousands): </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,907 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts billed that were included in the contract assets beginning balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,228)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized for performance obligations that have been satisfied but for which amounts have not been billed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,907 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,970 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,907 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The opening and closing balances of contract liabilities were as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,993 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,008 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant changes in contract liabilities balances consisted of the following (in thousands): </span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,284 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized that was included in the contract liabilities beginning balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(489)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,792)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to cash received and not recognized as revenue and billings in excess of revenue recognized during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,599 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,008 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 15395000 9907000 2575000 0 17970000 9907000 9907000 0 4228000 0 12291000 9907000 17970000 9907000 1993000 898000 1015000 0 3008000 898000 898000 2284000 489000 1792000 2599000 406000 3008000 898000 39700000 0.82 P12M Investments<div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Securities</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s investments in debt securities consisted of the following as of December 31, 2022 and 2021 (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,075 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,598)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,480 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency and government sponsored securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,999 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,924 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,755 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,523 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,123 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,909 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,945 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,835 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393,897 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,229)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,671 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393,897 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,229)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,671 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,938 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(474)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,465 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency and government sponsored securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,995 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,970 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,788 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,784 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,522 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(345)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,190 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,540 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,466 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419,783 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(922)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418,875 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418,833 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(922)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417,925 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the gross unrealized losses and the fair value for those debt securities that were in an unrealized loss position for less than 12 months as of December 31, 2022 and 2021 (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,598)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,888 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(474)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,454 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency and government sponsored securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,924 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,970 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,523 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,285 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,909 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(345)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,522 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,835 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,251 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,229)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360,079 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(922)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372,482 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the total amortized cost basis of the Company’s available-for-sale securities exceeded its fair value by $4.2 million, which was primarily attributable to widening credit spreads and rising interest rates since purchase. The Company reviewed its available-for-sale securities and concluded that the decline in fair value was not related to credit losses and that it is more likely than not that the entire amortized cost of each security will be recoverable before the Company is required to sell them or when the security matures. Accordingly, during the year ended December 31, 2022, no allowance for credit losses was recorded and instead the unrealized losses are reported as a component of accumulated other comprehensive income (loss).</span></div><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Investments</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s equity investments consisted of the following as of December 31, 2022 and 2021 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:41.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.605%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.609%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated Balance Sheets Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,056 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,654 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,643 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,216 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-marketable equity investment measured using the measurement alternative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,002 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,699 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,872 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)    Investments with readily determinable fair values.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)    Investment in privately held company without readily determinable fair value.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company made an investment in 1,495 Class A Preferred Units of Robotic Research OpCo, LLC (“Robotic Research”) for consideration of $10.0 million, which was settled by issuing 618,924 shares of Class A common stock of the Company. The Company’s investment in Robotic Research represents less than 5% of Robotic Research’s capitalization. The Company neither has a significant influence over Robotic Research nor does its investment amount to a controlling financial interest in Robotic Research. As such, the Company measured the initial investment in Robotic Research at cost as provided under the guidance for measurement of equity investment using the measurement alternative. In the fourth quarter of 2022, the Company recorded an impairment charge of $6.0 million related to the investment in Robotic Research.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Company made an investment in 1,500,000 Class A ordinary shares of ECARX Holdings Inc., (“ECARX”) for consideration of $15.0 million, which was settled by issuing 2,030,374 shares of Class A common stock of the Company. The Company’s investment in ECARX represents less than 5% of ECARX’s capitalization. The Company neither has a significant influence over ECARX nor does its investment amount to a controlling financial interest in ECARX. The Company measured the investment in ECARX using the quoted prices in active markets with changes recorded in other income (expense), net on the consolidated statement of operations. Jun Hong Heng is a director of ECARX. Mr. Heng is also a director of Luminar.</span></div> <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s investments in debt securities consisted of the following as of December 31, 2022 and 2021 (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,075 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,598)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,480 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency and government sponsored securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,999 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,924 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,755 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,523 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,123 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,909 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,945 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,835 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393,897 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,229)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,671 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393,897 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,229)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,671 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,938 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(474)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,465 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency and government sponsored securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,995 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,970 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,788 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,784 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,522 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(345)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,190 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,540 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,466 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419,783 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(922)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418,875 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418,833 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(922)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417,925 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 191075000 3000 2598000 188480000 4999000 0 75000 4924000 74755000 0 232000 74523000 111123000 0 1214000 109909000 11945000 0 110000 11835000 393897000 3000 4229000 389671000 393897000 3000 4229000 389671000 161938000 1000 474000 161465000 4995000 0 25000 4970000 40788000 0 4000 40784000 165522000 13000 345000 165190000 46540000 0 74000 46466000 419783000 14000 922000 418875000 950000 0 0 950000 418833000 14000 922000 417925000 <div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the gross unrealized losses and the fair value for those debt securities that were in an unrealized loss position for less than 12 months as of December 31, 2022 and 2021 (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,598)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,888 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(474)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,454 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency and government sponsored securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,924 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,970 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,523 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,285 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,909 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(345)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,522 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,835 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,251 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,229)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360,079 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(922)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372,482 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2598000 158888000 474000 146454000 75000 4924000 25000 4970000 232000 74523000 4000 30285000 1214000 109909000 345000 145522000 110000 11835000 74000 45251000 4229000 360079000 922000 372482000 4200000 <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s equity investments consisted of the following as of December 31, 2022 and 2021 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:41.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.605%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.609%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated Balance Sheets Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,056 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,654 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,643 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,216 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-marketable equity investment measured using the measurement alternative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,002 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,699 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,872 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)    Investments with readily determinable fair values.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)    Investment in privately held company without readily determinable fair value.</span></div> 42056000 25654000 29643000 44216000 4000000 10002000 75699000 79872000 1495 10000000 618924 0.05 6000000 1500000 15000000 2030374 0.05 Financial Statement Components <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consisted of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,496 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303,373 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,056 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,654 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,552 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329,977 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,614 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,866 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,329 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,171 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,849 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,305 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,792 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,342 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s inventory write-offs and write-downs (primarily due to obsolescence, lower of cost or market assessment, and other adjustments) was $12.2 million, $2.9 million and $4.4 million during the years ended December 31, 2022, 2021 and 2020, respectively.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prepaid Expenses and Other Current Assets</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,653 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,651 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,395 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,907 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advance payments to vendors</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,919 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,810 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,236 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,827 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,203 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,195 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,047 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,694 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,797 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,854 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,001 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">885 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles, including demonstration fleet</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,421 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,642 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,677 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,412 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,787 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,152)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,778)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,260 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,009 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment capitalized under finance lease (capital lease prior to adoption of ASC 842) were not material. Construction in progress increased due to increased capital expenditure related to capital projects to enable the Company to achieve series production readiness.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization associated with property and equipment was $4.3 million, $3.9 million and $2.5 million for the years ended December 31, 2022, 2021 and 2020, respectively.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity in the Company’s intangible assets (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,424 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,890 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,237)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,077 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,424 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets were acquired in connection with the Company’s acquisition of Optogration in August 2021, Freedom Photonics in April 2022 and Solfice in June 2022. See Note 3 for further details of these acquisitions. The components of intangible assets were as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:20.454%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.524%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.551%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.291%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/> Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying <br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining Period<br/>(Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/> Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying <br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining Period<br/>(Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,730 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(664)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,066 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer backlog</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradename</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assembled workforce</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,910 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,747 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,677 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,540 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,463)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,077 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,424 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6</span></td></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to intangible assets was $2.2 million, $0.2 million and $0.0 million for the year ended December 31, 2022, 2021 and 2020, respectively.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the expected future amortization expense for intangible assets was as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.379%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expected Future<br/>Amortization Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,730 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,373 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,373 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,726 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,510 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,865 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,077 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of goodwill allocated to the Company’s reportable segments was as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Autonomy Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ATS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,423 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,110 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired goodwill related to Freedom Photonics in 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,885 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,885 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,129 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,816 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Non-Current Assets</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-current assets consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Security deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,495 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-marketable equity investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,002 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advance payment for capital projects</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,683 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,575 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other non-current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,344 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,455 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accrued and Other Current Liabilities</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued and other current liabilities consisted of the following (in thousands): </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,682 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,899 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,358 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,727 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,584 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,798 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,993 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,526 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued and other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,962 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,844 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, the Company recorded $19.2 million in cost of sales (services) estimated losses expected to be incurred on NRE projects with certain customers. Estimated contract losses in the year ended December 31, 2021 and 2020 were not material. The estimated contract losses recorded in 2022 were primarily a result of (a) changes in estimates related to costs expected to be incurred for contractual milestones based on actual experience on similar projects and (b) changes in scope of project deliverables agreed upon with the respective customers during the year.</span></div> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consisted of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,496 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303,373 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,056 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,654 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,552 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329,977 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 27496000 303373000 42056000 25654000 0 950000 69552000 329977000 <div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,614 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,866 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,329 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,171 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,849 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,305 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,792 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,342 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 3614000 5866000 2329000 1171000 2849000 3305000 8792000 10342000 12200000 2900000 4400000 <div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,653 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,651 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,395 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,907 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advance payments to vendors</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,919 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,810 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,236 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,827 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,203 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,195 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 15653000 14651000 15395000 9907000 7919000 1810000 5236000 2827000 44203000 29195000 14047000 7694000 6797000 2854000 1001000 0 885000 869000 3222000 2421000 818000 272000 13642000 3677000 40412000 17787000 10152000 6778000 30260000 11009000 4300000 3900000 2500000 <div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity in the Company’s intangible assets (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,424 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,890 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,237)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,077 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,424 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>The components of intangible assets were as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:20.454%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.524%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.551%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.291%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/> Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying <br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining Period<br/>(Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/> Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying <br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining Period<br/>(Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,730 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(664)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,066 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer backlog</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradename</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assembled workforce</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,910 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,747 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,677 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,540 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,463)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,077 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,424 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6</span></td></tr></table> 2424000 0 21890000 2650000 2237000 226000 22077000 2424000 3730000 664000 3066000 P4Y4M24D 780000 33000 747000 P9Y7M6D 650000 292000 358000 P0Y10M24D 0 0 0 620000 214000 406000 P3Y3M18D 120000 120000 0 130000 130000 0 0 0 0 11910000 1163000 10747000 P7Y6M 1750000 73000 1677000 P9Y7M6D 7500000 0 7500000 0 0 0 24540000 2463000 22077000 P6Y7M6D 2650000 226000 2424000 P9Y7M6D 2200000 200000 0 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the expected future amortization expense for intangible assets was as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.379%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expected Future<br/>Amortization Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,730 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,373 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,373 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,726 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,510 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,865 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,077 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 2730000 2373000 2373000 1726000 1510000 3865000 7500000 22077000 <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of goodwill allocated to the Company’s reportable segments was as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Autonomy Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ATS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,423 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,110 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired goodwill related to Freedom Photonics in 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,885 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,885 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,129 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,816 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 687000 2423000 3110000 0 15885000 15885000 0 -179000 -179000 687000 18129000 18816000 <div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-current assets consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Security deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,495 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-marketable equity investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,002 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advance payment for capital projects</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,683 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,575 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other non-current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,344 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,455 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 5495000 1187000 4000000 10002000 27683000 0 2575000 0 591000 1266000 40344000 12455000 <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued and other current liabilities consisted of the following (in thousands): </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,682 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,899 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,358 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,727 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,584 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,798 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,993 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,526 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued and other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,962 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,844 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 16682000 9899000 22358000 6727000 3584000 1798000 1993000 898000 359000 316000 7526000 115000 460000 91000 52962000 19844000 19200000 0 0 Debt<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Convertible Senior Notes and Capped Call Transactions</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company issued $625.0 million aggregate principal amount of 1.25% Convertible Senior Notes due 2026</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in a private placement, which included $75.0 million aggregate principal amount of such notes pursuant to the exercise in full of the option granted to the initial purchasers to purchase additional notes (collectively, the “Convertible Senior Notes”). The interest on the Convertible Senior Notes is payable semi-annually in arrears on June 15 and December 15 of each year, beginning on June 15, 2022. The Convertible Senior Notes will mature on December 15, 2026, unless earlier repurchased or redeemed by the Company or converted pursuant to their terms.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total net proceeds from the debt offering, after deducting fees paid to the initial purchasers paid by the Company, was approximately $609.4 million. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each $1,000 principal amount of the Convertible Senior Notes is initially convertible into 50.0475 shares of the Company’s Class A common stock, par value $0.0001, which is equivalent to an initial conversion price of approximately $19.98 per share. The conversion rate is subject to adjustment upon the occurrence of certain specified events prior to the maturity date but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or if the Company delivers a notice of redemption in respect of some or all of the Convertible Senior Notes, the Company will, under certain circumstances, increase the conversion rate of the Convertible Senior Notes for a holder who elects to convert its Convertible Senior Notes in connection with such a corporate event or convert its Convertible Senior Notes called for redemption during the related redemption period, as the case may be. The Convertible Senior Notes are redeemable, in whole or in part (subject to certain limitations), at the Company’s option at any time, and from time to time, on or after December 20, 2024, and on or before the 40th scheduled trading day immediately before the maturity date, at a cash redemption price equal to the principal amount of the Convertible Senior Notes to be redeemed, plus accrued and unpaid </span></div><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interest, if any, to, but excluding, the redemption date, but only if certain liquidity conditions are satisfied and the last reported sale price per share of the Class A common stock exceeds 130% of the conversion price on (1) each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice, and (2) the trading day immediately before the date the Company sends such notice. If the Company undergoes a fundamental change (as defined in the indenture governing the Convertible Senior Notes) prior to the maturity date, holders may require the Company to repurchase for cash all or any portion of their Convertible Senior Notes in principal amounts of $1,000 or a multiple thereof at a fundamental change repurchase price equal to 100% of the principal amount of the Convertible Senior Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Convertible Senior Notes may convert their Convertible Senior Notes at their option at any time prior to the close of business on the business day immediately preceding December 15, 2026, in multiples of $1,000 principal amount, only under the following circumstances: (1) during any calendar quarter (and only during such calendar quarter) commencing after the calendar quarter ending on March 31, 2022, if the last reported sale price per share of the Class A common stock exceeds 130% of the conversion price for each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (2) during the five consecutive business days immediately after any 10 consecutive trading day period (such 10 consecutive trading day period, the “measurement period”) in which the trading price per $1,000 principal amount of Convertible Senior Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of the Class A common stock on such trading day and the conversion rate on such trading day; (3) upon the occurrence of specified corporate events or distributions on the Class A common stock; and (4) if the Convertible Senior Notes are called for redemption. On or after June 15, 2026, holders may convert all or any portion of their Convertible Senior Notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date, regardless of the foregoing circumstances. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of its Class A common stock or a combination of cash and shares of its Class A common stock, at the Company’s election. As of December 31, 2022, the conditions allowing holders of the Convertible Senior Notes to convert were not met.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is the Company’s current intent to settle the principal amount of its outstanding Convertible Senior Notes in cash and any excess in shares of the Company’s Class A common stock.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Convertible Senior Notes are senior unsecured obligations and will rank equal in right of payment with the Company’s future senior unsecured indebtedness; senior in right of payment to the Company’s future indebtedness that is expressly subordinated to the Convertible Senior Notes; effectively subordinated to the Company’s existing and future secured indebtedness, to the extent of the value of the collateral securing that indebtedness; and structurally subordinated to all existing and future indebtedness and other liabilities, including trade payables, and (to the extent the Company is not a holder thereof) preferred equity, if any, of the Company’s subsidiaries.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified the Convertible Senior Notes as a non-current liability under the guidance in ASC 470-20, as amended by ASU 2020-06. Debt discount and issuance costs aggregating approximately $16.2 million were initially recorded as a reduction to the principal amount of the Convertible Senior Notes and is being amortized as interest expense on a straight line basis over the contractual terms of the notes. The Company estimates that the difference between amortizing the debt discounts and the issuance costs using the straight line method as compared to using effective interest rate method is immaterial. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net carrying amount of the Convertible Senior Notes was as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625,000 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625,000 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt discount and issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,808)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,043)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying amount</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612,192 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608,957 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the interest expense recognized related to the Convertible Senior Notes (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,812 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt discount and issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,236 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,048 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining term over which the debt discount and issuance costs will be amortized is 3.96 years. Interest expense of $7.8 million and $0.5 million is reflected as a component of interest (expense) income, net in the accompanying consolidated statement of operations for the years ended December 31, 2022 and 2021, respectively.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the offering of the Convertible Senior Notes, the Company entered into privately negotiated capped call option transactions with certain counterparties (the “Capped Calls”). The Capped Calls each have an initial strike price of approximately $19.98 per share, subject to certain adjustments, which corresponds to the initial conversion price of the Convertible Senior Notes. The Capped Calls have initial cap prices of $30.16 per share, subject to certain adjustment events. The Capped Calls are generally intended to reduce the potential dilution to the Class A common stock upon any conversion of the Convertible Senior Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of converted Convertible Senior Notes, as the case may be, with such reduction and/or offset subject to a cap based on the cap price. The Capped Calls expire on April 6, 2027, subject to earlier exercise. The Capped Calls are subject to either adjustment or termination upon the occurrence of specified extraordinary events affecting the Company, including a merger event, a tender offer, and a nationalization, insolvency or delisting involving the Company. In addition, the Capped Calls are subject to certain specified additional disruption events that may give rise to a termination of the Capped Calls, including changes in law, failure to deliver, and hedging disruptions. The net cost of $73.4 million incurred to purchase the Capped Calls was recorded as a reduction to additional paid-in capital in the accompanying consolidated balance sheet. The Capped Calls are not accounted for as derivatives.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Secured Loan</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legacy Luminar had in August 2017 issued certain Senior Secured Promissory Notes (“Senior Secured Notes”). These Senior Secured Notes were subsequently amended, refinanced and partially repaid at various times through 2020. The Senior Secured Notes were repaid in full in December 2020 as required per the terms of the Merger Agreement. The Company had recorded loss on extinguishment of debt in connection with the Senior Secured Notes in the amount of approximately $4.0 million and interest expense in the amount of $2.5 million in 2020.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the issuance of Senior Secured Notes and its subsequent amendment, refinance and partial repayments at various times through 2020, Legacy Luminar had issued warrants in 2017, 2018 and 2019 (collectively “Legacy Warrants”). The Legacy Warrants were recorded at fair value with subsequent changes in fair value reflected in earnings. The change in fair value resulted in a loss of $27.3 million during the year ended December 31, 2020. Upon closing of the Business Combination, the Legacy Warrants were exercised for 1,466,155 shares of Class A common stock. No Legacy Warrants have been outstanding since December 31, 2020.</span></div> 625000000 0.0125 75000000 609400000 50.0475 0.0001 19.98 1.30 20 30 1 1.30 20 30 5 10 10 0.98 16200000 <span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net carrying amount of the Convertible Senior Notes was as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625,000 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625,000 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt discount and issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,808)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,043)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying amount</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612,192 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608,957 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 625000000 625000000 12808000 16043000 612192000 608957000 <span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the interest expense recognized related to the Convertible Senior Notes (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,812 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt discount and issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,236 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,048 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 7812000 316000 3236000 135000 11048000 451000 P3Y11M15D 7800000 500000 19.98 30.16 73400000 4000000 2500000 27300000 1466155 0 Fair Value Measurements<div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company carried cash equivalents, marketable investments and Private Warrants that are measured at fair value on a recurring basis. The Company had previously carried Public Warrants which were exercised and redeemed in March 2021.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is based on the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 — Observable inputs, which include unadjusted quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 — Observable inputs other than Level 1 inputs, such as quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 — Unobservable inputs that are supported by little or no market activity and that are based on management’s assumptions, including fair value measurements determined by using pricing models, discounted cash flow methodologies or similar techniques.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the fair value of its Level 1 financial instruments, which are traded in active markets, using quoted market prices for identical instruments.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable investments classified within Level 2 of the fair value hierarchy are valued based on other observable inputs, including broker or dealer quotations, alternative pricing sources or U.S. Government Treasury yield of appropriate term. When quoted prices in active markets for identical assets or liabilities are not available, the Company relies on non-binding quotes from its investment managers, which are based on proprietary valuation models of independent pricing services. These models generally use inputs such as observable market data, quoted market prices for similar instruments, historical pricing trends of a security as relative to its peers. To validate the fair value determination provided by its investment managers, the Company reviews the pricing movement in the context of overall market trends and trading information from its investment managers. The Company performs routine procedures such as comparing prices obtained from independent source to ensure that appropriate fair values are recorded.</span></div> Fair Value Measurements<div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company carried cash equivalents, marketable investments and Private Warrants that are measured at fair value on a recurring basis. The Company had previously carried Public Warrants which were exercised and redeemed in March 2021.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is based on the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 — Observable inputs, which include unadjusted quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 — Observable inputs other than Level 1 inputs, such as quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 — Unobservable inputs that are supported by little or no market activity and that are based on management’s assumptions, including fair value measurements determined by using pricing models, discounted cash flow methodologies or similar techniques.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the fair value of its Level 1 financial instruments, which are traded in active markets, using quoted market prices for identical instruments.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable investments classified within Level 2 of the fair value hierarchy are valued based on other observable inputs, including broker or dealer quotations, alternative pricing sources or U.S. Government Treasury yield of appropriate term. When quoted prices in active markets for identical assets or liabilities are not available, the Company relies on non-binding quotes from its investment managers, which are based on proprietary valuation models of independent pricing services. These models generally use inputs such as observable market data, quoted market prices for similar instruments, historical pricing trends of a security as relative to its peers. To validate the fair value determination provided by its investment managers, the Company reviews the pricing movement in the context of overall market trends and trading information from its investment managers. The Company performs routine procedures such as comparing prices obtained from independent source to ensure that appropriate fair values are recorded.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given that the transfer of Private Warrants to anyone outside of a small group of individuals constituting the sponsors of Gores Metropoulos, Inc. would result in the Private Warrants having substantially the same terms as the Public Warrants, management determined that the fair value of each Private Warrant is the same as that of a Public Warrant, with an insignificant adjustment for short-term marketability restrictions, as of December 31, 2021. As of December 31, 2022, management determined the fair value of the Private Warrants using observable inputs in the Black-Scholes valuation model, which used the remaining term of warrants of 2.92 years, volatility of 85.0% and a risk-free rate of 4.23%. Accordingly, the Private Warrants are classified as Level 3 financial instruments.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents changes in Level 3 liabilities relating to Private Warrants measured at fair value (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Private<br/>Warrants</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,230 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value prior to exercises</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,713 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction in liability due to exercises</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,003)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of outstanding warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,935)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,005 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used for such measurements were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value (in thousands) Measured as of<br/>December 31, 2022 Using:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,056 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,056 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,056 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,056 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable investments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,480 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,480 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency and government sponsored securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,924 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,924 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,523 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,523 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,909 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,909 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,835 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,835 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,643 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,643 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable investments</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,123 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,191 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419,314 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,005 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,005 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total warrant liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,005 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,005 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value (in thousands) Measured as of<br/>December 31, 2021 Using:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,654 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,654 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,654 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,604 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,465 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,465 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency and government sponsored securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,970 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,970 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,834 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,834 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,190 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,190 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,466 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,466 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,216 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,216 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,681 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,460 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462,141 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total warrant liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,230 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,230 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s non-marketable equity investment, measured at fair value on a non-recurring basis, that has been remeasured during the period due to impairment is classified within Level 3 in the fair value hierarchy because the Company estimated the value based on valuation methods which included unobservable inputs including projections received from Robotic Research, market conditions, preference rights, etc. of the investment the Company holds. See Note 5 for further information on the Company’s non-marketable equity investment.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022 and 2021, the estimated fair value of the Company’s outstanding Convertible Senior Notes was $352.5 million and $669.4 million, respectively. The fair value was determined based on the quoted price of the Convertible Senior Notes in an inactive market on the last trading day of the reporting period and have been classified as Level 2 in the fair value hierarchy. See Note 7 for further information on the Company’s Convertible Senior Notes.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s other financial instruments’ fair value, including accounts receivable, accounts payable and other current liabilities, approximate its carrying value due to the relatively short maturity of those instruments. The carrying amounts of the Company’s finance leases approximate their fair value, which is the present value of expected future cash payments based on assumptions about current interest rates and the creditworthiness of the Company.</span></div> P2Y11M1D 0.850 0.0423 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents changes in Level 3 liabilities relating to Private Warrants measured at fair value (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Private<br/>Warrants</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,230 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value prior to exercises</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,713 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction in liability due to exercises</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,003)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of outstanding warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,935)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,005 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 31230000 4713000 19003000 -13935000 3005000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used for such measurements were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value (in thousands) Measured as of<br/>December 31, 2022 Using:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,056 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,056 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,056 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,056 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable investments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,480 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,480 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency and government sponsored securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,924 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,924 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,523 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,523 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,909 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,909 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,835 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,835 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,643 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,643 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable investments</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,123 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,191 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419,314 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,005 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,005 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total warrant liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,005 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,005 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value (in thousands) Measured as of<br/>December 31, 2021 Using:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,654 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,654 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,654 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,604 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,465 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,465 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency and government sponsored securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,970 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,970 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,834 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,834 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,190 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,190 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,466 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,466 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,216 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,216 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,681 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,460 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462,141 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total warrant liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,230 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,230 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 42056000 0 0 42056000 42056000 0 0 42056000 188480000 0 0 188480000 0 4924000 0 4924000 0 74523000 0 74523000 0 109909000 0 109909000 0 11835000 0 11835000 29643000 0 0 29643000 218123000 201191000 0 419314000 0 0 3005000 3005000 0 0 3005000 3005000 25654000 0 0 25654000 0 950000 0 950000 25654000 950000 0 26604000 161465000 0 0 161465000 0 4970000 0 4970000 0 39834000 0 39834000 0 165190000 0 165190000 0 46466000 0 46466000 44216000 0 0 44216000 205681000 256460000 0 462141000 0 0 31230000 31230000 0 0 31230000 31230000 352500000 669400000 Convertible Preferred Stock<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Series A Convertible Preferred Stock</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 24, 2019, Legacy Luminar had amended and restated its Certificate of Incorporation (“Certificate”), which authorized the issuance of up to 102,740,023 shares of Series A Convertible Preferred Stock with a par value of $0.00001. On June 24, 2019, Legacy Luminar entered into a Series A Convertible Preferred Stock Purchase Agreement to issue preferred stock to investors for cash and in settlement of outstanding SAFEs and Bridge Note.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Series X Convertible Preferred Stock</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 24, 2020, Legacy Luminar had entered into the Series X Convertible Preferred Stock Purchase Agreement to offer shares of Legacy Luminar’s Series X Convertible Preferred Stock. In August 2020 and September of 2020, Legacy Luminar issued an aggregate of 17,065,536 convertible preferred stock for cash at a purchase price of $9.96 per share of preferred stock, which generated gross proceeds of $170.0 million. In October 2020, Legacy Luminar had issued an additional 1,391,694 shares of preferred stock for gross proceeds of $13.86 million. Accordingly, Legacy Luminar had amended and restated its certificate of incorporation, which authorized the issuance of up to 20,077,073 shares of Series X Convertible Preferred Stock with a par value of $0.00001.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon closing of the Business Combination on December 2, 2020, the outstanding shares of Series A and Series X Convertible Preferred Stock were automatically converted into 113,275,381 shares of the Company Class A common stock. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Beneficial Conversion Features (“BCFs”)</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had assessed whether BCFs existed for the optional conversion rights that did not require bifurcation as derivatives. If the conversion option was in-the-money as of the commitment date, the preferred stock contained a BCF. The BCF was recognized as a deemed dividend against the carrying amount of the preferred stock. The Company had monitored for the issuance of additional shares below the conversion price, which could have resulted in a contingent BCF. The Company had recorded a total BCF of $12.0 million from the issuance of preferred stock prior to the close of the Business Combination. Because the preferred stock was convertible at any time pursuant to the optional conversion feature, the Company recognized a dividend equal to the BCF at the applicable commitment date. As the Company had an accumulated deficit as of the end of all periods presented, the BCF resulted in an increase and decrease in additional paid-in capital by the same amount.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, the preferred stock contained a down-round protection provision that reduced the conversion price if the Company issues shares at less than the conversion price or for no consideration. This provision was not triggered upon consummation of the Business Combination and no contingent BCF was recorded during the year ended December 31, 2020.</span></div> 102740023 0.00001 17065536 9.96 170000000 1391694 13860000 20077073 0.00001 113275381 12000000 Earnings (Loss) Per Share<div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares of common stock during the period plus, common stock equivalents, as calculated under the treasury stock method, outstanding during the period. If the Company reports a net loss, the computation of diluted loss per share excludes the effect of dilutive common stock equivalents, as their effect would be antidilutive. The Company computes earnings (loss) per share using the two-class method for its Class A and Class B common stock. Earnings (loss) per share is same for both Class A and Class B common stock since they are entitled to the same liquidation and dividend rights. Earnings (loss) per share calculations for all periods prior to the Business Combination have been retrospectively restated to the equivalent number of shares reflecting the exchange ratio established in the reverse capitalization.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted loss for the years ended December 31, 2022, 2021, and 2020 as follows: (in thousands, except for share and per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(445,939)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237,986)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362,298)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividend attributable to BCF accretion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,757)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to common shareholders</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(445,939)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237,986)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369,055)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average Common shares outstanding- Basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,265,774 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346,300,975 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,096,996 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average Common shares outstanding- Diluted</span></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,265,774 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346,300,975 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,096,996 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per shares attributable to Common shareholders- Basic and Diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.25)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.69)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.54)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the potential shares of common stock outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,757,549 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,166,301 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,089,255 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based awards—Equity classified</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,372,534 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,156,973 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,003,962 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based awards—Liability classified</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,302,723 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,401,648 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor stock-in-lieu of cash program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,162,879 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,659,510 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,279,716 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,279,716 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earn-out shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,606,717 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,606,717 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,818,744 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,482,118 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,270,865 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,911,961 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the if converted method for calculating the dilutive effect of the Convertible Senior Notes using the initial conversion price of $19.981 per share. The closing price of Class A common stock as of December 31, 2022 was less than the initial conversion price.</span></div> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted loss for the years ended December 31, 2022, 2021, and 2020 as follows: (in thousands, except for share and per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(445,939)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237,986)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362,298)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividend attributable to BCF accretion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,757)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to common shareholders</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(445,939)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237,986)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369,055)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average Common shares outstanding- Basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,265,774 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346,300,975 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,096,996 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average Common shares outstanding- Diluted</span></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,265,774 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346,300,975 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,096,996 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per shares attributable to Common shareholders- Basic and Diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.25)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.69)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.54)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> -445939000 -237986000 -362298000 0 0 6757000 -445939000 -237986000 -369055000 356265774 346300975 145096996 356265774 346300975 145096996 -1.25 -1.25 -0.69 -0.69 -2.54 -2.54 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the potential shares of common stock outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,757,549 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,166,301 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,089,255 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based awards—Equity classified</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,372,534 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,156,973 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,003,962 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based awards—Liability classified</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,302,723 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,401,648 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor stock-in-lieu of cash program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,162,879 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,659,510 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,279,716 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,279,716 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earn-out shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,606,717 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,606,717 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,818,744 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,482,118 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,270,865 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,911,961 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 5757549 7166301 24089255 33372534 24156973 18003962 14302723 2401648 0 3162879 1659510 0 31279716 31279716 0 8606717 8606717 25818744 96482118 75270865 67911961 19.981 Stockholders’ Equity (Deficit)<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class A and Class B Common Stock</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s Board of Directors has authorized two classes of common stock, Class A and Class B. As of December 31, 2022, the Company had authorized 715,000,000 and 121,000,000 shares of Class A and Class B common stock with a par value of $0.0001 per share for each class. As of December 31, 2022, the Company had 291,942,087 shares issues and 270,078,637 shares outstanding shares of Class A common stock, and 97,088,670 shares of issued and outstanding Class B common stock. Holders of the Class A and Class B common stock have identical rights, except that holders of the Class A common stock are entitled to one vote per share and the holder of the Class B common stock is entitled to ten votes per share. Shares of Class B common stock can be converted to shares of Class A common stock at any time at the option of the stockholder and automatically convert upon sale or transfer, except for certain transfers specified in the Company’s amended and restated certificate of incorporation. During 2021, 15,000,000 shares of Class B common stock were converted into Class A common stock on a one-for-one basis.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the merger with Gores on December 2, 2020, the Company’s Chief Executive Officer exchanged 22,935,412 shares of Founders Preferred Stock and 82,182,791 shares of Class A common stock, which were entitled to one vote per share, into the same number of shares of Class B common stock, which are entitled to ten votes per share. The Company recorded the incremental value of $3.0 million associated with this transaction as stock-based compensation in general and administrative expenses.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Treasury Stock</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company’s Board of Directors authorized share repurchases up to $312.5 million of the Company’s Class A common stock. The Company’s share repurchase program does not obligate the Company to acquire any specific number of shares. Under the program, shares could be repurchased in privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). In the fourth quarter of 2021, the Company repurchased 15,263,761 shares Class A common stock for $235.9 million through negotiated and market purchase transactions. In the first and second quarters of 2022, the Company repurchased 2,682,548 and 3,917,141 shares of Class A common stock for $39.7 million and $36.9 million, respectively. As of December 31, 2022, no amount remained available for stock repurchases pursuant to our stock repurchase program. The repurchased shares have been recorded as Treasury Stock on the Balance Sheet as of December 31, 2022 and 2021.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Founders Preferred Stock</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,206,837 shares of Founders Preferred Stock were issued in 2015. The compensation expense associated with the Founders Preferred Stock was immaterial to the financial statements. The Founders Preferred Stock was substantively the same as common stock, as they share identical rights and features. The Founders Preferred Stock was convertible into common stock on a one-to-one basis at any time. The Founders Preferred Stock is presented as a component of the Company’s permanent equity. Upon closing of the Business Combination, Founders Preferred Stock was converted into shares of Class A and Class B common stock. No Founders Preferred Stock have been outstanding since the closing of the Business Combination. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Public and Private Warrants</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, 3,589,645 Private Warrants and 13,128,671 Public Warrants were exercised, and the Company received $153.9 million in cash proceeds from the exercise of these warrants. Pursuant to the terms of the agreements governing the rights of the holders of the Public Warrants, the Company redeemed the remaining unexercised and outstanding 204,638 Public Warrants after March 2021 for a redemption price of $0.01 per Public Warrant.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the Company had no Public Warrants and 3,077,021 Private Warrants outstanding.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022 and April 2022, 1,389,529 and 19,223 Private Warrants, respectively, were exercised on a cashless basis and the Company issued 401,365 and 4,387 shares of Class A common stock, respectively, pursuant to the exercises. The Company had 1,668,269 Private Warrants outstanding as of December 31, 2022. These Private Warrants expire on December 2, 2025. Each Private Warrant allows the holder to purchase one share of Class A common stock at $11.50 per share.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-in-lieu of Cash Program</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into arrangements with certain vendors and other third parties wherein the Company at its discretion may elect to pay amounts owed to the respective vendors or third parties for services provided either in cash or by issuing shares of the Company’s Class A common stock (“Stock-in-lieu of Cash Program”). During the year ended December 31, 2022, the Company issued 8,824,385 shares of Class A common stock, as part of the Stock-in-lieu of Cash </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Program. The Company considers the shares issuable under the Stock-in-lieu of Cash Program as liability classified awards when the arrangement with the vendors requires the Company to issue a variable number of shares to settle amounts owed. As of December 31, 2022, the Company had a total of $15.2 million in prepaid expenses and other current and non-current assets related to its Stock-in-lieu of Cash Program.</span></div><div style="margin-bottom:6pt;text-indent:26.28pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Company entered into an agreement with Daimler North America Corporation (“Daimler”) wherein Daimler is providing certain data and other services to the Company. To compensate Daimler for these services, the Company agreed to issue 1.5 million shares of Class A common stock to Daimler. These shares are subject to certain vesting conditions and vest over a period of two years. The Company recorded costs related to these shares as research and development expense of $7.9 million during the year ended December 31, 2022. During the year ended December 31, 2022, the Company issued <span id="ifab7854a919f4406a07991bf49fecd0f_9145"/>1,125,000 shares of Class A common stock related to this arrangement. The unamortized cost relating to the shares issued to Daimler under this agreement was recorded as $9.2 million in prepaid expenses and other current and non-current assets as of December 31, 2022.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s vendor Stock-in-lieu of Cash Program activity for the year ended December 31, 2022 was as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant Date Fair Value<br/>per Share</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.72 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,824,385 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.93 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,277,234)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.65 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047,151 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.90 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 715000000 121000000 0.0001 0.0001 291942087 270078637 97088670 97088670 1 10 15000000 15000000 1 1 22935412 82182791 1 10 3000000 312500000 15263761 235900000 2682548 3917141 39700000 36900000 0 26206837 1 0 3589645 13128671 153900000 204638 0.01 0 3077021 1389529 19223 401365 4387 1668269 1 11.50 8824385 15200000 1500000 P2Y 7900000 1125000 9200000 <div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s vendor Stock-in-lieu of Cash Program activity for the year ended December 31, 2022 was as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant Date Fair Value<br/>per Share</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.72 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,824,385 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.93 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,277,234)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.65 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047,151 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.90 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1500000 15.72 8824385 9.93 9277234 10.65 1047151 11.90 Stock-based Compensation <div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to becoming a publicly traded entity, the Company issued incentive stock options, non-qualified stock options, and restricted stock to employees and non-employee consultants under its 2015 Stock Plan (the “2015 Plan”). Since the closing of the Business Combination, the Company has not issued any new stock-based awards under the 2015 Plan.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Board adopted, and the Company’s stockholders approved the 2020 Equity Incentive Plan (the “2020 Plan”). The 2020 Plan became effective upon the closing of the Business Combination. Under the 2020 Plan, the Company was originally authorized to issue a maximum number of 36,588,278 shares of Class A common stock.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company’s stockholders approved an amendment and restatement of the Company’s 2020 Plan (the “Amended 2020 Plan”) to increase the number of shares of Class A common stock authorized for issuance by 36,000,000 additional shares and added an evergreen provision under which the number of shares of Class A common stock available for issuance under the Amended 2020 Plan will be increased on the first day of each fiscal year of the Company beginning with the 2023 fiscal year and ending on (and including) the first day of the 2030 fiscal year, in an amount equal to the lesser of (i) 5% of the outstanding shares of common stock on the last day of the immediately preceding fiscal year, (ii) 40,000,000 shares or (iii) such number of shares determined by the Board. Pursuant to the evergreen provision, 18,358,365 additional shares of Class A common stock were added to the Amended 2020 Plan on January 1, 2023.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the 2015 Plan, incentive stock options had an exercise price at or above the fair market value of the stock on the date of the grant, while non-qualified stock options were permitted to be granted below fair market value of the stock on the date of grant. Stock options granted had service-based vesting conditions only. The service-based vesting conditions varied, though typically, stock options vest over four years with 25% of stock options vesting on the first anniversary of the grant and the remaining 75% vesting monthly over the remaining 36 months. Option holders have a 10-year period to exercise the options before they expire. Forfeitures are recognized in the period of occurrence.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s stock option activity for the year ended December 31, 2022 was as follows (in thousands, except years and per share data):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,507,643 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.72 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,370,989)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(973,804)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.67 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,162,850 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.74 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.03</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,763 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and exercisable as of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,472,821 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.73 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.95</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,654 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest as of December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,162,850 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.74 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.03</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,763 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No stock options were granted by the Company in 2022 or 2021. The weighted-average grant date fair value per share of options granted during the year ended December 31, 2020 was $0.98. The total grant-date fair value of options that vested during the year ended December 31, 2022, 2021 and 2020 was $2.9 million, $7.1 million and $1.4 million, respectively.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value of stock options exercised during the year ended December 31, 2022 was $20.6 million. The intrinsic value is calculated as the difference between the exercise price and the fair value of the common stock on the exercise date.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company had $2.7 million of unrecognized stock-based compensation expense related to stock options. This cost is expected to be recognized over a weighted-average period of 0.63 years.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Awards</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to June 30, 2019, the Company granted restricted stock awards (“RSAs”) to employees. Recipients purchased the restricted stock on the grant date and the Company has the right to repurchase the restricted shares at the same price recipients paid to obtain those shares. The restrictions lapse solely based on continued service, and generally lapse over 4 years —25% on the first anniversary of the date of issuance, and the remaining 75% monthly over the remaining 36 months. At the grant date of the award, recipients of restricted stock were granted voting rights and right to receive dividends on unvested shares. No restricted stock awards have been granted after June 30, 2019.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s RSAs activity for the year ended December 31, 2022 was as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant Date Fair Value<br/>per Share</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666,298 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.21 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,476)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(583,336)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,486 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total grant-date fair value of restricted stock awards vested during the year ended December 31, 2022, 2021 and 2020 was $0.7 million, $1.0 million and $2.2 million, respectively.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company had $0.1 million of unrecognized stock-based compensation expense related to restricted stock awards, which is expected to be recognized in the first quarter of 2023.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Units</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the closing of the Business Combination, the Company has granted restricted stock units (“RSUs”) under the Amended 2020 Plan (and prior to its amendment and restatement, under the 2020 Plan). Each RSU granted under the Amended 2020 Plan represents a right to receive one share of the Company’s Class A common stock when the RSU vests. RSUs generally vest over a period up to six years. The Company has granted certain performance-based equity awards that vest upon achievement of certain performance milestones. The fair value of RSU is equal to the fair value of the Company’s common stock on the date of grant.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s RSUs activity for the year ended December 31, 2022 was as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant Date Fair<br/>Value per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,983,032 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.56 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,213,889 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,069,915)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,532,971)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.40 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,594,035 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.66 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of RSUs vested during the year ended December 31, 2022 and 2021was $116.0 million and $32.8 million, respectively.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company had $277.7 million of unrecognized stock-based compensation expense related to RSUs. This cost is expected to be recognized over a weighted-average period of 1.53 years.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fixed Value Equity Awards</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issues fixed value equity awards to certain employees as a part of their compensation package. These awards are issued as RSUs out of the Amended 2020 Plan (and prior to its amendment and restatement, under the 2020 Plan) and are accounted for as liability classified awards under ASC 718 — Stock Compensation. Fixed value equity awards granted have service-based conditions only and vest quarterly over a period a period up to four years. These awards represent a fixed dollar amount settled in a variable number of shares determined at each vesting date. For the year ended December 31, 2022, the Company recorded $7.6 million in stock-based compensation expense related to these awards.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Board and the Company’s stockholders adopted the 2020 Employee Stock Purchase Plan (“ESPP”) under which 7,317,655 shares were authorized for issuance. The 2020 ESPP became effective on February 26, 2021.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ESPP permits eligible employees to purchase the Company’s Class A common stock through payroll deduction with up to 15% of their pre-tax earnings subject to certain Internal Revenue Code limitations. The purchase price of shares is 85% of the lower of the fair market value of the Company’s common stock on the first day of a six-month offering period, or the relevant purchase date. In addition, no participant may purchase more than 5,000 shares of common stock in each purchase period.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, 168,147 shares were purchased at a weighted average price of $7.56 per share.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions used to value purchase rights under the ESPP during the year ended December 31, 2022 were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">May 16, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">November 16, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expect term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.3%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.5%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.54%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.54%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—%</span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Optogration Milestone Awards</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 3, as part of the Optogration acquisition in August 2021, the Company owed up to $22.0 million of post combination compensation related to certain service and performance conditions (“Optogration Milestone Awards”). In August 2022, the Company issued 1,632,056 shares of Class A common stock for $11.0 million of the Optogration Milestone Awards due to achievement of the service and performance conditions. As of December 31, 2022, it is probable that the service and performance conditions for the remaining $11.0 million obligation will be met. The Company recorded $16.5 million in stock-based compensation expense from inception to December 31, 2022 for Optogration Milestone Awards.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Freedom Photonics Awards</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Freedom Photonics acquisition in April 2022, the Company owes up to $28.3 million of post combination compensation related to certain service and performance conditions including achievement of certain technical and financial </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">milestones. As of December 31, 2022, Freedom Photonics did not achieve a portion of its stipulated financial milestone. As of December 31, 2022, it is probable that the remaining conditions will be met, and as a result, the Company recorded $7.6 million in stock-based compensation expense through December 31, 2022.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Solfice Awards</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company owes up to $0.7 million in compensation related to certain service and performance conditions. As of December 31, 2022, it is probable that the conditions will be met, and as a result, the Company recorded $0.4 million in stock-based compensation expense through December 31, 2022.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Officer Awards</span></div><div style="margin-bottom:6pt;text-indent:26.78pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 2, 2022, the Board granted an award of 10.8 million RSUs to Austin Russell, the Company’s Chief Executive Officer. The grant date fair value per share was $8.70 per share. This award represents Mr. Russell’s total compensation from the Company. On August 19, 2022, the Board granted 500,000 RSUs to each of Thomas Fennimore, the Company’s Chief Financial Officer and Alan Prescott, the Company’s Chief Legal Officer. The grant date fair value per share was $6.12 per share.</span></div><div style="margin-bottom:6pt;text-indent:26.78pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measured compensation cost for the above executive officer awards using a Monte Carlo simulation model and recorded $14.7 million in stock-based compensation expense related to these awards in the year ended December 31, 2022. These awards to the executive officers are subject to all of the following vesting conditions:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Public Market condition: Achievement of three stock price milestones: $50 or more, $60 or more, and $70 or more. The stock price will be measured based on the volume-weighted average price per share for 90 consecutive trading days;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Service condition: Approximately 7-years of vesting; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Performance condition: Start of production for at least one series production program. </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company had $85.3 million of unrecognized stock-based compensation expense related to RSUs. This cost is expected to be recognized over a weighted-average period of 6.36 years.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation expense</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense by type of award was as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Classified Awards:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,666 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,137 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,179 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,682 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,532 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,992 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,191 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability Classified Awards:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity settled fixed value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,545 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,826 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optogration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,894 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,114 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Freedom Photonics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,633 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solfice</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,258 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">734 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,405 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,684 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,711 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense by function was as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,680 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,422 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,898 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,216 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,098 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,814 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,546 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,013 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,500 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,890 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,405 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,684 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,711 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 36588278 36000000 0.05 40000000 18358365 P4Y 0.25 0.75 P36M P10Y <div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s stock option activity for the year ended December 31, 2022 was as follows (in thousands, except years and per share data):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,507,643 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.72 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,370,989)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(973,804)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.67 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,162,850 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.74 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.03</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,763 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and exercisable as of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,472,821 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.73 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.95</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,654 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest as of December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,162,850 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.74 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.03</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,763 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 11507643 1.72 2370989 1.67 973804 1.67 8162850 1.74 P7Y10D 26763000 5472821 1.73 P6Y11M12D 17654000 8162850 1.74 P7Y10D 26763000 0 0 0.98 2900000 7100000 1400000 20600000 2700000 P0Y7M17D P4Y 0.25 0.75 P36M 0 <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s RSAs activity for the year ended December 31, 2022 was as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant Date Fair Value<br/>per Share</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666,298 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.21 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,476)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(583,336)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,486 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s RSUs activity for the year ended December 31, 2022 was as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant Date Fair<br/>Value per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,983,032 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.56 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,213,889 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,069,915)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,532,971)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.40 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,594,035 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.66 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 666298 1.21 18476 1.23 583336 1.20 64486 1.29 700000 1000000 2200000 100000 1 P6Y 11983032 19.56 23213889 10.29 2069915 16.15 7532971 15.40 25594035 12.66 116000000 32800000 277700000 P1Y6M10D P4Y 7600000 7317655 0.15 0.85 P6M 5000 168147 7.56 <div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions used to value purchase rights under the ESPP during the year ended December 31, 2022 were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">May 16, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">November 16, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expect term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.3%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.5%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.54%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.54%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—%</span></td></tr></table></div> P0Y6M P0Y6M 0.823 0.935 0.0154 0.0454 0 0 22000000 1632056 11000000 11000000 16500000 28300000 7600000 700000 400000 10800000 8.70 500000 500000 6.12 6.12 14700000 50 60 70 90 P7Y 85300000 P6Y4M9D <div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense by type of award was as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Classified Awards:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,666 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,137 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,179 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,682 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,532 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,992 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,191 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability Classified Awards:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity settled fixed value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,545 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,826 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optogration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,894 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,114 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Freedom Photonics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,633 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solfice</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,258 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">734 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,405 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,684 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,711 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense by function was as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,680 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,422 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,898 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,216 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,098 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,814 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,546 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,013 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,500 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,890 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,405 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,684 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,711 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2666000 5137000 3179000 293000 1682000 5532000 129992000 60191000 0 714000 0 0 7545000 3826000 0 10894000 6114000 0 7633000 0 0 410000 0 0 2258000 734000 0 162405000 77684000 8711000 7680000 6422000 309000 40898000 20216000 2098000 15814000 4546000 414000 98013000 46500000 5890000 162405000 77684000 8711000 Leases<div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases office and manufacturing facilities under non-cancelable operating leases expiring at various dates through September 2028. In October 2021, the Company entered into a lease agreement commencing on April 1, 2022 for a term of 65 months through August 31, 2027. In September 2022, the Company entered into a lease agreement for a term of 66 months through February 2028. Some of the Company’s leases include one or more options to renew, with renewal terms that if exercised by the Company, extend the lease term from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEyYjdjMWI3NDE1ZDQ3ZjM4NzA1YjBjMmY3NjQ0YjRjL3NlYzoxMmI3YzFiNzQxNWQ0N2YzODcwNWIwYzJmNzY0NGI0Y18xNDIvZnJhZzowYTgyMTk5ZDQ2MDY0ZGI0OTRhYmUzMGM4NjE3MTUwMy90ZXh0cmVnaW9uOjBhODIxOTlkNDYwNjRkYjQ5NGFiZTMwYzg2MTcxNTAzXzgxNQ_82863be0-f988-4c28-a880-c633a803c779">one</span> to six years. The exercise of these renewal options is at the Company’s discretion. The Company’s lease agreements do not contain any material terms and conditions of residual value guarantees or material restrictive covenants. The Company’s short-term leases and sublease income were not material.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted ASC 842 using the modified retrospective method on January 1, 2021 and elected the available package of practical expedients upon adoption. The most significant impact of the adoption of ASC 842 was the recognition of right-of-use, or ROU, assets and lease liabilities for operating leases of $10.8 million and $12.0 million, respectively, and a reversal of deferred rent of $1.2 million on January 1, 2021. The Company’s accounting for finance leases remained substantially unchanged. The adoption of ASC 842 did not have any impact on the Company’s operating results or cash flows.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expenses were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,533 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,654 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,230 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,763 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,357 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for operating leases included in operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,070)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,609)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,749 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,876 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,244 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,145 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,953 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,735 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,989 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,768 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,942 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,503 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining terms were as follows (in years):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.43</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.95</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average discount rates were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.45 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities were as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.521%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,190 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,123 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,193 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,732 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,927 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,149 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,314 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,372)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total leases liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,942 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> Leases<div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases office and manufacturing facilities under non-cancelable operating leases expiring at various dates through September 2028. In October 2021, the Company entered into a lease agreement commencing on April 1, 2022 for a term of 65 months through August 31, 2027. In September 2022, the Company entered into a lease agreement for a term of 66 months through February 2028. Some of the Company’s leases include one or more options to renew, with renewal terms that if exercised by the Company, extend the lease term from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEyYjdjMWI3NDE1ZDQ3ZjM4NzA1YjBjMmY3NjQ0YjRjL3NlYzoxMmI3YzFiNzQxNWQ0N2YzODcwNWIwYzJmNzY0NGI0Y18xNDIvZnJhZzowYTgyMTk5ZDQ2MDY0ZGI0OTRhYmUzMGM4NjE3MTUwMy90ZXh0cmVnaW9uOjBhODIxOTlkNDYwNjRkYjQ5NGFiZTMwYzg2MTcxNTAzXzgxNQ_82863be0-f988-4c28-a880-c633a803c779">one</span> to six years. The exercise of these renewal options is at the Company’s discretion. The Company’s lease agreements do not contain any material terms and conditions of residual value guarantees or material restrictive covenants. The Company’s short-term leases and sublease income were not material.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted ASC 842 using the modified retrospective method on January 1, 2021 and elected the available package of practical expedients upon adoption. The most significant impact of the adoption of ASC 842 was the recognition of right-of-use, or ROU, assets and lease liabilities for operating leases of $10.8 million and $12.0 million, respectively, and a reversal of deferred rent of $1.2 million on January 1, 2021. The Company’s accounting for finance leases remained substantially unchanged. The adoption of ASC 842 did not have any impact on the Company’s operating results or cash flows.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expenses were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,533 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,654 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,230 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,763 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,357 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for operating leases included in operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,070)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,609)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,749 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,876 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,244 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,145 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,953 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,735 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,989 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,768 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,942 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,503 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining terms were as follows (in years):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.43</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.95</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average discount rates were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.45 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities were as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.521%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,190 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,123 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,193 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,732 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,927 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,149 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,314 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,372)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total leases liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,942 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> P65M P66M 1 P6Y 0 0 10800000 12000000 -1200000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expenses were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,533 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,654 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,230 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,763 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,357 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for operating leases included in operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,070)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,609)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,749 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,876 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining terms were as follows (in years):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.43</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.95</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average discount rates were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.45 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 6533000 4654000 2230000 1703000 8763000 6357000 6070000 4609000 16749000 2876000 <div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,244 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,145 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,953 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,735 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,989 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,768 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,942 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,503 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 21244000 9145000 5953000 4735000 16989000 5768000 22942000 10503000 P4Y5M4D P2Y11M12D 0.0545 0.0280 <div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities were as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.521%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,190 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,123 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,193 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,732 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,927 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,149 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,314 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,372)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total leases liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,942 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 6190000 5123000 5193000 4732000 3927000 1149000 26314000 3372000 22942000 Income Taxes<div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents components of loss before provision for (benefit from) income taxes for the periods presented (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(445,720)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239,855)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362,338)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before provision for (benefit from) income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(445,267)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239,248)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362,298)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for (benefit from) income taxes for the periods presented consisted of (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,262)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. state</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,262)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for (benefit from) income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,262)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation between the U.S. federal statutory income tax rate of 21% to the Company’s effective tax for the periods presented is as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal provision at statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other permanent items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s effective tax rates differ from the federal statutory rate primarily due to the change in valuation allowance, non-deductible stock-based compensation expense net of excess windfall stock compensation deductions, nondeductible executive compensation, R&amp;D tax credits, state income taxes and the fluctuation of fair value on instruments treated as debt for GAAP and equity for tax purposes, which is not taxable/deductible for income tax purposes, for 2022, 2021 and 2020.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s deferred income tax assets and liabilities as of December 31, 2022 and 2021 were as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carry forward</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,881 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,544 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,322 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,296 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals and reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,309 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,535 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,944 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability (ASC 842)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,268 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,622 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 174 R&amp;D capitalization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,240 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,961 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,170 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249,706 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,038 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(243,811)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130,569)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax asset</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,895 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,469 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,983 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU asset (ASC 842)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,801 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,301 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,963 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,469 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets (liabilities)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses the realizability of deferred tax assets based on the available evidence, including a history of taxable income and estimates of future taxable income. In assessing the realizability of deferred tax assets, the Company considers whether it is more likely than not that all or some portion of deferred tax assets will not be realized. Due to the history of losses incurred by the Company, management believes it is not more likely than not that substantially all of the deferred tax assets can be realized. Accordingly, the Company established and recorded a full valuation allowance on its net deferred tax assets of $243.8 million and $130.6 million as of December 31, 2022 and 2021, respectively. The valuation allowance increased by $113.2 million in 2022.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No deferred tax liabilities for foreign withholding taxes have been recorded relating to the earnings of the Company’s foreign subsidiaries since all such earnings are intended to be indefinitely reinvested. The amount of the unrecognized deferred tax liability associated with these earnings is immaterial.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Utilization of the net operating loss and tax credit carryforwards is subject to a substantial annual limitation due to the “ownership change” limitations provided by Sections 382 and 383 of the Internal Revenue Code of 1986, as amended (“IRC”) and other similar state provisions. Any annual limitation may result in the expiration of net operating loss and tax credit carryforwards before utilization. As of December 31, 2022, the Company had $597.0 million of U.S. federal net operating loss carryforwards available to reduce future taxable income, of which $553.8 million will be carried forward indefinitely for U.S. federal tax purposes and $43.2 million will expire beginning in 2035 to 2037. The Company also has $547.8 million of U.S. state net operating loss carryforwards that will expire beginning in 2036.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has federal and state research and development (“R&amp;D”) tax credit carryforwards of $21.1 million and $3.9 million, respectively, as of December 31, 2022. The federal research credit carryforwards will begin expiring in 2035 and although a small portion, less than $0.05 million, of the state research credit carryforwards will begin expiring in 2023, $4.3 million of the state research credit carryforwards do not expire.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Tax Cuts and Jobs Act (“TCJA”), for tax years beginning after December 31, 2021, taxpayers are required to capitalize and amortize all R&amp;D expenditures that are paid or incurred in connection with their trade or business which represent costs in the experimental or laboratory sense. Specifically, costs for U.S.-based R&amp;D activities must be amortized over 5 years and costs for foreign R&amp;D activities must be amortized over 15 years. As of December 31, 2022, there is </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">insufficient Internal Revenue Service guidance on how to treat capitalizable R&amp;D expenditures. The Company will continue to monitor the status of any new guidance that might be issued and will update its estimated capitalized R&amp;D, accordingly.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning January 1, 2022, the TCJA eliminated the option to deduct research and development expenditures in the current year and requires taxpayers to capitalize such expenses pursuant to IRC Section 174. The capitalized expenses are amortized over a 5-year period for domestic expenses and a 15-year period for foreign expenses. As a result of this provision of the TCJA, deferred tax assets related to capitalized research expenses increased by $43.2 million.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrecognized Tax Benefits</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports income tax related interest and penalties within its provision for income tax in its consolidated statements of operations. The Company had no interest and penalties accrued through December 31, 2022. The Company does not expect the total amount of unrecognized tax benefits will significantly increase or decrease within 12 months of the reporting date.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a tabular reconciliation of the total amounts of unrecognized tax benefits (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits as of the beginning of the year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,296 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,975 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to prior year tax provisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,723)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase related to current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,031 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,786 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,251 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits as of the end of the year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,604 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,296 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,975 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the Company’s unrecognized tax benefits, if recognized, would affect the effective tax rate since the tax benefits would increase a deferred tax asset that is currently fully offset by a full valuation allowance. The Company and its subsidiaries file federal, state and foreign income tax returns. In the normal course of business, the Company is subject to examination by taxing authorities, for which the Company’s major tax jurisdictions are the United States and various states. The Company’s federal, state and foreign income tax returns from inception to December 31, 2022 remain subject to examination.</span></div> <div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents components of loss before provision for (benefit from) income taxes for the periods presented (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(445,720)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239,855)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362,338)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before provision for (benefit from) income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(445,267)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239,248)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362,298)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> -445720000 -239855000 -362338000 453000 607000 40000 -445267000 -239248000 -362298000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for (benefit from) income taxes for the periods presented consisted of (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,262)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. state</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,262)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for (benefit from) income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,262)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 440000 0 0 440000 0 0 204000 -1262000 0 28000 0 0 232000 -1262000 0 672000 -1262000 0 <div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation between the U.S. federal statutory income tax rate of 21% to the Company’s effective tax for the periods presented is as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal provision at statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other permanent items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 0.21 0.210 0.210 0.210 0.057 0.044 0.007 -0.024 -0.015 -0.006 0.004 -0.023 -0.156 -0.034 0.020 -0.004 -0.008 -0.011 0.000 0.002 -0.003 0.000 -0.014 -0.008 -0.003 -0.243 -0.240 -0.060 -0.002 0.004 0.000 <div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s deferred income tax assets and liabilities as of December 31, 2022 and 2021 were as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carry forward</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,881 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,544 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,322 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,296 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals and reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,309 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,535 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,944 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability (ASC 842)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,268 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,622 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 174 R&amp;D capitalization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,240 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,961 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,170 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249,706 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,038 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(243,811)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130,569)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax asset</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,895 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,469 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,983 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU asset (ASC 842)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,801 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,301 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,963 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,469 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets (liabilities)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 161881000 120544000 16322000 6296000 3309000 0 14535000 6944000 6268000 2622000 43240000 0 1961000 617000 2170000 0 20000 15000 249706000 137038000 243811000 130569000 5895000 6469000 0 1185000 0 2983000 162000 0 5801000 2301000 5963000 6469000 68000 0 243800000 130600000 113200000 597000000 553800000 43200000 547800000 21100000 3900000 50000.00 4300000 P5Y P15Y P5Y P15Y 43200000 0 0 <div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a tabular reconciliation of the total amounts of unrecognized tax benefits (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits as of the beginning of the year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,296 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,975 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to prior year tax provisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,723)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase related to current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,031 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,786 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,251 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits as of the end of the year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,604 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,296 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,975 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 6296000 3975000 2397000 0 535000 327000 3723000 0 0 6031000 1786000 1251000 8604000 6296000 3975000 0 Commitments and Contingencies<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Obligations</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company purchases goods and services from a variety of suppliers in the ordinary course of business. Purchase obligations are defined as agreements that are enforceable and legally binding and that specify all significant terms, including fixed or minimum quantities to be purchased, fixed, minimum, or variable price provisions, and the approximate timing of the transaction. The Company had purchase obligations primarily for purchases of inventory, R&amp;D, and general and administrative activities totaling $96.0 million as of December 31, 2022.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Matters</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is involved in actions, claims, suits and other proceedings in the ordinary course of business, including assertions by third parties relating to intellectual property infringement, breaches of contract or warranties or employment-related matters. When it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated, the Company records a liability for such loss contingencies. The Company’s estimates regarding potential losses and materiality are based on the Company’s judgment and assessment of the claims utilizing currently available information. Although the Company will continue to reassess its reserves and estimates based on future developments, the Company’s objective assessment of the legal merits of such claims may not always be predictive of the outcome and actual results may vary from the Company’s current estimates. The Company’s current legal accrual is not material to the financial statements.</span></div> 96000000 Segment and Customer Concentration InformationReportable segments are (i) Autonomy Solutions and (ii) ATS. These segments reflect the way the chief operating decision maker (“CODM”) evaluates the Company’s business performance and manages its operations. Each segment has distinct product offerings, customers and market penetration. The Chief Executive Officer is the CODM of the Company.<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Autonomy Solutions</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This segment manufactures and distributes commercial lidar sensors that measure distance using laser light for automotive mobility applications. This segment is impacted by trends in the autonomous vehicles and associated infrastructure/technology sector.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ATS</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This segment is in the business of development of semiconductor technology based lasers and sensors. This segment also designs, tests and provides consulting services for development of integrated circuits. This segment is impacted by trends in and the strength of the automobile and aeronautics sector as well as government spending in military and defense activities.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting policies of the operating segments are the same as those described in Note 2. Segment operating results and reconciliations to the Company’s consolidated balances are as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Autonomy<br/>Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ATS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>reportable<br/>segments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,353 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,345 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,698 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,698 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from internal customer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,748 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,485 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,233 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,233)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,101 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,830 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,931 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,233)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,698 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,110 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,456 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,566 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,566 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating gain (loss)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(412,673)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,394)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(442,067)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(442,402)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other significant items:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752,088 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,529 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812,617 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125,290)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687,327 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,664 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,138 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,792 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Autonomy<br/>Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ATS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>reportable<br/>segments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,497 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,447 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,944 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,944 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from internal customer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,098 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,929 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,027 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,027)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,595 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,376 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,971 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,027)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,944 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,723 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,162 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,162 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating gain (loss)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214,133)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214,457)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214,552)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other significant items:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">882,704 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,771 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">892,475 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,939)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883,536 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,179 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,342 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,342 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Autonomy<br/>Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ATS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>reportable<br/>segments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,387 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,564 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,951 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,951 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from internal customer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,516 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,248 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,764 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,764)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,903 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,812 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,715 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,764)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,951 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,395 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,523 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,517 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating gain (loss)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86,661)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(316)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86,977)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86,875)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other significant items:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511,676 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,975 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514,651 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,300)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510,351 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,604 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,613 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,613 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Represent the eliminations of all intercompany balances and transactions during the period presented.</span></div>Two customers accounted for 21%, and 17% of the Company’s revenue for the year ended December 31, 2022. Two customers accounted for 42% and 17% of the Company’s revenue for the year ended December 31, 2021. One customer accounted for 64% of the Company’s revenue for the year ended December 31, 2020. <div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting policies of the operating segments are the same as those described in Note 2. Segment operating results and reconciliations to the Company’s consolidated balances are as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Autonomy<br/>Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ATS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>reportable<br/>segments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,353 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,345 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,698 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,698 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from internal customer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,748 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,485 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,233 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,233)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,101 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,830 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,931 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,233)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,698 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,110 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,456 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,566 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,566 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating gain (loss)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(412,673)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,394)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(442,067)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(442,402)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other significant items:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752,088 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,529 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812,617 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125,290)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687,327 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,664 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,138 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,792 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Autonomy<br/>Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ATS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>reportable<br/>segments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,497 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,447 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,944 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,944 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from internal customer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,098 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,929 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,027 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,027)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,595 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,376 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,971 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,027)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,944 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,723 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,162 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,162 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating gain (loss)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214,133)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214,457)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214,552)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other significant items:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">882,704 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,771 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">892,475 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,939)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883,536 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,179 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,342 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,342 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Autonomy<br/>Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ATS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>reportable<br/>segments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,387 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,564 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,951 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,951 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from internal customer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,516 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,248 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,764 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,764)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,903 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,812 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,715 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,764)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,951 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,395 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,523 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,517 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating gain (loss)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86,661)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(316)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86,977)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86,875)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other significant items:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511,676 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,975 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514,651 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,300)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510,351 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,604 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,613 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,613 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Represent the eliminations of all intercompany balances and transactions during the period presented.</span></div> 24353000 16345000 40698000 40698000 -14748000 -12485000 -27233000 -27233000 39101000 28830000 67931000 -27233000 40698000 4110000 2456000 6566000 0 6566000 -412673000 -29394000 -442067000 -335000 -442402000 752088000 60529000 812617000 -125290000 687327000 8664000 474000 9138000 -346000 8792000 28497000 3447000 31944000 31944000 -8098000 -5929000 -14027000 -14027000 36595000 9376000 45971000 -14027000 31944000 3723000 439000 4162000 0 4162000 -214133000 -324000 -214457000 -95000 -214552000 882704000 9771000 892475000 -8939000 883536000 10179000 163000 10342000 0 10342000 11387000 2564000 13951000 13951000 -1516000 -3248000 -4764000 -4764000 12903000 5812000 18715000 -4764000 13951000 2395000 128000 2523000 -6000 2517000 -86661000 -316000 -86977000 102000 -86875000 511676000 2975000 514651000 -4300000 510351000 3604000 9000 3613000 0 3613000 0.21 0.17 0.42 0.17 0.64 Related Party Transactions<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Investments</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company invested $15.0 million in a special purpose acquisition company, of which Mr. Jun Hong Heng, was the Chairman and Chief Executive Officer, and a principal shareholder. Mr. Heng became a director of the Company in June 2021. The terms of such investment were no less favorable to the Company than to other third party investors. During 2021, the Company sold $2.9 million of this investment and had a remaining balance of $12.1 million as of December 31, 2021. The fair value of this investment as of December 31, 2021 was $12.2 million, which was included in marketable securities in the balance sheet. The Company sold this investment in its entirety in the second quarter of 2022. The special purpose acquisition company merged with ECARX on December 20, 2022 and Mr. Heng continues to be a director of the merged company.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company invested in a special purpose acquisition company through open market purchases, of which Mr. Alec Gores was the Chairman and Chief Executive Officer, and a principal shareholder. The special purpose acquisition company merged with Polestar Automotive Holdings UK PLC on June 24, 2022 and Mr. Gores continues to be a director of the merged company. Mr. Gores is a director of Luminar as well. The balance of this investment as of December 31, 2022 was not material.</span></div> 15000000 2900000 12100000 12200000 0 Subsequent Events<div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing the audited consolidated financial statements as of December 31, 2022, the Company has evaluated subsequent events through February 28, 2023.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, the Company executed an asset purchase agreement with Seagate Technology LLC and Seagate Singapore International Headquarters Pte. Ltd. (individually and collectively, “Seagate”) and concurrently completed the acquisition of certain fixed assets, inventory and intellectual property related to Seagate’s lidar-related projects and obtained a license to certain patents and other intangibles for an aggregate cash consideration of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$12.6 million. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Company hired certain former employees of Seagate who had been working on the above projects.</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, the Company executed an agreement with Swiss Re Solutions Ltd (“Swiss Re”) for use of certain of Swiss Re’s tools and services for assessment of the Company’s technology for purposes of potentially developing an insurance product and Swiss Re potentially providing reinsurance and other services. The Company agreed to pay Swiss Re $4.0 million in consideration for these services over 4 years, of which $1.0 million is non-cancelable. The Company may at its sole discretion pay the consideration owed to Swiss Re either in cash or shares of Class A common stock.</span></div> 12600000 4000000 P4Y 1000000 EXCEL 124 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 125 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 126 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 127 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 582 596 1 false 158 0 false 12 false false R1.htm 0000001 - Document - Cover Sheet http://www.luminartech.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Document - Audit Information Sheet http://www.luminartech.com/role/AuditInformation Audit Information Cover 2 false false R3.htm 0000003 - Statement - Consolidated Balance Sheets Sheet http://www.luminartech.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 3 false false R4.htm 0000004 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.luminartech.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 4 false false R5.htm 0000005 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss Consolidated Statements of Operations and Comprehensive Loss Statements 5 false false R6.htm 0000006 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders??? Equity (Deficit) Sheet http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit Consolidated Statements of Convertible Preferred Stock and Stockholders??? Equity (Deficit) Statements 6 false false R7.htm 0000007 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders??? Equity (Deficit) (Parenthetical) Sheet http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitParenthetical Consolidated Statements of Convertible Preferred Stock and Stockholders??? Equity (Deficit) (Parenthetical) Statements 7 false false R8.htm 0000008 - Statement - Consolidated Statements of Cash Flows Sheet http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows Consolidated Statements of Cash Flows Statements 8 false false R9.htm 0000009 - Statement - Consolidated Statements of Cash Flows (Parenthetical) Sheet http://www.luminartech.com/role/ConsolidatedStatementsofCashFlowsParenthetical Consolidated Statements of Cash Flows (Parenthetical) Statements 9 false false R10.htm 0000010 - Disclosure - Organization and Description of Business Sheet http://www.luminartech.com/role/OrganizationandDescriptionofBusiness Organization and Description of Business Notes 10 false false R11.htm 0000011 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Sheet http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies Basis of Presentation and Summary of Significant Accounting Policies Notes 11 false false R12.htm 0000012 - Disclosure - Business Combinations Sheet http://www.luminartech.com/role/BusinessCombinations Business Combinations Notes 12 false false R13.htm 0000013 - Disclosure - Revenue Sheet http://www.luminartech.com/role/Revenue Revenue Notes 13 false false R14.htm 0000014 - Disclosure - Investments Sheet http://www.luminartech.com/role/Investments Investments Notes 14 false false R15.htm 0000015 - Disclosure - Financial Statement Components Sheet http://www.luminartech.com/role/FinancialStatementComponents Financial Statement Components Notes 15 false false R16.htm 0000016 - Disclosure - Debt Sheet http://www.luminartech.com/role/Debt Debt Notes 16 false false R17.htm 0000017 - Disclosure - Fair Value Measurements Sheet http://www.luminartech.com/role/FairValueMeasurements Fair Value Measurements Notes 17 false false R18.htm 0000018 - Disclosure - Convertible Preferred Stock Sheet http://www.luminartech.com/role/ConvertiblePreferredStock Convertible Preferred Stock Notes 18 false false R19.htm 0000019 - Disclosure - Earnings (Loss) Per Share Sheet http://www.luminartech.com/role/EarningsLossPerShare Earnings (Loss) Per Share Notes 19 false false R20.htm 0000020 - Disclosure - Stockholders??? Equity (Deficit) Sheet http://www.luminartech.com/role/StockholdersEquityDeficit Stockholders??? Equity (Deficit) Notes 20 false false R21.htm 0000021 - Disclosure - Stock-based Compensation Sheet http://www.luminartech.com/role/StockbasedCompensation Stock-based Compensation Notes 21 false false R22.htm 0000022 - Disclosure - Leases Sheet http://www.luminartech.com/role/Leases Leases Notes 22 false false R23.htm 0000023 - Disclosure - Income Taxes Sheet http://www.luminartech.com/role/IncomeTaxes Income Taxes Notes 23 false false R24.htm 0000024 - Disclosure - Commitment and Contingencies Sheet http://www.luminartech.com/role/CommitmentandContingencies Commitment and Contingencies Notes 24 false false R25.htm 0000025 - Disclosure - Segment and Customer Concentration Information Sheet http://www.luminartech.com/role/SegmentandCustomerConcentrationInformation Segment and Customer Concentration Information Notes 25 false false R26.htm 0000026 - Disclosure - Related Party Transactions Sheet http://www.luminartech.com/role/RelatedPartyTransactions Related Party Transactions Notes 26 false false R27.htm 0000027 - Disclosure - Subsequent Events Sheet http://www.luminartech.com/role/SubsequentEvents Subsequent Events Notes 27 false false R28.htm 0000028 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) Sheet http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies Basis of Presentation and Summary of Significant Accounting Policies (Policies) Policies http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies 28 false false R29.htm 0000029 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) Sheet http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables Basis of Presentation and Summary of Significant Accounting Policies (Tables) Tables http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies 29 false false R30.htm 0000030 - Disclosure - Business Combinations (Tables) Sheet http://www.luminartech.com/role/BusinessCombinationsTables Business Combinations (Tables) Tables http://www.luminartech.com/role/BusinessCombinations 30 false false R31.htm 0000031 - Disclosure - Revenue (Tables) Sheet http://www.luminartech.com/role/RevenueTables Revenue (Tables) Tables http://www.luminartech.com/role/Revenue 31 false false R32.htm 0000032 - Disclosure - Investments (Tables) Sheet http://www.luminartech.com/role/InvestmentsTables Investments (Tables) Tables http://www.luminartech.com/role/Investments 32 false false R33.htm 0000033 - Disclosure - Financial Statement Components (Tables) Sheet http://www.luminartech.com/role/FinancialStatementComponentsTables Financial Statement Components (Tables) Tables http://www.luminartech.com/role/FinancialStatementComponents 33 false false R34.htm 0000034 - Disclosure - Debt (Tables) Sheet http://www.luminartech.com/role/DebtTables Debt (Tables) Tables http://www.luminartech.com/role/Debt 34 false false R35.htm 0000035 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.luminartech.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.luminartech.com/role/FairValueMeasurements 35 false false R36.htm 0000036 - Disclosure - Earnings (Loss) Per Share (Tables) Sheet http://www.luminartech.com/role/EarningsLossPerShareTables Earnings (Loss) Per Share (Tables) Tables http://www.luminartech.com/role/EarningsLossPerShare 36 false false R37.htm 0000037 - Disclosure - Stockholders??? Equity (Deficit) (Tables) Sheet http://www.luminartech.com/role/StockholdersEquityDeficitTables Stockholders??? Equity (Deficit) (Tables) Tables http://www.luminartech.com/role/StockholdersEquityDeficit 37 false false R38.htm 0000038 - Disclosure - Stock-based Compensation (Tables) Sheet http://www.luminartech.com/role/StockbasedCompensationTables Stock-based Compensation (Tables) Tables http://www.luminartech.com/role/StockbasedCompensation 38 false false R39.htm 0000039 - Disclosure - Leases (Tables) Sheet http://www.luminartech.com/role/LeasesTables Leases (Tables) Tables http://www.luminartech.com/role/Leases 39 false false R40.htm 0000040 - Disclosure - Income Taxes (Tables) Sheet http://www.luminartech.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.luminartech.com/role/IncomeTaxes 40 false false R41.htm 0000041 - Disclosure - Segment and Customer Concentration Information (Tables) Sheet http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationTables Segment and Customer Concentration Information (Tables) Tables http://www.luminartech.com/role/SegmentandCustomerConcentrationInformation 41 false false R42.htm 0000042 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Segment Information (Details) Sheet http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesSegmentInformationDetails Basis of Presentation and Summary of Significant Accounting Policies - Segment Information (Details) Details 42 false false R43.htm 0000043 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Concentration of Credit Risk (Details) Sheet http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationofCreditRiskDetails Basis of Presentation and Summary of Significant Accounting Policies - Concentration of Credit Risk (Details) Details 43 false false R44.htm 0000044 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Property and Equipment (Details) Sheet http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails Basis of Presentation and Summary of Significant Accounting Policies - Property and Equipment (Details) Details 44 false false R45.htm 0000045 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Intangible Assets and Goodwill (Details) Sheet http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails Basis of Presentation and Summary of Significant Accounting Policies - Intangible Assets and Goodwill (Details) Details 45 false false R46.htm 0000046 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Impairment of Long-Lived Assets (Details) Sheet http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesImpairmentofLongLivedAssetsDetails Basis of Presentation and Summary of Significant Accounting Policies - Impairment of Long-Lived Assets (Details) Details 46 false false R47.htm 0000047 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Public and Private Warrants (Details) Sheet http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails Basis of Presentation and Summary of Significant Accounting Policies - Public and Private Warrants (Details) Details 47 false false R48.htm 0000048 - Disclosure - Business Combinations - Narrative (Details) Sheet http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails Business Combinations - Narrative (Details) Details 48 false false R49.htm 0000049 - Disclosure - Business Combinations - Schedule of Recognized Identified Assets and Liabilities (Details) Sheet http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails Business Combinations - Schedule of Recognized Identified Assets and Liabilities (Details) Details 49 false false R50.htm 0000050 - Disclosure - Business Combinations - Components of Intangible Assets and Estimated Useful Lives (Details) Sheet http://www.luminartech.com/role/BusinessCombinationsComponentsofIntangibleAssetsandEstimatedUsefulLivesDetails Business Combinations - Components of Intangible Assets and Estimated Useful Lives (Details) Details 50 false false R51.htm 0000051 - Disclosure - Business Combinations - Impact of Adjustments to the Unaudited Pro Forma (Details) Sheet http://www.luminartech.com/role/BusinessCombinationsImpactofAdjustmentstotheUnauditedProFormaDetails Business Combinations - Impact of Adjustments to the Unaudited Pro Forma (Details) Details 51 false false R52.htm 0000052 - Disclosure - Business Combinations - Unaudited Pro Forma (Details) Sheet http://www.luminartech.com/role/BusinessCombinationsUnauditedProFormaDetails Business Combinations - Unaudited Pro Forma (Details) Details 52 false false R53.htm 0000053 - Disclosure - Revenue - Schedule of Disaggregation of Revenue (Details) Sheet http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails Revenue - Schedule of Disaggregation of Revenue (Details) Details 53 false false R54.htm 0000054 - Disclosure - Revenue - Narrative (Details) Sheet http://www.luminartech.com/role/RevenueNarrativeDetails Revenue - Narrative (Details) Details 54 false false R55.htm 0000055 - Disclosure - Revenue - Schedule of Opening and Closing Balances of Contract Assets and Contract Liabilities (Details) Sheet http://www.luminartech.com/role/RevenueScheduleofOpeningandClosingBalancesofContractAssetsandContractLiabilitiesDetails Revenue - Schedule of Opening and Closing Balances of Contract Assets and Contract Liabilities (Details) Details 55 false false R56.htm 0000056 - Disclosure - Revenue - Schedule of Significant Changes in Contract Assets and Contract Liabilities (Details) Sheet http://www.luminartech.com/role/RevenueScheduleofSignificantChangesinContractAssetsandContractLiabilitiesDetails Revenue - Schedule of Significant Changes in Contract Assets and Contract Liabilities (Details) Details 56 false false R57.htm 0000057 - Disclosure - Revenue - Remaining Performance Obligations (Details) Sheet http://www.luminartech.com/role/RevenueRemainingPerformanceObligationsDetails Revenue - Remaining Performance Obligations (Details) Details 57 false false R58.htm 0000058 - Disclosure - Investments - Amortized Cost (Details) Sheet http://www.luminartech.com/role/InvestmentsAmortizedCostDetails Investments - Amortized Cost (Details) Details 58 false false R59.htm 0000059 - Disclosure - Investments - Continuous Loss Position (Details) Sheet http://www.luminartech.com/role/InvestmentsContinuousLossPositionDetails Investments - Continuous Loss Position (Details) Details 59 false false R60.htm 0000060 - Disclosure - Investments - Narrative (Details) Sheet http://www.luminartech.com/role/InvestmentsNarrativeDetails Investments - Narrative (Details) Details 60 false false R61.htm 0000061 - Disclosure - Investments - Schedule of Equity Investments (Details) Sheet http://www.luminartech.com/role/InvestmentsScheduleofEquityInvestmentsDetails Investments - Schedule of Equity Investments (Details) Details 61 false false R62.htm 0000062 - Disclosure - Financial Statement Components - Cash and Cash Equivalents (Details) Sheet http://www.luminartech.com/role/FinancialStatementComponentsCashandCashEquivalentsDetails Financial Statement Components - Cash and Cash Equivalents (Details) Details 62 false false R63.htm 0000063 - Disclosure - Financial Statement Components - Inventory (Details) Sheet http://www.luminartech.com/role/FinancialStatementComponentsInventoryDetails Financial Statement Components - Inventory (Details) Details 63 false false R64.htm 0000064 - Disclosure - Financial Statement Components - Prepaid Expenses and Other Current Assets (Details) Sheet http://www.luminartech.com/role/FinancialStatementComponentsPrepaidExpensesandOtherCurrentAssetsDetails Financial Statement Components - Prepaid Expenses and Other Current Assets (Details) Details 64 false false R65.htm 0000065 - Disclosure - Financial Statement Components - Property and Equipment (Details) Sheet http://www.luminartech.com/role/FinancialStatementComponentsPropertyandEquipmentDetails Financial Statement Components - Property and Equipment (Details) Details 65 false false R66.htm 0000066 - Disclosure - Financial Statement Components - Schedule of Intangible Assets (Details) Sheet http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails Financial Statement Components - Schedule of Intangible Assets (Details) Details 66 false false R67.htm 0000067 - Disclosure - Financial Statement Components - Future Amortization Expense (Details) Sheet http://www.luminartech.com/role/FinancialStatementComponentsFutureAmortizationExpenseDetails Financial Statement Components - Future Amortization Expense (Details) Details 67 false false R68.htm 0000068 - Disclosure - Financial Statement Components - Goodwill (Details) Sheet http://www.luminartech.com/role/FinancialStatementComponentsGoodwillDetails Financial Statement Components - Goodwill (Details) Details 68 false false R69.htm 0000069 - Disclosure - Financial Statement Components - Other Noncurrent Assets (Details) Sheet http://www.luminartech.com/role/FinancialStatementComponentsOtherNoncurrentAssetsDetails Financial Statement Components - Other Noncurrent Assets (Details) Details 69 false false R70.htm 0000070 - Disclosure - Financial Statement Components - Accrued and Other Current Liabilities (Details) Sheet http://www.luminartech.com/role/FinancialStatementComponentsAccruedandOtherCurrentLiabilitiesDetails Financial Statement Components - Accrued and Other Current Liabilities (Details) Details 70 false false R71.htm 0000071 - Disclosure - Debt - Additional Information (Details) Sheet http://www.luminartech.com/role/DebtAdditionalInformationDetails Debt - Additional Information (Details) Details 71 false false R72.htm 0000072 - Disclosure - Debt - Schedule of Net Carrying Amount (Details) Sheet http://www.luminartech.com/role/DebtScheduleofNetCarryingAmountDetails Debt - Schedule of Net Carrying Amount (Details) Details 72 false false R73.htm 0000073 - Disclosure - Debt - Schedule of Interest Expense (Details) Sheet http://www.luminartech.com/role/DebtScheduleofInterestExpenseDetails Debt - Schedule of Interest Expense (Details) Details 73 false false R74.htm 0000074 - Disclosure - Fair Value Measurements - Narrative (Details) Sheet http://www.luminartech.com/role/FairValueMeasurementsNarrativeDetails Fair Value Measurements - Narrative (Details) Details 74 false false R75.htm 0000075 - Disclosure - Fair Value Measurements - Schedule of Changes in Level 3 Liabilities Measured at Fair Value (Details) Sheet http://www.luminartech.com/role/FairValueMeasurementsScheduleofChangesinLevel3LiabilitiesMeasuredatFairValueDetails Fair Value Measurements - Schedule of Changes in Level 3 Liabilities Measured at Fair Value (Details) Details 75 false false R76.htm 0000076 - Disclosure - Fair Value Measurements - Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements on a Recurring Basis and the Level of Inputs Used (Details) Sheet http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails Fair Value Measurements - Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements on a Recurring Basis and the Level of Inputs Used (Details) Details 76 false false R77.htm 0000077 - Disclosure - Convertible Preferred Stock (Details) Sheet http://www.luminartech.com/role/ConvertiblePreferredStockDetails Convertible Preferred Stock (Details) Details http://www.luminartech.com/role/ConvertiblePreferredStock 77 false false R78.htm 0000078 - Disclosure - Earnings (Loss) Per Share - Basic and Diluted Loss Per Share (Details) Sheet http://www.luminartech.com/role/EarningsLossPerShareBasicandDilutedLossPerShareDetails Earnings (Loss) Per Share - Basic and Diluted Loss Per Share (Details) Details http://www.luminartech.com/role/EarningsLossPerShareTables 78 false false R79.htm 0000079 - Disclosure - Earnings (Loss) Per Share - Antidilutive Securities (Details) Sheet http://www.luminartech.com/role/EarningsLossPerShareAntidilutiveSecuritiesDetails Earnings (Loss) Per Share - Antidilutive Securities (Details) Details http://www.luminartech.com/role/EarningsLossPerShareTables 79 false false R80.htm 0000080 - Disclosure - Earnings (Loss) Per Share - Narrative (Details) Sheet http://www.luminartech.com/role/EarningsLossPerShareNarrativeDetails Earnings (Loss) Per Share - Narrative (Details) Details http://www.luminartech.com/role/EarningsLossPerShareTables 80 false false R81.htm 0000081 - Disclosure - Stockholders??? Equity (Deficit) (Details) Sheet http://www.luminartech.com/role/StockholdersEquityDeficitDetails Stockholders??? Equity (Deficit) (Details) Details http://www.luminartech.com/role/StockholdersEquityDeficitTables 81 false false R82.htm 0000082 - Disclosure - Stockholders??? Equity (Deficit) - Stock-in-lieu of Cash Program Activity (Details) Sheet http://www.luminartech.com/role/StockholdersEquityDeficitStockinlieuofCashProgramActivityDetails Stockholders??? Equity (Deficit) - Stock-in-lieu of Cash Program Activity (Details) Details http://www.luminartech.com/role/StockholdersEquityDeficitTables 82 false false R83.htm 0000083 - Disclosure - Stock-based Compensation - Narrative (Details) Sheet http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails Stock-based Compensation - Narrative (Details) Details 83 false false R84.htm 0000084 - Disclosure - Stock-based Compensation - Stock Option Activity (Details) Sheet http://www.luminartech.com/role/StockbasedCompensationStockOptionActivityDetails Stock-based Compensation - Stock Option Activity (Details) Details 84 false false R85.htm 0000085 - Disclosure - Stock-based Compensation - Restricted Stock Activity (Details) Sheet http://www.luminartech.com/role/StockbasedCompensationRestrictedStockActivityDetails Stock-based Compensation - Restricted Stock Activity (Details) Details 85 false false R86.htm 0000086 - Disclosure - Stock-based Compensation - Employee Stock Purchase Plan, Valuation Assumptions (Details) Sheet http://www.luminartech.com/role/StockbasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails Stock-based Compensation - Employee Stock Purchase Plan, Valuation Assumptions (Details) Details 86 false false R87.htm 0000087 - Disclosure - Stock-based Compensation - Compensation Expense (Details) Sheet http://www.luminartech.com/role/StockbasedCompensationCompensationExpenseDetails Stock-based Compensation - Compensation Expense (Details) Details 87 false false R88.htm 0000088 - Disclosure - Leases - Narrative (Details) Sheet http://www.luminartech.com/role/LeasesNarrativeDetails Leases - Narrative (Details) Details 88 false false R89.htm 0000089 - Disclosure - Leases - Components of Lease Expenses (Details) Sheet http://www.luminartech.com/role/LeasesComponentsofLeaseExpensesDetails Leases - Components of Lease Expenses (Details) Details 89 false false R90.htm 0000090 - Disclosure - Leases - Supplemental Cash Flow Information (Details) Sheet http://www.luminartech.com/role/LeasesSupplementalCashFlowInformationDetails Leases - Supplemental Cash Flow Information (Details) Details 90 false false R91.htm 0000091 - Disclosure - Leases - Supplemental Balance Sheet Information, Weighted Average Remaining Terms, and Weighted Average Discount Rates (Details) Sheet http://www.luminartech.com/role/LeasesSupplementalBalanceSheetInformationWeightedAverageRemainingTermsandWeightedAverageDiscountRatesDetails Leases - Supplemental Balance Sheet Information, Weighted Average Remaining Terms, and Weighted Average Discount Rates (Details) Details 91 false false R92.htm 0000092 - Disclosure - Leases - Maturities of Lease Liabilities (Details) Sheet http://www.luminartech.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails Leases - Maturities of Lease Liabilities (Details) Details 92 false false R93.htm 0000093 - Disclosure - Income Taxes - Components of Loss Before Provision for (Benefit from) Income Taxes (Details) Sheet http://www.luminartech.com/role/IncomeTaxesComponentsofLossBeforeProvisionforBenefitfromIncomeTaxesDetails Income Taxes - Components of Loss Before Provision for (Benefit from) Income Taxes (Details) Details 93 false false R94.htm 0000094 - Disclosure - Income Taxes - Provision for (benefit from) income taxes (Details) Sheet http://www.luminartech.com/role/IncomeTaxesProvisionforbenefitfromincometaxesDetails Income Taxes - Provision for (benefit from) income taxes (Details) Details 94 false false R95.htm 0000095 - Disclosure - Income Taxes - Narrative (Details) Sheet http://www.luminartech.com/role/IncomeTaxesNarrativeDetails Income Taxes - Narrative (Details) Details 95 false false R96.htm 0000096 - Disclosure - Income Taxes - Effective Income Tax Rate (Details) Sheet http://www.luminartech.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails Income Taxes - Effective Income Tax Rate (Details) Details 96 false false R97.htm 0000097 - Disclosure - Income Taxes - Deferred Income Tax Assets and Liabilities (Details) Sheet http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails Income Taxes - Deferred Income Tax Assets and Liabilities (Details) Details 97 false false R98.htm 0000098 - Disclosure - Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details) Sheet http://www.luminartech.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details) Details 98 false false R99.htm 0000099 - Disclosure - Commitment and Contingencies (Details) Sheet http://www.luminartech.com/role/CommitmentandContingenciesDetails Commitment and Contingencies (Details) Details http://www.luminartech.com/role/CommitmentandContingencies 99 false false R100.htm 0000100 - Disclosure - Segment and Customer Concentration Information - Segment Operating Results and Reconciliation to the Consolidated Balances (Details) Sheet http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationSegmentOperatingResultsandReconciliationtotheConsolidatedBalancesDetails Segment and Customer Concentration Information - Segment Operating Results and Reconciliation to the Consolidated Balances (Details) Details 100 false false R101.htm 0000101 - Disclosure - Segment and Customer Concentration Information - Narrative (Details) Sheet http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationNarrativeDetails Segment and Customer Concentration Information - Narrative (Details) Details 101 false false R102.htm 0000102 - Disclosure - Related Party Disclosures (Details) Sheet http://www.luminartech.com/role/RelatedPartyDisclosuresDetails Related Party Disclosures (Details) Details 102 false false R103.htm 0000103 - Disclosure - Subsequent Events (Details) Sheet http://www.luminartech.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.luminartech.com/role/SubsequentEvents 103 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 12 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName, lazr:SaleOfStockNumberOfWarrantsPerUnit, us-gaap:FiniteLivedIntangibleAssetUsefulLife, us-gaap:LesseeOperatingLeaseRenewalTerm, us-gaap:PropertyPlantAndEquipmentUsefulLife, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage - lazr-20221231.htm 4 lazr-20221231.htm exhibit104vendorequityfina.htm exhibit106amendedandrestat.htm exhibit211202210-k.htm exhibit51orricksopinion202.htm lazr-20221231.xsd lazr-20221231_cal.xml lazr-20221231_def.xml lazr-20221231_lab.xml lazr-20221231_pre.xml q4-2022exhibit231.htm q4-2022exhibit311.htm q4-2022exhibit312.htm q4-2022exhibit321.htm lazr-20221231_g1.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 130 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "lazr-20221231.htm": { "axisCustom": 3, "axisStandard": 43, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 1661, "http://xbrl.sec.gov/dei/2022": 39 }, "contextCount": 582, "dts": { "calculationLink": { "local": [ "lazr-20221231_cal.xml" ] }, "definitionLink": { "local": [ "lazr-20221231_def.xml" ] }, "inline": { "local": [ "lazr-20221231.htm" ] }, "labelLink": { "local": [ "lazr-20221231_lab.xml" ] }, "presentationLink": { "local": [ "lazr-20221231_pre.xml" ] }, "schema": { "local": [ "lazr-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 952, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 9, "http://www.luminartech.com/20221231": 2, "http://xbrl.sec.gov/dei/2022": 5, "total": 16 }, "keyCustom": 102, "keyStandard": 494, "memberCustom": 63, "memberStandard": 83, "nsprefix": "lazr", "nsuri": "http://www.luminartech.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://www.luminartech.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000010 - Disclosure - Organization and Description of Business", "menuCat": "Notes", "order": "10", "role": "http://www.luminartech.com/role/OrganizationandDescriptionofBusiness", "shortName": "Organization and Description of Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R100": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000100 - Disclosure - Segment and Customer Concentration Information - Segment Operating Results and Reconciliation to the Consolidated Balances (Details)", "menuCat": "Details", "order": "100", "role": "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationSegmentOperatingResultsandReconciliationtotheConsolidatedBalancesDetails", "shortName": "Segment and Customer Concentration Information - Segment Operating Results and Reconciliation to the Consolidated Balances (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i06faced3662b47e4ad95de23473b3498_I20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:Assets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R101": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i710560e3658248f6bf2b95da8c76248d_D20220101-20221231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000101 - Disclosure - Segment and Customer Concentration Information - Narrative (Details)", "menuCat": "Details", "order": "101", "role": "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationNarrativeDetails", "shortName": "Segment and Customer Concentration Information - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i710560e3658248f6bf2b95da8c76248d_D20220101-20221231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R102": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i8461b4ce3964418bbab2058fa3421e7c_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "lazr:InvestmentsRelatedParty", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000102 - Disclosure - Related Party Disclosures (Details)", "menuCat": "Details", "order": "102", "role": "http://www.luminartech.com/role/RelatedPartyDisclosuresDetails", "shortName": "Related Party Disclosures (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i8461b4ce3964418bbab2058fa3421e7c_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "lazr:InvestmentsRelatedParty", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R103": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "ic489155acb73419287b7cabaa4647d9c_D20230101-20230131", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AssetAcquisitionConsiderationTransferredOtherAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000103 - Disclosure - Subsequent Events (Details)", "menuCat": "Details", "order": "103", "role": "http://www.luminartech.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "ic489155acb73419287b7cabaa4647d9c_D20230101-20230131", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AssetAcquisitionConsiderationTransferredOtherAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000011 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "11", "role": "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000012 - Disclosure - Business Combinations", "menuCat": "Notes", "order": "12", "role": "http://www.luminartech.com/role/BusinessCombinations", "shortName": "Business Combinations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000013 - Disclosure - Revenue", "menuCat": "Notes", "order": "13", "role": "http://www.luminartech.com/role/Revenue", "shortName": "Revenue", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000014 - Disclosure - Investments", "menuCat": "Notes", "order": "14", "role": "http://www.luminartech.com/role/Investments", "shortName": "Investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000015 - Disclosure - Financial Statement Components", "menuCat": "Notes", "order": "15", "role": "http://www.luminartech.com/role/FinancialStatementComponents", "shortName": "Financial Statement Components", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000016 - Disclosure - Debt", "menuCat": "Notes", "order": "16", "role": "http://www.luminartech.com/role/Debt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueMeasurementPolicyPolicyTextBlock", "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000017 - Disclosure - Fair Value Measurements", "menuCat": "Notes", "order": "17", "role": "http://www.luminartech.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueMeasurementPolicyPolicyTextBlock", "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "lazr:TemporaryEquityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000018 - Disclosure - Convertible Preferred Stock", "menuCat": "Notes", "order": "18", "role": "http://www.luminartech.com/role/ConvertiblePreferredStock", "shortName": "Convertible Preferred Stock", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "lazr:TemporaryEquityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000019 - Disclosure - Earnings (Loss) Per Share", "menuCat": "Notes", "order": "19", "role": "http://www.luminartech.com/role/EarningsLossPerShare", "shortName": "Earnings (Loss) Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:AuditorName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "false", "longName": "0000002 - Document - Audit Information", "menuCat": "Cover", "order": "2", "role": "http://www.luminartech.com/role/AuditInformation", "shortName": "Audit Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:AuditorName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000020 - Disclosure - Stockholders\u2019 Equity (Deficit)", "menuCat": "Notes", "order": "20", "role": "http://www.luminartech.com/role/StockholdersEquityDeficit", "shortName": "Stockholders\u2019 Equity (Deficit)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000021 - Disclosure - Stock-based Compensation", "menuCat": "Notes", "order": "21", "role": "http://www.luminartech.com/role/StockbasedCompensation", "shortName": "Stock-based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000022 - Disclosure - Leases", "menuCat": "Notes", "order": "22", "role": "http://www.luminartech.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000023 - Disclosure - Income Taxes", "menuCat": "Notes", "order": "23", "role": "http://www.luminartech.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000024 - Disclosure - Commitment and Contingencies", "menuCat": "Notes", "order": "24", "role": "http://www.luminartech.com/role/CommitmentandContingencies", "shortName": "Commitment and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000025 - Disclosure - Segment and Customer Concentration Information", "menuCat": "Notes", "order": "25", "role": "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformation", "shortName": "Segment and Customer Concentration Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000026 - Disclosure - Related Party Transactions", "menuCat": "Notes", "order": "26", "role": "http://www.luminartech.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000027 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "27", "role": "http://www.luminartech.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000028 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "28", "role": "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000029 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "29", "role": "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": null }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000003 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "3", "role": "http://www.luminartech.com/role/ConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RestrictedCashCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000030 - Disclosure - Business Combinations (Tables)", "menuCat": "Tables", "order": "30", "role": "http://www.luminartech.com/role/BusinessCombinationsTables", "shortName": "Business Combinations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000031 - Disclosure - Revenue (Tables)", "menuCat": "Tables", "order": "31", "role": "http://www.luminartech.com/role/RevenueTables", "shortName": "Revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000032 - Disclosure - Investments (Tables)", "menuCat": "Tables", "order": "32", "role": "http://www.luminartech.com/role/InvestmentsTables", "shortName": "Investments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000033 - Disclosure - Financial Statement Components (Tables)", "menuCat": "Tables", "order": "33", "role": "http://www.luminartech.com/role/FinancialStatementComponentsTables", "shortName": "Financial Statement Components (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000034 - Disclosure - Debt (Tables)", "menuCat": "Tables", "order": "34", "role": "http://www.luminartech.com/role/DebtTables", "shortName": "Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000035 - Disclosure - Fair Value Measurements (Tables)", "menuCat": "Tables", "order": "35", "role": "http://www.luminartech.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000036 - Disclosure - Earnings (Loss) Per Share (Tables)", "menuCat": "Tables", "order": "36", "role": "http://www.luminartech.com/role/EarningsLossPerShareTables", "shortName": "Earnings (Loss) Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "lazr:VendorStockInLieuOfCashProgramTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000037 - Disclosure - Stockholders\u2019 Equity (Deficit) (Tables)", "menuCat": "Tables", "order": "37", "role": "http://www.luminartech.com/role/StockholdersEquityDeficitTables", "shortName": "Stockholders\u2019 Equity (Deficit) (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "lazr:VendorStockInLieuOfCashProgramTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000038 - Disclosure - Stock-based Compensation (Tables)", "menuCat": "Tables", "order": "38", "role": "http://www.luminartech.com/role/StockbasedCompensationTables", "shortName": "Stock-based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000039 - Disclosure - Leases (Tables)", "menuCat": "Tables", "order": "39", "role": "http://www.luminartech.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000004 - Statement - Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "4", "role": "http://www.luminartech.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i01ac3a558e60480ba54fb3ee068d1713_I20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000040 - Disclosure - Income Taxes (Tables)", "menuCat": "Tables", "order": "40", "role": "http://www.luminartech.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000041 - Disclosure - Segment and Customer Concentration Information (Tables)", "menuCat": "Tables", "order": "41", "role": "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationTables", "shortName": "Segment and Customer Concentration Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "operating_segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000042 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Segment Information (Details)", "menuCat": "Details", "order": "42", "role": "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesSegmentInformationDetails", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Segment Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "operating_segment", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:IntercompanyForeignCurrencyBalanceAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000043 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Concentration of Credit Risk (Details)", "menuCat": "Details", "order": "43", "role": "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationofCreditRiskDetails", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Concentration of Credit Risk (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:IntercompanyForeignCurrencyBalanceAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "ieae5ee8248044f9b8d00396aa8da6b47_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000044 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Property and Equipment (Details)", "menuCat": "Details", "order": "44", "role": "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Property and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "ieae5ee8248044f9b8d00396aa8da6b47_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill", "span", "div", "us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000045 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Intangible Assets and Goodwill (Details)", "menuCat": "Details", "order": "45", "role": "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Intangible Assets and Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill", "span", "div", "us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000046 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Impairment of Long-Lived Assets (Details)", "menuCat": "Details", "order": "46", "role": "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesImpairmentofLongLivedAssetsDetails", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Impairment of Long-Lived Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "div", "lazr:WarrantsAndRightsPolicyDisclosurePolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "2", "first": true, "lang": "en-US", "name": "lazr:ClassOfWarrantOrRightCashSettlementTransactionThresholdPercentageOfShareholders", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000047 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Public and Private Warrants (Details)", "menuCat": "Details", "order": "47", "role": "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Public and Private Warrants (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "lazr:WarrantsAndRightsPolicyDisclosurePolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "2", "first": true, "lang": "en-US", "name": "lazr:ClassOfWarrantOrRightCashSettlementTransactionThresholdPercentageOfShareholders", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000048 - Disclosure - Business Combinations - Narrative (Details)", "menuCat": "Details", "order": "48", "role": "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "shortName": "Business Combinations - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4020f21cbc524de2b0b6223f679372ca_D20201202-20201202", "decimals": "-5", "lang": "en-US", "name": "lazr:BusinessCombinationContingentEquityEquityInterestsIssuable", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000049 - Disclosure - Business Combinations - Schedule of Recognized Identified Assets and Liabilities (Details)", "menuCat": "Details", "order": "49", "role": "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails", "shortName": "Business Combinations - Schedule of Recognized Identified Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "ib01e183f3e5f4bf0ac1a54c774075a4c_I20220413", "decimals": "-3", "lang": "en-US", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000005 - Statement - Consolidated Statements of Operations and Comprehensive Loss", "menuCat": "Statements", "order": "5", "role": "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss", "shortName": "Consolidated Statements of Operations and Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "ie562bd2082104d4785f2559cdd27b899_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000050 - Disclosure - Business Combinations - Components of Intangible Assets and Estimated Useful Lives (Details)", "menuCat": "Details", "order": "50", "role": "http://www.luminartech.com/role/BusinessCombinationsComponentsofIntangibleAssetsandEstimatedUsefulLivesDetails", "shortName": "Business Combinations - Components of Intangible Assets and Estimated Useful Lives (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i0be1f5475b9a4abda8ec2c1d282053ba_I20220413", "decimals": "-3", "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "ia12c240c02c64136b875892a09d92031_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000051 - Disclosure - Business Combinations - Impact of Adjustments to the Unaudited Pro Forma (Details)", "menuCat": "Details", "order": "51", "role": "http://www.luminartech.com/role/BusinessCombinationsImpactofAdjustmentstotheUnauditedProFormaDetails", "shortName": "Business Combinations - Impact of Adjustments to the Unaudited Pro Forma (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "ia12c240c02c64136b875892a09d92031_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000052 - Disclosure - Business Combinations - Unaudited Pro Forma (Details)", "menuCat": "Details", "order": "52", "role": "http://www.luminartech.com/role/BusinessCombinationsUnauditedProFormaDetails", "shortName": "Business Combinations - Unaudited Pro Forma (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000053 - Disclosure - Revenue - Schedule of Disaggregation of Revenue (Details)", "menuCat": "Details", "order": "53", "role": "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails", "shortName": "Revenue - Schedule of Disaggregation of Revenue (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i83efdf50f52541aabc39fb220c448c3c_D20220101-20221231", "decimals": "INF", "lang": "en-US", "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:WarrantsAndRightsOutstanding", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000054 - Disclosure - Revenue - Narrative (Details)", "menuCat": "Details", "order": "54", "role": "http://www.luminartech.com/role/RevenueNarrativeDetails", "shortName": "Revenue - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i62dd4b424dd64ab591a1606811c2c5e3_I20200331", "decimals": "INF", "lang": "en-US", "name": "lazr:ClassOfWarrantOrRightNumberOfTranches", "reportCount": 1, "unique": true, "unitRef": "tranche", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetNetCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000055 - Disclosure - Revenue - Schedule of Opening and Closing Balances of Contract Assets and Contract Liabilities (Details)", "menuCat": "Details", "order": "55", "role": "http://www.luminartech.com/role/RevenueScheduleofOpeningandClosingBalancesofContractAssetsandContractLiabilitiesDetails", "shortName": "Revenue - Schedule of Opening and Closing Balances of Contract Assets and Contract Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiabilityNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i5367b2b1040d40bf96ba4de93501c4d5_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000056 - Disclosure - Revenue - Schedule of Significant Changes in Contract Assets and Contract Liabilities (Details)", "menuCat": "Details", "order": "56", "role": "http://www.luminartech.com/role/RevenueScheduleofSignificantChangesinContractAssetsandContractLiabilitiesDetails", "shortName": "Revenue - Schedule of Significant Changes in Contract Assets and Contract Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetReclassifiedToReceivable", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i164c5a8a372c4b2d8e9960f10a4b1b7c_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000057 - Disclosure - Revenue - Remaining Performance Obligations (Details)", "menuCat": "Details", "order": "57", "role": "http://www.luminartech.com/role/RevenueRemainingPerformanceObligationsDetails", "shortName": "Revenue - Remaining Performance Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i164c5a8a372c4b2d8e9960f10a4b1b7c_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000058 - Disclosure - Investments - Amortized Cost (Details)", "menuCat": "Details", "order": "58", "role": "http://www.luminartech.com/role/InvestmentsAmortizedCostDetails", "shortName": "Investments - Amortized Cost (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000059 - Disclosure - Investments - Continuous Loss Position (Details)", "menuCat": "Details", "order": "59", "role": "http://www.luminartech.com/role/InvestmentsContinuousLossPositionDetails", "shortName": "Investments - Continuous Loss Position (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i542caa53d7e745bf81ea9d788b2dd2d6_I20191231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquitySharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000006 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders\u2019 Equity (Deficit)", "menuCat": "Statements", "order": "6", "role": "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "shortName": "Consolidated Statements of Convertible Preferred Stock and Stockholders\u2019 Equity (Deficit)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i542caa53d7e745bf81ea9d788b2dd2d6_I20191231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquitySharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000060 - Disclosure - Investments - Narrative (Details)", "menuCat": "Details", "order": "60", "role": "http://www.luminartech.com/role/InvestmentsNarrativeDetails", "shortName": "Investments - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "ie53dfda1a7d14299b9b583716e94e923_I20211231", "decimals": "INF", "lang": "en-US", "name": "lazr:InvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000061 - Disclosure - Investments - Schedule of Equity Investments (Details)", "menuCat": "Details", "order": "61", "role": "http://www.luminartech.com/role/InvestmentsScheduleofEquityInvestmentsDetails", "shortName": "Investments - Schedule of Equity Investments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000062 - Disclosure - Financial Statement Components - Cash and Cash Equivalents (Details)", "menuCat": "Details", "order": "62", "role": "http://www.luminartech.com/role/FinancialStatementComponentsCashandCashEquivalentsDetails", "shortName": "Financial Statement Components - Cash and Cash Equivalents (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000063 - Disclosure - Financial Statement Components - Inventory (Details)", "menuCat": "Details", "order": "63", "role": "http://www.luminartech.com/role/FinancialStatementComponentsInventoryDetails", "shortName": "Financial Statement Components - Inventory (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OtherPrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000064 - Disclosure - Financial Statement Components - Prepaid Expenses and Other Current Assets (Details)", "menuCat": "Details", "order": "64", "role": "http://www.luminartech.com/role/FinancialStatementComponentsPrepaidExpensesandOtherCurrentAssetsDetails", "shortName": "Financial Statement Components - Prepaid Expenses and Other Current Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OtherPrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000065 - Disclosure - Financial Statement Components - Property and Equipment (Details)", "menuCat": "Details", "order": "65", "role": "http://www.luminartech.com/role/FinancialStatementComponentsPropertyandEquipmentDetails", "shortName": "Financial Statement Components - Property and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i5367b2b1040d40bf96ba4de93501c4d5_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsNetIncludingGoodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000066 - Disclosure - Financial Statement Components - Schedule of Intangible Assets (Details)", "menuCat": "Details", "order": "66", "role": "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails", "shortName": "Financial Statement Components - Schedule of Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if3382a548eaf4b4b98d871d6662aee29_D20220101-20220331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i7aacc2ad7fdf416fb0e47dd568aa1ef1_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000067 - Disclosure - Financial Statement Components - Future Amortization Expense (Details)", "menuCat": "Details", "order": "67", "role": "http://www.luminartech.com/role/FinancialStatementComponentsFutureAmortizationExpenseDetails", "shortName": "Financial Statement Components - Future Amortization Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i7aacc2ad7fdf416fb0e47dd568aa1ef1_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i5367b2b1040d40bf96ba4de93501c4d5_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000068 - Disclosure - Financial Statement Components - Goodwill (Details)", "menuCat": "Details", "order": "68", "role": "http://www.luminartech.com/role/FinancialStatementComponentsGoodwillDetails", "shortName": "Financial Statement Components - Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:GoodwillPurchaseAccountingAdjustments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DepositsAssetsNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000069 - Disclosure - Financial Statement Components - Other Noncurrent Assets (Details)", "menuCat": "Details", "order": "69", "role": "http://www.luminartech.com/role/FinancialStatementComponentsOtherNoncurrentAssetsDetails", "shortName": "Financial Statement Components - Other Noncurrent Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DepositsAssetsNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4563a425f2464deb872b0b981155a4c5_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "lazr:PaymentsForTemporaryEquityIssuanceCosts", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000007 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders\u2019 Equity (Deficit) (Parenthetical)", "menuCat": "Statements", "order": "7", "role": "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitParenthetical", "shortName": "Consolidated Statements of Convertible Preferred Stock and Stockholders\u2019 Equity (Deficit) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4563a425f2464deb872b0b981155a4c5_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:PaymentsOfStockIssuanceCosts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccruedEmployeeBenefitsCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000070 - Disclosure - Financial Statement Components - Accrued and Other Current Liabilities (Details)", "menuCat": "Details", "order": "70", "role": "http://www.luminartech.com/role/FinancialStatementComponentsAccruedandOtherCurrentLiabilitiesDetails", "shortName": "Financial Statement Components - Accrued and Other Current Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccruedEmployeeBenefitsCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProceedsFromConvertibleDebt", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000071 - Disclosure - Debt - Additional Information (Details)", "menuCat": "Details", "order": "71", "role": "http://www.luminartech.com/role/DebtAdditionalInformationDetails", "shortName": "Debt - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i206b5f688e4c4c3c9aaf65e8f6137403_D20200101-20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:FairValueAdjustmentOfWarrants", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "ic58b642d137d4f45bbe857111ac023ac_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000072 - Disclosure - Debt - Schedule of Net Carrying Amount (Details)", "menuCat": "Details", "order": "72", "role": "http://www.luminartech.com/role/DebtScheduleofNetCarryingAmountDetails", "shortName": "Debt - Schedule of Net Carrying Amount (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "ic58b642d137d4f45bbe857111ac023ac_I20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:UnamortizedDebtIssuanceExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000073 - Disclosure - Debt - Schedule of Interest Expense (Details)", "menuCat": "Details", "order": "73", "role": "http://www.luminartech.com/role/DebtScheduleofInterestExpenseDetails", "shortName": "Debt - Schedule of Interest Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "lazr:ScheduleOfInterestExpenseTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i472388cbd60f488bbd1b2e15addd73cc_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:InterestExpenseDebtExcludingAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "ie5b444fdb41f4d5fa55b1748c211fac1_I20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:WarrantsAndRightsOutstandingTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000074 - Disclosure - Fair Value Measurements - Narrative (Details)", "menuCat": "Details", "order": "74", "role": "http://www.luminartech.com/role/FairValueMeasurementsNarrativeDetails", "shortName": "Fair Value Measurements - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "ie5b444fdb41f4d5fa55b1748c211fac1_I20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:WarrantsAndRightsOutstandingTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i3b8afb8a6c8c4e70945fef11a93420f9_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000075 - Disclosure - Fair Value Measurements - Schedule of Changes in Level 3 Liabilities Measured at Fair Value (Details)", "menuCat": "Details", "order": "75", "role": "http://www.luminartech.com/role/FairValueMeasurementsScheduleofChangesinLevel3LiabilitiesMeasuredatFairValueDetails", "shortName": "Fair Value Measurements - Schedule of Changes in Level 3 Liabilities Measured at Fair Value (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i3b8afb8a6c8c4e70945fef11a93420f9_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000076 - Disclosure - Fair Value Measurements - Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements on a Recurring Basis and the Level of Inputs Used (Details)", "menuCat": "Details", "order": "76", "role": "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails", "shortName": "Fair Value Measurements - Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements on a Recurring Basis and the Level of Inputs Used (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i59e3d28c75fe4678a80112c835711710_I20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "iab47007800d649079c3656dc95ddd248_D20190624-20201202", "decimals": "-5", "first": true, "lang": "en-US", "name": "lazr:TemporaryEquityConvertibleBeneficialConversionFeature", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000077 - Disclosure - Convertible Preferred Stock (Details)", "menuCat": "Details", "order": "77", "role": "http://www.luminartech.com/role/ConvertiblePreferredStockDetails", "shortName": "Convertible Preferred Stock (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "iab47007800d649079c3656dc95ddd248_D20190624-20201202", "decimals": "-5", "first": true, "lang": "en-US", "name": "lazr:TemporaryEquityConvertibleBeneficialConversionFeature", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000078 - Disclosure - Earnings (Loss) Per Share - Basic and Diluted Loss Per Share (Details)", "menuCat": "Details", "order": "78", "role": "http://www.luminartech.com/role/EarningsLossPerShareBasicandDilutedLossPerShareDetails", "shortName": "Earnings (Loss) Per Share - Basic and Diluted Loss Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000079 - Disclosure - Earnings (Loss) Per Share - Antidilutive Securities (Details)", "menuCat": "Details", "order": "79", "role": "http://www.luminartech.com/role/EarningsLossPerShareAntidilutiveSecuritiesDetails", "shortName": "Earnings (Loss) Per Share - Antidilutive Securities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000008 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "8", "role": "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "ibb0d8bc7e0fc49fca061775e6a57b742_I20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000080 - Disclosure - Earnings (Loss) Per Share - Narrative (Details)", "menuCat": "Details", "order": "80", "role": "http://www.luminartech.com/role/EarningsLossPerShareNarrativeDetails", "shortName": "Earnings (Loss) Per Share - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "ibb0d8bc7e0fc49fca061775e6a57b742_I20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if11b95378bfe479db8685f70089f2576_I20201202", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000081 - Disclosure - Stockholders\u2019 Equity (Deficit) (Details)", "menuCat": "Details", "order": "81", "role": "http://www.luminartech.com/role/StockholdersEquityDeficitDetails", "shortName": "Stockholders\u2019 Equity (Deficit) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "INF", "lang": "en-US", "name": "us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i5367b2b1040d40bf96ba4de93501c4d5_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000082 - Disclosure - Stockholders\u2019 Equity (Deficit) - Stock-in-lieu of Cash Program Activity (Details)", "menuCat": "Details", "order": "82", "role": "http://www.luminartech.com/role/StockholdersEquityDeficitStockinlieuofCashProgramActivityDetails", "shortName": "Stockholders\u2019 Equity (Deficit) - Stock-in-lieu of Cash Program Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "lazr:VendorStockInLieuOfCashProgramTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "iad0917a1747e4e03b3454b63f650a5a6_I20211231", "decimals": "INF", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4563a425f2464deb872b0b981155a4c5_D20200101-20201231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000083 - Disclosure - Stock-based Compensation - Narrative (Details)", "menuCat": "Details", "order": "83", "role": "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails", "shortName": "Stock-based Compensation - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4563a425f2464deb872b0b981155a4c5_D20200101-20201231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i5367b2b1040d40bf96ba4de93501c4d5_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000084 - Disclosure - Stock-based Compensation - Stock Option Activity (Details)", "menuCat": "Details", "order": "84", "role": "http://www.luminartech.com/role/StockbasedCompensationStockOptionActivityDetails", "shortName": "Stock-based Compensation - Stock Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "INF", "lang": "en-US", "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i3ab1f953646e45dd995dcded82a727d6_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000085 - Disclosure - Stock-based Compensation - Restricted Stock Activity (Details)", "menuCat": "Details", "order": "85", "role": "http://www.luminartech.com/role/StockbasedCompensationRestrictedStockActivityDetails", "shortName": "Stock-based Compensation - Restricted Stock Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i3ab1f953646e45dd995dcded82a727d6_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "ia2a7ff7db39e40f7ba647c8752be3d1f_D20221116-20221116", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000086 - Disclosure - Stock-based Compensation - Employee Stock Purchase Plan, Valuation Assumptions (Details)", "menuCat": "Details", "order": "86", "role": "http://www.luminartech.com/role/StockbasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails", "shortName": "Stock-based Compensation - Employee Stock Purchase Plan, Valuation Assumptions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "ia2a7ff7db39e40f7ba647c8752be3d1f_D20221116-20221116", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000087 - Disclosure - Stock-based Compensation - Compensation Expense (Details)", "menuCat": "Details", "order": "87", "role": "http://www.luminartech.com/role/StockbasedCompensationCompensationExpenseDetails", "shortName": "Stock-based Compensation - Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "ief678c167b4c4363bbc66f47adfb6c7b_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i8bfe9207b56e49c5b4928c0984e72f90_I20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseTermOfContract", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000088 - Disclosure - Leases - Narrative (Details)", "menuCat": "Details", "order": "88", "role": "http://www.luminartech.com/role/LeasesNarrativeDetails", "shortName": "Leases - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i8bfe9207b56e49c5b4928c0984e72f90_I20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseTermOfContract", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000089 - Disclosure - Leases - Components of Lease Expenses (Details)", "menuCat": "Details", "order": "89", "role": "http://www.luminartech.com/role/LeasesComponentsofLeaseExpensesDetails", "shortName": "Leases - Components of Lease Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "lazr:PaymentsToAcquireDebtSecuritiesAvailableForSaleRelatedParty", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000009 - Statement - Consolidated Statements of Cash Flows (Parenthetical)", "menuCat": "Statements", "order": "9", "role": "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlowsParenthetical", "shortName": "Consolidated Statements of Cash Flows (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "lazr:PaymentsToAcquireDebtSecuritiesAvailableForSaleRelatedParty", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000090 - Disclosure - Leases - Supplemental Cash Flow Information (Details)", "menuCat": "Details", "order": "90", "role": "http://www.luminartech.com/role/LeasesSupplementalCashFlowInformationDetails", "shortName": "Leases - Supplemental Cash Flow Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "lazr:AssetsAndLiabilitiesLesseeTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000091 - Disclosure - Leases - Supplemental Balance Sheet Information, Weighted Average Remaining Terms, and Weighted Average Discount Rates (Details)", "menuCat": "Details", "order": "91", "role": "http://www.luminartech.com/role/LeasesSupplementalBalanceSheetInformationWeightedAverageRemainingTermsandWeightedAverageDiscountRatesDetails", "shortName": "Leases - Supplemental Balance Sheet Information, Weighted Average Remaining Terms, and Weighted Average Discount Rates (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": null, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000092 - Disclosure - Leases - Maturities of Lease Liabilities (Details)", "menuCat": "Details", "order": "92", "role": "http://www.luminartech.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails", "shortName": "Leases - Maturities of Lease Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000093 - Disclosure - Income Taxes - Components of Loss Before Provision for (Benefit from) Income Taxes (Details)", "menuCat": "Details", "order": "93", "role": "http://www.luminartech.com/role/IncomeTaxesComponentsofLossBeforeProvisionforBenefitfromIncomeTaxesDetails", "shortName": "Income Taxes - Components of Loss Before Provision for (Benefit from) Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CurrentForeignTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000094 - Disclosure - Income Taxes - Provision for (benefit from) income taxes (Details)", "menuCat": "Details", "order": "94", "role": "http://www.luminartech.com/role/IncomeTaxesProvisionforbenefitfromincometaxesDetails", "shortName": "Income Taxes - Provision for (benefit from) income taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CurrentForeignTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000095 - Disclosure - Income Taxes - Narrative (Details)", "menuCat": "Details", "order": "95", "role": "http://www.luminartech.com/role/IncomeTaxesNarrativeDetails", "shortName": "Income Taxes - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000096 - Disclosure - Income Taxes - Effective Income Tax Rate (Details)", "menuCat": "Details", "order": "96", "role": "http://www.luminartech.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails", "shortName": "Income Taxes - Effective Income Tax Rate (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i4942a687b6db427bbb3344fde93b5f17_D20220101-20221231", "decimals": "3", "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000097 - Disclosure - Income Taxes - Deferred Income Tax Assets and Liabilities (Details)", "menuCat": "Details", "order": "97", "role": "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails", "shortName": "Income Taxes - Deferred Income Tax Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i5367b2b1040d40bf96ba4de93501c4d5_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000098 - Disclosure - Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details)", "menuCat": "Details", "order": "98", "role": "http://www.luminartech.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails", "shortName": "Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "i0c322cd3533d40c68f8f173b9610c094_I20191231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R99": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:PurchaseObligationDueInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000099 - Disclosure - Commitment and Contingencies (Details)", "menuCat": "Details", "order": "99", "role": "http://www.luminartech.com/role/CommitmentandContingenciesDetails", "shortName": "Commitment and Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "lazr-20221231.htm", "contextRef": "if2d16e5477c54f448950cef13f727e44_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:PurchaseObligationDueInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } } }, "segmentCount": 158, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r867", "r868", "r869" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID", "terseLabel": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/AuditInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r867", "r868", "r869" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/AuditInformation" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r867", "r868", "r869" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/AuditInformation" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r867", "r868", "r869" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r870" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r865" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r864" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r864" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r864" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r871" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r864" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r864" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r864" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r864" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r872" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r867", "r868", "r869" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r863" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r866" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.luminartech.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "lazr_A2015PlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2015 Plan", "label": "2015 Plan [Member]", "terseLabel": "2015 Plan" } } }, "localname": "A2015PlanMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "lazr_A20172018And2020WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2017, 2018, And 2020 Warrants", "label": "2017, 2018, And 2020 Warrants [Member]", "terseLabel": "2017, 2018, And 2020 Warrants" } } }, "localname": "A20172018And2020WarrantsMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "lazr_A2020PlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2020 Plan", "label": "2020 Plan [Member]", "terseLabel": "2020 Plan" } } }, "localname": "A2020PlanMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "lazr_AdjustmentsToAdditionalPaidInCapitalIncreaseFromSettlementOfRecapitalizationOfEscrow": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments To Additional Paid In Capital, Increase From Settlement Of Recapitalization Of Escrow", "label": "Adjustments To Additional Paid In Capital, Increase From Settlement Of Recapitalization Of Escrow", "terseLabel": "Cash received from Gores on settlement of recapitalization of escrow" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalIncreaseFromSettlementOfRecapitalizationOfEscrow", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "lazr_AdjustmentsToAdditionalPaidInCapitalWarrants": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustments to Additional Paid in Capital, Warrants", "label": "Adjustments to Additional Paid in Capital, Warrants", "negatedTerseLabel": "Public and Private Warrants" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalWarrants", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "lazr_AdvancedTechnologiesAndServicesSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Advanced Technologies and Services Segment", "label": "Advanced Technologies and Services Segment [Member]", "terseLabel": "ATS", "verboseLabel": "ATS" } } }, "localname": "AdvancedTechnologiesAndServicesSegmentMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsGoodwillDetails", "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails", "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationSegmentOperatingResultsandReconciliationtotheConsolidatedBalancesDetails" ], "xbrltype": "domainItemType" }, "lazr_AdvancesForCapitalProjectsAndEquipment": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Advances for Capital Projects and Equipment", "label": "Advances for Capital Projects and Equipment", "negatedTerseLabel": "Advances for capital projects and equipment" } } }, "localname": "AdvancesForCapitalProjectsAndEquipment", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "lazr_AdvancesPaymentForCapitalProjects": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsOtherNoncurrentAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Advances payment For Capital Projects", "label": "Advances payment For Capital Projects", "terseLabel": "Advance payment for capital projects" } } }, "localname": "AdvancesPaymentForCapitalProjects", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsOtherNoncurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "lazr_Amended2020PlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amended 2020 Plan", "label": "Amended 2020 Plan [Member]", "terseLabel": "Amended 2020 Plan" } } }, "localname": "Amended2020PlanMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "lazr_AmountsPayableForSharesRepurchased": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amounts Payable For Shares Repurchased", "label": "Amounts Payable For Shares Repurchased", "terseLabel": "Amounts payable for shares repurchased" } } }, "localname": "AmountsPayableForSharesRepurchased", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "lazr_AssembledWorkforceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assembled Workforce", "label": "Assembled Workforce [Member]", "terseLabel": "Assembled workforce" } } }, "localname": "AssembledWorkforceMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "lazr_AssetAcquisitionConsiderationServicePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset Acquisition, Consideration Service, Period", "label": "Asset Acquisition, Consideration Service, Period", "terseLabel": "Asset acquisition, consideration service, period" } } }, "localname": "AssetAcquisitionConsiderationServicePeriod", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/SubsequentEventsDetails" ], "xbrltype": "durationItemType" }, "lazr_AssetAcquisitionConsiderationTransferredNonCancelableAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Asset Acquisition, Consideration Transferred, Non-Cancelable Amount", "label": "Asset Acquisition, Consideration Transferred, Non-Cancelable Amount", "terseLabel": "Asset acquisition, consideration transferred, non-cancelable amount" } } }, "localname": "AssetAcquisitionConsiderationTransferredNonCancelableAmount", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "lazr_AssetsAcquiredOnCapitalLeases": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Assets Acquired On Capital Leases", "label": "Assets Acquired On Capital Leases", "terseLabel": "Assets acquired under finance leases (capital leases prior to adoption of ASC 842)" } } }, "localname": "AssetsAcquiredOnCapitalLeases", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "lazr_AssetsAndLiabilitiesLesseeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets And Liabilities, Lessee", "label": "Assets And Liabilities, Lessee [Table Text Block]", "terseLabel": "Schedule of Supplemental Balance Sheet Information" } } }, "localname": "AssetsAndLiabilitiesLesseeTableTextBlock", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "lazr_AuditInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Audit Information", "label": "Audit Information [Abstract]" } } }, "localname": "AuditInformationAbstract", "nsuri": "http://www.luminartech.com/20221231", "xbrltype": "stringItemType" }, "lazr_AutonomySolutionsSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Autonomy Solutions Segment", "label": "Autonomy Solutions Segment [Member]", "terseLabel": "Autonomy Solutions", "verboseLabel": "Autonomy Solutions" } } }, "localname": "AutonomySolutionsSegmentMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsGoodwillDetails", "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails", "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationSegmentOperatingResultsandReconciliationtotheConsolidatedBalancesDetails" ], "xbrltype": "domainItemType" }, "lazr_BusinessAcquisitionContingentConsiderationSharePriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Acquisition, Contingent Consideration, Share Price Trigger", "label": "Business Acquisition, Contingent Consideration, Share Price Trigger", "terseLabel": "Share price (in dollars per share)" } } }, "localname": "BusinessAcquisitionContingentConsiderationSharePriceTrigger", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "lazr_BusinessAcquisitionContingentConsiderationTriggeringEventAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Acquisition, Contingent Consideration Triggering Event", "label": "Business Acquisition, Contingent Consideration Triggering Event [Axis]", "terseLabel": "Business Acquisition, Contingent Consideration Triggering Event [Axis]" } } }, "localname": "BusinessAcquisitionContingentConsiderationTriggeringEventAxis", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "stringItemType" }, "lazr_BusinessAcquisitionContingentConsiderationTriggeringEventDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Acquisition, Contingent Consideration Triggering Event", "label": "Business Acquisition, Contingent Consideration Triggering Event [Domain]", "terseLabel": "Business Acquisition, Contingent Consideration Triggering Event [Domain]" } } }, "localname": "BusinessAcquisitionContingentConsiderationTriggeringEventDomain", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "lazr_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesRemaining": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares, Remaining", "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares, Remaining", "terseLabel": "Earn-out shares remaining (in shares)" } } }, "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesRemaining", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "lazr_BusinessAcquisitionNumberOfTriggeringEvents": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Acquisition, Number Of Triggering Events", "label": "Business Acquisition, Number Of Triggering Events", "terseLabel": "Number of triggering events" } } }, "localname": "BusinessAcquisitionNumberOfTriggeringEvents", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "integerItemType" }, "lazr_BusinessAcquisitionNumberOfTriggeringEventsMet": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Acquisition, Number Of Triggering Events Met", "label": "Business Acquisition, Number Of Triggering Events Met", "terseLabel": "Number of triggering events met" } } }, "localname": "BusinessAcquisitionNumberOfTriggeringEventsMet", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "integerItemType" }, "lazr_BusinessCombinationContingentEquityEquityInterestsIssuable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Contingent Equity, Equity Interests Issuable", "label": "Business Combination, Contingent Equity, Equity Interests Issuable", "terseLabel": "Estimated fair value of the potential earn-out shares" } } }, "localname": "BusinessCombinationContingentEquityEquityInterestsIssuable", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "lazr_BusinessCombinationContingentEquityEquityInterestsIssuableMeasurementInput": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Combination, Contingent Equity, Equity Interests Issuable, Measurement Input", "label": "Business Combination, Contingent Equity, Equity Interests Issuable, Measurement Input", "terseLabel": "Earn out shares, measurement input" } } }, "localname": "BusinessCombinationContingentEquityEquityInterestsIssuableMeasurementInput", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "decimalItemType" }, "lazr_BusinessCombinationContingentEquityShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Combination, Contingent Equity, Shares", "label": "Business Combination, Contingent Equity, Shares", "terseLabel": "Aggregate number of Class A and Class B Common Stock shares entitled to stockholders (in shares)" } } }, "localname": "BusinessCombinationContingentEquityShares", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "lazr_BusinessCombinationExchangeRatioPerAcquireeShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Combination, Exchange Ratio, Per Acquiree Share", "label": "Business Combination, Exchange Ratio, Per Acquiree Share", "terseLabel": "Exchange ratio (in dollars per share)" } } }, "localname": "BusinessCombinationExchangeRatioPerAcquireeShare", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "lazr_BusinessCombinationNumberOfTriggeringEvents": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Combination, Number Of Triggering Events", "label": "Business Combination, Number Of Triggering Events", "terseLabel": "Number of triggering events" } } }, "localname": "BusinessCombinationNumberOfTriggeringEvents", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "integerItemType" }, "lazr_BusinessCombinationPurchasePriceIncludesWorkingCapitalAdjustments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Purchase Price Includes Working Capital Adjustments", "label": "Business Combination, Purchase Price Includes Working Capital Adjustments", "terseLabel": "Purchase price includes working capital adjustments" } } }, "localname": "BusinessCombinationPurchasePriceIncludesWorkingCapitalAdjustments", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "lazr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractAsset": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails": { "order": 9.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contract Asset", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contract Asset", "terseLabel": "Contract asset" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractAsset", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "lazr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current and Noncurrent Liabilities", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current and Noncurrent Liabilities", "negatedTerseLabel": "Current and non-current liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "lazr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-Use Assets", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-Use Assets", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "lazr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Warrants", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Warrants", "verboseLabel": "Liability recorded related to warrants from business combination" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrants", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "lazr_BusinessCombinationStockRedeemedRedemptionPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Combination, Stock Redeemed, Redemption Price Per Share", "label": "Business Combination, Stock Redeemed, Redemption Price Per Share", "terseLabel": "Stock redeemed, redemption price (in dollars per share)" } } }, "localname": "BusinessCombinationStockRedeemedRedemptionPricePerShare", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "lazr_BusinessCombinationStockRedeemedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Combination, Stock Redeemed, Shares", "label": "Business Combination, Stock Redeemed, Shares", "terseLabel": "Stock redeemed (in shares)" } } }, "localname": "BusinessCombinationStockRedeemedShares", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "lazr_BusinessCombinationThresholdStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Combination, Threshold Stock Price Trigger", "label": "Business Combination, Threshold Stock Price Trigger", "terseLabel": "Threshold stock price trigger (in dollars per share)" } } }, "localname": "BusinessCombinationThresholdStockPriceTrigger", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "lazr_CashAcquiredFromAcquisitionFinancingActivities": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash Acquired From Acquisition, Financing Activities", "label": "Cash Acquired From Acquisition, Financing Activities", "verboseLabel": "Cash received from Gores on recapitalization" } } }, "localname": "CashAcquiredFromAcquisitionFinancingActivities", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "lazr_CashFlowLesseeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash Flow, Lessee [Abstract]", "label": "Cash Flow, Lessee [Abstract]", "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:" } } }, "localname": "CashFlowLesseeAbstract", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/LeasesSupplementalCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "lazr_ChiefLegalOfficerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chief Legal Officer", "label": "Chief Legal Officer [Member]", "terseLabel": "Chief Legal Officer" } } }, "localname": "ChiefLegalOfficerMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "lazr_ClassAPreferredUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class A Preferred Units", "label": "Class A Preferred Units [Member]", "terseLabel": "Class A Preferred Units" } } }, "localname": "ClassAPreferredUnitsMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "lazr_ClassOfWarrantOrRightCashSettlementTransactionThresholdPercentageOfShareholders": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Cash Settlement, Transaction Threshold Percentage Of Shareholders", "label": "Class Of Warrant Or Right, Cash Settlement, Transaction Threshold Percentage Of Shareholders", "terseLabel": "Percentage of Class A shareholders" } } }, "localname": "ClassOfWarrantOrRightCashSettlementTransactionThresholdPercentageOfShareholders", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails" ], "xbrltype": "percentItemType" }, "lazr_ClassOfWarrantOrRightExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Exercised", "label": "Class Of Warrant Or Right, Exercised", "terseLabel": "Warrants exercised (in shares)" } } }, "localname": "ClassOfWarrantOrRightExercised", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "lazr_ClassOfWarrantOrRightNumberOfTranches": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Number Of Tranches", "label": "Class Of Warrant Or Right, Number Of Tranches", "terseLabel": "Number of tranches" } } }, "localname": "ClassOfWarrantOrRightNumberOfTranches", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/RevenueNarrativeDetails" ], "xbrltype": "integerItemType" }, "lazr_ClassOfWarrantOrRightRedemptionPricePerWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Redemption Price Per Warrant", "label": "Class Of Warrant Or Right, Redemption Price Per Warrant", "terseLabel": "Redemption price per warrant (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightRedemptionPricePerWarrant", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "perShareItemType" }, "lazr_ClassOfWarrantOrRightWarrantsRedeemedDuringPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Warrants Redeemed During Period", "label": "Class Of Warrant Or Right, Warrants Redeemed During Period", "terseLabel": "Remaining warrants redeemed (in shares)" } } }, "localname": "ClassOfWarrantOrRightWarrantsRedeemedDuringPeriod", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "lazr_CommonStockConvertibleConversionRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock, Convertible, Conversion Ratio", "label": "Common Stock, Convertible, Conversion Ratio", "terseLabel": "Conversion ratio" } } }, "localname": "CommonStockConvertibleConversionRatio", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "pureItemType" }, "lazr_CommonStockVotingRightsVotesPerCommonShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock, Voting Rights, Votes Per Common Share", "label": "Common Stock, Voting Rights, Votes Per Common Share", "terseLabel": "Common stock, votes per share" } } }, "localname": "CommonStockVotingRightsVotesPerCommonShare", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "integerItemType" }, "lazr_ComputerHardwareAndSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Computer Hardware And Software", "label": "Computer Hardware And Software [Member]", "terseLabel": "Computer hardware and software", "verboseLabel": "Computer hardware and software" } } }, "localname": "ComputerHardwareAndSoftwareMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails", "http://www.luminartech.com/role/FinancialStatementComponentsPropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "lazr_ConsecutiveTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consecutive Trading Days", "label": "Consecutive Trading Days", "terseLabel": "Consecutive trading days" } } }, "localname": "ConsecutiveTradingDays", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "integerItemType" }, "lazr_ContractWithCustomerAssetRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contract With Customer Asset", "label": "Contract With Customer Asset [Roll Forward]", "terseLabel": "Contract With Customer Asset [Roll Forward]" } } }, "localname": "ContractWithCustomerAssetRollForward", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/RevenueScheduleofOpeningandClosingBalancesofContractAssetsandContractLiabilitiesDetails", "http://www.luminartech.com/role/RevenueScheduleofSignificantChangesinContractAssetsandContractLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "lazr_ContractWithCustomerLiabilityIncreaseDueToCashReceivedBillingsInExcessOfRevenue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contract With Customer, Liability, Increase Due To Cash Received Billings In Excess Of Revenue", "label": "Contract With Customer, Liability, Increase Due To Cash Received Billings In Excess Of Revenue", "terseLabel": "Increase due to cash received and not recognized as revenue and billings in excess of revenue recognized during the period" } } }, "localname": "ContractWithCustomerLiabilityIncreaseDueToCashReceivedBillingsInExcessOfRevenue", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/RevenueScheduleofSignificantChangesinContractAssetsandContractLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "lazr_ContractWithCustomerLiabilityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contract with Customer, Liability", "label": "Contract with Customer, Liability [Roll Forward]", "terseLabel": "Contract with Customer, Liability [Roll Forward]" } } }, "localname": "ContractWithCustomerLiabilityRollForward", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/RevenueScheduleofOpeningandClosingBalancesofContractAssetsandContractLiabilitiesDetails", "http://www.luminartech.com/role/RevenueScheduleofSignificantChangesinContractAssetsandContractLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "lazr_ConversionOfTemporaryEquityAmountIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Conversion Of Temporary Equity, Amount Issued", "label": "Conversion Of Temporary Equity, Amount Issued", "terseLabel": "Conversion of Series A, Series X and Founders\u2019 convertible preferred stock into Class A and Class B common stock" } } }, "localname": "ConversionOfTemporaryEquityAmountIssued", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "lazr_ConversionOfWarrantsAmountIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Conversion Of Warrants, Amount Issued", "label": "Conversion Of Warrants, Amount Issued", "terseLabel": "Issuance of Class A common stock upon exercise of warrants" } } }, "localname": "ConversionOfWarrantsAmountIssued", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "lazr_ConvertibleSeniorNotesDue2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Notes Due 2026", "label": "Convertible Senior Notes Due 2026 [Member]", "terseLabel": "Convertible Senior Notes Due 2026" } } }, "localname": "ConvertibleSeniorNotesDue2026Member", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails", "http://www.luminartech.com/role/DebtScheduleofInterestExpenseDetails", "http://www.luminartech.com/role/DebtScheduleofNetCarryingAmountDetails" ], "xbrltype": "domainItemType" }, "lazr_CustomerBacklogMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Backlog", "label": "Customer Backlog [Member]", "terseLabel": "Customer backlog" } } }, "localname": "CustomerBacklogMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsComponentsofIntangibleAssetsandEstimatedUsefulLivesDetails", "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "lazr_CustomerOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer One", "label": "Customer One [Member]", "terseLabel": "Customer One" } } }, "localname": "CustomerOneMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationofCreditRiskDetails", "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "lazr_CustomerThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Three", "label": "Customer Three [Member]", "terseLabel": "Customer Three" } } }, "localname": "CustomerThreeMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationofCreditRiskDetails" ], "xbrltype": "domainItemType" }, "lazr_CustomerTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Two", "label": "Customer Two [Member]", "terseLabel": "Customer Two" } } }, "localname": "CustomerTwoMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationofCreditRiskDetails", "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "lazr_DaimlerNorthAmericaCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Daimler North America Corporation", "label": "Daimler North America Corporation [Member]", "terseLabel": "Daimler North America Corporation" } } }, "localname": "DaimlerNorthAmericaCorporationMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "lazr_DebtInstrumentConvertibleSharesIssuable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Convertible, Shares Issuable", "label": "Debt Instrument, Convertible, Shares Issuable", "terseLabel": "Debt instrument, convertible, shares issuable (in shares)" } } }, "localname": "DebtInstrumentConvertibleSharesIssuable", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "lazr_DebtInstrumentConvertibleThresholdPercentOfConversionPriceTriggeringConvertibleFeature": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Convertible, Threshold Percent Of Conversion Price Triggering Convertible Feature", "label": "Debt Instrument, Convertible, Threshold Percent Of Conversion Price Triggering Convertible Feature", "terseLabel": "Debt instrument, convertible, threshold percent of conversion price triggering convertible feature" } } }, "localname": "DebtInstrumentConvertibleThresholdPercentOfConversionPriceTriggeringConvertibleFeature", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "lazr_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCostsIncreaseDecrease": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Deferred Expense, Capitalized Research and Development Costs Increase (Decrease)", "label": "Deferred Tax Assets, Deferred Expense, Capitalized Research and Development Costs Increase (Decrease)", "terseLabel": "Deferred tax assets, deferred expense, capitalized research and development costs increase (decrease)" } } }, "localname": "DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCostsIncreaseDecrease", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "lazr_DeferredTaxAssetsLeaseLiability": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Lease liability", "label": "Deferred Tax Assets, Lease liability", "terseLabel": "Lease liability (ASC 842)" } } }, "localname": "DeferredTaxAssetsLeaseLiability", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "lazr_DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangiblesDepreciationAndAmortization": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails": { "order": 9.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Property, Plant and Equipment And Intangibles, Depreciation And Amortization", "label": "Deferred Tax Assets, Property, Plant and Equipment And Intangibles, Depreciation And Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangiblesDepreciationAndAmortization", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "lazr_DeferredTaxLiabilitiesPropertyPlantAndEquipmentAndIntangiblesDepreciationAndAmortization": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Liabilities, Property, Plant and Equipment And Intangibles, Depreciation And Amortization", "label": "Deferred Tax Liabilities, Property, Plant and Equipment And Intangibles, Depreciation And Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipmentAndIntangiblesDepreciationAndAmortization", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "lazr_DemonstrationFleetAndDemonstrationUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Demonstration Fleet And Demonstration Units", "label": "Demonstration Fleet And Demonstration Units [Member]", "verboseLabel": "Demonstration fleet and demonstration units" } } }, "localname": "DemonstrationFleetAndDemonstrationUnitsMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "lazr_ECARXHoldingsIncECXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ECARX Holdings, Inc. (ECX)", "label": "ECARX Holdings, Inc. (ECX) [Member]", "terseLabel": "ECARX Holdings, Inc. (ECX)" } } }, "localname": "ECARXHoldingsIncECXMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "lazr_ECARXHoldingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ECARX Holdings Inc.,", "label": "ECARX Holdings Inc., [Member]", "terseLabel": "ECARX Holdings Inc.," } } }, "localname": "ECARXHoldingsIncMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "lazr_EarnOutSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earn-Out Shares", "label": "Earn-Out Shares [Member]", "terseLabel": "Earn-out shares" } } }, "localname": "EarnOutSharesMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/EarningsLossPerShareAntidilutiveSecuritiesDetails" ], "xbrltype": "domainItemType" }, "lazr_EarningsPerShareBasicAndDilutedEPSAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnings Per Share, Basic and Diluted EPS", "label": "Earnings Per Share, Basic and Diluted EPS [Abstract]", "terseLabel": "Shares used in computing net loss per share attributable to common stockholders:" } } }, "localname": "EarningsPerShareBasicAndDilutedEPSAbstract", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" ], "xbrltype": "stringItemType" }, "lazr_EffectiveIncomeTaxRateReconciliationExecutiveCompensationPercent": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": { "order": 6.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Executive Compensation, Percent", "label": "Effective Income Tax Rate Reconciliation, Executive Compensation, Percent", "terseLabel": "Executive compensation" } } }, "localname": "EffectiveIncomeTaxRateReconciliationExecutiveCompensationPercent", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "lazr_EffectiveIncomeTaxRateReconciliationFairValueOfFinancialInstrumentsPercent": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": { "order": 4.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Fair Value Of Financial Instruments, Percent", "label": "Effective Income Tax Rate Reconciliation, Fair Value Of Financial Instruments, Percent", "terseLabel": "Fair value of financial instruments" } } }, "localname": "EffectiveIncomeTaxRateReconciliationFairValueOfFinancialInstrumentsPercent", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "lazr_EmployeeStockPurchasePlanLengthOfOfferingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee Stock Purchase Plan, Length of Offering Period", "label": "Employee Stock Purchase Plan, Length of Offering Period", "terseLabel": "Length of offering period (in months)" } } }, "localname": "EmployeeStockPurchasePlanLengthOfOfferingPeriod", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "lazr_EquityClassifiedAwardsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity Classified Awards", "label": "Equity Classified Awards [Axis]", "terseLabel": "Equity Classified Awards [Axis]" } } }, "localname": "EquityClassifiedAwardsAxis", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "lazr_EquityClassifiedAwardsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity Classified Awards [Domain]", "label": "Equity Classified Awards [Domain]", "terseLabel": "Equity Classified Awards [Domain]" } } }, "localname": "EquityClassifiedAwardsDomain", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "lazr_EuropeAndMiddleEastMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Europe And Middle East", "label": "Europe And Middle East [Member]", "terseLabel": "Europe and Middle East" } } }, "localname": "EuropeAndMiddleEastMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "lazr_FairValueAdjustmentOfWarrantsAndFinancialInstrumentsSubjectToMandatoryRedemption": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair Value Adjustment Of Warrants And Financial Instruments Subject to Mandatory Redemption", "label": "Fair Value Adjustment Of Warrants And Financial Instruments Subject to Mandatory Redemption", "terseLabel": "Change in fair value of warrants" } } }, "localname": "FairValueAdjustmentOfWarrantsAndFinancialInstrumentsSubjectToMandatoryRedemption", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "lazr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsPriorToExercise": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings, Prior to Exercise", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings, Prior to Exercise", "terseLabel": "Change in fair value prior to exercises" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsPriorToExercise", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofChangesinLevel3LiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "monetaryItemType" }, "lazr_FixedValueEquityAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fixed Value Equity Awards", "label": "Fixed Value Equity Awards [Member]", "terseLabel": "Equity settled fixed value" } } }, "localname": "FixedValueEquityAwardsMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationCompensationExpenseDetails", "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "lazr_FreedomPhotonicsAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Freedom Photonics Awards", "label": "Freedom Photonics Awards [Member]", "terseLabel": "Freedom Photonics" } } }, "localname": "FreedomPhotonicsAwardsMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationCompensationExpenseDetails", "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "lazr_FreedomPhotonicsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Freedom Photonics", "label": "Freedom Photonics [Member]", "terseLabel": "Freedom Photonics" } } }, "localname": "FreedomPhotonicsMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsComponentsofIntangibleAssetsandEstimatedUsefulLivesDetails", "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails", "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/FinancialStatementComponentsGoodwillDetails" ], "xbrltype": "domainItemType" }, "lazr_GoresMetropoulosMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gores Metropoulos", "label": "Gores Metropoulos [Member]", "terseLabel": "Gores Metropoulos" } } }, "localname": "GoresMetropoulosMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails", "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "lazr_IntangibleAssetsIncludingGoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible Assets (Including Goodwill)", "label": "Intangible Assets (Including Goodwill) [Roll Forward]", "terseLabel": "Intangible Assets (Including Goodwill) [Roll Forward]" } } }, "localname": "IntangibleAssetsIncludingGoodwillRollForward", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "lazr_InterestIncomeExpenseAndOtherNonoperatingNet": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest Income (Expense) And Other, Nonoperating, Net", "label": "Interest Income (Expense) And Other, Nonoperating, Net", "terseLabel": "Interest income and other" } } }, "localname": "InterestIncomeExpenseAndOtherNonoperatingNet", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "lazr_InvestmentInEquitySecuritiesFVNIShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment in Equity Securities, FV-NI, Shares", "label": "Investment in Equity Securities, FV-NI, Shares", "terseLabel": "Sale of stock (in shares)" } } }, "localname": "InvestmentInEquitySecuritiesFVNIShares", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "lazr_InvestmentOwnershipPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment, Ownership Percentage", "label": "Investment, Ownership Percentage", "terseLabel": "Investment in Robotic Research, percentage of capitalization (percent, less than)" } } }, "localname": "InvestmentOwnershipPercentage", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "percentItemType" }, "lazr_InvestmentSoldRelatedParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investment Sold, Related Party", "label": "Investment Sold, Related Party", "terseLabel": "Portion of investment sold" } } }, "localname": "InvestmentSoldRelatedParty", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/RelatedPartyDisclosuresDetails" ], "xbrltype": "monetaryItemType" }, "lazr_InvestmentsRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investments, Related Party", "label": "Investments, Related Party", "terseLabel": "Investment" } } }, "localname": "InvestmentsRelatedParty", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/RelatedPartyDisclosuresDetails" ], "xbrltype": "monetaryItemType" }, "lazr_InvestmentsRelatedPartyFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investments, Related Party, Fair Value", "label": "Investments, Related Party, Fair Value", "terseLabel": "Investment, fair value" } } }, "localname": "InvestmentsRelatedPartyFairValue", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/RelatedPartyDisclosuresDetails" ], "xbrltype": "monetaryItemType" }, "lazr_IssuanceOfSharesForInvestmentInShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of Shares for Investment in Shares", "label": "Issuance of Shares for Investment in Shares", "terseLabel": "Issuance of shares for investment in Robotic Research Opco, LLC (in shares)" } } }, "localname": "IssuanceOfSharesForInvestmentInShares", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "lazr_IssuanceOfSharesForInvestmentInValues": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of Shares for Investment in Values", "label": "Issuance of Shares for Investment in Values", "terseLabel": "Issuance of shares for investment in Robotic Research Opco, LLC" } } }, "localname": "IssuanceOfSharesForInvestmentInValues", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "lazr_LeasesWeightedAverageDiscountRateAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Leases, Weighted Average Discount Rate [Abstract]", "label": "Leases, Weighted Average Discount Rate [Abstract]", "terseLabel": "Weighted average discount rate" } } }, "localname": "LeasesWeightedAverageDiscountRateAbstract", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/LeasesSupplementalBalanceSheetInformationWeightedAverageRemainingTermsandWeightedAverageDiscountRatesDetails" ], "xbrltype": "stringItemType" }, "lazr_LesseeOperatingLeaseNumberOfRenewalOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee, Operating Lease, Number Of Renewal Options", "label": "Lessee, Operating Lease, Number Of Renewal Options", "terseLabel": "Number of renewal options" } } }, "localname": "LesseeOperatingLeaseNumberOfRenewalOptions", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/LeasesNarrativeDetails" ], "xbrltype": "integerItemType" }, "lazr_LiabilityClassifiedAwardsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liability Classified Awards", "label": "Liability Classified Awards [Axis]", "terseLabel": "Liability Classified Awards [Axis]" } } }, "localname": "LiabilityClassifiedAwardsAxis", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "lazr_LiabilityClassifiedAwardsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liability Classified Awards [Domain]", "label": "Liability Classified Awards [Domain]", "terseLabel": "Liability Classified Awards [Domain]" } } }, "localname": "LiabilityClassifiedAwardsDomain", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "lazr_MarketOneMemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Market One Member", "label": "Market One Member [Member]", "terseLabel": "Market One Member" } } }, "localname": "MarketOneMemberMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "lazr_MarketThreeMemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Market Three Member", "label": "Market Three Member [Member]", "terseLabel": "Market Three Member" } } }, "localname": "MarketThreeMemberMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "lazr_MarketTwoMemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Market Two Member", "label": "Market Two Member [Member]", "terseLabel": "Market Two Member" } } }, "localname": "MarketTwoMemberMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "lazr_MarketableSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Marketable Securities", "label": "Marketable Securities [Member]", "terseLabel": "Included in marketable securities", "verboseLabel": "Marketable securities" } } }, "localname": "MarketableSecuritiesMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/InvestmentsAmortizedCostDetails", "http://www.luminartech.com/role/InvestmentsScheduleofEquityInvestmentsDetails" ], "xbrltype": "domainItemType" }, "lazr_MrAlecGoresMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mr Alec Gores", "label": "Mr Alec Gores [Member]", "terseLabel": "Mr Alec Gores" } } }, "localname": "MrAlecGoresMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/RelatedPartyDisclosuresDetails" ], "xbrltype": "domainItemType" }, "lazr_MrHengMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mr. Heng", "label": "Mr. Heng [Member]", "terseLabel": "Mr. Heng" } } }, "localname": "MrHengMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/RelatedPartyDisclosuresDetails" ], "xbrltype": "domainItemType" }, "lazr_NonMarketableEquityInvestmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non-Marketable Equity Investment", "label": "Non-Marketable Equity Investment [Member]", "terseLabel": "Non-Marketable Equity Investment" } } }, "localname": "NonMarketableEquityInvestmentMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/InvestmentsScheduleofEquityInvestmentsDetails" ], "xbrltype": "domainItemType" }, "lazr_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating Lease, Assets And Liabilities, Lessee [Abstract]", "label": "Operating Lease, Assets And Liabilities, Lessee [Abstract]", "terseLabel": "Operating leases:" } } }, "localname": "OperatingLeaseAssetsAndLiabilitiesLesseeAbstract", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/LeasesSupplementalBalanceSheetInformationWeightedAverageRemainingTermsandWeightedAverageDiscountRatesDetails" ], "xbrltype": "stringItemType" }, "lazr_OperatingLossCarryforwardsNotSubjectToExpiration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Loss Carryforwards, Not Subject To Expiration", "label": "Operating Loss Carryforwards, Not Subject To Expiration", "terseLabel": "Net operating loss carryforwards, not subject to expiration" } } }, "localname": "OperatingLossCarryforwardsNotSubjectToExpiration", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "lazr_OperatingLossCarryforwardsSubjectToExpiration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Loss Carryforwards, Subject To Expiration", "label": "Operating Loss Carryforwards, Subject To Expiration", "terseLabel": "Net operating loss carryforwards, subject to expiration" } } }, "localname": "OperatingLossCarryforwardsSubjectToExpiration", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "lazr_OptogrationAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Optogration Awards", "label": "Optogration Awards [Member]", "terseLabel": "Optogration" } } }, "localname": "OptogrationAwardsMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "lazr_OptogrationIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Optogration, Inc.", "label": "Optogration, Inc. [Member]", "terseLabel": "Optogration, Inc." } } }, "localname": "OptogrationIncMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsComponentsofIntangibleAssetsandEstimatedUsefulLivesDetails", "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/FinancialStatementComponentsFutureAmortizationExpenseDetails", "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "lazr_OptogrationMilestoneAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Optogration Milestone Awards", "label": "Optogration Milestone Awards [Member]", "terseLabel": "Optogration Milestone Awards" } } }, "localname": "OptogrationMilestoneAwardsMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "lazr_OtherAccruedLiabilitiesMiscellaneousCurrent": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsAccruedandOtherCurrentLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other Accrued Liabilities, Miscellaneous, Current", "label": "Other Accrued Liabilities, Miscellaneous, Current", "terseLabel": "Other" } } }, "localname": "OtherAccruedLiabilitiesMiscellaneousCurrent", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsAccruedandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "lazr_OtherAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Awards", "label": "Other Awards [Member]", "terseLabel": "Other" } } }, "localname": "OtherAwardsMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "lazr_PaymentsForRepurchaseOfCommonStockAndWarrants": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments For Repurchase Of Common Stock And Warrants", "label": "Payments For Repurchase Of Common Stock And Warrants", "negatedTerseLabel": "Repurchases of common stock and redemption of warrants" } } }, "localname": "PaymentsForRepurchaseOfCommonStockAndWarrants", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "lazr_PaymentsForTemporaryEquityIssuanceCosts": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments For Temporary Equity Issuance Costs", "label": "Payments For Temporary Equity Issuance Costs", "negatedTerseLabel": "Issuance cost paid for Series X convertible preferred stock", "terseLabel": "Issuance of Series X convertible preferred stock for cash, net of issuance costs" } } }, "localname": "PaymentsForTemporaryEquityIssuanceCosts", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitParenthetical" ], "xbrltype": "monetaryItemType" }, "lazr_PaymentsToAcquireDebtSecuritiesAvailableForSaleRelatedParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments to Acquire Debt Securities, Available-for-sale, Related Party", "label": "Payments to Acquire Debt Securities, Available-for-sale, Related Party", "terseLabel": "Purchases of marketable securities with related parties" } } }, "localname": "PaymentsToAcquireDebtSecuritiesAvailableForSaleRelatedParty", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "lazr_PaymentsToPurchaseCappedCalls": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments To Purchase Capped Calls", "label": "Payments To Purchase Capped Calls", "terseLabel": "Payments to purchase capped calls" } } }, "localname": "PaymentsToPurchaseCappedCalls", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "lazr_PaymentsToVendorsForServicesNoncashOperatingActivities": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Payments To Vendors For Services, Noncash, Operating Activities", "label": "Payments To Vendors For Services, Noncash, Operating Activities", "terseLabel": "Vendor stock-in-lieu of cash program" } } }, "localname": "PaymentsToVendorsForServicesNoncashOperatingActivities", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "lazr_PrepaidExpensesAndOtherCurrentAssetsRelatedToStockInLieuOfCashProgram": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepaid Expenses And Other Current Assets Related To Stock-In-Lieu of Cash Program", "label": "Prepaid Expenses And Other Current Assets Related To Stock-In-Lieu of Cash Program", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpensesAndOtherCurrentAssetsRelatedToStockInLieuOfCashProgram", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "monetaryItemType" }, "lazr_PrivateAndPublicWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private And Public Warrants", "label": "Private And Public Warrants [Member]", "terseLabel": "Private and Public Warrants" } } }, "localname": "PrivateAndPublicWarrantsMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails", "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "lazr_PrivateWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private Warrants", "label": "Private Warrants [Member]", "terseLabel": "Private Warrants" } } }, "localname": "PrivateWarrantsMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails", "http://www.luminartech.com/role/FairValueMeasurementsNarrativeDetails", "http://www.luminartech.com/role/FairValueMeasurementsScheduleofChangesinLevel3LiabilitiesMeasuredatFairValueDetails", "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "lazr_ProceedsFromDebtSecuritiesAvailableForSaleRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from Debt Securities, Available-for-Sale, Related Party", "label": "Proceeds from Debt Securities, Available-for-Sale, Related Party", "terseLabel": "Proceeds from sales/redemptions of marketable securities with related parties" } } }, "localname": "ProceedsFromDebtSecuritiesAvailableForSaleRelatedParty", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "lazr_ProceedsFromRefundableSecurityDeposits": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds From Refundable Security Deposits", "label": "Proceeds From Refundable Security Deposits", "terseLabel": "Proceeds from refundable security deposits" } } }, "localname": "ProceedsFromRefundableSecurityDeposits", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "lazr_PublicWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public Warrants", "label": "Public Warrants [Member]", "terseLabel": "Public Warrants" } } }, "localname": "PublicWarrantsMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "lazr_PurchasesOfCappedCallOptionsRelatedToTheConvertibleSeniorNotesValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Purchases of Capped Call Options Related to the Convertible Senior Notes Value", "label": "Purchases of Capped Call Options Related to the Convertible Senior Notes Value", "terseLabel": "Purchases of capped call options related to the convertible senior notes" } } }, "localname": "PurchasesOfCappedCallOptionsRelatedToTheConvertibleSeniorNotesValue", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "lazr_ResearchAndDevelopmentActivitiesAmortizedOverPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Research and Development Activities, Amortized Over Period", "label": "Research and Development Activities, Amortized Over Period", "terseLabel": "Research and development activities, amortized over period" } } }, "localname": "ResearchAndDevelopmentActivitiesAmortizedOverPeriod", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "durationItemType" }, "lazr_RestrictedStockAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Stock Awards", "label": "Restricted Stock Awards [Member]", "terseLabel": "RSAs" } } }, "localname": "RestrictedStockAwardsMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "lazr_RevenueRecognitionTimingConcentrationRiskMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue Recognition Timing Concentration Risk", "label": "Revenue Recognition Timing Concentration Risk [Member]", "terseLabel": "Revenue Recognition Timing Concentration Risk" } } }, "localname": "RevenueRecognitionTimingConcentrationRiskMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "lazr_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract]", "label": "Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract]", "terseLabel": "Right of use assets obtained in exchange for lease obligations:" } } }, "localname": "RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/LeasesSupplementalCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "lazr_RoboticResearchOpCoLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Robotic Research OpCo, LLC", "label": "Robotic Research OpCo, LLC [Member]", "terseLabel": "Robotic Research OpCo, LLC" } } }, "localname": "RoboticResearchOpCoLLCMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "lazr_SaleOfStockNumberOfSharesOfCommonStockPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale Of Stock, Number Of Shares Of Common Stock Per Unit", "label": "Sale Of Stock, Number Of Shares Of Common Stock Per Unit", "terseLabel": "Sale of stock, number of shares of common stock per unit (in shares)" } } }, "localname": "SaleOfStockNumberOfSharesOfCommonStockPerUnit", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails" ], "xbrltype": "sharesItemType" }, "lazr_SaleOfStockNumberOfWarrantsPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale Of Stock, Number Of Warrants Per Unit", "label": "Sale Of Stock, Number Of Warrants Per Unit", "terseLabel": "Sale of stock, number of warrants per unit (in shares)" } } }, "localname": "SaleOfStockNumberOfWarrantsPerUnit", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails" ], "xbrltype": "sharesItemType" }, "lazr_ScheduleOfInterestExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Interest Expense", "label": "Schedule of Interest Expense [Table Text Block]", "terseLabel": "Schedule of Interest Expense" } } }, "localname": "ScheduleOfInterestExpenseTableTextBlock", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "lazr_SeagateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Seagate", "label": "Seagate [Member]", "terseLabel": "Seagate" } } }, "localname": "SeagateMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "lazr_SegmentConcentrationRiskMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Segment Concentration Risk", "label": "Segment Concentration Risk [Member]", "terseLabel": "Segment Concentration Risk" } } }, "localname": "SegmentConcentrationRiskMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "lazr_SeriesAAndSeriesXConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series A And Series X Convertible Preferred Stock", "label": "Series A And Series X Convertible Preferred Stock [Member]", "terseLabel": "Series A And Series X Convertible Preferred Stock" } } }, "localname": "SeriesAAndSeriesXConvertiblePreferredStockMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConvertiblePreferredStockDetails" ], "xbrltype": "domainItemType" }, "lazr_SeriesAConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series A Convertible Preferred Stock", "label": "Series A Convertible Preferred Stock [Member]", "terseLabel": "Series A Convertible Preferred Stock" } } }, "localname": "SeriesAConvertiblePreferredStockMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/ConvertiblePreferredStockDetails" ], "xbrltype": "domainItemType" }, "lazr_SeriesXConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series X Convertible Preferred Stock", "label": "Series X Convertible Preferred Stock [Member]", "terseLabel": "Series X Convertible Preferred Stock" } } }, "localname": "SeriesXConvertiblePreferredStockMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitParenthetical", "http://www.luminartech.com/role/ConvertiblePreferredStockDetails" ], "xbrltype": "domainItemType" }, "lazr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Aggregate Intrinsic Value", "label": "Share-based Compensation Arrangement By Share-based Payment Award, Aggregate Intrinsic Value [Abstract]", "terseLabel": "Aggregate Intrinsic Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "lazr_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncrementalNumberOfSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Incremental Number of Shares Authorized", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Incremental Number of Shares Authorized", "terseLabel": "Incremental number of shares authorized (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardIncrementalNumberOfSharesAuthorized", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "lazr_ShareBasedCompensationArrangementByShareBasedPaymentAwardMarketVestingConditionStockPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Market Vesting Condition, Stock Price", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Market Vesting Condition, Stock Price", "terseLabel": "RSU vesting, market condition, stock price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMarketVestingConditionStockPrice", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "lazr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssuedForEachVestedRSU": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Issued for Each Vested RSU", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Issued for Each Vested RSU", "terseLabel": "Number of shares issued for each vested RSU (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssuedForEachVestedRSU", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "lazr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPreTaxEarningsPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Pre-Tax Earnings, Percent", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Pre-Tax Earnings, Percent", "terseLabel": "Percentage of pre-tax earnings" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPreTaxEarningsPercent", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "lazr_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingMilestoneObligations": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Remaining Milestone Obligations", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Remaining Milestone Obligations", "terseLabel": "Optogration milestone awards, remaining obligations" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingMilestoneObligations", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "lazr_ShareBasedPaymentArrangementEquityClassifiedAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Payment Arrangement, Equity Classified Awards", "label": "Share-Based Payment Arrangement, Equity Classified Awards [Member]", "terseLabel": "Stock-based awards\u2014Equity classified" } } }, "localname": "ShareBasedPaymentArrangementEquityClassifiedAwardsMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/EarningsLossPerShareAntidilutiveSecuritiesDetails" ], "xbrltype": "domainItemType" }, "lazr_ShareBasedPaymentArrangementLiabilityClassifiedAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Payment Arrangement, Liability Classified Awards", "label": "Share-Based Payment Arrangement, Liability Classified Awards [Member]", "terseLabel": "Stock-based awards\u2014Liability classified" } } }, "localname": "ShareBasedPaymentArrangementLiabilityClassifiedAwardsMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/EarningsLossPerShareAntidilutiveSecuritiesDetails" ], "xbrltype": "domainItemType" }, "lazr_ShareBasedPaymentArrangementTrancheFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Payment Arrangement, Tranche Four", "label": "Share-Based Payment Arrangement, Tranche Four [Member]", "terseLabel": "Tranche Four" } } }, "localname": "ShareBasedPaymentArrangementTrancheFourMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "lazr_SharePriceTriggeringEventFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Price Triggering Event Five", "label": "Share Price Triggering Event Five [Member]", "terseLabel": "Period of Time, Five" } } }, "localname": "SharePriceTriggeringEventFiveMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "lazr_SharePriceTriggeringEventFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Price Triggering Event Four", "label": "Share Price Triggering Event Four [Member]", "terseLabel": "Period of Time, Four" } } }, "localname": "SharePriceTriggeringEventFourMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "lazr_SharePriceTriggeringEventOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Price Triggering Event One", "label": "Share Price Triggering Event One [Member]", "terseLabel": "Period of Time, One" } } }, "localname": "SharePriceTriggeringEventOneMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "lazr_SharePriceTriggeringEventSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Price Triggering Event Six", "label": "Share Price Triggering Event Six [Member]", "terseLabel": "Period of Time, Six" } } }, "localname": "SharePriceTriggeringEventSixMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "lazr_SharePriceTriggeringEventThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Price Triggering Event Three", "label": "Share Price Triggering Event Three [Member]", "terseLabel": "Period of Time, Three" } } }, "localname": "SharePriceTriggeringEventThreeMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "lazr_SharePriceTriggeringEventTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Price Triggering Event Two", "label": "Share Price Triggering Event Two [Member]", "terseLabel": "Period of Time, Two" } } }, "localname": "SharePriceTriggeringEventTwoMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "lazr_SolficeAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Solfice Awards", "label": "Solfice Awards [Member]", "terseLabel": "Solfice" } } }, "localname": "SolficeAwardsMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationCompensationExpenseDetails", "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "lazr_SolficeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Solfice", "label": "Solfice [Member]", "terseLabel": "Solfice" } } }, "localname": "SolficeMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "lazr_StockBasedCompensationCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Based Compensation Costs", "label": "Stock Based Compensation Costs [Member]", "terseLabel": "Stock Based Compensation Costs" } } }, "localname": "StockBasedCompensationCostsMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsImpactofAdjustmentstotheUnauditedProFormaDetails" ], "xbrltype": "domainItemType" }, "lazr_StockIssuedDuringPeriodContingentConsiderationEquityShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Contingent Consideration, Equity, Shares", "label": "Stock Issued During Period, Contingent Consideration, Equity, Shares", "terseLabel": "Issuance of earn-out shares (in shares)" } } }, "localname": "StockIssuedDuringPeriodContingentConsiderationEquityShares", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "lazr_StockIssuedDuringPeriodContingentConsiderationEquityValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Contingent Consideration, Equity, Value", "label": "Stock Issued During Period, Contingent Consideration, Equity, Value", "terseLabel": "Issuance of earn-out shares" } } }, "localname": "StockIssuedDuringPeriodContingentConsiderationEquityValue", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "lazr_StockIssuedDuringPeriodSharesInvestment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Shares, Investment", "label": "Stock Issued During Period, Shares, Investment", "terseLabel": "Investment in ECARX Holdings, Inc. (ECX) (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesInvestment", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "lazr_StockIssuedDuringPeriodSharesReverseRecapitalization": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Shares, Reverse Recapitalization", "label": "Stock Issued During Period, Shares, Reverse Recapitalization", "terseLabel": "Merger recapitalization\u2014Class A (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesReverseRecapitalization", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "lazr_StockIssuedDuringPeriodSharesWarrantsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Shares, Warrants Exercised", "label": "Stock Issued During Period, Shares, Warrants Exercised", "terseLabel": "Issuance of Class A common stock upon exercise of Public and Private Warrants (in shares)", "verboseLabel": "Shares issued for exercise of warrants (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesWarrantsExercised", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "lazr_StockIssuedDuringPeriodValueInvestment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Value, Investment", "label": "Stock Issued During Period, Value, Investment", "terseLabel": "Investment in ECARX Holdings, Inc." } } }, "localname": "StockIssuedDuringPeriodValueInvestment", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "lazr_StockIssuedDuringPeriodValueReverseRecapitalization": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Value, Reverse Recapitalization", "label": "Stock Issued During Period, Value, Reverse Recapitalization", "terseLabel": "Merger recapitalization\u2014Class A" } } }, "localname": "StockIssuedDuringPeriodValueReverseRecapitalization", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "lazr_StockIssuedDuringPeriodValueWarrantsExercised": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Value, Warrants Exercised", "label": "Stock Issued During Period, Value, Warrants Exercised", "terseLabel": "Issuance of Class A common stock upon exercise of Public and Private Warrants" } } }, "localname": "StockIssuedDuringPeriodValueWarrantsExercised", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "lazr_StockOptionCappedCallsInitialCapPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Option, Capped Calls, Initial Cap Price", "label": "Stock Option, Capped Calls, Initial Cap Price", "terseLabel": "Stock option, capped calls, initial cap price (in dollars per share)" } } }, "localname": "StockOptionCappedCallsInitialCapPrice", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "lazr_StockOptionCappedCallsInitialStrikePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Option, Capped Calls, Initial Strike Price", "label": "Stock Option, Capped Calls, Initial Strike Price", "terseLabel": "Stock option, capped calls, initial strike price (in dollars per share)" } } }, "localname": "StockOptionCappedCallsInitialStrikePrice", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "lazr_StockholdersEquityExchangeOfCommonStockShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stockholders Equity, Exchange Of Common Stock, Shares", "label": "Stockholders Equity, Exchange Of Common Stock, Shares", "terseLabel": "Conversion of certain shares into Class B common stock (in shares)" } } }, "localname": "StockholdersEquityExchangeOfCommonStockShares", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "lazr_StockholdersEquityExchangeOfCommonStockValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stockholders Equity, Exchange Of Common Stock, Value", "label": "Stockholders Equity, Exchange Of Common Stock, Value", "terseLabel": "Conversion of certain shares into Class B common stock" } } }, "localname": "StockholdersEquityExchangeOfCommonStockValue", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "lazr_SwissReMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Swiss Re", "label": "Swiss Re [Member]", "terseLabel": "Swiss Re" } } }, "localname": "SwissReMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "lazr_TaxCreditCarryforwardNotSubjectToExpiration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Tax Credit Carryforward, Not Subject To Expiration", "label": "Tax Credit Carryforward, Not Subject To Expiration", "terseLabel": "Tax credit carryforward, not subject to expiration" } } }, "localname": "TaxCreditCarryforwardNotSubjectToExpiration", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "lazr_TaxCreditCarryforwardSubjectToExpiration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Tax Credit Carryforward, Subject To Expiration", "label": "Tax Credit Carryforward, Subject To Expiration", "terseLabel": "Tax credit carryforward, subject to expiration" } } }, "localname": "TaxCreditCarryforwardSubjectToExpiration", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "lazr_TemporaryEquityConvertibleBeneficialConversionFeature": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Temporary Equity, Convertible, Beneficial Conversion Feature", "label": "Temporary Equity, Convertible, Beneficial Conversion Feature", "terseLabel": "Beneficial conversion feature" } } }, "localname": "TemporaryEquityConvertibleBeneficialConversionFeature", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConvertiblePreferredStockDetails" ], "xbrltype": "monetaryItemType" }, "lazr_TemporaryEquityEliminationAsPartOfReorganizationShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary Equity, Elimination As Part Of Reorganization, Shares", "label": "Temporary Equity, Elimination As Part Of Reorganization, Shares", "negatedLabel": "Merger recapitalization (in shares)", "terseLabel": "Merger recapitalization (in shares)" } } }, "localname": "TemporaryEquityEliminationAsPartOfReorganizationShares", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/ConvertiblePreferredStockDetails" ], "xbrltype": "sharesItemType" }, "lazr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary Equity, Stock Issued During Period, Shares, New Issues", "label": "Temporary Equity, Stock Issued During Period, Shares, New Issues", "terseLabel": "Preferred stock issued (in shares)", "verboseLabel": "Issuance of Series X convertible preferred stock for cash, net of issuance costs (in shares)" } } }, "localname": "TemporaryEquityStockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/ConvertiblePreferredStockDetails" ], "xbrltype": "sharesItemType" }, "lazr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary Equity, Stock issued During Period, Value, New Issues, Price Per Share", "label": "Temporary Equity, Stock issued During Period, Value, New Issues, Price Per Share", "terseLabel": "Purchase price (in dollars per share)" } } }, "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssuesPricePerShare", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConvertiblePreferredStockDetails" ], "xbrltype": "perShareItemType" }, "lazr_TemporaryEquityTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary Equity", "label": "Temporary Equity [Text Block]", "terseLabel": "Convertible Preferred Stock" } } }, "localname": "TemporaryEquityTextBlock", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/ConvertiblePreferredStock" ], "xbrltype": "textBlockItemType" }, "lazr_ToolingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tooling", "label": "Tooling [Member]", "terseLabel": "Tooling" } } }, "localname": "ToolingMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "lazr_VendorPaymentsInStockInLieuOfCashLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Vendor Payments In Stock In Lieu Of Cash, Liability", "label": "Vendor Payments In Stock In Lieu Of Cash, Liability", "terseLabel": "Vendor payments under the stock-in-lieu of cash program" } } }, "localname": "VendorPaymentsInStockInLieuOfCashLiability", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "monetaryItemType" }, "lazr_VendorPaymentsInStockInLieuOfCashShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vendor Payments In Stock in Lieu Of Cash, Shares", "label": "Vendor Payments In Stock in Lieu Of Cash, Shares", "terseLabel": "Vendor payments in shares in lieu of cash (in shares)" } } }, "localname": "VendorPaymentsInStockInLieuOfCashShares", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "lazr_VendorStockInLieuOfCashProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vendor Stock-In-Lieu Of Cash Program", "label": "Vendor Stock-In-Lieu Of Cash Program [Member]", "terseLabel": "Vendor stock-in-lieu of cash program" } } }, "localname": "VendorStockInLieuOfCashProgramMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/EarningsLossPerShareAntidilutiveSecuritiesDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitStockinlieuofCashProgramActivityDetails" ], "xbrltype": "domainItemType" }, "lazr_VendorStockInLieuOfCashProgramTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vendor Stock-in-lieu of Cash Program", "label": "Vendor Stock-in-lieu of Cash Program [Table Text Block]", "terseLabel": "Schedule of Vendor Stock-in-lieu of Cash Program" } } }, "localname": "VendorStockInLieuOfCashProgramTableTextBlock", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/StockholdersEquityDeficitTables" ], "xbrltype": "textBlockItemType" }, "lazr_VolvoCarTechnologyFundWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Volvo Car Technology Fund Warrant", "label": "Volvo Car Technology Fund Warrant [Member]", "terseLabel": "VCTF warrant" } } }, "localname": "VolvoCarTechnologyFundWarrantMember", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/RevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "lazr_WarrantsAndRightsPolicyDisclosurePolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants And Rights Policy Disclosure", "label": "Warrants And Rights Policy Disclosure [Policy Text Block]", "terseLabel": "Public and Private Warrants" } } }, "localname": "WarrantsAndRightsPolicyDisclosurePolicyTextBlock", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "lazr_WeightedAverageRemainingLeaseTermAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Lease Term [Abstract]", "label": "Weighted Average Remaining Lease Term [Abstract]", "terseLabel": "Weighted average remaining lease term" } } }, "localname": "WeightedAverageRemainingLeaseTermAbstract", "nsuri": "http://www.luminartech.com/20221231", "presentation": [ "http://www.luminartech.com/role/LeasesSupplementalBalanceSheetInformationWeightedAverageRemainingTermsandWeightedAverageDiscountRatesDetails" ], "xbrltype": "stringItemType" }, "srt_AffiliatedEntityMember": { "auth_ref": [ "r809", "r937", "r989", "r990", "r992" ], "lang": { "en-us": { "role": { "label": "Affiliated Entity [Member]", "verboseLabel": "Related Party" } } }, "localname": "AffiliatedEntityMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asia Pacific [Member]", "terseLabel": "Asia Pacific" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r900" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]", "terseLabel": "Chief Executive Officer" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r292", "r339", "r357", "r358", "r359", "r360", "r361", "r363", "r367", "r447", "r448", "r449", "r450", "r452", "r453", "r455", "r457", "r458", "r927", "r928" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationSegmentOperatingResultsandReconciliationtotheConsolidatedBalancesDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r292", "r339", "r357", "r358", "r359", "r360", "r361", "r363", "r367", "r447", "r448", "r449", "r450", "r452", "r453", "r455", "r457", "r458", "r927", "r928" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationSegmentOperatingResultsandReconciliationtotheConsolidatedBalancesDetails" ], "xbrltype": "domainItemType" }, "srt_ExecutiveOfficerMember": { "auth_ref": [ "r900" ], "lang": { "en-us": { "role": { "label": "Executive Officer [Member]", "terseLabel": "Executive Officer" } } }, "localname": "ExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r373", "r841", "r933", "r1004" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]", "terseLabel": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationofCreditRiskDetails", "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r443", "r444", "r445", "r446", "r542", "r749", "r779", "r810", "r811", "r836", "r851", "r862", "r929", "r995", "r996", "r997", "r998", "r999", "r1000" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails", "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails", "http://www.luminartech.com/role/BusinessCombinationsComponentsofIntangibleAssetsandEstimatedUsefulLivesDetails", "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/LeasesNarrativeDetails", "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r443", "r444", "r445", "r446", "r542", "r749", "r779", "r810", "r811", "r836", "r851", "r862", "r929", "r995", "r996", "r997", "r998", "r999", "r1000" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails", "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails", "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r373", "r841", "r933", "r1004" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]", "terseLabel": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationofCreditRiskDetails", "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "North America [Member]", "terseLabel": "North America" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r369", "r751", "r839", "r860", "r924", "r925", "r933", "r1003" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r369", "r751", "r839", "r860", "r924", "r925", "r933", "r1003" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r443", "r444", "r445", "r446", "r534", "r542", "r572", "r573", "r574", "r725", "r749", "r779", "r810", "r811", "r836", "r851", "r862", "r923", "r929", "r996", "r997", "r998", "r999", "r1000" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails", "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails", "http://www.luminartech.com/role/BusinessCombinationsComponentsofIntangibleAssetsandEstimatedUsefulLivesDetails", "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/LeasesNarrativeDetails", "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r443", "r444", "r445", "r446", "r534", "r542", "r572", "r573", "r574", "r725", "r749", "r779", "r810", "r811", "r836", "r851", "r862", "r923", "r929", "r996", "r997", "r998", "r999", "r1000" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails", "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails", "http://www.luminartech.com/role/BusinessCombinationsComponentsofIntangibleAssetsandEstimatedUsefulLivesDetails", "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/LeasesNarrativeDetails", "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r370", "r371", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807", "r808", "r840", "r861", "r933" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r370", "r371", "r795", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807", "r808", "r840", "r861", "r933" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r900", "r991" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]", "terseLabel": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]", "terseLabel": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate201602Member": { "auth_ref": [ "r683" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).", "label": "Accounting Standards Update 2016-02 [Member]", "terseLabel": "Accounting Standards Update 2016-02" } } }, "localname": "AccountingStandardsUpdate201602Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows", "http://www.luminartech.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r18", "r859" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r796" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]", "terseLabel": "Accounts Receivable" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationofCreditRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r375", "r376" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": { "auth_ref": [ "r60" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Accretion (Amortization) of Discounts and Premiums, Investments", "negatedLabel": "Amortization of premium on marketable securities" } } }, "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedEmployeeBenefitsCurrent": { "auth_ref": [ "r20" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsAccruedandOtherCurrentLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Employee Benefits, Current", "terseLabel": "Accrued compensation and benefits" } } }, "localname": "AccruedEmployeeBenefitsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsAccruedandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r20" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.luminartech.com/role/FinancialStatementComponentsAccruedandOtherCurrentLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued and other current liabilities", "totalLabel": "Total accrued and other current liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets", "http://www.luminartech.com/role/FinancialStatementComponentsAccruedandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r105", "r247" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsPropertyandEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedTerseLabel": "Accumulated depreciation and amortization" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsPropertyandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r30", "r31", "r32", "r256", "r775", "r787", "r791" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r29", "r32", "r181", "r709", "r782", "r783", "r880", "r881", "r882", "r893", "r894", "r895" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Income Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AcquisitionRelatedCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Category of acquisition-related costs allocated to (included in) reported pro forma earnings (supplemental pro forma information).", "label": "Acquisition-related Costs [Member]", "terseLabel": "Acquisition-related Costs" } } }, "localname": "AcquisitionRelatedCostsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsImpactofAdjustmentstotheUnauditedProFormaDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r10", "r859" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional\u00a0paid-in\u00a0capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r581", "r582", "r583", "r893", "r894", "r895", "r980" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentOfWarrantsGrantedForServices": { "auth_ref": [ "r59" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustment for noncash service expenses paid for by granting of warrants.", "label": "Adjustment of Warrants Granted for Services", "terseLabel": "Expense related to Volvo Warrants" } } }, "localname": "AdjustmentOfWarrantsGrantedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r235", "r236", "r237", "r238", "r239", "r296", "r297", "r298", "r299", "r308", "r380", "r381", "r393", "r394", "r395", "r396", "r397", "r398", "r581", "r582", "r583", "r608", "r609", "r610", "r611", "r627", "r628", "r629", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r678", "r679", "r684", "r685", "r686", "r687", "r704", "r705", "r706", "r707", "r708", "r709", "r753", "r754", "r755", "r780", "r781", "r782", "r783", "r784", "r785", "r786", "r787", "r788", "r789", "r790", "r791" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Accounting Standards Update [Axis]", "terseLabel": "Accounting Standards Update [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows", "http://www.luminartech.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation", "negatedTerseLabel": "Payments of employee taxes related to vested restricted stock units" } } }, "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r150", "r151", "r544" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Share-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": { "auth_ref": [ "r118", "r128", "r135" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.", "label": "Adjustments to Additional Paid in Capital, Warrant Issued", "terseLabel": "Expense related to Volvo Warrants" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r576" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-Based Payment Arrangement, Expense", "terseLabel": "Compensation cost", "verboseLabel": "Compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationCompensationExpenseDetails", "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r41", "r59", "r194", "r482" ], "calculation": { "http://www.luminartech.com/role/DebtScheduleofInterestExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_InterestExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of Debt Discount (Premium)", "verboseLabel": "Amortization of debt discount and issuance costs" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtScheduleofInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r482", "r681", "r834", "r835", "r887" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 22.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of Debt Issuance Costs and Discounts", "terseLabel": "Amortization of debt discount and issuance costs" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r59", "r92", "r97" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "negatedLabel": "Amortization" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r319" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Total (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/EarningsLossPerShareAntidilutiveSecuritiesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/EarningsLossPerShareAntidilutiveSecuritiesDetails", "http://www.luminartech.com/role/EarningsLossPerShareNarrativeDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitStockinlieuofCashProgramActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/EarningsLossPerShareAntidilutiveSecuritiesDetails", "http://www.luminartech.com/role/EarningsLossPerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/EarningsLossPerShareAntidilutiveSecuritiesDetails", "http://www.luminartech.com/role/EarningsLossPerShareNarrativeDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitStockinlieuofCashProgramActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AssetAcquisitionAxis": { "auth_ref": [ "r976" ], "lang": { "en-us": { "role": { "documentation": "Information by asset acquisition.", "label": "Asset Acquisition [Axis]", "terseLabel": "Asset Acquisition [Axis]" } } }, "localname": "AssetAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable": { "auth_ref": [ "r977", "r978", "r979" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition.", "label": "Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable", "terseLabel": "Issuance of Class A common stock for investment in Robotic Research OpCo, LLC" } } }, "localname": "AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetAcquisitionConsiderationTransferredOtherAssets": { "auth_ref": [ "r977", "r978", "r979" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tangible and intangible assets included as part of consideration transferred in asset acquisition, classified as other. Excludes cash.", "label": "Asset Acquisition, Consideration Transferred, Other Assets", "terseLabel": "Aggregate cash consideration" } } }, "localname": "AssetAcquisitionConsiderationTransferredOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetAcquisitionDomain": { "auth_ref": [ "r976" ], "lang": { "en-us": { "role": { "documentation": "Asset acquisition.", "label": "Asset Acquisition [Domain]", "terseLabel": "Asset Acquisition [Domain]" } } }, "localname": "AssetAcquisitionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AssetBackedSecuritiesMember": { "auth_ref": [ "r846", "r901" ], "lang": { "en-us": { "role": { "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.", "label": "Asset-Backed Securities [Member]", "terseLabel": "Asset-backed securities" } } }, "localname": "AssetBackedSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails", "http://www.luminartech.com/role/InvestmentsAmortizedCostDetails", "http://www.luminartech.com/role/InvestmentsContinuousLossPositionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r59", "r102" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charges", "terseLabel": "Impairment charges" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r205", "r221", "r251", "r288", "r347", "r359", "r365", "r392", "r447", "r448", "r450", "r451", "r452", "r454", "r456", "r458", "r459", "r633", "r637", "r662", "r859", "r927", "r928", "r993" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets", "verboseLabel": "Segment assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets", "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationSegmentOperatingResultsandReconciliationtotheConsolidatedBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r242", "r259", "r288", "r392", "r447", "r448", "r450", "r451", "r452", "r454", "r456", "r458", "r459", "r633", "r637", "r662", "r859", "r927", "r928", "r993" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets:" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "auth_ref": [ "r85" ], "calculation": { "http://www.luminartech.com/role/InvestmentsAmortizedCostDetails": { "order": 1.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax", "terseLabel": "Gross Unrealized Gains" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/InvestmentsAmortizedCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "auth_ref": [ "r86" ], "calculation": { "http://www.luminartech.com/role/InvestmentsAmortizedCostDetails": { "order": 2.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax", "negatedTerseLabel": "Gross Unrealized Losses" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/InvestmentsAmortizedCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": { "auth_ref": [ "r383", "r408" ], "calculation": { "http://www.luminartech.com/role/InvestmentsAmortizedCostDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale, Amortized Cost", "totalLabel": "Cost" } } }, "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/InvestmentsAmortizedCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "auth_ref": [ "r84", "r382", "r408", "r770" ], "calculation": { "http://www.luminartech.com/role/InvestmentsAmortizedCostDetails": { "order": 3.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale", "terseLabel": "Fair Value", "verboseLabel": "Marketable investments" } } }, "localname": "AvailableForSaleSecuritiesDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails", "http://www.luminartech.com/role/InvestmentsAmortizedCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": { "auth_ref": [ "r83", "r408" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.", "label": "Debt Securities, Available-for-Sale, Current", "terseLabel": "Marketable securities (including $0 and $12,200 with a related party as of December\u00a031, 2022 and 2021, see Note 17)", "verboseLabel": "Marketable securities, related party" } } }, "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets", "http://www.luminartech.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r547", "r548", "r549", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r571", "r572", "r573", "r574", "r575" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails", "http://www.luminartech.com/role/StockbasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/InvestmentsAmortizedCostDetails", "http://www.luminartech.com/role/InvestmentsScheduleofEquityInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r182", "r183" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/InvestmentsAmortizedCostDetails", "http://www.luminartech.com/role/InvestmentsScheduleofEquityInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation and Consolidation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r625", "r849", "r850" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsComponentsofIntangibleAssetsandEstimatedUsefulLivesDetails", "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails", "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/FinancialStatementComponentsFutureAmortizationExpenseDetails", "http://www.luminartech.com/role/FinancialStatementComponentsGoodwillDetails", "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails", "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r165", "r166", "r625", "r849", "r850" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsComponentsofIntangibleAssetsandEstimatedUsefulLivesDetails", "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails", "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/FinancialStatementComponentsFutureAmortizationExpenseDetails", "http://www.luminartech.com/role/FinancialStatementComponentsGoodwillDetails", "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails", "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.", "label": "Business Acquisition, Transaction Costs", "terseLabel": "Transaction costs" } } }, "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsImpactofAdjustmentstotheUnauditedProFormaDetails", "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r176" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares", "terseLabel": "Earn-out shares issued (in shares)" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsComponentsofIntangibleAssetsandEstimatedUsefulLivesDetails", "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]", "terseLabel": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]" } } }, "localname": "BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsImpactofAdjustmentstotheUnauditedProFormaDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable": { "auth_ref": [ "r164" ], "lang": { "en-us": { "role": { "documentation": "Schedule of the nature and amount of any material, nonrecurring adjustments directly attributable to the business combination(s) included in the reported pro forma revenue and earnings (supplemental pro forma information).", "label": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table]", "terseLabel": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table]" } } }, "localname": "BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsImpactofAdjustmentstotheUnauditedProFormaDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock": { "auth_ref": [ "r164" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the nature and amount of any material, nonrecurring adjustments directly attributable to the business combination(s) included in the reported pro forma revenue and earnings (supplemental pro forma information).", "label": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table Text Block]", "terseLabel": "Schedule of the impact of Adjustments to the Unaudited Pro Forma" } } }, "localname": "BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r974", "r975" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "Business Acquisition, Pro Forma Information [Table Text Block]", "terseLabel": "Business Acquisition, Pro Forma Information" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "auth_ref": [ "r623", "r624" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition, Pro Forma Net Income (Loss)", "terseLabel": "Net loss" } } }, "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsUnauditedProFormaDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "auth_ref": [ "r623", "r624" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Business Acquisition, Pro Forma Revenue", "terseLabel": "Revenue" } } }, "localname": "BusinessAcquisitionsProFormaRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsUnauditedProFormaDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r163" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "terseLabel": "Merger related expenses incurred" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r173", "r174", "r175" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Aggregate consideration transferred" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": { "auth_ref": [ "r173", "r174" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.", "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable", "terseLabel": "Stock consideration", "verboseLabel": "Issuance of Class A common stock to acquire Optogration, Inc." } } }, "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": { "auth_ref": [ "r172", "r173", "r174", "r631" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.", "label": "Business Combination, Consideration Transferred, Liabilities Incurred", "terseLabel": "Contingent stock consideration" } } }, "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r177", "r626" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Business Combinations" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinations" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r168" ], "calculation": { "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "totalLabel": "Total assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r168" ], "calculation": { "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "terseLabel": "Cash and cash equivalents" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": { "auth_ref": [ "r168" ], "calculation": { "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other", "terseLabel": "Other current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r168" ], "calculation": { "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "terseLabel": "Accounts receivable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": { "auth_ref": [ "r168" ], "calculation": { "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities", "negatedTerseLabel": "Current Liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r168" ], "calculation": { "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Total intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsComponentsofIntangibleAssetsandEstimatedUsefulLivesDetails", "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r167", "r168" ], "calculation": { "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails": { "order": 10.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "terseLabel": "Inventories, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r168" ], "calculation": { "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "negatedTotalLabel": "Total liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r167", "r168" ], "calculation": { "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "totalLabel": "Net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities": { "auth_ref": [ "r168" ], "calculation": { "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities", "negatedTerseLabel": "Non-current liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": { "auth_ref": [ "r168" ], "calculation": { "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets", "terseLabel": "Other non-current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r167", "r168" ], "calculation": { "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Property and equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r63", "r64", "r65" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.", "label": "Capital Expenditures Incurred but Not yet Paid", "terseLabel": "Purchases of property and equipment recorded in accounts payable and accrued liabilities" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedContractCostAmortizationPeriod": { "auth_ref": [ "r909" ], "lang": { "en-us": { "role": { "documentation": "Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Capitalized Contract Cost, Amortization Period", "terseLabel": "Capitalized expenses, amortization period" } } }, "localname": "CapitalizedContractCostAmortizationPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_CapitalizedCostsSupportEquipmentAndFacilities": { "auth_ref": [ "r200", "r201" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Capitalized costs incurred for support equipment and facilities used in oil and gas producing activities (such as seismic equipment, drilling equipment, construction and grading equipment, vehicles, repair shops, warehouses, supply points, camps, and division, district, or field offices).", "label": "Capitalized Costs, Support Equipment and Facilities", "terseLabel": "Capitalized costs" } } }, "localname": "CapitalizedCostsSupportEquipmentAndFacilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Cash": { "auth_ref": [ "r793", "r794", "r859", "r874" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsCashandCashEquivalentsDetails": { "order": 3.0, "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsCashandCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAcquiredFromAcquisition": { "auth_ref": [ "r44" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).", "label": "Cash Acquired from Acquisition", "terseLabel": "Cash received from acquisition of Optogration, Inc." } } }, "localname": "CashAcquiredFromAcquisition", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r61", "r245", "r814" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.luminartech.com/role/FinancialStatementComponentsCashandCashEquivalentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents", "totalLabel": "Total cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets", "http://www.luminartech.com/role/FinancialStatementComponentsCashandCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAxis": { "auth_ref": [ "r245" ], "lang": { "en-us": { "role": { "documentation": "Information by type of cash and cash equivalent balance.", "label": "Cash and Cash Equivalents [Axis]", "terseLabel": "Cash and Cash Equivalents [Axis]" } } }, "localname": "CashAndCashEquivalentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Total cash equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Member]", "terseLabel": "Included in cash and cash equivalents", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/InvestmentsAmortizedCostDetails", "http://www.luminartech.com/role/InvestmentsScheduleofEquityInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r62", "r204" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Restricted Cash" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r62" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents with respect to unrestricted balances.", "label": "Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r56", "r61", "r66" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Ending cash, cash equivalents and restricted cash", "periodStartLabel": "Beginning cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r56", "r193" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r253", "r254", "r255", "r288", "r312", "r313", "r316", "r318", "r326", "r327", "r392", "r447", "r450", "r451", "r452", "r458", "r459", "r488", "r489", "r492", "r496", "r503", "r662", "r812", "r873", "r889", "r896" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails", "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/ConsolidatedBalanceSheets", "http://www.luminartech.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitParenthetical", "http://www.luminartech.com/role/ConvertiblePreferredStockDetails", "http://www.luminartech.com/role/Cover", "http://www.luminartech.com/role/DebtAdditionalInformationDetails", "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails", "http://www.luminartech.com/role/InvestmentsNarrativeDetails", "http://www.luminartech.com/role/RevenueNarrativeDetails", "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "terseLabel": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r138", "r140" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]", "terseLabel": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails", "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/DebtAdditionalInformationDetails", "http://www.luminartech.com/role/FairValueMeasurementsNarrativeDetails", "http://www.luminartech.com/role/FairValueMeasurementsScheduleofChangesinLevel3LiabilitiesMeasuredatFairValueDetails", "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails", "http://www.luminartech.com/role/RevenueNarrativeDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]", "terseLabel": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails", "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/DebtAdditionalInformationDetails", "http://www.luminartech.com/role/FairValueMeasurementsNarrativeDetails", "http://www.luminartech.com/role/FairValueMeasurementsScheduleofChangesinLevel3LiabilitiesMeasuredatFairValueDetails", "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails", "http://www.luminartech.com/role/RevenueNarrativeDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r504" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Stock price of warrants (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails", "http://www.luminartech.com/role/RevenueNarrativeDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]", "terseLabel": "Class of Warrant or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails", "http://www.luminartech.com/role/RevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "terseLabel": "Share per warrant (in shares)" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r504" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "terseLabel": "Conversion of warrants into securities (in shares)" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/RevenueNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Warrants outstanding (in shares)" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails", "http://www.luminartech.com/role/DebtAdditionalInformationDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r138", "r140" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]", "terseLabel": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails", "http://www.luminartech.com/role/RevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommercialPaperAtCarryingValue": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsCashandCashEquivalentsDetails": { "order": 2.0, "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Unsecured short-term debt instrument issued by corporations which are highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.", "label": "Commercial Paper, at Carrying Value", "terseLabel": "Commercial paper" } } }, "localname": "CommercialPaperAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsCashandCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommercialPaperMember": { "auth_ref": [ "r114" ], "lang": { "en-us": { "role": { "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.", "label": "Commercial Paper [Member]", "terseLabel": "Commercial paper" } } }, "localname": "CommercialPaperMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails", "http://www.luminartech.com/role/InvestmentsAmortizedCostDetails", "http://www.luminartech.com/role/InvestmentsContinuousLossPositionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember": { "auth_ref": [ "r936", "r983" ], "lang": { "en-us": { "role": { "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds that is excluded from cash and cash equivalents.", "label": "Commercial Paper, Not Included with Cash and Cash Equivalents [Member]", "terseLabel": "Commercial paper" } } }, "localname": "CommercialPaperNotIncludedWithCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r25", "r210", "r225" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (see Note 15)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r109", "r441", "r442", "r797", "r926" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/CommitmentandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]", "terseLabel": "Class A Common Stock" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails", "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/ConsolidatedBalanceSheets", "http://www.luminartech.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/Cover", "http://www.luminartech.com/role/DebtAdditionalInformationDetails", "http://www.luminartech.com/role/InvestmentsNarrativeDetails", "http://www.luminartech.com/role/RevenueNarrativeDetails", "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]", "terseLabel": "Class B Common Stock" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/ConsolidatedBalanceSheets", "http://www.luminartech.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/Cover", "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r893", "r894", "r980" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/DebtAdditionalInformationDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.luminartech.com/role/DebtAdditionalInformationDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r9", "r128" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)", "terseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r9", "r859" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Components of Deferred Tax Assets [Abstract]", "terseLabel": "Deferred tax assets:" } } }, "localname": "ComponentsOfDeferredTaxAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Components of Deferred Tax Liabilities [Abstract]", "terseLabel": "Deferred tax liabilities:" } } }, "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r33", "r265", "r267", "r273", "r771", "r776" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]", "terseLabel": "Comprehensive Loss:" } } }, "localname": "ComprehensiveIncomeNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r72", "r73", "r190", "r191", "r373", "r796" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationofCreditRiskDetails", "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails", "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r72", "r73", "r190", "r191", "r373", "r792", "r796" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationofCreditRiskDetails", "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails", "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r72", "r73", "r190", "r191", "r373", "r796", "r1005" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationofCreditRiskDetails", "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails", "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r218", "r331" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]", "terseLabel": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationofCreditRiskDetails", "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r72", "r73", "r190", "r191", "r373" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Percentage of revenue (as percent)", "verboseLabel": "Percentage of accounts receivable (as percent)" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationofCreditRiskDetails", "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails", "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r69", "r72", "r73", "r74", "r190", "r192", "r796" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]", "terseLabel": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationofCreditRiskDetails", "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r72", "r73", "r190", "r191", "r373", "r796" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationofCreditRiskDetails", "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails", "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConstructionInProgressMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress [Member]", "terseLabel": "Construction in progress" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsPropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss": { "auth_ref": [ "r399", "r401", "r403", "r508" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss for right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Contract with Customer, Asset, Allowance for Credit Loss", "terseLabel": "Estimated contract losses" } } }, "localname": "ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsAccruedandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent": { "auth_ref": [ "r399", "r508" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsAccruedandOtherCurrentLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss for right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.", "label": "Contract with Customer, Asset, Allowance for Credit Loss, Current", "terseLabel": "Contract losses" } } }, "localname": "ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsAccruedandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r931" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.", "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]", "terseLabel": "Schedule of Opening and Closing Balances of Contract Liabilities and Significant Changes in Contract Liabilities" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetCreditLossExpense": { "auth_ref": [ "r402", "r528", "r837" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Contract with Customer, Asset, Credit Loss Expense (Reversal)", "terseLabel": "Revenue recognized for performance obligations that have been satisfied but for which amounts have not been billed" } } }, "localname": "ContractWithCustomerAssetCreditLossExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/RevenueScheduleofSignificantChangesinContractAssetsandContractLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerAssetNet": { "auth_ref": [ "r506", "r508", "r530" ], "calculation": { "http://www.luminartech.com/role/RevenueScheduleofOpeningandClosingBalancesofContractAssetsandContractLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Contract with Customer, Asset, after Allowance for Credit Loss", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "terseLabel": "Contract assets", "totalLabel": "Contract with customer, asset, total" } } }, "localname": "ContractWithCustomerAssetNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/RevenueNarrativeDetails", "http://www.luminartech.com/role/RevenueScheduleofOpeningandClosingBalancesofContractAssetsandContractLiabilitiesDetails", "http://www.luminartech.com/role/RevenueScheduleofSignificantChangesinContractAssetsandContractLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerAssetNetCurrent": { "auth_ref": [ "r506", "r508", "r530" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsPrepaidExpensesandOtherCurrentAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 }, "http://www.luminartech.com/role/RevenueScheduleofOpeningandClosingBalancesofContractAssetsandContractLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_ContractWithCustomerAssetNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.", "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current", "terseLabel": "Contract assets, current" } } }, "localname": "ContractWithCustomerAssetNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsPrepaidExpensesandOtherCurrentAssetsDetails", "http://www.luminartech.com/role/RevenueScheduleofOpeningandClosingBalancesofContractAssetsandContractLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerAssetNetNoncurrent": { "auth_ref": [ "r506", "r508", "r530" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsOtherNoncurrentAssetsDetails": { "order": 5.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 }, "http://www.luminartech.com/role/RevenueScheduleofOpeningandClosingBalancesofContractAssetsandContractLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_ContractWithCustomerAssetNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as noncurrent.", "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent", "terseLabel": "Contract assets, non-current", "verboseLabel": "Contract assets" } } }, "localname": "ContractWithCustomerAssetNetNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsOtherNoncurrentAssetsDetails", "http://www.luminartech.com/role/RevenueScheduleofOpeningandClosingBalancesofContractAssetsandContractLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerAssetReclassifiedToReceivable": { "auth_ref": [ "r838" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time from transfer to receivable due to right to consideration becoming unconditional.", "label": "Contract with Customer, Asset, Reclassified to Receivable", "negatedTerseLabel": "Amounts billed that were included in the contract assets beginning balance" } } }, "localname": "ContractWithCustomerAssetReclassifiedToReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/RevenueScheduleofSignificantChangesinContractAssetsandContractLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r506", "r507", "r530" ], "calculation": { "http://www.luminartech.com/role/RevenueScheduleofOpeningandClosingBalancesofContractAssetsandContractLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Contract with customer, liability, total", "verboseLabel": "Contract liabilities" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/RevenueNarrativeDetails", "http://www.luminartech.com/role/RevenueScheduleofOpeningandClosingBalancesofContractAssetsandContractLiabilitiesDetails", "http://www.luminartech.com/role/RevenueScheduleofSignificantChangesinContractAssetsandContractLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r506", "r507", "r530" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsAccruedandOtherCurrentLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 }, "http://www.luminartech.com/role/RevenueScheduleofOpeningandClosingBalancesofContractAssetsandContractLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_ContractWithCustomerLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "terseLabel": "Contract liabilities, current", "verboseLabel": "Contract liabilities" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsAccruedandOtherCurrentLiabilitiesDetails", "http://www.luminartech.com/role/RevenueScheduleofOpeningandClosingBalancesofContractAssetsandContractLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "auth_ref": [ "r506", "r507", "r530" ], "calculation": { "http://www.luminartech.com/role/RevenueScheduleofOpeningandClosingBalancesofContractAssetsandContractLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_ContractWithCustomerLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Contract with Customer, Liability, Noncurrent", "terseLabel": "Contract liabilities, non-current" } } }, "localname": "ContractWithCustomerLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/RevenueScheduleofOpeningandClosingBalancesofContractAssetsandContractLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r531" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "negatedTerseLabel": "Revenue recognized that was included in the contract liabilities beginning balance" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/RevenueScheduleofSignificantChangesinContractAssetsandContractLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockSharesConverted1": { "auth_ref": [ "r63", "r64", "r65" ], "lang": { "en-us": { "role": { "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Shares Converted", "terseLabel": "Shares converted (in shares)" } } }, "localname": "ConversionOfStockSharesConverted1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ConversionOfStockSharesIssued1": { "auth_ref": [ "r63", "r64", "r65" ], "lang": { "en-us": { "role": { "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Shares Issued", "terseLabel": "Shares issued upon conversion (in shares)" } } }, "localname": "ConversionOfStockSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ConvertibleDebtFairValueDisclosures": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt, Fair Value Disclosures", "terseLabel": "Convertible senior notes, fair value" } } }, "localname": "ConvertibleDebtFairValueDisclosures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r117", "r460", "r461", "r472", "r473", "r474", "r478", "r479", "r480", "r481", "r482", "r831", "r832", "r833", "r834", "r835" ], "lang": { "en-us": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]", "terseLabel": "Convertible Debt" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails", "http://www.luminartech.com/role/DebtScheduleofInterestExpenseDetails", "http://www.luminartech.com/role/DebtScheduleofNetCarryingAmountDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleDebtNoncurrent": { "auth_ref": [ "r23" ], "calculation": { "http://www.luminartech.com/role/DebtScheduleofNetCarryingAmountDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.", "label": "Convertible Debt, Noncurrent", "totalLabel": "Net carrying amount" } } }, "localname": "ConvertibleDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtScheduleofNetCarryingAmountDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtSecuritiesMember": { "auth_ref": [ "r936" ], "lang": { "en-us": { "role": { "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.", "label": "Convertible Debt Securities [Member]", "terseLabel": "Convertible Senior Notes" } } }, "localname": "ConvertibleDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/EarningsLossPerShareAntidilutiveSecuritiesDetails", "http://www.luminartech.com/role/EarningsLossPerShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.", "label": "Convertible Debt [Table Text Block]", "terseLabel": "Schedule of Net Carrying Amount" } } }, "localname": "ConvertibleDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleLongTermNotesPayable": { "auth_ref": [ "r23" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible Notes Payable, Noncurrent", "terseLabel": "Convertible senior notes" } } }, "localname": "ConvertibleLongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateBondSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).", "label": "Corporate Bond Securities [Member]", "terseLabel": "Corporate bonds" } } }, "localname": "CorporateBondSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails", "http://www.luminartech.com/role/InvestmentsAmortizedCostDetails", "http://www.luminartech.com/role/InvestmentsContinuousLossPositionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r38", "r288", "r392", "r447", "r448", "r450", "r451", "r452", "r454", "r456", "r458", "r459", "r662", "r927" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "terseLabel": "Total cost of sales" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of sales" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfSalesPolicyTextBlock": { "auth_ref": [ "r935" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.", "label": "Cost of Goods and Service [Policy Text Block]", "terseLabel": "Cost of Sales" } } }, "localname": "CostOfSalesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r892", "r970" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesProvisionforbenefitfromincometaxesDetails": { "order": 1.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense (Benefit)", "terseLabel": "Foreign" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesProvisionforbenefitfromincometaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r161", "r605", "r615", "r892" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesProvisionforbenefitfromincometaxesDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense (Benefit)", "totalLabel": "Total current:" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesProvisionforbenefitfromincometaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Current:" } } }, "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesProvisionforbenefitfromincometaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r70", "r373" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationofCreditRiskDetails", "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r170" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsComponentsofIntangibleAssetsandEstimatedUsefulLivesDetails", "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r122", "r286", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r476", "r483", "r484", "r486" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r2", "r3", "r4", "r206", "r208", "r220", "r292", "r460", "r461", "r462", "r463", "r464", "r466", "r472", "r473", "r474", "r475", "r477", "r478", "r479", "r480", "r481", "r482", "r682", "r831", "r832", "r833", "r834", "r835", "r890" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails", "http://www.luminartech.com/role/DebtScheduleofInterestExpenseDetails", "http://www.luminartech.com/role/DebtScheduleofNetCarryingAmountDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r119", "r462" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Conversion price (in dollars per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails", "http://www.luminartech.com/role/EarningsLossPerShareNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days", "terseLabel": "Debt instrument, convertible, threshold consecutive trading days" } } }, "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.", "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger", "terseLabel": "Debt instrument, convertible, threshold percentage of stock price trigger" } } }, "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Trading Days", "terseLabel": "Debt instrument, convertible, threshold trading days" } } }, "localname": "DebtInstrumentConvertibleThresholdTradingDays", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r195", "r197", "r460", "r682", "r832", "r833" ], "calculation": { "http://www.luminartech.com/role/DebtScheduleofNetCarryingAmountDetails": { "order": 2.0, "parentTag": "us-gaap_ConvertibleDebtNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Principal" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails", "http://www.luminartech.com/role/DebtScheduleofNetCarryingAmountDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r22", "r461" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate (as a percent)" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails", "http://www.luminartech.com/role/DebtScheduleofInterestExpenseDetails", "http://www.luminartech.com/role/DebtScheduleofNetCarryingAmountDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r23", "r292", "r460", "r461", "r462", "r463", "r464", "r466", "r472", "r473", "r474", "r475", "r477", "r478", "r479", "r480", "r481", "r482", "r682", "r831", "r832", "r833", "r834", "r835", "r890" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails", "http://www.luminartech.com/role/DebtScheduleofInterestExpenseDetails", "http://www.luminartech.com/role/DebtScheduleofNetCarryingAmountDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodAxis": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "documentation": "Information about timing of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period [Axis]", "terseLabel": "Debt Instrument, Redemption, Period [Axis]" } } }, "localname": "DebtInstrumentRedemptionPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodDomain": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "documentation": "Period as defined under terms of the debt agreement for debt redemption features.", "label": "Debt Instrument, Redemption, Period [Domain]", "terseLabel": "Debt Instrument, Redemption, Period [Domain]" } } }, "localname": "DebtInstrumentRedemptionPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodOneMember": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period One [Member]", "terseLabel": "Debt Instrument, Redemption, Period One" } } }, "localname": "DebtInstrumentRedemptionPeriodOneMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period Three [Member]", "terseLabel": "Debt Instrument, Redemption, Period Three" } } }, "localname": "DebtInstrumentRedemptionPeriodThreeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period Two [Member]", "terseLabel": "Debt Instrument, Redemption, Period Two" } } }, "localname": "DebtInstrumentRedemptionPeriodTwoMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument, Redemption Price, Percentage", "terseLabel": "Debt instrument, redemption price, percentage" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r23", "r129", "r132", "r133", "r134", "r194", "r195", "r197", "r217", "r292", "r460", "r461", "r462", "r463", "r464", "r466", "r472", "r473", "r474", "r475", "r477", "r478", "r479", "r480", "r481", "r482", "r485", "r682", "r831", "r832", "r833", "r834", "r835", "r890" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails", "http://www.luminartech.com/role/DebtScheduleofInterestExpenseDetails", "http://www.luminartech.com/role/DebtScheduleofNetCarryingAmountDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "verboseLabel": "Note term (in months)" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r194", "r197", "r930" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "terseLabel": "Proceeds from issuance of convertible senior notes, net of debt discounts" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtPolicyTextBlock": { "auth_ref": [ "r115" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.", "label": "Debt, Policy [Policy Text Block]", "terseLabel": "Convertible Senior Notes" } } }, "localname": "DebtPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": { "auth_ref": [ "r387", "r410", "r828" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months", "terseLabel": "Fair Value" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/InvestmentsContinuousLossPositionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": { "auth_ref": [ "r387", "r410" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss", "negatedTerseLabel": "Gross Unrealized Losses", "terseLabel": "Available-for-sale securities in excess of fair value" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/InvestmentsContinuousLossPositionDetails", "http://www.luminartech.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleTable": { "auth_ref": [ "r388" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale [Table]", "terseLabel": "Debt Securities, Available-for-sale [Table]" } } }, "localname": "DebtSecuritiesAvailableForSaleTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/InvestmentsAmortizedCostDetails", "http://www.luminartech.com/role/InvestmentsContinuousLossPositionDetails", "http://www.luminartech.com/role/InvestmentsNarrativeDetails", "http://www.luminartech.com/role/InvestmentsScheduleofEquityInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": { "auth_ref": [ "r902" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale [Table Text Block]", "terseLabel": "Debt Securities, Available-for-sale" } } }, "localname": "DebtSecuritiesAvailableForSaleTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": { "auth_ref": [ "r386", "r828", "r907" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]", "terseLabel": "Schedule of Gross Unrealized Losses and the Fair Value for Marketable Investments" } } }, "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r892", "r971", "r972" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesProvisionforbenefitfromincometaxesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred Federal Income Tax Expense (Benefit)", "terseLabel": "U.S. federal" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesProvisionforbenefitfromincometaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r196", "r930" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "terseLabel": "Debt issuance costs, net" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r59", "r161", "r606", "r614", "r615", "r892" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.luminartech.com/role/IncomeTaxesProvisionforbenefitfromincometaxesDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "terseLabel": "Deferred taxes", "totalLabel": "Total deferred:" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows", "http://www.luminartech.com/role/IncomeTaxesProvisionforbenefitfromincometaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Deferred:" } } }, "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesProvisionforbenefitfromincometaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r5", "r6", "r207", "r219", "r599" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "totalLabel": "Total deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRentAssetNetCurrent": { "auth_ref": [ "r234", "r877" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of rental income recognized over rental payment required by lease, classified as current.", "label": "Deferred Rent Asset, Net, Current", "terseLabel": "Reversal of deferred rent" } } }, "localname": "DeferredRentAssetNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r892", "r971", "r972" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesProvisionforbenefitfromincometaxesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "terseLabel": "U.S. state" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesProvisionforbenefitfromincometaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r600" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Total deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": { "auth_ref": [ "r159", "r969" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.", "label": "Deferred Tax Assets, in Process Research and Development", "terseLabel": "Section 174 R&D capitalization" } } }, "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsInventory": { "auth_ref": [ "r159", "r969" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.", "label": "Deferred Tax Assets, Inventory", "terseLabel": "Inventory reserves" } } }, "localname": "DeferredTaxAssetsInventory", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r968" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Deferred Tax Assets, Net", "totalLabel": "Net deferred tax assets (liabilities)" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r968" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Total deferred tax asset" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r159", "r969" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "terseLabel": "Net operating loss carry forward" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r159", "r969" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Deferred Tax Assets, Other", "terseLabel": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "auth_ref": [ "r157", "r159", "r969" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.", "label": "Deferred Tax Assets, Tax Credit Carryforwards", "terseLabel": "Tax credits" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": { "auth_ref": [ "r159", "r969" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits", "terseLabel": "Stock-based compensation expense" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": { "auth_ref": [ "r159", "r969" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals", "terseLabel": "Accruals and reserves" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r601" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedTerseLabel": "Valuation allowance", "terseLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails", "http://www.luminartech.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r153", "r968" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities, Net", "negatedTotalLabel": "Net deferred tax assets (liabilities)" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": { "auth_ref": [ "r159", "r969" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.", "label": "Deferred Tax Liabilities, Leasing Arrangements", "terseLabel": "ROU asset (ASC 842)" } } }, "localname": "DeferredTaxLiabilitiesLeasingArrangements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesOther": { "auth_ref": [ "r159", "r969" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.", "label": "Deferred Tax Liabilities, Other", "terseLabel": "Other" } } }, "localname": "DeferredTaxLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesPrepaidExpenses": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.", "label": "Deferred Tax Liabilities, Prepaid Expenses", "terseLabel": "Prepaid expenses" } } }, "localname": "DeferredTaxLiabilitiesPrepaidExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesDeferredIncomeTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositsAssetsNoncurrent": { "auth_ref": [ "r875" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsOtherNoncurrentAssetsDetails": { "order": 4.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.", "label": "Deposits Assets, Noncurrent", "terseLabel": "Security deposits" } } }, "localname": "DepositsAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsOtherNoncurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r59", "r103" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation and amortization" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsPropertyandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r59", "r342" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization", "verboseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows", "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationSegmentOperatingResultsandReconciliationtotheConsolidatedBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DevelopedTechnologyRightsMember": { "auth_ref": [ "r171" ], "lang": { "en-us": { "role": { "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.", "label": "Developed Technology Rights [Member]", "terseLabel": "Developed technology" } } }, "localname": "DevelopedTechnologyRightsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsComponentsofIntangibleAssetsandEstimatedUsefulLivesDetails", "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r529", "r839", "r840", "r841", "r842", "r843", "r844", "r845" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r933" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of Disaggregation of Revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r546", "r577", "r578", "r580", "r585", "r852" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-Based Payment Arrangement [Text Block]", "terseLabel": "Stock-based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Tax Authority [Member]", "terseLabel": "United States" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Net loss per share attributable to common stockholders:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r274", "r300", "r301", "r302", "r303", "r304", "r309", "r312", "r316", "r317", "r318", "r322", "r650", "r651", "r772", "r777", "r825" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic (in dollars per share)", "verboseLabel": "Net loss per share attributable to common shareholders- Basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss", "http://www.luminartech.com/role/EarningsLossPerShareBasicandDilutedLossPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r274", "r300", "r301", "r302", "r303", "r304", "r312", "r316", "r317", "r318", "r322", "r650", "r651", "r772", "r777", "r825" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted (in dollars per share)", "verboseLabel": "Net loss per share attributable to common shareholders- Diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss", "http://www.luminartech.com/role/EarningsLossPerShareBasicandDilutedLossPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r319", "r320", "r321", "r323" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings (Loss) Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/EarningsLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r590" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "totalLabel": "Effective tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r290", "r590", "r617" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": { "order": 1.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "U.S. federal provision at statutory rate", "verboseLabel": "Statutory tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails", "http://www.luminartech.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r966", "r973" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": { "order": 9.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "terseLabel": "Change in valuation allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": { "order": 7.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent", "terseLabel": "Other permanent items" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": { "auth_ref": [ "r965", "r966" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": { "order": 5.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.", "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent", "terseLabel": "Stock-based compensation expense" } } }, "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r966", "r973" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": { "order": 2.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent", "terseLabel": "State income taxes" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies": { "auth_ref": [ "r966", "r973" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": { "order": 8.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.", "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Percent", "terseLabel": "Uncertain tax benefits" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits": { "auth_ref": [ "r966", "r973" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": { "order": 3.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Percent", "negatedTerseLabel": "Tax credits" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxCredits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r579" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Unrecognized compensation expense, period for recognition" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "auth_ref": [ "r964" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized stock-based compensation expense for restricted stock" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r964" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized stock-based compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Employee Stock [Member]", "terseLabel": "ESPP" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationCompensationExpenseDetails", "http://www.luminartech.com/role/StockbasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails", "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-Based Payment Arrangement, Option [Member]", "verboseLabel": "Stock options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationCompensationExpenseDetails", "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average purchase price of capital shares purchased through an employee stock ownership plan.", "label": "Employee Stock Ownership Plan (ESOP), Weighted Average Purchase Price of Shares Purchased", "terseLabel": "Weighted average purchase price (in dollars per share)" } } }, "localname": "EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r128", "r237", "r269", "r270", "r271", "r293", "r294", "r295", "r297", "r305", "r307", "r325", "r396", "r505", "r581", "r582", "r583", "r610", "r611", "r649", "r671", "r672", "r673", "r674", "r675", "r676", "r709", "r782", "r783", "r784" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/DebtAdditionalInformationDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentsMember": { "auth_ref": [ "r88" ], "lang": { "en-us": { "role": { "documentation": "Investment in the stock of an investee which is adjusted for the investor's share of the earnings or losses of the investee after the date of acquisition.", "label": "Equity Method Investments [Member]", "terseLabel": "Marketable equity investments" } } }, "localname": "EquityMethodInvestmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/InvestmentsScheduleofEquityInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquitySecuritiesFVNINoncurrent": { "auth_ref": [ "r661" ], "calculation": { "http://www.luminartech.com/role/InvestmentsScheduleofEquityInvestmentsDetails": { "order": 1.0, "parentTag": "us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as noncurrent.", "label": "Equity Securities, FV-NI, Noncurrent", "terseLabel": "Non-marketable equity investment measured using the measurement alternative" } } }, "localname": "EquitySecuritiesFVNINoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/InvestmentsScheduleofEquityInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesFvNi": { "auth_ref": [ "r252", "r661", "r816" ], "calculation": { "http://www.luminartech.com/role/InvestmentsScheduleofEquityInvestmentsDetails": { "order": 2.0, "parentTag": "us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.", "label": "Equity Securities, FV-NI, Current", "terseLabel": "Marketable equity investments" } } }, "localname": "EquitySecuritiesFvNi", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails", "http://www.luminartech.com/role/InvestmentsScheduleofEquityInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent": { "auth_ref": [ "r252", "r661" ], "calculation": { "http://www.luminartech.com/role/InvestmentsScheduleofEquityInvestmentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Equity Securities, FV-NI", "totalLabel": "Marketable equity investments" } } }, "localname": "EquitySecuritiesFvNiCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/InvestmentsScheduleofEquityInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": { "auth_ref": [ "r390" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsOtherNoncurrentAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Amount", "terseLabel": "Non-marketable equity investment" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsOtherNoncurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock": { "auth_ref": [ "r391" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment in equity security without readily determinable fair value, which does not qualify for practical expedient to estimate fair value using net asset value per share. Includes, but is not limited to, information considered for determining upward and downward adjustment from observable price change.", "label": "Equity Securities without Readily Determinable Fair Value [Policy Text Block]", "terseLabel": "Non-Marketable Equity Investments Measured Using the Measurement Alternative" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r59", "r123" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "negatedTerseLabel": "Change in fair value of warrant liabilities", "terseLabel": "Change in fair value of warrant liabilities" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss", "http://www.luminartech.com/role/DebtAdditionalInformationDetails", "http://www.luminartech.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r653", "r654", "r659" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]", "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "auth_ref": [ "r185" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]", "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r186" ], "lang": { "en-us": { "role": { "documentation": "Class of asset.", "label": "Asset Class [Domain]", "terseLabel": "Asset Class [Domain]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/InvestmentsScheduleofEquityInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r184", "r189" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Asset Class [Axis]", "terseLabel": "Asset Class [Axis]" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/InvestmentsScheduleofEquityInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r474", "r535", "r536", "r537", "r538", "r539", "r540", "r654", "r722", "r723", "r724", "r832", "r833", "r846", "r847", "r848" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/FairValueMeasurementsNarrativeDetails", "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r188", "r189" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]", "terseLabel": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofChangesinLevel3LiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r653", "r654", "r656", "r657", "r660" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r658" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r474", "r535", "r540", "r654", "r722", "r846", "r847", "r848" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level\u00a01" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r474", "r535", "r540", "r654", "r723", "r832", "r833", "r846", "r847", "r848" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level\u00a02" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsNarrativeDetails", "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r474", "r535", "r536", "r537", "r538", "r539", "r540", "r654", "r724", "r832", "r833", "r846", "r847", "r848" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level\u00a03" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/FairValueMeasurementsNarrativeDetails", "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r186" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]", "terseLabel": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofChangesinLevel3LiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofChangesinLevel3LiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofChangesinLevel3LiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r186", "r189" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofChangesinLevel3LiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r186", "r189" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of Changes in Level 3 Liabilities Measured at Fair Value" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": { "auth_ref": [ "r186" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)", "terseLabel": "Change in fair value of outstanding warrants" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofChangesinLevel3LiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "auth_ref": [ "r187" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements", "negatedTerseLabel": "Reduction in liability due to exercises" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofChangesinLevel3LiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r186" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Balance at end of period", "periodStartLabel": "Balance at beginning of period" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofChangesinLevel3LiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r474", "r535", "r536", "r537", "r538", "r539", "r540", "r722", "r723", "r724", "r832", "r833", "r846", "r847", "r848" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/FairValueMeasurementsNarrativeDetails", "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r658", "r660" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinanceLeasePrincipalPayments": { "auth_ref": [ "r690", "r697" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for principal payment on finance lease.", "label": "Finance Lease, Principal Payments", "negatedTerseLabel": "Principal payments on finance leases (capital leases prior to adoption of ASC 842)" } } }, "localname": "FinanceLeasePrincipalPayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r384", "r385", "r400", "r404", "r405", "r406", "r407", "r409", "r411", "r412", "r485", "r501", "r639", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r735", "r736", "r737", "r738", "r739", "r740", "r741", "r742", "r743", "r744", "r745", "r746", "r747", "r748", "r828", "r903", "r904", "r905", "r1006", "r1007", "r1008", "r1009", "r1010", "r1011", "r1012" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]", "terseLabel": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails", "http://www.luminartech.com/role/InvestmentsAmortizedCostDetails", "http://www.luminartech.com/role/InvestmentsContinuousLossPositionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Weighted Average Remaining Period (Years)", "verboseLabel": "Useful life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails", "http://www.luminartech.com/role/BusinessCombinationsComponentsofIntangibleAssetsandEstimatedUsefulLivesDetails", "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r249", "r434" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedTerseLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsFutureAmortizationExpenseDetails": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r98" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsFutureAmortizationExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r98" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsFutureAmortizationExpenseDetails": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r98" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsFutureAmortizationExpenseDetails": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r98" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsFutureAmortizationExpenseDetails": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r98" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsFutureAmortizationExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r431", "r433", "r434", "r435", "r752", "r756" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsComponentsofIntangibleAssetsandEstimatedUsefulLivesDetails", "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r96", "r756" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Gross Carrying Amount", "verboseLabel": "Recorded Value" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsComponentsofIntangibleAssetsandEstimatedUsefulLivesDetails", "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails", "http://www.luminartech.com/role/FinancialStatementComponentsFutureAmortizationExpenseDetails", "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r93", "r95" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsComponentsofIntangibleAssetsandEstimatedUsefulLivesDetails", "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r96", "r752" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsFutureAmortizationExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Net Carrying Amount" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsFutureAmortizationExpenseDetails", "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinitelivedIntangibleAssetsAcquired1": { "auth_ref": [ "r432" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.", "label": "Finite-Lived Intangible Assets Acquired", "terseLabel": "Additions" } } }, "localname": "FinitelivedIntangibleAssetsAcquired1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]", "terseLabel": "Foreign Tax Authority" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]", "terseLabel": "Furniture and fixtures", "verboseLabel": "Furniture and fixtures" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails", "http://www.luminartech.com/role/FinancialStatementComponentsPropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r59" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "negatedTerseLabel": "Loss on sale or disposal of property and equipment" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r59", "r120", "r121" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedTerseLabel": "Loss on extinguishment of debt", "terseLabel": "Loss on extinguishment of debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows", "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss", "http://www.luminartech.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r39" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and Administrative Expense [Member]", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GeographicConcentrationRiskMember": { "auth_ref": [ "r71", "r796" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).", "label": "Geographic Concentration Risk [Member]", "terseLabel": "Geographic Concentration Risk" } } }, "localname": "GeographicConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r248", "r417", "r769", "r830", "r859", "r910", "r917" ], "calculation": { "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 }, "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Balance as of December\u00a031, 2022", "periodStartLabel": "Balance as of December\u00a031, 2021", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails", "http://www.luminartech.com/role/ConsolidatedBalanceSheets", "http://www.luminartech.com/role/FinancialStatementComponentsGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r420", "r830" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill, Acquired During Period", "terseLabel": "Acquired goodwill related to Freedom Photonics in 2022" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "auth_ref": [ "r429", "r430", "r830" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.", "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]", "terseLabel": "Intangible Assets and Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r59", "r418", "r423", "r429", "r830" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impairment Loss", "terseLabel": "Impairment of goodwill" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillPurchaseAccountingAdjustments": { "auth_ref": [ "r162", "r916" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Purchase Accounting Adjustments", "terseLabel": "Purchase accounting adjustments" } } }, "localname": "GoodwillPurchaseAccountingAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill [Roll Forward]" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GranteeStatusAxis": { "auth_ref": [ "r543", "r545", "r547", "r548", "r549", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r571", "r572", "r573", "r574", "r575" ], "lang": { "en-us": { "role": { "documentation": "Information by status of recipient to whom award is granted.", "label": "Grantee Status [Axis]", "terseLabel": "Grantee Status [Axis]" } } }, "localname": "GranteeStatusAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails", "http://www.luminartech.com/role/StockbasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GranteeStatusDomain": { "auth_ref": [ "r543", "r545", "r547", "r548", "r549", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r571", "r572", "r573", "r574", "r575" ], "lang": { "en-us": { "role": { "documentation": "Status of recipient to whom award is granted.", "label": "Grantee Status [Domain]", "terseLabel": "Grantee Status [Domain]" } } }, "localname": "GranteeStatusDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails", "http://www.luminartech.com/role/StockbasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r37", "r288", "r347", "r358", "r364", "r367", "r392", "r447", "r448", "r450", "r451", "r452", "r454", "r456", "r458", "r459", "r662", "r827", "r927" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross loss" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]", "terseLabel": "IPO" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r59", "r100" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.", "label": "Impairment of Intangible Assets (Excluding Goodwill)", "terseLabel": "Impairment of intangible assets" } } }, "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": { "auth_ref": [ "r59", "r102", "r107" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).", "label": "Impairment, Long-Lived Asset, Held-for-Use", "terseLabel": "Impairment of long-lived assets" } } }, "localname": "ImpairmentOfLongLivedAssetsHeldForUse", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesImpairmentofLongLivedAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r101", "r108" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "terseLabel": "Impairment of Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InProcessResearchAndDevelopmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.", "label": "In Process Research and Development [Member]", "terseLabel": "IPR&D" } } }, "localname": "InProcessResearchAndDevelopmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsComponentsofIntangibleAssetsandEstimatedUsefulLivesDetails", "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r289", "r616" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesComponentsofLossBeforeProvisionforBenefitfromIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "terseLabel": "United States" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesComponentsofLossBeforeProvisionforBenefitfromIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r34", "r202", "r211", "r227", "r347", "r358", "r364", "r367", "r773", "r827" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.luminartech.com/role/IncomeTaxesComponentsofLossBeforeProvisionforBenefitfromIncomeTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before provision for (benefit from) income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss", "http://www.luminartech.com/role/IncomeTaxesComponentsofLossBeforeProvisionforBenefitfromIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [ "r289", "r616" ], "calculation": { "http://www.luminartech.com/role/IncomeTaxesComponentsofLossBeforeProvisionforBenefitfromIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "terseLabel": "International" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesComponentsofLossBeforeProvisionforBenefitfromIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r436", "r438" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationCompensationExpenseDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r438" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationCompensationExpenseDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r155" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r290", "r591", "r597", "r604", "r612", "r618", "r620", "r621", "r622" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r291", "r306", "r307", "r345", "r589", "r613", "r619", "r778" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 }, "http://www.luminartech.com/role/IncomeTaxesProvisionforbenefitfromincometaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Provision for (benefit from) income taxes", "totalLabel": "Total provision for (benefit from) income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss", "http://www.luminartech.com/role/IncomeTaxesProvisionforbenefitfromincometaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r268", "r587", "r588", "r597", "r598", "r603", "r607" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r58" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r58" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedTerseLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r58" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued and other current liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi": { "auth_ref": [ "r280", "r389" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Increase (Decrease) in Equity Securities, FV-NI", "terseLabel": "Stock consideration" } } }, "localname": "IncreaseDecreaseInEquitySecuritiesFvNi", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r58" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedTerseLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherCurrentAssets": { "auth_ref": [ "r886" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in current assets classified as other.", "label": "Increase (Decrease) in Other Current Assets", "negatedTerseLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInOtherCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": { "auth_ref": [ "r886" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.", "label": "Increase (Decrease) in Other Noncurrent Assets", "negatedTerseLabel": "Other non-current assets" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.", "label": "Increase (Decrease) in Other Noncurrent Liabilities", "terseLabel": "Other non-current liabilities" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Temporary Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInTemporaryEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r99" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsFutureAmortizationExpenseDetails": { "order": 7.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 }, "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)", "terseLabel": "IPR&D" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsFutureAmortizationExpenseDetails", "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [ "r248" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "totalLabel": "Intangible assets, gross" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r91", "r94" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net", "totalLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets", "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetIncludingGoodwill": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.", "label": "Intangible Assets, Net (Including Goodwill)", "periodEndLabel": "End of the period", "periodStartLabel": "Beginning of the period" } } }, "localname": "IntangibleAssetsNetIncludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntercompanyForeignCurrencyBalanceAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of an intercompany foreign currency transactions that is of a long-term-investment nature, that is, settlement is not planned of anticipated in the foreseeable future.", "label": "Intercompany Foreign Currency Balance, Amount", "terseLabel": "Cash held in foreign entities" } } }, "localname": "IntercompanyForeignCurrencyBalanceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationofCreditRiskDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r196", "r213", "r272", "r341", "r680" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 }, "http://www.luminartech.com/role/DebtScheduleofInterestExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedTerseLabel": "Interest expense and other", "totalLabel": "Total interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss", "http://www.luminartech.com/role/DebtScheduleofInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r41", "r480", "r487", "r834", "r835" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt", "terseLabel": "Accrued interest repaid" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebtExcludingAmortization": { "auth_ref": [ "r42", "r481", "r834", "r835" ], "calculation": { "http://www.luminartech.com/role/DebtScheduleofInterestExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_InterestExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.", "label": "Interest Expense, Debt, Excluding Amortization", "terseLabel": "Contractual interest expense" } } }, "localname": "InterestExpenseDebtExcludingAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtScheduleofInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r279", "r283", "r284" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r20" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsAccruedandOtherCurrentLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable, Current", "terseLabel": "Accrued interest payable" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsAccruedandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntersegmentEliminationMember": { "auth_ref": [ "r339", "r357", "r358", "r359", "r360", "r361", "r363", "r367" ], "lang": { "en-us": { "role": { "documentation": "Eliminating entries used in operating segment consolidation.", "label": "Intersegment Eliminations [Member]", "terseLabel": "Eliminations" } } }, "localname": "IntersegmentEliminationMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationSegmentOperatingResultsandReconciliationtotheConsolidatedBalancesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r89", "r818" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsInventoryDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r258", "r815", "r859" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.luminartech.com/role/FinancialStatementComponentsInventoryDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventory", "totalLabel": "Total inventory", "verboseLabel": "Inventories, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets", "http://www.luminartech.com/role/FinancialStatementComponentsInventoryDetails", "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationSegmentOperatingResultsandReconciliationtotheConsolidatedBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r244", "r257", "r324", "r413", "r415", "r416", "r750", "r822" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "terseLabel": "Inventory" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "auth_ref": [ "r89", "r820" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsInventoryDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.", "label": "Inventory, Raw Materials, Net of Reserves", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterialsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r89", "r819" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsInventoryDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work-in-process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r414" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Inventory Write-down", "terseLabel": "Inventory write-offs and write-downs", "verboseLabel": "Inventory write-downs" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows", "http://www.luminartech.com/role/FinancialStatementComponentsInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, Debt and Equity Securities [Abstract]" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r653" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, Fair Value Disclosure", "terseLabel": "Total marketable investments" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "auth_ref": [ "r87", "r203", "r215", "r228", "r813" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investments in certain debt and equity securities.", "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "terseLabel": "Investments" } } }, "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/Investments" ], "xbrltype": "textBlockItemType" }, "us-gaap_LandMember": { "auth_ref": [ "r934" ], "lang": { "en-us": { "role": { "documentation": "Part of earth's surface not covered by water.", "label": "Land [Member]", "terseLabel": "Land" } } }, "localname": "LandMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsPropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r701", "r858" ], "calculation": { "http://www.luminartech.com/role/LeasesComponentsofLeaseExpensesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "totalLabel": "Total operating lease cost" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/LeasesComponentsofLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r987" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Schedule of Components of Lease Expenses, Supplemental Cash Flow Information, Weighted Average Remaining Terms, and Weighted Average Discount Rates" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r104" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsPropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LesseeFinanceLeasesTextBlock": { "auth_ref": [ "r703" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.", "label": "Lessee, Finance Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeFinanceLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r693" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r988" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Schedule of Maturities of Lease Liabilities" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r702" ], "calculation": { "http://www.luminartech.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.luminartech.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r702" ], "calculation": { "http://www.luminartech.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r702" ], "calculation": { "http://www.luminartech.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r702" ], "calculation": { "http://www.luminartech.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "terseLabel": "2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r702" ], "calculation": { "http://www.luminartech.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r702" ], "calculation": { "http://www.luminartech.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r702" ], "calculation": { "http://www.luminartech.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r702" ], "calculation": { "http://www.luminartech.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedTerseLabel": "Less: imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "auth_ref": [ "r985" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Renewal Term", "terseLabel": "Renewal lease term (in years)" } } }, "localname": "LesseeOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/LeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r985" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Term of Contract", "terseLabel": "Term of lease (in moths)" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/LeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r703" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r19", "r288", "r392", "r447", "r448", "r450", "r451", "r452", "r454", "r456", "r458", "r459", "r634", "r637", "r638", "r662", "r826", "r927", "r993", "r994" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities [Abstract]" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r14", "r209", "r223", "r859", "r891", "r906", "r984" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity (deficit)" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY (DEFICIT)" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r21", "r243", "r288", "r392", "r447", "r448", "r450", "r451", "r452", "r454", "r456", "r458", "r459", "r634", "r637", "r638", "r662", "r859", "r927", "r993", "r994" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails", "http://www.luminartech.com/role/DebtScheduleofInterestExpenseDetails", "http://www.luminartech.com/role/DebtScheduleofNetCarryingAmountDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r23", "r116" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-Term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails", "http://www.luminartech.com/role/DebtScheduleofInterestExpenseDetails", "http://www.luminartech.com/role/DebtScheduleofNetCarryingAmountDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery and equipment" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsPropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MarketableSecuritiesPolicy": { "auth_ref": [ "r214" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment classified as marketable security.", "label": "Marketable Securities, Policy [Policy Text Block]", "terseLabel": "Debt Securities Marketable Equity Investments" } } }, "localname": "MarketableSecuritiesPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_MeasurementInputExpectedTermMember": { "auth_ref": [ "r981" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.", "label": "Measurement Input, Expected Term [Member]", "terseLabel": "Expected Term" } } }, "localname": "MeasurementInputExpectedTermMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r981" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Measurement Input, Price Volatility [Member]", "terseLabel": "Price Volatility" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r981" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Measurement Input, Risk Free Interest Rate [Member]", "terseLabel": "Risk Free Interest Rate" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r655" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]", "terseLabel": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]", "terseLabel": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MoneyMarketFundsAtCarryingValue": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsCashandCashEquivalentsDetails": { "order": 1.0, "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.", "label": "Money Market Funds, at Carrying Value", "terseLabel": "Money market funds" } } }, "localname": "MoneyMarketFundsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsCashandCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r936" ], "lang": { "en-us": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]", "terseLabel": "Money market funds" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails", "http://www.luminartech.com/role/InvestmentsScheduleofEquityInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r328", "r334" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature of Operations [Text Block]", "terseLabel": "Organization and Description of Business" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/OrganizationandDescriptionofBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r282" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r282" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r56", "r57", "r60" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r35", "r60", "r212", "r226", "r241", "r263", "r266", "r271", "r288", "r296", "r300", "r301", "r302", "r303", "r306", "r307", "r314", "r347", "r358", "r364", "r367", "r392", "r447", "r448", "r450", "r451", "r452", "r454", "r456", "r458", "r459", "r651", "r662", "r827", "r927" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://www.luminartech.com/role/EarningsLossPerShareBasicandDilutedLossPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net loss", "totalLabel": "Net loss", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss", "http://www.luminartech.com/role/EarningsLossPerShareBasicandDilutedLossPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r300", "r301", "r302", "r303", "r309", "r310", "r315", "r318", "r347", "r358", "r364", "r367", "r827" ], "calculation": { "http://www.luminartech.com/role/EarningsLossPerShareBasicandDilutedLossPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "terseLabel": "Net loss attributable to common stockholders", "totalLabel": "Net loss attributable to common shareholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss", "http://www.luminartech.com/role/EarningsLossPerShareBasicandDilutedLossPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]", "terseLabel": "Numerator:" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/EarningsLossPerShareBasicandDilutedLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recently Adopted Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash Investing and Financing Items [Abstract]", "terseLabel": "Supplemental disclosures of noncash investing and financing activities:" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r40" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income (expense), net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonrecurringAdjustmentAxis": { "auth_ref": [ "r164" ], "lang": { "en-us": { "role": { "documentation": "Information about material and nonrecurring adjustment directly attributable to the business combination(s) included in the reported pro forma revenue and earnings (supplemental pro forma information).", "label": "Nonrecurring Adjustment [Axis]", "terseLabel": "Nonrecurring Adjustment [Axis]" } } }, "localname": "NonrecurringAdjustmentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsImpactofAdjustmentstotheUnauditedProFormaDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NonrecurringAdjustmentDomain": { "auth_ref": [ "r164" ], "lang": { "en-us": { "role": { "documentation": "Material, nonrecurring adjustment(s) allocated (included) to (in) reported pro forma revenue and earnings (supplemental pro forma information).", "label": "Nonrecurring Adjustment [Domain]", "terseLabel": "Nonrecurring Adjustment [Domain]" } } }, "localname": "NonrecurringAdjustmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsImpactofAdjustmentstotheUnauditedProFormaDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r899" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesSegmentInformationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r347", "r358", "r364", "r367", "r827" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Operating gain (loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss", "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationSegmentOperatingResultsandReconciliationtotheConsolidatedBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r694", "r858" ], "calculation": { "http://www.luminartech.com/role/LeasesComponentsofLeaseExpensesDetails": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/LeasesComponentsofLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid [Abstract]", "terseLabel": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]" } } }, "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r689" ], "calculation": { "http://www.luminartech.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 }, "http://www.luminartech.com/role/LeasesSupplementalBalanceSheetInformationWeightedAverageRemainingTermsandWeightedAverageDiscountRatesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Operating lease liabilities", "totalLabel": "Total operating lease liabilities", "verboseLabel": "Total leases liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails", "http://www.luminartech.com/role/LeasesNarrativeDetails", "http://www.luminartech.com/role/LeasesSupplementalBalanceSheetInformationWeightedAverageRemainingTermsandWeightedAverageDiscountRatesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r689" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.luminartech.com/role/LeasesSupplementalBalanceSheetInformationWeightedAverageRemainingTermsandWeightedAverageDiscountRatesDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities", "verboseLabel": "Operating lease liabilities, current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets", "http://www.luminartech.com/role/LeasesSupplementalBalanceSheetInformationWeightedAverageRemainingTermsandWeightedAverageDiscountRatesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r689" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.luminartech.com/role/LeasesSupplementalBalanceSheetInformationWeightedAverageRemainingTermsandWeightedAverageDiscountRatesDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities, non-current", "verboseLabel": "Operating lease liabilities, non-current" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets", "http://www.luminartech.com/role/LeasesSupplementalBalanceSheetInformationWeightedAverageRemainingTermsandWeightedAverageDiscountRatesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r691", "r697" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "negatedTerseLabel": "Cash paid for operating leases included in operating activities" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/LeasesSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r688" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets", "verboseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets", "http://www.luminartech.com/role/LeasesNarrativeDetails", "http://www.luminartech.com/role/LeasesSupplementalBalanceSheetInformationWeightedAverageRemainingTermsandWeightedAverageDiscountRatesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r887" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Operating Lease, Right-of-Use Asset, Amortization Expense", "terseLabel": "Amortization of operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r700", "r858" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Operating leases (as a percent)" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/LeasesSupplementalBalanceSheetInformationWeightedAverageRemainingTermsandWeightedAverageDiscountRatesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r699", "r858" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Operating leases (in years)" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/LeasesSupplementalBalanceSheetInformationWeightedAverageRemainingTermsandWeightedAverageDiscountRatesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r157" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "Net operating loss carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Loss Carryforwards [Line Items]", "terseLabel": "Operating Loss Carryforwards [Line Items]" } } }, "localname": "OperatingLossCarryforwardsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsTable": { "auth_ref": [ "r158" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Operating Loss Carryforwards [Table]", "terseLabel": "Operating Loss Carryforwards [Table]" } } }, "localname": "OperatingLossCarryforwardsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r357", "r358", "r359", "r360", "r361", "r367" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Reportable Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationSegmentOperatingResultsandReconciliationtotheConsolidatedBalancesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r20" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsAccruedandOtherCurrentLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Accrued expenses" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsAccruedandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetImpairmentCharges": { "auth_ref": [ "r887", "r922" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 23.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.", "label": "Other Asset Impairment Charges", "negatedTerseLabel": "Impairment of investments and certain other assets", "terseLabel": "Impairment of investments and certain other assets" } } }, "localname": "OtherAssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows", "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsMiscellaneousNoncurrent": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsOtherNoncurrentAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.", "label": "Other Assets, Miscellaneous, Noncurrent", "terseLabel": "Other non-current assets" } } }, "localname": "OtherAssetsMiscellaneousNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsOtherNoncurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r250" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.luminartech.com/role/FinancialStatementComponentsOtherNoncurrentAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other non-current assets", "totalLabel": "Other non-current assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets", "http://www.luminartech.com/role/FinancialStatementComponentsOtherNoncurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": { "auth_ref": [ "r260", "r261", "r262" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax", "terseLabel": "Net unrealized gains (losses) on available-for-sale debt securities" } } }, "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r178", "r179", "r180", "r264", "r267" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "verboseLabel": "Other comprehensive (loss) income" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r24" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "verboseLabel": "Other non-current liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherMachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other tangible personal property, nonconsumable in nature, with finite lives used to produce goods and services.", "label": "Other Machinery and Equipment [Member]", "terseLabel": "Machinery and equipment" } } }, "localname": "OtherMachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r60" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedTerseLabel": "Other" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent assets.", "label": "Other Noncurrent Assets [Member]", "terseLabel": "Other non-current assets" } } }, "localname": "OtherNoncurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/InvestmentsScheduleofEquityInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherPrepaidExpenseCurrent": { "auth_ref": [ "r876", "r908" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsPrepaidExpensesandOtherCurrentAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Other Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "OtherPrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsPrepaidExpensesandOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivablesNetCurrent": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsPrepaidExpensesandOtherCurrentAssetsDetails": { "order": 4.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.", "label": "Other Receivables, Net, Current", "terseLabel": "Other receivables" } } }, "localname": "OtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsPrepaidExpensesandOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForDerivativeInstrumentFinancingActivities": { "auth_ref": [ "r278", "r821" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.", "label": "Payments for Derivative Instrument, Financing Activities", "negatedTerseLabel": "Purchases of capped call options" } } }, "localname": "PaymentsForDerivativeInstrumentFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtExtinguishmentCosts": { "auth_ref": [ "r54" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.", "label": "Payment for Debt Extinguishment or Debt Prepayment Cost", "negatedLabel": "Debt prepayment charges" } } }, "localname": "PaymentsOfDebtExtinguishmentCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r53" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedTerseLabel": "Debt issuance costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities": { "auth_ref": [ "r55" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for financing costs associated with business combinations.", "label": "Payments of Merger Related Costs, Financing Activities", "negatedTerseLabel": "Transaction costs related to merger with Gores" } } }, "localname": "PaymentsOfMergerRelatedCostsFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r55" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "terseLabel": "Gores shares recapitalized, net of redemptions and equity issuance costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r277" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "negatedTerseLabel": "Payments of employee taxes related to stock-based awards" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": { "auth_ref": [ "r46", "r82", "r275" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Payments to Acquire Debt Securities, Available-for-Sale", "negatedTerseLabel": "Purchases of marketable securities (including $17,846 and $16,423 with related parties in 2022 and 2021, respectively, see Note 17)" } } }, "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r47", "r630" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "negatedTerseLabel": "Acquisitions" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r49" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "terseLabel": "Investment in ECARX Holdings, Inc." } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r48" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedTerseLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r938", "r939", "r940", "r941", "r942", "r943", "r944", "r945", "r946", "r947", "r948", "r949", "r950", "r951", "r952", "r953", "r954", "r955", "r956", "r957", "r958", "r959", "r960", "r961", "r962", "r963" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r938", "r939", "r940", "r941", "r942", "r943", "r944", "r945", "r946", "r947", "r948", "r949", "r950", "r951", "r952", "r953", "r954", "r955", "r956", "r957", "r958", "r959", "r960", "r961", "r962", "r963" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred Stock" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets", "http://www.luminartech.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r8", "r488" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r8", "r488" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)", "terseLabel": "Preferred stock, shares outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r8", "r859" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r878" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.luminartech.com/role/FinancialStatementComponentsPrepaidExpensesandOtherCurrentAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets", "totalLabel": "Total prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets", "http://www.luminartech.com/role/FinancialStatementComponentsPrepaidExpensesandOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]", "terseLabel": "Private Placement" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r51" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from Convertible Debt", "terseLabel": "Proceeds from issuance of convertible senior notes, net of debt discounts of $15,625", "verboseLabel": "Proceeds from convertible debt" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows", "http://www.luminartech.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r50" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from sale of Class A common stock under ESPP" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": { "auth_ref": [ "r50" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.", "label": "Proceeds from Issuance of Convertible Preferred Stock", "terseLabel": "Proceeds from issuance of Series X convertible preferred stock" } } }, "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r51" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-Term Debt", "terseLabel": "Proceeds from the issuance of debt" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt": { "auth_ref": [ "r51" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from issuance of long-term debt classified as other.", "label": "Proceeds from Issuance of Other Long-Term Debt", "terseLabel": "Proceeds from the issuance of debt" } } }, "localname": "ProceedsFromIssuanceOfOtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": { "auth_ref": [ "r82", "r275", "r276" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale", "terseLabel": "Proceeds from maturities of marketable securities" } } }, "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r884", "r885" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "Other financing activities" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": { "auth_ref": [ "r43", "r82", "r275" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Proceeds from Sale of Debt Securities, Available-for-Sale", "terseLabel": "Proceeds from sales/redemptions of marketable securities (including $24,753 and $4,396 with related parties in 2022 and 2021, respectively, see Note 17)" } } }, "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r45" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Proceeds from Sale of Property, Plant, and Equipment", "terseLabel": "Disposal of property and equipment" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r50", "r149" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from exercise of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r883" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Proceeds from Warrant Exercises", "terseLabel": "Proceeds from exercise of warrants" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails", "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r839" ], "lang": { "en-us": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Product [Member]", "terseLabel": "Products" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" ], "xbrltype": "domainItemType" }, "us-gaap_ProductWarrantyAccrualClassifiedCurrent": { "auth_ref": [ "r20", "r110", "r111" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsAccruedandOtherCurrentLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Product Warranty Accrual, Current", "terseLabel": "Warranty reserves" } } }, "localname": "ProductWarrantyAccrualClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsAccruedandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyExpense": { "auth_ref": [ "r58", "r112" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The expense charged against earnings for the period pertaining to standard and extended warranties on the entity's goods and services granted to customers.", "label": "Product Warranty Expense", "terseLabel": "Warranty related to sensors" } } }, "localname": "ProductWarrantyExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r241", "r263", "r266", "r281", "r288", "r296", "r306", "r307", "r347", "r358", "r364", "r367", "r392", "r447", "r448", "r450", "r451", "r452", "r454", "r456", "r458", "r459", "r632", "r635", "r636", "r651", "r662", "r773", "r827", "r856", "r857", "r882", "r927" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "(Decrease) / increase to expenses as a result of transaction costs and stock-based compensation expense" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsImpactofAdjustmentstotheUnauditedProFormaDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": { "auth_ref": [ "r921", "r986" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.", "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization", "terseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r106" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails", "http://www.luminartech.com/role/FinancialStatementComponentsPropertyandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r104", "r246" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsPropertyandEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Total property and equipment" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsPropertyandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails", "http://www.luminartech.com/role/FinancialStatementComponentsPropertyandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r106", "r224", "r774", "r859" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsPropertyandEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "totalLabel": "Total property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsPropertyandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r106", "r798", "r799" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r106" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Schedule of Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables", "http://www.luminartech.com/role/FinancialStatementComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r104" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails", "http://www.luminartech.com/role/FinancialStatementComponentsPropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Estimated useful life (in years)" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" ], "xbrltype": "durationItemType" }, "us-gaap_PurchaseObligationDueInNextTwelveMonths": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Purchase Obligation, to be Paid, Year One", "terseLabel": "Purchase obligations" } } }, "localname": "PurchaseObligationDueInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/CommitmentandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]", "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]" } } }, "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r541", "r712", "r713" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.luminartech.com/role/InvestmentsNarrativeDetails", "http://www.luminartech.com/role/RelatedPartyDisclosuresDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/RelatedPartyDisclosuresDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r541", "r712", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r992" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.luminartech.com/role/InvestmentsNarrativeDetails", "http://www.luminartech.com/role/RelatedPartyDisclosuresDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r710", "r711", "r713", "r714", "r715" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLongTermCapitalLeaseObligations": { "auth_ref": [ "r230" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).", "label": "Repayments of Long-Term Capital Lease Obligations", "negatedTerseLabel": "Principal payments on finance leases (capital leases prior to adoption of ASC 842)" } } }, "localname": "RepaymentsOfLongTermCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r52" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-Term Debt", "negatedTerseLabel": "Repayment of debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r152", "r229", "r1001" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationCompensationExpenseDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r152" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Expense, Policy [Policy Text Block]", "terseLabel": "Research and Development (R&D)" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchMember": { "auth_ref": [ "r158" ], "lang": { "en-us": { "role": { "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.", "label": "Research Tax Credit Carryforward [Member]", "terseLabel": "Research Tax Credit Carryforward" } } }, "localname": "ResearchMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "auth_ref": [ "r245" ], "lang": { "en-us": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Domain]", "terseLabel": "Cash and Cash Equivalents [Domain]" } } }, "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashCurrent": { "auth_ref": [ "r874", "r888" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Current", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCashCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Stock-based awards\u2014Liability classified", "verboseLabel": "Restricted Stock" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails", "http://www.luminartech.com/role/StockbasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "RSUs" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationCompensationExpenseDetails", "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r11", "r135", "r222", "r786", "r791", "r859" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r237", "r293", "r294", "r295", "r297", "r305", "r307", "r396", "r581", "r582", "r583", "r610", "r611", "r649", "r782", "r784" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r338", "r339", "r357", "r362", "r363", "r369", "r370", "r373", "r527", "r529", "r751" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Total revenue", "verboseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss", "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails", "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationSegmentOperatingResultsandReconciliationtotheConsolidatedBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerMember": { "auth_ref": [ "r373", "r898" ], "lang": { "en-us": { "role": { "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue from Contract with Customer Benchmark [Member]", "terseLabel": "Revenue from contract with customer benchmark" } } }, "localname": "RevenueFromContractWithCustomerMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails", "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r533", "r823" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue from Contract with Customer [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r509", "r510", "r511", "r512", "r513", "r514", "r517", "r518", "r532", "r533" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/Revenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r515" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Revenue, remaining performance obligation, amount" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/RevenueRemainingPerformanceObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/RevenueRemainingPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "auth_ref": [ "r516" ], "lang": { "en-us": { "role": { "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "terseLabel": "Revenue, remaining performance obligation, period" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/RevenueRemainingPerformanceObligationsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "auth_ref": [ "r516" ], "lang": { "en-us": { "role": { "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/RevenueRemainingPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/RevenueRemainingPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationPercentage": { "auth_ref": [ "r932" ], "lang": { "en-us": { "role": { "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Percentage", "terseLabel": "Revenue, remaining performance obligation, percentage" } } }, "localname": "RevenueRemainingPerformanceObligationPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/RevenueRemainingPerformanceObligationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r698", "r858" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Operating lease right-of-use assets obtained in exchange for lease obligations", "verboseLabel": "Operating leases" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows", "http://www.luminartech.com/role/LeasesSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]", "terseLabel": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails", "http://www.luminartech.com/role/StockbasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails", "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of Stock, Number of Shares Issued in Transaction", "terseLabel": "Sale of stock (in shares)" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Sale of stock, price per share (in dollars per share)" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule of Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of Accrued and Other Current Liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/EarningsLossPerShareAntidilutiveSecuritiesDetails", "http://www.luminartech.com/role/EarningsLossPerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/EarningsLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Securities, Available-for-Sale [Line Items]", "terseLabel": "Debt Securities, Available-for-sale [Line Items]" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/InvestmentsAmortizedCostDetails", "http://www.luminartech.com/role/InvestmentsContinuousLossPositionDetails", "http://www.luminartech.com/role/InvestmentsNarrativeDetails", "http://www.luminartech.com/role/InvestmentsScheduleofEquityInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r165", "r166", "r625" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsComponentsofIntangibleAssetsandEstimatedUsefulLivesDetails", "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/BusinessCombinationsScheduleofRecognizedIdentifiedAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "auth_ref": [ "r165", "r166" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.", "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of cash and cash equivalents.", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Schedule of Cash and Cash Equivalents" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r160" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Schedule of Provision for Benefit From Income Taxes" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r156" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Schedule of Deferred Tax Assets and Liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r897" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/EarningsLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r154" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of Effective Tax Rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r147" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "terseLabel": "Schedule of Stock-based Compensation Expense by Function" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r653", "r654" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements on a Recurring Basis and the Level of Inputs Used" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": { "auth_ref": [ "r93" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.", "label": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r93", "r95", "r752" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails", "http://www.luminartech.com/role/FinancialStatementComponentsFutureAmortizationExpenseDetails", "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r93", "r95" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r830" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r830", "r910", "r911", "r912", "r913", "r914", "r915", "r916", "r917", "r918", "r919", "r920" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Schedule of Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r892" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]", "terseLabel": "Schedule of Loss Before Provision for (Benefit from) Income Taxes" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r0", "r15", "r16", "r17" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of Inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": { "auth_ref": [ "r875" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of noncurrent assets.", "label": "Schedule of Other Assets, Noncurrent [Table Text Block]", "terseLabel": "Schedule of Other Noncurrent Assets" } } }, "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amounts of other current assets.", "label": "Schedule of Other Current Assets [Table Text Block]", "terseLabel": "Schedule of Prepaid Expenses and Other Current Assets" } } }, "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r106" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails", "http://www.luminartech.com/role/FinancialStatementComponentsPropertyandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r198", "r199" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/RelatedPartyDisclosuresDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r78", "r79", "r80", "r90" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationSegmentOperatingResultsandReconciliationtotheConsolidatedBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r78", "r79", "r80", "r90" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of Segment Operating Results and Reconciliations to the Consolidated Balances" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r543", "r545", "r547", "r548", "r549", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r571", "r572", "r573", "r574", "r575" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationCompensationExpenseDetails", "http://www.luminartech.com/role/StockbasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails", "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails", "http://www.luminartech.com/role/StockbasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r141", "r142", "r144" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Schedule of Stock Option Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": { "auth_ref": [ "r146" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of Employee Stock Purchase Plan, Valuation Assumptions" } } }, "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Schedule of Restricted Stock Activity" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r124", "r126", "r127", "r129", "r130", "r131", "r132", "r133", "r134", "r135", "r253", "r254", "r255", "r326", "r488", "r489", "r490", "r492", "r496", "r501", "r503", "r836", "r873", "r889" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]", "terseLabel": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockholdersEquityDeficitDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitStockinlieuofCashProgramActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "auth_ref": [ "r855", "r967" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in unrecognized tax benefits.", "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]", "terseLabel": "Schedule of Reconciliation of the Total Amounts of Unrecognized Tax Benefits" } } }, "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r95" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of Future Amortization Expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r335", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r367", "r373", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r439", "r440", "r830", "r1003" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsGoodwillDetails", "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails", "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationSegmentOperatingResultsandReconciliationtotheConsolidatedBalancesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract]", "terseLabel": "Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract]" } } }, "localname": "SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationSegmentOperatingResultsandReconciliationtotheConsolidatedBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r335", "r336", "r337", "r347", "r350", "r361", "r365", "r366", "r367", "r368", "r369", "r372", "r373", "r374" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment and Customer Concentration Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationSegmentOperatingResultsandReconciliationtotheConsolidatedBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingInformationRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting Information, Revenue for Reportable Segment [Abstract]", "terseLabel": "Revenue:" } } }, "localname": "SegmentReportingInformationRevenueAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationSegmentOperatingResultsandReconciliationtotheConsolidatedBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting, Other Significant Reconciling Item, Consolidated [Abstract]", "terseLabel": "Other significant items:" } } }, "localname": "SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationSegmentOperatingResultsandReconciliationtotheConsolidatedBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r351", "r352", "r353", "r354", "r355", "r356", "r370" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting, Policy [Policy Text Block]", "terseLabel": "Segment Information" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpenseMember": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling and marketing expense.", "label": "Selling and Marketing Expense [Member]", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeniorNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.", "label": "Senior Notes [Member]", "terseLabel": "Senior Notes" } } }, "localname": "SeniorNotesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ServiceMember": { "auth_ref": [ "r839" ], "lang": { "en-us": { "role": { "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.", "label": "Service [Member]", "terseLabel": "Services" } } }, "localname": "ServiceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r58" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Share-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": { "auth_ref": [ "r852" ], "lang": { "en-us": { "role": { "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period", "terseLabel": "Service period (in years)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r852" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "terseLabel": "Award vesting period (in years and in months)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r564" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedTerseLabel": "Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r564" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r562" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails", "http://www.luminartech.com/role/StockbasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue": { "auth_ref": [ "r562" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average intrinsic value of award granted under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Intrinsic Value, Amount Per Share", "terseLabel": "Grant date fair value (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r562" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r559", "r560" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Outstanding at end of period (in shares)", "periodStartLabel": "Outstanding at beginning of period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r559", "r560" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Outstanding at end of period (in dollars per share)", "periodStartLabel": "Outstanding at beginning of period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted Average Grant Date\u00a0Fair Value per Share" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r563" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedTerseLabel": "Vested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationRestrictedStockActivityDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitStockinlieuofCashProgramActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "auth_ref": [ "r566" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value", "terseLabel": "Fair value of restricted stock vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r563" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationRestrictedStockActivityDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitStockinlieuofCashProgramActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r573" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "verboseLabel": "Dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r572" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "verboseLabel": "Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r574" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "verboseLabel": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationCompensationExpenseDetails", "http://www.luminartech.com/role/StockbasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails", "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails", "http://www.luminartech.com/role/StockbasedCompensationRestrictedStockActivityDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitStockinlieuofCashProgramActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": { "auth_ref": [ "r148" ], "lang": { "en-us": { "role": { "documentation": "The highest quantity of shares an employee can purchase under the plan per period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee", "terseLabel": "Shares of common stock in each purchase period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized", "terseLabel": "Additional shares authorized for issuance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r854" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "terseLabel": "Shares authorized for issuance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]", "terseLabel": "Weighted- Average Remaining Contractual Life (Years)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r566" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value", "terseLabel": "Intrinsic value of stock options exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r557" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedTerseLabel": "Cancelled/Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r555" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitStockinlieuofCashProgramActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r565" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted-average grant date fair value (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r148" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Outstanding balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r551", "r552" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Outstanding at end of period (in shares)", "periodStartLabel": "Outstanding at beginning of period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationStockOptionActivityDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitStockinlieuofCashProgramActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Number\u00a0of Stock\u00a0Options", "verboseLabel": "Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationStockOptionActivityDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitStockinlieuofCashProgramActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r551", "r552" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Outstanding as of Ending Balance", "periodStartLabel": "Outstanding as of Beginning Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationStockOptionActivityDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitStockinlieuofCashProgramActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted- Average Exercise Price", "verboseLabel": "Weighted Average Grant Date\u00a0Fair Value per Share" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationStockOptionActivityDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitStockinlieuofCashProgramActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": { "auth_ref": [ "r568" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value", "terseLabel": "Vested and exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": { "auth_ref": [ "r568" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number", "terseLabel": "Vested and exercisable (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r568" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price", "terseLabel": "Vested and exercisable (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "auth_ref": [ "r567" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value", "terseLabel": "Vested and expected to vest" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "auth_ref": [ "r567" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number", "terseLabel": "Vested and expected to vest (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r567" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price", "terseLabel": "Vested and expected to vest (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum", "terseLabel": "Percentage of outstanding stock maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "auth_ref": [ "r148" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period", "terseLabel": "Shares issued in period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r547", "r548", "r549", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r571", "r572", "r573", "r574", "r575" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails", "http://www.luminartech.com/role/StockbasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r556" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercised (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r557" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Cancelled/Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r555" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockholdersEquityDeficitStockinlieuofCashProgramActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share-Based Payment Arrangement, Tranche One [Member]", "terseLabel": "Tranche One" } } }, "localname": "ShareBasedCompensationAwardTrancheOneMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share-Based Payment Arrangement, Tranche Three [Member]", "terseLabel": "Tranche Three" } } }, "localname": "ShareBasedCompensationAwardTrancheThreeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share-Based Payment Arrangement, Tranche Two [Member]", "terseLabel": "Tranche Two" } } }, "localname": "ShareBasedCompensationAwardTrancheTwoMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r550", "r569", "r570", "r571", "r572", "r575", "r584", "r585" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-Based Payment Arrangement [Policy Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedPaymentArrangementEmployeeMember": { "auth_ref": [ "r545", "r547", "r548", "r549", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r571", "r572", "r573", "r574", "r575" ], "lang": { "en-us": { "role": { "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.", "label": "Share-Based Payment Arrangement, Employee [Member]", "terseLabel": "Share-based Payment Arrangement, Employee" } } }, "localname": "ShareBasedPaymentArrangementEmployeeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails", "http://www.luminartech.com/role/StockbasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedPaymentArrangementNonemployeeMember": { "auth_ref": [ "r543", "r547", "r548", "r549", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r571", "r572", "r573", "r574", "r575" ], "lang": { "en-us": { "role": { "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor does not exercise nor has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Excludes nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.", "label": "Share-Based Payment Arrangement, Nonemployee [Member]", "terseLabel": "Share-based Payment Arrangement, Nonemployee" } } }, "localname": "ShareBasedPaymentArrangementNonemployeeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails", "http://www.luminartech.com/role/StockbasedCompensationRestrictedStockActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r938" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage", "terseLabel": "Award vesting percentage" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r853" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period", "terseLabel": "Award expiration period (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r571" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "verboseLabel": "Expect term (years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r145" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Outstanding balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r568" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Vested and exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r567" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Vested and expected to vest" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "auth_ref": [ "r566" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value", "terseLabel": "Fair value of options vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent", "terseLabel": "Percentage of purchase price of shares" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShortTermLeasePayments": { "auth_ref": [ "r692" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for short-term lease payment excluded from lease liability.", "label": "Short-Term Lease Payments", "terseLabel": "Short-term leases" } } }, "localname": "ShortTermLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r67", "r285" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Basis of Presentation and Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StandardProductWarrantyPolicy": { "auth_ref": [ "r113" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.", "label": "Standard Product Warranty, Policy [Policy Text Block]", "terseLabel": "Product Warranties" } } }, "localname": "StandardProductWarrantyPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.", "label": "State and Local Jurisdiction [Member]", "terseLabel": "U.S. State" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r240", "r335", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r367", "r373", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r437", "r439", "r440", "r830", "r1003" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsGoodwillDetails", "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails", "http://www.luminartech.com/role/SegmentandCustomerConcentrationInformationSegmentOperatingResultsandReconciliationtotheConsolidatedBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r253", "r254", "r255", "r288", "r312", "r313", "r316", "r318", "r326", "r327", "r392", "r447", "r450", "r451", "r452", "r458", "r459", "r488", "r489", "r492", "r496", "r503", "r662", "r812", "r873", "r889", "r896" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails", "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/ConsolidatedBalanceSheets", "http://www.luminartech.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitParenthetical", "http://www.luminartech.com/role/ConvertiblePreferredStockDetails", "http://www.luminartech.com/role/Cover", "http://www.luminartech.com/role/DebtAdditionalInformationDetails", "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails", "http://www.luminartech.com/role/InvestmentsNarrativeDetails", "http://www.luminartech.com/role/RevenueNarrativeDetails", "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r27", "r128", "r237", "r269", "r270", "r271", "r293", "r294", "r295", "r297", "r305", "r307", "r325", "r396", "r505", "r581", "r582", "r583", "r610", "r611", "r649", "r671", "r672", "r673", "r674", "r675", "r676", "r709", "r782", "r783", "r784" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/DebtAdditionalInformationDetails", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets", "http://www.luminartech.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitParenthetical", "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r293", "r294", "r295", "r325", "r751" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets", "http://www.luminartech.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitParenthetical", "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r63", "r64", "r65" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Stock Issued", "terseLabel": "Vendor stock-in-lieu of cash program\u2014advances for capital projects and equipment" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r8", "r9", "r135" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Shares issued to acquiree shareholders (in shares)", "verboseLabel": "Acquisition (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r26", "r128", "r129", "r135", "r477" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "terseLabel": "Conversion of SAFE into Series A common stock and Issuance of Class A common stock upon exercise of warrants (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r8", "r9", "r128", "r135" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans", "terseLabel": "Issuance of Class A common stock under ESPP (in shares)", "verboseLabel": "Weighted average purchase price (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock Issued During Period, Shares, Issued for Services", "terseLabel": "Shares issued for services (in shares)", "verboseLabel": "Vendor payments under the stock-in-lieu of cash program (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r8", "r9", "r128", "r135" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.", "label": "Stock Issued During Period, Shares, Purchase of Assets", "terseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesPurchaseOfAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r8", "r9", "r128", "r135" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Optogration milestone awards (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r8", "r9", "r128", "r135", "r556" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "negatedLabel": "Exercised (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r27", "r128", "r135" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock Issued During Period, Value, Acquisitions", "terseLabel": "Acquisitions" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r27", "r128", "r135" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "terseLabel": "Conversion of SAFE into Series A common stock and Issuance of Class A common stock upon exercise of warrants" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "auth_ref": [ "r8", "r9", "r128", "r135" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.", "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan", "terseLabel": "Issuance of Class A common stock under ESPP" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock Issued During Period, Value, Issued for Services", "terseLabel": "Vendor payments under the stock-in-lieu of cash program" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r8", "r9", "r128", "r135" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r8", "r9", "r135", "r143" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Optogration milestone awards" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsNarrativeDetails", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Shares repurchased" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount remaining of a stock repurchase plan authorized.", "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount", "terseLabel": "Stock repurchase program, remaining authorized repurchase amount" } } }, "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "auth_ref": [ "r8", "r9", "r128", "r135" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased and retired during the period.", "label": "Stock Repurchased and Retired During Period, Shares", "negatedTerseLabel": "Retirement of Class A shares (in shares)", "terseLabel": "Repurchase of Class A shares (in shares)" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": { "auth_ref": [ "r8", "r9", "r128", "r135" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).", "label": "Stock Repurchased and Retired During Period, Value", "negatedTerseLabel": "Retirement of Class A shares" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r8", "r9", "r128", "r135" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedTerseLabel": "Shares repurchased" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r9", "r12", "r13", "r81", "r859", "r891", "r906", "r984" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total stockholders\u2019 equity (deficit)" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets", "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders\u2019 equity (deficit):" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets", "http://www.luminartech.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r139", "r287", "r489", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r502", "r505", "r640" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Stockholders\u2019 Equity (Deficit)" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockholdersEquityDeficit" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubleaseIncome": { "auth_ref": [ "r696", "r858" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of sublease income excluding finance and operating lease expense.", "label": "Sublease Income", "terseLabel": "Sublease income" } } }, "localname": "SubleaseIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r677", "r717" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails", "http://www.luminartech.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r677", "r717" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r677", "r717" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails", "http://www.luminartech.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r677", "r717" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails", "http://www.luminartech.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r716", "r718" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]", "terseLabel": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPublicandPrivateWarrantsDetails", "http://www.luminartech.com/role/StockbasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails", "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "auth_ref": [ "r879" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "terseLabel": "Financial Statement Components" } } }, "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Elements [Abstract]", "terseLabel": "Supplemental disclosures of cash flow information:" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_Supplies": { "auth_ref": [ "r817", "r829", "r908" ], "calculation": { "http://www.luminartech.com/role/FinancialStatementComponentsPrepaidExpensesandOtherCurrentAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration paid in advance for supplies that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Supplies", "terseLabel": "Advance payments to vendors" } } }, "localname": "Supplies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FinancialStatementComponentsPrepaidExpensesandOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxCreditCarryforwardAmount": { "auth_ref": [ "r157" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Tax Credit Carryforward, Amount", "terseLabel": "Research and development tax credit carryforwards" } } }, "localname": "TaxCreditCarryforwardAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxCreditCarryforwardAxis": { "auth_ref": [ "r158" ], "lang": { "en-us": { "role": { "documentation": "Information by specific tax credit related to an unused tax credit.", "label": "Tax Credit Carryforward [Axis]", "terseLabel": "Tax Credit Carryforward [Axis]" } } }, "localname": "TaxCreditCarryforwardAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardNameDomain": { "auth_ref": [ "r158" ], "lang": { "en-us": { "role": { "documentation": "The name of the tax credit carryforward.", "label": "Tax Credit Carryforward, Name [Domain]", "terseLabel": "Tax Credit Carryforward, Name [Domain]" } } }, "localname": "TaxCreditCarryforwardNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/EarningsLossPerShareBasicandDilutedLossPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.", "label": "Temporary Equity, Accretion to Redemption Value, Adjustment", "negatedTerseLabel": "Deemed dividend attributable to BCF accretion" } } }, "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/EarningsLossPerShareBasicandDilutedLossPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityByClassOfStockTable": { "auth_ref": [ "r1", "r125" ], "lang": { "en-us": { "role": { "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable.", "label": "Temporary Equity, by Class of Stock [Table]", "terseLabel": "Temporary Equity, by Class of Stock [Table]" } } }, "localname": "TemporaryEquityByClassOfStockTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConvertiblePreferredStockDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r447", "r450", "r451", "r452", "r458", "r459" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Temporary Equity Disclosure [Abstract]" } } }, "localname": "TemporaryEquityDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityEliminationAsPartofReorganization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Redemption of temporary equity as the result of a triggering event associated with the temporary equity.", "label": "Temporary Equity, Elimination as Part of Reorganization", "negatedLabel": "Merger recapitalization\u2014Class A" } } }, "localname": "TemporaryEquityEliminationAsPartofReorganization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Temporary Equity [Line Items]", "terseLabel": "Temporary Equity [Line Items]" } } }, "localname": "TemporaryEquityLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConvertiblePreferredStockDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "auth_ref": [ "r1", "r125" ], "lang": { "en-us": { "role": { "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.", "label": "Temporary Equity, Par or Stated Value Per Share", "terseLabel": "Par value (in dollars per share)" } } }, "localname": "TemporaryEquityParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConvertiblePreferredStockDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesAuthorized": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Authorized", "terseLabel": "Shares authorized (in shares)" } } }, "localname": "TemporaryEquitySharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConvertiblePreferredStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Outstanding", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of new stock classified as temporary equity issued during the period.", "label": "Temporary Equity, Stock Issued During Period, Value, New Issues", "terseLabel": "Gross proceeds from stock issuance", "verboseLabel": "Issuance of Series X convertible preferred stock for cash, net of issuance costs" } } }, "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit", "http://www.luminartech.com/role/ConvertiblePreferredStockDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceAxis": { "auth_ref": [ "r844", "r933" ], "lang": { "en-us": { "role": { "documentation": "Information by timing of transfer of good or service to customer.", "label": "Timing of Transfer of Good or Service [Axis]", "terseLabel": "Timing of Transfer of Good or Service [Axis]" } } }, "localname": "TimingOfTransferOfGoodOrServiceAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceDomain": { "auth_ref": [ "r844", "r933" ], "lang": { "en-us": { "role": { "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.", "label": "Timing of Transfer of Good or Service [Domain]", "terseLabel": "Timing of Transfer of Good or Service [Domain]" } } }, "localname": "TimingOfTransferOfGoodOrServiceDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r231", "r232", "r233", "r377", "r378", "r379" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts Receivable [Policy Text Block]", "terseLabel": "Accounts Receivable" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r169" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]", "terseLabel": "Tradename" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BusinessCombinationsComponentsofIntangibleAssetsandEstimatedUsefulLivesDetails", "http://www.luminartech.com/role/FinancialStatementComponentsScheduleofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]", "terseLabel": "Schedule of Equity Investments Included in Marketable Securities" } } }, "localname": "TradingSecuritiesAndCertainTradingAssetsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_TransferredAtPointInTimeMember": { "auth_ref": [ "r844" ], "lang": { "en-us": { "role": { "documentation": "Contract with customer in which good or service is transferred at point in time.", "label": "Transferred at Point in Time [Member]", "terseLabel": "Recognized at a point in time" } } }, "localname": "TransferredAtPointInTimeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransferredOverTimeMember": { "auth_ref": [ "r844" ], "lang": { "en-us": { "role": { "documentation": "Contract with customer in which good or service is transferred over time.", "label": "Transferred over Time [Member]", "terseLabel": "Recognized over time" } } }, "localname": "TransferredOverTimeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r384", "r385", "r485", "r501", "r639", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r735", "r736", "r737", "r738", "r739", "r740", "r741", "r742", "r743", "r744", "r745", "r746", "r747", "r748", "r903", "r904", "r905", "r1006", "r1007", "r1008", "r1009", "r1010", "r1011", "r1012" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]", "terseLabel": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails", "http://www.luminartech.com/role/InvestmentsAmortizedCostDetails", "http://www.luminartech.com/role/InvestmentsContinuousLossPositionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockCommonMember": { "auth_ref": [ "r136" ], "lang": { "en-us": { "role": { "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common [Member]", "terseLabel": "Treasury Stock" } } }, "localname": "TreasuryStockCommonMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockCommonShares": { "auth_ref": [ "r136" ], "lang": { "en-us": { "role": { "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Shares", "terseLabel": "Treasury stock, at cost (in shares)", "verboseLabel": "Treasury stock, shares outstanding (in shares)" } } }, "localname": "TreasuryStockCommonShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockCommonValue": { "auth_ref": [ "r28", "r136", "r137" ], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Value", "negatedTerseLabel": "Treasury stock, at cost, 21,863,450 and 15,263,761 shares as of December\u00a031, 2022 and 2021, respectively" } } }, "localname": "TreasuryStockCommonValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "auth_ref": [ "r128", "r135", "r136" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.", "label": "Treasury Stock, Value, Acquired, Cost Method", "verboseLabel": "Purchase transaction" } } }, "localname": "TreasuryStockValueAcquiredCostMethod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r235", "r236", "r237", "r238", "r239", "r296", "r297", "r298", "r299", "r308", "r380", "r381", "r393", "r394", "r395", "r396", "r397", "r398", "r581", "r582", "r583", "r608", "r609", "r610", "r611", "r627", "r628", "r629", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r678", "r679", "r684", "r685", "r686", "r687", "r704", "r705", "r706", "r707", "r708", "r709", "r753", "r754", "r755", "r780", "r781", "r782", "r783", "r784", "r785", "r786", "r787", "r788", "r789", "r790", "r791" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Accounting Standards Update [Domain]", "terseLabel": "Accounting Standards Update [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofCashFlows", "http://www.luminartech.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember": { "auth_ref": [ "r1002" ], "lang": { "en-us": { "role": { "documentation": "This category includes information about debt issued by US Government Corporations and Agencies. Investments in such US Government Corporations may include debt securities issued by the Government National Mortgage Association (Ginnie Mae) and by the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac).", "label": "US Government Corporations and Agencies Securities [Member]", "terseLabel": "U.S. agency securities", "verboseLabel": "U.S. agency and government sponsored securities" } } }, "localname": "USGovernmentCorporationsAndAgenciesSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails", "http://www.luminartech.com/role/InvestmentsAmortizedCostDetails", "http://www.luminartech.com/role/InvestmentsContinuousLossPositionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_USTreasurySecuritiesMember": { "auth_ref": [ "r824", "r846", "r848", "r1002" ], "lang": { "en-us": { "role": { "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).", "label": "US Treasury Securities [Member]", "terseLabel": "U.S. treasury securities" } } }, "localname": "USTreasurySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails", "http://www.luminartech.com/role/InvestmentsAmortizedCostDetails", "http://www.luminartech.com/role/InvestmentsContinuousLossPositionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnamortizedDebtIssuanceExpense": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/DebtScheduleofNetCarryingAmountDetails": { "order": 1.0, "parentTag": "us-gaap_ConvertibleDebtNoncurrent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.", "label": "Unamortized Debt Issuance Expense", "negatedTerseLabel": "Unamortized debt discount and issuance costs" } } }, "localname": "UnamortizedDebtIssuanceExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/DebtScheduleofNetCarryingAmountDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r586", "r593" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Unrecognized tax benefits as of the end of the year", "periodStartLabel": "Unrecognized tax benefits as of the beginning of the year" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r594" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions", "negatedTerseLabel": "Decreases related to prior year tax provisions" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r592" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Interest and penalties accrued" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [ "r595" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.", "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions", "terseLabel": "Increase related to current year tax positions" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r594" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions", "terseLabel": "Increases related to prior year tax positions" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "auth_ref": [ "r596" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.", "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate", "terseLabel": "Unrecognized tax benefits that would impact effective tax rate, if recognized" } } }, "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r75", "r76", "r77", "r329", "r330", "r332", "r333" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r602" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "terseLabel": "Valuation allowance, increase (decrease), amount" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableLeaseCost": { "auth_ref": [ "r695", "r858" ], "calculation": { "http://www.luminartech.com/role/LeasesComponentsofLeaseExpensesDetails": { "order": 2.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.", "label": "Variable Lease, Cost", "terseLabel": "Variable lease cost" } } }, "localname": "VariableLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/LeasesComponentsofLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VehiclesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment used primarily for road transportation.", "label": "Vehicles [Member]", "terseLabel": "Vehicles, including demonstration fleet" } } }, "localname": "VehiclesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails", "http://www.luminartech.com/role/FinancialStatementComponentsPropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VestingAxis": { "auth_ref": [ "r938", "r939", "r940", "r941", "r942", "r943", "r944", "r945", "r946", "r947", "r948", "r949", "r950", "r951", "r952", "r953", "r954", "r955", "r956", "r957", "r958", "r959", "r960", "r961", "r962", "r963" ], "lang": { "en-us": { "role": { "documentation": "Information by vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Axis]", "terseLabel": "Vesting [Axis]" } } }, "localname": "VestingAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VestingDomain": { "auth_ref": [ "r938", "r939", "r940", "r941", "r942", "r943", "r944", "r945", "r946", "r947", "r948", "r949", "r950", "r951", "r952", "r953", "r954", "r955", "r956", "r957", "r958", "r959", "r960", "r961", "r962", "r963" ], "lang": { "en-us": { "role": { "documentation": "Vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Domain]", "terseLabel": "Vesting [Domain]" } } }, "localname": "VestingDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/StockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrants" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/EarningsLossPerShareAntidilutiveSecuritiesDetails", "http://www.luminartech.com/role/FairValueMeasurementsScheduleofChangesinLevel3LiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstanding": { "auth_ref": [], "calculation": { "http://www.luminartech.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.", "label": "Warrants and Rights Outstanding", "terseLabel": "Fair value of warrants outstanding", "verboseLabel": "Warrant liabilities" } } }, "localname": "WarrantsAndRightsOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedBalanceSheets", "http://www.luminartech.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsonaRecurringBasisandtheLevelofInputsUsedDetails", "http://www.luminartech.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "auth_ref": [ "r657" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.", "label": "Warrants and Rights Outstanding, Measurement Input", "terseLabel": "Warrants outstanding, measurement input" } } }, "localname": "WarrantsAndRightsOutstandingMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r982" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Warrants term (in years)" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r311", "r318" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (in shares)", "verboseLabel": "Weighted average Common shares outstanding- Diluted (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss", "http://www.luminartech.com/role/EarningsLossPerShareBasicandDilutedLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r309", "r318" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted average Common shares outstanding- Basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss", "http://www.luminartech.com/role/EarningsLossPerShareBasicandDilutedLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]", "terseLabel": "Denominator:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.luminartech.com/role/EarningsLossPerShareBasicandDilutedLossPerShareDetails" ], "xbrltype": "stringItemType" } }, "unitCount": 12 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1000": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1001": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1002": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1003": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1004": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1005": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1006": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1007": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1008": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1009": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1010": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1011": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1012": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907644&loc=d3e11281-110244", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12524-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(3,4))", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(4)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r177": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61901-109447", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61926-109447", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r203": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "940", "URI": "https://asc.fasb.org/subtopic&trid=2176304", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62652-112803", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r215": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org/subtopic&trid=2209399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r228": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "946", "URI": "https://asc.fasb.org/subtopic&trid=2324412", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123415192&loc=d3e39927-112707", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3444-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org/topic&trid=2196928", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=123583714&loc=SL75117360-209713", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "8", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r622": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(3)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r67": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL77916155-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r703": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r715": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r718": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(6))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r785": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r795": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r812": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r813": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1403", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(7)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r819": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r820": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r821": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3505-108585", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r822": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r823": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r824": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r825": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r826": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r827": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r828": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r829": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r830": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r831": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r832": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r833": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r834": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r835": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r836": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r837": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r838": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r839": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r840": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r841": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r842": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r843": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r844": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r845": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r846": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r847": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r848": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r849": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r850": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r851": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r852": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r853": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r854": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r855": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r856": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r857": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r858": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r859": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r860": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r861": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r862": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r863": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r864": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r865": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r866": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r867": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r868": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r869": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r87": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org/topic&trid=2196928", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r870": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r871": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r872": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r873": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r874": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r875": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r876": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r877": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r878": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r879": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "210", "URI": "https://asc.fasb.org/topic&trid=2122208", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=123583895&loc=d3e30768-111565", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r880": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r881": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r882": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r883": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r884": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r885": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r886": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r887": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r888": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r889": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r890": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r891": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r892": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r893": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r894": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r895": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r896": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r897": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r898": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r899": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r900": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r901": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r902": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org/topic&trid=2196928", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r903": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r904": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r905": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r906": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r907": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r908": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r909": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131251-203054", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r910": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r911": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r912": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r913": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r914": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r915": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r916": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r917": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r918": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r919": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r920": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r921": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r922": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r923": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r924": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r925": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r926": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r927": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r928": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r929": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r930": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r931": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r932": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r933": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r934": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r935": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "705", "URI": "https://asc.fasb.org/topic&trid=2122478", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r936": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r937": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r938": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r939": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r940": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r941": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r942": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r943": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r944": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r945": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r946": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r947": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r948": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r949": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r950": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r951": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r952": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r953": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r954": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r955": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r956": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r957": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r958": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r959": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r960": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r961": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r962": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r963": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r964": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r965": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "740", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126970579&loc=d3e23163-113944", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r966": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r967": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r968": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r969": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r970": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r971": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r972": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r973": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r974": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r975": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r976": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "15", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r977": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=127000608&loc=d3e9135-128495", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r978": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9212-128498", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r979": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9215-128498", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r980": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r981": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r982": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r983": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r984": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r985": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r986": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r987": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r988": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r989": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r990": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r991": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r992": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r993": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r994": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r995": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r996": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r997": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r998": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r999": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" } }, "version": "2.2" } ZIP 131 0001628280-23-005649-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001628280-23-005649-xbrl.zip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�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�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

%MN;_]*YY>9@L1- N.,"9);T0C>,EL38Q:B=PP8BW6EQHBY=:77 M7@2.:_<&A^!PRNK ]&WHOF'R_6RQ.#.!*Z^+A:1KD7].Q 5CG'8()EA,V6?= M^L+FPY2,>Q@X.+8:B/]G385?2V16WL^F7U9*N!+]6*GPYRGJ(A6^I^"&3X5' M(;/,PH..M2$S5P%\MHF^=5Q$6X2PO+$Q&2X5OKT;W!'O?^-Y'4I-CLF91VYT M"1D,JQZ)RQR6J#;J.2G]2F?KR,Y_6C M_'$^^1Z6^(\PG],OCF50GR.G!VNZE\A.<*HHG7;.UD-Q84!IIRF&)TR+X,C) M5(('UMJN##AFYSPL%A_*6J0?YI\F7[ZNBZN2Y@JM(0?(63('Z )YT608O)-1 MI1!ER:VWC,>IZ=9H[H.&>[49;83?00CS^3(N)GE":_ES6$VE7,[2NGTS[1TV MN@C96(K%,#,(H8Z=+-$K;5#%YE',H\2,W BMD;;O'CTW$7T/&+HA_VIBP9\D MIP6ML3I[\NK6D"B*W 3EP,900"F>(%HEP9I /TT\*]G:)#U/U??RPN3/F=&(\&V#.1E "#015&/@0O&8Y!*=;7_:]?OG(6&FLU;LQ MP$$B[@ ;:[_RXWE(N-5EPTOC69&:), S*"GKM%&I*"A*Q$>N$4,;)V7O\$L[?DGNX_'%ULTW[>O=4DTO(2[V/S,'746K*A:*" M4-P9]@1N%IC^SY?9]_^B1U]!AKZX0S35\"ST41V2$X@W4('@DC*D\2<9YL&PLQV]W&R#W\_/$4?KBB9FVE MUH'O\*#Y6RT#&XLLVBEP49(3E 5"3+7PR[LDB\HNF];NPZ/$C#Q'99C(MXWH M>\70>GD5QU3,DH.LS::5U;RV+Z>@SK+:1X>A3LTGJ3Q.3H<9E/T5O@N,#I#^ MV+O0VI%^-5L&,&.CI&'&. Z)6DR.O R,]#9Z^BDSBAVZT'4#QZ:ZVW6 M4HBCH^#V.=JFJ:A&AI([,/0W<< U..\B%.2A=O[V+NQE( [ 0?,@=5@<'"W& M#GR/SZ2$5=YE;3IO\L>.B>R)*(A::9(+FGH=G;98E53DD6L?FM\B?(R8D2%,])4\!C,M(SXUSS0_+[5(R<;6^C MWH>]U4-EW0-:9A<7L^F*CU>;:S:1.^^Y(J<=B0,M230BD)/&BI=U(GG:[8+1 M/FBY1T47GNO!>KTWQ>@H(?< DX>,[OOKBM_LG-0.*2TDVE\(^U$+[ MG#'[TV17WN]U\VBP]JNG3+$6=+?"0:V^NU'1XE M'H>J@27?(:8VX>B&'<&YE<@4T)(@=CSG$(HA\V^X2CXZ)5D\%$AWWM7A*<,P MZ#E&QGWM@Q_GDX3$QFH]G 6=44?A(,:XNL1),O+$EN29/F%<*ARPONX6+1U& M_,WWM\.%WP&('A31V[]PGB8+7'%VLT[6GR[X6;2RD,?)*. MM3*,_@BN6"B! M^8PV6PS-)]@>0FB'WGP;^ VOMEZQ>;WU8[JMRI#Z?&[&#J[!6_'RZ7BV68 MUION9\%10*^U NZ8)H'"!Y*IY5HG'G MOGC![AJ:=T&=_%O0=JHRQ X8' MF7D3%E\_XW)YODI7;\77?Q)V%E]GY_EF!OHZ=*H_)(K.:$_(T5D%EI'GHFPD M]T60%"QGB=.NX#CN.+NO+6$[H=&](#2.KKTND;MQ7/)9#"XK$07X5'LDAQ)J M!VU-WG,)1K,48]HM7_+T>W;"E?\I<'68;#O8/3_.9PDQ+WXE^:U9VO"R.&-) M>%M'1+GHJXRXKE=3'-@JN4V6:/WY649!04S,@+S.BK!>D[O)$*+#9*R0#N-NUPKV M>^]NT'IQ9P,#"G]L7*URC%>G9MMKX^KH8[-Z;G9YKFUQ,EM01M"ZB9E$6# ! MYI"SU#.[B/1I?>+BC\KN M3A:3U8\VS4>,=#PFGX"S MBD[&+81,=DDKJR12:*=]ZZZ4^U'8;NC%YKU;+UF\_K'UW56QBW*L%.$=Y+I* ME3,:/*?8UC'%,'"NA&PMD7UI'+=R8T"$/3X48P#E=1!G/L#5JKQ3"V=*9A&D MJ)TCA5'@M/*0"U?P//[\_5!RAP5E;<8Z- MB,^S\T*1[?5D$HG&! '4PJW'CEM,.*#^#Q?> MV&K_\&TY^S)?Z>#=-*T9T-848ST#46S%;;V)XEPA1R]E2T&H*TSMI/V'GCYN M3>" (#A:E!UAX??).2[(EN&K?X=YWM@S+83P64<@HT; ULJ!-XR!],$6(67A M;+?>-&ZMWVDP -BHX$X.XA7'K_D&"RF))*#E.OHK%!JNX5L("?/BH_"N?:UQ$== M'S[!5*@3Q,%M%-(!LAZX$%E\LEK1BG"JMA.KOK73W(%V6BBO$8T=J"CS!5PJ MWDN]SU\JWD?6/:#E_GU7+G@6P100JYY 3N@J$(2D(V:3I$7=_(9H_Y>*]]+K M\Y>*]Q%R7S!YO6G_$;-*03'PWBA0,FF(0B<01+Q65ENE6P\RO$]%%_?N!H#) M(4+N81UF/C;[>0W)C3T"^ M-;J9>!/1281(LVP0E)?J6'/^>3+U^P5G6]_4Z?735U,MPFFQ0P3:)2,1<(Y$&1LY,S M<2FC$W<*RQ_)@QU%QKBIU)/X$"?6U8M%Y29!Z;DJY&"#"ZZVLQ 90N0";.(J M"BS6\#PL+L?,FYP:+$TP>H#FQD;IJJYU52Q]AY-D^_I%50':J%;6/TZNYRO^7')"$0RM(P,+7FY-L!J MLCPS=1HR\!2/ DK!/)* ML8"T&9GR41O-4X/1*Z8.TT&WF/H\^6O-#@4R+@;GH$BF*- 1!@(J M#H[KR%W*%*G;XR!U_:YQ6A5UBJC#--#!:>JO83+_>SB_Q-<_KK_\[PE);YZ^ M_GB/W_%\%4"K+(VS48/3I39IE;7"L/0@>@]N1&ND 7%NR6C'S)_V[J^1T-+9PZ\&AJ*&RCN!)9*!- M2L4%4SAKC:S':!FW_>1)=],FZN@45NN%5SO &4]K(VL7JBN*X"BJ 4O6WS', MBN-30ZQ; :N'G;&-MG> T &B[Q!$JQ#G[[-STL_Y9/ECD]-+*4B*B4&ZVN6D ME@0$3E97(/&D4!IO6G =?Q*ND09V__^H9IB?E/G&^J3313 MA;Q0"UPIDEEA#)S'*Q%J)Q2W'R[LR 4-R9)@ MI"9/ :T@-]$4D%A"E"8X9T[2"WQG)VNP+LLG=;+:**179&WB&ZF5QU@@Y[1: M@QYBO40AN;!.)FX#MFY'^@+'>^^E\#W&>^\C_;$3^,],L8U:.L14QQ3Q&M & M!^2=.A"%69N.]]]+E'N.]]Q%L!\;F^H+@6S+%RQ]O9A??9M.: M8EDM)&F%CZ)>TC+UQ$H[#5%J#86[@H91V*)E8W/S)$'CMFD?YV+NT8KI &5W M>%@O0>VU<<%K2 HU,<$LF6E:*DJPI'RP2:C6"?8'">GDBN[QBIZUEGH'T-F: MN'=]C(Z1Z%>@R^I(0=/NSDL$HV(JANQO]*USF/>(&! ML,COK[OR1A-YD+G03EPG(WMI(%BRR-X;DI(TS-T=CCE$#[QK>L8="C%VF\7# MU-(1Q+9:H=ZI_PC3Q15E5POTW91>CHOE>A0M>8SUBY5,LR=?4'A[=?M=E9C M>6X D1C7V:-)K7,$#(#?'^\G*>O83WA[]TTG5]F M7/QC-O_79/KE3?@V68;S5_F?EXOEZCCV3%G#E=9U)A!9!T4Q(C@D;NNI:ZX7 M]CW;K3/DT:1TUT3P.&B.H)\^+>V61#_A.7G,^AEP>_]),1: M/##!!;DGE_5'M<&Z*DI7MP,-*.[KQ')G 2-*DX/RY68>U.D!^0#%XY:H]0#1 M8]78 6B?G*RT^O,U.=*Y9M.0-H(7I$2-Y$X8P*6;?. M&.U/Y;CG9B%5_58^\OJ9.KUCYM?^1A^U!^MVI)_PGKP0/*X M[E;^(9Y/OEP-0#O+OC"KL@*MJ\153G6FIH.$*2@;LS9NM[&FP] W;A9^F$Q1 M!YKLP+IN'69=;1I72_#TJ$ZZ M/'\/\PWQ5\G'E/I GL6+O+ H5K1,"8LI55DY"Y-I!3AAL MM#DS,4Q?Z2?)&GF*\RG0U40C'8#LX+W_PVIR]>*W517CN^F5;_O;?+98G$E1 MF'(\@5F=8DH1P6NC0 J2/!;IM&F=0AR C9%'1@\7EHRL\0Y _V"%[Q^7M8+I M0_F,B:*UFKMZ$\[/,;_^L:G57?_BXLQYX[2,&>*J9LJJ!$$F!QY9R"SKG,@ +O$$:;!7.G9=#B3+!<#^(M!)8=A?#DQ\2B M,WBK!),%? M;_G;^2.9I!51*N#95JXU0H@&023E4>LB4;3.W+6A?#?$OKP3D1'TVHN!W&+Y M,$ MJC.C?$2;&$B6:DLK&X&^+W7)2(V!/-8=[^SN\=+=ZJE?SDG%H$+O$$R/]"J] MUUST+&1&_JG,4*2M%Q:T)+$J2>C!$G406-1NKN M7C#Z1![H 3=V=:%+INAXIEC>A%#OU&(FD5/TQ5 %3,6SE'9KRG\X#;OA\.6< M8YQ2)2\7>7=;9YV5I)CG'"&+VH6+6&SXP$N_2M!LR7\ZA MQ)@JZQ"I;_]*7^N9XJ?ZW4>(K4^89E^FD__!_"Z3T"=E4E?0J\4"EXO-Y:U7 MT^V+"/39Y07FS0G@&5.2Z5@R[0"&'!!=:'$QS8%<9Z;);Z8@;3]_L25UNV'T MY9^!G%:-!^/X.\[C[!072[9[:IR%HAPO)H+)7)"+[$CDM>%8*JA3D3IY;#W1 M8F?B=@/HRSE3&58['1K0%:.?,"/Y&VOVSI(H/"LLX*,N)#BL8Y110'3!QT!8 M$3=G#ON:Q ?>MQN&7LXIQU"B[AT]]>^+56W8*@MU70F98RF^7F%QUGE0+'N( MBN)\JYV+FHM8_,'M/78A8#=\O=!#C2&5T0QP_]]_W1,]B>!?JX]6G]1_]0G+ M_ZI__^W3NUO//[^\( ;G2TQ?_T^:75R]X0'V%YO65+-RWYT@]V'E3(1;3L0O MN R3\\5M?A>3BV_G^!P@VQ+P7S>BN"ND-1WW('EJL>!?2YQFS/^[?7.6Z145 M6POD55PLYR$MSR(W1BG'($5#X8G/$H*A/X2+4FG+A?)#'=WO1N'1;N#>_=2\ ML$X4"SG[FM2W%AQ:!RBX1:^SLJSU!9)]:>RCP=< "+OG)0ZIO#[K;U9M1=&0 M<+C60#0[4+)P"-$G*)@P,HM*J=:W31XA9>3FJX/J__FBF;V5T2FFUAFIF][: M3"H7@9R?E4],WK&HWE%VP7%7I+][\W<0=-TBJ@^3=I3J=X#3X7H8.S;YE3=.: 2^DB1DU"434,S\5:W%U!&N*$)YIC'=;^3Z" MAX>>WEWSR%9H.%J4?6X[-U%X("1'7^/ANCW4'*:6CB#6XESC35A\I0_J"?'W<+XJ)70VHXP\T0K3F98OU^!,R6!= M3-QE*5UN/6YL6(ZZVST/1-[S_='&@L'/MBAJ![GI\NHWZ2E(0J%_66]*<6^D M3:!X(IT%^B,([T&8R+-+7@@Y5 /5(?GJSJ'H<(&T@,38KFI3@R=AMI:9L4( 4574K1JWB"INW',])Q,^U>S/MA2O_)D']K MC_NP_%J'*3NC==8*3*HC*G6DD$NS#$E8QH1T.J?6'6:'Y:CC=MZ]K(4C8?"3 M+8J/\]DWG"]_?#P/)).K$.E;+9D^TRX%EIB#@*6.+ GU5G"F "FJJ(W1UK 3 M-*YOSUC'[<1[62)M0/$SA0,?OJUN!TZ_O,>PP%6SHP_E;XOU/STKV5C))01 M*14H;*J7OTI1]7*-H3W4%F#<.INMX6A:#RD>G*F.&ZGWLE4<#X:?;'6\(X1, MOTRN?WDEH#^_ANEOLUG^]^3\_$P*BK%T1N Y<%"LR%HZRB!I;T3B'!WO.^Y^ MAL&.6[KWLFK:@J2#%71-MW726R$5N, U*!]$;=>+8*+C4BD5X]T9E$>#>R_< MC=3._1C@'23;#C#18"^#T?\;!G.^PHW-SFJ:;YQK;9^ZPSK71<=.812>RXPAZ0F+X Y M&[%XB0[+Z<^CGB:ZYR;V742<+96^_V+P5XMABE]J#_X_N]P%WMP72BCHA:^- MP336:Z.%02WE!28,T\H;97GI>$>XSU'/;?)[V1V.Q,'/N3@>-AJ"Y\)M3B"+ MJW*Q%$>$)$$BXU(J5W37:9DC=I+_[!/?X]'PXDUFL?/B:( M/B5@T9682E*V#%6NW)B5GL<%]+(B#M7\T>O@Z/!B$/N R[/"-4_!1?"Q1E=% M9 C6DZ*0.8?)QL)[+O?\8]<^R__9A[G[:KI9''V:;@5UZ-)L6DNZ9^5N6C5, M\]O%@K*9Y,.C ZE3T38P7N[>*OY/;5BPE^KW;EBP MCQ[&+O)[Y(:]URD))CVD6$?:2.,AHDJ066)1$(,A['9AYV4V+-A+@SLT+-A' MG&,CXL%;]A1S289(T9<+"$H)8B"Z.I9&BF"""*J$G?#P$AL6'(R&HT79P;;S MZV0Z66(-;^Y5W;S^\7OXYVR^FGFZ,JO*6Y9H+X8B0Z[IT0!!9!*409-RSL:E MUAUB]R#OA;4S.,;E&4II?>/QAK$_PL5F\5JG98Y&@)2Q]B:R#)P)!G@L 1U9 M8G2MKRCM2>*XF^%@4-D=DD?K;>PM\\WE8CF[P/GKD/YU/ONR-O126R&C4" Y M)N) 4FQ,*QJBC\H9D9R7<:<]\\''=XN:X[4Y:RK:#FS6AHE/>'Z56_PZ^;9Q M#9U"XV1PP"@H <6B@BBU Z]0Z>"R,\4UMD]/D#/N'GD*5+7620?P^@6_X_GL M6STR3E^G,UHF/Z[&R:_9X5ZYJ%)M.E'/+"R/$!/SX#VQR7G*%)0TAM@S)(W; M;>&4,&NIFPZ@]F[Z<3Y+Y+Q^(I41);4KT)K%>K]QTY^/"6DIX@7I:GK%V 0^ M(X>4=#",:\.Q=6' 3H2-V^G@E+!KKZ<.P/?G/&2L MHL'L&S<(CU_F#ML&-Y MAJ@SN0'&1Z,Q*]>\!_5=&L9M&'!*2!TE_1'1LY@OSS[5P5.K$"998C_+ "R: M2GD,X)@SD!4Q($QARNS4R)V>N@47^NX&*K=>..Y.=Y*DP^$"[@$5:S"G(@6A MEABWH0 %$1Q\2A&$E;0[6U%RB*UP,68 =X2R[JK[ ,F-K/#?PU^3B\N+->%6 MN%":[T^[QC,IOO71DI1^BLED+^77@/3Q9;)80 MT1JA 6,4H%3)Y EE$DO].:"G;=.0 M@N7%)HI%4YT[R)V$8*V&*)E4-LB@9,]-TMKT\ACG,N(QL.\7)"]L5N"[BV\A M+6?E5?[GY6)94W.+Y8P$\+=IN,QD66HKN5]G\XO0N.9^[_<.66E_G!!&JJ\7 M03#R&H!I5L>U$1Q=3@FT3P6#P.+\"9H0#5A?_X#MV*CAW;34O^J/_IA-YU@O M2DZF7[;4MPX+@O):.0<44-8 412(65I8I1:$$M:YH8S[X53WX0B4#L"54'74B -RZ@N@M9'SD$/[+BY/$M0CG [1 M^VPH)8Q=L;B:T?XZ+"H'%]]PNE@I9YN;DITM+ D0L3"2DQ<0/$;Z-GLR[UX5 ME9^+/'9[U;BIH>9@&4"^'=B?8[R"FYP#X\Y(U G0:6):^ +.180B@DL4RBLA MAYH==Q3AW64O3^F1G5[U'>"=."R3Y?N:PM6%.XNL@)$Y5=DAT/>T7'GAC).U M$[YU&'OS]I<;"QRH^ED3/72 H =D5^W_A[+)AKZ=+B?+'W_. ^T.Z7I[. LH M;:B3%%5D$90)##S7!J+T.CFF&.8I-/S"\ME#YZU'R4_W MG(=6P2C&HJZMMSBYD=F3490(6>ELE$].J1/TH#IM'GJQT<,G_([32SPSR+W- M*H%VMEZD#1H"[0A@K&8^)8[1G:"MQEVR^MBZ!\#1#G;P*!7UN7E?L_0'+M]- MR6#@RBLQA067N8*BZOQY[RUYUB6"4?0_'IEQS>^7[DQ<'QOTR @\7%T=[[WK M9;6IU)N57R:+\.7+O+9,I*?/ROH7CMA^]WU%JQWX*-8:;<+K5_Q*F-X,OOW' M9/EUA9L%I Q!5!91P@N&) !,X4F+@EL?0J\(VE'WRF\)?0/&Z%? M91.293HR\EB-D9(6$6KP3@OZ(^80G-+*M'8ZGJ)GW(UV"*S(XM.: Q0T(6@4 B(Z!!TIB#)&(S)M2C&?Y2 M<3'43K^SUL(>&S'XY2X+Z]R\2%8*:W0=BD;K*7@/DZU?P< M8AXC8+RK'(T4.VLMY9&A\L=LOOSZBDPND;^Y76TS:ATC%$:K1E&, 2ZAJV/K M=70L*>5W.A=]!B/WWSPB.-JH&=F1GN-DIG_\,*.Z]>)QH;!A,'"?5L4^_WU[6 -4A+='04-! M=I#O^7-"D>B7#V65JR<*/I1:??YA_AGGWR?IZK(L5\98K1E@[7FEDG?@C)80 M-9(I#%)KT;I3SPYDC9OC:>ZX#J60_C&V7HM9>FZ4"/5";;TP) H$VF#!!$4[ M+&,YXDX-"MJAK(<*P>9PV ]N!^BF!\"MF:DW;Y8?9Y/I\MV4&-W< L\V!ZU5 MKB::$S>%T\KT!K XRYR6%DOK+,[3%'4-L4,@<+^#2BM]](6N#]]QOL6(<4QK MQ^K446= B6AJ.ZL$R'T0Y HF<7>Z9DM@W29FW.WQI)@Z0@L=P.DZJ;$YRUF[ MJ^O.HQB3M"R -Z4>'S)>F?&U3"-I5)*SYO=$GR1HW'N=@WE=[930 Z*N:-\T M\?:>*55J 6\-2&@]0!1*TG+ PE1F4IC6O:EO$3#RP(UVBKT+F8.E/'86X-7E MK.[3Q$RVHY M0W E[#8689^WCMS'OA%BAA)S!QO/FQEQ5D^"5Q>%)HM_O?[Q&J?IZT68_VME M;S43$3778!A#VJ)# <^8H!T[9I9"1BU;#Q5^CJ9Q.TX-YM T5467T-IPLUF0 M-DL=K 2A:L,,I4A8@3%(CE90B4ZZYHW,GJ-IW!VN+0*>A=<1ZN@ 7L_4LFR. M>IBQ$2FH=+'4KI%%@DBU"$LZW3X$^0,VZ7YU/NC@T"TY&E+KUK=,GR.G-2AVH\N>@=*#\.X#2S0'Y M/:8VF7J'!JU*0 *+M.8*HWBV>)(63R8%D31O?=_D6:(Z@]6AZI\-J8NQ(PWDXV0DG$@_[34DF%%O"4)LM2_O TZW,E9/I)>V//%XV88 M6F-I<-&/#:MULN0Q5IP7*19:$MR*#(H%#UZ* AJ]=UR+3('.3BAZ^CWC'HD, M IJ&@NU@7WO$C7Q_?1=:8(G)^ )V-16Y" [.1K*L.A?BRV5TK=-2S]&T$ZC, MBW.\FZJB V@]$YZ^_2N=7^9Z W^Q0/HO_QG^.HNI1&YY31VS&JS2%AZ\UY"D M4M$4*YQI/97L #*[O!=R($[VRRD*#M E/6]7!A\"3#%CU=EG*VP5HS-?1_)_>/,*]L?F]P]_;>HQK? ML7V:U!/?I:5(+5A+6VE4OJ* \SJ$P0'+M+IB0G;@.*\] X4 9VA-:0SHO/=*\M95*8]3\S+NT>Z#DWMF MJ(TF.O"XK@MZUBRM&@Y>W0'TQ9%=KG.8*'Q5S <(]8_L//U$.65]ZQ/ 1XD9 M.2G52-N/%6N>$01+"@4*XFT2J(SAM7LE;)-_>([E'1 M2:G<<>I]V/(<*NL>T#*[N)A-5WR\VDP ]8XEFQ483]Z;,ME##,00)LPR,N%8 M\Z[I]ZGHPL85]="0-54P!E5""RY%#"3H9)GG0 ML7EIRF/$C)SA'F9C:B/Z7C&T7EU%N.AKK\;B.46AFNQOC,F#K#,O+(6AAK4. M$YX@IPOC*.CV9%Q# M;<6M$HG(U[(9KEWP)3L9[][I?>1L9(>7=8B50[0Z&U#$O=J>FR18('GD4G?S M6.K4-))2K)7M+$>70S9.M7=YGJ1HY&.W$^YDARFA5TC]<5E7!WF.M3OQ:A[> MFW!^COGUC_7O+=:_N#A3QC%FB@,4!D$)23)UDM:H)M=0^5B,;%UO>23)'9JZ M ]&S"S '4F6OR'W[%\[39($?YY.$UQ]>\\C/)$NT>]3[(%+6BFJ3P6%B(#AS M6@<949_$1CY':(=!P( H;:JVL7V[)]=AO1.=ON+B+"7/N;&TVGB5H4\<2(0> MC!'%: K&I=[M>M9.K^MP)SX.3@-)N@.[M@'_JVF^0O^'R^5B&:;UN/N,2V^% M<@6DC]5QJ>5"VFG05O-L;2@DQ\;FZREZQKV9-:"5:J:$#@#U:YC,_Q[.+_%F MQL2-B3UC6G);@H7,>2VLKO._N180@N,HD"/SK4=Z/$G0N-<9!H14.S5T@*D' M3T%K]_0_<'FFD$6A(@,6:6FH%!@X;3@8X75T3I$0![A"^B@]X];I#>E*M5)" MIX#:S&/_<282]X5E4=LVUO(>U! TQ>LFQTBK1O@4VA_F/$'03I"R/PFD#E-# MPPJ[$XPH^/ -I[2UTP;_YGRVH*]>A_/: V Q*QN1K%;6HO[&^@<;N5!,W7*4 M02-2!AMY,(2H3ES.%51PVGJ$@AAJVC=!-*GVO+=:H9!>VM8#C@;YK"Y@)A("!SN[O.UE5&WM M X?;\6=K@7>Z$6^7\RKWLX(.M0T9@F#DK,J4P1G+(:FDB:DZ*N>4#MZ: MK'' -A 0]G#U#M%*YT#[8S9-:ZZ$I]#(QP!"UZ,:DP0X&Q(4;@37!84QK>/3 MW2@;)T,[/MP.U$WGB#O+RJO@70$K(ZT>0SM!3(%#R$E)Q4+RKO6XI*.#UN8) MV_'1M9<>#L?4;!G.&V3ZGXJ6MJ5EI&%!. >2F7HU27IPCKXR7L80G(ON[E"J M/9RNA]XX[O'1*([7T8+OU$)=\[79YW7)2J>0N"B:/0Q\>97 M87>AJS/WZW@X[),:.40WO>-M:Z/WS$272&ZQIJB5H"7K-/.0/=;;=5'Y]J7W MNY'6F1=V6M0=J*'>@7?&O2\\E03&1EN;(C#PM3MKB,%S5(7X:=VD_?AT[^F< ML=.";"]M-//(3I#S_3SY,JU#HL)T^>9KF'[!Q61ZZF3OL30,EN5M*IP3IW<] M5SEI&0"5Y: *EQ26>@)L"DH["E@X_VG3N](F'042V][50BG+P*&F0*IH$V-! MEG4Y.-)XF>G=?>"P?WIW'X%WNO%>Q]YH@PQ2DY'/M=<^RCQX.QM0WG$]F^?.2MH)AD?4)4SVPIMT$\Y\S^@XG MW]==BB3J0$&_#)Z!L;3A=X)HN4@I8?(:?63FA'VT2HRX^^CAR!WW[32?\.2!">ZS)8F).C> @O4(0=<*>"$LUUHYI=C!\<#+ M/7EH&A,<+?A.K=16"JADFSRYH4P8$E?F&KR7%DP6B%'J'-4I H/]$G(CGS7L M!8#]$G)[:*/K\.!&;K'78^ M+.+N4=A98'!:"!ZGK_$C@^?%^&Z:YA@6^,LE_CE[$Q9?KZ(@S*\GY_2T+XMW MT[=_):QUV&MAG$7$;%4RP"@)M>Q]M-(TQ!CM+ M^X2U10LMI(\X+[/Y1;T&\"&>3Z[:]#8X*-OQ!8U/P0YAZ\1'7#:()&*.4- 5 M4/4Z]6Z7]F)&M+NI(.:"DK5$UC/,/],/UT4>GN=G7'5X456 MESA$"NA3!,5I+4?DG%QFCBA,YH6UOBC=AO*7<::V#_X>Z>U^2@UWL%,?S?4J M%/N%_-]5$S7RJZ-AJG8QL/&JW"/J@%"XI0#01BZ:5V2UY: +G)\4@ZV7P>& M^!F6P_OK^ZY6!D >O;;8%2W9VH)&?#:CO(EWZHI?!84!X M*4O@#)6C_TSM38<,E$X,8JY_H$BR6.5=:=V%?R?"7KC]/A UAX!W+Q6^%%S> MS$@Y*\&3#"TY?[+>._3*@I.VU-6O6J]:6@]BDI M?UQE3OB9RM&Y* 3(D#0HQ8AO+ R<%4B+.+K 36_NQ)KV<;N\O22]O!:O+F;S93T+>S-;+(]( M?3[WR%;"VXOT1NG-K7?^@G'Y:IK?_M_+R?+'37?:FU%*+L2@0P(GC 256*1X MEB7@(OD4>,B,MQZ,OCMU1X\[I<=O/?4[";P&4K_.YI_#^7J&9Q%""5V/'R(G M\R,5!]J#!:00LA3"AG3WSO#1 MB!K''=_H'P_4H&8)HFX?S= ME 1T646X2ANQ.@XV8(&2DP<5G8107;W(N:&P7=@BFK=_?)B4D:>9ME;YW>Z/ M#>3? 8QJ4]T%O;DV1OV,\^^3M'*?'N!N48=<+Q[^:#W:(?+ A5?D486 H)B* MX#BY6II"CYR*U\6T3FVTI']XB0<1-CW2#Q>"5U8"\W2PA?SZHX[RP9#JY\B:-P)"1TAKY72.D#@ZM;8ZY#^A?=9"80C?H:Z6P#K"W;K;]^2OB\GW][:K+5?U/K//EHP4O M/%GQK +)IT001F7OHQ%*M4X7/D;+N'[?T)F<)AKH%$GKM<8_H!TB,[O.E:M%##VU+S? MP_Q?N*S6^=X6S4D &.LICF4U&$8+SF8$ADGZXETT?+=!R(^_8]PMJS$V6LJS M QNS:4KWH=S=S&\X>W]=.J)I"Q=1*V Q)%#U7K1SWD'*9*,U+]*[UC=C]B)P MW%3$T,[1<+KJ (AW6;HCS.TBBM=A03Y";044$5L5,"Q Y MO:-U,+@GC>-NB@/"Y6X(.*3N1NQ#OR-_*5U>7)[7R_._S6>+Q=^F'? M:)-YC64VI\7_UUD,Q117Y1#:0N9962ZV")":[^@">'C^@O]0_MP M+8_?AN0QWF_XOBV%,V>M23ZM6G$[4!P3A#KBR5EGDV4R<-7Z/&U7VL8]Z!@/ MITUTU7'Y^%;)9;T1/IE>SBX7==%]G"TFJT"U2:GST\\>H.9Y#V9.7_SL47#- M'=9I#H9"L.#IJQB "=1266U"\V%4?14_I^AS"3H"C]S6H5(<(KHZPEAQ'IUV M(?[_Q<]M\'-(\?,^ZNG @WRL5M*Q7$Q.&6R*#%2B?2#X',$6E:QP(1G?&F4O MMOAY+Y7O6/R\C_P[@%';\VR3"H^9@0VE]FL0!GPD*6"61DP%JT.+G/;3; ;*?J*:57C&-7$$Q=2M),4*4Y#J3PQRX5\2.;7T=]C^C^'D? MA.Q>_+R/NKH WOZUL3+D&$T6X$KMHU>BO.K5+9B1/M'.Y)M7)_R'%S\?!=5A M%=P!AA^NJF5,.\FU!,\4,>%T 5\$0M"LY&RX9+[]#+N?O/3Y"!P>KZ0ND/94 M%6U*J5[P2L!93&3Z58*HE *K>1 <25RB?;']?TCI\U'(:Z6T#A#X5"5M5%[I M&A*RQ,CYCCR#,Z(6'T4TO%[*LLU/N_\S2I^/0%\KA76 O?UR_$D9+[@0P$(- M!6O1>&2IT+=.*R&UP^870=K7 8U:)'U,QF%=W.P0(C656'0@HQ9D!9J_95AL7C5NIWEH R] MI JCO8"X5][\E*CHYV"[K4S.BG>>6S)&L0@%2O,(09H,W*7Z$Z8";QWYM^7@ M)=4I];,6]M+[RSA*_R/,:R+D.[8Y/;_WN $.S)\F>80&809M#MD",C*&*M;I M;461]^J,SLQ00-_\PEM?9^2F&)>M5E#O+X)")/==UK,/%/0U:F%LZPS3SW1& MO@]^#CDCWT<]'3BUGTE)N,K2UM&_'\KGY2S]:W6HIKS)D2L&AG,#BOL(3N0" M,3F5--/T5VN']%%B^C\GWTOM=Z.F)CKH $S;]*^3&#(:2PZ%!69SHCU<"?!! M(FB=@M7!,!F:SZ*Z1\7(L4@;]=[-+QXGZ['O_:W(?_5Q\^J_32?7UQ=+HH ' M@P#CO:UL<" O-!$;H;C:R8SS\)R3],P[Q@7$L:J;M9=C#\9C=G$QFU[QL^; MR$CK(TDPI3:U$ZK07ITCL,2=2)Y'C*T#O_M4C!N\-<)*(R%W )-/N,J.?*20 MY<8HX4NN>U?>I&'LPRS#Z M?@)6!PA_;*?GTRS.EI/TB71#1'S]\.W-[/W[-YO>?U[6,FT&NC9O5085^)0Y M...L_G_LO5ES6TF2+OA7QN;=Y\:^F,V+<)%HN'A"X*4 .@ M,M6_?CRP4!1)D%CB\ 347=:=J4PI>7SYPL/=PQA *A= )8O@HK3 \-D2[#R[A25 M/7!X^.>/O1NG'1 :R*^#:^6X)+UD23J6#4B7%2AK(L6,7I%)U5%HU-FRUC?. M3S;MXJQ\S6"ZZ@"(P[YG*A6D M?.\\MG4K+0/H<$*-+%'5T_91WP:_< M1P'Q65^YCT'%V-?U]Z>&5[.[CPPO__GZU?M/I+J:VA/(BL^0(^,D["(@>*?K M+K6@A15)XF'#JP[[WB6],)^"PZ%$WX'!)9>E=G7@;[CY^P.\?7T]G3!K2Z3; M"6J9/%U8T8&7,H/1&'32B:?F,P .H^R2)E6<8P('T%,'Z%LG%E\ME]>8?R,V MULO4IO.\.4IOKRFR(E9)N+6>=#D)W#FMHP9RE6KA?+ 0BLW *-SBI8CH;.O1 MCD<1>$G3*,[!XG!:Z^=Z??/GC'[DI^F76\M)/>?64VN^. MR6FB@Y[ M(D[_KZ>58'YS>Q=E5X-4]8S=O\QF\T6_/9VEZ M-5VK]+84MF]#7GF4)44(:#DH)2RX8 ($B3:E))FY^S3:#HN->1EY@$X;J.T# M\)AZ[P#_?Y_/\-MF /_+ZUG>U>'EK(-+I4Z3UAY4< &\CPB:,Q8%)R\[M!ZE M\S EG6!O5)3,FZNL ^!MO)V_X^K3/-_RA7:KKCAGHLY5";9RI-5Z K0#EX.0 MC#D1FK^Y/4K0N&\57<*PG0+'SM^]GL^^KR"Y&T3N*DZYQ^ 4 ^ME;3'D$D+0 M"K2.W@HF@U&'%7@?\+%Q7R>Z ML@^NG ^NW?U6583,%FX)B)#ZR9+$="RH(% M[UV0J?EDG,O=C7=.!--$ YTB:7O@$D>G'"_ )2I0O$CB1"DZ=8QLDLV2Y>?8 ML]A#$-%&VX?OQCM&]!V Z-'5;.A82DA7N:5@JS9;9""1)8B!)T1>8@FMFRHO M43H_9C?>,0H8=Y9H9" @(S^6U)A C*"0_1R@3! M(P6VG)N@6K^2/$+.N#[X0%:FE?@[N+&.W*)B-9/)(6CI'$4'=-5'69!N>K/3_'U1Y.5QT \<&".I$L2BTB,,XIU$UHMS=VB0J=-EB:O_B> M7.;82:7W46I_,!5UA@YZQ-$_7[_Z;JHGUD>6R R#5%+4?%J$X P';13WQ@09 MFL^D>)RB2ZK>;HJMT_72(\KHI/RZ]09F^19?W"8=DR=W0/%0>XT4A,@4V"(< MDDN@/&_=K74H;9=4O-W:JIVMJV;[7]N7JMV,%?X^?&;^^_'Q M&65KIW^L50E;(W8;E;.]67P,L^E_K5GY=3Y;SJ^F>7.F9OGM+39O37^^H?M[ MI5(J#+V,$J0DS"MC&03E+6B5F4JL**%;6XTFA+?(GTU<(;=8R0PI!6)>T8&, MR21PRHH<2I!SC^N5M M4N=)).\=9.8T*%&#_&@Y1?I9U74C4H360X2>(&E<=V]\E+746 < O+-CY"XW M1F0;'9TD0>P0-X:!#R0IDS)C2@2N6>M"RL?.VX=Z1D MTE900"6*JI,&A8&H?21Y>1>R*2BP==+N(,+&;=CK (O-M7>A04DM0ID1TK\- M%(?<^_G/$7H\SE17T4:4SK+" B1+UZW"$L#+',#8LI[,DW-L[7!W$6W:<:"*^0 ISI'LY G0O\,0;A42&P*;6O1 M/$W5SQ"I'(.Y^]WX3?76P45^P]&_YHM_OYJ]70]3/$,TVPV$AS/8&19#9=?L+\M_D\WV&)*2\-LP:L MKOO)N">_)V<%)@1EBR6!-2\R.("LGR&Z:0+&1IKK"8S$Q22E'%(2'K)7 915 M=2L>)I HBC'>YZS;S\'Y_OV?(6!I J]C==$L+FEQPRZF*_QM_N=LPJ3&%*.% M8JW<[.'TH@[DEY9+%XF#TOHI^#X5X\X;Z0A3I^FE837>\\:\)-TO89I__^L+ MSI:X#+.\+BK[]79%V4#A\#&??HY(^611=!5$$^H%]UY#'5D(RD0)7ANZ8;,3 MQ=7%F;EUIUT70?1:5S^J<*NY2< B5"09,/3D]]:-L\ZH.@Z- C!OT>38>F+8 M?FI^AJ#Y&(P]6+-ZOIXZ< GKQ-$JCG]-5Y]^O5ZNYI]QL;82Y);L6))<%.5" M!IZ1@_)>@5^/%M7&"!Y5D:)UW_4!9/T,P?(Y&&RMN0[ ^/[ZRY>K:0WR!0L2 M&=:2;Z);6P].V "EQ(A"^F!*\['+>LZ_.\_74 >)^O/]? M;#WMC8N]8RFZ0G*RF6(X02RQI.L2X #($DKR#8H3K;VV \CZ&>+DWEZ%V6X;7[Y]H!^Q64=K!/&2!>@2 MZQME;?!"QL!&$4TRW+OFXY(/(*N7QKN6>+AWL;=53L]XJPQMVZ^94YE+H0!5 M=9RE]N!Y;<1F,7#%*=AO?D\<0-:X>&L.A4.A=J)>.H#:WP/)=(:+;[?9V7;B MQRAR=)P!9W4+'+G7X(D)8"'+F#UG/+1^+7Z$G$ZA=:KJ[Y;U-]+#V"/LJOM] M33_K?X=%_I,D2^R\GY=5_>5N/*2RC",%6:5632A3/$2-&HP-TF3I!?'S5-AQ MV*?&S18/A9@!Q-R!'?J#HK0=W M&IHJ#7.K^41D5>"-J.[,/6CIR0GWK1/#W MKX^;"A[:RIPHY1[P4;=&?9I?Y5>?ORSF7_'VB$^G&('<&D ;ZUAZ92!&"EZL M(#:L34;&TAHP^\D9-]D[.((:Z:$#2/T3/TW3U:GULMKE/5S+KH M_2.QLN-%%52,?Y8K5][-K+_"2A(A:#AN1\KLM;70URZ6+0 MK&AE*%9AK5O^6M'>:?*J#5Q'4?#QP/8;8,_P8Z7TP_"FL_8%B2*3TX*!1583 M,\P02^NGV(PIFU+0M9YR_A@]G2;$!C:;QRJB@P:MVP=I4G*EMTY-9I%<%3+_ MX*)WX%QV(5B6B('&(+K]_4YS8&U <[*@.][.^U@=U?>]MJ_H8[./4_*%!^VO M>OJ#SU$^=B3;7161:8S9%AZ!,QG)=#D#D1$J==0R< J5G6SM]W161%8;N%?X MQ_0KYKOJVP1SB-H95Q#$>JVV$QE\4!:8,;PDH[B,K:_9PZG[&0K)CL'@_D*R MIGKL(+3YY7I)E]!R^2+1I;2+8S2*G"T MS5U82HE^!*DE!2PB)< ME!0E/0.N?B!JY,5)+51_ )Q.U\/8-3QOOJSF'Q=ADQ%/NQ4_2BFF> $IBZCF M',$G+L$JXW-D5I6[DSCWE.T\]-/[0\09VINW%&4'1N810_S+M[^'_Y@OOF_" M#D(;8Z0"S)Z!TEQ "(+X4\8ZQZU(+C0U\L[PZ!7VU#JZAN)WQE['3[O MCBWRZ%/V'EBPDJ+\.E>%^ *3) _H/ ;=NA/O2!)'WBH^%%0.A^39>NL EKM. M_'=XM5;=\M/TR\TR=!4E%SP!G5A.)YD,?O3D7Q3/@@R,I)=;UU _0DZW<#L? M!G>?]1OI9&Q?;,?'+R']^VK^<>=!2!V+U42W4K&F+VM%.!U+C.AX+HY+'WX*N1] M&@V!&2N]1%5D./LWF9"N_O9M^ M_'13]QUXX494US 65VLO/41&<;*1PAF9E(^RM8_S!$GCEE(_IP5JJ9L.H'8S M +J.VR5*ZGZ'+8NW&N)*LJ6D**&&':"L"1!LCJ!ECE$KPUCSI.9!A(U;??V< ML&NOIP[ ]_T1N$KJ37F_FJ=_KX-?'1/Y?08!BUV_\CMR#XDO%JWAB-+:V'H- MT5YB>MDZ.6@2JXTJ.L#4;?JWY\XI:5BI^1.L*^)J'MEEI-N?.\.#-@I]ZZS4 M?2I&?N5KH]Z[,?]YLNX!+?//G^>S-1^_[)(5EEDOZRHW%K<-B>.M$P"%TC1O[C?\&?I[&-=D/'G].KJW?SJ MZN5\\6=8Y$DJ&;UC'BCV<%5R!KS6 :+PV:/R&?.=TJH]^8-COMIM:OM$A<^? M0_H=V+*[O+W&U3WV)BY'RY$YX#J05Z"=K*&*@!R,Q20SQ]"ZP_\0NL;!W,"0 MN!?I-=;/R9C[@HOI/)/KN%@UO$6O'CJSV_*/S">!X<]XK8'.06?9RN<9YHGA=YS?73@;6[W=7TYEYA^21)DA!C'&*0 532Y.#* M6$!$9-KZ8#AK'1H^3M$XR8;GQ5E#G9S;8O9\-RJ:*&3=T2Q+I,-C4-"YT1Z< M,CH9K8QA[??/-;I1FT<''=ZHQ^CGS!OU]UD;W#WB V^ZD+-1*3!E(&&PY/^6 M E'*#)D9)ZWCQ3?O;'R*IFY+'MUTH=3V6W%1.#P["%VOII['Z$T=I1S$U"J4T&K@PQ M%;,CI\*3#)443$N3B+7GP^+H"SG'Q-VQZNB@P7L_-_]88KF^^F-:<%+[[ 1# M$A*F.O:3'!.G?0:=)%.*92,DI<%.M1T\=1MFXD_2> 7[-U=/!M?N YW"? M)^F\PE(T6,T"*,8*!%$[_)1.O""W0K=NWSZ$KH, YWX:P)VMF@M=ZO7R>CT4 M]5;\M%US-M" EB>_]QSS68YCNJOQ+"H%F] QNFSK/"E=LRY%L1I]"*T1HS&M MDZ^7-I[%^Z!5R0:D4W1JO:+[09'$5.(YUT4&7@RWY>N_PWB68S!XQGB68_38 M@8>Y;SB$X2J@40($YDH\%XZ>-9CM+\@>-9CE%#IVCZ M<; $ZA1T4AP*J\/O/2-?V&D+7I?('7H;;.MY"1W(\RS&B[,#('!1E M:8JIC @&BLX9%'<%/+,R B>TW1 MUX<_\>HK_GT^6WU:3F3U/(/R8+@A;G/T$*VR@,(E%"&9@JT;^,ZC^ *JBX]" MT!$/M(W5>7'@_?\P+#[\.9_HZ(KPMK;VUX5Z=6%:O70@2%FR6:0 M'JN^BP/IBT)?OF'59.MBH5O")%>=&V;!"7)SLI$L9QF"U\\X=/4I>@ M*NL DD]4_,9@DW6<0]:NIO$2!Q^C!1VLS"(+)_@S.IZ'%F"/6Z SD#$\5AT7 M6IJS.T@#5>+<_?'/47CS*$M=U=F@8+8HS\&%6ENFBH! (/L V-.B^A#:Q>^ MLSJ;G:ZV"VQ-)'^" C=F61T&6,];(LE$93,=165":MT4GZ&"YAAT[:^@ M.5U#'5RW-U+9O=&^QX\;(6TVJEA>$ZP0F&1U:X8@\RX-U&T:$EFN>_9:P^TQ M@GHIG3E#Y?O&Y)TM_Q[ M*%]^Z9?K)4";=TW4#0H0\0[$35$;I3D&)#)Y@6 MMPGH9$#>^8J]"YF3I3QVWF44 M/"O%(11R*P5Z)G22(B)_RM4ZX#LCX^)T[7HJ,A?Z8:^-?]XBDNZQM_C MXNLTX1W&DJ=;F2OB1-2#XW*!:'VD>]LSXY021AXVF>R8KXY/% 'AA8"IN!XR#Q)W?@2.J?L]QDJI=KY+BUD MWH'7\G1UHK92<>XM,*5)2"8H"%P7D-G%4C(S2K3N]KC0&M^C5']TC>\Q>AC[ M5GM)9.?YY[>?YG113]-NFG_2QH>422*J-FW4IMV8Z6(NJ%&SQ(Q!=M#]]?#/ M[P\59VAPWE:<'9B:G>V]E9L-@?S^& !=94 (NLF=*!0(6"PJ<.F:O_S=(Z*7 M>?3M;J;SY-P14'Z86*:TQV("N%BS59G5B=D)0=;*S>(E.?6MD]4[%[ M8'*JE#L"RH0,J T^!S#*6:*;+*O/2=)?3&1:2I-SZU3=N$-TFREQ#RB.DF@W M(W%WU._FJ_YVO9C./KY=?V42ZX1\FRAL9%&"J@/C'(L&$O>A)&DMRM:O*8_1 M,VY$-!1NSI9\1U;E[?4B?0I+?)'2_'JV(GY>Y/^X7J[6B7@$G)I'&/.MGZ+/XBPYEQRC M)!ZY2S+FV#JT'G=2[>#7UC$2;3IW]GG+,MZL/N'B]7R6KA=5W)N2E(%J-![] MUG,4;!S.;%?5&YP@F(LB &/D]17"$12U :Z-*74&:&J^.KN+ZHW?\,M\.:6? MMZF3NM';1'*AI4(/) 5!O@ B66F'9*]U$DIKF6UH+)!]M/P,]1O'X.O^VLT& M.NK@)OV=O,W5M_=(Y$]74US^:[KZ-+]>O<.0IU??R$;@HAJ;>(4OPW3QSW!U M72:G4SLN*'"^&A]'BV/G3/? M/E$NWX9O573D%OT:ODQ7X>KM8OX?F,C-55'JF)F 8.NRD'7^..0"4JL:0X54 MC'SJIC_L4^,&$>,A;@!%=& E289KD=1S\RL%3?//N%A;_M?T?]]M/\7H(KN( M@%R3[^Q= )\#15$Q6ZM89XP<)&;?EL"N\G:B="^V^ M>9'2XAISF.6U"'[=%]5%*FBKNM\)C_-OB+_@#,MTM=RJ<*)9-"$G#>@+ MDEAL B]-A&"T-;X$,@FMW_0?I^AG2 L=@[5[JP3;Z:N;2WW#TBUSL>,F<%1* MBP#.U\'JEJZ.X(D;'BU/&85-MG4&Z'&*?H8TSSGH:ZBO#M#W=C'/UQ2SA<4B MS%;?UGR%JU^OPG(Y+5/,.[9\\9'.4RUIKP,98\D0=;)@#6:.-FL6L#$,#R3M M9T@"G8/'(338 3 ?RB;LCMNWF\.FDF4Y(KCUC"14 KQ5#'R0GGS(3#YVZ]#G M$+I^ADS0.9!LKKLN\D"O9H1N7*[>AF\UB;_CPP2;ZB8[T*G4&ECGP5EK@)P/ MDZ*.,N .WX?H.1GR/><@[H&^NG4[JV3"K=W>%Y=S?^LR?^:]"<2IZL_YLL; M#R2BC;;D L3=>I2(A.!001+1F^)%5*QUO'(VT3]#[JBUQ1Q.ZV._(>YQH7_( MTMX<7X_!ULVA NOZ4.U3K;=2(*1S+NDDO;Y3CK%OY/[A'QUW/-5X:!Q4.1W8 MUOU1&T\A"(.I-L]RBMHXG9YL)5@KG;1HD6'KS7+G!=B#3:L:WQ:VT5('.PU/ M-^J38%2.-G#(Q=5'4D;RR[;4Z5W9"F^MCZTW29Q.[4& ]3\O8)])S\T,:/O7 MH=\PKE[DO.XF#5>O9F6^^+S^N6>\_#SY,UN]ZAQ'?*,7F_K1W^A*O9HOZW[% M'0R#+PIY5("L7JC&<(AD\X#E.E."14$VKWGQZ4.4G%]>&U>O9O2SKNLYVW2+ M(GD*FF4"NTH$<2,E^$1@+ZY$\EV+8\W7NSU QKBO)PWT?K]*]CQ1=^"8_DJ!-H4)"EL 7::P/2!)Q&L'V2L98EU\TCRU=Y^*\;%REF(?!-U_"AD3A3XV.D& M\L^^XF)5I^*^Q]ETOG@]7^'RMVLDG9KMD H5;##.9=!UUJ0JQI+_)RUDM#8H MR1F[^\B_)\UPP,=Z0LBI*IT/*-\.#,T?\]G'6J]?A?6!_IOU04J)&R5RJF7Z MQ(-F#&*I(4-RAGN=#6]N9!ZB8]P'^-:7TMF2[A MVP/%//,6LX7$'1VH1,%= M"%F#<$;H$%.(NO6;^<.4C&MPSM?P$Y Y0=P=@.:6U:R,W*Q%5,MJ[= M90@A)PNURT#V6'WJ>AD5OAYZKU[*YTGZQ[0,O_\>3Y; M\_%B:RQMW=*@':- ,M(ILHF30"B0E!&Y0OI?P?8=FG>I&!IJJ M<4LYA\T GZV%[G&U.WH8;5*>CIX@QI37)#)F&%A=L,3"*?Q\7F3U<*&UQL)1 M4#M!,=V#[^L-9+[ \DK6?(G8*) MHT!WFH*ZQ]V'/^<[ME0H3#@.P<7:XA'J*[**D()./F<=_-W%&P/C[H:TGG+6 MSXZ[TQ34/^X(0KL#I;/7-J,'B9QN"A\T.25,@ H,G3:!KHYG1MYWXGI*,SP_ M]DY44@?HV\90V\:V-XMWTX^?-B_:A=E:$J,@U=4ZB@=!!XK,MZ^#CD+B3"?> M&&U[B1FWZZ9U@-!&YKV"9WO:N+'"L8A \3()*'D)T2D$CSI&D9V/IGF#S'YR MNDA4G*OP0V!T@O3'KAQY(1BW]/_NQ2R33MF6H=VK0+&ZB@0!>2#/%C]('+\![]3H<(.467\V$$VX&QND,1M#!(W;:S?8L\O9LN\ 2'=XV)XRC$8$*2.XXFH! M7W+@DE903+(\66N3:]V<]" AG3S G*_H!P>WGB/U#J"S>2)8/SCLW/T8"V:* M(B0+EH)-BBRB#A&$Y1Y)5#PV+[>_1\2XD&F@V BD,3HJFX]^VL/*>,VWP[[XG*:O+N#S F'- M--,!YMXNY@DQ+U^2'%\ME]>U]_9-J<6"'[;%@A.5T)%_6)W$0()3+-&O>(*( M0GMKG9.^=8O9TU3UE*UN@['&FN@,6W?JBBU:L]1!T8'6U$\FL&(3,!(4A M)1GF6B<7'R&GI_*5]F@Z1_:CCA1;Y\!^E,[M)JI/)-WE^JA4]]-D'F3R#(1) MJ2Z[J<_6*8,6TD;&,>:[B-J393SP@SV]:)R'F<'$W($-NA6)O@V+-XO-?;W> M*D.7]IJWB639"B429"_K)N]"L:D(#D1,3KN@E,36JZP.(*NG_&,;F]1:%QW M:^^IV?QR61^8%].$?!*XTMX'!71"2' 8B;%8- BIN)$D0UN&]=@?(:ZG7,(0 M#GLKO?0,N%K!L/PTO[H5BVP+J]>,?EA,/W[$Q00-0\Z% ,-E[>1R%GQT%"$K MC]DY\@@&GA=Q-,GCSOEZ5G .H,.+@.R'1KZ5>\Q2>?"":EE26# MB2:"BMK6JFX%NNB@!$>!X?F!N(?8PW*Z[.="90O%=8?06X6)U>3?2BRZ1)Y( M5A&8]8&$:1(XN@;JPJ3B@PTAIF&?GO:2=ACZ+OA)H8U2QJ[2.MCM>%/N>,E; MQX-.V*W_ZB6&U35%;,A#*4E3B)9Y'1R> @1M$9A7.6N&FHD[71S'YEW.HN\P M<%[$:T0O6NS":&X^NYE52E'=L M% 8CL/DNT0?(. PP%_$$T4K88_M8ZV3-F[6K^&OX\@7SK^'J:OEJ-EVMYVDO MIO_&]5T\06FJT21/,81Z#+@AZTF7;LDZ.F&4Y/G)T<]'??$PL%S$>\)PDNX: M/O1O-ARI&#P*JR&45/O-HP8O8UUD4L>A9YXT'O;2>=#G#@/.1;P.#"3CL5'S M-GQ;3^G_,'][O4B?PA)O,39)B46LU=Z:)4V>?984HB8#3,1H"I/&^'006A[] MS&$HN8@T?6.9=N#Q_BU,9\NZ2 &7;V:__[6B$/!ZNOST>1TEKN_8+%BQS@B0 M">M:!>-JANEB_8#_(O_']7*U M8637I3:)VBE77")?W^@ZRXG,J9()HDR6,R6+,ZVKGA\EZ+#"U(M*D[=30 =H M6E_-M=((\V_7-5&U:<[?5"!]SV;M,EO;4=J)_FA=?S0QSL=<0H(2N: [FP(% MES4#C=KSF(KVS9LSSJ/X,#Q>5.+\&578 6 ?;/I]<[U:KL*L/DA-M$S.&BTA M*DO\L!# :TD1B/4E>\Y9:3^G^ F:#@/=123$!U%#Y_NCWJ=/F*^O<%Y>X^I7 MXO@;,;CI=SESB]0!/[GE+JEC&1EVHQ1'9-F@ .X-P2\0\ER.#"(6Z9+P/ODA M9I$]ST8IH8O1^R4>H847=P M@3VP!X>GY)U(EH0A$BA3J\MDU,!U-BZ@LT4,NR.HSXU21RGVZ8U2QTBY.YS< MVH9C).94WXVCD)'X$!Q"RJ:&KTQX%F02PY8U=[Q1ZB@='[I1ZAB!CYV8/&3C M$28A-%,&DM,D)%T8."%*C5@]RSX$)P]+3U[N1JFC5'KL1JECY-N!H7EX"XY% MJYU;&]L 2AF*$KA!B"49*X-@+N3&1N8R-DJ=D.T;(;7:*<*,%P8!OK MJPLXG6L3D5>*%UU',@^,EQZNI/,U?-A&J6/$W0%H'EYQ%*)DS*<,1;-#D;I8[2\$$;I8X1=P>8V9>URC+&Y*2$DA*O$[(YN%@, M1..R-$+72=F#NK]_'#4/Z%FW!+6+F$Z3=W>PN369)FO-Z$ 1X:+0@6)DCX-. M"DPIT@H1F2ZMWULO:Q[048H^=![0,5+O #W_F(7/<[*<_X5YS=)V*,BV-F[" M?-"<4\1@LI)TDRL'WA8'A1ETDBN4OG7H_3A%/?G';9#44 /'X\EO\#3#C[5- M_L-0_L_K^2Q=+ZJ$)SQRC8RN8@I!*5;,H=KN$('N:NNDUBDVC[/V$M/3?=8& M3&WD?KI=FJ_"U3,^3]TKY6WT.+7GYP[S-'4($\,^3)%#'#%GA"03V1A!L//2 MDLO,?2HH! MA"$_A>1ZF3-0FB$)N/Y<"%-H(7F4-6J5@ D.A!]Z'T>_#U#%Z M/^1AZAA1=^#[/)!.CUB"-LZ 3W4T3"ED>YVP%(0ZJ9)B,HAAFW3Z?)@Z2K%/ M/TP=(^7N<'(KJ5X<9A., ![H.E5:"'"R:$A18LQ,*Y5;5]Y3Z4+K@AIY79=.EW0HD<(!DE?@PEBEM9:B]8R0RWB8.N=2.EO2':)EM\#, MZZPY-R"T1U!UC([G7(#P#IDE\VNQ=6W-Q3Q,':7APQZFCA%W!Z!Y^*5$*)FS M)!/)577_8Y#@K8H0O3&2#+-, ^RGN)2'J:,T?-##U#'B[@ S^Q)54@GM1"A@ MDR$V6$GD[ D%V6H>@ZW5T,/6977\,-4N8CI-WAW YH$^^]__2E?7>5.#75/> M:Q5-;+9))\D >:8#%FNHP+T'Z4-V+%*DP%N'48?2UI/3?"(0GIY^<+Y6.D#; M;=HW?8XUX56?Y-XN\//T^O/$J*@E$PFDK)NFJ\""(JX8:CJ:+&3.6P_4>)*H MGKSJ-OAJJX<>I[-,E+#HF*;KF]5UG$XZ\(9)<%DJ8PKSIOD J#LD]'3?#6*6 MCI)QQ\]5-ZVS?\=04^_K?O_7M8>LCI0\X[WJL!_X6KZ8Y3^F(4ZO MUFVK6\GG-[-WM96UMKW2'W@]GRUV__A+6$Z7];]?Z_@#*7 V_<]K7&X3!9#<#/N(Y9,U3N;[4?&0(=>'0WLOCEV\TO M__<4%T34IV]_X%>\VN1TB&J7C 7FD&X=48L!C43(0EMF*'9'/QBP'Z6L$XB. MCJ1]$&^GUI[ >ON&O,_?;EFW%=(H*R&Q5-\E&(?ZW &:<9*CB=;%UD501Q'8 M"70;(F0?")NKJRN MR]I'2R>PZLVM:Z*Z3B&X/:2*F:B2M."5T[7-64"T]N(T0F0,P0A9WX)Y\;%U M$OEIJOH#U2GZ?P)69RJC0WBMQPG_<;O?ZL,*S A6,!F\T MUAG5CAQ,;V/S_K^#"!OW GTFD)VOD@YQ]FZZ_/?+!>+MY?1;SC+CW+)B(& @ MV>7$Z 2A!^&TMR$&=+'U.(3#J1OWN>R9$-=(.1W [L%1BVOOPAKABF81+,4U ML-D'@VC >*D-"NZS;#Y 81\QXX*JVSB@C?)Z1>%N5D4RLHB@@&)I25ZN(G\A MV@2VL)1%BL[H]!PX["$4:*3P0V!T@O3'[@(A/^ K&>+=M.RM0>;995TK)9BU M=9N5XA!\2,"8DIEK;^3=D1[[]B4\].,[Q,,IFILW%6,'%F4@F_W'30%.8*)D M*QP$HPK)(R,=.(IJI-3"J1"R=ZV=L*%Y.@C+@^TKZ_:6[0I*'1RMG6$@/M?V M9GEK,O=Z)9S13EH?&3!9IW.OB_BSR9"4-61]LHFZ]=%XBJ9.'K^Z0-!\0'5V M#L^[<=S$.U>RXQF$#!:42Q)<(;>I.&,$V840'3XC5._2]U.^?PP/V[/4W &$ M[W0R/50!-PG")Q\D@Z G)JTIJL *P1CQTXCB?B[Z],=T8 MJN[!P]B;2.1.1:.U ,/J\VPB@4:6!4DU\.)BL4FWQNQY:?_AP3<*1@Y.]1^C ML%Z1MTU9"CJXL:@ Q@I?D]@%'%H-/F DKT@'9IJ/1KB\5/]1"C\BU7^,]#M- M]2M> BH##&TB]YE+B(Y;<"S9@HE'=7<[W\^1ZC]*

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�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ϓ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htm IDEA: XBRL DOCUMENT v3.22.4
Cover - USD ($)
$ in Billions
12 Months Ended
Dec. 31, 2022
Feb. 17, 2023
Jun. 30, 2022
Document Information [Line Items]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2022    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-38791    
Entity Registrant Name Luminar Technologies, Inc./DE    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 83-1804317    
Entity Address, Address Line One 2603 Discovery Drive    
Entity Address, Address Line Two Suite 100    
Entity Address, City or Town Orlando    
Entity Address, State or Province FL    
Entity Address, Postal Zip Code 32826    
City Area Code 407    
Local Phone Number 900-5259    
Title of 12(b) Security Class A common stock, par value of $0.0001 per share    
Trading Symbol LAZR    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Entity Shell Company false    
Entity Public Float     $ 1.5
Documents Incorporated by Reference DOCUMENTS INCORPORATED BY REFERENCEPart III incorporates by reference certain information from the registrant’s definitive proxy statement (the “Proxy Statement”) relating to its 2023 Annual Meeting of Stockholders. The Proxy Statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.    
Entity Central Index Key 0001758057    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Amendment Flag false    
Class A Common Stock      
Document Information [Line Items]      
Entity Common Stock, Shares Outstanding   272,176,538  
Class B Common Stock      
Document Information [Line Items]      
Entity Common Stock, Shares Outstanding   97,088,670